OBO_ID (LABEL):	CHEBI_27300 (vitamin D)

IGNORANCE CATEGORY:	probable_understanding

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC5030591	9/2016	S80-PMC5030591	["caption (table-wrap): table 4\n\nthemes and elements relating to specific Conception and Pregnancy information for women with rheumatoid arthritis and their familiessaying : information that should be discussed by health professionals doing : actions that SHOULD BE undertaken by health professionals review of current Medications in relation to safety during Conception and Pregnancy (100%) prior to Conception and Pregnancy, review current Medication(s) and discuss:\nmedications vary with respect to their SAFETY during Pregnancy and RISKS related to Fertility, Ovulation, Conception and Miscarriage\nSOME Medicines used in ra care MAY have EFFECTS on Fertility, Conception and Pregnancy process, for example, regular Nsaids MAY impair fertility and ASSOCIATED RISKS with fetus\nit is IMPORTANT to time Conceptionprovide GUIDANCE as to WHERE to obtain reliable information about SAFETY of Medicines in Pregnancywhere current Medication(s) is (are) contraindicated for Conception/Pregnancy the following SHOULD BE discussed with the patient:\nthere are SAFE Medication options pre, during (including Delivery) and Postpregnancy (including Breast feeding)\ntiming is IMPORTANT in RELATION to ceasing or switching of current Medications and allowing for washout periods prior to Conception\nthere is a need for close supervision/monitoring by a rheumatologist when discontinuing current Medications prior to Pregnancy, including CONSIDERING POTENTIAL NEED for disease stabilisation on new treatment prior to Conception and Pregnancydiscuss IMPACT of ra pathology on Pregnancy and Pregnancy on ra (100%) there are DIFFERENT SCENARIOS regarding ra disease activity during Pregnancy (eg, POSSIBLE remission/low disease activity)discuss: ra-related pain management options during Pregnancyconception MAY take longer compared with women who do not have rathere is a need to balance disease Control with maternal and fetal health and safetyra MAY AFFECT Pregnancy and Pregnancy MAY AFFECT ra, and there are POSSIBLE adverse outcomes where risks are identified (eg, Prematurity)there are significant risks ASSOCIATED with active or uncontrolled ra for the mother and baby, ESPECIALLY irreversible Joint damage and functional impairmentpregnancy MAY change a patient’s health outlook in the futurethe size of the baby MAY BE smaller than women without ra and MAY also be Delivered pre-term discuss IMPORTANT elements of Preconception care RELEVANT to patient (97.1%) it is IMPORTANT to achieve optimal disease control prior to considering Pregnancy—Planning Conception is preferable after patients achieve and maintain low disease activityencourage and facilitate early discussions with all health practitioners involved in care about family planning to allow for adequate preparationthere is a CRITICAL need for a planned Pregnancy RATHER than an unplanned Pregnancyreview Prenatal nutrition, including need for dietary/vitamin supplements (ie, Folic Acid, calcium, Vitamin D, Iodine, iron)history of previous Attempts To Conceive/Pregnancies or Pregnancy-related complications (eg, Miscarriage) and other relevant patient history (such as smoking/Illicit Drug use history, family history of hereditary issues) MAY AFFECT Pregnancyundertake RELEVANT health checks such as immunisation status (eg, rubella, varicella, pertussis), Sexually Transmitted disease screening, pap test, screening for other Autoimmune disorders that MAY IMPACT on Pregnancyweight management and appropriate exercise are very IMPORTANTCONSIDER the NEED for review of diabetes or impaired Glucose tolerance if RISK factors are present (eg, on Steroid medication or overweight/obese)it is IMPORTANT to manage comorbid conditions, such as diabetes and hypertensionsome women MAY NEED to avoid Conception during a flarera disease activity MAY or MAY not improve with Pregnancy and there is a LIKELIHOOD of Postpartum flares importance of maintaining optimistic outlook and providing positive messages (97.1%) Pregnancy and Breast feeding success rates are near normal in women with mild to moderate ra nowadays (where appropriate for the patient's clinical status)ra is not a BARRIER to Pregnancystrategies to address anxiety, stress and depression (if relevant) are IMPORTANT, such as mindfulness meditation need for close monitoring of a patient prior to and during Pregnancy, where indicated (94.1%) it is IMPORTANCE to have a healthcare team with expertise in Autoimmune disorders for SOME women with radetermine THE NEED for high-level obstetric care during a Pregnancy (where indicated), including the need for Anaesthetic inputsome women REQUIRE closer monitoring of their Pregnancy and this is USUALLY proportional to disease activity, comorbidities and maternal historyassess the REQUIREMENTS for any extra treatment or monitoring prior to, or during, Pregnancyit is IMPORTANT to develop a Pregnancy plan, which includes different options for management of ra and support for different scenariosvaginal Delivery MAY NOT always BE POSSIBLE, depending on condition of the patient's Hips."]	[('FUTURE_WORK', 254), ('IMPORTANT_CONSIDERATION', 506), ('IMPORTANT_CONSIDERATION', 534), ('INCOMPLETE_EVIDENCE', 600), ('INCOMPLETE_EVIDENCE', 631), ('SUPERFICIAL_RELATIONSHIP', 640), ('INCOMPLETE_EVIDENCE', 724), ('SUPERFICIAL_RELATIONSHIP', 749), ('IMPORTANT_CONSIDERATION', 760), ('IMPORTANT_CONSIDERATION', 783), ('FUTURE_WORK', 819), ('EXPLICIT_QUESTION', 834), ('IMPORTANT_CONSIDERATION', 877), ('FUTURE_WORK', 1001), ('IMPORTANT_CONSIDERATION', 1049), ('IMPORTANT_CONSIDERATION', 1161), ('SUPERFICIAL_RELATIONSHIP', 1174), ('FUTURE_WORK', 1421), ('IMPORTANT_CONSIDERATION', 1421), ('INCOMPLETE_EVIDENCE', 1433), ('SUPERFICIAL_RELATIONSHIP', 1532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1605), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('INCOMPLETE_EVIDENCE', 1677), ('INCOMPLETE_EVIDENCE', 1788), ('INCOMPLETE_EVIDENCE', 1929), ('SUPERFICIAL_RELATIONSHIP', 1933), ('INCOMPLETE_EVIDENCE', 1964), ('SUPERFICIAL_RELATIONSHIP', 1968), ('INCOMPLETE_EVIDENCE', 1993), ('SUPERFICIAL_RELATIONSHIP', 2091), ('IMPORTANT_CONSIDERATION', 2158), ('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2302), ('INCOMPLETE_EVIDENCE', 2343), ('IMPORTANT_CONSIDERATION', 2382), ('SUPERFICIAL_RELATIONSHIP', 2423), ('IMPORTANT_CONSIDERATION', 2457), ('IMPORTANT_CONSIDERATION', 2779), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2817), ('INCOMPLETE_EVIDENCE', 3196), ('SUPERFICIAL_RELATIONSHIP', 3200), ('IMPORTANT_CONSIDERATION', 3226), ('INCOMPLETE_EVIDENCE', 3410), ('SUPERFICIAL_RELATIONSHIP', 3414), ('IMPORTANT_CONSIDERATION', 3485), ('INCOMPLETE_EVIDENCE', 3507), ('SUPERFICIAL_RELATIONSHIP', 3568), ('IMPORTANT_CONSIDERATION', 3646), ('INCOMPLETE_EVIDENCE', 3731), ('FUTURE_WORK', 3735), ('IMPORTANT_CONSIDERATION', 3735), ('INCOMPLETE_EVIDENCE', 3794), ('INCOMPLETE_EVIDENCE', 3801), ('PROBABLE_UNDERSTANDING', 3847), ('DIFFICULT_TASK', 4131), ('IMPORTANT_CONSIDERATION', 4222), ('IMPORTANT_CONSIDERATION', 4364), ('INCOMPLETE_EVIDENCE', 4444), ('INCOMPLETE_EVIDENCE', 4472), ('IMPORTANT_CONSIDERATION', 4600), ('INCOMPLETE_EVIDENCE', 4657), ('IMPORTANT_CONSIDERATION', 4744), ('IMPORTANT_CONSIDERATION', 4831), ('INCOMPLETE_EVIDENCE', 4976), ('DIFFICULT_TASK', 4980)]	66	[('GO_0007631', 'feeding behavior', 72, 'conception ...'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_25441', 'mycothiols', 317, 'medications'), ('GO_0007620', 'copulation', 358, 'conception'), ('GO_0007565', 'female pregnancy', 373, 'pregnancy'), ('GO_0007620', 'copulation', 399, 'conception'), ('GO_0007565', 'female pregnancy', 414, 'pregnancy'), ('CHEBI_60211', 'compound Z', 440, 'medication'), ('GO_0007565', 'female pregnancy', 520, 'pregnancy'), ('GO_0009566', 'fertilization', 551, 'fertility'), ('GO_0030728', 'ovulation', 562, 'ovulation'), ('GO_0007620', 'copulation', 573, 'conception'), ('GO_0046660', 'female sex differentiation', 588, 'miscarriage'), ('CHEBI_25179', 'melanins', 605, 'medicines'), ('GO_0009566', 'fertilization', 651, 'fertility'), ('GO_0007620', 'copulation', 662, 'conception'), ('GO_0007565', 'female pregnancy', 677, 'pregnancy'), ('CHEBI_16039', 'ITP', 717, 'NSAIDs'), ('GO_0070268', 'cornification', 801, 'conceptionProvide'), ('CHEBI_25179', 'melanins', 887, 'medicines'), ('GO_0000712', 'resolution of meiotic recombination intermediates', 900, 'pregnancyWhere'), ('CHEBI_60211', 'compound Z', 923, 'medication'), ('GO_0007620', 'copulation', 966, 'conception'), ('GO_0007565', 'female pregnancy', 977, 'pregnancy'), ('CHEBI_60211', 'compound Z', 1054, 'medication'), ('GO_0007567', 'parturition', 1096, 'delivery'), ('GO_0007565', 'female pregnancy', 1110, 'postpregnancy'), ('UBERON_0000310', 'breast', 1135, 'breast'), ('CHEBI_25441', 'mycothiols', 1218, 'medications'), ('GO_0007620', 'copulation', 1272, 'conception'), ('CHEBI_25441', 'mycothiols', 1379, 'medications'), ('GO_0007565', 'female pregnancy', 1400, 'pregnancy'), ('GO_0007620', 'copulation', 1500, 'conception'), ('GO_0006915', 'apoptotic process', 1515, 'pregnancyDiscuss'), ('GO_0007565', 'female pregnancy', 1558, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1572, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1662, 'pregnancy'), ('GO_0007602', 'phototransduction', 1768, 'pregnancyConception'), ('GO_0065007', 'biological regulation', 1877, 'control'), ('GO_0007565', 'female pregnancy', 1940, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1954, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2051, 'prematurity'), ('UBERON_0004905', 'articulation', 2182, 'joint'), ('GO_0007567', 'parturition', 2355, 'delivered'), ('GO_0007565', 'female pregnancy', 2404, 'preconception'), ('GO_0007565', 'female pregnancy', 2523, 'pregnancy'), ('GO_0006260', 'DNA replication', 2533, 'planning'), ('GO_0007620', 'copulation', 2542, 'conception'), ('GO_0007565', 'female pregnancy', 2807, 'pregnancy'), ('GO_0006412', 'translation', 2842, 'pregnancyReview'), ('GO_0007565', 'female pregnancy', 2858, 'prenatal'), ('CHEBI_30751', 'formic acid', 2930, 'folic acid'), ('CHEBI_27300', 'vitamin D', 2951, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 2962, 'iodine'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 2995, 'attempts to conceive'), ('GO_0007565', 'female pregnancy', 3016, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3031, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3068, 'miscarriage'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 3133, 'illicit drug'), ('GO_0051610', 'serotonin uptake', 3207, 'pregnancyUndertake'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 3314, 'sexually transmitted'), ('UBERON_0001442', 'skeleton of manus', 3384, 'autoimmune'), ('GO_0006412', 'translation', 3424, 'pregnancyWeight'), ('CHEBI_17234', 'glucose', 3547, 'glucose'), ('CHEBI_35341', 'steroid', 3601, 'steroid'), ('GO_0007620', 'copulation', 3749, 'conception'), ('GO_0007565', 'female pregnancy', 3822, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3861, 'postpartum'), ('GO_0007565', 'female pregnancy', 3964, 'Pregnancy'), ('UBERON_0000310', 'breast', 3978, 'breast'), ('GO_0006915', 'apoptotic process', 4142, 'pregnancyStrategies'), ('GO_0007565', 'female pregnancy', 4323, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 4419, 'autoimmune'), ('GO_0007565', 'female pregnancy', 4520, 'pregnancy'), ('CHEBI_38867', 'anaesthetic', 4572, 'anaesthetic'), ('GO_0007565', 'female pregnancy', 4635, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4816, 'pregnancyIt'), ('GO_0007565', 'female pregnancy', 4854, 'pregnancy'), ('GO_0007567', 'parturition', 4967, 'delivery'), ('UBERON_0000988', 'pons', 5044, 'hips')]
PMC5706533	11/2017	S18-PMC5706533	['beyond its established INFLUENCE on bone growth and Calcium Homeostasis,1vitamin D and its RELATED Metabolites have HYPOTHESISED EFFECTS on the risk of Cardiovascular diseases,2cancer,3respiratory infections,4asthma,5conditions RELATED to Pregnancy (such as pre-eclampsia, Gestational diabetes), and Birth outcomes.6concern that Vitamin D deficiency is a global PUBLIC HEALTH PROBLEM HAS BEEN sparked by numerous REPORTS of the high proportion of Individuals in studies throughout the world who have relatively low Serum/Plasma concentrations of 25-hydroxyvitamin d (25(Oh)D),7the conventional circulating BIOMARKER of Vitamin D status.8there HAS BEEN particular ATTENTION to the high prevalence of vitamin d deficiency in Pregnant women and newborns.7\nin 2010, dietary reference intakes for Vitamin D for canada and the us from the institute of medicine were based solely on bone health—particularly in young children (for instance, rickets) and older Adults (for instance, osteoporosis).1considerable SKEPTICISM was cast onto the LINK between Vitamin D and Extraskeletal health conditions or the POTENTIAL benefits (versus risks) of intakes larger than the recommended dietary allowance (600 iu/day for MOST children and Adults).1THE institute’s report DID NOT RECOMMEND higher intakes during Pregnancy and Lactation.1a 2016 update of the cochrane collaboration systematic review and meta-analysis of trials of Vitamin D in Pregnancy (versus placebo or no Supplement), HOWEVER, TENTATIVELY CONCLUDED that Prenatal Vitamin D supplementation “MAY reduce the risk of pre-eclampsia, low birthweight and Preterm Birth.”6other RECENT systematic reviews that included trials with active control arms (in which participants received Vitamin D) ACKNOWLEDGED the POTENTIAL EFFECT of Vitamin D on fetal growth910but DID NOT FIND evidence of EFFECTS on OTHER maternal, fetal, or infant outcomes.91011citing the 2016 cochrane review,6the world health organization guidelines for Antenatal care ADVISE against routine Vitamin D supplementation in Pregnancy.12dietary and supplementation RECOMMENDATIONS, HOWEVER, vary widely across other professional organisations (appendix 1), and there REMAINS a LACK OF CONSENSUS on target health outcomes, indications for Prenatal supplementation, or EVIDENCE BASED regimens for supplement dose (or fortification STRATEGIES).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 129), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 362), ('IMPORTANT_CONSIDERATION', 376), ('PROBLEM_COMPLICATION', 376), ('INCOMPLETE_EVIDENCE', 384), ('INCOMPLETE_EVIDENCE', 413), ('SUPERFICIAL_RELATIONSHIP', 606), ('INCOMPLETE_EVIDENCE', 643), ('IMPORTANT_CONSIDERATION', 663), ('INCOMPLETE_EVIDENCE', 663), ('IMPORTANT_CONSIDERATION', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1098), ('PROBABLE_UNDERSTANDING', 1205), ('INCOMPLETE_EVIDENCE', 1231), ('INCOMPLETE_EVIDENCE', 1255), ('FUTURE_WORK', 1263), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1471), ('INCOMPLETE_EVIDENCE', 1480), ('INCOMPLETE_EVIDENCE', 1492), ('INCOMPLETE_EVIDENCE', 1543), ('INCOMPLETE_EVIDENCE', 1623), ('INCOMPLETE_EVIDENCE', 1738), ('PROBABLE_UNDERSTANDING', 1738), ('INCOMPLETE_EVIDENCE', 1755), ('SUPERFICIAL_RELATIONSHIP', 1765), ('INCOMPLETE_EVIDENCE', 1807), ('SUPERFICIAL_RELATIONSHIP', 1832), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1843), ('FUTURE_WORK', 1983), ('FUTURE_WORK', 2075), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2092), ('ANOMALY_CURIOUS_FINDING', 2092), ('INCOMPLETE_EVIDENCE', 2177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2187), ('INCOMPLETE_EVIDENCE', 2187), ('INCOMPLETE_EVIDENCE', 2277), ('FUTURE_WORK', 2339)]	42	[('GO_0055073', 'cadmium ion homeostasis', 52, 'calcium homeostasis'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 81, 'D'), ('CHEBI_25212', 'metabolite', 99, 'metabolites'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'gestational'), ('GO_0007567', 'parturition', 300, 'birth'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('NCBITaxon_1', 'root', 447, 'individuals'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('UBERON_0001969', 'blood plasma', 521, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 619, 'vitamin D'), ('GO_0007565', 'female pregnancy', 723, 'pregnant'), ('CHEBI_27300', 'vitamin D', 792, 'vitamin D'), ('UBERON_0007023', 'adult organism', 953, 'adults'), ('CHEBI_27300', 'vitamin D', 1045, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 1059, 'extraskeletal'), ('UBERON_0007023', 'adult organism', 1223, 'adults'), ('GO_0007565', 'female pregnancy', 1295, 'pregnancy'), ('GO_0007595', 'lactation', 1309, 'lactation'), ('CHEBI_27300', 'vitamin D', 1413, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1426, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 1458, 'supplement'), ('GO_0007565', 'female pregnancy', 1507, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1516, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1601, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 1727, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1775, 'vitamin D'), ('GO_0007567', 'parturition', 1968, 'antenatal'), ('CHEBI_27300', 'vitamin D', 2006, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2035, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2248, 'prenatal')]
BMJ_2010_Apr_29_340_c1640	4/2010	S18-BMJ_2010_Apr_29_340_c1640	['this EVIDENCE comes from both case-control and cohort studies and INDICATES that age of operation for such a PROTECTIVE EFFECT MIGHT include both childhood and early Adulthood.67891011\nexposure to ultraviolet radiation in early Life has NOT YET been formally examined but MIGHT be LINKED to excess risk of multiple sclerosis at Birth through seasonal deficiency in maternal Vitamin D concentrations.12A study of half siblings with multiple sclerosis has ALSO SHOWN that risk CAN be maternally MEDIATED.13pregnancy is a vulnerable time for Vitamin d deficiency BECAUSE of increased physiological needs and reduced maternal outdoor activity.14experimental data on Animal Fetal Development INDICATE that Cerebral White Matter is responsive to Vitamin D and that Oligodendrocytes in the Brain and Spinal Cord have Vitamin D Receptors.1516furthermore, maternal Vitamin D depletion alters Neurogenesis in the developing Rat Brain,17with subsequent altered Gene Expression in Adult Life.18a RECENT Genetic STUDY in Humans has FURTHER IMPLICATED Vitamin D as a strong environmental CANDIDATE by SHOWING direct functional INTERACTION with the major locus that determines susceptibility to multiple sclerosis.19ALTHOUGH Human EVIDENCE pertaining to fetal development HAS BEEN DIFFICULT to obtain, the body of RELATED EVIDENCE to date has led SOME to RECOMMEND Antenatal supplementation with Vitamin D to prevent multiple sclerosis.14\nAS an indicator of POSSIBLE Perinatal environmental exposures, such as ultraviolet radiation, individual studies in the northern hemisphere have examined month of Birth and risk of multiple sclerosis with VARIED results.2021222324a large RECENT pooled analysis of Births in the northern hemisphere, HOWEVER, SHOWED an excess of multiple sclerosis among People Born in may and a relative deficit among those Born in november; these results were stronger in familial cases and SUGGESTED INTERACTIONS between Genes and environment that are RELATED to climate and that MIGHT act during Gestation or shortly after Birth.12we EXAMINED month of Birth and risk of multiple sclerosis in australia.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 127), ('FULL_UNKNOWN', 237), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 281), ('INCOMPLETE_EVIDENCE', 399), ('INCOMPLETE_EVIDENCE', 454), ('INCOMPLETE_EVIDENCE', 475), ('SUPERFICIAL_RELATIONSHIP', 493), ('PROBABLE_UNDERSTANDING', 560), ('INCOMPLETE_EVIDENCE', 687), ('INCOMPLETE_EVIDENCE', 984), ('INCOMPLETE_EVIDENCE', 1019), ('SUPERFICIAL_RELATIONSHIP', 1027), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1087), ('SUPERFICIAL_RELATIONSHIP', 1113), ('ANOMALY_CURIOUS_FINDING', 1199), ('ANOMALY_CURIOUS_FINDING', 1199), ('INCOMPLETE_EVIDENCE', 1216), ('INCOMPLETE_EVIDENCE', 1257), ('DIFFICULT_TASK', 1266), ('INCOMPLETE_EVIDENCE', 1299), ('SUPERFICIAL_RELATIONSHIP', 1299), ('INCOMPLETE_EVIDENCE', 1332), ('FUTURE_WORK', 1340), ('PROBABLE_UNDERSTANDING', 1424), ('INCOMPLETE_EVIDENCE', 1443), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1629), ('INCOMPLETE_EVIDENCE', 1662), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1723), ('INCOMPLETE_EVIDENCE', 1732), ('INCOMPLETE_EVIDENCE', 1899), ('SUPERFICIAL_RELATIONSHIP', 1909), ('SUPERFICIAL_RELATIONSHIP', 1961), ('INCOMPLETE_EVIDENCE', 1989), ('QUESTION_ANSWERED_BY_THIS_WORK', 2044)]	40	[('UBERON_0000113', 'post-juvenile adult stage', 166, 'adulthood'), ('UBERON_0000104', 'life cycle', 228, 'life'), ('GO_0007567', 'parturition', 328, 'birth'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 539, 'vitamin'), ('NCBITaxon_33208', 'Metazoa', 662, 'animal'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 669, 'fetal development'), ('UBERON_0002437', 'cerebral hemisphere white matter', 701, 'cerebral white matter'), ('CHEBI_27300', 'vitamin D', 740, 'vitamin D'), ('CL_0000128', 'oligodendrocyte', 759, 'oligodendrocytes'), ('UBERON_0000955', 'brain', 783, 'brain'), ('UBERON_0002240', 'spinal cord', 793, 'spinal cord'), ('CHEBI_27300', 'vitamin D', 810, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 810, 'vitamin D receptors'), ('CHEBI_27300', 'vitamin D', 856, 'vitamin D'), ('GO_0022008', 'neurogenesis', 883, 'neurogenesis'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 914, 'rat'), ('UBERON_0000955', 'brain', 918, 'brain'), ('GO_0010467', 'gene expression', 950, 'gene expression'), ('SO_0000704', 'gene', 950, 'gene'), ('UBERON_0000113', 'post-juvenile adult stage', 969, 'adult life'), ('SO_0000704', 'gene', 991, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 1008, 'humans'), ('CHEBI_27300', 'vitamin D', 1038, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 1210, 'human'), ('GO_0007567', 'parturition', 1350, 'antenatal'), ('CHEBI_27300', 'vitamin D', 1381, 'vitamin D'), ('GO_0036268', 'swimming', 1452, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1452, 'perinatal'), ('GO_0007567', 'parturition', 1587, 'birth'), ('GO_0007567', 'parturition', 1688, 'births'), ('NCBITaxon_10088', 'Mus <genus>', 1777, 'people'), ('GO_0007567', 'parturition', 1784, 'born'), ('GO_0007567', 'parturition', 1831, 'born'), ('SO_0000704', 'gene', 1930, 'genes'), ('GO_0007565', 'female pregnancy', 2006, 'gestation'), ('GO_0007567', 'parturition', 2033, 'birth'), ('GO_0007567', 'parturition', 2062, 'birth')]
PMC4785305	3/2016	S25-PMC4785305	['the 2010 institute of medicine (iom) report on dietary reference intakes for Calcium and Vitamin D RECOMMENDED 600\u2005iu to Pregnant women as the recommended daily allowance (rda), the rda being the dose that is projected to allow at least 97.5% of the Pregnant women population to reach the DESIRABLE target 25(Oh)D level ≥50\u2005nmol/l.29this RECOMMENDATION was BASED ON OBSERVATIONAL studies, NONE of which were conducted in the middle east.29CONVERSELY, the Endocrine society 2011 GUIDELINES RECOMMENDED that 1500–2000\u2005iu daily of Vitamin D is NEEDED to reach a target 25(Oh)D level ≥75\u2005nmol/l (a RECOMMENDATION that was graded as weak with moderate quality of evidence).30the american college of obstetricians and gynecologists (acog) does not RECOMMEND screening for Vitamin D level in Pregnancy, and abides by the iom RECOMMENDATIONS.31moreover, the who 2012 guidelines on Vitamin D replacement during Pregnancy DID NOT RECOMMEND vitamin D supplementation as part of Prenatal care.32this was based ON a meta-analysis of Vitamin D trials during Pregnancy, which IDENTIFIED a LIMITED NUMBER of high-quality studies DEMONSTRATING a beneficial EFFECT of supplementation on maternal and neonatal outcomes, and CONCLUDED that FURTHER randomised controlled trials (rcts) ARE NEEDED.33in the uk, HOWEVER, Pregnant women are CONSIDERED AT RISK of Vitamin D deficiency, and supplementation with 400\u2005iu daily is REQUIRED.34\nit is NOT CLEAR WHETHER any of the above RECOMMENDED doses are applicable to non-western populations, with lower baseline Vitamin D levels, such as in lebanon and other middle eastern countries.']	[('FUTURE_WORK', 99), ('IMPORTANT_CONSIDERATION', 289), ('FUTURE_WORK', 338), ('INCOMPLETE_EVIDENCE', 357), ('INCOMPLETE_EVIDENCE', 366), ('INCOMPLETE_EVIDENCE', 389), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 437), ('PROBABLE_UNDERSTANDING', 478), ('FUTURE_WORK', 489), ('FUTURE_WORK', 541), ('IMPORTANT_CONSIDERATION', 541), ('FUTURE_WORK', 594), ('FUTURE_WORK', 742), ('FUTURE_WORK', 818), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 920), ('ANOMALY_CURIOUS_FINDING', 998), ('ANOMALY_CURIOUS_FINDING', 998), ('INCOMPLETE_EVIDENCE', 1061), ('INCOMPLETE_EVIDENCE', 1074), ('INCOMPLETE_EVIDENCE', 1113), ('SUPERFICIAL_RELATIONSHIP', 1140), ('INCOMPLETE_EVIDENCE', 1205), ('FUTURE_WORK', 1220), ('FUTURE_WORK', 1264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1288), ('IMPORTANT_CONSIDERATION', 1316), ('INCOMPLETE_EVIDENCE', 1316), ('IMPORTANT_CONSIDERATION', 1327), ('IMPORTANT_CONSIDERATION', 1401), ('FULL_UNKNOWN', 1419), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1429), ('FUTURE_WORK', 1454)]	33	[('CHEBI_31341', 'calcium dihydroxide', 77, 'Calcium'), ('CHEBI_28384', 'vitamin K', 89, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 89, 'Vitamin'), ('GO_0007565', 'female pregnancy', 121, 'pregnant'), ('GO_0007565', 'female pregnancy', 250, 'pregnant'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 309, 'OH)D'), ('PR_000013502', 'parvalbumin alpha', 311, ')D'), ('UBERON_0005063', 'left ventricular compact myocardium', 455, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 528, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 566, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 566, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 766, 'vitamin D'), ('GO_0007565', 'female pregnancy', 785, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin D'), ('GO_0007565', 'female pregnancy', 902, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 938, 'D'), ('GO_0007565', 'female pregnancy', 967, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1020, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1044, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1297, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1338, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1535, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S103-BMJ_2010_Apr_29_340_c1640	['overall, epidemiological studies SUPPORT a PROTECTIVE ROLE for Vitamin D in Autoimmune disease, PARTICULARLY in childhood and Adolescence, and Vitamin D supplementation in early Adulthood EFFECTIVELY reduces the risk of multiple sclerosis; THEREFORE, supplementation of adolescents and young Adults COULD BE effectively used for PREVENTION.6the FINDINGS HERE provide the FIRST population BASED evidence beyond month of Birth PATTERNS to INDICATE that Vitamin D supplementation for the PREVENTION of multiple sclerosis MIGHT also NEED to be CONSIDERED during in utero development.14they are CONSISTENT with a multi-hit causal cascade for multiple sclerosis, with PUTATIVE adverse environmental FACTORS, such as low Vitamin D concentrations, acting at more than one stage of Life.53\n\nwhat is already known on this topic\nin the northern hemisphere, there are more cases of multiple sclerosis in People Born in may and fewer in those Born in november\nmaternal exposure to ambient ultraviolet radiation in Pregnancy can be used as an instrumental variable for Vitamin D status during Pregnancy\nlow Vitamin D concentrations HAVE BEEN ASSOCIATED with a higher risk of multiple sclerosis\n\nwhat THIS STUDY adds\nin australia there is a reciprocal PATTERN of month of Birth and risk of multiple sclerosis, with a higher risk for those Born in november-december compared with may-june\nthis PATTERN was accounted FOR by maternal exposure to ambient ultraviolet radiation in the first trimester\nlow maternal exposure to Ultraviolet Radiation in the first trimester was inversely RELATED to risk of multiple sclerosis in the offspring after adjustment for either month of Birth or place of Birth\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 188), ('PROBABLE_UNDERSTANDING', 240), ('INCOMPLETE_EVIDENCE', 299), ('SUPERFICIAL_RELATIONSHIP', 329), ('INCOMPLETE_EVIDENCE', 345), ('QUESTION_ANSWERED_BY_THIS_WORK', 354), ('INCOMPLETE_EVIDENCE', 371), ('QUESTION_ANSWERED_BY_THIS_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 437), ('SUPERFICIAL_RELATIONSHIP', 485), ('INCOMPLETE_EVIDENCE', 518), ('FUTURE_WORK', 529), ('IMPORTANT_CONSIDERATION', 529), ('FUTURE_WORK', 540), ('IMPORTANT_CONSIDERATION', 540), ('INCOMPLETE_EVIDENCE', 590), ('SUPERFICIAL_RELATIONSHIP', 590), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 693), ('INCOMPLETE_EVIDENCE', 1118), ('SUPERFICIAL_RELATIONSHIP', 1128), ('QUESTION_ANSWERED_BY_THIS_WORK', 1186), ('SUPERFICIAL_RELATIONSHIP', 1237), ('SUPERFICIAL_RELATIONSHIP', 1378), ('QUESTION_ANSWERED_BY_THIS_WORK', 1400), ('SUPERFICIAL_RELATIONSHIP', 1565)]	31	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 76, 'autoimmune'), ('GO_0048848', 'neurohypophysis morphogenesis', 126, 'adolescence'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('UBERON_0007023', 'adult organism', 292, 'adults'), ('GO_0007567', 'parturition', 419, 'birth'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 714, 'vitamin D'), ('UBERON_0000104', 'life cycle', 773, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 892, 'people'), ('GO_0007567', 'parturition', 899, 'born'), ('GO_0007567', 'parturition', 930, 'born'), ('GO_0007565', 'female pregnancy', 1001, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1079, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007567', 'parturition', 1257, 'birth'), ('GO_0007567', 'parturition', 1324, 'born'), ('CHEBI_52927', 'To-Pro-1(2+)', 1506, 'ultraviolet radiation'), ('GO_0007567', 'parturition', 1657, 'birth'), ('GO_0007567', 'parturition', 1675, 'birth')]
PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]
PMC3075531	7/2010	S58-PMC3075531	['THEREFORE, Genetic variations in Vitamin-D-related Genes MIGHT also AFFECT ms risk, EITHER directly OR by modifying the EFFECTS of Vitamin D.40\nour IMPLICATIONS for FUTURE RESEARCH and ms prevention and ACCORDING TO the basis of the results of the ONLY longitudinal study of Serum 25-Hydroxyvitamin D and ms onset,18and ASSUM-ING that these results are unbiased and Vitamin D is TRULY PROTECTIVE against ms, over 70% of ms cases in the usa and europe COULD BE PREVENTED by increasing the Serum 25-Hydroxyvitamin D concentration of adolescents and young Adults to above 100 nmol/l.4142these concentrations are commonly FOUND ONLY in Individuals with outdoor lifestyles in sunny regions, BUT COULD BE reached in MOST People by taking 1000-4000 iu Colecalciferol daily.8254344ALTHOUGH these doses are LARGELY CONSIDERED SAFE and POTENTIALLY beneficial for other outcomes,819CONFIRMATION of SAFETY and efficacy in a LARGE randomized TRIAL is NEEDED before making general RECOMMENDATIONS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 84), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 148), ('FUTURE_WORK', 165), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 320), ('PROBABLE_UNDERSTANDING', 379), ('SUPERFICIAL_RELATIONSHIP', 385), ('INCOMPLETE_EVIDENCE', 451), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 618), ('ANOMALY_CURIOUS_FINDING', 624), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 686), ('INCOMPLETE_EVIDENCE', 690), ('PROBABLE_UNDERSTANDING', 710), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 773), ('INCOMPLETE_EVIDENCE', 798), ('INCOMPLETE_EVIDENCE', 806), ('IMPORTANT_CONSIDERATION', 817), ('INCOMPLETE_EVIDENCE', 826), ('INCOMPLETE_EVIDENCE', 871), ('IMPORTANT_CONSIDERATION', 887), ('INCOMPLETE_EVIDENCE', 912), ('FUTURE_WORK', 938), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 11, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 33, 'vitamin-D'), ('SO_0000704', 'gene', 51, 'genes'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0001977', 'blood serum', 275, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 281, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 366, 'vitamin D'), ('UBERON_0001977', 'blood serum', 488, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 494, '25-hydroxyvitamin D'), ('UBERON_0007023', 'adult organism', 553, 'adults'), ('NCBITaxon_1', 'root', 632, 'individuals'), ('NCBITaxon_10088', 'Mus <genus>', 715, 'people'), ('CHEBI_50553', 'mancude carbobicyclic parent', 745, 'colecalciferol')]
PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
PMC4998950	4/2016	S10-PMC4998950	['environmental and Genetic FACTORS APPEAR equally IMPORTANT,1ALTHOUGH asd with and without intellectual disability MAY IN PART have DIFFERENT origins.2,3\nin high-latitude countries such as sweden, children of mothers with dark complexion are at PARTICULARLY elevated RISK of asd with intellectual disability.3because such women OFTEN have very low Vitamin d levels due to Melanin absorption of uvb radiation, maternal Vitamin D deficiency HAS BEEN SUGGESTED to CONTRIBUTE to asd risk in offspring.4,5indeed, experimentally induced Vitamin D deficiency in Pregnant dams is REPORTED to AFFECT foetal Neurodevelopment and behaviour in Adult offspring in Rats,4AND a RECENT STUDY DEMONSTRATED lower neonatal Vitamin D levels in children with asd compared with their siblings.6\nearly Life Vitamin D deficiency is THUS a POSSIBLE RISK FACTOR for asd, BUT direct SUPPORT of an ASSOCIATION IS LACKING.4maternal hypovitaminosis d is treatable, THUS INVESTIGATION of the matter IS WARRANTED.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 49), ('ANOMALY_CURIOUS_FINDING', 59), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('ANOMALY_CURIOUS_FINDING', 244), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 266), ('PROBABLE_UNDERSTANDING', 327), ('INCOMPLETE_EVIDENCE', 438), ('SUPERFICIAL_RELATIONSHIP', 460), ('INCOMPLETE_EVIDENCE', 571), ('SUPERFICIAL_RELATIONSHIP', 583), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 655), ('INCOMPLETE_EVIDENCE', 662), ('INCOMPLETE_EVIDENCE', 675), ('PROBABLE_UNDERSTANDING', 807), ('INCOMPLETE_EVIDENCE', 814), ('SUPERFICIAL_RELATIONSHIP', 823), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 844), ('INCOMPLETE_EVIDENCE', 855), ('SUPERFICIAL_RELATIONSHIP', 869), ('INCOMPLETE_EVIDENCE', 881), ('FULL_UNKNOWN', 884), ('PROBABLE_UNDERSTANDING', 934), ('FUTURE_WORK', 939), ('FUTURE_WORK', 967)]	29	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 347, 'vitamin'), ('CHEBI_25179', 'melanins', 371, 'melanin'), ('CHEBI_27300', 'vitamin D', 417, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 530, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnant'), ('GO_0007399', 'nervous system development', 597, 'neurodevelopment'), ('UBERON_0007023', 'adult organism', 631, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 650, 'rats'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin D'), ('UBERON_0000104', 'life cycle', 778, 'life'), ('CHEBI_27300', 'vitamin D', 783, 'vitamin D')]
PMC3432839	8/2012	S24-PMC3432839	['HOWEVER, they MAY BE an INDICATOR of increased risk of arthritis in Adulthood, SINCE it HAS BEEN SHOWN that children with Limb pains are more LIKELY to have parents and/or grandparents with a history of arthritis COMPARED TO the general population.1among SMALL STUDIES of selected groups of children, recurrent Limb pains HAVE BEEN REPORTED to be PARTICULARLY PREVALENT in obese children,4and in those with some Vitamin D deficiency,5THOUGH this WAS NOT FOUND in a SMALL STUDY in new mexico.6other POSSIBILITIES HAVE BEEN summarised by evans and scutter.7\nAdult arthritis HAS long BEEN CONSIDERED to be a condition that COULD BE ameliorated or prevented by dietary manipulation, with SUGGESTIONS of different components of the diet being IMPORTANT—particularly Ω-3 Fatty Acids.8TO OUR KNOWLEDGE the ONLY specific dietary factor that has BEEN CONSIDERED in regard to childhood Limb pain concerns a study of 532 greek children aged 4–12.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 79), ('INCOMPLETE_EVIDENCE', 88), ('PROBABLE_UNDERSTANDING', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('INCOMPLETE_EVIDENCE', 255), ('INCOMPLETE_EVIDENCE', 322), ('INCOMPLETE_EVIDENCE', 332), ('ANOMALY_CURIOUS_FINDING', 347), ('IMPORTANT_CONSIDERATION', 360), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 433), ('INCOMPLETE_EVIDENCE', 446), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 454), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 512), ('INCOMPLETE_EVIDENCE', 572), ('INCOMPLETE_EVIDENCE', 586), ('INCOMPLETE_EVIDENCE', 620), ('INCOMPLETE_EVIDENCE', 684), ('IMPORTANT_CONSIDERATION', 738), ('PROBABLE_UNDERSTANDING', 777), ('INCOMPLETE_EVIDENCE', 799), ('ANOMALY_CURIOUS_FINDING', 837), ('INCOMPLETE_EVIDENCE', 842)]	27	[('UBERON_0000113', 'post-juvenile adult stage', 68, 'adulthood'), ('UBERON_0002101', 'limb', 122, 'limb'), ('UBERON_0002101', 'limb', 311, 'limb'), ('CHEBI_27300', 'vitamin D', 412, 'vitamin D'), ('UBERON_0007023', 'adult organism', 556, 'Adult'), ('CHEBI_18320', '1,4-dithiothreitol', 761, 'ω-3'), ('CHEBI_35366', 'fatty acid', 765, 'fatty acids'), ('UBERON_0002101', 'limb', 876, 'limb')]
PMC3427192	4/2012	S19-PMC3427192	['Biosynthesis Of Vitamin D.\n\nVitamin D THRESHOLDS\nSerum concentrations of 25(Oh)D are CONSIDERED to be a BIOMARKER and INDICATOR of Vitamin D status.44,45ALTHOUGH Vitamin D insufficiency HAS TRADITIONALLY BEEN defined as a Serum 25(Oh)D concentration of 20 to 29 ng/ml,46a panel of experts from the institute of medicine RECENTLY SUGGESTED that Vitamin D INSUFFICIENCY be redefined AS a Serum 25(Oh)D concentration less than 20 ng/ml.47this RECOMMENDATION was based ON INCONCLUSIVE evidence for the threshold of 29 ng/ml and EVIDENCE for adverse Skeletal EFFECTS at thresholds less than 20 ng/ml.47HOWEVER, this revised definition of Vitamin D insufficiency has generated significant CONTROVERSY48,49AND THUS there is presently NO universally ACCEPTED definition for “optimal” 25(Oh)d concentrations INDEPENDENT of Musculoskeletal health.']	[('PROBABLE_UNDERSTANDING', 38), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 118), ('ANOMALY_CURIOUS_FINDING', 151), ('IMPORTANT_CONSIDERATION', 186), ('INCOMPLETE_EVIDENCE', 190), ('PROBABLE_UNDERSTANDING', 190), ('INCOMPLETE_EVIDENCE', 320), ('INCOMPLETE_EVIDENCE', 329), ('IMPORTANT_CONSIDERATION', 354), ('PROBABLE_UNDERSTANDING', 381), ('FUTURE_WORK', 440), ('ANOMALY_CURIOUS_FINDING', 465), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 468), ('INCOMPLETE_EVIDENCE', 524), ('SUPERFICIAL_RELATIONSHIP', 554), ('ANOMALY_CURIOUS_FINDING', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 683), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 697), ('PROBABLE_UNDERSTANDING', 703), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 742), ('INCOMPLETE_EVIDENCE', 742), ('SUPERFICIAL_RELATIONSHIP', 799)]	25	[('GO_0033593', 'BRCA2-MAGE-D1 complex', 0, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 28, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 49, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 228, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D'), ('UBERON_0001977', 'blood serum', 386, 'serum'), ('CHEBI_71657', 'versiconol acetate', 392, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 392, '25(OH)D'), ('UBERON_0004288', 'skeleton', 545, 'skeletal'), ('CHEBI_27300', 'vitamin D', 633, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 776, '25(OH)'), ('UBERON_0002204', 'musculoskeletal system', 814, 'musculoskeletal')]
PMC4764019	1/2016	S7-PMC4764019	['the barker HYPOTHESIS HAS BEEN ELABORATED and evaluated in several reviews,2–4BUT TO THE BEST OF MY KNOWLEDGE, there HAS BEEN NO ATTEMPT to evaluate the HYPOTHESIS specifically for Vitamin D. THUS, what i PROPOSE TO explore in THIS very brief REVIEW is the EVIDENCE RELATING UNRECOGNIZED, Perinatal Vitamin D inadequacy to increased risk of certain chronic diseases later in Life, that is, to ascertain WHETHER any such EFFECTS MIGHT be an instance of the “barker HYPOTHESIS.”\ni deliberately avoid use of labels such as “deficient” or “insufficient” in characterizing Vitamin D status, AS these terms are OFTEN LINKED to specific values for serum 25-Hydroxyvitamin D [25(Oh)D], about which there is considerable CONTROVERSY.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 153), ('PROBABLE_UNDERSTANDING', 192), ('INCOMPLETE_EVIDENCE', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 243), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 266), ('INCOMPLETE_EVIDENCE', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('SUPERFICIAL_RELATIONSHIP', 420), ('INCOMPLETE_EVIDENCE', 428), ('INCOMPLETE_EVIDENCE', 464), ('PROBABLE_UNDERSTANDING', 586), ('PROBABLE_UNDERSTANDING', 605), ('SUPERFICIAL_RELATIONSHIP', 611), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 712)]	25	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('GO_0036268', 'swimming', 289, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 289, 'perinatal'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('UBERON_0000104', 'life cycle', 375, 'life'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 647, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 668, '25(OH)D')]
PMC3717170	5/2013	S141-PMC3717170	['the results from SMALL clinical trials and post hoc analyses of larger trials on the EFFECT of Vitamin D supplementation on diabetes-related parameters HAVE BEEN INCONCLUSIVE, although Vitamin D APPEARS to have beneficial EFFECTS in Persons AT RISK for diabetes.36–39HOWEVER, no firm conclusions can be drawn from the available intervention studies BECAUSE of several LIMITATIONS: (1) NEARLY ALL studies were UNDERPOWERED; (2) the MINORITY of studies were designed specifically for Glycemic outcomes; (3) MOST STUDIES DID NOT REPORT use of diabetes medications at baseline or during the study; (4) SOME TRIALS used large infrequent doses of Vitamin D, which MAY BE Metabolized DIFFERENTLY compared to daily doses and MAY provide EITHER no benefit OR result in an UNFAVORABLE benefit/risk ratio.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 85), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('ANOMALY_CURIOUS_FINDING', 195), ('SUPERFICIAL_RELATIONSHIP', 222), ('IMPORTANT_CONSIDERATION', 241), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 265), ('PROBLEM_COMPLICATION', 349), ('INCOMPLETE_EVIDENCE', 368), ('PROBLEM_COMPLICATION', 368), ('PROBABLE_UNDERSTANDING', 385), ('PROBLEM_COMPLICATION', 409), ('INCOMPLETE_EVIDENCE', 431), ('INCOMPLETE_EVIDENCE', 505), ('INCOMPLETE_EVIDENCE', 518), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 658), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 677), ('INCOMPLETE_EVIDENCE', 717), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 729), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 747), ('IMPORTANT_CONSIDERATION', 763)]	23	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'persons'), ('GO_0006096', 'glycolytic process', 482, 'glycemic'), ('CHEBI_27300', 'vitamin D', 641, 'vitamin D'), ('GO_0008152', 'metabolic process', 665, 'metabolized')]
PMC4910734	6/2015	S135-PMC4910734	['MANY of the Micronutrients STUDIES HAVE BEEN BASED ON Plasma and Urinary clinical results, which SUGGEST the elevation of Lipid Peroxide-generated Aldehydes (Hne, mda)84–86as well as deficiencies in antioxidants, such as Vitamin E, Sulfur-containing Compounds, such as cysteine, methionine, and Gsh,119carnitine,120biotin,121and ( n -3) pufas.122given the depressed levels of Sulfur-containing Compounds in asd Individuals, it is NOT SURPRISING that these children are more sensitive than neurotypicals to the exposure of mercury and other heavy metals.78the antioxidant supplements, which SHOW symptom improvements include, but are not limited to Ubiquinol,123nac,124carnosine, and Vitamin C.125other Micronutrients, including b1,126B6-Mg2+,127Folate, Vitamin E, Retinol, and Zn2+, HAVE BEEN selected for a variety of reasons RELATING to the INVOLVEMENT in abnormal Metabolic pathways IMPLICATED in asd,1even THOUGH the clinical assays do not always show a deficiency in asd Individuals compared to neurotypical controls.119with all of the single Micronutrient STUDIES, there are CONFLICTING results regarding efficacy.119there are a FEW STUDIES, which utilize broad-spectrum Micronutrient supplementation and report improvements in clinical BIOMARKERS and/or various autism-rating scales.76,121,128the broad-spectrum Micronutrient STUDIES are very PROMISING BECAUSE all DEMONSTRATE a significant CORRELATION between nutritional deficiencies and severity of autistic symptoms.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 430), ('ANOMALY_CURIOUS_FINDING', 434), ('INCOMPLETE_EVIDENCE', 590), ('INCOMPLETE_EVIDENCE', 783), ('SUPERFICIAL_RELATIONSHIP', 827), ('SUPERFICIAL_RELATIONSHIP', 843), ('SUPERFICIAL_RELATIONSHIP', 886), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 910), ('ANOMALY_CURIOUS_FINDING', 910), ('INCOMPLETE_EVIDENCE', 1062), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('INCOMPLETE_EVIDENCE', 1135), ('SUPERFICIAL_RELATIONSHIP', 1243), ('INCOMPLETE_EVIDENCE', 1333), ('PROBABLE_UNDERSTANDING', 1350), ('PROBABLE_UNDERSTANDING', 1360), ('INCOMPLETE_EVIDENCE', 1372), ('SUPERFICIAL_RELATIONSHIP', 1398)]	23	[('CHEBI_33839', 'macromolecule', 12, 'micronutrients'), ('UBERON_0001969', 'blood plasma', 54, 'plasma'), ('UBERON_0001088', 'urine', 65, 'urinary'), ('CHEBI_48107', 'nitric acid', 122, 'lipid peroxide'), ('CHEBI_17478', 'aldehyde', 147, 'aldehydes'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 158, 'HNE'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin E'), ('CHEBI_36933', 'oxygen-19 atom', 232, 'sulfur'), ('CHEBI_36357', 'polyatomic entity', 250, 'compounds'), ('CHEBI_16856', 'glutathione', 295, 'GSH'), ('CHEBI_36933', 'oxygen-19 atom', 376, 'sulfur'), ('CHEBI_36357', 'polyatomic entity', 394, 'compounds'), ('NCBITaxon_1', 'root', 411, 'individuals'), ('CHEBI_17976', 'ubiquinol', 648, 'ubiquinol'), ('CHEBI_27300', 'vitamin D', 683, 'vitamin C'), ('CHEBI_33839', 'macromolecule', 702, 'micronutrients'), ('CHEBI_73173', '2,4-DB', 731, '126B6'), ('CHEBI_6636', 'magnesium dichloride', 737, 'Mg2+,'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 742, '127folate'), ('CHEBI_27300', 'vitamin D', 753, 'vitamin E'), ('CHEBI_26536', 'retinoic acid', 764, 'retinol'), ('CHEBI_29105', 'zinc(2+)', 777, 'Zn2+,'), ('GO_0008152', 'metabolic process', 867, 'metabolic'), ('NCBITaxon_1', 'root', 976, 'individuals'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1048, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1177, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 1319, 'micronutrient')]
PMC5051327	9/2016	S17-PMC5051327	['introduction\nVitamin D is NECESSARY for optimal Skeletal function and deficiency is RELATED to rachitis.1\nit is, HOWEVER, IMPORTANT for bone Metabolism, as well as for optimal function of Striated and Smooth Muscle strength including Heart Muscle, and is RELATED to Postnatal muscle strength.2vitamin D supplementation has a positive IMPACT on muscle strength on Individuals with Vitamin D deficiency.134THE institute of medicine (iom), usa RECOMMENDS daily nutritional intake of Vitamin D of 600\u2005u, BUT OTHERS RECOMMEND higher doses.56a RECENT swedish STUDY SHOWED that the mean nutritional intake of Vitamin D was <200\u2005u/day.7ALTHOUGH Vitamin D is found in low amounts in the diet, mainly in oily fish and egg, the primary source of Vitamin D for Humans is skin conversion to Vitamin D from solar ultraviolet radiation.1pregnant women residing at high latitudes are AT RISK of Vitamin D deficiency BECAUSE of low solar intensity, especially during the winter months.18vitamin D deficiency is common in the nordic countries, ESPECIALLY among those not exposing themselves to the sun.8since fetal Vitamin D levels are directly RELATED to that of their mothers there is also a high LIKELIHOOD of fetal Vitamin D deficiency in our population.9\nBirth asphyxia is ASSOCIATED with Cardiovascular dysfunction, including low Ventricular output, lower left Ventricular Ejection fraction and increased troponin levels.1011congestive Heart failure MAY occur in severe cases of asphyxia.12intrauterine fetal distress is RELATED to an increase in Blood pressure, redistribution and a change in fetal Heart rate pattern.']	[('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('IMPORTANT_CONSIDERATION', 122), ('SUPERFICIAL_RELATIONSHIP', 255), ('SUPERFICIAL_RELATIONSHIP', 334), ('INCOMPLETE_EVIDENCE', 401), ('FUTURE_WORK', 441), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 500), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504), ('FUTURE_WORK', 511), ('INCOMPLETE_EVIDENCE', 538), ('INCOMPLETE_EVIDENCE', 559), ('ANOMALY_CURIOUS_FINDING', 627), ('IMPORTANT_CONSIDERATION', 868), ('PROBABLE_UNDERSTANDING', 900), ('ANOMALY_CURIOUS_FINDING', 1026), ('SUPERFICIAL_RELATIONSHIP', 1127), ('PROBABLE_UNDERSTANDING', 1181), ('SUPERFICIAL_RELATIONSHIP', 1260), ('INCOMPLETE_EVIDENCE', 1438), ('SUPERFICIAL_RELATIONSHIP', 1509)]	22	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0004288', 'skeleton', 48, 'skeletal'), ('GO_0008152', 'metabolic process', 141, 'metabolism'), ('UBERON_0002435', 'striatum', 188, 'striated'), ('UBERON_0001135', 'smooth muscle tissue', 201, 'smooth muscle'), ('UBERON_0001133', 'cardiac muscle tissue', 234, 'heart muscle'), ('GO_0007567', 'parturition', 266, 'postnatal'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 301, 'D'), ('NCBITaxon_1', 'root', 363, 'individuals'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 480, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 637, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 735, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 749, 'humans'), ('CHEBI_27300', 'vitamin D', 778, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 879, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 978, 'D'), ('CHEBI_27300', 'vitamin D', 1097, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1201, 'vitamin D'), ('GO_0007567', 'parturition', 1242, 'Birth'), ('UBERON_0004535', 'cardiovascular system', 1276, 'cardiovascular'), ('UBERON_0002082', 'cardiac ventricle', 1318, 'ventricular'), ('UBERON_0002082', 'cardiac ventricle', 1349, 'ventricular'), ('UBERON_0000970', 'eye', 1361, 'ejection'), ('UBERON_0000948', 'heart', 1424, 'heart'), ('UBERON_0000178', 'blood', 1535, 'blood'), ('UBERON_0000948', 'heart', 1588, 'heart')]
PMC3348565	4/2012	S121-PMC3348565	['ALTHOUGH this is PROBABLY TRUE, a sufficient Serum concentrations for the immunological EFFECTS of Vitamin D is UNKNOWN and COULD BE higher or lower than that of the Skeletal system accepted concentrations.6THE NEED for a steady state is currently highly SPECULATIVE and RELATES to Vitamin D2Supplementation for negative cancer22and bone outcomes.23\nour findings are AT ODDS with SMALLER case-control hospital STUDIES that show an enhanced rate of Vitamin D deficiency or rickets in children with pneumonia and the INCREASING EVIDENCE SUGGESTING that Calcitriol, the biologically active Metabolite of Vitamin D, has an IMPORTANT ROLE in the Human Immune System.4a systematic review of the ROLE of Vitamin D supplementation in infectious diseases had MIXED findings, CONCLUDING that more rigorously designed clinical trials ARE NEEDED (panel).25NO STUDIES report the EFFECT of Vitamin D on radiologically confirmed pneumonias.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 17), ('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 88), ('FULL_UNKNOWN', 112), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('INCOMPLETE_EVIDENCE', 380), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 619), ('SUPERFICIAL_RELATIONSHIP', 629), ('SUPERFICIAL_RELATIONSHIP', 689), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 750), ('PROBABLE_UNDERSTANDING', 766), ('FUTURE_WORK', 823), ('INCOMPLETE_EVIDENCE', 844), ('SUPERFICIAL_RELATIONSHIP', 866)]	21	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0004288', 'skeleton', 166, 'skeletal'), ('CHEBI_52910', 'delta-lactam ring', 282, 'vitamin D2supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 282, 'vitamin D2supplementation'), ('CHEBI_27300', 'vitamin D', 448, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 551, 'calcitriol'), ('CHEBI_39382', 'flufenoxuron', 587, 'metabolite'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 641, 'human'), ('UBERON_0002405', 'immune system', 647, 'immune system'), ('CHEBI_27300', 'vitamin D', 697, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 876, 'vitamin D')]
PMC3702245	6/2013	S93-PMC3702245	['another RECENT STUDY from the united arab emirates among Pregnant arab women with a high prevalence of Vitamin D deficiency also CONFIRMED that 4000 iu/day of Vitamin D supplementation was SAFE and more EFFECTIVE than 2000 iu/day and 400 iu/day in optimizing Vitamin D status during Pregnancy and in achieving Vitamin D sufficiency at Birth in mothers and offspring.106in the united arab emirates study, the increment from baseline to Delivery was about four-fold higher than expected BASED ON previous pharmacokinetic STUDIES, POSSIBLY RELATED to low baseline Vitamin D status.100this INDICATES that baseline Vitamin D status SHOULD BE taken INTO CONSIDERATION when evaluating Vitamin D supplementation.100,107\nthe FINDINGS of these RECENT intervention STUDIES INDICATE an URGENT NEED for more randomized controlled trials in diverse geographic locations with large sample sizes to identify the Vitamin D intake REQUIRED to optimize Vitamin D status, and TO ASSESS the EFFECT on Pregnancy-related and infant-related COMPLICATIONS.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 189), ('SUPERFICIAL_RELATIONSHIP', 203), ('PROBABLE_UNDERSTANDING', 485), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 528), ('SUPERFICIAL_RELATIONSHIP', 537), ('INCOMPLETE_EVIDENCE', 586), ('FUTURE_WORK', 627), ('IMPORTANT_CONSIDERATION', 643), ('FUTURE_WORK', 648), ('INCOMPLETE_EVIDENCE', 716), ('INCOMPLETE_EVIDENCE', 734), ('INCOMPLETE_EVIDENCE', 762), ('IMPORTANT_CONSIDERATION', 774), ('FUTURE_WORK', 781), ('IMPORTANT_CONSIDERATION', 913), ('QUESTION_ANSWERED_BY_THIS_WORK', 956), ('SUPERFICIAL_RELATIONSHIP', 970), ('PROBLEM_COMPLICATION', 1017)]	21	[('GO_0007565', 'female pregnancy', 57, 'pregnant'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('GO_0007565', 'female pregnancy', 283, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D'), ('GO_0007567', 'parturition', 335, 'birth'), ('GO_0007567', 'parturition', 435, 'delivery'), ('CHEBI_27300', 'vitamin D', 561, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 610, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 896, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 934, 'vitamin D'), ('GO_0007565', 'female pregnancy', 980, 'pregnancy')]
PMC3798907	8/2013	S21-PMC3798907	['these considerations RAISE the POSSIBILITY that the OBSERVED epidemiological ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc responses MAY NOT be a direct ASSOCIATION BUT MERELY a consequence of CONFOUNDING by other Nutrients ASSOCIATED with Vitamin E.\nTO INVESTIGATE these ISSUES further, and to inform any intervention trial, we CONDUCTED an ex vivo study to test WHETHER the OBSERVED epidemiological ASSOCIATION between reduced maternal Vitamin E intake during Pregnancy and increased cbmc responses COULD BE EXPLAINED by a direct causal EFFECT.']	[('EXPLICIT_QUESTION', 21), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 159), ('ANOMALY_CURIOUS_FINDING', 163), ('SUPERFICIAL_RELATIONSHIP', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('ANOMALY_CURIOUS_FINDING', 195), ('ANOMALY_CURIOUS_FINDING', 195), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 250), ('QUESTION_ANSWERED_BY_THIS_WORK', 277), ('PROBLEM_COMPLICATION', 298), ('QUESTION_ANSWERED_BY_THIS_WORK', 355), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 390), ('INCOMPLETE_EVIDENCE', 402), ('SUPERFICIAL_RELATIONSHIP', 427), ('INCOMPLETE_EVIDENCE', 527), ('PROBABLE_UNDERSTANDING', 536), ('SUPERFICIAL_RELATIONSHIP', 565)]	21	[('CHEBI_27300', 'vitamin D', 106, 'vitamin E'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_33284', 'nutrient', 240, 'nutrients'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin E'), ('GO_0007565', 'female pregnancy', 488, 'pregnancy')]
PMC4380518	9/2014	S7-PMC4380518	['introduction\nPerinatal health outcomes VARY dramatically by race in the united states.1african american women develop Preeclampsia more OFTEN than their white counterparts2and are more LIKELY to develop preterm labor.3the result is that black infants are 60% more LIKELY BE preterm and four times more LIKELY to die due to prematurity than white infants.1BECAUSE of less efficient Vitamin D Synthesis in the skin of darker Pigmented Individuals, african americans are at higher RISK than white americans of Vitamin D deficiency.4,5black women are also more LIKELY than white women to be overweight or obese6which is of CONCERN BECAUSE obesity is another RISK FACTOR for Vitamin D deficiency5,7and poor Perinatal outcomes.8in OBSERVATIONAL studies, 25-Hydroxyvitamin D (25[Oh]D) levels HAVE BEEN SHOWN to be ASSOCIATED with higher risk of several adverse Perinatal outcomes including Gestational diabetes9,10, preeclampsia,11preterm Birth12And small-for-Gestational age status.13,14,15,16,17BECAUSE of the PAUCITY of Vitamin D trial data with respect to Perinatal outcomes, WHETHER DIFFERENCES in Vitamin D status during Pregnancy explains or partially explains Perinatal DISPARITIES is PLAUSIBLE18but REMAINS UNKNOWN.']	[('DIFFICULT_TASK', 39), ('PROBABLE_UNDERSTANDING', 136), ('PROBABLE_UNDERSTANDING', 185), ('PROBABLE_UNDERSTANDING', 264), ('PROBABLE_UNDERSTANDING', 302), ('PROBABLE_UNDERSTANDING', 355), ('IMPORTANT_CONSIDERATION', 478), ('PROBABLE_UNDERSTANDING', 557), ('PROBLEM_COMPLICATION', 619), ('PROBABLE_UNDERSTANDING', 627), ('SUPERFICIAL_RELATIONSHIP', 654), ('INCOMPLETE_EVIDENCE', 725), ('INCOMPLETE_EVIDENCE', 785), ('SUPERFICIAL_RELATIONSHIP', 807), ('PROBABLE_UNDERSTANDING', 990), ('INCOMPLETE_EVIDENCE', 1005), ('EXPLICIT_QUESTION', 1073), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('IMPORTANT_CONSIDERATION', 1171), ('INCOMPLETE_EVIDENCE', 1186), ('FULL_UNKNOWN', 1201)]	21	[('GO_0036268', 'swimming', 13, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 13, 'Perinatal'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 381, 'vitamin D synthesis'), ('CHEBI_26130', 'biological pigment', 423, 'pigmented'), ('NCBITaxon_1', 'root', 433, 'individuals'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D'), ('GO_0036268', 'swimming', 702, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 702, 'perinatal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 748, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 769, '25[OH]D'), ('GO_0036268', 'swimming', 854, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 854, 'perinatal'), ('GO_0007565', 'female pregnancy', 883, 'gestational'), ('GO_0007594', 'puparial adhesion', 932, 'birth12and'), ('GO_0007565', 'female pregnancy', 953, 'gestational'), ('CHEBI_27300', 'vitamin D', 1016, 'vitamin D'), ('GO_0036268', 'swimming', 1053, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1053, 'perinatal'), ('CHEBI_27300', 'vitamin D', 1096, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1120, 'pregnancy'), ('GO_0036268', 'swimming', 1161, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1161, 'perinatal')]
PMC4785305	3/2016	S24-PMC4785305	["ASSOCIATION between maternal Vitamin D level and neonatal adverse outcomes\nlow maternal 25(Oh)D levels were RECENTLY LINKED to fetal programming, and were found TO be ASSOCIATED with adverse events in neonates, resulting in small for Gestational age (sga) at Birth,1923and also later on during childhood, leading to reduced muscle and bone mass in offspring at 4 and 9\u2005years.2425this MAY BE EXPLAINED by the fact that maternal Vitamin D is ESSENTIAL for fetal Musculoskeletal integrity, as it Regulates neonatal bone accrual, POSSIBLY through specific proteins that are responsible for Placental Calcium Transport.26RECENTLY, data from the southampton women's survey (sws) SHOWED that maternal 25(Oh)D level is significantly CORRELATED with Placental Amino Acid transporters Expression, that mediate the Transport Of various Nutrients to the fetus.27furthermore, maternal Vitamin D MAY INFLUENCE the fetal muscle motor Unit size, and CONSEQUENTLY muscle mass and strength after Birth.25it is NOTEWORTHY that fetal bone development is one of the PREDICTORS of peak bone mass, Adult bone Mineral content and Hip geometry, THUS CORRELATING with fracture risk later in Life.2628\n\nVitamin d replacement guidelines during Pregnancy\nthe guidelines regarding Vitamin D replacement or supplementation during Pregnancy VARY substantially."]	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 161), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 384), ('ANOMALY_CURIOUS_FINDING', 388), ('PROBABLE_UNDERSTANDING', 391), ('IMPORTANT_CONSIDERATION', 440), ('INCOMPLETE_EVIDENCE', 526), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 614), ('INCOMPLETE_EVIDENCE', 673), ('SUPERFICIAL_RELATIONSHIP', 725), ('INCOMPLETE_EVIDENCE', 882), ('SUPERFICIAL_RELATIONSHIP', 886), ('PROBABLE_UNDERSTANDING', 934), ('ANOMALY_CURIOUS_FINDING', 992), ('SUPERFICIAL_RELATIONSHIP', 1045), ('PROBABLE_UNDERSTANDING', 1120), ('SUPERFICIAL_RELATIONSHIP', 1125), ('DIFFICULT_TASK', 1309)]	21	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('GO_0007565', 'female pregnancy', 234, 'gestational'), ('GO_0007567', 'parturition', 259, 'birth'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 460, 'musculoskeletal'), ('GO_0065007', 'biological regulation', 493, 'regulates'), ('UBERON_0001987', 'placenta', 586, 'placental'), ('GO_0006816', 'calcium ion transport', 596, 'calcium transport'), ('CHEBI_71657', 'versiconol acetate', 694, '25(OH)D'), ('UBERON_0001987', 'placenta', 741, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 751, 'amino acid'), ('GO_0010467', 'gene expression', 775, 'expression'), ('GO_0006415', 'translational termination', 804, 'transport of ... nutrients'), ('CHEBI_33284', 'nutrient', 825, 'nutrients'), ('CHEBI_27300', 'vitamin D', 872, 'vitamin D'), ('UBERON_0002105', 'vestibulo-auditory system', 919, 'unit'), ('GO_0007567', 'parturition', 978, 'birth'), ('UBERON_0007023', 'adult organism', 1075, 'adult'), ('CHEBI_46662', 'mineral', 1086, 'mineral'), ('UBERON_0001464', 'hip', 1106, 'hip'), ('UBERON_0000104', 'life cycle', 1165, 'life'), ('CHEBI_33229', 'vitamin (role)', 1176, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1216, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1251, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1299, 'pregnancy')]
PMC4973215	8/2016	S12-PMC4973215	['far FEWER STUDIES have EXAMINED the RELATIONSHIP between Cord Blood Vitamin D levels, which MAY more ACCURATELY REFLECT fetal levels of Vitamin D, and neonatal outcomes.14,24GIVEN the racial DISPARITIES SEEN in both Vitamin D deficiency and Perinatal outcomes, Vitamin D HAS BEEN PROPOSED as part of the EXPLANATION for this DISPARITY, PARTICULARLY with regard to fetal growth and sga.8\nINCREASED AWARENESS of the GROWING PREVALENCE of maternal Vitamin D deficiency has LED TO an URGENT NEED for CONSIDERATION of supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 92), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 112), ('PROBABLE_UNDERSTANDING', 174), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 271), ('INCOMPLETE_EVIDENCE', 280), ('PROBABLE_UNDERSTANDING', 304), ('IMPORTANT_CONSIDERATION', 325), ('IMPORTANT_CONSIDERATION', 336), ('IMPORTANT_CONSIDERATION', 387), ('INCOMPLETE_EVIDENCE', 414), ('IMPORTANT_CONSIDERATION', 422), ('SUPERFICIAL_RELATIONSHIP', 470), ('IMPORTANT_CONSIDERATION', 480), ('FUTURE_WORK', 487), ('FUTURE_WORK', 496)]	21	[('UBERON_0002240', 'spinal cord', 57, 'cord'), ('UBERON_0000178', 'blood', 62, 'blood'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0036268', 'swimming', 241, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 241, 'perinatal'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0007565', 'female pregnancy', 536, 'pregnancy')]
PMC4990268	8/2016	S1116-PMC4990268	['intable 6below, we have offered very brief comments on such implementation CONSIDERATIONS.10.1371/journal.pone.0160562.t006\n\ncaption (table-wrap): table 6\n“best buy” ratings for interventions reviewed.interventionpopulation impactease of Deliverycommentsbreastfeeding—early initiation ✓ ☺large magnitude EFFECT on newborn mortalityiron/ anemia ✓✓✓ ☺LIKELY a significant mortality EFFECT, BUT EVIDENCE is WEAK; clear benefit however for iugr multi-Micronutrient supplementation✓ ☺ ALTHOUGH iugr is reduced , in many low income settings there MAY BE no net benefit; under SOME conditions there MAY BE net harm Calcium ✓✓✓😐 large magnitude EFFECTS but significant logistical barriers at currently recommended dose antenatal Vitamin A ☺ no effects on our outcomes of interest Postnatal Vitamin A ✓ ☺EVIDENCE for IMPACT on early infant deaths in Vitamin-A deficient populationsiodine ✓ ☺major benefit in ↓’d burden of Cognitive disabilitybalanced protein-energy supplementation ✓✓✓😐 significant benefits, but cost & logistical challenges limit scalability deworming ☺ no effects on our outcomes of interest iptp/itns ✓✓✓✓ ☺large magnitude EFFECTS in malarious areastetanus Toxoid ✓ ☺in most settings, coverage is now relatively high; this NEEDS to be sustainedchlorhexidine advance distribution ✓ ☺large magnitude EFFECT on newborn mortality in high nmr populationssyphilis screening & treatment ✓✓✓ ☺relatively inexpensive and straightforward diagnostics and treatmentpmtct ✓😐 high population effective coverage REQUIRES robust services and systemsmisoprostol advance distribution ✓ ☺to ensure SAFETY, Delivery strategy NEEDS to reliably ensure counseling on correct timing of use (i.e.']	[('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 304), ('PROBABLE_UNDERSTANDING', 349), ('SUPERFICIAL_RELATIONSHIP', 380), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('INCOMPLETE_EVIDENCE', 392), ('INCOMPLETE_EVIDENCE', 404), ('ANOMALY_CURIOUS_FINDING', 480), ('INCOMPLETE_EVIDENCE', 541), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 592), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 795), ('SUPERFICIAL_RELATIONSHIP', 808), ('SUPERFICIAL_RELATIONSHIP', 1134), ('FUTURE_WORK', 1234), ('SUPERFICIAL_RELATIONSHIP', 1309), ('IMPORTANT_CONSIDERATION', 1508), ('IMPORTANT_CONSIDERATION', 1590), ('FUTURE_WORK', 1616), ('IMPORTANT_CONSIDERATION', 1616)]	21	[('GO_0031078', 'histone deacetylase activity (H3-K14 specific)', 238, 'DeliveryCommentsBreastfeeding'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 447, 'micronutrient'), ('CHEBI_31341', 'calcium dihydroxide', 608, 'Calcium'), ('CHEBI_77082', 'O-adipoylcarnitine(1-)', 616, '✓✓✓😐'), ('CHEBI_33233', 'fundamental particle', 721, 'vitamin A ☺'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 721, 'vitamin A ☺'), ('GO_0007567', 'parturition', 772, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 782, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 841, 'vitamin'), ('PR_000027594', 'histone H3', 841, 'vitamin-A'), ('GO_0050890', 'cognition', 913, 'cognitive'), ('CHEBI_29238', 'tritium atom', 1168, 'toxoid'), ('GO_0007567', 'parturition', 1598, 'delivery')]
PMC3702245	6/2013	S13-PMC3702245	['HOWEVER, sustained Vitamin D deficiency results in rickets in children and osteomalacia in Adults.28the COMMONLY evaluated BIOMARKERS of Vitamin D nutrition include Serum 25(Oh)D concentrations, the inverse RELATIONSHIP between 25(Oh)D and Parathyroid hormone, Intestinal calcium absorption, and assessment of Skeletal integrity.29WHILE there is an inverse RELATIONSHIP between Serum Parathyroid hormone and 25(Oh)D in nonpregnant states, this RELATIONSHIP HAS BEEN SHOWN in RECENT STUDIES to be weak during Pregnancy,6,18,30,31INDICATING that Serum Parathyroid hormone MAY BE a LESS RELIABLE BIOMARKER of maternal Vitamin D status during Pregnancy than Serum 25(Oh)d.32the maternal 25(Oh)D level does not vary significantly during Pregnancy unless there is a change in Vitamin D intake or Endogenous Synthesis.2,33,34HOWEVER, Serum 1,25(Oh)2D levels increase by 100%–200% starting in the first trimester in both the mother and the fetus.35–37the increase in maternal 1,25(Oh)2D, which originates mostly from the Kidneys, accounts for increased Intestinal calcium absorption during Pregnancy.38,39the increase in fetal 1,25(Oh)2D level SEEMS to BE RELATED to synthesis in Placental and Fetal Tissues.39,40\nan IMPORTANT aspect of Vitamin D nutrition in Pregnancy is that the Vitamin D status of the infant at Birth and in early infancy DEPENDS ON the vitamin d status of the mother during Pregnancy.41vitamin D stores in the infant start with transplacental Transfer of 25(Oh)D in early Pregnancy from mother to fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('SUPERFICIAL_RELATIONSHIP', 357), ('SUPERFICIAL_RELATIONSHIP', 444), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 526), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 579), ('IMPORTANT_CONSIDERATION', 584), ('SUPERFICIAL_RELATIONSHIP', 593), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 816), ('ANOMALY_CURIOUS_FINDING', 1136), ('ANOMALY_CURIOUS_FINDING', 1145), ('SUPERFICIAL_RELATIONSHIP', 1148), ('IMPORTANT_CONSIDERATION', 1209), ('SUPERFICIAL_RELATIONSHIP', 1335)]	20	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0007023', 'adult organism', 91, 'adults'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 177, 'D'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 240, 'parathyroid'), ('UBERON_0000160', 'intestine', 261, 'intestinal'), ('UBERON_0004288', 'skeleton', 310, 'skeletal'), ('UBERON_0001977', 'blood serum', 378, 'serum'), ('UBERON_0001132', 'parathyroid gland', 384, 'parathyroid'), ('CHEBI_71657', 'versiconol acetate', 408, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 411, 'OH ... D'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy'), ('UBERON_0001977', 'blood serum', 544, 'serum'), ('UBERON_0001132', 'parathyroid gland', 550, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('GO_0007565', 'female pregnancy', 639, 'pregnancy'), ('UBERON_0001977', 'blood serum', 654, 'serum'), ('CHEBI_30778', 'gallic acid', 660, '25(OH)'), ('CHEBI_71657', 'versiconol acetate', 683, '25(OH)D'), ('GO_0007565', 'female pregnancy', 732, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 770, 'vitamin D'), ('GO_0042400', 'ectoine catabolic process', 790, 'endogenous synthesis'), ('UBERON_0001977', 'blood serum', 827, 'serum'), ('CHEBI_37958', 'dye', 833, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 835, '25(OH)2D'), ('CHEBI_37958', 'dye', 968, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 970, '25(OH)2D'), ('UBERON_0002113', 'kidney', 1013, 'kidneys'), ('UBERON_0000160', 'intestine', 1045, 'intestinal'), ('GO_0007565', 'female pregnancy', 1082, 'pregnancy'), ('CHEBI_37958', 'dye', 1119, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 1121, '25(OH)2D'), ('UBERON_0001987', 'placenta', 1172, 'placental'), ('UBERON_0005291', 'embryonic tissue', 1186, 'fetal tissues'), ('CHEBI_27300', 'vitamin D', 1229, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1252, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1274, 'vitamin D'), ('GO_0007567', 'parturition', 1308, 'birth'), ('GO_0007565', 'female pregnancy', 1388, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1408, 'D'), ('GO_0006412', 'translation', 1457, 'transfer'), ('CHEBI_71657', 'versiconol acetate', 1469, '25(OH)D'), ('GO_0007565', 'female pregnancy', 1486, 'pregnancy')]
PMC4586450	10/2015	S252-PMC4586450	['WHETHER fortification of Foods COULD BE the answer to THIS problem was EXAMINED; the THEORETICAL intakes from DIFFERENT fortification regimens tested SUGGESTED that milk fortified at 2 µg vitamin d/100 g would provide MOST preschool children with adequate but not excessive intakes.24later work in the alspac looking at Plasma concentrations in mid-childhood of Vitamin D (25-Hydroxyvitamin-D2And 25-Hydroxyvitamin-D3) in RELATION to Cortical bone measures FOUND positive ASSOCIATIONS with D3Only, SUGGESTING that in supplementation OR fortification, d3should be used in PREFERENCE to d2.25these 2 PAPERS give valuable INSIGHTS into HOW the lack of Vitamin D in the diets of the majority of uk residents COULD BE TACKLED.iron\niron is a Nutrient that is ESSENTIAL to a child’s growth and development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('QUESTION_ANSWERED_BY_THIS_WORK', 71), ('INCOMPLETE_EVIDENCE', 85), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('INCOMPLETE_EVIDENCE', 150), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 422), ('INCOMPLETE_EVIDENCE', 457), ('SUPERFICIAL_RELATIONSHIP', 472), ('INCOMPLETE_EVIDENCE', 498), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 533), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 571), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 619), ('EXPLICIT_QUESTION', 633), ('INCOMPLETE_EVIDENCE', 704), ('FUTURE_WORK', 713), ('IMPORTANT_CONSIDERATION', 753)]	20	[('CHEBI_33290', 'food', 25, 'foods'), ('UBERON_0001969', 'blood plasma', 320, 'plasma'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin D'), ('CHEBI_66469', 'senegin III', 373, '25-hydroxyvitamin-D2and'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 373, '25'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 390, '-D2and'), ('CHEBI_65129', '2-hydroxy-AMP', 397, '25-hydroxyvitamin-D3'), ('PR_000000037', 'BMP receptor type-2', 414, '-D3'), ('UBERON_0001851', 'cortex', 434, 'cortical'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 490, 'D3only'), ('CHEBI_27300', 'vitamin D', 649, 'vitamin D'), ('CHEBI_33284', 'nutrient', 736, 'nutrient')]
PMC5115165	1/2016	S14-PMC5115165	['introduction\npotatoes are the third most commonly Consumed Food crop in the world, after rice and wheat.1in the united states, about 35% of women of Reproductive Age (that is, aged 19-50) Consume potatoes daily, accounting FOR 8% of daily total energy intake.2the health EFFECTS of potatoes are INCONCLUSIVE,13and there HAVE BEEN longstanding DEBATES on the appropriate placement of potatoes in dietary guidance.456nonetheless, the dietary guidelines for americans continue to include potatoes in the vegetable Food group and encourage Consumption.7THOUGH potatoes are rich in Vitamin C, Potassium, dietary fiber, and some Phytochemicals,6unlike other vegetables they CAN have DETRIMENTAL EFFECTS on Glucose Metabolism because they contain large amounts of rapidly absorbable Starch.3indeed, SEVERAL epidemiologic STUDIES have LINKED higher potato Consumption to increased concentrations of fasting Plasma Glucose,8insulin resistance,8and an increased risk of type 2 diabetes mellitus.910\nGestational diabetes mellitus (gdm) is a common COMPLICATION of Pregnancy characterized by Glucose intolerance with onset or first recognition during Pregnancy.11gdm is not only ASSOCIATED with adverse Perinatal outcomes,12it is also RELATED to increased long term Cardiometabolic risk in both mothers and their offspring.1113it is THEREFORE CRUCIAL to identify modifiable RISK FACTORS that COULD CONTRIBUTE to the PREVENTION of gdm.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 223), ('SUPERFICIAL_RELATIONSHIP', 271), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('INCOMPLETE_EVIDENCE', 320), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('ANOMALY_CURIOUS_FINDING', 548), ('INCOMPLETE_EVIDENCE', 668), ('IMPORTANT_CONSIDERATION', 677), ('SUPERFICIAL_RELATIONSHIP', 689), ('INCOMPLETE_EVIDENCE', 792), ('SUPERFICIAL_RELATIONSHIP', 827), ('PROBLEM_COMPLICATION', 1037), ('SUPERFICIAL_RELATIONSHIP', 1167), ('SUPERFICIAL_RELATIONSHIP', 1223), ('PROBABLE_UNDERSTANDING', 1321), ('IMPORTANT_CONSIDERATION', 1331), ('SUPERFICIAL_RELATIONSHIP', 1362), ('INCOMPLETE_EVIDENCE', 1380), ('SUPERFICIAL_RELATIONSHIP', 1386), ('SUPERFICIAL_RELATIONSHIP', 1404)]	20	[('GO_0007631', 'feeding behavior', 50, 'consumed'), ('CHEBI_33290', 'food', 59, 'food'), ('GO_0000003', 'reproduction', 149, 'reproductive age'), ('GO_0007631', 'feeding behavior', 188, 'consume'), ('CHEBI_33290', 'food', 511, 'food'), ('GO_0007631', 'feeding behavior', 536, 'consumption'), ('CHEBI_27300', 'vitamin D', 577, 'vitamin C'), ('CHEBI_22314', 'alkali metal atom', 588, 'potassium'), ('CHEBI_26254', 'prenylnaphthoquinone', 623, 'phytochemicals'), ('CHEBI_17234', 'glucose', 700, 'glucose'), ('GO_0006006', 'glucose metabolic process', 700, 'glucose metabolism'), ('CHEBI_28017', 'starch', 776, 'starch'), ('GO_0007631', 'feeding behavior', 848, 'consumption'), ('UBERON_0001969', 'blood plasma', 899, 'plasma'), ('CHEBI_17234', 'glucose', 906, 'glucose'), ('GO_0007565', 'female pregnancy', 989, 'Gestational'), ('GO_0007565', 'female pregnancy', 1053, 'pregnancy'), ('CHEBI_17234', 'glucose', 1080, 'glucose'), ('GO_0007565', 'female pregnancy', 1139, 'pregnancy'), ('GO_0036268', 'swimming', 1191, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1191, 'perinatal'), ('GO_0007599', 'hemostasis', 1254, 'cardiometabolic')]
PMC3713405	7/2013	S40-PMC3713405	['• schizophrenia\nNeurodevelopmental disorder ASSOCIATED with altered Dopamine function both prior to and during disease onset\n• developmental Vitamin D (Dvd) deficiency\nASSOCIATED with INCREASED susceptibility to schizophrenia\n• Dvd Rat MODEL\nDvd-deficiency in the Rat LEADS to a pattern of altered developmental and Adult Dopaminergic function\n• Vitamin D and Dopamine\nearly Vitamin D signaling is intrinsically LINKED with the developing Dopamine system\n• Animal MODELS of schizophrenia\nmultiple Animal MODELS of schizophrenia SHOW alterations in Dopamine Development prior to post-adolescent alterations in behavior\n• Dopamine and schizophrenia\nALTHOUGH FOCUS REMAINS TIED to Dopamine as a common endpoint in schizophrenia, understanding common Dopaminergic origins MAY BE\n\nthe epidemiology of vitamin d and schizophrenia\nnumerous pieces of epidemiological EVIDENCE IMPLICATE low levels of maternal Vitamin D AS a POTENTIAL risk factor for schizophrenia.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 184), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 268), ('SUPERFICIAL_RELATIONSHIP', 412), ('INCOMPLETE_EVIDENCE', 464), ('INCOMPLETE_EVIDENCE', 504), ('INCOMPLETE_EVIDENCE', 528), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 647), ('ANOMALY_CURIOUS_FINDING', 647), ('IMPORTANT_CONSIDERATION', 656), ('INCOMPLETE_EVIDENCE', 662), ('SUPERFICIAL_RELATIONSHIP', 670), ('INCOMPLETE_EVIDENCE', 768), ('INCOMPLETE_EVIDENCE', 859), ('SUPERFICIAL_RELATIONSHIP', 868), ('PROBABLE_UNDERSTANDING', 911), ('INCOMPLETE_EVIDENCE', 916)]	19	[('GO_0007285', 'primary spermatocyte growth', 16, 'Neurodevelopmental'), ('CHEBI_18243', 'dopamine', 68, 'dopamine'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 152, 'DVD'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 228, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 232, 'rat'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 242, 'DVD'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 264, 'rat'), ('UBERON_0007023', 'adult organism', 316, 'adult'), ('CHEBI_18243', 'dopamine', 322, 'dopaminergic'), ('CHEBI_28384', 'vitamin K', 346, 'Vitamin D'), ('CHEBI_18243', 'dopamine', 360, 'dopamine'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D'), ('CHEBI_18243', 'dopamine', 439, 'dopamine'), ('NCBITaxon_33208', 'Metazoa', 457, 'Animal'), ('NCBITaxon_33208', 'Metazoa', 497, 'animal'), ('CHEBI_18243', 'dopamine', 548, 'dopamine'), ('GO_0048597', 'post-embryonic camera-type eye morphogenesis', 548, 'dopamine development'), ('CHEBI_18243', 'dopamine', 620, 'Dopamine'), ('CHEBI_18243', 'dopamine', 678, 'dopamine'), ('CHEBI_18243', 'dopamine', 747, 'dopaminergic'), ('CHEBI_27300', 'vitamin D', 901, 'vitamin D')]
PMC3888066	12/2012	S14-PMC3888066	['methodologies used in this study HAVE BEEN CRITICIZED, including aggregating Heart defects as Neural Crest defects, ESTIMATING missing information on Retinol supplementation and DEMONSTRATING the Vitamin A threshold of >10,000 iu/day.9SUBSEQUENT STUDIES have DISPUTED the 10,000 iu/day THRESHOLD BASED ON Non-Human Primate STUDIES and SMALL clinical trials in Humans.10\n\nEVIDENCE to SUPPORT the NOTION that a Toxin is responsible for SOME Neurodevelopmental disorders\na Toxin that MAY cause Neurodevelopmental disorders MUST BE able to cross NOT ONLY the Placenta, BUT ALSO the Blood Brain Barrier (bbb).']	[('INCOMPLETE_EVIDENCE', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('INCOMPLETE_EVIDENCE', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 259), ('PROBABLE_UNDERSTANDING', 286), ('INCOMPLETE_EVIDENCE', 296), ('PROBABLE_UNDERSTANDING', 296), ('INCOMPLETE_EVIDENCE', 323), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 371), ('INCOMPLETE_EVIDENCE', 383), ('INCOMPLETE_EVIDENCE', 395), ('INCOMPLETE_EVIDENCE', 434), ('INCOMPLETE_EVIDENCE', 481), ('IMPORTANT_CONSIDERATION', 520), ('ANOMALY_CURIOUS_FINDING', 542)]	19	[('UBERON_0000948', 'heart', 77, 'heart'), ('UBERON_0002342', 'neural crest', 94, 'neural crest'), ('CHEBI_26536', 'retinoic acid', 150, 'retinol'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 305, 'non'), ('NCBITaxon_9606', 'Homo sapiens', 309, 'human'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 315, 'primate'), ('NCBITaxon_9606', 'Homo sapiens', 360, 'humans'), ('CHEBI_27026', 'toxin', 409, 'toxin'), ('GO_0007399', 'nervous system development', 439, 'neurodevelopmental'), ('CHEBI_27026', 'toxin', 470, 'toxin'), ('GO_0007399', 'nervous system development', 491, 'neurodevelopmental'), ('UBERON_0001987', 'placenta', 555, 'placenta'), ('UBERON_0000120', 'blood brain barrier', 578, 'blood brain barrier')]
PMC4113768	7/2014	S479-PMC4113768	['conclusions: (1) SINCE the use of supplements containing Vitamin A as well as Vitamin D is common, WHETHER in Cod Liver oil OR multi-vitamins, especially in developed countries, Vitamin A status is LIKELY to CONFOUND rcts of Vitamin D in westernized populations; (2) in particular, high Vitamin A Intakes COULD ACCOUNT for j or inverse u shaped curves for outcomes in rcts, AS COULD Gene polymorphisms increasing circulating Retinol/Retinoids; (3) CONVERSELY, poor Vitamin D status MAY BE expected to CONFOUND rcts of Vitamin A in developing countries; (4) as well as Vitamin A intakes, other lifestyle factors that are POTENTIAL CONFOUNDERS of the EFFECTS of Vitamin D SHOULD BE CONSIDERED in the PLANNING of FUTURE rcts of supplemental Vitamin D, including intakes of other Nutrients, tobacco usage, and also betel-chewing which MAY increase Catabolism Of Vitamin D and is a habit used by 10% of the world population.']	[('PROBABLE_UNDERSTANDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('PROBABLE_UNDERSTANDING', 198), ('PROBLEM_COMPLICATION', 208), ('INCOMPLETE_EVIDENCE', 305), ('IMPORTANT_CONSIDERATION', 311), ('PROBABLE_UNDERSTANDING', 374), ('INCOMPLETE_EVIDENCE', 377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 448), ('INCOMPLETE_EVIDENCE', 482), ('PROBLEM_COMPLICATION', 501), ('INCOMPLETE_EVIDENCE', 620), ('PROBLEM_COMPLICATION', 630), ('SUPERFICIAL_RELATIONSHIP', 649), ('FUTURE_WORK', 670), ('FUTURE_WORK', 680), ('FUTURE_WORK', 698), ('FUTURE_WORK', 710), ('INCOMPLETE_EVIDENCE', 831)]	19	[('CHEBI_27300', 'vitamin D', 57, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'cod'), ('UBERON_0002107', 'liver', 114, 'liver'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A'), ('GO_0007631', 'feeding behavior', 297, 'intakes'), ('SO_0000704', 'gene', 383, 'gene'), ('CHEBI_26536', 'retinoic acid', 425, 'retinol'), ('CHEBI_26537', 'retinoid', 433, 'retinoids'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 518, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 738, 'vitamin D'), ('CHEBI_33284', 'nutrient', 776, 'nutrients'), ('GO_0044851', 'hair cycle phase', 844, 'catabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 858, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S96-BMJ_2010_Apr_29_340_c1640	['by the time of Delivery, maternal and infant Cord Serum 25-Hydroxyvitamin d3concentrations are highly CORRELATED.37UNFORTUNATELY, much REMAINS UNKNOWN, leading to large international variations in maternal Vitamin D monitoring and supplementation during Pregnancy.353839\na maternal EFFECT operating Antenatally would also be CONSISTENT with the stronger maternal than paternal “parent of origin” EFFECT in familial multiple sclerosis.1340it HAS BEEN PREVIOUSLY PROPOSED14THAT maternal Vitamin D deficiency, a PROBLEM for SOME dark skinned women migrating to regions with low ambient ultraviolet radiation, such as the uk, MIGHT EXPLAIN the increase in incidence of disease SEEN among second generation migrants in such locations.41our FINDINGS are CONSISTENT with this EXPLANATION.']	[('SUPERFICIAL_RELATIONSHIP', 102), ('ANOMALY_CURIOUS_FINDING', 113), ('ANOMALY_CURIOUS_FINDING', 113), ('FULL_UNKNOWN', 135), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 325), ('SUPERFICIAL_RELATIONSHIP', 396), ('INCOMPLETE_EVIDENCE', 441), ('INCOMPLETE_EVIDENCE', 450), ('INCOMPLETE_EVIDENCE', 461), ('IMPORTANT_CONSIDERATION', 509), ('INCOMPLETE_EVIDENCE', 521), ('INCOMPLETE_EVIDENCE', 622), ('PROBABLE_UNDERSTANDING', 628), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 735), ('INCOMPLETE_EVIDENCE', 748), ('PROBABLE_UNDERSTANDING', 769)]	18	[('GO_0007567', 'parturition', 15, 'delivery'), ('UBERON_0002240', 'spinal cord', 45, 'cord'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_67376', 'dihydrooroxylin A', 56, '25-hydroxyvitamin'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy'), ('GO_0007288', 'sperm axoneme assembly', 299, 'antenatally'), ('CHEBI_27300', 'vitamin D', 485, 'vitamin D')]
PMC3385441	2/2012	S269-PMC3385441	['caption (table-wrap): table 3\n\nchallenges to developing comprehensive fish Consumption ADVICE.viewpoint and challengesexamplestoxicological hazards: fish contaminants (e.g., mehg, Pcbs, Pesticides)multiple co-occurring contaminantssynergistic adverse EFFECTS on Neurodevelopment with Joint mehg and pcb exposureadvisories for single contaminantfarmed salmon low in mehg but can be high in pcbstoxicant levels vary within and across speciestilefish Mehg: high in gulf of mexico but low in atlanticvariable susceptibility to toxicitiesprenatal exposure: increased susceptibility to Mehg neurotoxicityconfounding by nutritional BENEFITSUNDERESTIMATION of hazard from mehg if CONFOUNDED by n‑3 lcpufasnutritional BENEFITS: fish Nutrients (e.g., n‑3 lcpufas, Vitamin D, Iodine, Selenium)multiple co-occurring nutrientsfor Neurodevelopment, fish intake more CONSISTENTLY beneficial than n‑3 lcpufa supplementsanutrient levels vary within and across specieshealth benefits associated with high n‑3 lcpufa fishaconfounding by contaminant riskunderestimation of benefit from n‑3 lcpufas if CONFOUNDED by Mehgincreased fish intake (for most populations) RECOMMENDED by nutrition GUIDELINESAVAILABLE fish insufficient to meet demand EVEN without greater intakeenvironmental sustainability: overfishing, habitat destruction, aquaculturemodern harvesting can deplete fish stocks, other aquatic wildlife, and habitatsfishing trawls plough the Seafloor, removing most, if not all, aquatic Life and structures in their pathwild fish stocks insufficient to meet projected GLOBAL demandapproximately 90% of large predatory fish stocks (e.g., bluefin Tuna, atlantic salmon) are already depletedaquaculture CAN adversely AFFECT wild fish and ecosystems; CONTAMINANTSFARMED salmon can escape and outcompete wild fish and MAY have higher Pcb levelseconomic INFLUENCES: consumer choice, industry stakeholders, fisheries managementeconomic ASSUMPTION of improved consumer welfare with more information not necessarily TRUE for fish choiceu.s.']	[('FUTURE_WORK', 87), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 625), ('DIFFICULT_TASK', 672), ('IMPORTANT_CONSIDERATION', 709), ('PROBABLE_UNDERSTANDING', 852), ('DIFFICULT_TASK', 1081), ('FUTURE_WORK', 1144), ('PROBABLE_UNDERSTANDING', 1169), ('ANOMALY_CURIOUS_FINDING', 1222), ('IMPORTANT_CONSIDERATION', 1555), ('INCOMPLETE_EVIDENCE', 1687), ('SUPERFICIAL_RELATIONSHIP', 1701), ('IMPORTANT_CONSIDERATION', 1734), ('INCOMPLETE_EVIDENCE', 1800), ('SUPERFICIAL_RELATIONSHIP', 1835), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1916), ('PROBABLE_UNDERSTANDING', 1994)]	18	[('GO_0007631', 'feeding behavior', 75, 'consumption'), ('CHEBI_26199', 'polyprenol', 180, 'PCBs'), ('CHEBI_35392', 'glucarate(1-)', 186, 'pesticides'), ('GO_0007399', 'nervous system development', 262, 'neurodevelopment'), ('UBERON_0004905', 'articulation', 284, 'joint'), ('CHEBI_82056', 'Mebenil', 448, 'MeHg'), ('CHEBI_82056', 'Mebenil', 580, 'MeHg'), ('CHEBI_33284', 'nutrient', 724, 'nutrients'), ('CHEBI_27300', 'vitamin D', 754, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 765, 'iodine'), ('CHEBI_27568', 'selenium atom', 773, 'selenium'), ('GO_0007399', 'nervous system development', 817, 'neurodevelopment'), ('CHEBI_82492', 'N-Methylolacrylamide', 1095, 'MeHgIncreased'), ('UBERON_0001273', 'ilium', 1429, 'seafloor'), ('UBERON_0000104', 'life cycle', 1474, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 1632, 'tuna'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 1816, 'PCB')]
PMC3717170	5/2013	S139-PMC3717170	['HOWEVER, pittas CAUTIONED that one SHOULD RESIST making inferences on the basis of OBSERVATIONAL studies BECAUSE of the POSSIBILITY of CONFOUNDING ISSUES, which MAY BE especially TRUE when assessing Vitamin D status, BECAUSE WHILE 25(Oh)D3Concentration is an excellent MARKER of good health many of the VARIABLES that CONTRIBUTE to 25(Oh)d3concentration (e.g., skin pigmentation, physical inactivity, Aging, unhealthy dietary patterns) are also RISK FACTORS for the development of diabetes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 83), ('PROBLEM_COMPLICATION', 105), ('INCOMPLETE_EVIDENCE', 120), ('PROBLEM_COMPLICATION', 135), ('PROBLEM_COMPLICATION', 147), ('INCOMPLETE_EVIDENCE', 161), ('PROBABLE_UNDERSTANDING', 179), ('PROBABLE_UNDERSTANDING', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('SUPERFICIAL_RELATIONSHIP', 269), ('SUPERFICIAL_RELATIONSHIP', 303), ('SUPERFICIAL_RELATIONSHIP', 318), ('SUPERFICIAL_RELATIONSHIP', 445)]	18	[('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 231, '25(OH)D3concentration'), ('CHEBI_30778', 'gallic acid', 332, '25(OH)'), ('GO_0007568', 'aging', 401, 'aging')]
PMC4691762	12/2015	S17-PMC4691762	['RECENT EVIDENCE SUGGESTS that low Vitamin D at Birth or during Infancy is ASSOCIATED with an increased RISK of Food allergy6and eczema.7in addition Food allergy and eczema prevalence is higher the further from the equator a Person resides, LENDING SUPPORT to the HYPOTHESES that low Vitamin D (through low ultraviolet (uv) exposure) MAY play a ROLE in aberrant Immune Development in early Life and increase the risk of developing Food allergy and eczema.3food allergy is one of the earliest manifestations of the Immune deviation,8but also STRONGLY COASSOCIATES with eczema in infancy and asthma later in Life.9\nVitamin D supplementation in the first year of Life has also BEEN ASSOCIATED with a reduced risk of lris10and reduced recovery time in infants with acute bronchiolitis.11since early Life wheezy lris are also strongly ASSOCIATED with longer term respiratory outcomes including asthma12understanding the ROLE of Vitamin D in the RISK of early Life Respiratory diseases is also IMPORTANT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 248), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 263), ('INCOMPLETE_EVIDENCE', 263), ('INCOMPLETE_EVIDENCE', 333), ('SUPERFICIAL_RELATIONSHIP', 344), ('PROBABLE_UNDERSTANDING', 540), ('SUPERFICIAL_RELATIONSHIP', 549), ('ANOMALY_CURIOUS_FINDING', 673), ('SUPERFICIAL_RELATIONSHIP', 678), ('SUPERFICIAL_RELATIONSHIP', 829), ('SUPERFICIAL_RELATIONSHIP', 914), ('IMPORTANT_CONSIDERATION', 939), ('IMPORTANT_CONSIDERATION', 987)]	18	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007567', 'parturition', 47, 'birth'), ('GO_0007631', 'feeding behavior', 63, 'infancy'), ('CHEBI_33290', 'food', 111, 'food'), ('CHEBI_33290', 'food', 148, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 224, 'person'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0001822', 'kidney development', 361, 'immune development'), ('UBERON_0002405', 'immune system', 361, 'immune'), ('UBERON_0000104', 'life cycle', 389, 'life'), ('CHEBI_33290', 'food', 430, 'food'), ('UBERON_0002405', 'immune system', 513, 'immune'), ('UBERON_0000104', 'life cycle', 605, 'life'), ('CHEBI_28384', 'vitamin K', 612, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 659, 'life'), ('UBERON_0000104', 'life cycle', 794, 'life'), ('CHEBI_27300', 'vitamin D', 922, 'vitamin D'), ('UBERON_0000104', 'life cycle', 953, 'life'), ('UBERON_0001004', 'respiratory system', 958, 'respiratory')]
PMC5028238	10/2016	S201-PMC5028238	["COMMENT on Vitamin D3's in-direct inhibition of Dhcr7\nOF NOTE, Vitamin D (Cholecalciferol) decreases the Dhcr7 activity through an indirect mechanism.54there HAS BEEN SOME SPECULATION on the POSSIBILITY of Teratogenic AFFECTS resulting from high doses of Vitamin D when taken as a Prenatal supplement.89HOWEVER, a RECENT REVIEW of Vitamin D supplementation among Pregnant women FOUND that Vitamin D supplementation MAY reduce the RISK of pre-eclampsia, low Birth weight, Preterm Birth90,91and adverse Kidney outcomes in offspring.92BECAUSE the mechanism of Vitamin D3's inhibition of Dhcr7 is indirect (UNLIKE our studied Pharmacological Dhcr7 Inhibitors) it is LIKELY to be MEDIATED through a COMPLEX pathway with many INTERACTING feedback loops."]	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 54), ('INCOMPLETE_EVIDENCE', 158), ('INCOMPLETE_EVIDENCE', 167), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 191), ('SUPERFICIAL_RELATIONSHIP', 218), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('INCOMPLETE_EVIDENCE', 314), ('INCOMPLETE_EVIDENCE', 378), ('INCOMPLETE_EVIDENCE', 415), ('IMPORTANT_CONSIDERATION', 430), ('PROBABLE_UNDERSTANDING', 530), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 603), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 675), ('DIFFICULT_TASK', 694), ('SUPERFICIAL_RELATIONSHIP', 720)]	18	[('CHEBI_33279', 'vitamin D5', 11, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 11, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 48, 'DHCR7'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 74, 'cholecalciferol'), ('PR_000006474', 'ATP-dependent RNA helicase A', 105, 'DHCR7'), ('CHEBI_50905', 'teratogenic agent', 206, 'teratogenic'), ('GO_0031649', 'heat generation', 206, 'teratogenic'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D'), ('GO_0007565', 'female pregnancy', 281, 'prenatal'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D'), ('GO_0007565', 'female pregnancy', 363, 'pregnant'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('GO_0007567', 'parturition', 457, 'birth'), ('GO_0007565', 'female pregnancy', 471, 'preterm'), ('GO_0042633', 'hair cycle', 479, 'birth90'), ('UBERON_0002113', 'kidney', 501, 'kidney'), ('CHEBI_33279', 'vitamin D5', 557, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 557, 'vitamin D3'), ('PR_000006474', 'ATP-dependent RNA helicase A', 584, 'DHCR7'), ('CHEBI_52217', 'pharmaceutical', 622, 'pharmacological'), ('PR_000006474', 'ATP-dependent RNA helicase A', 638, 'DHCR7'), ('CHEBI_35222', 'inhibitor', 644, 'inhibitors')]
PMC4973215	8/2016	S67-PMC4973215	['Vitamin D MAY AFFECT fetal growth through its EFFECT on Calcium Metabolism, bone growth and Placental Development.32ALTHOUGH INITIAL STUDIES SHOWED CONFLICTING results, more RECENT STUDIES SUGGEST that Vitamin D deficiency MAY adversely AFFECT growth and LEAD TO low Birth weight or sga infants.7,9,11,12,18,22,23,33BECAUSE of a KNOWN RELATIONSHIP between race and Vitamin D status, ATTENTION then turned to investigation of the RELATIONSHIP between race, Vitamin D deficiency and sga.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 223), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 255), ('PROBABLE_UNDERSTANDING', 316), ('INCOMPLETE_EVIDENCE', 329), ('SUPERFICIAL_RELATIONSHIP', 335), ('IMPORTANT_CONSIDERATION', 383), ('SUPERFICIAL_RELATIONSHIP', 429)]	17	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 56, 'calcium metabolism'), ('GO_0001890', 'placenta development', 92, 'placental development'), ('UBERON_0001987', 'placenta', 92, 'placental'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('GO_0007567', 'parturition', 267, 'birth'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 456, 'vitamin D')]
PMC5129897	10/2016	S16-PMC5129897	['NEITHER ASSUMPTION holds for Vitamin D. robert heaney OUTLINED the GUIDELINES for Nutrient studies including Vitamin D. the most RELEVANT features are that one SHOULD start with an understanding of the 25(Oh)D concentration–health outcome RELATION, 25(Oh)D concentrations SHOULD BE measured in prospective participants, ONLY those with low concentrations SHOULD BE enrolled, sufficient Vitamin D SHOULD BE given to raise 25(Oh)D concentrations to where a significant beneficial EFFECT is expected, and achieved 25(Oh)D concentrations SHOULD BE measured.2until those steps are followed routinely, FEW Vitamin D clinical TRIALS will report beneficial EFFECTS.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 67), ('PROBABLE_UNDERSTANDING', 67), ('IMPORTANT_CONSIDERATION', 129), ('FUTURE_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 239), ('FUTURE_WORK', 272), ('INCOMPLETE_EVIDENCE', 320), ('FUTURE_WORK', 355), ('FUTURE_WORK', 396), ('SUPERFICIAL_RELATIONSHIP', 478), ('FUTURE_WORK', 534), ('INCOMPLETE_EVIDENCE', 596), ('FUTURE_WORK', 619), ('SUPERFICIAL_RELATIONSHIP', 649)]	17	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_33284', 'nutrient', 82, 'nutrient'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 249, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 386, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 421, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 427, 'D'), ('CHEBI_71657', 'versiconol acetate', 511, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 517, 'D'), ('CHEBI_27300', 'vitamin D', 600, 'vitamin D')]
PMC3717170	5/2013	S41-PMC3717170	['THUS, IT IS POSSIBLE that Vitamin D deficiency has a generalized DETRIMENTAL IMPACT on antibacterial responses and MAY THEREFORE play a ROLE in many types of infectious diseases.5an IMPORTANT NOTE by hewison is that current data SUGGEST that this particular Immune Response to Vitamin D is restricted to Primates, UNDERLINING a POTENTIAL ROLE for Vitamin D in the evolution of Primate Immunity, BUT also LIMITING the scope of FURTHER in vivo STUDIES to explore this activity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 65), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('SUPERFICIAL_RELATIONSHIP', 136), ('IMPORTANT_CONSIDERATION', 182), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 229), ('PROBABLE_UNDERSTANDING', 314), ('INCOMPLETE_EVIDENCE', 328), ('SUPERFICIAL_RELATIONSHIP', 338), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 395), ('INCOMPLETE_EVIDENCE', 404), ('FUTURE_WORK', 426)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0006955', 'immune response', 258, 'immune response'), ('UBERON_0002405', 'immune system', 258, 'immune'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 304, 'primates'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 377, 'primate'), ('GO_0007566', 'embryo implantation', 385, 'immunity')]
PMC3717170	5/2013	S142-PMC3717170	['pittas CONCLUDED that ALTHOUGH the OBSERVATION studies STRONGLY SUGGEST an IMPORTANT ROLE for Vitamin D in type 2 diabetes, and such a ROLE is biologically PLAUSIBLE, there is LACK OF EVIDENCE from intervention studies to SUPPORT the CONTENTION that type 2 diabetes CAN be improved or PREVENTED by raising 25(Oh)D3Concentration.']	[('INCOMPLETE_EVIDENCE', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 55), ('INCOMPLETE_EVIDENCE', 64), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 85), ('SUPERFICIAL_RELATIONSHIP', 135), ('INCOMPLETE_EVIDENCE', 156), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234), ('INCOMPLETE_EVIDENCE', 266), ('SUPERFICIAL_RELATIONSHIP', 285)]	16	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 306, '25(OH)D3concentration'), ('PR_000005058', 'extracellular calcium-sensing receptor', 306, '25(OH ... D3concentration')]
PMC4800340	5/2016	S25-PMC4800340	["THIS STUDY SUGGESTS that low sunlight and PRESUMABLY suboptimal Vitamin D status at Birth is ASSOCIATED with Food Allergy Development in childhood.30a large scale population-based study in australia SHOWED that infants with low Serum 25-Hydroxyvitamin (Oh) D3Levels (≤50 nmol/l) had almost 12 times and 4 times higher risk of developing Peanut and egg allergies, respectively, in the first year of Life THAN infants with adequate Serum Vitamin D level.31HOWEVER, ANOTHER STUDY conducted in germany DEMONSTRATED that 25(Oh)D3Concentration in Pregnant women's Serum and in Cord Blood were positively ASSOCIATED with increased risk of Food Allergy Development among children in the first 2 years.32a RECENT randomized double-blind controlled TRIAL SHOWED that maternal Vitamin D3Supplementation for 6 weeks during Lactation increased the risk of Food allergy diagnosis by 3.42 times [95% confidence interval (ci)=1.02–11.77] among children of supplementation group compared to control group by 2 years of age.33due to lack OF robustly designed studies, a causal ASSOCIATION between Vitamin D status during Prenatal and Neonatal Period and Food allergy Development In Children remains INCONCLUSIVE."]	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 199), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 452), ('INCOMPLETE_EVIDENCE', 463), ('INCOMPLETE_EVIDENCE', 498), ('SUPERFICIAL_RELATIONSHIP', 598), ('INCOMPLETE_EVIDENCE', 697), ('INCOMPLETE_EVIDENCE', 739), ('INCOMPLETE_EVIDENCE', 745), ('ANOMALY_CURIOUS_FINDING', 1020), ('SUPERFICIAL_RELATIONSHIP', 1059), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1181)]	16	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007567', 'parturition', 84, 'birth'), ('CHEBI_33290', 'food', 109, 'food'), ('GO_0048467', 'gynoecium development', 109, 'food allergy development'), ('UBERON_0001977', 'blood serum', 228, 'serum'), ('CHEBI_60346', 'alpha-Kdo-(2->8)-alpha-Kdo-OAll', 234, '25-hydroxyvitamin (OH) D3levels'), ('NCBITaxon_10088', 'Mus <genus>', 337, 'peanut'), ('UBERON_0000104', 'life cycle', 398, 'life'), ('UBERON_0001977', 'blood serum', 430, 'serum'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 516, '25(OH)D3concentration'), ('GO_0007565', 'female pregnancy', 541, 'pregnant'), ('UBERON_0001977', 'blood serum', 558, 'serum'), ('UBERON_0009472', 'axilla', 571, 'cord blood'), ('CHEBI_33290', 'food', 632, 'food'), ('GO_0048467', 'gynoecium development', 632, 'food allergy development'), ('CHEBI_52915', 'phosphatediyl group', 766, 'vitamin D3supplementation'), ('GO_0007595', 'lactation', 811, 'lactation'), ('CHEBI_33290', 'food', 843, 'food'), ('CHEBI_27300', 'vitamin D', 1079, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1103, 'prenatal'), ('UBERON_0007221', 'neonate stage', 1116, 'neonatal period'), ('CHEBI_33290', 'food', 1136, 'food'), ('GO_0030163', 'protein catabolic process', 1149, 'development in children')]
PMC4973215	8/2016	S11-PMC4973215	['several large OBSERVATIONAL studies and meta-analyses have DESCRIBED the ASSOCIATION of maternal Vitamin D deficiency with Pregnancy COMPLICATIONS such as pre-eclampsia, Gestational diabetes and premature Birth.10,11,12,13racial DISPARITIES in maternal and neonatal Vitamin D deficiency HAVE BEEN DESCRIBED.1,14,15vitamin D deficiency is MORE COMMON and more SEVERE in black mothers.10,15,16,17,18,19racial DISPARITIES are also SEEN with Pregnancy COMPLICATIONS such as Preterm birth, pre-eclampsia and Gestational diabetes, as well as adverse neonatal outcomes including low Birth weight and small-for-Gestational-age (sga) status.15,17,20,21HOWEVER, the MAJORITY of studies EXAMINED maternal Vitamin D levels during the first and second Trimesters of Pregnancy7,8,22,23and CORRELATED these levels to neonatal outcomes.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBLEM_COMPLICATION', 133), ('IMPORTANT_CONSIDERATION', 229), ('INCOMPLETE_EVIDENCE', 287), ('INCOMPLETE_EVIDENCE', 297), ('PROBABLE_UNDERSTANDING', 338), ('IMPORTANT_CONSIDERATION', 359), ('IMPORTANT_CONSIDERATION', 407), ('INCOMPLETE_EVIDENCE', 428), ('PROBLEM_COMPLICATION', 448), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('PROBABLE_UNDERSTANDING', 656), ('INCOMPLETE_EVIDENCE', 676), ('SUPERFICIAL_RELATIONSHIP', 775)]	16	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy'), ('GO_0007565', 'female pregnancy', 170, 'gestational'), ('GO_0007567', 'parturition', 205, 'birth'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 322, 'D'), ('GO_0007565', 'female pregnancy', 438, 'pregnancy'), ('GO_0007565', 'female pregnancy', 470, 'preterm'), ('GO_0007565', 'female pregnancy', 503, 'gestational'), ('GO_0007567', 'parturition', 576, 'birth'), ('GO_0007565', 'female pregnancy', 603, 'gestational'), ('CHEBI_27300', 'vitamin D', 694, 'vitamin D'), ('GO_0043033', 'isoamylase complex', 739, 'trimesters'), ('GO_0007565', 'female pregnancy', 753, 'pregnancy7')]
PMC5385921	4/2017	S13-PMC5385921	['within the domain of nutritional exposures, there is GROWING INTEREST in the POSSIBLE LINKS between Gestational Vitamin D deficiency and an INCREASED RISK of asd.3–6this research HAS BEEN inspired BY Birth cohort studies, which have provided EVIDENCE that Prenatal Vitamin D deficiency (as assessed in maternal Sera) is ASSOCIATED with a range of later Brain-related outcomes including impaired Language Development7,8and Cognitive Development in offspring.9,10ALTHOUGH SEVERAL STUDIES HAVE REPORTED that Vitamin D deficiency or insufficiency is MORE COMMON in children with asd compared with controls,11few STUDIES addressed the specific HYPOTHESIS that Vitamin D deficiency during Gestation, a CRUCIAL time point in Neurodevelopment, is RELATED to the risk of subsequent asd.']	[('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 86), ('IMPORTANT_CONSIDERATION', 140), ('INCOMPLETE_EVIDENCE', 179), ('ANOMALY_CURIOUS_FINDING', 197), ('INCOMPLETE_EVIDENCE', 242), ('SUPERFICIAL_RELATIONSHIP', 320), ('ANOMALY_CURIOUS_FINDING', 459), ('INCOMPLETE_EVIDENCE', 470), ('INCOMPLETE_EVIDENCE', 486), ('PROBABLE_UNDERSTANDING', 546), ('INCOMPLETE_EVIDENCE', 608), ('INCOMPLETE_EVIDENCE', 639), ('IMPORTANT_CONSIDERATION', 696), ('SUPERFICIAL_RELATIONSHIP', 739)]	16	[('GO_0007565', 'female pregnancy', 100, 'gestational'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007567', 'parturition', 200, 'birth'), ('GO_0007565', 'female pregnancy', 256, 'prenatal'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('UBERON_0001977', 'blood serum', 311, 'sera'), ('UBERON_0000955', 'brain', 353, 'brain'), ('GO_0001763', 'morphogenesis of a branching structure', 395, 'language development7'), ('GO_0050787', 'detoxification of mercury ion', 422, 'cognitive development'), ('CHEBI_27300', 'vitamin D', 505, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 655, 'vitamin D'), ('GO_0007565', 'female pregnancy', 683, 'gestation'), ('GO_0007399', 'nervous system development', 718, 'neurodevelopment')]
PMC5706533	11/2017	S154-PMC5706533	['two trials INDICATED that Vitamin D COULD enhance Postnatal linear growth, an outcome RELATED to growth plates for which a HYPOTHESISED ROLE of Vitamin D is logical,26and which is the primary focus of our AS YET unpublished trial in bangladesh.27in the FEW STUDIES reporting EFFECTS on infant bone mass, results were MIXED; the largest of these trials—the mavidos study in the uk, which excluded women with 25(Oh)D concentrations <25 nmol/l28—has scheduled follow-up of children at age 4 years.29infant rickets was NOT REPORTED in any trials; THOUGH RARE, this is one of the MOST LIKELY paediatric conditions to be directly caused by poor maternal and early infant Vitamin D status.30adverse events were infrequently REPORTED, resulting in unreliable meta-analyses.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 205), ('ANOMALY_CURIOUS_FINDING', 208), ('INCOMPLETE_EVIDENCE', 253), ('SUPERFICIAL_RELATIONSHIP', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 515), ('ANOMALY_CURIOUS_FINDING', 543), ('INCOMPLETE_EVIDENCE', 550), ('PROBABLE_UNDERSTANDING', 575), ('PROBABLE_UNDERSTANDING', 580), ('INCOMPLETE_EVIDENCE', 717)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 50, 'postnatal'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 407, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 413, 'D'), ('CHEBI_27300', 'vitamin D', 665, 'vitamin D')]
PMC2913107	8/2010	S48-PMC2913107	['IF this THEORY is TRUE, the PATH TOWARDS EFFECTIVE PREVENTION – and PERHAPS a treatment EFFECT IF ADEQUATE physiological doses of Vitamin D are given – is so SIMPLE, so SAFE, so INEXPENSIVE, so READILY AVAILABLE and so easy, that it DEFIES IMAGINATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18), ('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 95), ('IMPORTANT_CONSIDERATION', 98), ('IMPORTANT_CONSIDERATION', 158), ('IMPORTANT_CONSIDERATION', 169), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 194), ('ANOMALY_CURIOUS_FINDING', 233)]	15	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3075531	7/2010	S43-PMC3075531	['relative to sun exposure, diet is a POOR source of Colecalciferol, providing ONLY 40-400 iu per Food serving,12WHEREAS whole-body uvb exposure for 20 min for a light-skinned Person during the summer months will produce AT LEAST 10,000 iu.713HOWEVER, increased skin pigmentation, age, use of sunscreen, built environment, and environmental FACTORS that reduce the strength of uvb reaching the earth’s surface (e.g., winter season, high latitude, pollution, cloud cover, and Ozone levels) all CONTRIBUTE to reduce skin Colecalciferol production to the point at which diet MIGHT become the primary source.7–14BECAUSE Melanin Pigment in Human skin absorbs uvb,28black People have lower 25 Hydroxyvitamin D concentrations than white People, and are OFTEN Vitamin D deficient.21HOWEVER, the risk of ms in black People is lower than in white People (BECAUSE of Genetic differences).28analyses of the RELATION between Vitamin D status and ms risk are THEREFORE BETTER done separately within each race/ethnic group.']	[('IMPORTANT_CONSIDERATION', 36), ('ANOMALY_CURIOUS_FINDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('PROBABLE_UNDERSTANDING', 219), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 241), ('SUPERFICIAL_RELATIONSHIP', 339), ('SUPERFICIAL_RELATIONSHIP', 491), ('INCOMPLETE_EVIDENCE', 570), ('PROBABLE_UNDERSTANDING', 606), ('PROBABLE_UNDERSTANDING', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 772), ('PROBABLE_UNDERSTANDING', 843), ('SUPERFICIAL_RELATIONSHIP', 893), ('PROBABLE_UNDERSTANDING', 943), ('IMPORTANT_CONSIDERATION', 953)]	15	[('CHEBI_50553', 'mancude carbobicyclic parent', 51, 'colecalciferol'), ('CHEBI_33290', 'food', 96, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 174, 'person'), ('CHEBI_25812', 'ozone', 473, 'ozone'), ('CHEBI_50553', 'mancude carbobicyclic parent', 517, 'colecalciferol'), ('CHEBI_25179', 'melanins', 614, 'melanin'), ('CHEBI_26130', 'biological pigment', 622, 'pigment'), ('NCBITaxon_9606', 'Homo sapiens', 633, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 664, 'people'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 682, '25 hydroxyvitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 728, 'people'), ('CHEBI_27300', 'vitamin D', 750, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 805, 'people'), ('NCBITaxon_10088', 'Mus <genus>', 835, 'people'), ('SO_0000704', 'gene', 854, 'genetic'), ('CHEBI_27300', 'vitamin D', 910, 'vitamin D')]
PMC4516377	6/2015	S79-PMC4516377	['SOME STUDIES17,18,20that evaluated the ASSOCIATION of Calcium and Vitamin D with obesity SHOWED a cross-sectional design and it is IMPORTANT to CONSIDER the existence of SOME LIMITATIONS, especially REVERSE causality, AS the exposure and outcome are collected simultaneously.30moreover, it is IMPORTANT to TAKE INTO account that one of the STUDIES14DID not make adjustments for CONFOUNDING FACTORS in the statistical analyses, in addition to the SMALL sample size used by others,13,14which CAN lead to erroneous conclusions.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 89), ('IMPORTANT_CONSIDERATION', 131), ('IMPORTANT_CONSIDERATION', 144), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 175), ('PROBLEM_COMPLICATION', 199), ('PROBABLE_UNDERSTANDING', 218), ('IMPORTANT_CONSIDERATION', 293), ('IMPORTANT_CONSIDERATION', 306), ('INCOMPLETE_EVIDENCE', 340), ('PROBLEM_COMPLICATION', 378), ('INCOMPLETE_EVIDENCE', 446), ('INCOMPLETE_EVIDENCE', 490)]	15	[('CHEBI_22313', 'alkaline earth metal atom', 54, 'calcium'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC4910734	6/2015	S133-PMC4910734	['autistic children are NOTORIOUS picky eaters, leading to SOME DOCUMENTED DEFICIENCIES in individual case STUDIES, such as Vitamin A deficiencies.53nutritional status based on dietary record keeping, not surprisingly, gives CONFLICTING results,118in PART BECAUSE autistic children OFTEN SUFFER from Gastrointestinal mal-absorption PROBLEMS77OR BECAUSE Genetic factors MAY play a ROLE in nutritional deficiency.']	[('IMPORTANT_CONSIDERATION', 22), ('IMPORTANT_CONSIDERATION', 22), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 73), ('INCOMPLETE_EVIDENCE', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 223), ('SUPERFICIAL_RELATIONSHIP', 249), ('PROBABLE_UNDERSTANDING', 254), ('PROBABLE_UNDERSTANDING', 280), ('IMPORTANT_CONSIDERATION', 286), ('IMPORTANT_CONSIDERATION', 330), ('PROBABLE_UNDERSTANDING', 343), ('INCOMPLETE_EVIDENCE', 367), ('SUPERFICIAL_RELATIONSHIP', 378)]	15	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 298, 'gastrointestinal'), ('SO_0000704', 'gene', 351, 'genetic')]
PMC5014971	8/2016	S24-PMC5014971	['other researchers have QUESTIONED this FINDING, citing both a CONCERN that circulating levels of 25-Oh-D at 20\u2009ng/ml have not been shown to be sufficient for bone health for all populations and that OTHER nonskeletal functions of Vitamin D POTENTIALLY IMPORTANT for health, which the iom report DISCOUNTS BASED ON INADEQUATE evidence, MAY yet be shown to be IMPORTANT and REQUIRE higher circulating levels of 25-Oh-D [17,18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 199), ('INCOMPLETE_EVIDENCE', 240), ('IMPORTANT_CONSIDERATION', 252), ('INCOMPLETE_EVIDENCE', 295), ('PROBABLE_UNDERSTANDING', 305), ('ANOMALY_CURIOUS_FINDING', 311), ('IMPORTANT_CONSIDERATION', 314), ('PROBLEM_COMPLICATION', 314), ('INCOMPLETE_EVIDENCE', 335), ('IMPORTANT_CONSIDERATION', 358), ('IMPORTANT_CONSIDERATION', 372)]	15	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 97, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 409, '25-OH-D')]
PMC5385921	4/2017	S123-PMC5385921	['Rodent MODELS BASED ON transient Prenatal exposure to Vitamin D deficiency have FOUND a range of persistent molecular, neurochemical and behavioural changes of interest to neuropsychiatry.32a number OF STUDIES have LINKED asd with Neuronal Migration.33migration-ASSOCIATED phenotypes such as changes in Neuronal density and volume, aberrant Minicolumns and heterotopias HAVE BEEN detected in patients with asd.34,35as Neuronal Migration starts at 6 weeks Gestation and USUALLY ends around 24 weeks Gestation, the OBSERVED ASSOCIATION between our mid-Gestation samples, which were drawn at ~20 weeks Gestation, and risk of asd CORROBORATES our PREVIOUS FINDINGS LINKING Vitamin D deficiency with abnormal Brain Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 199), ('SUPERFICIAL_RELATIONSHIP', 215), ('SUPERFICIAL_RELATIONSHIP', 262), ('INCOMPLETE_EVIDENCE', 370), ('INCOMPLETE_EVIDENCE', 469), ('INCOMPLETE_EVIDENCE', 513), ('SUPERFICIAL_RELATIONSHIP', 522), ('INCOMPLETE_EVIDENCE', 626), ('INCOMPLETE_EVIDENCE', 643), ('SUPERFICIAL_RELATIONSHIP', 661)]	15	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rodent'), ('GO_0007565', 'female pregnancy', 33, 'prenatal'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CL_0000540', 'neuron', 231, 'neuronal'), ('GO_0001764', 'neuron migration', 231, 'neuronal migration'), ('CL_0000540', 'neuron', 303, 'neuronal'), ('UBERON_0016512', 'lumen of duodenum', 341, 'minicolumns'), ('CL_0000540', 'neuron', 418, 'neuronal'), ('GO_0001764', 'neuron migration', 418, 'neuronal migration'), ('GO_0007565', 'female pregnancy', 455, 'gestation'), ('GO_0007565', 'female pregnancy', 498, 'gestation'), ('GO_0007565', 'female pregnancy', 550, 'gestation'), ('GO_0007565', 'female pregnancy', 599, 'gestation'), ('CHEBI_27300', 'vitamin D', 669, 'vitamin D'), ('GO_0007420', 'brain development', 704, 'brain development'), ('UBERON_0000955', 'brain', 704, 'brain')]
PMC5952272	5/2018	S141-PMC5952272	['methionine MAY then be activated by methionine adenosyltransferase to form S-Adenosylmethionine (sam), the primary Methyl Donor for most cellular methyltransferase reactions, including the methylation of dna, rna, proteins, Phospholipids, and Neurotransmitters.34\n\nVitamin D status as a risk factor for autism\nthe main source of Vitamin D is the solar uv-b radiation–RELATED Conversion Of 7-Dehydrocholesterol to Previtamin D3 in the skin and a lesser amount of Vitamin D from Food.35there is a GROWING BODY of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a risk of autism.36moreover, epidemiologic EVIDENCE SUPPORTS the ROLE of maternal Vitamin D deficiency AS a RISK FACTOR for the development of infantile autism.37maternal status of Vitamin D IS CONSIDERED INSUFFICIENT not ONLY in countries where solar radiation is low but also in very sunny places such saudi arabia, uae, iran, and jordan.38\nVitamin D functions in the body have been extensively studied by researchers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 367), ('INCOMPLETE_EVIDENCE', 495), ('INCOMPLETE_EVIDENCE', 525), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 572), ('INCOMPLETE_EVIDENCE', 589), ('INCOMPLETE_EVIDENCE', 639), ('INCOMPLETE_EVIDENCE', 648), ('SUPERFICIAL_RELATIONSHIP', 661), ('PROBABLE_UNDERSTANDING', 699), ('SUPERFICIAL_RELATIONSHIP', 704), ('INCOMPLETE_EVIDENCE', 787), ('PROBLEM_COMPLICATION', 801), ('INCOMPLETE_EVIDENCE', 818)]	15	[('CHEBI_50770', 'N,N-dihydroxypentahomomethionine', 75, 'S-adenosylmethionine'), ('CHEBI_81933', 'methasulfocarb', 115, 'methyl donor'), ('CHEBI_16247', 'phospholipid', 224, 'phospholipids'), ('CHEBI_25512', 'neurotransmitter', 243, 'neurotransmitters'), ('CHEBI_28384', 'vitamin K', 265, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('GO_0048669', 'collateral sprouting in absence of injury', 375, 'conversion of ... dehydrocholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 389, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 413, 'previtamin D3'), ('CHEBI_29238', 'tritium atom', 424, 'D3'), ('CHEBI_27300', 'vitamin D', 462, 'vitamin D'), ('CHEBI_33290', 'food', 477, 'food'), ('CHEBI_27300', 'vitamin D', 539, 'vitamin D'), ('UBERON_0000104', 'life cycle', 584, 'life'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 777, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 939, 'Vitamin D')]
PMC2290997	4/2008	S109-PMC2290997	['holick and others ASSERT that levels of 29 ng/ml or lower CAN be considered to INDICATE a relative insufficiency of Vitamin D. using this scale and considering VARIOUS epidemiologic STUDIES, an ESTIMATED 1 billion People worldwide have Vitamin D deficiency or insufficiency, says holick, who adds, “ACCORDING TO SEVERAL STUDIES, SOME forty to one hundred percent of the u.s. and european elderly men and women STILL living in the community [that is, not in nursing homes] are Vitamin D DEFICIENT.” holick ASSERTS that a large NUMBER of infants, children, adolescents, and Postmenopausal women also are Vitamin D INSUFFICIENT.']	[('INCOMPLETE_EVIDENCE', 18), ('PROBABLE_UNDERSTANDING', 18), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 194), ('INCOMPLETE_EVIDENCE', 299), ('INCOMPLETE_EVIDENCE', 312), ('INCOMPLETE_EVIDENCE', 329), ('IMPORTANT_CONSIDERATION', 410), ('IMPORTANT_CONSIDERATION', 486), ('INCOMPLETE_EVIDENCE', 505), ('INCOMPLETE_EVIDENCE', 526), ('IMPORTANT_CONSIDERATION', 612)]	14	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 214, 'people'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 476, 'vitamin D'), ('GO_0007595', 'lactation', 572, 'postmenopausal'), ('CHEBI_27300', 'vitamin D', 602, 'vitamin D')]
PMC3075531	7/2010	S12-PMC3075531	['there are DIFFERENCES in OPTIMAL level of 25-Hydroxy Vitamin D BUT nowadays internationally ACCEPTED normal range is between 75 nmol/l and 200 nmol/l, and we CONSIDER Serum level below 75 nmol/l and below 2 nmol/l as insufficiency and deficiency, respectively.42325even it SEEMS to achieve the prevention of Autoimmune diseases, the Serum level of Vitamin D MUST BE higher than the level required to reduce osteoporosis (higher than 75 nmol/l).4in attention to high prevalence of ms in iran and especially in isfahan which is ABOUT 43.5/100,0002627and GIVEN that iran is located in an latitude of 32° 50’ and longitude of 51° 43’ with enough sun exposure and BECAUSE nobody INVESTIGATED the RELATIONSHIP between Vitamin D, AS an environmental agent, and ms disease in iran before, we DECIDED to compare the Serum level of 25-Hydroxy Vitamin D in ms patients and healthy control group in isfahan region.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 92), ('INCOMPLETE_EVIDENCE', 158), ('ANOMALY_CURIOUS_FINDING', 273), ('IMPORTANT_CONSIDERATION', 358), ('INCOMPLETE_EVIDENCE', 526), ('PROBABLE_UNDERSTANDING', 552), ('PROBABLE_UNDERSTANDING', 659), ('QUESTION_ANSWERED_BY_THIS_WORK', 674), ('SUPERFICIAL_RELATIONSHIP', 691), ('PROBABLE_UNDERSTANDING', 723), ('QUESTION_ANSWERED_BY_THIS_WORK', 784)]	14	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 42, '25-hydroxy vitamin D'), ('UBERON_0001977', 'blood serum', 167, 'serum'), ('UBERON_0001442', 'skeleton of manus', 308, 'autoimmune'), ('UBERON_0001977', 'blood serum', 333, 'serum'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 712, 'vitamin D'), ('UBERON_0001977', 'blood serum', 807, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 822, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 841, 'D')]
PMC3427192	4/2012	S9-PMC3427192	['indeed, numerous dietary hypotheses HAVE BEEN PROPOSED.13-15among the Nutrients and antioxidants included in this HYPOTHESIS, Vitamin D is of particular INTEREST SINCE Vitamin D concentrations decrease with increased time spent indoors, decreased exposure to sunlight, less exercise, obesity, and inadequate Calcium intake.16additionally, a GROWING BODY of literature SUGGESTS that there is a RELATIONSHIP between Vitamin D status and asthma-RELATED Respiratory symptoms,17-22PRESUMABLY through the immunomodulatory EFFECTS of Vitamin D.23,24this brief review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on EMERGING Human STUDIES over the past decade.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 114), ('ANOMALY_CURIOUS_FINDING', 153), ('PROBABLE_UNDERSTANDING', 162), ('INCOMPLETE_EVIDENCE', 341), ('INCOMPLETE_EVIDENCE', 368), ('SUPERFICIAL_RELATIONSHIP', 393), ('SUPERFICIAL_RELATIONSHIP', 442), ('ANOMALY_CURIOUS_FINDING', 474), ('SUPERFICIAL_RELATIONSHIP', 516), ('SUPERFICIAL_RELATIONSHIP', 586), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 645)]	14	[('CHEBI_33284', 'nutrient', 70, 'nutrients'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 308, 'calcium'), ('CHEBI_27300', 'vitamin D', 414, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 450, 'respiratory'), ('CHEBI_27300', 'vitamin D', 527, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 570, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 654, 'human')]
PMC3659910	1/2013	S141-PMC3659910	['Vitamin D-deficiency in mothers have significantly INCREASED RISK of infantile rickets DUE TO INADEQUATE Maternal–fetal transfer of 25-Hydroxyvitamin D.[32] RECENT retrospective STUDIES FOUND a significant and PREVIOUSLY UNDETECTED ASSOCIATION of maternal Vitamin D deficiency with rickets-ASSOCIATED infant Heart Failure and with acute Lower Respiratory Tract infection,[33] a SERIOUS COMPLICATION OFTEN ASSOCIATED with sepsis without clinical signs of rickets.']	[('IMPORTANT_CONSIDERATION', 51), ('PROBABLE_UNDERSTANDING', 87), ('IMPORTANT_CONSIDERATION', 94), ('INCOMPLETE_EVIDENCE', 157), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 186), ('INCOMPLETE_EVIDENCE', 210), ('ANOMALY_CURIOUS_FINDING', 221), ('SUPERFICIAL_RELATIONSHIP', 232), ('SUPERFICIAL_RELATIONSHIP', 290), ('IMPORTANT_CONSIDERATION', 378), ('IMPORTANT_CONSIDERATION', 386), ('PROBABLE_UNDERSTANDING', 399), ('SUPERFICIAL_RELATIONSHIP', 405)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007618', 'mating', 105, 'maternal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 132, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('UBERON_0002081', 'cardiac atrium', 308, 'heart failure'), ('UBERON_0004905', 'articulation', 337, 'lower respiratory tract')]
PMC3668200	5/2013	S10-PMC3668200	['HOWEVER, measuring 1,25-Oh2-D levels AS a PREDICTOR of Vitamin D status CAN LEAD TO ERRONEOUS CONCLUSIONS BECAUSE, compared with 25(Oh)D levels, 1,25-Oh2-D levels CAN be normal or EVEN elevated DESPITE Vitamin D deficiency due to secondary hyperparathyroidism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 72), ('PROBABLE_UNDERSTANDING', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('PROBLEM_COMPLICATION', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 94), ('PROBABLE_UNDERSTANDING', 106), ('PROBLEM_COMPLICATION', 106), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 194)]	14	[('CHEBI_78731', '9(R)-HPETE', 21, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 129, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 135, 'D'), ('CHEBI_78731', '9(R)-HPETE', 147, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC3717170	5/2013	S144-PMC3717170	['THEREFORE, CONFIRMATION of a POTENTIAL beneficial EFFECT of Vitamin D in type 2 diabetes IS NEEDED in trials conducted in well-defined populations (e.g., pre-diabetes and early diabetes) SPECIFICALLY DESIGNED TO TEST the COMPELLING BUT YET UNPROVEN HYPOTHESIS that Vitamin D status is a direct CONTRIBUTOR to the pathogenesis of type 2 diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 50), ('FUTURE_WORK', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 187), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232), ('ANOMALY_CURIOUS_FINDING', 236), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 240), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 294)]	14	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D')]
PMC4998950	4/2016	S45-PMC4998950	['there are, HOWEVER, biological UNDERPINNINGS of a TRUE ASSOCIATION AS experimental studies INDICATE CRITICAL ROLES of Vitamin D in the Development and functioning Of the Brain.4\nIN SUMMARY, our results SUPPORT, BUT DO NOT PROVE, the HYPOTHESIS that maternal Vitamin D status is IMPLICATED in the aetiology of asd with comorbid intellectual disability.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('PROBABLE_UNDERSTANDING', 50), ('SUPERFICIAL_RELATIONSHIP', 55), ('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('FULL_UNKNOWN', 215), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 278)]	14	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0050887', 'determination of sensory modality', 135, 'development ... of ... brain'), ('UBERON_0000955', 'brain', 170, 'brain'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC3075531	7/2010	S11-PMC3075531	['SHOWED that sun exposure in Childhood period PREVENTS from ms.16third, it SEEMS low risk of ms in white population is ASSOCIATED with high Serum level of vitamin d or high oral Intake via supplements or oily fish in SOME STUDIES.217–19fourth, it HAVE BEEN SHOWN that Vitamin D CAN be a PROTECTIVE agent against experimental Autoimmune encephalitis in Mice (like ms in Humans).48finally, some scientists administered 100-1700 iu/day Vitamin D supplements in ms patients and OBSERVED the reduction of relapses.20–22the CANDIDATE for estimating Serum level of Vitamin D is 25-Hydroxy Vitamin D, BECAUSE of its prolonged half-Life.823–25it is used to assess an Individual’s overall Vitamin D nutritional status, BECAUSE its formation, UNLIKE that of 1, 25-Dihydroxy Vitamin D, is not tightly Regulated and it has a relatively long half-life (20-60 days).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 118), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 246), ('INCOMPLETE_EVIDENCE', 277), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 473), ('INCOMPLETE_EVIDENCE', 517), ('PROBABLE_UNDERSTANDING', 592), ('PROBABLE_UNDERSTANDING', 708), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 731)]	13	[('UBERON_0013628', 'pollical pad', 28, 'childhood'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('GO_0007631', 'feeding behavior', 177, 'intake'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 324, 'autoimmune'), ('NCBITaxon_10088', 'Mus <genus>', 351, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 368, 'humans'), ('CHEBI_27300', 'vitamin D', 432, 'vitamin D'), ('UBERON_0001977', 'blood serum', 542, 'serum'), ('CHEBI_27300', 'vitamin D', 557, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 570, '25-hydroxy vitamin D'), ('UBERON_0000104', 'life cycle', 622, 'life'), ('NCBITaxon_1', 'root', 657, 'individual'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_43176', 'hydroxy group', 752, 'dihydroxy'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('GO_0065007', 'biological regulation', 788, 'regulated')]
PMC3347028	3/2012	S226-PMC3347028	['the health effects data from Vitamin D supplementation trials THUS FAR, WHILE TANTALIZING, are NOT CONCLUSIVE in SHOWING definitive “proof” for Vitamin D AS a POTENTIAL CANDIDATE in the reduction of comorbidities of Pregnancy, YET one CANNOT DISMISS the strong CORRELATION between reduced RISK with increased Serum 25(Oh)D concentrations.']	[('INCOMPLETE_EVIDENCE', 62), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 113), ('PROBABLE_UNDERSTANDING', 154), ('INCOMPLETE_EVIDENCE', 159), ('INCOMPLETE_EVIDENCE', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('ANOMALY_CURIOUS_FINDING', 227), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235), ('SUPERFICIAL_RELATIONSHIP', 261), ('IMPORTANT_CONSIDERATION', 289)]	13	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy'), ('UBERON_0001977', 'blood serum', 309, 'serum'), ('CHEBI_71657', 'versiconol acetate', 315, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 315, '25(OH)D')]
PMC3470091	9/2012	S20-PMC3470091	['THEREFORE, Vitamin D supplementation in high doses HAS BEEN RECOMMENDED, and oral doses of 20000 or 40000 iu were ASSOCIATED with positive outcomes.6,14moreover, higher oral dose of (6400 iu per day) to Lactating mothers significantly increased Vitamin D status in mothers as well as the Vitamin D content and antirachitic activity of their Milk.14THEREFORE, high doses of Vitamin D, EITHER orally OR through injection, HAS RECENTLY BEEN RECOMMENDED.15-24\na single dose of Vitamin D, administered parenterally, WOULD BE more EFFECTIVE, BECAUSE it is not associated with the NONCOMPLIANCE ASSOCIATED with an oral dose.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 51), ('FUTURE_WORK', 60), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 384), ('INCOMPLETE_EVIDENCE', 420), ('FUTURE_WORK', 438), ('FUTURE_PREDICTION', 511), ('SUPERFICIAL_RELATIONSHIP', 525), ('PROBLEM_COMPLICATION', 536), ('PROBLEM_COMPLICATION', 574), ('SUPERFICIAL_RELATIONSHIP', 588)]	13	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 203, 'lactating'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin D'), ('UBERON_0001913', 'milk', 341, 'milk'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D')]
PMC3717763	8/2013	S18-PMC3717763	["in RECENT YEARS, there HAS BEEN particular CONCERN about Vitamin D levels among children in the uk, and the rise in Vitamin D deficiency disease, presenting as rickets, symptomatic hypocalcaemia and motor delay.5–12vitamin d is hard to source through diet alone; 90% comes from exposure to sunlight.13if the mother's Vitamin D status is low during Pregnancy, the infant will also have low levels.14estimates CONSISTENTLY SHOW that the MAJORITY of uk children aged between 1.5 and 3\u2005years do not get their daily reference Nutrient intake of Vitamin D.15–18one RECENT STUDY REPORTS that supplying hs Vitamins to all Pregnant women and young children resulted in a substantial reduction in symptomatic Vitamin D deficiency in children in one primary care trust (pct), where 75% of the population were from ethnic minority groups PARTICULARLY AT RISK of Vitamin D deficiency.19\nTHIS PAPER reports on research with parents and professionals with the AIM of understanding WHY the provision of free hs Vitamins has not resulted in higher levels of use among low income families in england."]	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 43), ('PROBABLE_UNDERSTANDING', 408), ('INCOMPLETE_EVIDENCE', 421), ('PROBABLE_UNDERSTANDING', 435), ('INCOMPLETE_EVIDENCE', 559), ('INCOMPLETE_EVIDENCE', 572), ('IMPORTANT_CONSIDERATION', 826), ('IMPORTANT_CONSIDERATION', 839), ('QUESTION_ANSWERED_BY_THIS_WORK', 874), ('QUESTION_ANSWERED_BY_THIS_WORK', 945), ('EXPLICIT_QUESTION', 966)]	13	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin D'), ('GO_0007565', 'female pregnancy', 348, 'pregnancy'), ('CHEBI_33284', 'nutrient', 521, 'nutrient'), ('CHEBI_27300', 'vitamin D', 540, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 598, 'vitamins'), ('GO_0007565', 'female pregnancy', 614, 'pregnant'), ('CHEBI_27300', 'vitamin D', 699, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 850, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 995, 'vitamins')]
PMC4377879	3/2015	S128-PMC4377879	['christian and stewart [52] have SUGGESTED a conceptual FRAMEWORK for HOW Maternal diet and Micronutrient status MAY EFFECT the development of chronic disease; the MOST LIKELY, GIVEN PRESENT KNOWLEDGE, SEEM to be Vitamin A, Folate, iron and zinc and PERHAPS calcium and magnesium AS SHOWN in their conceptual framework (figure 1).']	[('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 55), ('EXPLICIT_QUESTION', 69), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 116), ('PROBABLE_UNDERSTANDING', 163), ('PROBABLE_UNDERSTANDING', 168), ('INCOMPLETE_EVIDENCE', 176), ('PROBABLE_UNDERSTANDING', 176), ('INCOMPLETE_EVIDENCE', 182), ('ANOMALY_CURIOUS_FINDING', 201), ('INCOMPLETE_EVIDENCE', 249), ('INCOMPLETE_EVIDENCE', 279)]	13	[('GO_0007618', 'mating', 73, 'maternal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 91, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 223, 'folate')]
PMC4684854	12/2015	S57-PMC4684854	['LIMITATIONS of Vitamin D research as RELATED to Gestational outcomes\nALTHOUGH maternal-fetal outcomes in the presence of adequate Gestational Vitamin D are GENERALLY favorable as REPORTED in the medical literature, SOME reports HAVE BEEN INCONSISTENT and CAST DOUBT on the LINK between Gestational Vitamin D sufficiency and health.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('ANOMALY_CURIOUS_FINDING', 69), ('PROBABLE_UNDERSTANDING', 156), ('INCOMPLETE_EVIDENCE', 179), ('INCOMPLETE_EVIDENCE', 215), ('INCOMPLETE_EVIDENCE', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 260), ('INCOMPLETE_EVIDENCE', 260), ('SUPERFICIAL_RELATIONSHIP', 273)]	13	[('CHEBI_28384', 'vitamin K', 15, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'Gestational'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0007565', 'female pregnancy', 286, 'gestational'), ('CHEBI_27300', 'vitamin D', 298, 'vitamin D')]
PMC5045784	10/2016	S74-PMC5045784	['fetal and newborn concentrations of 25(Oh)D DEPEND ON and CORRELATE with maternal Serum levels AS the fetus has no endogenous production of 25(Oh)d and DEPENDS on transplacental transfer.28THIS occurs MAINLY in the third trimester and THEREFORE, as we and others PREVIOUSLY REPORTED, preterm infants are at INCREASED RISK of Vitamin D deficiency.10,29our PRIOR STUDY DEMONSTRATED that Birth before 32 completed weeks of Gestation is an INDEPENDENT RISK FACTOR for low 25(Oh)d levels at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 152), ('PROBABLE_UNDERSTANDING', 187), ('PROBABLE_UNDERSTANDING', 201), ('PROBABLE_UNDERSTANDING', 235), ('INCOMPLETE_EVIDENCE', 263), ('IMPORTANT_CONSIDERATION', 307), ('INCOMPLETE_EVIDENCE', 355), ('INCOMPLETE_EVIDENCE', 367), ('SUPERFICIAL_RELATIONSHIP', 436), ('SUPERFICIAL_RELATIONSHIP', 448)]	13	[('CHEBI_71657', 'versiconol acetate', 36, '25(OH)D'), ('UBERON_0001977', 'blood serum', 82, 'serum'), ('CHEBI_63056', 'zinc cation', 140, '25(OH'), ('CHEBI_27300', 'vitamin D', 325, 'vitamin D'), ('GO_0007567', 'parturition', 385, 'birth'), ('GO_0007565', 'female pregnancy', 420, 'gestation'), ('CHEBI_30778', 'gallic acid', 468, '25(OH)'), ('GO_0007567', 'parturition', 486, 'birth')]
PMC2821652	2/2010	S77-PMC2821652	["in developing a definition of adherence by Serum 25(Oh)D levels, SEVERAL ASSUMPTIONS were made a priori about WHAT types of PATTERNS of 25(Oh)D levels would be exhibited by adherent and nonadherent patients BASED ON CURRENT KNOWLEDGE about the Metabolism Of Vitamin D.\nassumption 1\nBASED ON KNOWN pharmacokinetics of Vitamin D [64], adherent patients' 25(Oh)D levels would be expected to rise over time, eventually reaching a steady state after 2 months of therapy; nonadherent patients' 25(Oh)D levels would be expected to be erratic and to exhibit variable PATTERNS that would differ significantly from adherent patients' 25(Oh)D levels over the same dosing interval."]	[('INCOMPLETE_EVIDENCE', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('EXPLICIT_QUESTION', 110), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 207), ('PROBABLE_UNDERSTANDING', 207), ('SUPERFICIAL_RELATIONSHIP', 207), ('INCOMPLETE_EVIDENCE', 216), ('PROBABLE_UNDERSTANDING', 282), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 291), ('SUPERFICIAL_RELATIONSHIP', 559)]	12	[('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 49, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 136, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 142, 'D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 244, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 317, 'vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 325, 'D'), ('CHEBI_71657', 'versiconol acetate', 352, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 358, 'D'), ('CHEBI_71657', 'versiconol acetate', 488, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 488, '25'), ('PR_000011614', 'opioid growth factor receptor', 491, 'OH'), ('PR_000006444', 'diacylglycerol kinase delta', 494, 'D'), ('CHEBI_71657', 'versiconol acetate', 624, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 624, '25(OH ... D')]
PMC2913107	8/2010	S49-PMC2913107	['seventeen Vitamin D EXPERTS RECENTLY STATED, ‘IN OUR OPINION, children with chronic illnesses such as autism, diabetes and/or frequent infections SHOULD BE supplemented with higher doses of sunshine or Vitamin D3, doses ADEQUATE to maintain their 25(Oh)D levels in the mid-normal of the reference range [65 ng/ml (162 nmol/l)] – and SHOULD BE so supplemented year round.’ (22)\nfinally, IF TRUE, a DARKER SIDE of the THEORY EMERGES.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 146), ('IMPORTANT_CONSIDERATION', 220), ('IMPORTANT_CONSIDERATION', 333), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 386), ('PROBABLE_UNDERSTANDING', 389), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 397), ('INCOMPLETE_EVIDENCE', 416), ('INCOMPLETE_EVIDENCE', 423)]	12	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 202, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 202, 'vitamin D3'), ('CHEBI_71657', 'versiconol acetate', 247, '25(OH)D')]
PMC3695234	7/2013	S17-PMC3695234	['ANOTHER STUDY REPORTED regional DIFFERENCES in the number of prescriptions of epipens within the united states; the highest rates were FOUND in new england, and the lowest in the southern states.2THESE results MAY provide IMPORTANT etiologic CLUES and INDICATE the POTENTIAL ROLE of Vitamin D in atopic disease susceptibility.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 135), ('PROBABLE_UNDERSTANDING', 195), ('PROBABLE_UNDERSTANDING', 195), ('INCOMPLETE_EVIDENCE', 210), ('IMPORTANT_CONSIDERATION', 222), ('INCOMPLETE_EVIDENCE', 242), ('INCOMPLETE_EVIDENCE', 252), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 275)]	12	[('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
PMC3717170	5/2013	S76-PMC3717170	['it WAS THOUGHT for decades that Human Milk was minimally sufficient in Vitamin D;17yet, PRELIMINARY results of the RECENTLY COMPLETED nichd Vitamin D supplementation trial during Lactation SHOW that when a mother is Vitamin D replete, with an Intake of 6400 iu Vitamin D3/day, Breast Milk is replete and a breastfeeding infant has excellent Vitamin D status without infant supplementation that is COMPARABLE to combined maternal and infant supplementation of 400 iu Vitamin D3/day.18the IMPLICATIONS of SAFELY achieving vitamin d SUFFICIENCY for both mother and breastfeeding infant solely through maternal supplementation is just BEGINNING TO BE UNDERSTOOD and will LIKELY CHALLENGE researchers for decades to come.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 397), ('IMPORTANT_CONSIDERATION', 487), ('IMPORTANT_CONSIDERATION', 503), ('IMPORTANT_CONSIDERATION', 530), ('INCOMPLETE_EVIDENCE', 631), ('PROBABLE_UNDERSTANDING', 667), ('DIFFICULT_TASK', 674)]	12	[('NCBITaxon_9606', 'Homo sapiens', 32, 'human'), ('UBERON_0001913', 'milk', 38, 'milk'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007595', 'lactation', 179, 'lactation'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0007631', 'feeding behavior', 243, 'intake'), ('CHEBI_33279', 'vitamin D5', 261, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 261, 'vitamin D3'), ('UBERON_0000310', 'breast', 277, 'breast'), ('UBERON_0001913', 'milk', 284, 'milk'), ('CHEBI_27300', 'vitamin D', 341, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 466, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 466, 'vitamin D3')]
PMC3717170	5/2013	S191-PMC3717170	['the iom EXPERT panel CONCLUDED that MOST americans (97.5%) had adequate levels of Vitamin D, BASED ON their CONCLUSION that a 25(Oh)d3of 20 ng/ml or greater was sufficient, RAISING the QUESTION of WHETHER supplementation was EVEN NEEDED.']	[('PROBABLE_UNDERSTANDING', 8), ('INCOMPLETE_EVIDENCE', 21), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 93), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 173), ('EXPLICIT_QUESTION', 185), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('EXPLICIT_QUESTION', 197), ('ANOMALY_CURIOUS_FINDING', 225), ('IMPORTANT_CONSIDERATION', 230)]	12	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 126, '25(OH)')]
PMC3933171	3/2014	S12-PMC3933171	['introduction\nlow Vitamin D (vitd) status is a risk FACTOR for rickets and HAS BEEN ASSOCIATED with INCREASED prevalence of Respiratory infections and other adverse health outcomes in infants and children.12in response to the CONCERN about widespread childhood vitd deficiency, professional bodies have RECOMMENDED vitd intake of 400\u2005iu/ day for all infants.13the european society for paediatrics gastroenterology, hepatology and nutrition RECOMMENDS 800–1000\u2005iu/day for preterm infants.4based on BIOMARKERS of vitd status MOSTLY in adults, Serum 25-Hydroxyvitamin-D [25(Oh)D] concentration ≥50\u2005nmol/l was also RECOMMENDED.13HOWEVER, the functional benefit of this level is CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 225), ('FUTURE_WORK', 302), ('FUTURE_WORK', 439), ('SUPERFICIAL_RELATIONSHIP', 496), ('PROBABLE_UNDERSTANDING', 522), ('FUTURE_WORK', 610), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 622), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 673)]	12	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 123, 'respiratory'), ('UBERON_0001977', 'blood serum', 540, 'serum'), ('CHEBI_67320', 'majusculamide A', 546, '25-hydroxyvitamin-D'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D')]
PMC4216020	10/2014	S72-PMC4216020	['a larger prospective study, HOWEVER, DID NOT demonstrate an ASSOCIATED RISK between maternal smoking and jia.92\nOTHER Perinatal exposures and Pregnancy-related FACTORS HAVE BEEN investigated.47,92an australian study that reviewed 262 cases and matched controls IDENTIFIED a TREND towards a PROTECTIVE EFFECT with Prenatal Nutritional Supplements.47the mothers of children that eventually developed jia were less LIKELY to receive supplementation with Prenatal multivitamins (24.9% versus 30.8%), Vitamin D (3.3% versus 7.8%), Fish Oil (2.9% versus 6.4%), Calcium (10.2% versus 14.9%), Iron (35.4% versus 40.3%), and Folate (61.4% versus 64.8%) while Pregnant compared to controls.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 160), ('INCOMPLETE_EVIDENCE', 168), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 274), ('SUPERFICIAL_RELATIONSHIP', 290), ('SUPERFICIAL_RELATIONSHIP', 301), ('PROBABLE_UNDERSTANDING', 412)]	12	[('GO_0036268', 'swimming', 118, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 118, 'perinatal'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy'), ('GO_0007565', 'female pregnancy', 313, 'prenatal'), ('CHEBI_7495', 'nefazodone hydrochloride', 322, 'nutritional'), ('CHEBI_33341', 'titanium atom', 334, 'supplements'), ('GO_0007565', 'female pregnancy', 451, 'prenatal'), ('CHEBI_27300', 'vitamin D', 496, 'vitamin D'), ('CHEBI_34766', 'Furamizole', 526, 'fish oil'), ('CHEBI_22313', 'alkaline earth metal atom', 555, 'calcium'), ('CHEBI_24870', 'ion', 585, 'iron'), ('CHEBI_30863', '5-azaorotic acid', 616, 'folate'), ('GO_0007565', 'female pregnancy', 650, 'pregnant')]
PMC4329404	10/2014	S162-PMC4329404	['a mechanism for this FINDING was NOT REPORTED, but IN AGREEMENT with OUR FINDINGS, Vitamin D supplementation in that MODEL also ONLY SHOWED an improvement in allergic inflammation, BUT NOT a complete resolution down to levels in nonallergic Mice, and THUS, the authors conclude Vitamin D supplementation is LIKELY an IMPORTANT adjunct in the treatment of asthma, RATHER than a candidate that will achieve a cure.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 133), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('PROBABLE_UNDERSTANDING', 251), ('PROBABLE_UNDERSTANDING', 307), ('IMPORTANT_CONSIDERATION', 317), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 363)]	12	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 241, 'mice'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D')]
PMC4340999	3/2015	S109-PMC4340999	['results in the PRESENT STUDY IMPLY that Prenatal Vitamin D status MIGHT be a POTENTIAL pathway LINKING ll with Adult risks of obesity39,40and a range of chronic diseases.8–10HOWEVER, seasonal variation in ll DEPENDING ON region SUGGESTS that ll CAN ONLY be used as anthropometric BIOMARKER of Prenatal Vitamin D status in SOME geographic regions.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('PROBABLE_UNDERSTANDING', 29), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 245), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 280), ('INCOMPLETE_EVIDENCE', 322)]	12	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adult'), ('GO_0007565', 'female pregnancy', 293, 'prenatal'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC4516109	5/2015	S20-PMC4516109	['clinical presentations include Abdominal pain, vomiting, lethargy, hallucinations, confusion, hypoglycemia, deafness, tinnitus, tachypnea, irritability, Metabolic acidosis, coma and death.15\nrisks of OTHER topical agents, such as Anthralin and Calcipotriol on Human studies are NOT KNOWN and THUS most authors CONTRAINDICATE these treatments.7,15calcipotriol is a by-product of Vitamin D3, OFTEN used in combination with topical Corticosteroids in order to increase their effectiveness and minimize irritation.12nevertheless, studies evidenced its systemic absorption in Humans after application on psoriasis plaques and the development of Vitamin D-induced toxicity after treatment with Calcipotriol TENDS to increase the risk of teratogenicity.12\nALTHOUGH the NUMBER OF cases is LIMITED, coal tar HAS BEEN ASSOCIATED with spontaneous Abortions and congenital disorders, and WAS CONSIDERED Teratogenic in Animal studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('FULL_UNKNOWN', 278), ('PROBABLE_UNDERSTANDING', 292), ('IMPORTANT_CONSIDERATION', 310), ('PROBABLE_UNDERSTANDING', 390), ('SUPERFICIAL_RELATIONSHIP', 701), ('ANOMALY_CURIOUS_FINDING', 749), ('INCOMPLETE_EVIDENCE', 762), ('INCOMPLETE_EVIDENCE', 781), ('INCOMPLETE_EVIDENCE', 799), ('SUPERFICIAL_RELATIONSHIP', 808), ('INCOMPLETE_EVIDENCE', 876)]	12	[('UBERON_0000916', 'abdomen', 31, 'abdominal'), ('GO_0008152', 'metabolic process', 153, 'metabolic'), ('CHEBI_37510', 'anthralin', 230, 'anthralin'), ('CHEBI_50749', 'calcipotriol', 244, 'calcipotriol'), ('NCBITaxon_9606', 'Homo sapiens', 260, 'human'), ('CHEBI_33279', 'vitamin D5', 378, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 378, 'vitamin D3'), ('CHEBI_50850', 'etabonate ester', 429, 'corticosteroids'), ('NCBITaxon_9606', 'Homo sapiens', 571, 'humans'), ('CHEBI_27300', 'vitamin D', 640, 'vitamin D'), ('CHEBI_50749', 'calcipotriol', 688, 'calcipotriol'), ('GO_0006915', 'apoptotic process', 836, 'abortions'), ('CHEBI_50905', 'teratogenic agent', 891, 'teratogenic'), ('NCBITaxon_33208', 'Metazoa', 906, 'animal')]
PMC4684854	12/2015	S112-PMC4684854	['AS hypersensitivity outcomes MAY also be seen in those children Born to mothers contaminated with assorted Xenobiotics in Pregnancy [84–89], HOWEVER, it is NOT KNOWN WHETHER the Immune Dysregulation and hypersensitivity MAY BE the consequence of a primary Gestational insufficiency of Vitamin D, OR WHETHER various chemical Toxicants MIGHT play a ROLE by impairing Vitamin D Uptake, Renal synthesis, and assimilation [25,90] WHILE at the same time inducing Immune compromise and hypersensitivity through OTHER mechanisms [91].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('FULL_UNKNOWN', 156), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166), ('INCOMPLETE_EVIDENCE', 220), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 296), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 299), ('INCOMPLETE_EVIDENCE', 334), ('SUPERFICIAL_RELATIONSHIP', 347), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 425), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 504)]	12	[('GO_0007567', 'parturition', 64, 'born'), ('CHEBI_35703', 'xenobiotic', 107, 'xenobiotics'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy'), ('GO_0001774', 'microglial cell activation', 178, 'immune dysregulation'), ('UBERON_0002405', 'immune system', 178, 'immune'), ('GO_0007565', 'female pregnancy', 256, 'gestational'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 324, 'toxicants'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D'), ('GO_0071939', 'vitamin A import', 365, 'vitamin D uptake'), ('UBERON_0002113', 'kidney', 383, 'renal'), ('UBERON_0002405', 'immune system', 457, 'immune')]
PMC4684854	12/2015	S132-PMC4684854	['it is APPARENT that training is REQUIRED to establish clinical competency in (i) understanding of the ROLE of various Nutrients in Human health, (ii) HOW TO ASSESS nutritional biochemistry in patients, and (iii) and HOW to intervene to secure Nutrient sufficiency for Individuals and population groups\nwith the MOUNTING EVIDENCE of several health sequelae ASSOCIATED with Gestational Vitamin D deficiency, the VALUE of Preconception education and care by health providers and PUBLIC HEALTH bodies to secure Vitamin D sufficiency throughout Gestation is EVIDENT.']	[('ANOMALY_CURIOUS_FINDING', 6), ('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 102), ('EXPLICIT_QUESTION', 150), ('QUESTION_ANSWERED_BY_THIS_WORK', 154), ('EXPLICIT_QUESTION', 216), ('INCOMPLETE_EVIDENCE', 311), ('SUPERFICIAL_RELATIONSHIP', 356), ('IMPORTANT_CONSIDERATION', 410), ('IMPORTANT_CONSIDERATION', 476), ('PROBABLE_UNDERSTANDING', 553)]	12	[('CHEBI_33284', 'nutrient', 118, 'nutrients'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('CHEBI_33284', 'nutrient', 243, 'nutrient'), ('NCBITaxon_1', 'root', 268, 'individuals'), ('GO_0007565', 'female pregnancy', 372, 'gestational'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D'), ('GO_0007565', 'female pregnancy', 419, 'preconception'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('GO_0007565', 'female pregnancy', 540, 'gestation')]
PMC5028238	10/2016	S86-PMC5028238	['improved hip formation IS THOUGHT TO enable females to produce more offspring and thereby provide another carrier advantage.11,35in addition, Vitamin D HAS BEEN SHOWN to increase chances of Pregnancy for infertile women receiving in Vitro Fertilization.48vitamin d has many pleiotropic ROLES in Reproductive outcomes and CAN AFFECT both male and female Fertility.49THEREFORE, there COULD BE MULTIPLE mechanisms that COULD EXPLAIN WHY evolution favors Vitamin D Production in northern climates through mutations in Dhcr7 (and other Genes).']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 321), ('SUPERFICIAL_RELATIONSHIP', 325), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 363), ('INCOMPLETE_EVIDENCE', 382), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 391), ('INCOMPLETE_EVIDENCE', 416), ('PROBABLE_UNDERSTANDING', 422), ('EXPLICIT_QUESTION', 430)]	12	[('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy'), ('GO_0007601', 'visual perception', 233, 'vitro'), ('GO_0009566', 'fertilization', 239, 'fertilization'), ('GO_0000003', 'reproduction', 295, 'reproductive'), ('GO_0009566', 'fertilization', 353, 'fertility'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 451, 'vitamin D production'), ('PR_000006474', 'ATP-dependent RNA helicase A', 514, 'DHCR7'), ('SO_0000704', 'gene', 531, 'genes')]
PMC5784894	1/2018	S191-PMC5784894	['THIS work THUS establishes Early Life Vitamin D deficiency as a FACTOR that CAN CONTRIBUTE to Adult osteoporosis; offers a POTENTIAL Solution–supplementation of Vitamin D during Pregnancy and infancy; and presents a MODEL system TO IDENTIFY pathways that COULD BE TARGETED in Adult Life to prevent or treat osteoporosis, a GLOBAL health PROBLEM.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 10), ('SUPERFICIAL_RELATIONSHIP', 64), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 216), ('QUESTION_ANSWERED_BY_THIS_WORK', 229), ('INCOMPLETE_EVIDENCE', 255), ('FUTURE_WORK', 264), ('IMPORTANT_CONSIDERATION', 323), ('IMPORTANT_CONSIDERATION', 337)]	12	[('UBERON_0001847', 'lobule of pinna', 27, 'early life'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0007023', 'adult organism', 94, 'adult'), ('CHEBI_75958', 'solution', 133, 'solution'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('GO_0007565', 'female pregnancy', 178, 'pregnancy'), ('UBERON_0000113', 'post-juvenile adult stage', 276, 'adult life')]
PMC2841444	2/2010	S11-PMC2841444	['the following are SUPPORTED by moderate- to high-quality evidence and STRONGLY RECOMMENDED for lmics:\n• two INTERVENTIONS PREVENT Preterm Births—smoking cessation and Progesterone\n• eight INTERVENTIONS PREVENT stillbirths—balanced protein energy supplementation, screening and treatment of syphilis, intermittant presumptive treatment for malaria during Pregnancy, Insecticide-treated mosquito nets, Birth preparedness, emergency obstetric care, cesarean section for breech presentation, and elective induction for post-term Delivery\n• eleven INTERVENTIONS improve survival of Preterm newborns—prophylactic Steroids in Preterm labor, Antibiotics for prom, Vitamin K supplementation at Delivery, case management of neonatal sepsis and pneumonia, delayed Cord clamping, room air (vs. 100% oxygen) for resuscitation, hospital-based kangaroo mother care, early breastfeeding, thermal care, and Surfactant therapy and application of continued distending pressure to the Lungs for Respiratory Distress syndrome\n\nconclusion\nthe research paradigm for discovery science and intervention development MUST BE BALANCED to address PREVENTION as well as improve morbidity and mortality in all settings.']	[('INCOMPLETE_EVIDENCE', 18), ('PROBABLE_UNDERSTANDING', 70), ('FUTURE_WORK', 79), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 543), ('IMPORTANT_CONSIDERATION', 1090), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1098), ('SUPERFICIAL_RELATIONSHIP', 1118)]	11	[('GO_0007565', 'female pregnancy', 130, 'preterm births'), ('CHEBI_17026', 'progesterone', 167, 'progesterone'), ('GO_0007565', 'female pregnancy', 354, 'pregnancy'), ('CHEBI_24852', 'insecticide', 365, 'insecticide'), ('GO_0007567', 'parturition', 400, 'birth'), ('GO_0007567', 'parturition', 525, 'delivery'), ('GO_0007565', 'female pregnancy', 577, 'preterm'), ('CHEBI_35341', 'steroid', 607, 'steroids'), ('GO_0007565', 'female pregnancy', 619, 'preterm'), ('CHEBI_33282', 'antibacterial agent', 634, 'antibiotics'), ('CHEBI_27300', 'vitamin D', 656, 'vitamin K'), ('GO_0007567', 'parturition', 685, 'delivery'), ('UBERON_0002240', 'spinal cord', 753, 'cord'), ('CHEBI_35195', 'surfactant', 890, 'surfactant'), ('UBERON_0002048', 'lung', 965, 'lungs'), ('UBERON_0003495', 'respiratory system arteriole', 975, 'respiratory distress')]
PMC2889879	5/2010	S141-PMC2889879	['our results of a PROTECTIVE EFFECT of Vitamin D intake MUST BE CONSIDERED AS ROUGH, SINCE we ONLY measure the dietary intake of Vitamin D. a more complete picture of the Vitamin D status COULD have been supplied through Vitamin D levels in Blood; HOWEVER, NO biological samples are AVAILABLE.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 63), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 77), ('PROBLEM_COMPLICATION', 84), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 187), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('FULL_UNKNOWN', 256)]	11	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('UBERON_0000178', 'blood', 240, 'blood')]
PMC2963768	10/2010	S13-PMC2963768	['HOWEVER, SINCE Vitamin D status has become READILY estimable BASED on Serum/Plasma 25-Hydroxyvitamin D concentration [25(Oh)D] (2), epidemiologic RESEARCH aimed at identifying PREVIOUSLY-UNCHARACTERIZED AT-risk populations and characterizing NOVEL disease ASSOCIATIONS with Vitamin D status HAS BEEN greatly facilitated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('PROBABLE_UNDERSTANDING', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('FUTURE_WORK', 146), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 187), ('IMPORTANT_CONSIDERATION', 203), ('FULL_UNKNOWN', 242), ('SUPERFICIAL_RELATIONSHIP', 256), ('INCOMPLETE_EVIDENCE', 291)]	11	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('UBERON_0001969', 'blood plasma', 76, 'plasma'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 83, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC2963768	10/2010	S106-PMC2963768	['HOWEVER, these age-DEPENDENT DIFFERENCES MAY HAVE BEEN CONFOUNDED by seasonal timing of Gestation—a younger age IMPLIED that the third trimester COINCIDED with the expected seasonal nadir of Vitamin D Synthesis, when maternal Vitamin D stores MIGHT be relatively depleted and, THUS, when transfer of Vitamin D Metabolites to the foetus MAY have been minimized.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 45), ('DIFFICULT_TASK', 55), ('SUPERFICIAL_RELATIONSHIP', 112), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 243), ('PROBABLE_UNDERSTANDING', 277), ('INCOMPLETE_EVIDENCE', 336)]	11	[('GO_0007565', 'female pregnancy', 88, 'gestation'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 191, 'vitamin D synthesis'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin D'), ('CHEBI_25212', 'metabolite', 310, 'metabolites')]
PMC3171895	9/2011	S149-PMC3171895	['FURTHER INVESTIGATIONS are REQUIRED AS the concentrations of these Vitamins REMAIN significantly reduced in women with Preeclampsia, but in the absence OF FURTHER EVIDENCE, routine supplementation with higher dose Vitamin C and E is not RECOMMENDED AS they CAN be POTENTIALLY dangerous in high concentrations.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('IMPORTANT_CONSIDERATION', 27), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 76), ('ANOMALY_CURIOUS_FINDING', 152), ('INCOMPLETE_EVIDENCE', 155), ('FUTURE_WORK', 237), ('PROBABLE_UNDERSTANDING', 249), ('INCOMPLETE_EVIDENCE', 257), ('INCOMPLETE_EVIDENCE', 264)]	11	[('CHEBI_33277', 'gamma-tocotrienol', 67, 'vitamins'), ('GO_0007128', 'meiotic prophase I', 119, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 228, 'E')]
PMC3277098	12/2011	S184-PMC3277098	['this data has the advantage of focussing on the Early Life Period and MAY THEREFORE provide INSIGHT into the aetiological ROLE of Vitamin D. DESPITE the OBSERVED PROTECTIVE ASSOCIATION of Serum 25(Oh)D and allergy, it has been NOTED that the widespread practice of supplementation COINCIDED with the rise in allergic disease [35].']	[('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('ANOMALY_CURIOUS_FINDING', 141), ('INCOMPLETE_EVIDENCE', 153), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 173), ('ANOMALY_CURIOUS_FINDING', 227), ('SUPERFICIAL_RELATIONSHIP', 281)]	11	[('UBERON_0019248', 'early embryo', 48, 'early life period'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('UBERON_0001977', 'blood serum', 188, 'serum'), ('CHEBI_71657', 'versiconol acetate', 194, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 194, '25(OH)D')]
PMC3427192	4/2012	S15-PMC3427192	['vdrs are Expressed on a variety of Airway Immune Cells, where they function as classic Nuclear Steroid Hormone receptors and ultimately Regulate the transcription of numerous Genes associated with inflammation and Immunomodulation.27vitamin d also plays an IMPORTANT ROLE in Respiratory infection by facilitating Toll-Like Receptor Signaling through increased Synthesis of Human Cathelicidin Antimicrobial peptide,28-30which is cleaved to generate the active Cationic peptide, Ll-37.31,32vitamin D also exerts direct EFFECTS on target cells independent of Gene transcription33and MAY THEREFORE be of relevance to Airway inflammatory disorders.34while Vitamin D can suppress il-1735and Il-4-mediated Expression of Il-13,35,36it CAN also shift the th1/th2 balance toward th2 dominance.37THESE CONTRADICTORY actions MAY BE DUE to the direct actions of Vitamin D on cd4+T Cells to promote an Il-10-secreting T-Regulatory population.38\n\nBiosynthesis Of Vitamin D\nBiosynthesis Of Vitamin D begins PRIMARILY with absorption of solar ultravoilet-b (uvb) radiation and secondarily via Consumption of Vitamin D-rich and fortified foods, such as oily fish, fortified grains and dairy products.26following exposure to uvb radiation, 7-Dehydrocholesterol within the skin is converted to Previtamin D3( fig.']	[('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267), ('SUPERFICIAL_RELATIONSHIP', 517), ('INCOMPLETE_EVIDENCE', 580), ('PROBABLE_UNDERSTANDING', 584), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 783), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 791), ('INCOMPLETE_EVIDENCE', 813), ('IMPORTANT_CONSIDERATION', 820), ('PROBABLE_UNDERSTANDING', 991)]	11	[('GO_0010467', 'gene expression', 9, 'expressed'), ('UBERON_0001005', 'respiratory airway', 35, 'airway'), ('CL_0000738', 'leukocyte', 42, 'immune cells'), ('UBERON_0002405', 'immune system', 42, 'immune'), ('GO_0005634', 'nucleus', 87, 'nuclear'), ('CHEBI_26764', 'steroid hormone', 95, 'steroid hormone'), ('GO_0065007', 'biological regulation', 136, 'regulate'), ('SO_0000704', 'gene', 175, 'genes'), ('GO_0050900', 'leukocyte migration', 214, 'immunomodulation'), ('UBERON_0001004', 'respiratory system', 275, 'respiratory'), ('GO_0002770', 'T cell inhibitory signaling pathway', 313, 'Toll-like receptor signaling'), ('GO_0009057', 'macromolecule catabolic process', 360, 'synthesis'), ('NCBITaxon_9606', 'Homo sapiens', 373, 'human'), ('PR_000006009', 'alpha-catulin', 379, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 392, 'antimicrobial'), ('CHEBI_36916', 'cation', 459, 'cationic'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 477, 'LL-37'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 496, 'D'), ('SO_0000704', 'gene', 556, 'gene'), ('UBERON_0001005', 'respiratory airway', 613, 'airway'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 685, 'IL-4'), ('GO_0010467', 'gene expression', 699, 'expression'), ('PR_000001470', 'interleukin-28B', 713, 'IL-13'), ('CHEBI_27300', 'vitamin D', 849, 'vitamin D'), ('CL_0000084', 'T cell', 866, 'T cells'), ('PR_000001470', 'interleukin-28B', 888, 'IL-10'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 904, 'T'), ('CL_0000232', 'erythrocyte', 906, 'regulatory'), ('GO_0065007', 'biological regulation', 906, 'regulatory'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 932, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 948, 'vitamin D'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 958, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 974, 'vitamin D'), ('GO_0007631', 'feeding behavior', 1076, 'consumption'), ('CHEBI_27300', 'vitamin D', 1091, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 1221, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 1274, 'previtamin D3')]
PMC3427192	4/2012	S18-PMC3427192	['1,25(Oh)2D3, also referred to as Calcitriol, is then transported throughout the body via the Blood to various cells types that Express vdrs, where Gene Expression is induced.24,39BECAUSE the MAJORITY of Vitamin D Metabolism occurs in this skin, several FACTORS ARE THOUGHT TO INFLUENCE Vitamin D skin Metabolism, including age, body fat, the level of skin Melanin, and OTHER variables such as latitude, the amount and degree of sun exposure, and use of sunscreen products with uv protection.40these FACTORS HAVE BEEN PREVIOUSLY ASSOCIATED with Vitamin D deficiency in epidemiologic studies.41-43\n\ncaption (fig): figure 2.']	[('PROBABLE_UNDERSTANDING', 177), ('PROBABLE_UNDERSTANDING', 191), ('SUPERFICIAL_RELATIONSHIP', 253), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 276), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 369), ('SUPERFICIAL_RELATIONSHIP', 499), ('INCOMPLETE_EVIDENCE', 507), ('INCOMPLETE_EVIDENCE', 517), ('SUPERFICIAL_RELATIONSHIP', 528)]	11	[('CHEBI_37958', 'dye', 0, '1,'), ('CHEBI_73394', 'Ala-Ser', 2, '25(OH)2D3'), ('CHEBI_17823', 'calcitriol', 33, 'calcitriol'), ('UBERON_0000178', 'blood', 93, 'blood'), ('GO_0010467', 'gene expression', 127, 'express'), ('GO_0010467', 'gene expression', 147, 'gene expression'), ('SO_0000704', 'gene', 147, 'gene'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 203, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0008152', 'metabolic process', 301, 'metabolism'), ('CHEBI_25179', 'melanins', 356, 'melanin'), ('CHEBI_27300', 'vitamin D', 544, 'vitamin D')]
PMC3702245	6/2013	S94-PMC3702245	['BASED ON BIOMARKERS AFFECTED by Vitamin D status, and FINDINGS from observational studies and recent randomized trials, FUTURE STUDIES SHOULD include trial arms to achieve Serum 25(Oh)D concentrations that HAVE BEEN ASSOCIATED with POTENTIAL Extraskeletal benefits8,82,84,94–96of Vitamin D to understand BETTER both the benefits and risks of Vitamin D supplementation to mother and offspring.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 54), ('FUTURE_WORK', 120), ('FUTURE_WORK', 135), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 216), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 304)]	11	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0001977', 'blood serum', 172, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 181, 'OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 242, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D')]
PMC3717170	5/2013	S136-PMC3717170	['in Humans, the ROLE of Vitamin D in type 2 diabetes is SUGGESTED by a large NUMBER OF cross-sectional STUDIES that have CONSISTENTLY FOUND an inverse ASSOCIATION between Vitamin D status and prevalent hyperglycemia, including a REPORTED seasonal variation in the Control Of Glycemia in patients with diabetes, being worse in the winter when hypovitaminosis d is more prevalent.35in the MAJORITY of longitudinal OBSERVATIONAL studies, lower Vitamin D status is also ASSOCIATED with INCREASED RISK of incident type 2 diabetes.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 120), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 150), ('INCOMPLETE_EVIDENCE', 228), ('PROBABLE_UNDERSTANDING', 386), ('INCOMPLETE_EVIDENCE', 411), ('SUPERFICIAL_RELATIONSHIP', 465), ('IMPORTANT_CONSIDERATION', 481)]	11	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('GO_0006936', 'muscle contraction', 263, 'control of glycemia'), ('CHEBI_27300', 'vitamin D', 440, 'vitamin D')]
PMC3760821	9/2013	S28-PMC3760821	['this APPARENT rise in 1,25(Oh)2D has LED TO the SUGGESTION that Pregnant women MAY REQUIRE higher cellular exposure to active Vitamin D during the second and third trimesters, and HAS BEEN interpreted by SOME as PROVIDING EVIDENCE for its POTENTIAL ROLE in obstetric well-Being[8].']	[('ANOMALY_CURIOUS_FINDING', 5), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 79), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 180), ('INCOMPLETE_EVIDENCE', 204), ('PROBABLE_UNDERSTANDING', 212), ('INCOMPLETE_EVIDENCE', 222), ('INCOMPLETE_EVIDENCE', 239), ('SUPERFICIAL_RELATIONSHIP', 249)]	11	[('CHEBI_17996', 'chloride', 23, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 24, '25(OH)2D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0016441', 'posttranscriptional gene silencing', 271, '-being')]
PMC3760821	9/2013	S39-PMC3760821	['WHILE it HAS BEEN SPECULATED that Vitamin D deficiency MAY BE causal in the development of adiposity and, POTENTIALLY, its co-morbidities, a RECENT STUDY using Genetic Markers AS instrumental VARIABLES in bi-directional mendelian randomization analysis has PROVIDED EVIDENCE that a higher bmi leads to lower 25ohd and that the LIKELIHOOD of lower 25ohd increasing bmi is small[19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 141), ('PROBABLE_UNDERSTANDING', 176), ('SUPERFICIAL_RELATIONSHIP', 192), ('PROBABLE_UNDERSTANDING', 257), ('INCOMPLETE_EVIDENCE', 266), ('PROBABLE_UNDERSTANDING', 327)]	11	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0001645', 'genetic_marker', 160, 'genetic markers')]
PMC3798907	8/2013	S102-PMC3798907	['before embarking on a Vitamin E intervention study during Pregnancy we wanted TO TEST WHETHER in vitro Vitamin E supplementation COULD Modulate Neonatal Immune Responses, REASONING that the demonstration of a direct EFFECT would justify Vitamin E supplementation, WHEREAS FAILURE to demonstrate a direct EFFECT would justify ALTERNATIVE dietary STRATEGIES to increase Vitamin E intake.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 129), ('PROBABLE_UNDERSTANDING', 171), ('PROBABLE_UNDERSTANDING', 171), ('SUPERFICIAL_RELATIONSHIP', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('PROBLEM_COMPLICATION', 272), ('SUPERFICIAL_RELATIONSHIP', 304), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 325), ('FUTURE_WORK', 345)]	11	[('CHEBI_27300', 'vitamin D', 22, 'vitamin E'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin E'), ('GO_0065007', 'biological regulation', 135, 'modulate'), ('GO_0007567', 'parturition', 144, 'neonatal'), ('GO_0006955', 'immune response', 153, 'immune responses'), ('UBERON_0002405', 'immune system', 153, 'immune'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin E')]
PMC3798907	8/2013	S139-PMC3798907	['a SMALL number ( n = 40) of Adult Pbmc samples were obtained to investigate a POSSIBLE age RELATED differential responsiveness to Vitamin E. consequently the concentrations of Ascorbate and Α-Tocopherol used to supplement these pbmc cultures, was the same as that used to supplement cbmc cultures, HOWEVER these levels are lower than those FOUND in the Plasma of healthy Adults, which COULD EXPLAIN the LACK OF EFFECTS SEEN in pbmc cultures.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 298), ('ANOMALY_CURIOUS_FINDING', 298), ('INCOMPLETE_EVIDENCE', 340), ('INCOMPLETE_EVIDENCE', 385), ('PROBABLE_UNDERSTANDING', 391), ('INCOMPLETE_EVIDENCE', 403), ('SUPERFICIAL_RELATIONSHIP', 411), ('INCOMPLETE_EVIDENCE', 419)]	11	[('UBERON_0007023', 'adult organism', 28, 'adult'), ('UBERON_2005026', 'primary head sinus', 34, 'PBMC'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin E'), ('CHEBI_22651', 'ascorbate', 176, 'ascorbate'), ('CHEBI_27725', 'butin', 190, 'α-tocopherol'), ('UBERON_0001969', 'blood plasma', 353, 'plasma'), ('UBERON_0007023', 'adult organism', 371, 'adults')]
PMC4113768	7/2014	S2104-PMC4113768	['conclusions: low Vitamin D levels were ASSOCIATED with an INCREASED RISK of stroke in this prospective cohort study of older primary care patients.this ASSOCIATION was INDEPENDENT of several IMPORTANT CONFOUNDERS and ONLY PARTLY EXPLAINED by conventional risk factors and Cardiovascular disease AS POTENTIAL causal intermediates.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 191), ('PROBLEM_COMPLICATION', 201), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 222), ('PROBABLE_UNDERSTANDING', 229), ('PROBABLE_UNDERSTANDING', 295), ('INCOMPLETE_EVIDENCE', 298)]	11	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 272, 'cardiovascular')]
PMC4383226	2/2015	S147-PMC4383226	['WHILE the PROTECTIVE ASSOCIATION between Vitamin A and malaria REMAINED, the low prevalence of maternal hiv in our study population (and HENCE LOW statistical power) makes it DIFFICULT to RULE OUT POTENTIAL Vitamin A–hiv INTERACTIONS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 63), ('PROBABLE_UNDERSTANDING', 137), ('PROBLEM_COMPLICATION', 143), ('DIFFICULT_TASK', 175), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 221)]	11	[('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A')]
PMC4466139	6/2015	S119-PMC4466139	['it is THEREFORE IMPORTANT to correct the deficiency in utero with higher doses in those AT RISK of SERIOUS deficiency and to closely follow these infants re the early detection of diseases RELATED to lack of Vitamin D.\nknowledge of a generalized Vitamin D deficiency and of RELATED RISK FACTORS MAY LEAD TO IMPROVING education and to more effective PUBLIC HEALTH initiatives.']	[('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 16), ('IMPORTANT_CONSIDERATION', 88), ('IMPORTANT_CONSIDERATION', 99), ('SUPERFICIAL_RELATIONSHIP', 189), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 282), ('INCOMPLETE_EVIDENCE', 295), ('PROBABLE_UNDERSTANDING', 299), ('FUTURE_WORK', 307), ('IMPORTANT_CONSIDERATION', 349)]	11	[('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
PMC4586451	10/2015	S212-PMC4586451	['there was also no evidence of an association between maternal Vitamin D status during Pregnancy and offspring bone Mineral content (table 3).24the SUGGESTION that maternal body fat stores are IMPORTANT for fetal bone Mineral deposition was investigated in a further study.25there was NO evidence of an independent association between maternal Prepregnancy bmi and offspring bone mass at age 9 years once adjustments were made for Birth weight and the current height and weight of the child.25\nthese data SUGGEST it is UNLIKELY that Pregnancy diet has an IMPORTANT EFFECT on any of the outcomes investigated in this section, ALTHOUGH the ASSOCIATIONS that were FOUND were with Nutrients that are most LIKELY to be inadequate in the diet of this population.8\n\nNeurocognitive and behavioral development Of the offspring\nBrain Cell Membranes have a high content of n-3 lc-pufas, and the predominant sources of these Nutrients in the diets of uk residents are fish and seafood.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 284), ('INCOMPLETE_EVIDENCE', 504), ('PROBABLE_UNDERSTANDING', 518), ('IMPORTANT_CONSIDERATION', 554), ('SUPERFICIAL_RELATIONSHIP', 564), ('ANOMALY_CURIOUS_FINDING', 624), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 660), ('PROBABLE_UNDERSTANDING', 700)]	11	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('CHEBI_46662', 'mineral', 115, 'mineral'), ('CHEBI_46662', 'mineral', 217, 'mineral'), ('GO_0007565', 'female pregnancy', 343, 'prepregnancy'), ('GO_0007567', 'parturition', 430, 'birth'), ('GO_0007565', 'female pregnancy', 532, 'pregnancy'), ('CHEBI_33284', 'nutrient', 676, 'nutrients'), ('GO_0043102', 'amino acid salvage', 758, 'Neurocognitive ... of ...'), ('UBERON_0000955', 'brain', 817, 'Brain'), ('GO_0005886', 'plasma membrane', 823, 'cell membranes'), ('CHEBI_33284', 'nutrient', 912, 'nutrients')]
PMC4770602	1/2016	S23-PMC4770602	['[518]\nbased ON the ROLE of maternal Vitamin D deficiency, AS a POTENTIAL in DEPENDENT RISK FACTOR for Preeclampsia, Vitamin D supplementation in early Pregnancy REMAINS a POSSIBLE intervention and POSSIBLE improved Pregnancy outcomes through PREVENTION or delay of Preeclampsia.']	[('ANOMALY_CURIOUS_FINDING', 12), ('ANOMALY_CURIOUS_FINDING', 12), ('SUPERFICIAL_RELATIONSHIP', 19), ('PROBABLE_UNDERSTANDING', 58), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 242)]	11	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 102, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 265, 'preeclampsia')]
PMC4785305	3/2016	S174-PMC4785305	['FINDINGS from our trial, and SIMILAR TO results derived from Nutrient rcts, are PRONE to the CONFOUNDING effect of several FACTORS.52indeed, the baseline 25(Oh)D level, the dietary Intake of Vitamin D and OTHER Nutrients, such as Calcium and proteins, sun exposure and others, REMAIN IMPORTANT PREDICTORS AFFECTING the response to Vitamin D supplementation, but are very DIFFICULT to quantify accurately.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 80), ('PROBLEM_COMPLICATION', 93), ('SUPERFICIAL_RELATIONSHIP', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205), ('INCOMPLETE_EVIDENCE', 277), ('IMPORTANT_CONSIDERATION', 284), ('SUPERFICIAL_RELATIONSHIP', 294), ('SUPERFICIAL_RELATIONSHIP', 305), ('DIFFICULT_TASK', 371)]	11	[('CHEBI_33284', 'nutrient', 61, 'nutrient'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 157, 'OH)D'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('CHEBI_33284', 'nutrient', 211, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 230, 'calcium'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D')]
PMC4897157	5/2016	S13-PMC4897157	['among such FACTORS, there is GROWING RECOGNITION of the INFLUENCE of sunlight exposure and Vitamin D. since its immunomodulatory EFFECT was FIRST CONFIRMED, Vitamin D has emerged as a variable of interest in the pathogenesis of Allergic diseases; accordingly, there is also interest in sunlight exposure because of its ASSOCIATION with the generation of vitamin D. SEVERAL STUDIES HAVE SHOWN that Vitamin D has an EFFECT on the pathogenesis of allergic diseases56).']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 129), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 319), ('INCOMPLETE_EVIDENCE', 365), ('INCOMPLETE_EVIDENCE', 381), ('SUPERFICIAL_RELATIONSHIP', 414)]	11	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0040011', 'locomotion', 228, 'allergic'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 362, 'D'), ('CHEBI_27300', 'vitamin D', 397, 'vitamin D')]
PMC4973215	8/2016	S10-PMC4973215	['THUS, levels of neonates at Birth depend entirely on that of the mother and, ACCORDINGLY, SEVERAL STUDIES have CONSISTENTLY CORRELATED Cord Blood 25(Oh)D levels to those of their mothers.1,2,3,4,5,6in addition, maternal Vitamin D deficiency HAS BEEN LINKED to decreased fetal growth and Birth size in OBSERVATIONAL studies.7,8,9\nmaternal Vitamin D deficiency is PREVALENT, the extent of which CAN be INFLUENCED by many variables including skin pigmentation, sun exposure, season, age, Vitamin supplementation and obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 90), ('PROBABLE_UNDERSTANDING', 111), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 241), ('SUPERFICIAL_RELATIONSHIP', 250), ('INCOMPLETE_EVIDENCE', 301), ('IMPORTANT_CONSIDERATION', 362), ('INCOMPLETE_EVIDENCE', 393), ('SUPERFICIAL_RELATIONSHIP', 400)]	11	[('GO_0007567', 'parturition', 28, 'birth'), ('UBERON_0002240', 'spinal cord', 135, 'cord'), ('UBERON_0000178', 'blood', 140, 'blood'), ('CHEBI_71657', 'versiconol acetate', 146, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007567', 'parturition', 287, 'birth'), ('CHEBI_27300', 'vitamin D', 338, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 485, 'vitamin')]
PMC5028238	10/2016	S202-PMC5028238	['studies involving moderate Prenatal Vitamin D supplementation HAVE REPORTED no adverse EFFECTS.89THEREFORE, we would not expect Vitamin D to result in slos-RELATED Teratogenic EFFECTS, ALTHOUGH ADDITIONAL STUDIES would BE NEEDED to ascertain the EFFECTS of large doses of Prenatal Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 87), ('PROBABLE_UNDERSTANDING', 95), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 156), ('SUPERFICIAL_RELATIONSHIP', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 185), ('FUTURE_WORK', 194), ('FUTURE_WORK', 205), ('FUTURE_WORK', 219), ('SUPERFICIAL_RELATIONSHIP', 246)]	11	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_50905', 'teratogenic agent', 164, 'teratogenic'), ('GO_0007565', 'female pregnancy', 272, 'prenatal'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D')]
PMC5045784	10/2016	S17-PMC5045784	['in addition, Animal studies SUPPORT the HYPOTHESIS that Vitamin D status MIGHT AFFECT the RISK of bpd GIVEN that both Vitamin D and the Vitamin D receptor (vdr) have IMPORTANT ROLES in Perinatal Lung Development.7,8thus, we SPECULATED that Vitamin D deficiency MIGHT predispose to and/or have a ROLE in the pathogenesis of bpd.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 90), ('PROBABLE_UNDERSTANDING', 102), ('IMPORTANT_CONSIDERATION', 166), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 261), ('SUPERFICIAL_RELATIONSHIP', 295)]	11	[('NCBITaxon_33208', 'Metazoa', 13, 'animal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0036268', 'swimming', 185, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 185, 'perinatal'), ('GO_0030324', 'lung development', 195, 'lung development'), ('UBERON_0002048', 'lung', 195, 'lung'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
PMC5045784	10/2016	S86-PMC5045784	['mccarthy et al.29REPORTED that in a cohort of 274 preterm infants (<32 weeks) in ireland, levels of 25(Oh)D REMAINED under 20\u2009ng\u2009ml−1in 78% of subjects DESPITE 18 days on average of enteral Feeding and Vitamin D supplementation.29a RECENT intervention TRIAL by fort et al.17DEMONSTRATED that biochemical Vitamin D deficiency among EXTREMELY preterm infants CAN be reduced by additional supplementation with 200 units of Vitamin D daily, and PREVENTED by additional supplementation with 800 units of Vitamin D daily17and these two regimens were FOUND TO BE SAFE.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 108), ('ANOMALY_CURIOUS_FINDING', 152), ('INCOMPLETE_EVIDENCE', 232), ('PROBABLE_UNDERSTANDING', 272), ('PROBABLE_UNDERSTANDING', 272), ('IMPORTANT_CONSIDERATION', 331), ('INCOMPLETE_EVIDENCE', 357), ('SUPERFICIAL_RELATIONSHIP', 441), ('ANOMALY_CURIOUS_FINDING', 544), ('IMPORTANT_CONSIDERATION', 556)]	11	[('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 106, 'D'), ('GO_0007631', 'feeding behavior', 190, 'feeding'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 420, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D')]
PMC5129897	10/2016	S8-PMC5129897	['introduction\nduring the past 15\xa0years, CONSIDERABLE INTEREST in the health BENEFITS of Vitamin D has emerged BECAUSE People with higher ultraviolet-b (uvb) exposure and/or 25-Hydroxyvitamin D [25(Oh)D] concentrations have lower RISK of many diseases and conditions.1our analysis is LIMITED to the diseases with the greatest economic EFFECT and the STRONGEST evidence of PROTECTIVE ROLES of Vitamin D—namely, cancer, Cardiovascular disease (cvd), dementia, diabetes mellitus (dm), falls and fractures, multiple sclerosis (ms), and Respiratory Tract infections.']	[('ANOMALY_CURIOUS_FINDING', 39), ('IMPORTANT_CONSIDERATION', 52), ('INCOMPLETE_EVIDENCE', 52), ('IMPORTANT_CONSIDERATION', 75), ('PROBABLE_UNDERSTANDING', 109), ('IMPORTANT_CONSIDERATION', 228), ('INCOMPLETE_EVIDENCE', 282), ('SUPERFICIAL_RELATIONSHIP', 333), ('INCOMPLETE_EVIDENCE', 348), ('SUPERFICIAL_RELATIONSHIP', 370), ('SUPERFICIAL_RELATIONSHIP', 381)]	11	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 117, 'people'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 172, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 193, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 390, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 416, 'cardiovascular'), ('UBERON_0000065', 'respiratory tract', 530, 'respiratory tract')]
PMC5129897	10/2016	S161-PMC5129897	['those ESTIMATES are SIMILAR TO those in the PREVIOUS PAPER on THIS topic, which ESTIMATED that if the 25(Oh)D concentration of all canadians were raised from a mean value of 67\xa0nmol/l to 105\xa0nmol/l, the death rate could fall by 37,000 (22,300–52,300 deaths), REPRESENTING 16.1% (9.7%–22.7%) of annual deaths, and the economic BURDEN could fall by 6.9% (3.8%–10.0%), or $14.4\xa0billion ($8.0\xa0billion–$20.1\xa0billion).89that paper CONSIDERED HOW Vitamin D AFFECTS cancer, cvd, dm, falls and fractures, Heart disease, influenza and pneumonia, ms, and septicemia as well as Pregnancy and Birth outcomes.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('INCOMPLETE_EVIDENCE', 80), ('PROBABLE_UNDERSTANDING', 259), ('IMPORTANT_CONSIDERATION', 326), ('INCOMPLETE_EVIDENCE', 425), ('EXPLICIT_QUESTION', 436), ('SUPERFICIAL_RELATIONSHIP', 450)]	11	[('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 440, 'vitamin D'), ('UBERON_0000948', 'heart', 496, 'heart'), ('GO_0007565', 'female pregnancy', 566, 'pregnancy'), ('GO_0007567', 'parturition', 580, 'birth')]
PMC5129897	10/2016	S176-PMC5129897	['the results of observational studies are GENERALLY not well-SUPPORTED by clinical trials of Vitamin D supplementation.94the primary REASON for that lack OF support SEEMS TO be that the trials were NOT WELL DESIGNED, being based LARGELY on the guidelines for Pharmaceutical Drugs RATHER than for Nutrients.2another WORRISOME POINT is that clinical trials have BEEN much more successful when baseline 25(Oh)D concentrations were low.']	[('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 60), ('PROBABLE_UNDERSTANDING', 132), ('ANOMALY_CURIOUS_FINDING', 153), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 279), ('IMPORTANT_CONSIDERATION', 314), ('IMPORTANT_CONSIDERATION', 324), ('ANOMALY_CURIOUS_FINDING', 359)]	11	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_52217', 'pharmaceutical', 258, 'pharmaceutical'), ('CHEBI_23888', 'drug', 273, 'drugs'), ('CHEBI_33284', 'nutrient', 295, 'nutrients'), ('CHEBI_71657', 'versiconol acetate', 399, '25(OH)D')]
PMC5129897	10/2016	S187-PMC5129897	['the institute FOUND no EVIDENCE of adverse health EFFECTS for the general population for intakes as high as 10,000 iu/d.96given the latitudes of canada, sun exposure is a good source of Vitamin D primarily in the summer and then best near solar noon.97\nmore than12 million canadians do not meet the minimum Vitamin D GUIDELINES of 50\xa0nmol/l put forth by health canada.98sun exposure HAS BEEN RECOGNIZED AS a KEY FACTOR INFLUENCING Vitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 317), ('PROBABLE_UNDERSTANDING', 317), ('INCOMPLETE_EVIDENCE', 383), ('PROBABLE_UNDERSTANDING', 392), ('PROBABLE_UNDERSTANDING', 403), ('IMPORTANT_CONSIDERATION', 408), ('SUPERFICIAL_RELATIONSHIP', 412), ('SUPERFICIAL_RELATIONSHIP', 419)]	11	[('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 307, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 431, 'vitamin D')]
PMC5318550	2/2017	S21-PMC5318550	['the MAJORITY of studies focused on maternal influenza as the primary cause for a higher prevalence of schizophrenia ASSOCIATED with certain Birth months.3poor Prenatal nutrition HAS BEEN PROPOSED to be RELATED to the Birth seasonality of Individuals who develop schizophrenia.4\nadverse Birth outcomes are RISK FACTORS for impaired Cognitive Development.56PREVIOUS STUDIES have repeatedly described RELATIONSHIPS between season of Birth and Birth weight, and duration of Gestation.7\nRECENTLY, a strong INTEREST in the EFFECTS of Vitamin D on development of the Brain emerged.']	[('PROBABLE_UNDERSTANDING', 4), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 305), ('INCOMPLETE_EVIDENCE', 353), ('SUPERFICIAL_RELATIONSHIP', 398), ('INCOMPLETE_EVIDENCE', 482), ('INCOMPLETE_EVIDENCE', 501), ('SUPERFICIAL_RELATIONSHIP', 517)]	11	[('GO_0007567', 'parturition', 140, 'birth'), ('GO_0007565', 'female pregnancy', 159, 'prenatal'), ('GO_0007567', 'parturition', 217, 'birth'), ('NCBITaxon_1', 'root', 238, 'individuals'), ('GO_0007567', 'parturition', 286, 'birth'), ('GO_0050787', 'detoxification of mercury ion', 331, 'cognitive development'), ('GO_0007567', 'parturition', 430, 'birth'), ('GO_0007567', 'parturition', 440, 'birth'), ('GO_0007565', 'female pregnancy', 470, 'gestation'), ('CHEBI_27300', 'vitamin D', 528, 'vitamin D'), ('UBERON_0000955', 'brain', 560, 'brain')]
PMC5359891	3/2017	S108-PMC5359891	['omission from control group SUPPORTED by usual clinical practiceβ-Carotene720\xa0μg (15% of Vitamin A REQUIREMENTS, as Retinol equivalents)required in Pregnancy in some jurisdictionsfolic acid400\xa0μgstandard Preconception RECOMMENDATIONIRON12\xa0mgiron is routinely prescribed and taken before/during Pregnancy, THOUGH WITHOUT CONVINCING EVIDENCE of benefit; low dose included to lessen LIKELIHOOD of additionally receiving a high-dose iron product, which HAS BEEN LINKED with Glucose Metabolism in Pregnancycalcium150\xa0mga low dose of Calcium is commonly taken before/during Pregnancy; provision of this will lessen the LIKELIHOOD of additional products being takeniodine150\xa0μgstandard preconception recommendationprobiotictaking a combination of two Probiotics HAS BEEN LINKED with maintenance of healthy Glucose Metabolism in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 99), ('FUTURE_WORK', 218), ('ANOMALY_CURIOUS_FINDING', 305), ('INCOMPLETE_EVIDENCE', 312), ('PROBABLE_UNDERSTANDING', 380), ('INCOMPLETE_EVIDENCE', 449), ('SUPERFICIAL_RELATIONSHIP', 458), ('PROBABLE_UNDERSTANDING', 613), ('INCOMPLETE_EVIDENCE', 755), ('SUPERFICIAL_RELATIONSHIP', 764)]	11	[('CHEBI_85000', '1-octadecenoyl-2-icosatetraenoyl-sn-glycero-3-phosphoethanolamine', 65, '-carotene720'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 116, 'retinol'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'preconception'), ('GO_0007565', 'female pregnancy', 294, 'pregnancy'), ('CHEBI_17234', 'glucose', 470, 'glucose'), ('GO_0006006', 'glucose metabolic process', 470, 'glucose metabolism'), ('GO_0051561', 'positive regulation of mitochondrial calcium ion concentration', 492, 'pregnancyCalcium150'), ('CHEBI_22313', 'alkaline earth metal atom', 528, 'calcium'), ('GO_0007565', 'female pregnancy', 568, 'pregnancy'), ('CHEBI_26346', 'prostaglandins J', 744, 'probiotics'), ('CHEBI_17234', 'glucose', 799, 'glucose'), ('GO_0006006', 'glucose metabolic process', 799, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 821, 'pregnancy')]
PMC5640793	9/2017	S44-PMC5640793	["the lancet 's 2013 maternal and child nutrition series RECOMMENDS ten nutrition-specific INTERVENTIONS, including sufficient and diverse Foods for adolescent girls and women; iron, Folic Acid, and Calcium supplementation in Pregnancy; good infant and young child Feeding practices; Vitamin A, iron, and preventive zinc supplementation for children; and treatment for moderate and severe acute malnutrition.5strikingly HOWEVER, expanding the coverage of these nutrition-specific INTERVENTIONS to 90% of mothers and children would only reduce stunting by an ESTIMATED 20%.5larger reductions than these REQUIRE increasing access to family Planning, health services for Pregnant women and children, investments in Water and sanitation, social safety nets, girls' education, and women's empowerment.6a pragmatic approach to design community STRATEGIES for stunting reduction MIGHT THEREFORE be to prioritise action on immediate determinants (infection control, nutrition, and care in the first 1000 days) while providing an enabling social environment for changes in more distal determinants, for example by sharing information about health, nutrition, and sanitation entitlements, and bolstering women's agency."]	[('FUTURE_WORK', 55), ('SUPERFICIAL_RELATIONSHIP', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 418), ('ANOMALY_CURIOUS_FINDING', 418), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 556), ('FUTURE_WORK', 600), ('IMPORTANT_CONSIDERATION', 600), ('FUTURE_WORK', 836), ('INCOMPLETE_EVIDENCE', 870), ('PROBABLE_UNDERSTANDING', 876)]	11	[('CHEBI_33290', 'food', 137, 'foods'), ('CHEBI_30751', 'formic acid', 181, 'folic acid'), ('CHEBI_22313', 'alkaline earth metal atom', 197, 'calcium'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('GO_0007631', 'feeding behavior', 263, 'feeding'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin A'), ('GO_0006260', 'DNA replication', 636, 'planning'), ('GO_0007565', 'female pregnancy', 666, 'pregnant'), ('CHEBI_15377', 'water', 710, 'water')]
PMC5679631	11/2017	S26-PMC5679631	['GIVEN that Vitamin D status is a MODIFIABLE FACTOR which MAY INFLUENCE Intestinal Microbiotic Homeostasis, which in turn is INDICATED to be IMPORTANT in the prevention of Immune mediated diseases, we INVESTIGATED WHETHER maternal use of multivitamin supplements containing Vitamin D, maternal Vitamin D status (25 Hydroxyvitamin D (25(Oh)D), OR administration of Vitamin D supplement to the baby INFLUENCES the presence and abundance of several key bacterial taxa of the infant Gut microbiota.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 140), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 342), ('SUPERFICIAL_RELATIONSHIP', 396)]	11	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000160', 'intestine', 71, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 82, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 82, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 171, 'immune'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 311, '25 hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 332, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 478, 'gut')]
PMC5706533	11/2017	S177-PMC5706533	['cautious PROJECTIONS for the next decade SUGGEST that we will eventually know more about Vitamin D in Pregnancy THAN we do now, BUT in the absence of a coordinated effort and funding to conduct large new trials, SOME of the most CRITICAL QUESTIONS about the effectiveness of Prenatal Vitamin D supplementation will PROBABLY REMAIN unanswered in the foreseeable FUTURE.']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 9), ('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 128), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 229), ('EXPLICIT_QUESTION', 238), ('PROBABLE_UNDERSTANDING', 315), ('INCOMPLETE_EVIDENCE', 324), ('FUTURE_WORK', 361)]	11	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('GO_0007565', 'female pregnancy', 275, 'prenatal'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D')]
PMC5941617	5/2018	S271-PMC5941617	['at PRESENT, SOME UNANSWERED QUESTIONS REMAIN [CRITICAL times during which supplementation MAY BE most EFFECTIVE, regimen and length of supplementation (continuous or intermittent), gender difference] [227], THUS Vitamin D supplementation to optimize bone mass acquisition SHOULD BE reserved for children AT RISK for deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 17), ('EXPLICIT_QUESTION', 28), ('INCOMPLETE_EVIDENCE', 38), ('IMPORTANT_CONSIDERATION', 46), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 102), ('PROBABLE_UNDERSTANDING', 207), ('FUTURE_WORK', 272), ('IMPORTANT_CONSIDERATION', 304)]	11	[('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC2581757	11/2008	S4-PMC2581757	['THUS, we conclude that the use of Vitamins C and e SHOULD BE CONSIDERED for the Control of certain IMPORTANT biochemical indices during the development of Preeclampsia; HOWEVER, FURTHER STUDIES ARE NEEDED to develop methods for the PREVENTION of Preeclampsia in women at high RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 51), ('FUTURE_WORK', 61), ('IMPORTANT_CONSIDERATION', 61), ('IMPORTANT_CONSIDERATION', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('FUTURE_WORK', 178), ('FUTURE_WORK', 186), ('SUPERFICIAL_RELATIONSHIP', 232), ('IMPORTANT_CONSIDERATION', 276)]	10	[('CHEBI_27300', 'vitamin D', 34, 'vitamins C'), ('PR_000004900', 'complement C3', 43, 'C'), ('GO_0065007', 'biological regulation', 80, 'control'), ('GO_0007128', 'meiotic prophase I', 155, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 246, 'preeclampsia')]
PMC2889879	5/2010	S191-PMC2889879	['MISCLASSIFICATION of fish and Pufa or Vitamin D Intake due to measurement ERROR ASSOCIATED with the Food frequency questionnaire is UNAVOIDABLE, BUT GIVEN the study design LIKELY non-differential, and THUS attenuating any TRUE ASSOCIATION.']	[('PROBLEM_COMPLICATION', 0), ('PROBLEM_COMPLICATION', 74), ('SUPERFICIAL_RELATIONSHIP', 80), ('PROBLEM_COMPLICATION', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 145), ('PROBABLE_UNDERSTANDING', 149), ('PROBABLE_UNDERSTANDING', 172), ('PROBABLE_UNDERSTANDING', 201), ('PROBABLE_UNDERSTANDING', 222), ('SUPERFICIAL_RELATIONSHIP', 227)]	10	[('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 30, 'PUFA'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007631', 'feeding behavior', 48, 'intake'), ('CHEBI_33290', 'food', 100, 'food')]
PMC2996405	11/2010	S152-PMC2996405	['this adaptation process was compulsory, SINCE Pelvic deformities due to Vitamin D deficiency COULD PREVENT normal Childbirth, BUT it is REASONABLE to SUGGEST that also OTHER molecular mechanisms apart from depigmentation COULD HAVE been subject to selective pressure in order to increase the levels of Vitamin D in the body.']	[('PROBABLE_UNDERSTANDING', 40), ('PROBLEM_COMPLICATION', 40), ('INCOMPLETE_EVIDENCE', 93), ('SUPERFICIAL_RELATIONSHIP', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 168), ('INCOMPLETE_EVIDENCE', 221), ('IMPORTANT_CONSIDERATION', 227)]	10	[('UBERON_0002108', 'small intestine', 46, 'pelvic'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007623', 'circadian rhythm', 114, 'childbirth'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
PMC3004407	12/2010	S159-PMC3004407	["TAKING INTO account Vitamin D's EMERGING ROLE in Immune maintenance throughout the body and the MOUNTING EVIDENCE TO SUPPORT the IMPORTANCE of Vitamin D in maintaining good health, at the very LEAST, women who are deficient in Vitamin D SHOULD BE counseled regarding the risks of Vitamin D deficiency for themselves and their offspring and RECOMMENDED a therapy to ensure Vitamin D adequacy [60–62,68–70]."]	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 7), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 117), ('IMPORTANT_CONSIDERATION', 129), ('PROBABLE_UNDERSTANDING', 193), ('FUTURE_WORK', 237), ('FUTURE_WORK', 340)]	10	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0002405', 'immune system', 49, 'immune'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 372, 'vitamin D')]
PMC3061267	2/2011	S40-PMC3061267	['WHILE DEFICIENCIES of several Nutrients besides iron CAN cause anemia, and SOME Nutrients like Vitamin A are OFTEN LINKED to iron status, a RECENT review FOUND no greater IMPACT of a multimicronutrient supplement on iron status THAN supplementing with iron alone [17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 171), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	10	[('CHEBI_33284', 'nutrient', 30, 'nutrients'), ('CHEBI_33284', 'nutrient', 80, 'nutrients'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin A')]
PMC3075531	7/2010	S40-PMC3075531	['discussion\nwe FOUND the same results as studies in europe and north america, which IMPLICATES lower Serum Vitamin D level in ms patients than in normal population, IN SPITE of sufficient sun exposure in isfahan region.23815the HYPOTHESIS that Vitamin D deficiency is a RISK FACTOR for ms was first PROPOSED over 30 years ago4and GAINED CREDIBILITY after the discovery of the immunomodulatory EFFECTS of Vitamin D.5moreover, in the past few years, the epidemiological EVIDENCE of an increased ms risk among Individuals with low Vitamin D concentrations has ACHIEVED SUBSTANTIAL STRENGTH.']	[('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 83), ('ANOMALY_CURIOUS_FINDING', 164), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 269), ('INCOMPLETE_EVIDENCE', 298), ('PROBABLE_UNDERSTANDING', 329), ('SUPERFICIAL_RELATIONSHIP', 392), ('INCOMPLETE_EVIDENCE', 467), ('PROBABLE_UNDERSTANDING', 556)]	10	[('UBERON_0001977', 'blood serum', 100, 'serum'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 403, 'vitamin D'), ('NCBITaxon_1', 'root', 506, 'individuals'), ('CHEBI_27300', 'vitamin D', 527, 'vitamin D')]
PMC3271033	1/2012	S14-PMC3271033	['Serum 25-Hydroxyvitamin D (25(Oh)D) is ACCEPTED as the BEST MARKER of Vitamin D status ALTHOUGH it MAY serve PRIMARILY as a MARKER of exposure RATHER than clinical outcomes [2].there are FEW DATA that CORRELATE Serum 25(Oh)D levels with functional outcomes in newborns and small infants.']	[('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('INCOMPLETE_EVIDENCE', 99), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 201)]	10	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 6, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0001977', 'blood serum', 211, 'serum'), ('CHEBI_71657', 'versiconol acetate', 217, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 217, '25(OH)D')]
PMC3470091	9/2012	S21-PMC3470091	['a dose of 600,000 iu Vitamin D resulted in hypercalcemia, THEREFORE, it can not be REGARDED a SAFE dose.17there is NO STUDY to evaluate Vitamin D status in mothers with previous gdm, and present oral Vitamin D products are not fully EFFECTIVE,16THEREFORE, THIS STUDY was DESIGNED TO EVALUATE the EFFECT of intramuscular injection of 300,000 iu during a three-month period.']	[('PROBABLE_UNDERSTANDING', 58), ('PROBABLE_UNDERSTANDING', 83), ('IMPORTANT_CONSIDERATION', 94), ('FULL_UNKNOWN', 115), ('SUPERFICIAL_RELATIONSHIP', 233), ('PROBABLE_UNDERSTANDING', 245), ('QUESTION_ANSWERED_BY_THIS_WORK', 256), ('QUESTION_ANSWERED_BY_THIS_WORK', 271), ('QUESTION_ANSWERED_BY_THIS_WORK', 280), ('SUPERFICIAL_RELATIONSHIP', 296)]	10	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC3515553	12/2012	S169-PMC3515553	['the differences in CONFOUNDERS between sample subsets and the overall alspac sample are UNLIKELY to AFFECT the ASSOCIATION between genotypes and Cord Blood Vitamin B-12 or genotypes and iq because, as EXPECTED, there was no association between genotypes and POTENTIAL CONFOUNDERS, OTHER than what MAY have arisen by chance DUE TO performing a large number of tests on the data.']	[('PROBLEM_COMPLICATION', 19), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 100), ('SUPERFICIAL_RELATIONSHIP', 111), ('INCOMPLETE_EVIDENCE', 201), ('INCOMPLETE_EVIDENCE', 258), ('PROBLEM_COMPLICATION', 268), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 281), ('INCOMPLETE_EVIDENCE', 297), ('PROBLEM_COMPLICATION', 323)]	10	[('UBERON_0002240', 'spinal cord', 145, 'cord'), ('UBERON_0000178', 'blood', 150, 'blood'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 156, 'vitamin B-12')]
PMC3552819	12/2012	S218-PMC3552819	['these erratic PATTERNS COULD NOT EASILY BE EXPLAINED on THE BASIS OF KNOWN Vitamin D pharmacokinetics, but were MOST LIKELY ATTRIBUTABLE TO small-sample ARTIFACTS, biological variability in the absorption and Metabolism Of Vitamin D, and inherent imprecision in the laboratory assessment of [25(Oh)D].']	[('SUPERFICIAL_RELATIONSHIP', 14), ('DIFFICULT_TASK', 23), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 43), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 124), ('QUESTION_ANSWERED_BY_THIS_WORK', 137), ('PROBLEM_COMPLICATION', 153)]	10	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 209, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 292, '25(OH)D')]
PMC3695234	7/2013	S50-PMC3695234	['a PROTECTIVE EFFECT for Vitamin D against wheezing and asthma was found to be strongest for non-atopic and older subjects, SUGGESTING that Vitamin D modifies the risk of allergic and Respiratory disease through multiple mechanisms.7\nalthough Vitamin D deficiency is DEFINED AS a Serum level <20 ng/ml of 25(Oh)d3, there is also an increasing CONCERN about Vitamin D INSUFFICIENCY, which is characterized by levels of 25(Oh)D3Between 20 and 29 ng/ml.8in THIS STUDY, we FOUND that most participants with ad COULD BE categorized as having Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 123), ('PROBABLE_UNDERSTANDING', 266), ('PROBABLE_UNDERSTANDING', 274), ('IMPORTANT_CONSIDERATION', 342), ('IMPORTANT_CONSIDERATION', 366), ('QUESTION_ANSWERED_BY_THIS_WORK', 453), ('INCOMPLETE_EVIDENCE', 468), ('INCOMPLETE_EVIDENCE', 505)]	10	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 183, 'respiratory'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('UBERON_0001977', 'blood serum', 279, 'serum'), ('CHEBI_30778', 'gallic acid', 304, '25(OH)'), ('CHEBI_27300', 'vitamin D', 356, 'vitamin D'), ('CHEBI_52744', 'fort orange 600', 417, '25(OH)D3between 20'), ('CHEBI_27300', 'vitamin D', 536, 'vitamin D')]
PMC3702245	6/2013	S6-PMC3702245	['in addition, it is now known to be INVOLVED in Immunomodulation, Cell Proliferation, and Cell Differentiation, and in other physiologic functions in diverse Tissues and Organs, including the Brain, Pancreas, and Heart.6despite the REPORTED high prevalence of Vitamin D deficiency and its POSSIBLE consequences, the criteria for defining an optimal level in the body, and HENCE the amount of Vitamin D intake REQUIRED to maintain adequate levels, is CONTROVERSIAL.3,7,8this overview addresses the CURRENT INFORMATION about Vitamin D function, the GLOBAL BURDEN and POTENTIAL consequences of low Vitamin D status in Pregnancy, and current STRATEGIES to optimize Vitamin D status in Pregnant mothers and their offspring.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 231), ('INCOMPLETE_EVIDENCE', 288), ('PROBABLE_UNDERSTANDING', 371), ('IMPORTANT_CONSIDERATION', 408), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 449), ('INCOMPLETE_EVIDENCE', 496), ('IMPORTANT_CONSIDERATION', 546), ('INCOMPLETE_EVIDENCE', 564), ('FUTURE_WORK', 637)]	10	[('GO_0050900', 'leukocyte migration', 47, 'immunomodulation'), ('GO_0008283', 'cell proliferation', 65, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 89, 'cell differentiation'), ('UBERON_0000479', 'tissue', 157, 'tissues'), ('UBERON_0000062', 'organ', 169, 'organs'), ('UBERON_0000955', 'brain', 191, 'brain'), ('UBERON_0001264', 'pancreas', 198, 'pancreas'), ('UBERON_0000948', 'heart', 212, 'heart'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 391, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 594, 'vitamin D'), ('GO_0007565', 'female pregnancy', 614, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('GO_0007565', 'female pregnancy', 680, 'pregnant')]
PMC3702245	6/2013	S21-PMC3702245	['a Serum 25(Oh)D concentration <25 nmol/l (10 ng/ml), which is ASSOCIATED with INCREASED RISK of osteomalacia in Adults,7is common during Pregnancy, AS INDICATED by RECENT REPORTS from many parts of the world.1for example, Serum 25(Oh)D < 25 nmol/l during Pregnancy HAS BEEN REPORTED in 17%–18% of the caucasian population in the uk,48,4961% of a mixed population in new zealand,5432%–42% in the indian population,15,4559%–84% of a nonwestern population in the netherlands,1441% of the kuwaiti population,1680% of the iranian population,17and 75% of the arab population in the united arab emirates.1HOWEVER, there are LIMITED STUDIES on the ASSOCIATION between such low levels of Vitamin D status and Skeletal integrity in Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 78), ('PROBABLE_UNDERSTANDING', 148), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 265), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 597), ('INCOMPLETE_EVIDENCE', 617), ('SUPERFICIAL_RELATIONSHIP', 640)]	10	[('UBERON_0001977', 'blood serum', 2, 'serum'), ('CHEBI_71657', 'versiconol acetate', 8, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 8, '25(OH)D'), ('UBERON_0007023', 'adult organism', 112, 'adults'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 228, '25(OH)D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 679, 'vitamin D'), ('UBERON_0004288', 'skeleton', 700, 'skeletal'), ('GO_0007565', 'female pregnancy', 722, 'pregnant')]
PMC3702245	6/2013	S26-PMC3702245	['from Animal studies and SOME Human data, it is SUGGESTED that mineralization of the Fetal Skeleton is independent of Vitamin D and, THEREFORE, maternal Vitamin D deficiency has little EFFECT on fetal Skeletal Development.59IN CONTRAST, SOME recent OBSERVATIONAL STUDIES SUGGEST that Vitamin D nutrition during Pregnancy MAY AFFECT fetal Bone Development.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 47), ('PROBABLE_UNDERSTANDING', 132), ('SUPERFICIAL_RELATIONSHIP', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 248), ('INCOMPLETE_EVIDENCE', 270), ('INCOMPLETE_EVIDENCE', 320), ('SUPERFICIAL_RELATIONSHIP', 324)]	10	[('NCBITaxon_33208', 'Metazoa', 5, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 29, 'human'), ('UBERON_0000922', 'embryo', 84, 'fetal'), ('UBERON_0004288', 'skeleton', 90, 'skeleton'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('GO_0001501', 'skeletal system development', 200, 'skeletal development'), ('UBERON_0004288', 'skeleton', 200, 'skeletal'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0007565', 'female pregnancy', 310, 'pregnancy'), ('GO_0048539', 'bone marrow development', 337, 'bone development')]
PMC3717170	5/2013	S10-PMC3717170	['WHILE it was LONG HELD that Vitamin D ACTED only at the Intestine, Kidney, and Skeleton, and that its function was LIMITED to calcium Homeostasis, the POSSIBILITY of Extraskeletal EFFECTS HAS BEEN CONSIDERED for decades AS a result of the discovery of the vdr in Tissues that have no involvement in Calcium Homeostasis (e.g., skin, Placenta, Pancreas, Breast, Prostate and Colon cancer cells, and Activated T Cells).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 151), ('SUPERFICIAL_RELATIONSHIP', 180), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 197), ('PROBABLE_UNDERSTANDING', 220)]	10	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0000160', 'intestine', 56, 'intestine'), ('UBERON_0002113', 'kidney', 67, 'kidney'), ('UBERON_0004288', 'skeleton', 79, 'skeleton'), ('GO_0042592', 'homeostatic process', 134, 'homeostasis'), ('UBERON_0001431', 'distal carpal bone 2', 166, 'extraskeletal'), ('UBERON_0000479', 'tissue', 263, 'tissues'), ('GO_0055073', 'cadmium ion homeostasis', 299, 'calcium homeostasis'), ('UBERON_0001987', 'placenta', 332, 'placenta'), ('UBERON_0001264', 'pancreas', 342, 'pancreas'), ('UBERON_0000310', 'breast', 352, 'breast'), ('UBERON_0002367', 'prostate gland', 360, 'prostate'), ('UBERON_0001155', 'colon', 373, 'colon'), ('CL_0002129', 'regular atrial cardiac myocyte', 397, 'activated T cells')]
PMC3760821	9/2013	S35-PMC3760821	['IMPORTANTLY, this cohort was largely of white european origin and THEREFORE, less AT RISK of Vitamin D deficiency[15]; furthermore, the authors counselled that their FINDINGS SHOULD NOT BE taken to mean that individual 25Ohd concentrations are not an IMPORTANT DETERMINANT of bone health, and, moreover, that their study WAS NOT designed to examine non-bone health outcomes[14].']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 82), ('INCOMPLETE_EVIDENCE', 166), ('FUTURE_WORK', 175), ('ANOMALY_CURIOUS_FINDING', 186), ('IMPORTANT_CONSIDERATION', 251), ('SUPERFICIAL_RELATIONSHIP', 261), ('INCOMPLETE_EVIDENCE', 321), ('ANOMALY_CURIOUS_FINDING', 325)]	10	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 219, '25OHD')]
PMC3760821	9/2013	S185-PMC3760821	['GIVEN the SAFETY of Vitamin D, the low cost of supplementation and its REQUIREMENT for OPTIMAL bone health (and POTENTIALLY other health outcomes) in both the mother and off-spring, the FINDINGS of THE CURRENT STUDY SUPPORT the case for determining Vitamin D status and, IF NECESSARY, administering Vitamin D in t1dm pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('IMPORTANT_CONSIDERATION', 71), ('IMPORTANT_CONSIDERATION', 87), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 186), ('QUESTION_ANSWERED_BY_THIS_WORK', 198), ('INCOMPLETE_EVIDENCE', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 271), ('IMPORTANT_CONSIDERATION', 274)]	10	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
PMC3798907	8/2013	S153-PMC3798907	['this DISPARITY, in conjunction with RECENT Antenatal intervention DATA [21] EMPHASISES the COMPLEX nature of ASSOCIATIONS between Nutrients and disease and the NEED carefully to CONSIDER the nature of any Vitamin E based Antenatal intervention intended to reduce the LIKELIHOOD of childhood asthma.']	[('ANOMALY_CURIOUS_FINDING', 5), ('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 76), ('DIFFICULT_TASK', 91), ('SUPERFICIAL_RELATIONSHIP', 109), ('FUTURE_WORK', 160), ('FUTURE_WORK', 178), ('PROBABLE_UNDERSTANDING', 267)]	10	[('GO_0007567', 'parturition', 43, 'antenatal'), ('CHEBI_33284', 'nutrient', 130, 'nutrients'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin E'), ('GO_0007567', 'parturition', 221, 'antenatal')]
PMC4072587	6/2014	S148-PMC4072587	['SOME authors have also SUGGESTED that the cut off for sufficient Vitamin D levels during Pregnancy SHOULD BE as high as 100–150 nmo/l[10],[11], and THEREFORE the PROBLEM of Vitamin D deficiency in vietnam and OTHER south east asian countries MAY BE EVEN more widespread than PREVIOUSLY THOUGHT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 23), ('FUTURE_WORK', 99), ('PROBABLE_UNDERSTANDING', 148), ('IMPORTANT_CONSIDERATION', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 209), ('INCOMPLETE_EVIDENCE', 242), ('ANOMALY_CURIOUS_FINDING', 249), ('INCOMPLETE_EVIDENCE', 275), ('INCOMPLETE_EVIDENCE', 286)]	10	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC4072587	6/2014	S153-PMC4072587	['HOWEVER, SIMILAR FINDINGS in PREVIOUS STUDIES[24],[38],[41],[42],[43]and the INCREASING EVIDENCE for Vitamin D deficiency AS a POTENTIAL environmental risk FACTOR for autism[10],[25],[26]SUGGEST that these ASSOCIATIONS SHOULD NOT BE discounted.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 122), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 156), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 206), ('FUTURE_WORK', 219)]	10	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4161853	8/2014	S218-PMC4161853	['AS SEVERE malnutrition is one of the risk FACTORS to develop malaria-ibi co-infection, it is IMPORTANT TO evaluate the IMPACT of Vitamin A administration in the clinical management of children with malaria and ibi-co-infection in africa, EITHER as a therapeutic and/OR prophylactic measure, ESPECIALLY due to recent EVIDENCE of the positive IMPACT of Vitamin A and zinc supplementation on malaria morbidity in a study conducted in ghana [121,122].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 3), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('SUPERFICIAL_RELATIONSHIP', 119), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('IMPORTANT_CONSIDERATION', 291), ('INCOMPLETE_EVIDENCE', 316), ('SUPERFICIAL_RELATIONSHIP', 341)]	10	[('CHEBI_27300', 'vitamin D', 129, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin A')]
PMC4169453	9/2014	S19-PMC4169453	['HOWEVER, the OPTIMAL Vitamin D intake as well as OPTIMAL 25(Oh)D level for Lactating women (BASED ON ESTIMATED maternal NEEDS) STILL REMAINS NOT fully ESTABLISHED, or AT LEAST not accepted worldwide.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 49), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 127), ('FULL_UNKNOWN', 133), ('PROBABLE_UNDERSTANDING', 167)]	10	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('GO_0007594', 'puparial adhesion', 75, 'lactating')]
PMC4329404	10/2014	S149-PMC4329404	['overall, GIVEN OUR FINDINGS in a neonatal Mouse MODEL, and PREVIOUS REPORTS of Vitamin D deficiency in utero through Adulthood not resulting in significantly WORSE ahr, it SEEMS LIKELY that in the context of asthma in early Life, Vitamin D deficiency modifies Immunological Responses To Allergen by the induction of an exaggerated th2 skewed response and eosinophilia.']	[('INCOMPLETE_EVIDENCE', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 68), ('IMPORTANT_CONSIDERATION', 158), ('ANOMALY_CURIOUS_FINDING', 172), ('PROBABLE_UNDERSTANDING', 172), ('PROBABLE_UNDERSTANDING', 178)]	10	[('NCBITaxon_10088', 'Mus <genus>', 42, 'mouse'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 117, 'adulthood'), ('UBERON_0000104', 'life cycle', 224, 'life'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 260, 'immunological responses to allergen'), ('CHEBI_50904', 'allergen', 287, 'allergen')]
PMC4377870	3/2015	S94-PMC4377870	['THUS, in SUMMARY, WHILE OBSERVATIONAL data has SUGGESTED that Vitamin C is IMPORTANT for Lung health, intervention trials SHOWING efficacy are lacking and it APPEARS that supplementation with Vitamin C-rich whole foods, such as fruit and vegetables MAY BE more EFFECTIVE.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 18), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 47), ('IMPORTANT_CONSIDERATION', 75), ('INCOMPLETE_EVIDENCE', 122), ('ANOMALY_CURIOUS_FINDING', 158), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 261)]	10	[('CHEBI_27300', 'vitamin D', 62, 'vitamin C'), ('UBERON_0002048', 'lung', 89, 'lung'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin C')]
PMC4377896	3/2015	S148-PMC4377896	['this MAY BE attributable to the synergistic EFFECTS of Food [34] and ASSOCIATED with fish being a source of OTHER Nutrients which are IMPORTANT for infant development such as Iodine and Vitamin D. presently, there HAVE BEEN NO randomised control TRIALS examining Neurocognitive outcomes ASSOCIATED with Prenatal multivitamin use and infant Neurodevelopment, and these are UNLIKELY to occur given ethical IMPLICATIONS of such [35].']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('IMPORTANT_CONSIDERATION', 134), ('INCOMPLETE_EVIDENCE', 214), ('FULL_UNKNOWN', 224), ('SUPERFICIAL_RELATIONSHIP', 287), ('PROBABLE_UNDERSTANDING', 372), ('IMPORTANT_CONSIDERATION', 404)]	10	[('CHEBI_33290', 'food', 55, 'food'), ('CHEBI_33284', 'nutrient', 114, 'nutrients'), ('CHEBI_24859', 'iodine atom', 175, 'iodine'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0050905', 'neuromuscular process', 263, 'neurocognitive'), ('GO_0007565', 'female pregnancy', 303, 'prenatal'), ('GO_0007399', 'nervous system development', 340, 'neurodevelopment')]
PMC4383226	2/2015	S43-PMC4383226	['the underlying mechanisms of these EFFECTS are UNCLEAR, ALTHOUGH it HAS BEEN THEORIZED that Vitamin A MAY act as Adjuvant to dtp, which is POSTULATED to cause DETRIMENTAL EFFECTS (jorgensen et al., 2011).']	[('SUPERFICIAL_RELATIONSHIP', 35), ('FULL_UNKNOWN', 47), ('ANOMALY_CURIOUS_FINDING', 56), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 77), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 171)]	10	[('CHEBI_27300', 'vitamin D', 92, 'vitamin A'), ('CHEBI_60809', 'adjuvant', 113, 'adjuvant')]
PMC4396835	1/2015	S170-PMC4396835	['ALTHOUGH low levels of Vitamin D COULD have a Genetic origin and as SUCH be ASSOCIATED with asd, OUR STUDY is the FIRST TO RULE OUT asd-related lifestyle mechanisms AS EXPLANATION for low 25(Oh)D levels, SINCE the samples were taken in the Newborn Period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 68), ('SUPERFICIAL_RELATIONSHIP', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 97), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 123), ('PROBABLE_UNDERSTANDING', 165), ('PROBABLE_UNDERSTANDING', 168), ('PROBABLE_UNDERSTANDING', 204)]	10	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('SO_0000704', 'gene', 46, 'genetic'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 194, 'D'), ('UBERON_0007221', 'neonate stage', 240, 'newborn period')]
PMC4417995	4/2015	S186-PMC4417995	['similarly, to devise a STRATEGY for using Vitamin D in the therapy of ad SEEMS at present to be NOT FEASIBLE for DIFFERENT reasons: many CONFOUNDING and unidentified VARIABLES appear in EXISTING STUDIES, and they are OFTEN LIMITED by SMALL numbers of participants, their short durations, and the use of a fixed dose without optimizing for adequate Serum levels.']	[('FUTURE_WORK', 23), ('ANOMALY_CURIOUS_FINDING', 73), ('DIFFICULT_TASK', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('PROBLEM_COMPLICATION', 137), ('SUPERFICIAL_RELATIONSHIP', 166), ('INCOMPLETE_EVIDENCE', 186), ('PROBABLE_UNDERSTANDING', 217), ('INCOMPLETE_EVIDENCE', 223), ('INCOMPLETE_EVIDENCE', 234)]	10	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0001977', 'blood serum', 348, 'serum')]
PMC4600246	10/2015	S44-PMC4600246	['furthermore, most Individuals taking warfarin are counselled to avoid Vitamin K-containing foods, such as green leafy vegetables, which MAY lead to an EVEN further increase in cac.36vitamin k deficiency CAN be exacerbated further when Warfarin is initiated.38the negative IMPACT that warfarin CAN have on the body HAS LONG BEEN RECOGNISED.39\nwarfarin HAS BEEN SHOWN to cause SEVERE Arterial calcifications in the Aorta and the Carotid Arteries of Rats.']	[('INCOMPLETE_EVIDENCE', 136), ('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 272), ('INCOMPLETE_EVIDENCE', 293), ('INCOMPLETE_EVIDENCE', 314), ('PROBABLE_UNDERSTANDING', 318), ('PROBABLE_UNDERSTANDING', 328), ('INCOMPLETE_EVIDENCE', 351), ('IMPORTANT_CONSIDERATION', 375)]	10	[('NCBITaxon_1', 'root', 18, 'individuals'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin K'), ('CHEBI_10033', 'warfarin', 235, 'warfarin'), ('UBERON_0001637', 'artery', 382, 'arterial'), ('UBERON_0000947', 'aorta', 413, 'aorta'), ('UBERON_0005396', 'carotid artery segment', 427, 'carotid arteries'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 447, 'rats')]
PMC4600246	10/2015	S74-PMC4600246	['combining Vitamin K2With an Ace Inhibitor (Perindopril) HAS SHOWN synergistic EFFECTS on hcc recurrence and survival, and THUS this combination SHOULD also BE FURTHER explored.60moreover, ADDITIONAL STUDIES SHOULD BE explored combining Vitamin K2With Acyclic Retinoids, AS this combination HAS also SHOWN positive results on Human Hcc cell lines.69the health benefits of Vitamin K have been summarised inbox 1.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 78), ('PROBABLE_UNDERSTANDING', 122), ('FUTURE_WORK', 144), ('ANOMALY_CURIOUS_FINDING', 156), ('FUTURE_WORK', 159), ('FUTURE_WORK', 188), ('FUTURE_WORK', 207), ('PROBABLE_UNDERSTANDING', 270), ('INCOMPLETE_EVIDENCE', 290)]	10	[('CHEBI_77570', 'tropisetron hydrochloride', 10, 'vitamin K2with'), ('CHEBI_78720', 'tetramethylrhodamine ethyl ester perchlorate', 28, 'ACE inhibitor'), ('CHEBI_8024', 'perindopril', 43, 'perindopril'), ('CHEBI_77570', 'tropisetron hydrochloride', 236, 'vitamin K2with'), ('CHEBI_33333', 'alkylidene group', 251, 'acyclic retinoids'), ('NCBITaxon_9606', 'Homo sapiens', 325, 'human'), ('CL_0000745', 'retina horizontal cell', 331, 'HCC'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin K')]
PMC4600246	10/2015	S77-PMC4600246	['finally, in the RECENT vitamin k italian (viki) dialysis STUDY, 23.5% of patients were FOUND to be Vitamin K deficient, and this deficiency was FOUND TO BE the strongest PREDICTOR of vertebral fractures (or: 2.94; 95% ci 1.38 to 6.26).72other data HAVE SHOWN that vitamin K2May improve Bone Remodelling in patients with haemodialysis with low Serum Parathyroid hormone levels.73supplementing with at LEAST 200\u2005µg Menaquinone-7 (a form of Vitamin K2) daily MAY help to achieve near maximal protection from vascular calcification, osteoporosis and cancer (measured by maximal gamma carboxylation of Vitamin K dependent proteins).35\n\nconclusion\nVitamin K has a plethora of POTENTIAL IMPLICATIONS, including prevention and treatment of Arterial calcifications, Coronary Heart disease and cancer, improvements in bone strength and reduced risks of fractures as well as improvements in Insulin sensitivity.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 87), ('ANOMALY_CURIOUS_FINDING', 144), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 248), ('PROBABLE_UNDERSTANDING', 400), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 670), ('IMPORTANT_CONSIDERATION', 680)]	10	[('CHEBI_27300', 'vitamin D', 99, 'vitamin K'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 272, 'K2may'), ('GO_0046849', 'bone remodeling', 286, 'bone remodelling'), ('UBERON_0001977', 'blood serum', 343, 'serum'), ('UBERON_0001132', 'parathyroid gland', 349, 'parathyroid'), ('CHEBI_18154', 'polysaccharide', 413, 'menaquinone'), ('CHEBI_28934', 'vitamin D2', 438, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 438, 'vitamin K2'), ('CHEBI_27300', 'vitamin D', 597, 'vitamin K'), ('CHEBI_28384', 'vitamin K', 642, 'Vitamin K'), ('UBERON_0001637', 'artery', 732, 'arterial'), ('UBERON_0004151', 'cardiac chamber', 757, 'coronary heart'), ('PR_000045358', 'insulin family protein', 880, 'insulin')]
PMC4691762	12/2015	S18-PMC4691762	['Vitamin D deficiency (currently defined as 25Ohd3<50\u2005nmol/l) has become MORE COMMON in modern communities over time, PRESUMABLY DUE TO INADEQUATE sun exposure resulting from indoor activities and skin cancer CONCERNS.13vitamin d deficiency is common in victoria, australia and also APPEARS TO BE increasing among Pregnant women14and infants.6in addition, the prevalence of infant Vitamin D deficiency was fourfold higher among fully Breastfed infants than fully formula Fed (p<0.001) EVEN at 12\u2005months after solid Food had been introduced.15\nUNLIKE OTHER countries in the northern hemisphere, australia does not RECOMMEND universal Vitamin D supplementation.']	[('PROBABLE_UNDERSTANDING', 72), ('PROBABLE_UNDERSTANDING', 117), ('PROBABLE_UNDERSTANDING', 128), ('IMPORTANT_CONSIDERATION', 135), ('IMPORTANT_CONSIDERATION', 208), ('ANOMALY_CURIOUS_FINDING', 282), ('ANOMALY_CURIOUS_FINDING', 484), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 542), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 549), ('FUTURE_WORK', 612)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_63058', '(2R,3S)-EHNA', 43, '25OHD3'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 43, '25OHD3'), ('GO_0007565', 'female pregnancy', 313, 'pregnant'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D'), ('GO_0007567', 'parturition', 433, 'breastfed'), ('GO_0007631', 'feeding behavior', 470, 'fed'), ('CHEBI_33290', 'food', 514, 'food'), ('CHEBI_27300', 'vitamin D', 632, 'vitamin D')]
PMC4714725	1/2016	S96-PMC4714725	['ab, a Micronutrients and Herbal supplements\nthere is NO CLEAR EVIDENCE that dietary supplementation with Vitamins, Minerals, herbs, or spices CAN improve diabetes, and there MAY BE safety CONCERNS regarding the long-term use of antioxidant supplements such as Vitamins E and C and Carotene.c Alcohol\nadults with diabetes who drink alcohol SHOULD do so in moderation (no more than one drink per day for Adult women and no more than two drinks per day for Adult men).c\nAlcohol Consumption MAY place People with diabetes at INCREASED risk for delayed hypoglycemia, ESPECIALLY IF taking Insulin or Insulin secretagogues.']	[('FULL_UNKNOWN', 53), ('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 174), ('PROBLEM_COMPLICATION', 188), ('FUTURE_WORK', 339), ('INCOMPLETE_EVIDENCE', 487), ('IMPORTANT_CONSIDERATION', 521), ('ANOMALY_CURIOUS_FINDING', 562), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 573)]	10	[('CHEBI_34850', 'milrinone lactate', 6, 'Micronutrients'), ('NCBITaxon_7955', 'Danio rerio', 25, 'herbal'), ('CHEBI_33277', 'gamma-tocotrienol', 105, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 115, 'minerals'), ('CHEBI_27300', 'vitamin D', 260, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 275, 'C'), ('PR_000004900', 'complement C3', 275, 'C'), ('CHEBI_23042', 'carotene', 281, 'carotene'), ('CHEBI_30879', 'alcohol', 292, 'Alcohol'), ('UBERON_0007023', 'adult organism', 402, 'adult'), ('UBERON_0007023', 'adult organism', 454, 'adult'), ('CHEBI_30879', 'alcohol', 467, 'Alcohol'), ('GO_0007631', 'feeding behavior', 475, 'consumption'), ('NCBITaxon_10088', 'Mus <genus>', 497, 'people'), ('PR_000045358', 'insulin family protein', 583, 'insulin'), ('PR_000045358', 'insulin family protein', 594, 'insulin')]
PMC4934634	11/2015	S266-PMC4934634	['as PREVIOUSLY mentioned, short-term studies GENERALLY AGREE with its SAFETY BUT long-term STUDIES ARE NEEDED to address the QUESTION of WHETHER large bolus Vitamin D supplementation during Pregnancy is ASSOCIATED with any adverse health outcomes in the offspring later in Life.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 44), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('FUTURE_WORK', 90), ('EXPLICIT_QUESTION', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('EXPLICIT_QUESTION', 136), ('SUPERFICIAL_RELATIONSHIP', 202)]	10	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('UBERON_0000104', 'life cycle', 272, 'life')]
PMC4971719	8/2016	S152-PMC4971719	['the LACK OF association OBSERVED between Vitamin D level in early or late Pregnancy and the 6–8 week Postpartum bdi score MAY BE EXPLAINED by the COMPLEXITY of the pathogenesis of Postpartum depression symptoms, OR it MAY represent a TRUE negative FINDING.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 122), ('ANOMALY_CURIOUS_FINDING', 126), ('PROBABLE_UNDERSTANDING', 129), ('DIFFICULT_TASK', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 212), ('INCOMPLETE_EVIDENCE', 218), ('PROBABLE_UNDERSTANDING', 234), ('INCOMPLETE_EVIDENCE', 248)]	10	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007565', 'female pregnancy', 101, 'postpartum'), ('GO_0007565', 'female pregnancy', 180, 'postpartum')]
PMC4973215	8/2016	S14-PMC4973215	['THUS, sufficient EVIDENCE is LACKING at this time to RECOMMEND routine Vitamin D supplementation during Pregnancy.12HOWEVER, identification of specific RISK FACTORS for Vitamin D deficiency and the additive EFFECTS of these RISK FACTORS MAY LEAD TO OPPORTUNITIES for targeted supplementation with improved outcomes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('FUTURE_WORK', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 207), ('SUPERFICIAL_RELATIONSHIP', 224), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 241), ('FUTURE_WORK', 249)]	10	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC5014971	8/2016	S111-PMC5014971	['a RECENT STUDY on a mother-offspring cohort in singapore FOUND NO EVIDENCE for an effect of Vitamin D status on Birth outcome, THOUGH the authors CAUTION that the population had a low prevalence of Vitamin D deficiency/insufficiency and THUS they MAY NOT HAVE BEEN able to detect small EFFECTS [29].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('INCOMPLETE_EVIDENCE', 146), ('PROBABLE_UNDERSTANDING', 237), ('INCOMPLETE_EVIDENCE', 247), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 286)]	10	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007567', 'parturition', 112, 'birth'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
PMC5146866	12/2016	S107-PMC5146866	['our data SHOULD ENCOURAGE pediatricians to supplement infants with Vitamin D ESPECIALLY CONSIDERING the REPORTED POOR COMPLIANCE with the aap’s RECOMMENDATIONS by both, pediatricians and parents [38].']	[('FUTURE_WORK', 9), ('FUTURE_WORK', 16), ('IMPORTANT_CONSIDERATION', 77), ('IMPORTANT_CONSIDERATION', 88), ('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 104), ('IMPORTANT_CONSIDERATION', 113), ('PROBLEM_COMPLICATION', 113), ('PROBLEM_COMPLICATION', 118), ('FUTURE_WORK', 144)]	10	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC5812027	2/2018	S136-PMC5812027	['supplementation CAN THEREFORE ONLY PARTLY EXPLAIN the large proportion with high Vitamin D status, and OTHER LIKELY CONTRIBUTORS are Pregnancy associated Endocrine changes and POSSIBLY lifestyle FACTORS.']	[('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 195)]	10	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy'), ('GO_0006397', 'mRNA processing', 154, 'endocrine')]
PMC5941617	5/2018	S32-PMC5941617	['caption (table-wrap): table 2\n\ndefinition of Vitamin D status according to several societies and organizations in the last 10\xa0yearssociety/organizationyearsevere deficiencydeficiencyinsufficiencysufficiency/adequacycanadian pediatric society [8]2007–<\u2009 10\xa0ng/ml10–29\xa0ng/ml≥ 30\xa0ng/mllawson wilkins pediatric Endocrine society [9]2008<\u2009 5\xa0ng/ml5–14\xa0ng/ml15–19\xa0ng/ml≥ 20\xa0ng/mlinstitute of medicine [10]2011–<\u2009 12\xa0ng/ml12–20\xa0ng/mla≥ 20\xa0ng/mlthe Endocrine society [11]2011–<\u2009 20\xa0ng/ml21–29\xa0ng/ml≥ 30\xa0ng/mlbritish paediatric and adolescent bone group [12]2012–<\u200910\xa0ng/ml10–19\xa0ng/ml≥ 20\xa0ng/mlfrench society of paediatrics [13]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlasociación espanola de pediatría (spain) [14]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlfederal commission for nutrition (switzerland) [15]2012<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlnordic nutrition recommendations [16]2012–<\u2009 12\xa0ng/ml12–20\xa0ng/ml≥ 20\xa0ng/mlgerman nutrition society [17]2012–––≥ 20\xa0ng/mlhealth council of the netherlands [18]2012–––≥ 12\xa0ng/mleuropean society for paediatric gastroenterology hepatology and nutrition [19]2013<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlcentral europe [20]2013–< 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlsociety for adolescent health and medicine [21]2013–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlaustralia/new zealand [22]2013<\u2009 5\xa0ng/ml5–11\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mlamerican academy of pediatrics [23]2014–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyb[24]2015–<\u2009 20\xa0ng/ml––scientific advisory committee on nutrition [25]2016–––≥ 10\xa0ng/mleuropean Food safety authority [26]2016–––≥ 20\xa0ng/mlunited arab emirates [27]2016–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlglobal consensus for rickets [28]2016–<\u2009 12\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyc[29]2017–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mleuropean academy of pediatrics [30]2017definition of Vitamin D status is UNCLEAR DUE TO a lack OF consensus\navitamin D inadequacy\nbdiagnostic criteria for rickets\ncassessment criteria for Vitamin D deficiency/insufficiency (authors REPORTED that DIFFERENT criteria MAY BE needed for children)\nsevere Vitamin D deficiency is DEFINED as 25(Oh)d levels <\u200910\xa0ng/ml by SEVERAL authors and societies BECAUSE the risk of rickets is high below this cut-off also in presence of an adequate Calcium intake [31–33] (see chapter “nutritional rickets”).']	[('FULL_UNKNOWN', 1894), ('PROBLEM_COMPLICATION', 1902), ('ANOMALY_CURIOUS_FINDING', 1916), ('ANOMALY_CURIOUS_FINDING', 1916), ('INCOMPLETE_EVIDENCE', 2053), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2067), ('INCOMPLETE_EVIDENCE', 2086), ('PROBABLE_UNDERSTANDING', 2145), ('INCOMPLETE_EVIDENCE', 2185), ('PROBABLE_UNDERSTANDING', 2215)]	10	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 307, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 441, 'Endocrine'), ('CHEBI_46662', 'mineral', 1396, 'Mineral'), ('GO_0009790', 'embryo development', 1420, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1420, 'Endocrine'), ('CHEBI_33290', 'food', 1533, 'Food'), ('CHEBI_46662', 'mineral', 1738, 'Mineral'), ('GO_0009790', 'embryo development', 1762, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1762, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 1874, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1938, 'D'), ('CHEBI_27300', 'vitamin D', 2009, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2121, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 2156, '25(OH)'), ('CHEBI_22313', 'alkaline earth metal atom', 2302, 'calcium')]
PMC5941617	5/2018	S144-PMC5941617	['OTHER authors and GUIDELINES for central europe RECOMMENDED Vitamin D supplementation in preterm infants at higher dosages (400–1000\xa0iu/day) THAN those SUGGESTED for healthy term newborns [1,9,20,126], BUT such an intake SHOULD NOT BE prolonged over the THEORETICAL term (40\xa0weeks of post-Conceptional age) due to the POTENTIAL risk of Vitamin D intoxication [126].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 18), ('FUTURE_WORK', 48), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('FUTURE_WORK', 221), ('INCOMPLETE_EVIDENCE', 254), ('INCOMPLETE_EVIDENCE', 318)]	10	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007620', 'copulation', 289, 'conceptional'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D')]
PMC5941617	5/2018	S729-PMC5941617	['CONSIDERING AVAILABLE EVIDENCE, PARTICULARLY the LACK OF italian studies, at PRESENT we DO NOT RECOMMEND OTHER modalities DIFFERENT from daily or weekly administration of Vitamin D to treat asymptomatic Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 32), ('INCOMPLETE_EVIDENCE', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 77), ('FULL_UNKNOWN', 88), ('FUTURE_WORK', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	10	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 211, 'D')]
PMC1888711	5/2007	S46-PMC1888711	['beneficial EFFECTS on Birth weight and the risk of Postpartum endometritis were SEEN for high-risk women" [22].moderatedietary Vitamin A deficiencyvitamin a supplementation"further EVIDENCE on biologically PLAUSIBLE mechanisms of morbidity reduction such as reduced incidence of sepsis and/or reduced MARKERS of inflammation ARE NEEDED" [60].lowdietary Micronutrient deficienciesmultiple Micronutrient supplementationone trial in tanzania showed no additional effect on markers of infection (C-Reactive Protein) compared with Iron and Folic Acid [15].lowanemia p. falciparum infectionanti-malarial Drugs"Drugs given routinely for malaria during Pregnancy reduce SEVERE Antenatal anaemia in the mother, and are ASSOCIATED with higher Birth weight in the baby and PROBABLY fewer Perinatal deaths.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 80), ('INCOMPLETE_EVIDENCE', 181), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 301), ('FUTURE_WORK', 325), ('IMPORTANT_CONSIDERATION', 662), ('SUPERFICIAL_RELATIONSHIP', 710), ('PROBABLE_UNDERSTANDING', 762)]	9	[('GO_0007567', 'parturition', 22, 'birth'), ('GO_0007565', 'female pregnancy', 51, 'postpartum'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 353, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 388, 'micronutrient'), ('PR_000005890', 'crooked neck-like protein 1', 492, 'C-reactive protein'), ('CHEBI_24870', 'ion', 526, 'iron'), ('CHEBI_30751', 'formic acid', 535, 'folic acid'), ('CHEBI_23888', 'drug', 598, 'drugs'), ('CHEBI_23888', 'drug', 604, 'Drugs'), ('GO_0007565', 'female pregnancy', 645, 'pregnancy'), ('GO_0007567', 'parturition', 669, 'antenatal'), ('GO_0007567', 'parturition', 733, 'birth'), ('GO_0036268', 'swimming', 777, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 777, 'perinatal')]
PMC2581757	11/2008	S200-PMC2581757	['THUS, we conclude that use of Vitamins C and E DEFINITELY Controls certain IMPORTANT biochemical indices during the development of Preeclampsia, and that FURTHER STUDIES ARE NEEDED to DEVELOP STRATEGIES for the PREVENTION of Preeclampsia in women at high RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 47), ('IMPORTANT_CONSIDERATION', 75), ('FUTURE_WORK', 154), ('FUTURE_WORK', 162), ('FUTURE_WORK', 184), ('FUTURE_WORK', 192), ('SUPERFICIAL_RELATIONSHIP', 211), ('IMPORTANT_CONSIDERATION', 255)]	9	[('CHEBI_27300', 'vitamin D', 30, 'vitamins C'), ('PR_000004900', 'complement C3', 39, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 45, 'E'), ('GO_0065007', 'biological regulation', 58, 'controls'), ('GO_0007128', 'meiotic prophase I', 131, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 225, 'preeclampsia')]
PMC2582131	11/2008	S100-PMC2582131	['OUR FINDINGS are also GENERALLY CONSISTENT with a relatively large body of LITERATURE documenting a significant and inverse ASSOCIATION of circulating Vitamin D concentrations with measurements of glycemia or presence of type 2 dm among non-Pregnant women, ALTHOUGH the majority of THESE FINDINGS are based ON cross-sectional/RETROSPECTIVE data.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 22), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 124), ('ANOMALY_CURIOUS_FINDING', 257), ('INCOMPLETE_EVIDENCE', 282), ('ANOMALY_CURIOUS_FINDING', 307), ('INCOMPLETE_EVIDENCE', 326)]	9	[('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 241, 'pregnant')]
PMC2874518	6/2010	S111-PMC2874518	['women in our cohort were receiving adequate amounts of these Micronutrients from their diet alone, as assessed by the 24-hour dietary Recall (table 2), confirming the inverse Supplement HYPOTHESIS, that women who least NEED Supplements are most LIKELY to take them.22\nOTHER STUDIES have SUGGESTED POTENTIAL adverse EFFECTS of SOME Supplements, specifically those containing antioxidant Vitamins such as Vitamins C and E, on Pregnancy outcome when taken by women with adequate dietary Micronutrient intake.']	[('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 219), ('PROBABLE_UNDERSTANDING', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 268), ('INCOMPLETE_EVIDENCE', 268), ('INCOMPLETE_EVIDENCE', 287), ('INCOMPLETE_EVIDENCE', 297), ('SUPERFICIAL_RELATIONSHIP', 315), ('INCOMPLETE_EVIDENCE', 326)]	9	[('CHEBI_33839', 'macromolecule', 61, 'micronutrients'), ('GO_0060033', 'anatomical structure regression', 134, 'recall'), ('CHEBI_16158', 'steroid sulfate', 175, 'supplement'), ('CHEBI_33341', 'titanium atom', 224, 'supplements'), ('CHEBI_33341', 'titanium atom', 331, 'supplements'), ('CHEBI_33277', 'gamma-tocotrienol', 386, 'vitamins'), ('CHEBI_27300', 'vitamin D', 403, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 418, 'E'), ('GO_0007565', 'female pregnancy', 424, 'pregnancy'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 484, 'micronutrient')]
PMC2963768	10/2010	S117-PMC2963768	['SINCE the concentration of Vitamin D Metabolites in Breastmilk is determined by maternal Vitamin D status, maternal Vitamin D deficiency during Lactation MAY cause ongoing deficits in Postnatal infants’ Vitamin D intake (42); YET, maternal FACTORS CANNOT ENTIRELY ACCOUNT for the persistence of low 25(Oh)D among toddlers (table 1) who experience direct exposure to sun and should BE unaffected by the conservative clothing practices of their mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226), ('ANOMALY_CURIOUS_FINDING', 226), ('SUPERFICIAL_RELATIONSHIP', 240), ('INCOMPLETE_EVIDENCE', 248), ('IMPORTANT_CONSIDERATION', 264), ('ANOMALY_CURIOUS_FINDING', 381)]	9	[('CHEBI_26871', 'terpene alkaloid', 27, 'vitamin D metabolites'), ('UBERON_0001348', 'brown adipose tissue', 52, 'breastmilk'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007595', 'lactation', 144, 'lactation'), ('GO_0007567', 'parturition', 184, 'postnatal'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 299, '25(OH)D')]
PMC2996405	11/2010	S9-PMC2996405	['in an ATTEMPT to try to EXPLAIN this POSSIBLE LINK between latitude and schizophrenia, we INVESTIGATED their ASSOCIATIONS with Vitamin D. we FOUND in a set of vitamin d related Genes a significant enrichment of both lrgs and of Genes INVOLVED in schizophrenia.']	[('DIFFICULT_TASK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('PROBABLE_UNDERSTANDING', 24), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 234)]	9	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('SO_0000704', 'gene', 177, 'genes'), ('SO_0000704', 'gene', 228, 'genes')]
PMC2996405	11/2010	S59-PMC2996405	['in an ATTEMPT to try to EXPLAIN this POSSIBLE LINK between latitude and schizophrenia, we INVESTIGATED their ASSOCIATION with Vitamin D, which had been PREVIOUSLY ASSOCIATED, separately, to both of them.']	[('DIFFICULT_TASK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('PROBABLE_UNDERSTANDING', 24), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 46), ('QUESTION_ANSWERED_BY_THIS_WORK', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 163)]	9	[('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC2996405	11/2010	S155-PMC2996405	['this result MAY SUGGEST that Vitamin D related Genes COULD have been subject, AT LEAST IN PART, to a latitude-DEPENDENT adaptation, SUPPORTING the HYPOTHESIS that selection also ACTED on OTHER mechanisms different from depigmentation.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 53), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 110), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187)]	9	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('SO_0000704', 'gene', 47, 'genes')]
PMC3257641	3/2010	S153-PMC3257641	['HOWEVER, the MAJORITY of POTENTIAL adverse offspring health outcomes pertain to low Prenatal Vitamin D status and the EVOLVING EVIDENCE has provided greater IMPETUS for PUBLIC HEALTH EFFORTS to ensure mothers are not frankly Vitamin D deficient (<25 nmol/l) in Pregnancy, ALTHOUGH the value of treating relative Vitamin D insufficiency in Pregnancy is NOT clearly ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 169), ('FUTURE_WORK', 183), ('ANOMALY_CURIOUS_FINDING', 272), ('FULL_UNKNOWN', 352)]	9	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('GO_0007565', 'female pregnancy', 261, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D'), ('GO_0007565', 'female pregnancy', 339, 'pregnancy')]
PMC3277098	12/2011	S20-PMC3277098	['more RECENTLY variations in Vitamin D status and intake HAS BEEN IMPLICATED in Allergy Development and CONSIDERED AS one of a NUMBER OF EXPLANATIONS for epidemiological and immunological ASSOCIATIONS.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 103), ('PROBABLE_UNDERSTANDING', 114), ('INCOMPLETE_EVIDENCE', 126), ('PROBABLE_UNDERSTANDING', 136), ('SUPERFICIAL_RELATIONSHIP', 187)]	9	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0060021', 'roof of mouth development', 79, 'allergy development')]
PMC3407995	7/2012	S303-PMC3407995	['HOWEVER, one SHOULD CONSIDER the COMPLEX nature of Vitamin D EFFECTS SINCE EITHER deficiency OR excess MAY BE harmful [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 13), ('FUTURE_WORK', 20), ('DIFFICULT_TASK', 33), ('SUPERFICIAL_RELATIONSHIP', 61), ('PROBABLE_UNDERSTANDING', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('INCOMPLETE_EVIDENCE', 103)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
PMC3427192	4/2012	S35-PMC3427192	['HOWEVER, it is IMPORTANT TO NOTE that a large percentage of children were lost to follow-up, and THUS the resulting sample of mothers had higher concentrations of 25(Oh)D and were older, less LIKELY to smoke during Pregnancy, and more educated.63therefore WHILE there MAY BE therapeutic window for vitamin D supplementation in early Life, FURTHER STUDIES ARE NEEDED to more clearly understand the RISKS of high Vitamin D intake and bioavailability during the early childhood years.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 15), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 192), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('INCOMPLETE_EVIDENCE', 268), ('FUTURE_WORK', 339), ('FUTURE_WORK', 347), ('IMPORTANT_CONSIDERATION', 397)]	9	[('CHEBI_71657', 'versiconol acetate', 163, '25(OH)D'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 306, 'D'), ('UBERON_0000104', 'life cycle', 333, 'life'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D')]
PMC3465343	10/2012	S177-PMC3465343	['GIVEN that vad is STILL a SERIOUS and PREVALENT PUBLIC HEALTH PROBLEM in the world especially among Pregnant women and children and dietary Vitamin A is ONLY available from limited sources, including vegetables in the form of Β-Carotene or meat as Retinyl Esters, vad MAY BE an IMPORTANT cause of Human congenital Spinal deformities[43].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 18), ('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 38), ('IMPORTANT_CONSIDERATION', 48), ('PROBLEM_COMPLICATION', 62), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 268), ('IMPORTANT_CONSIDERATION', 278)]	9	[('GO_0007565', 'female pregnancy', 100, 'pregnant'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin A'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 226, 'β-carotene'), ('CHEBI_26523', 'reactive oxygen species', 248, 'retinyl esters'), ('NCBITaxon_9606', 'Homo sapiens', 297, 'human'), ('UBERON_0001130', 'vertebral column', 314, 'spinal')]
PMC3472720	8/2012	S31-PMC3472720	['the QUESTION we have ADDRESSED was WHETHER one’s parents’ season of Birth (AS a PROXY-measure of developmental Vitamin D status) COULD BE an additional RISK FACTOR for ms patients?']	[('EXPLICIT_QUESTION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('EXPLICIT_QUESTION', 35), ('PROBABLE_UNDERSTANDING', 75), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 152), ('EXPLICIT_QUESTION', 179)]	9	[('GO_0007567', 'parturition', 68, 'birth'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 119, 'D')]
PMC3501517	11/2012	S226-PMC3501517	['THEREFORE, an UNANSWERED QUESTION is IF Vitamin D augmentation CAN be PROTECTIVE in our Lps MODEL for ali.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('ANOMALY_CURIOUS_FINDING', 14), ('EXPLICIT_QUESTION', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 92)]	9	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_16412', 'lipopolysaccharide', 88, 'LPS')]
PMC3651971	5/2013	S139-PMC3651971	['the lack of EFFECT is UNLIKELY to be DUE TO a lack of Vitamin A deficiency among Pregnant women; ∼20% of mothers were NOTED to have a Serum Retinol concentration below 0.70\u2005µmol/l, a prevalence that fell to ∼3% with supplementation.20gestational night blindness of ∼10% also responded to Vitamin A supplementation,37and the risk of Maternal death was reduced by ∼40% through supplementation.20there was no lack of Cognitive or motor effect, which is LIKELY to be OWING TO the POOR response to supplementation among the offspring; infants Born to supplemented women had a higher Serum Retinol than infants Born to Placebo mothers by 3\u2005months of age.24the children Born to supplemented women also had better Lung function (as measured by the forced Expiratory volume at 1\u2005s and forced vital capacity)25and raised natural Antibody levels26in childhood, FURTHER EVIDENCE of a physiological EFFECT.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('PROBABLE_UNDERSTANDING', 22), ('PROBLEM_COMPLICATION', 37), ('ANOMALY_CURIOUS_FINDING', 118), ('PROBABLE_UNDERSTANDING', 450), ('PROBLEM_COMPLICATION', 463), ('PROBLEM_COMPLICATION', 476), ('INCOMPLETE_EVIDENCE', 850), ('SUPERFICIAL_RELATIONSHIP', 886)]	9	[('CHEBI_27300', 'vitamin D', 54, 'vitamin A'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('UBERON_0001977', 'blood serum', 134, 'serum'), ('CHEBI_26536', 'retinoic acid', 140, 'retinol'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin A'), ('GO_0007618', 'mating', 332, 'maternal'), ('GO_0050890', 'cognition', 414, 'cognitive'), ('GO_0007567', 'parturition', 538, 'born'), ('UBERON_0001977', 'blood serum', 578, 'serum'), ('CHEBI_26536', 'retinoic acid', 584, 'retinol'), ('GO_0007567', 'parturition', 605, 'born'), ('CHEBI_26130', 'biological pigment', 613, 'placebo'), ('GO_0007567', 'parturition', 663, 'born'), ('UBERON_0002048', 'lung', 706, 'lung'), ('GO_0010467', 'gene expression', 747, 'expiratory'), ('GO_0042571', 'immunoglobulin complex, circulating', 819, 'antibody')]
PMC3668200	5/2013	S0-PMC3668200	['comparison of the Serum Vitamin D level between breastfed and formula-Fed infants: several FACTORS which CAN AFFECT Serum Vitamin D concentration\nit is COMMON KNOWLEDGE among pediatricians that exclusively breastfed infants SHOULD BE supplemented with Vitamin D (400 iu/day) BECAUSE Human Breast Milk contains an INADEQUATE amount of Vitamin D. accordingly, choi et al.1)REPORTED a vitamin deficiency in early infants in a comparative study between Breastfed and formula-Fed infants in this issue.']	[('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 152), ('FUTURE_WORK', 159), ('FUTURE_WORK', 224), ('PROBABLE_UNDERSTANDING', 275), ('IMPORTANT_CONSIDERATION', 313), ('INCOMPLETE_EVIDENCE', 371)]	9	[('UBERON_0001977', 'blood serum', 18, 'serum'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007631', 'feeding behavior', 70, 'fed'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 283, 'human'), ('UBERON_0001348', 'brown adipose tissue', 289, 'breast milk'), ('CHEBI_27300', 'vitamin D', 334, 'vitamin D'), ('GO_0007567', 'parturition', 449, 'breastfed'), ('GO_0007631', 'feeding behavior', 471, 'fed')]
PMC3702245	6/2013	S72-PMC3702245	['the institute of MEDICINE7CONSIDERS a Serum 25(Oh)D concentration >50 nmol/l AS acceptable, WHILE the Endocrine society and Vitamin D EXPERTS RECOMMEND >75 nmol/l.8,99a RECENT STUDY among traditional populations in tanzania with type vi (dark) skin color living in a sun-abundant environment RECOMMENDED a mean Serum 25(Oh)D concentration of 115 nmol/l in nonpregnant Adults and 139 nmol/l in Pregnant women.57the question then is: WHAT Serum concentration of 25(Oh)D is “normal” in Adults, including during Pregnancy?']	[('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('PROBABLE_UNDERSTANDING', 134), ('FUTURE_WORK', 142), ('INCOMPLETE_EVIDENCE', 169), ('FUTURE_WORK', 292), ('EXPLICIT_QUESTION', 432), ('EXPLICIT_QUESTION', 517)]	9	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_71657', 'versiconol acetate', 44, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 44, '25(OH)D'), ('UBERON_0005063', 'left ventricular compact myocardium', 102, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('UBERON_0001977', 'blood serum', 311, 'serum'), ('CHEBI_71657', 'versiconol acetate', 317, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 317, '25(OH)D'), ('UBERON_0007023', 'adult organism', 368, 'adults'), ('GO_0007565', 'female pregnancy', 393, 'pregnant'), ('UBERON_0001977', 'blood serum', 437, 'serum'), ('CHEBI_71657', 'versiconol acetate', 460, '25(OH)D'), ('UBERON_0007023', 'adult organism', 483, 'adults'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy')]
PMC3705320	3/2013	S204-PMC3705320	['the most direct application of the present OBSERVATIONS is to guide the design of FUTURE TRIALS of Vitamin D3 (at doses up to 35,000 iu per week) AIMED at CONFIRMING SAFETY and establishing the health benefits of Antenatal Vitamin D supplementation in south asia, where many POTENTIALLY Vitamin D-responsive outcomes (e.g., infant growth and infectious disease morbidity) are MAJOR PUBLIC HEALTH PRIORITIES.']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 146), ('PROBABLE_UNDERSTANDING', 155), ('IMPORTANT_CONSIDERATION', 166), ('INCOMPLETE_EVIDENCE', 275), ('IMPORTANT_CONSIDERATION', 376), ('IMPORTANT_CONSIDERATION', 382), ('IMPORTANT_CONSIDERATION', 396)]	9	[('CHEBI_33279', 'vitamin D5', 99, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 99, 'vitamin D3'), ('GO_0007567', 'parturition', 213, 'antenatal'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D')]
PMC3717170	5/2013	S69-PMC3717170	["in addition, FEW randomized controlled trials HAVE BEEN conducted in Pregnant women to determine optimal Vitamin D status.13–15\ncarol l. wagner (medical university of south carolina) DISCUSSED two RECENT STUDIES performed by her group in collaboration with bruce hollis's group—the national institute of child health and Human development (nichd) Vitamin D Pregnancy trial12and the thrasher research fund Vitamin D community-based supplementation trial16—that INDICATE that 400 iu Vitamin D, the amount found in MOST Prenatal Vitamins, is INADEQUATE and that 4000 iu/day is NECESSARY to optimize 1,25(Oh)2D3Production, achieved when total circulating 25(Oh)d3is at least 40 ng/ml (fig."]	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 460), ('PROBABLE_UNDERSTANDING', 512), ('IMPORTANT_CONSIDERATION', 539), ('PROBLEM_COMPLICATION', 539), ('IMPORTANT_CONSIDERATION', 574)]	9	[('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 321, 'Human'), ('CHEBI_28384', 'vitamin K', 347, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 357, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 405, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 405, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 481, 'vitamin D'), ('GO_0007565', 'female pregnancy', 517, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 526, 'vitamins'), ('CHEBI_37983', 'sulfur-35 atom', 596, '1'), ('CHEBI_74151', 'S-palmitoyl-L-cysteine residue', 597, ',25(OH)2D3production'), ('PR_000029121', 'leucine-rich repeat and guanylate kinase domain-containing protein', 604, '2D3production'), ('CHEBI_33310', 'neon atom', 653, '(OH)')]
PMC3717170	5/2013	S102-PMC3717170	['in RELATION to the systemic pathology of copd the ROLE of Vitamin D has generated interest, AS Vitamin D deficiency is OFTEN present in patients with copd,24dependent on the severity of copd.25indeed, the prevalence of Vitamin D deficiency, defined as Plasma 25(Oh) D3Concentrations below 20 ng/ml (50 nmol/l), was 58% in a cross-sectional study of 151 copd patients entering Pulmonary rehabilitation during summer.26in the bergen copd cohort study, the prevalence of Vitamin D deficiency was INDEED higher in the copd patients than in the control subjects, INDEPENDENT of season, age, smoking, comorbidity, and body mass index.27several POTENTIAL EXPLANATIONS for the increased risk of Vitamin D deficiency in patients with copd include poor diet, less outdoor activity and THUS less exposure to sunlight, accelerated Skin Aging due to smoking, Renal dysfunction, and treatment with Corticosteroids.']	[('SUPERFICIAL_RELATIONSHIP', 3), ('SUPERFICIAL_RELATIONSHIP', 50), ('PROBABLE_UNDERSTANDING', 92), ('PROBABLE_UNDERSTANDING', 119), ('ANOMALY_CURIOUS_FINDING', 493), ('SUPERFICIAL_RELATIONSHIP', 558), ('INCOMPLETE_EVIDENCE', 638), ('PROBABLE_UNDERSTANDING', 648), ('PROBABLE_UNDERSTANDING', 775)]	9	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 252, 'plasma'), ('CHEBI_73735', 'gadoterate', 259, '25(OH) D3concentrations'), ('PR_000016555', 'thymocyte selection-associated high mobility group box protein TOX', 259, '25(OH) D3concentrations'), ('UBERON_0002048', 'lung', 376, 'pulmonary'), ('CHEBI_27300', 'vitamin D', 468, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 687, 'vitamin D'), ('GO_0036331', 'avascular cornea development in camera-type eye', 819, 'skin'), ('GO_0007568', 'aging', 824, 'aging'), ('UBERON_0002113', 'kidney', 846, 'renal'), ('CHEBI_50850', 'etabonate ester', 884, 'corticosteroids')]
PMC3717170	5/2013	S163-PMC3717170	['in large population-based studies, low levels of Vitamin D PREDICT loss of mobility and disability in Basic activities Of daily living, independent of age and other POTENTIAL CONFOUNDERS.47BASED on THESE FINDINGS, SOME gerontologists CLAIM that Vitamin D has antiaging EFFECTS.']	[('SUPERFICIAL_RELATIONSHIP', 59), ('INCOMPLETE_EVIDENCE', 165), ('PROBLEM_COMPLICATION', 175), ('PROBABLE_UNDERSTANDING', 187), ('PROBABLE_UNDERSTANDING', 187), ('INCOMPLETE_EVIDENCE', 198), ('INCOMPLETE_EVIDENCE', 214), ('INCOMPLETE_EVIDENCE', 234), ('SUPERFICIAL_RELATIONSHIP', 269)]	9	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'basic'), ('UBERON_0002828', 'ventral cochlear nucleus', 119, 'of'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
PMC3798907	8/2013	S107-PMC3798907	['this is an IMPORTANT differential result because, together with the between-subject variation and the COMPLEX EFFECTS on Cytokine Production, it INDICATES that the observed in vivo epidemiological ASSOCIATION between maternal Vitamin E intake during Pregnancy and cbmc responses and childhood asthma/wheeze cannot be EXPLAINED by a direct and CONSISTENT EFFECT on overall th-cell responsiveness, as originally HYPOTHESISED [22].']	[('IMPORTANT_CONSIDERATION', 11), ('DIFFICULT_TASK', 102), ('SUPERFICIAL_RELATIONSHIP', 110), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 197), ('PROBABLE_UNDERSTANDING', 317), ('INCOMPLETE_EVIDENCE', 343), ('SUPERFICIAL_RELATIONSHIP', 354), ('INCOMPLETE_EVIDENCE', 410)]	9	[('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 121, 'cytokine production'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin E'), ('GO_0007565', 'female pregnancy', 250, 'pregnancy')]
PMC3798907	8/2013	S111-PMC3798907	['the DIFFERENTIAL EFFECTS of supplementation on hdm and tg responses EXCLUDES the POSSIBILITY that any suppressive EFFECTS of Vitamin E supplementation REPRESENT toxicity, which was also avoided by adding physiological concentrations representative of those measured in Cord Blood at Birth in the epidemiological study DEMONSTRATING an ASSOCIATION between Vitamin E and cbmc responses [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('SUPERFICIAL_RELATIONSHIP', 17), ('PROBABLE_UNDERSTANDING', 68), ('PROBABLE_UNDERSTANDING', 68), ('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 151), ('INCOMPLETE_EVIDENCE', 318), ('SUPERFICIAL_RELATIONSHIP', 335)]	9	[('CHEBI_27300', 'vitamin D', 125, 'vitamin E'), ('UBERON_0002240', 'spinal cord', 269, 'cord'), ('UBERON_0000178', 'blood', 274, 'blood'), ('GO_0007567', 'parturition', 283, 'birth'), ('CHEBI_27300', 'vitamin D', 355, 'vitamin E')]
PMC3873449	12/2013	S62-PMC3873449	['ALTHOUGH there HAS BEEN DEBATE over WHICH level of Serum 25(Oh)D REFLECTS optimum Vitamin D status, it is GENERALLY ACCEPTED that Serum 25(Oh)d level of < 30ng/ml(75nmol/l) is the cut-off value for insufficiency [15-17], which is ASSOCIATED with maximal suppression of Parathyroid hormone [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('EXPLICIT_QUESTION', 36), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 230)]	9	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001977', 'blood serum', 130, 'serum'), ('CHEBI_63056', 'zinc cation', 136, '25(OH'), ('UBERON_0001132', 'parathyroid gland', 269, 'parathyroid')]
PMC4072587	6/2014	S122-PMC4072587	['the OBSERVED ASSOCIATION between Antenatal Vitamin D concentration and infant development is PLAUSIBLE AS Vitamin D has an IMPORTANT ROLE in Neurodevelopment through Cell Differentiation, cytokine Regulation, neurotransmitter synthesis and anti-oxidant activity, and it is HAS BEEN SUGGESTED that in utero exposure to Vitamin D deficiency during the second and third trimesters MAY AFFECT the development of the perisylvian structures, which are responsible for Language in children[24],[39].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 103), ('IMPORTANT_CONSIDERATION', 123), ('SUPERFICIAL_RELATIONSHIP', 133), ('INCOMPLETE_EVIDENCE', 273), ('INCOMPLETE_EVIDENCE', 378), ('SUPERFICIAL_RELATIONSHIP', 382)]	9	[('GO_0007567', 'parturition', 33, 'antenatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007399', 'nervous system development', 141, 'neurodevelopment'), ('GO_0030154', 'cell differentiation', 166, 'cell differentiation'), ('GO_0065007', 'biological regulation', 197, 'regulation'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('GO_0006266', 'DNA ligation', 462, 'language')]
PMC4113768	7/2014	S852-PMC4113768	['most data regarding the EFFECTS of Vitamin D on non-Skeletal Tissues in young People HAS BEEN obtained from cross-sectional studies, with their ASSOCIATED LIMITATIONS.we have THEREFORE UNDERTAKEN a systematic review of randomised controlled trials (rcts) that has EXAMINED the IMPACT of Vitamin D on muscle strength and function in young People.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 144), ('INCOMPLETE_EVIDENCE', 155), ('PROBLEM_COMPLICATION', 155), ('PROBABLE_UNDERSTANDING', 175), ('QUESTION_ANSWERED_BY_THIS_WORK', 185), ('QUESTION_ANSWERED_BY_THIS_WORK', 264), ('SUPERFICIAL_RELATIONSHIP', 277)]	9	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0004288', 'skeleton', 52, 'skeletal'), ('UBERON_0000479', 'tissue', 61, 'tissues'), ('NCBITaxon_10088', 'Mus <genus>', 78, 'people'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 338, 'people')]
PMC4113768	7/2014	S1203-PMC4113768	['conclusions: pth is the MOST LIKELY MARKER to be outside the reference range (raised) IF the patient is Vitamin D deficient BUT the literature SUGGESTS the RELATIONSHIP between 25Ohd and pth MAY BE COMPLICATED by Glomerular filtration rate.']	[('PROBABLE_UNDERSTANDING', 24), ('PROBABLE_UNDERSTANDING', 29), ('SUPERFICIAL_RELATIONSHIP', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 156), ('INCOMPLETE_EVIDENCE', 191), ('DIFFICULT_TASK', 198)]	9	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 177, '25OHD'), ('UBERON_0000074', 'renal glomerulus', 213, 'glomerular')]
PMC4113768	7/2014	S1301-PMC4113768	['; wood, a.d.\nbackground: variation in Vitamin D binding protein (Vdbp) MAY EXPLAIN the INCONSISTENCIES between studies of Vitamin D; EITHER ( a ) through a mechanism by which the circulating half-life of 25-Hydroxy Vitamin D [25(Oh)D] MAY BE extended or ( b ) BECAUSE non-Vdbp bound or free Metabolites of Vitamin D MAY BETTER REFLECT biological activity.']	[('INCOMPLETE_EVIDENCE', 71), ('PROBABLE_UNDERSTANDING', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133), ('INCOMPLETE_EVIDENCE', 235), ('PROBABLE_UNDERSTANDING', 260), ('INCOMPLETE_EVIDENCE', 316), ('INCOMPLETE_EVIDENCE', 320), ('SUPERFICIAL_RELATIONSHIP', 327)]	9	[('CHEBI_28384', 'vitamin K', 38, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 38, 'Vitamin D'), ('PR_000017279', 'testis-specific basic protein Y 1', 65, 'VDBP'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 204, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 226, '25(OH)D'), ('PR_000017279', 'testis-specific basic protein Y 1', 272, 'VDBP'), ('CHEBI_25212', 'metabolite', 291, 'metabolites'), ('CHEBI_27300', 'vitamin D', 306, 'vitamin D')]
PMC4113768	7/2014	S2543-PMC4113768	['background: AS Vitamin D is ESSENTIAL to calcium Regulation, the concern HAS BEEN RAISED that high levels of Vitamin D MAY lead TO hypercalcemia (Plasma levels exceeding 2.6 mmol/l) that, in turn, MAY increase the RISK of adverse health events such as Cardiac arrest, Renal failure, and Hepatic injuries.']	[('PROBABLE_UNDERSTANDING', 12), ('IMPORTANT_CONSIDERATION', 28), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 73), ('EXPLICIT_QUESTION', 82), ('INCOMPLETE_EVIDENCE', 119), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('INCOMPLETE_EVIDENCE', 197), ('IMPORTANT_CONSIDERATION', 214)]	9	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0065007', 'biological regulation', 49, 'regulation'), ('CHEBI_28384', 'vitamin K', 109, 'Vitamin D'), ('UBERON_0001969', 'blood plasma', 146, 'plasma'), ('UBERON_0000948', 'heart', 252, 'cardiac'), ('UBERON_0002113', 'kidney', 268, 'renal'), ('UBERON_0002107', 'liver', 287, 'hepatic')]
PMC4171568	9/2014	S142-PMC4171568	['THEREFORE, the RELATIONSHIP between Vitamin D and schizophrenia NEEDS FURTHER INVESTIGATION, EVEN THOUGH a RECENT review of the EVIDENCE CONCLUDED that adequate levels of Vitamin D are needed for normal Brain Development and function and furthermore that at-risk groups SHOULD BE offered supplementation [112].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('FUTURE_WORK', 64), ('FUTURE_WORK', 70), ('ANOMALY_CURIOUS_FINDING', 93), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 137), ('FUTURE_WORK', 270)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007420', 'brain development', 203, 'brain development'), ('UBERON_0000955', 'brain', 203, 'brain')]
PMC4256222	12/2014	S121-PMC4256222	['IF a TRUE UNDERLYING beneficial EFFECT of maternal Vitamin D status on offspring bone health exists and is LIMITED to very low levels, we MAY not be able to detect such a RELATIONSHIP in our data, where ONLY 6.3% of the study population had a Vitamin D status below 25 nmol/l and 25.5% had a status below 50 nmol/l.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 5), ('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 171), ('ANOMALY_CURIOUS_FINDING', 203), ('INCOMPLETE_EVIDENCE', 203)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4256222	12/2014	S140-PMC4256222	['in this context, a POTENTIAL negative IMPACT of maternal Vitamin D deficiency MAY have been BLURRED in our data, SINCE data are lacking on POTENTIALLY IMPORTANT CONFOUNDERS.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('PROBABLE_UNDERSTANDING', 113), ('PROBLEM_COMPLICATION', 113), ('INCOMPLETE_EVIDENCE', 139), ('IMPORTANT_CONSIDERATION', 151), ('PROBLEM_COMPLICATION', 161)]	9	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC4302429	1/2015	S175-PMC4302429	['we THEREFORE ASKED WHETHER Vitamin D MIGHT Modulate the course of and survival from infection after bacterial meningoencephalitis and WHETHER Vitamin D COULD POTENTIALLY be used therapeutically to alleviate Cns pathology.']	[('PROBABLE_UNDERSTANDING', 3), ('EXPLICIT_QUESTION', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('EXPLICIT_QUESTION', 134), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 158)]	9	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0065007', 'biological regulation', 43, 'modulate'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 207, 'CNS')]
PMC4377870	3/2015	S104-PMC4377870	['as a result, meta-analysis of Vitamin E EFFECTS on asthma outcomes is EQUIVOCAL; it is LIKELY that supplementation with physiological concentrations of Α-Tocopherol in the context of a background diet low in Γ-Tocopherol, MAY BE MOST beneficial in asthma and FURTHER RESEARCH testing this HYPOTHESIS IS REQUIRED.']	[('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('PROBABLE_UNDERSTANDING', 87), ('INCOMPLETE_EVIDENCE', 222), ('PROBABLE_UNDERSTANDING', 229), ('FUTURE_WORK', 259), ('INCOMPLETE_EVIDENCE', 289), ('FUTURE_WORK', 300), ('IMPORTANT_CONSIDERATION', 303)]	9	[('CHEBI_27300', 'vitamin D', 30, 'vitamin E'), ('CHEBI_27725', 'butin', 152, 'α-tocopherol'), ('CHEBI_27725', 'butin', 208, 'γ-tocopherol')]
PMC4377879	3/2015	S87-PMC4377879	['DESPITE its IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System, the IMPACT of Antenatal Vitamin D is STILL poorly understood [40], not LEAST BECAUSE of uncertainties with appropriate BIOMARKERS and cut-off points.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('SUPERFICIAL_RELATIONSHIP', 22), ('SUPERFICIAL_RELATIONSHIP', 107), ('IMPORTANT_CONSIDERATION', 140), ('PROBABLE_UNDERSTANDING', 174), ('PROBABLE_UNDERSTANDING', 180), ('PROBLEM_COMPLICATION', 180), ('SUPERFICIAL_RELATIONSHIP', 222)]	9	[('GO_0055064', 'chloride ion homeostasis', 30, 'bone homeostasis'), ('GO_0007420', 'brain development', 48, 'brain development'), ('UBERON_0000955', 'brain', 48, 'brain'), ('GO_0002022', 'detection of dietary excess', 70, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 88, 'immune system'), ('GO_0007567', 'parturition', 117, 'antenatal'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC4377879	3/2015	S89-PMC4377879	['a cochrane review FOUND a significant RELATIONSHIP between an increase in Serum Vitamin D concentrations at term and borderline reduction in low Birthweight [42] but there is yet NOT ENOUGH EVIDENCE for policy AS the NUMBER OF high-quality trials IS THOUGHT TO be currently too SMALL to draw conclusions on its usefulness and SAFETY [18].']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 179), ('PROBABLE_UNDERSTANDING', 210), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 247), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 278), ('IMPORTANT_CONSIDERATION', 326)]	9	[('UBERON_0001977', 'blood serum', 74, 'serum'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007596', 'blood coagulation', 145, 'birthweight')]
PMC4448820	5/2015	S289-PMC4448820	['ALTHOUGH NEW DATA ARE NEEDED to FURTHER ELUCIDATE the magnitude of these RELATIONS, IT IS CLEAR that Vitamin A has multiple Genetically MEDIATED EFFECTS on the Immune Response via the activities of atra.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 9), ('FUTURE_WORK', 9), ('FUTURE_WORK', 32), ('FUTURE_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 136), ('SUPERFICIAL_RELATIONSHIP', 145)]	9	[('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('SO_0000704', 'gene', 124, 'genetically'), ('GO_0006955', 'immune response', 160, 'immune response'), ('UBERON_0002405', 'immune system', 160, 'immune')]
PMC4452099	6/2015	S27-PMC4452099	['the REPORTED REASON to initiate mandatory fortification was the need to substitute the lack of Vitamin D in Margarine COMPARED to butter, WHILE the decision to cancel mandatory margarine fortification was justified by the low Vitamin D doses added to the Margarine products—an ARGUMENT which, HOWEVER, DID NOT SEEM TO BE EVIDENCE-BASED.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 13), ('ANOMALY_CURIOUS_FINDING', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 277), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 293), ('INCOMPLETE_EVIDENCE', 302), ('ANOMALY_CURIOUS_FINDING', 310), ('INCOMPLETE_EVIDENCE', 315)]	9	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_6784', 'mestranol', 108, 'margarine'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('CHEBI_6784', 'mestranol', 255, 'margarine')]
PMC4452099	6/2015	S96-PMC4452099	['ANOTHER POTENTIAL REASON WHY we DID NOT detect EFFECTS of early exposure to Vitamin D fortification on later t1d risk MAY BE RELATED to statistical power ISSUES [32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18), ('EXPLICIT_QUESTION', 25), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 125), ('PROBLEM_COMPLICATION', 154)]	9	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4516377	6/2015	S73-PMC4516377	['as these FACTORS are INTERCONNECTED with worsening in the obesity context, the cause-and-effect ASSOCIATION between the two pathologies is NOT yet CLEAR.37\nlee et al.18EMPHASIZED that DIFFERENCES in Serum levels of Vitamin D in RELATION to gender CAN be EXPLAINED by the fact that girls reported having a healthier diet for all questions asked.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 96), ('FULL_UNKNOWN', 139), ('INCOMPLETE_EVIDENCE', 166), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('SUPERFICIAL_RELATIONSHIP', 228), ('INCOMPLETE_EVIDENCE', 247), ('PROBABLE_UNDERSTANDING', 254)]	9	[('UBERON_0001977', 'blood serum', 199, 'serum'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D')]
PMC4516377	6/2015	S74-PMC4516377	['ON THE OTHER HAND, this gender DIFFERENCE was NOT FOUND in ANOTHER study.20\nthe mechanism by which Vitamin D INFLUENCES adiposity is not COMPLETELY understood, but there are LINES OF RESEARCH that try to explain this phenomenon.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('ANOMALY_CURIOUS_FINDING', 46), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 109), ('PROBABLE_UNDERSTANDING', 137), ('INCOMPLETE_EVIDENCE', 174)]	9	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC4586450	10/2015	S544-PMC4586450	['overall, the diets of children in the alspac were adequate for most Nutrients, with the NOTABLE EXCEPTION of Vitamin D. at age 1.5 years and age 3.5 years, all of the alspac children were found to be below the united kingdom dietary recommendations for Vitamin D intake, and children who had low intakes at age 1.5 years were twice as LIKELY to have low intakes at age 3.5 years.24ALTHOUGH it HAS BEEN RECOMMENDED for 25 years or more that children aged <5 years SHOULD BE given Vitamin D supplements,93only a minority in either the alspac24or the national surveys actually were supplemented.101it IS POSSIBLE that a fortification program COULD be a good option to improve this situation.']	[('ANOMALY_CURIOUS_FINDING', 88), ('ANOMALY_CURIOUS_FINDING', 96), ('PROBABLE_UNDERSTANDING', 335), ('ANOMALY_CURIOUS_FINDING', 379), ('INCOMPLETE_EVIDENCE', 393), ('FUTURE_WORK', 402), ('FUTURE_WORK', 463), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 639)]	9	[('CHEBI_33284', 'nutrient', 68, 'nutrients'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 479, 'vitamin D')]
PMC4600246	10/2015	S12-PMC4600246	['a broad amount of DATA SEEMS to INDICATE substantial POTENTIAL for supplementary Vitamin K. HOWEVER, currently FEW GUIDELINES RECOMMEND Vitamin K therapy for PREVENTION or treatment of osteoporosis.']	[('FUTURE_WORK', 18), ('ANOMALY_CURIOUS_FINDING', 23), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('INCOMPLETE_EVIDENCE', 111), ('PROBABLE_UNDERSTANDING', 115), ('FUTURE_WORK', 126), ('SUPERFICIAL_RELATIONSHIP', 158)]	9	[('CHEBI_27300', 'vitamin D', 81, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin K')]
PMC4684854	12/2015	S54-PMC4684854	['these iom RECOMMENDATIONS for REQUIRED Vitamin D intake HAVE BEEN put into SERIOUS question [42], HOWEVER, AS a significant statistical ERROR HAS BEEN identified in the way their recommendations were arrived AT [43].']	[('FUTURE_WORK', 10), ('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('PROBABLE_UNDERSTANDING', 107), ('PROBLEM_COMPLICATION', 136), ('INCOMPLETE_EVIDENCE', 142), ('IMPORTANT_CONSIDERATION', 208)]	9	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4719746	1/2016	S131-PMC4719746	['INTERPRETATION\nOUR FINDINGS are IN LINE WITH others CONFIRMING widespread Vitamin D deficiency during Pregnancy among ethnic minorities [2,3,11,23,24], although SOME STUDIES from northern europe have FOUND a comparatively higher prevalence and more SEVERE deficiency THAN observed in OUR STUDY [6,25].']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 52), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 200), ('IMPORTANT_CONSIDERATION', 249), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 267), ('QUESTION_ANSWERED_BY_THIS_WORK', 284)]	9	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy')]
PMC4811441	3/2016	S31-PMC4811441	['case-control STUDIES OFTEN have INSUFFICIENT or no matching, GENERATING CONCERNS about CONFOUNDING AS VARIATIONS in Vitamin D status ASSOCIATED with season, skin pigmentation and lifestyle factors are known [15].']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 21), ('PROBLEM_COMPLICATION', 32), ('PROBABLE_UNDERSTANDING', 61), ('PROBLEM_COMPLICATION', 72), ('PROBLEM_COMPLICATION', 87), ('PROBABLE_UNDERSTANDING', 99), ('DIFFICULT_TASK', 102), ('SUPERFICIAL_RELATIONSHIP', 133)]	9	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4889866	5/2016	S116-PMC4889866	['SINCE the MAJORITY of our participants were Vitamin D deficient, IT IS POSSIBLE that higher Serum levels MIGHT be REQUIRED to reach optimal PROTECTIVE EFFECT to result in significant clinical DIFFERENCES.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 105), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192)]	9	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('UBERON_0001977', 'blood serum', 92, 'serum')]
PMC4889866	5/2016	S131-PMC4889866	['THIS STUDY EMPHASIZED that EVEN THOUGH Cord Vitamin D level was STRONGLY CORRELATED with maternal Vitamin D status, the extent of IMPACT on fetal Immune Cytokine Response MIGHT be distinctive.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 11), ('IMPORTANT_CONSIDERATION', 11), ('ANOMALY_CURIOUS_FINDING', 27), ('ANOMALY_CURIOUS_FINDING', 32), ('PROBABLE_UNDERSTANDING', 64), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 171)]	9	[('UBERON_0002240', 'spinal cord', 39, 'cord'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0002250', 'adaptive immune response', 146, 'immune cytokine response'), ('UBERON_0002405', 'immune system', 146, 'immune')]
PMC4897157	5/2016	S126-PMC4897157	['BECAUSE SEVERAL STUDIES SHOWED that winter Birth COULD BE a risk factor for fa718), and Vitamin D IS CONSIDERED AS the factor that MEDIATES the ASSOCIATION between Birth season and allergic diseases, we expected that insufficient sun exposure during infancy would exert a same INFLUENCE on the presence of Fa.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 98), ('PROBABLE_UNDERSTANDING', 112), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 277)]	9	[('GO_0007567', 'parturition', 43, 'birth'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007567', 'parturition', 164, 'birth'), ('CHEBI_30751', 'formic acid', 306, 'FA')]
PMC4934634	11/2015	S184-PMC4934634	['using dietary Intake data ALONE CAN be PROBLEMATIC SINCE uvb-induced skin Formation of Vitamin D CAN significantly alter Serum 25(Oh)D, THUS, dietary Intakes MIGHT not be a reliable INDICATOR of overall Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 26), ('INCOMPLETE_EVIDENCE', 32), ('PROBLEM_COMPLICATION', 39), ('PROBABLE_UNDERSTANDING', 51), ('PROBLEM_COMPLICATION', 51), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 182)]	9	[('GO_0007631', 'feeding behavior', 14, 'intake'), ('GO_0009057', 'macromolecule catabolic process', 74, 'formation'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum'), ('CHEBI_71657', 'versiconol acetate', 127, '25(OH)D'), ('GO_0007631', 'feeding behavior', 150, 'intakes'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
PMC4973215	8/2016	S62-PMC4973215	['ALTHOUGH the prevalence of Vitamin D deficiency in black mothers and neonates is WELL KNOWN, DEBATE exists as to the RELATIONSHIP between race, Vitamin D deficiency and sga.12,14,15,17,18we EXAMINED this RELATIONSHIP in conjunction with additional maternal characteristics in order TO IDENTIFY groups of Pregnant women who could BENEFIT MOST from Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 190), ('SUPERFICIAL_RELATIONSHIP', 204), ('QUESTION_ANSWERED_BY_THIS_WORK', 282), ('IMPORTANT_CONSIDERATION', 329), ('PROBABLE_UNDERSTANDING', 337)]	9	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 304, 'pregnant'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D')]
PMC4997421	8/2016	S23-PMC4997421	['THEREFORE, the OBJECTIVE of THIS STUDY was to use nhanes data to EXAMINE the Retinol status of women of Childbearing age in the united states, and TO ASSESS the IMPACT of poverty and race, as well as OTHER INDICATORS that have NOT previously BEEN EXAMINED in this population, including Food security and use of supplemental nutrition assistance programs (snap), on Vitamin A status.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 147), ('SUPERFICIAL_RELATIONSHIP', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('SUPERFICIAL_RELATIONSHIP', 206), ('FULL_UNKNOWN', 227)]	9	[('CHEBI_26536', 'retinoic acid', 77, 'retinol'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 104, 'childbearing'), ('CHEBI_33290', 'food', 286, 'food'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin A')]
PMC5129897	10/2016	S14-PMC5129897	['FEW well-designed clinical TRIALS SHOW beneficial EFFECTS of Vitamin D MAINLY BECAUSE many such trials were BASED ON GUIDELINES for Pharmaceutical Drugs.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 50), ('PROBABLE_UNDERSTANDING', 71), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 108), ('ANOMALY_CURIOUS_FINDING', 114), ('ANOMALY_CURIOUS_FINDING', 114), ('PROBABLE_UNDERSTANDING', 117)]	9	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 132, 'pharmaceutical drugs')]
PMC5385921	4/2017	S131-PMC5385921	['in FUTURE STUDIES, it will be OF INTEREST to explore the CRITICAL window during which low Vitamin D MAY CONTRIBUTE to asd RISK – it is FEASIBLE that exposure in the first few years of Life MAY also CONTRIBUTE to adverse Brain outcomes.']	[('FUTURE_WORK', 3), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 104), ('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 135), ('INCOMPLETE_EVIDENCE', 189), ('SUPERFICIAL_RELATIONSHIP', 198)]	9	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('UBERON_0000104', 'life cycle', 184, 'life'), ('UBERON_0000955', 'brain', 220, 'brain')]
PMC5474873	6/2017	S25-PMC5474873	['reviewed seven STUDIES on Vitamin D and psychosis and CONCLUDED that Individuals with psychosis showed lower Vitamin D levels than healthy controls (16), and a COMPREHENSIVE meta-analysis of observation studies SUGGESTED a strong RELATIONSHIP between Vitamin D deficiency and schizophrenia (17) Vitamin D HAS BEEN FOUND to Modulate Dopamine Neurotransmission (5), and SEVERAL STUDIES REPORTED an ASSOCIATION between early Life Vitamin D deficiency and later psychotic disorder.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 160), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 230), ('INCOMPLETE_EVIDENCE', 305), ('INCOMPLETE_EVIDENCE', 368), ('INCOMPLETE_EVIDENCE', 384), ('SUPERFICIAL_RELATIONSHIP', 396)]	9	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('NCBITaxon_1', 'root', 69, 'individuals'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 295, 'Vitamin D'), ('GO_0065007', 'biological regulation', 323, 'modulate'), ('CHEBI_18243', 'dopamine', 332, 'dopamine'), ('GO_0061527', 'dopamine secretion, neurotransmission', 332, 'dopamine neurotransmission'), ('UBERON_0000104', 'life cycle', 422, 'life'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D')]
PMC5634602	10/2017	S150-PMC5634602	['the OPTIMAL dose of Vitamin D supplementation for preterm infants during the early Neonatal Period WARRANTS FURTHER INVESTIGATION, but it is REASONABLE and SAFE to RECOMMEND daily supplementation in addition to dietary intake with 800 iu of Vitamin D to high-risk preterm infants while hospitalized in the nicu in order to TARGET a level of 25(Oh)D that is >75 nmol/l, AS we HAVE SHOWN this to improve bone health defined by dexa in this AT-RISK population.']	[('IMPORTANT_CONSIDERATION', 4), ('FUTURE_WORK', 99), ('PROBABLE_UNDERSTANDING', 141), ('IMPORTANT_CONSIDERATION', 156), ('FUTURE_WORK', 164), ('FUTURE_WORK', 323), ('PROBABLE_UNDERSTANDING', 369), ('INCOMPLETE_EVIDENCE', 375), ('IMPORTANT_CONSIDERATION', 438)]	9	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0007221', 'neonate stage', 83, 'neonatal period'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 344, 'OH)D')]
PMC5659607	10/2017	S151-PMC5659607	['combining this KNOWLEDGE with OUR FINDINGS from THIS combined analysis, SHOWING that Vitamin D supplementation has a PROTECTIVE EFFECT on childhood asthma/recurrent wheeze, makes Vitamin D a very PROMISING Nutrient for FUTURE PREVENTION of Immune-mediated disorders.']	[('FUTURE_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 128), ('PROBABLE_UNDERSTANDING', 196), ('FUTURE_WORK', 219), ('SUPERFICIAL_RELATIONSHIP', 226)]	9	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('UBERON_0002405', 'immune system', 240, 'immune')]
PMC5664622	9/2017	S13-PMC5664622	['IN LIGHT OF the ONGOING DEBATE on the OPTIMAL Vitamin D concentration in Pregnant women, MOST EXPERTS are of the OPINION that the 25(Oh)D concentration in maternal Blood SHOULD exceed 30 ng/ml [2,8,9].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('IMPORTANT_CONSIDERATION', 38), ('PROBABLE_UNDERSTANDING', 89), ('PROBABLE_UNDERSTANDING', 94), ('INCOMPLETE_EVIDENCE', 113), ('FUTURE_WORK', 170), ('IMPORTANT_CONSIDERATION', 170)]	9	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D'), ('UBERON_0000178', 'blood', 164, 'blood')]
PMC5706533	11/2017	S167-PMC5706533	['for example, for the EFFECT of Vitamin D on pre-eclampsia, de-regil and colleagues REPORTED a pooled risk ratio of 0.52 (95% confidence interval 0.25 to 1.05) based on two trials that we included in our review, but neither of which met our minimum criteria for case definitions and methods of ascertainment: one trial ONLY mentioned the exclusion of a participant for “severe pre-eclampsia,”38AND the other REPORTED frequencies of pre-eclampsia but DID NOT mention any screening or diagnostic procedures.39de-regil and colleagues also REPORTED that Vitamin D reduced the RISK of Preterm Birth based on thee trials,6but the current meta-analysis based on 15 comparisons produced REASONABLY strong evidence of a null effect.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 318), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 391), ('INCOMPLETE_EVIDENCE', 407), ('INCOMPLETE_EVIDENCE', 449), ('INCOMPLETE_EVIDENCE', 535), ('IMPORTANT_CONSIDERATION', 571), ('PROBABLE_UNDERSTANDING', 678)]	9	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 549, 'vitamin D'), ('GO_0007565', 'female pregnancy', 579, 'preterm birth')]
PMC5707701	11/2017	S177-PMC5707701	['HOWEVER, our results INDICATED that neither Vitamin A nor E intakes from one 24-h dietary Recall was associated with Vitamin A and E in Human milk, which MAY BE DUE TO the inherent Intake variability of one single 24-h dietary Recall questionnaire, which DID NOT ALLOW for estimations of an Individual’s usual diet, and THEREFORE, it is LIKELY to under- OR overestimate some Nutrient intakes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 154), ('PROBLEM_COMPLICATION', 161), ('DIFFICULT_TASK', 255), ('ANOMALY_CURIOUS_FINDING', 259), ('PROBABLE_UNDERSTANDING', 320), ('PROBABLE_UNDERSTANDING', 337), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 354)]	9	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 58, 'E'), ('GO_0060033', 'anatomical structure regression', 90, 'recall'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 131, 'E'), ('NCBITaxon_9606', 'Homo sapiens', 136, 'human'), ('GO_0007631', 'feeding behavior', 181, 'intake'), ('GO_0060033', 'anatomical structure regression', 227, 'recall'), ('NCBITaxon_1', 'root', 291, 'individual'), ('CHEBI_33284', 'nutrient', 375, 'nutrient')]
PMC5827025	2/2018	S102-PMC5827025	['the INCONSISTENCY of PAST FINDINGS MAY BE RELATED to following REASONS: first, cohort among Pregnant women with relatively Vitamin D replete, with a history of Preterm Delivery or at high risk for Preeclampsia; second, Gestational Vitamin D status is a LINK to ethnic DISPARITIES in adverse Birth outcomes24.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 63), ('SUPERFICIAL_RELATIONSHIP', 253), ('IMPORTANT_CONSIDERATION', 268)]	9	[('GO_0007565', 'female pregnancy', 92, 'pregnant'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'preterm'), ('GO_0007567', 'parturition', 168, 'delivery'), ('GO_0007128', 'meiotic prophase I', 197, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 219, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('GO_0007567', 'parturition', 291, 'birth')]
PMC5941617	5/2018	S211-PMC5941617	['a RECENT GLOBAL CONSENSUS RECOMMENDATIONS on prevention and management of nutritional rickets DEFINED Vitamin D deficiency AS Serum 25(Oh)D\u2009<\u2009\xa012\xa0ng/ml, CONSIDERING the increased incidence of rickets with Serum 25(Oh)D levels under this THRESHOLD [28].']	[('INCOMPLETE_EVIDENCE', 2), ('IMPORTANT_CONSIDERATION', 9), ('PROBABLE_UNDERSTANDING', 16), ('FUTURE_WORK', 26), ('INCOMPLETE_EVIDENCE', 94), ('PROBABLE_UNDERSTANDING', 94), ('PROBABLE_UNDERSTANDING', 123), ('IMPORTANT_CONSIDERATION', 153), ('PROBABLE_UNDERSTANDING', 237)]	9	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0001977', 'blood serum', 126, 'serum'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('UBERON_0001977', 'blood serum', 205, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 211, '25(OH ... D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S99-BMJ_2010_Apr_29_340_c1640	['ultraviolet radiation exposure during the first trimester would be expected to specifically INFLUENCE Vitamin D concentrations up to early in the second trimester, given that Vitamin D has a half life of one to two months.45in RECENT australian work, higher levels of ambient ultraviolet radiation were ASSOCIATED with higher Vitamin D concentrations at the population level with a lag of one and a half months.46\n\nPOSSIBLE mechanisms\nfirst trimester Vitamin D concentrations MIGHT be particularly IMPORTANT in the development of the Central Nervous System BECAUSE during Early Embryonic Development, Vitamin D receptors are Expressed in the Neuroepithelium and later in the Subventricular Zone.15myelination occurs later; EVEN in mid-Gestation (19-24 weeks) Cortical Axonal tracts are not yet myelinated,47with major myelination of several areas occurring as late as 29-39 weeks.48in addition, the in utero Development Of Immune central Tolerance occurs in the first trimester and Vitamin D has immunomodulating properties.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 303), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 476), ('IMPORTANT_CONSIDERATION', 498), ('PROBABLE_UNDERSTANDING', 557), ('ANOMALY_CURIOUS_FINDING', 723)]	8	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 326, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 534, 'central nervous system'), ('UBERON_0019248', 'early embryo', 572, 'early embryonic'), ('GO_0009790', 'embryo development', 578, 'embryonic development'), ('CHEBI_27300', 'vitamin D', 601, 'vitamin D'), ('GO_0010467', 'gene expression', 625, 'expressed'), ('UBERON_0034705', 'developing neuroepithelium', 642, 'neuroepithelium'), ('UBERON_0004922', 'postnatal subventricular zone', 675, 'subventricular zone'), ('GO_0007565', 'female pregnancy', 735, 'gestation'), ('UBERON_0001851', 'cortex', 759, 'cortical'), ('GO_0030424', 'axon', 768, 'axonal'), ('GO_0034102', 'erythrocyte clearance', 908, 'development of ... tolerance'), ('UBERON_0002405', 'immune system', 923, 'immune'), ('CHEBI_27300', 'vitamin D', 982, 'vitamin D')]
PMC2290997	4/2008	S76-PMC2290997	['“NEVERTHELESS, considering the SAFETY of Vitamin D EVEN in high doses, there is NO CLEAR contraindication, and BECAUSE Vitamin D deficiency is very PREVALENT, especially among ms patients, taking Vitamin D supplements and getting moderate sun exposure is more LIKELY to be beneficial than not.”\nas with ms, there APPEARS TO be a latitudinal gradient for type 1 diabetes, with a higher incidence at higher latitudes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 1), ('IMPORTANT_CONSIDERATION', 31), ('ANOMALY_CURIOUS_FINDING', 51), ('FULL_UNKNOWN', 80), ('PROBABLE_UNDERSTANDING', 111), ('IMPORTANT_CONSIDERATION', 148), ('PROBABLE_UNDERSTANDING', 260), ('ANOMALY_CURIOUS_FINDING', 313)]	8	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
PMC2290997	4/2008	S160-PMC2290997	['OTHER sun-dependent pathways\nthe sun MAY BE BEST KNOWN for boosting Production Of Vitamin D, BUT there are many OTHER uvr-MEDIATED EFFECTS independent of this pathway.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('SUPERFICIAL_RELATIONSHIP', 122), ('SUPERFICIAL_RELATIONSHIP', 131)]	8	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 68, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
PMC2581757	11/2008	S17-PMC2581757	['moreover, SOME results are at VARIANCE with the PREVAILING OPINION, SINCE increased Plasma levels of Vitamin E among women with Preeclampsia as compared to those in normotensive pregnant women HAVE BEEN REPORTED [14].']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('INCOMPLETE_EVIDENCE', 59), ('PROBABLE_UNDERSTANDING', 68), ('INCOMPLETE_EVIDENCE', 193)]	8	[('UBERON_0001969', 'blood plasma', 84, 'plasma'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin E'), ('GO_0007128', 'meiotic prophase I', 128, 'preeclampsia')]
PMC2606998	6/2007	S84-PMC2606998	['from this perspective, the most STRIKING result from THIS STUDY was the CONSIDERABLY lower than RECOMMENDED intakes of Folate and Vitamin\u2009D, both before and during Pregnancy, EVEN when PROBABLE UNDERREPORTING was taken INTO ACCOUNT.']	[('ANOMALY_CURIOUS_FINDING', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('ANOMALY_CURIOUS_FINDING', 72), ('FUTURE_WORK', 96), ('ANOMALY_CURIOUS_FINDING', 175), ('PROBABLE_UNDERSTANDING', 185), ('PROBLEM_COMPLICATION', 194), ('INCOMPLETE_EVIDENCE', 219)]	8	[('CHEBI_30863', '5-azaorotic acid', 119, 'folate'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0007565', 'female pregnancy', 164, 'pregnancy')]
PMC2873552	4/2010	S137-PMC2873552	['these results are SUGGESTIVE that Vitamin D MIGHT have been INVOLVED in the alteration of risk of disease and abnormal development and CONSEQUENTLY in the Genetic adaptation of modern Humans, BUT validation from FURTHER STUDY IS NECESSARY.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 135), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('FUTURE_WORK', 212), ('FUTURE_WORK', 226), ('FUTURE_WORK', 229)]	8	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('SO_0000704', 'gene', 155, 'genetic'), ('NCBITaxon_9606', 'Homo sapiens', 184, 'humans')]
PMC2963768	10/2010	S139-PMC2963768	['the Vitamin D receptor HAS BEEN FOUND within VIRTUALLY every Organ-System (55), and the active Metabolite of Vitamin D is WELL-DESCRIBED as a potent mediator of Cell Proliferation and Differentiation, PARTICULARLY NOTED for its range of EFFECTS on Immune function in laboratory MODELS (56).']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 45), ('PROBABLE_UNDERSTANDING', 122), ('ANOMALY_CURIOUS_FINDING', 201), ('ANOMALY_CURIOUS_FINDING', 214), ('SUPERFICIAL_RELATIONSHIP', 237), ('INCOMPLETE_EVIDENCE', 278)]	8	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0000062', 'organ', 61, 'organ'), ('UBERON_0000467', 'anatomical system', 67, 'system'), ('CHEBI_39382', 'flufenoxuron', 95, 'metabolite'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 117, 'D'), ('GO_0030154', 'cell differentiation', 161, 'cell proliferation ... differentiation'), ('UBERON_0002405', 'immune system', 248, 'immune')]
PMC2963768	10/2010	S141-PMC2963768	['if Vitamin D deficiency is CONFIRMED AS a RISK FACTOR for pneumonia, INTERVENTIONS to improve maternal-infant Vitamin D status COULD reduce THE GLOBAL BURDEN of alri, the single most IMPORTANT cause of early childhood death in the world (58).']	[('INCOMPLETE_EVIDENCE', 27), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('FUTURE_WORK', 69), ('INCOMPLETE_EVIDENCE', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 140), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 183)]	8	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC3034879	12/2010	S192-PMC3034879	['optimally, Vitamin D sufficiency SHOULD BE guaranteed during fetal Life AS the FINDINGS of the PRESENT STUDY SUGGEST that the CONSEQUENCES of POOR Vitamin D status during the fetal period cannot be totally reverted by Postnatal Vitamin D supplementation.']	[('FUTURE_WORK', 33), ('IMPORTANT_CONSIDERATION', 33), ('PROBABLE_UNDERSTANDING', 72), ('INCOMPLETE_EVIDENCE', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('INCOMPLETE_EVIDENCE', 109), ('PROBLEM_COMPLICATION', 126), ('IMPORTANT_CONSIDERATION', 142)]	8	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 218, 'postnatal'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC3271033	1/2012	S116-PMC3271033	['these extremely low values are NOT COMMONLY reported in the united states, ALTHOUGH we SPECULATE that an increasing NUMBER OF cases MAY BE reported in the FUTURE DUE TO INCREASED AWARENESS of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 31), ('ANOMALY_CURIOUS_FINDING', 75), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 116), ('INCOMPLETE_EVIDENCE', 132), ('FUTURE_PREDICTION', 155), ('PROBABLE_UNDERSTANDING', 162), ('IMPORTANT_CONSIDERATION', 169)]	8	[('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC3277098	12/2011	S198-PMC3277098	['IN SUMMARY, the CONTRARY epidemiological OBSERVATIONS between Serum status (GENERALLY PROTECTIVE) and Oral exposure (supplementation increasing allergy risk in MANY STUDIES) HIGHLIGHT the uncertainty surrounding Vitamin D in Allergy Development and precludes population RECOMMENDATIONS.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 76), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 174), ('FUTURE_WORK', 270)]	8	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('UBERON_0000165', 'mouth', 102, 'oral'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0060021', 'roof of mouth development', 225, 'allergy development')]
PMC3348565	4/2012	S130-PMC3348565	['these SPECULATIONS RELATE two studies in which supplementation of a single large dose (300\u200800033or 500\u200800023iu) of Vitamin D for reducing fractures in elderly women led to an increase in fractures, plus similar DISCREPANCIES in Prostate cancer research with Vitamin D.22our findings and particularly the slightly higher repeat episodes of pneumonia in the vitamin d group COULD BE DUE TO such fluctuations IF the HYPOTHESIS is TRUE.']	[('INCOMPLETE_EVIDENCE', 6), ('SUPERFICIAL_RELATIONSHIP', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('INCOMPLETE_EVIDENCE', 372), ('PROBLEM_COMPLICATION', 381), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 406), ('INCOMPLETE_EVIDENCE', 413), ('PROBABLE_UNDERSTANDING', 427)]	8	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 228, 'prostate'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
PMC3356951	4/2012	S15-PMC3356951	['black People Absorb more uvb in the Melanin of their skin than do white People and, THEREFORE, require more sun exposure to produce the same amount of vitamin D.[4]\nthe high prevalence of Vitamin D insufficiency is a PARTICULARLY IMPORTANT PUBLIC HEALTH ISSUE BECAUSE hypovitaminosis D is an INDEPENDENT RISK FACTOR for total mortality in the general population.']	[('PROBABLE_UNDERSTANDING', 84), ('ANOMALY_CURIOUS_FINDING', 217), ('IMPORTANT_CONSIDERATION', 230), ('IMPORTANT_CONSIDERATION', 240), ('PROBLEM_COMPLICATION', 254), ('PROBABLE_UNDERSTANDING', 260), ('SUPERFICIAL_RELATIONSHIP', 292), ('SUPERFICIAL_RELATIONSHIP', 304)]	8	[('NCBITaxon_10088', 'Mus <genus>', 6, 'people'), ('GO_0040011', 'locomotion', 13, 'absorb'), ('CHEBI_25179', 'melanins', 36, 'melanin'), ('NCBITaxon_10088', 'Mus <genus>', 72, 'people'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 159, 'D'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 284, 'D')]
PMC3356951	4/2012	S32-PMC3356951	['[614–16] the local Production Of 1,25(Oh)2D MAY BE responsible for Regulating up to 200 Genes[17] that MAY facilitate MANY of the pleiotropic health benefits that HAVE BEEN REPORTED for Vitamin D.[38914]\n\nVitamin D deficiency: prevalence\nvdd HAS BEEN historically defined and RECENTLY RECOMMENDED by the institute of medicine (iom) AS a 25(Oh)D of less than 0.8 iu.']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 242), ('INCOMPLETE_EVIDENCE', 276), ('FUTURE_WORK', 285), ('PROBABLE_UNDERSTANDING', 332)]	8	[('GO_0008283', 'cell proliferation', 19, 'production of ... )2D'), ('CHEBI_37958', 'dye', 33, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 35, '25(OH)2D'), ('GO_0065007', 'biological regulation', 67, 'regulating'), ('SO_0000704', 'gene', 88, 'genes'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 205, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 337, '25(OH)D')]
PMC3427192	4/2012	S3-PMC3427192	['additionally, a GROWING body of LITERATURE SUGGESTS that there is a RELATIONSHIP between Vitamin D status and Respiratory symptoms, PRESUMABLY through immunomodulatory EFFECTS of Vitamin D. this review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on Human studies.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 132), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 228), ('QUESTION_ANSWERED_BY_THIS_WORK', 278)]	8	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 110, 'respiratory'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 287, 'human')]
PMC3458940	9/2012	S160-PMC3458940	['THUS, the ROLES for the tra/rar target Genes IDENTIFIED in THIS STUDY in the aforementioned Renal anomalies ASSOCIATED to post-Natal Vitamin A deficiency DESERVE FURTHER studies.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('SUPERFICIAL_RELATIONSHIP', 108), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 154), ('FUTURE_WORK', 162)]	8	[('SO_0000704', 'gene', 39, 'genes'), ('UBERON_0002113', 'kidney', 92, 'renal'), ('GO_0007567', 'parturition', 127, 'natal'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin A')]
PMC3488410	10/2012	S114-PMC3488410	['INTERESTINGLY, SOME of the Vitamin D deficiency EFFECTS COULD BE RELATED to later Gestational periods THUS POSSIBLY expanding the HAZARDOUS time window for the neurobiological development of schizophrenia [129].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 102), ('INCOMPLETE_EVIDENCE', 107), ('IMPORTANT_CONSIDERATION', 130)]	8	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'gestational')]
PMC3488410	10/2012	S136-PMC3488410	['AS hippocampal Neurogenesis plays an IMPORTANT ROLE in Learning and Memory processes [74], we SPECULATE that the PREVIOUSLY DEMONSTRATED normalization of a Vitamin D deficiency-induced Habituation deficit in the hole board by Haloperidol [136] COULD result from an AT LEAST partially restored mitotic activity.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 37), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 244), ('PROBABLE_UNDERSTANDING', 265)]	8	[('GO_0022008', 'neurogenesis', 15, 'neurogenesis'), ('GO_0007612', 'learning', 55, 'learning'), ('GO_0007613', 'memory', 68, 'memory'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0046959', 'habituation', 185, 'habituation'), ('CHEBI_5613', 'haloperidol', 226, 'haloperidol')]
PMC3515553	12/2012	S135-PMC3515553	['FINDINGS in the context of existing literature\ntcn2 rs1801198 was ASSOCIATED with maternal Vitamin B-12 Consumption, with heterozygotes showing a higher intake than both homozygotes, ALTHOUGH this COULD WELL be a chance FINDING SINCE this Snp’s PUTATIVE action has not been RELATED to Intake[13].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 183), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 220), ('PROBLEM_COMPLICATION', 228), ('PROBABLE_UNDERSTANDING', 245), ('SUPERFICIAL_RELATIONSHIP', 274)]	8	[('CHEBI_27300', 'vitamin D', 91, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 91, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 104, 'consumption'), ('SO_0000694', 'SNP', 239, 'SNP'), ('GO_0007631', 'feeding behavior', 285, 'intake')]
PMC3613945	2/2013	S188-PMC3613945	['overall EVIDENCE SUGGESTS that Vitamin D PROTECTS against asthma, BUT the precise nature of this RELATIONSHIP is AMBIGUOUS and INCONSISTENT findings are LIKELY a function of epidemiological context.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('SUPERFICIAL_RELATIONSHIP', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('PROBABLE_UNDERSTANDING', 153)]	8	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
PMC3641012	4/2013	S163-PMC3641012	['ALTHOUGH δ25(Oh)D was inversely ASSOCIATED with baseline Vitamin D status, and ABOUT 24% of the variance in δ25(Oh)D in the Vitamin D group was EXPLAINED by baseline 25(Oh)D, this ASSOCIATION APPEARED TO BE due to regression to the mean, SINCE similar TRENDS were observed in both the Vitamin D and placebo groups.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 79), ('PROBABLE_UNDERSTANDING', 144), ('SUPERFICIAL_RELATIONSHIP', 180), ('ANOMALY_CURIOUS_FINDING', 192), ('PROBABLE_UNDERSTANDING', 238), ('SUPERFICIAL_RELATIONSHIP', 252)]	8	[('CHEBI_33010', 'chromide(1-)', 12, '(OH)D'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 111, '(OH)D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 166, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 166, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D')]
PMC3651971	5/2013	S24-PMC3651971	['introduction\nrisk for Cognitive and motor impairment begins in the Womb, where nutritional restrictions on Embryofetal Tissue growth, differentiation, development and Maturation MAY disturb growth, maturation and function of the Central Nervous System.1neural myelination and Synaptogenesis are underway before 24\u2005weeks’ Gestational age, Neural Tube Formation and Cell Migration are complete before the third Trimester of Pregnancy, and basic structures of the Brain formed before Birth.2as complex structures and functions extend as a cascade, disruptions to nascent systems by nutritional and OTHER insults CAN be amplified with age.3\nEmbryofetal Development is sensitive to Gestational deficiency in Vitamin A,4most EVIDENT in Animals by gross anomalies in Organ and Tissue Morphogenesis, development, structure and function.5–7Retinoic Acid, the oxidised Metabolite and transcriptional ligand of Vitamin A, Regulates the Expression of hox Genes that are essential in Neural Tube Formation,8the Development Of Neurons, and in Synaptic Signalling that UNDERLIES Learning and Memory.9–13developing neural Tissue in the Mouse is ESPECIALLY sensitive to variation in Retinoic Acid exposure near Parturition, a time analogous to the second Trimester of Human Gestation, when deficiency can induce behavioural problems and mild structural damage within the Limbic Cortex.14\nchronic dietary Vitamin A deficiency is common among Pregnant women in poor countries,1516leading TO concern that it MAY have adverse consequences for Cognitive and Motor Development Of the Fetus.']	[('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 609), ('PROBABLE_UNDERSTANDING', 719), ('SUPERFICIAL_RELATIONSHIP', 1054), ('ANOMALY_CURIOUS_FINDING', 1129), ('QUESTION_ANSWERED_BY_THIS_WORK', 1469), ('INCOMPLETE_EVIDENCE', 1488)]	8	[('GO_0050890', 'cognition', 22, 'cognitive'), ('UBERON_0002396', 'vomer', 67, 'womb'), ('UBERON_0000922', 'embryo', 107, 'embryofetal'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('GO_0007618', 'mating', 167, 'maturation'), ('UBERON_0001017', 'central nervous system', 229, 'central nervous system'), ('GO_0007416', 'synapse assembly', 276, 'synaptogenesis'), ('GO_0007565', 'female pregnancy', 321, 'gestational'), ('GO_0042136', 'neurotransmitter biosynthetic process', 338, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 338, 'neural tube'), ('GO_0016477', 'cell migration', 364, 'cell migration'), ('GO_0009294', 'DNA mediated transformation', 409, 'trimester'), ('GO_0007565', 'female pregnancy', 422, 'pregnancy'), ('UBERON_0000955', 'brain', 461, 'brain'), ('GO_0007567', 'parturition', 481, 'birth'), ('GO_0009790', 'embryo development', 637, 'Embryofetal development'), ('UBERON_0000922', 'embryo', 637, 'Embryofetal'), ('GO_0007565', 'female pregnancy', 677, 'gestational'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 730, 'animals'), ('UBERON_0000062', 'organ', 760, 'organ'), ('GO_0048729', 'tissue morphogenesis', 770, 'tissue morphogenesis'), ('UBERON_0000479', 'tissue', 770, 'tissue'), ('CHEBI_52071', 'dextran', 828, '5'), ('CHEBI_24115', 'fuconate', 830, '7Retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 859, 'metabolite'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin A'), ('GO_0065007', 'biological regulation', 911, 'regulates'), ('GO_0010467', 'gene expression', 925, 'expression'), ('SO_0000704', 'gene', 943, 'genes'), ('GO_0042136', 'neurotransmitter biosynthetic process', 971, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 971, 'neural tube'), ('GO_0046697', 'decidualization', 998, 'development of neurons'), ('CL_0000540', 'neuron', 1013, 'neurons'), ('GO_0045202', 'synapse', 1029, 'synaptic'), ('GO_0099536', 'synaptic signaling', 1029, 'synaptic signalling'), ('GO_0007612', 'learning', 1064, 'learning'), ('GO_0007613', 'memory', 1077, 'memory'), ('UBERON_0000479', 'tissue', 1106, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 1120, 'mouse'), ('CHEBI_26536', 'retinoic acid', 1166, 'retinoic acid'), ('GO_0019230', 'proprioception', 1194, 'parturition'), ('GO_0009294', 'DNA mediated transformation', 1238, 'trimester'), ('NCBITaxon_9606', 'Homo sapiens', 1251, 'human'), ('GO_0007565', 'female pregnancy', 1257, 'gestation'), ('UBERON_0016542', 'limbic cortex', 1354, 'limbic cortex'), ('CHEBI_27300', 'vitamin D', 1387, 'vitamin A'), ('GO_0007565', 'female pregnancy', 1424, 'pregnant'), ('GO_0050890', 'cognition', 1522, 'cognitive ...'), ('GO_0048870', 'cell motility', 1536, 'motor development of ... fetus')]
PMC3651971	5/2013	S142-PMC3651971	['the Human studies that have SUGGESTED a ROLE for Vitamin A in Cognitive and Motor Development are LIMITED to much younger children.1718another POSSIBLE EXPLANATION for our results is that differences between groups were attenuated by routine supplementation from the national Vitamin A programme started in 1995.30given the wide cis for experimental measures of Cognitive and motor development, and the POTENTIAL for Brain plasticity, the supplementation programme MIGHT have attenuated a treatment EFFECT, allowing placebo group children to regain the nutritional losses of their early Life.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 143), ('PROBABLE_UNDERSTANDING', 152), ('INCOMPLETE_EVIDENCE', 403), ('INCOMPLETE_EVIDENCE', 465), ('SUPERFICIAL_RELATIONSHIP', 499)]	8	[('NCBITaxon_9606', 'Homo sapiens', 4, 'human'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('GO_0050890', 'cognition', 62, 'cognitive ...'), ('GO_0009653', 'anatomical structure morphogenesis', 76, 'motor development'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin A'), ('GO_0050890', 'cognition', 362, 'cognitive'), ('UBERON_0000955', 'brain', 417, 'brain'), ('UBERON_0000104', 'life cycle', 587, 'life')]
PMC3668200	5/2013	S52-PMC3668200	['Vitamin D concentration is AFFECTED by many Genetic, dietary, and environmental FACTORS; THEREFORE, it is RECOMMENDED that researchers CONSIDER the relative and EFFECTIVE FACTORS when performing STUDIES concerning Vitamin D concentrations.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 80), ('PROBABLE_UNDERSTANDING', 89), ('FUTURE_WORK', 106), ('FUTURE_WORK', 135), ('SUPERFICIAL_RELATIONSHIP', 161), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 195)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('SO_0000704', 'gene', 44, 'genetic'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3672018	5/2013	S44-PMC3672018	['BOTH STUDIES SUGGEST that Prenatal malnutrition strongly IMPACTS Adult health, ALTHOUGH neither INDICATES specific EFFECTS from the lack of Vitamin D. the EFFECT of Vitamin D levels during Gestation, THUS, has never previously been followed in large populations.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 57), ('ANOMALY_CURIOUS_FINDING', 79), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 155), ('PROBABLE_UNDERSTANDING', 200)]	8	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('UBERON_0007023', 'adult organism', 65, 'adult'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'gestation')]
PMC3691177	6/2013	S109-PMC3691177	['our results SUGGEST that the MOST LIKELY EXPLANATION for the FINDING of decreased wheezing risk in offspring of mothers with a higher Vitamin D intake during Pregnancy in observational studies[1]–[4], is CONFOUNDING by OTHER dietary or lifestyle factors ASSOCIATED with Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 29), ('PROBABLE_UNDERSTANDING', 34), ('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 61), ('PROBLEM_COMPLICATION', 204), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 219), ('SUPERFICIAL_RELATIONSHIP', 254)]	8	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC3695234	7/2013	S67-PMC3695234	['in that study, a significant INTERACTION between Il4 Gene polymorphism and Vitamin D deficiency was OBSERVED.17THESE data INDICATE that Vitamin D deficiency MAY increase the risk of Food sensitization in certain genotypes, PROVIDING EVIDENCE of Gene-Vitamin D INTERACTION in Food sensitization.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 100), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 122), ('INCOMPLETE_EVIDENCE', 157), ('PROBABLE_UNDERSTANDING', 223), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 260)]	8	[('PR_000008989', 'interleukin-1 family member 7', 49, 'IL4'), ('SO_0000704', 'gene', 53, 'gene'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_33290', 'food', 182, 'food'), ('SO_0000704', 'gene', 245, 'gene'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('CHEBI_33290', 'food', 275, 'food')]
PMC3702245	6/2013	S60-PMC3702245	['HOWEVER, a committee of Vitamin D EXPERTS99AND the Endocrine society8recommend a target Serum concentration >75 nmol/l BASED ON the AVAILABLE EVIDENCE in order to achieve optimal benefits for Skeletal health as well as POTENTIAL nonskeletal BENEFITS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 34), ('INCOMPLETE_EVIDENCE', 119), ('PROBABLE_UNDERSTANDING', 119), ('SUPERFICIAL_RELATIONSHIP', 119), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 219), ('IMPORTANT_CONSIDERATION', 241)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 51, 'Endocrine'), ('UBERON_0001977', 'blood serum', 88, 'serum'), ('UBERON_0004288', 'skeleton', 192, 'skeletal')]
PMC3702245	6/2013	S62-PMC3702245	['these RECOMMENDATIONS are based MOSTLY ON STUDIES from the us and MAY not be applicable worldwide DUE TO DIFFERENCES in baseline Vitamin D status,100particularly in populations where severe Vitamin D deficiency is PREVALENT.']	[('FUTURE_WORK', 6), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 32), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 66), ('PROBLEM_COMPLICATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('IMPORTANT_CONSIDERATION', 214)]	8	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
PMC3702245	6/2013	S73-PMC3702245	['WHILE the DEBATE and studies to identify OPTIMAL Serum 25(Oh)D concentration CONTINUE, it is PRUDENT to monitor Vitamin D status and develop STRATEGIES to ensure AT LEAST a minimum Serum 25(Oh)D concentration of 50 nmol/l in Pregnant women, especially in an environment where Vitamin D deficiency is endemic.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 41), ('FUTURE_WORK', 77), ('FUTURE_WORK', 93), ('IMPORTANT_CONSIDERATION', 93), ('FUTURE_WORK', 141), ('PROBABLE_UNDERSTANDING', 162)]	8	[('UBERON_0001977', 'blood serum', 49, 'serum'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 55, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0001977', 'blood serum', 181, 'serum'), ('CHEBI_71657', 'versiconol acetate', 187, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 187, '25(OH)D'), ('GO_0007565', 'female pregnancy', 225, 'pregnant'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D')]
PMC3760821	9/2013	S174-PMC3760821	['POTENTIAL mechanisms by which Vitamin D MIGHT INFLUENCE Glycaemic Control in t1dm include, the IMPACT of this Vitamin on Intracellular Calcium Regulation and, THUS, Glucose transport in target Tissues, INFLUENCES on Insulin receptor Expression and the EFFECT of Vitamin D on systemic inflammation ASSOCIATED with Insulin resistance[31],[32].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 95), ('PROBABLE_UNDERSTANDING', 159), ('SUPERFICIAL_RELATIONSHIP', 202), ('SUPERFICIAL_RELATIONSHIP', 252), ('SUPERFICIAL_RELATIONSHIP', 297)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0051162', 'L-arabitol metabolic process', 56, 'glycaemic control'), ('CHEBI_33229', 'vitamin (role)', 110, 'vitamin'), ('GO_0005622', 'intracellular anatomical structure', 121, 'intracellular'), ('GO_0006260', 'DNA replication', 121, 'intracellular'), ('GO_0051303', 'establishment of chromosome localization', 135, 'calcium regulation'), ('CHEBI_17234', 'glucose', 165, 'glucose'), ('UBERON_0000479', 'tissue', 193, 'tissues'), ('PR_000045358', 'insulin family protein', 216, 'insulin'), ('GO_0010467', 'gene expression', 233, 'expression'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D'), ('PR_000045358', 'insulin family protein', 313, 'insulin')]
PMC3773018	4/2013	S79-PMC3773018	['furthermore, OUR FINDINGS REMAINED SIMILAR after controlling for season of Birth or stratification by season of Birth, INDICATING that Birth season is UNLIKELY to MEDIATE the ASSOCIATIONS between persistently low Vitamin D and risk of fs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 119), ('PROBABLE_UNDERSTANDING', 151), ('SUPERFICIAL_RELATIONSHIP', 163), ('SUPERFICIAL_RELATIONSHIP', 175)]	8	[('GO_0007567', 'parturition', 75, 'birth'), ('GO_0007567', 'parturition', 112, 'birth'), ('GO_0007567', 'parturition', 135, 'birth'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC3798907	8/2013	S16-PMC3798907	['BASED ON these FINDINGS, there HAVE BEEN CALLS FOR trials of Vitamin E based intervention during Pregnancy [14].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 41)]	8	[('CHEBI_27300', 'vitamin D', 61, 'vitamin E'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy')]
PMC3798907	8/2013	S136-PMC3798907	['the original ASSOCIATION between maternal Vitamin E and cbmc responses was INDEPENDENT of many POTENTIALLY CONFOUNDING FACTORS (Birth order, maternal atopy, maternal smoking, sex [12], and maternal bmi [27], MAKING IT UNLIKELY that any EFFECT of in vitro Vitamin E supplementation was being negated by extraneous factors, moreover the EFFECT of supplementation was compared with an unsupplemented control for each subject.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('SUPERFICIAL_RELATIONSHIP', 75), ('INCOMPLETE_EVIDENCE', 95), ('PROBLEM_COMPLICATION', 107), ('PROBABLE_UNDERSTANDING', 208), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 236), ('SUPERFICIAL_RELATIONSHIP', 335)]	8	[('CHEBI_27300', 'vitamin D', 42, 'vitamin E'), ('GO_0007567', 'parturition', 128, 'birth'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin E')]
PMC3814422	10/2013	S11-PMC3814422	['it HAS BEEN ARGUED that maternal Vitamin D deficiency MIGHT, AT LEAST IN PART, EXPLAIN the rising PREVALENCE of asthma and allergic disease in SOME countries2.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 61), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 79), ('IMPORTANT_CONSIDERATION', 98), ('INCOMPLETE_EVIDENCE', 143)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC3827489	10/2013	S65-PMC3827489	['THUS, the QUESTION has BEEN RAISED as to WHETHER Vitamin D status INFLUENCES the RISK of Respiratory Tract infections such as common Viral infections or Pulmonary tuberculosis in children.']	[('PROBABLE_UNDERSTANDING', 0), ('EXPLICIT_QUESTION', 10), ('ANOMALY_CURIOUS_FINDING', 23), ('EXPLICIT_QUESTION', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('EXPLICIT_QUESTION', 41), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 81)]	8	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 89, 'respiratory tract'), ('NCBITaxon_1', 'root', 133, 'viral'), ('UBERON_0002048', 'lung', 153, 'pulmonary')]
PMC4113768	7/2014	S1783-PMC4113768	['the epidemiological data INDICATE that Vitamin D deficiency is relatively COMMON, AT LEAST in SOME parts of the united states and europe, and that INADEQUATE Serum levels of the Vitamin D are ASSOCIATED with an INCREASED RISK and POOR prognosis of several types of cancer.']	[('INCOMPLETE_EVIDENCE', 25), ('PROBABLE_UNDERSTANDING', 74), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 94), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 192), ('IMPORTANT_CONSIDERATION', 211), ('IMPORTANT_CONSIDERATION', 230)]	8	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0001977', 'blood serum', 158, 'serum'), ('CHEBI_28384', 'vitamin K', 178, 'Vitamin D')]
PMC4169453	9/2014	S183-PMC4169453	['in CONSEQUENCE, fundamental QUESTIONS of: a) HOW much Vitamin D is enough to reach and maintain OPTIMAL 25(Oh)D level, and b) what is the OPTIMAL range for 25(Oh)D levels, REMAIN an ISSUE of DEBATE[32],[33].']	[('PROBABLE_UNDERSTANDING', 3), ('EXPLICIT_QUESTION', 28), ('EXPLICIT_QUESTION', 45), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 138), ('INCOMPLETE_EVIDENCE', 172), ('PROBLEM_COMPLICATION', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191)]	8	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 104, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 106, '(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 156, '25(OH)D')]
PMC4251419	12/2014	S145-PMC4251419	['TRADITIONALLY the level of total 25(Oh)D HAS BEEN CONSIDERED the best ESTIMATE of Vitamin D status, BUT RECENT STUDIES have SUGGESTED that the “bioavailable” (albumin-bound and free) 25(Oh)D concentration MAY BE more RELEVANT to health and disease [83].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 217)]	8	[('CHEBI_71657', 'versiconol acetate', 33, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 39, 'D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 183, '25(OH)D')]
PMC4405493	4/2015	S24-PMC4405493	['THUS, we SOUGHT TO DETERMINE IF Vitamin D deficiency in the first trimester of nulliparous patients is ASSOCIATED with clinical outcomes MOST ASSOCIATED with SIGNIFICANT maternal and fetal morbidity and mortality: Preeclampsia, Gestational diabetes, Preterm Delivery, spontaneous abortion, and growth restriction.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('SUPERFICIAL_RELATIONSHIP', 103), ('PROBABLE_UNDERSTANDING', 137), ('SUPERFICIAL_RELATIONSHIP', 142), ('IMPORTANT_CONSIDERATION', 158)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 214, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 228, 'gestational'), ('GO_0007565', 'female pregnancy', 250, 'preterm'), ('GO_0007567', 'parturition', 258, 'delivery')]
PMC4417995	4/2015	S4-PMC4417995	['as of today, the ROLE of Vitamin D in ad is FAR FROM CLEAR; ADDITIONAL STUDIES ARE PARTICULARLY NEEDED in order to confirm the PROMISING therapeutic ROLE of Vitamin D supplementation in childhood ad.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('FULL_UNKNOWN', 44), ('FUTURE_WORK', 60), ('FUTURE_WORK', 71), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 127), ('PROBABLE_UNDERSTANDING', 127), ('SUPERFICIAL_RELATIONSHIP', 149)]	8	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4417995	4/2015	S79-PMC4417995	['SINCE sun/uvb exposure increases Vitamin D Serum levels, SOME authors have logically HYPOTHESIZED that ad clinical improvement by sun/uvb MIGHT be MEDIATED at a molecular level by Vitamin D.\nthis is SUPPORTED by the observation that Vitamin D deficiency is ASSOCIATED with more SEVERE skin lesions localized on body sites that are not exposed to sun [37].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 199), ('SUPERFICIAL_RELATIONSHIP', 257), ('IMPORTANT_CONSIDERATION', 278)]	8	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D')]
PMC4448820	5/2015	S162-PMC4448820	['the case study Nutrients covered in this review are Vitamin A, iron, zinc, Vitamin D, Folic Acid, and Selenium and were chosen on the basis of their PUBLIC HEALTH IMPORTANCE and BECAUSE they provide the MOST RELEVANT EVIDENCE with regard to their KNOWN EFFECT on Immunity.']	[('IMPORTANT_CONSIDERATION', 149), ('IMPORTANT_CONSIDERATION', 163), ('PROBABLE_UNDERSTANDING', 178), ('PROBABLE_UNDERSTANDING', 203), ('IMPORTANT_CONSIDERATION', 208), ('INCOMPLETE_EVIDENCE', 217), ('INCOMPLETE_EVIDENCE', 247), ('SUPERFICIAL_RELATIONSHIP', 253)]	8	[('CHEBI_33284', 'nutrient', 15, 'nutrients'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_30751', 'formic acid', 86, 'folic acid'), ('CHEBI_27568', 'selenium atom', 102, 'selenium'), ('GO_0007566', 'embryo implantation', 263, 'immunity')]
PMC4448820	5/2015	S1471-PMC4448820	['BECAUSE Human Milk HAS BEEN SUGGESTED as a POTENTIALLY useful BIOMARKER of Vitamin A status of women and, by extrapolation, of their children and POTENTIALLY OTHER groups within the population (324), it is useful to explore the POTENTIAL IMPACT of inflammation on the use of Breast-Milk Vitamin A concentrations and interpretation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 238)]	8	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('UBERON_0001913', 'milk', 14, 'milk'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin A'), ('UBERON_0000310', 'breast', 275, 'breast'), ('UBERON_0001913', 'milk', 282, 'milk'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A')]
PMC4488777	5/2015	S31-PMC4488777	['research on the ROLE of Vitamin D in Reproduction Process Modulation SEEMS ESPECIALLY INTERESTING; their CONCLUSIONS PRESUMABLY have a significant practical meaning in infertility treatment, a SERIOUS medical PROBLEM affecting up to 53 million people worldwide [8].']	[('SUPERFICIAL_RELATIONSHIP', 16), ('ANOMALY_CURIOUS_FINDING', 69), ('ANOMALY_CURIOUS_FINDING', 75), ('ANOMALY_CURIOUS_FINDING', 86), ('PROBABLE_UNDERSTANDING', 105), ('PROBABLE_UNDERSTANDING', 117), ('IMPORTANT_CONSIDERATION', 193), ('IMPORTANT_CONSIDERATION', 209)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0003301', 'physiological cardiac muscle hypertrophy', 37, 'reproduction process modulation')]
PMC4499946	7/2015	S98-PMC4499946	['our PREVIOUS pharmacokinetic FINDINGS among Pregnant women in dhaka [16,40] HAVE GENERALLY BEEN CONSISTENT with published ESTIMATES of the Vitamin D-to-25(Oh)D dose–response RELATIONSHIP in non-Pregnant Adults (i.e., an APPROXIMATELY 0.7 nmol/l increase in 25(Oh)D at steady state for each 1 μg/day of Vitamin D3[41,42]).']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 81), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 220)]	8	[('GO_0007565', 'female pregnancy', 44, 'pregnant'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 155, 'OH)D'), ('GO_0007565', 'female pregnancy', 194, 'pregnant'), ('UBERON_0007023', 'adult organism', 203, 'adults'), ('CHEBI_63056', 'zinc cation', 257, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 263, 'D'), ('CHEBI_33279', 'vitamin D5', 302, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 302, 'vitamin D3')]
PMC4516377	6/2015	S70-PMC4516377	['it is NOTEWORTHY that ALTHOUGH 25 (Oh) D3 (Calcidiol) is not the most active Metabolite, is the most COMMONLY ASSESSED, AS Plasma levels of active Vitamin D, 1,25 Dihydroxyvitamin D (1,25 (Oh) 2D3), are regularly maintained at normal concentrations; furthermore, Plasma levels of 25 (Oh) D3 are APPROXIMATELY 100 times higher than those of 1,25 (Oh) 2D3 and the half-life of 1,25 (Oh) 2D3 is APPROXIMATELY six hours, whereas that of 25 (Oh) D3 is two to three weeks.11\nwhen comparing Serum levels of Vitamin D in the children assessed in the study carried out by lourenço21in brazil with a study carried out in the usa,35higher levels were observed in brazil.']	[('ANOMALY_CURIOUS_FINDING', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 110), ('PROBABLE_UNDERSTANDING', 120), ('INCOMPLETE_EVIDENCE', 295), ('INCOMPLETE_EVIDENCE', 392)]	8	[('CHEBI_62946', 'ammonium sulfate', 31, '25 (OH) D3'), ('CHEBI_17933', 'calcidiol', 43, 'calcidiol'), ('CHEBI_39382', 'flufenoxuron', 77, 'metabolite'), ('UBERON_0001969', 'blood plasma', 123, 'plasma'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_67469', '15-hydroxyajubractin C', 158, '1,25 dihydroxyvitamin D'), ('CHEBI_72779', '11-trans-LTE4', 183, '1,25 (OH) 2D3'), ('UBERON_0001969', 'blood plasma', 263, 'plasma'), ('CHEBI_62946', 'ammonium sulfate', 280, '25 (OH) D3'), ('CHEBI_73394', 'Ala-Ser', 342, '25 (OH) 2D3'), ('CHEBI_34898', 'OM-174', 381, 'OH) 2D3'), ('CHEBI_62946', 'ammonium sulfate', 433, '25 (OH) D3'), ('UBERON_0001977', 'blood serum', 484, 'serum'), ('CHEBI_27300', 'vitamin D', 500, 'vitamin D')]
PMC4516377	6/2015	S72-PMC4516377	['webb, kline & holick36have already EXPLAINED this phenomenon, SHOWING that latitude and seasons AFFECT the quality and quantity of solar radiation that reach earth, especially uvb spectrum, drastically INFLUENCING the cutaneous Synthesis Of Vitamin D. it is also BELIEVED that Vitamin D deficiency MAY BE RELATED to lack of sun exposure in obese Individuals, as they become more sedentary and remain more sheltered from the sun.']	[('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 35), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 202), ('INCOMPLETE_EVIDENCE', 263), ('INCOMPLETE_EVIDENCE', 298), ('SUPERFICIAL_RELATIONSHIP', 305)]	8	[('GO_0030474', 'spindle pole body duplication', 228, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('NCBITaxon_1', 'root', 346, 'individuals')]
PMC4586450	10/2015	S445-PMC4586450	['both Iron and Vitamin C intakes were lower and calcium intakes higher in the highest compared with the lowest fat intake quartiles ( p< 0.001), and these DIFFERENCES MAY ACCOUNT FOR the lower ferritin concentration FOUND.60because the strongest ASSOCIATION between Nutrient intake and ferritin at age 1.5 years was a negative one with Calcium Intake ( p< 0.001), IT IS POSSIBLE that this is due to the presence of Calcium in the Gut adversely AFFECTING the absorption of iron from the diet.114cows’ Milk is the main source of calcium in the diet at this age (61% of calcium), and the amount of Cows’ Milk consumed was negatively ASSOCIATED with ferritin ( p< 0.001).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 154), ('INCOMPLETE_EVIDENCE', 166), ('PROBABLE_UNDERSTANDING', 170), ('INCOMPLETE_EVIDENCE', 215), ('SUPERFICIAL_RELATIONSHIP', 245), ('INCOMPLETE_EVIDENCE', 363), ('SUPERFICIAL_RELATIONSHIP', 443), ('SUPERFICIAL_RELATIONSHIP', 629)]	8	[('CHEBI_24870', 'ion', 5, 'iron'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin C'), ('CHEBI_33284', 'nutrient', 265, 'nutrient'), ('CHEBI_22313', 'alkaline earth metal atom', 335, 'calcium'), ('GO_0007631', 'feeding behavior', 343, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 414, 'calcium'), ('UBERON_0001555', 'digestive tract', 429, 'gut'), ('UBERON_0001913', 'milk', 499, 'milk'), ('NCBITaxon_33208', 'Metazoa', 594, 'cows'), ('UBERON_0001913', 'milk', 600, 'milk')]
PMC4600246	10/2015	S50-PMC4600246	['it HAS BEEN PRESUMED that Prenatal Vitamin K deficiency induced by warfarin MAY BE the UNDERLYING cause of these calcifications.4344indeed, SEVERAL STUDIES INDICATE a CONNECTION between warfarin and Arterial calcifications.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 167)]	8	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin K'), ('UBERON_0001637', 'artery', 199, 'arterial')]
PMC4600246	10/2015	S68-PMC4600246	['IN SUMMARY, Vitamin K MAY improve Insulin sensitivity in men with diabetes.40\n\nVitamin K and cancer\nVitamin K2Has BEEN SHOWN to inhibit the growth of Human cancer cell lines, including Hepatoma lines, as well as to treat myelodysplastic syndrome.50–53two trials SEEM to INDICATE that Vitamin K245\u2005mg/day reduces the Development Of Hepatocellular Carcinoma (Hcc) in patients with Liver cirrhosis and that Vitamin K2Significantly reduces the recurrence of hcc in patients following the curative treatment of hcc with an ASSOCIATED reduction in all-cause mortality in these patients.54–61the POSSIBLE reduction in mortality with Vitamin K2May be EXPLAINED by multiple mechanisms.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 114), ('ANOMALY_CURIOUS_FINDING', 262), ('INCOMPLETE_EVIDENCE', 270), ('SUPERFICIAL_RELATIONSHIP', 518), ('INCOMPLETE_EVIDENCE', 589), ('PROBABLE_UNDERSTANDING', 643)]	8	[('CHEBI_27300', 'vitamin D', 12, 'vitamin K'), ('PR_000045358', 'insulin family protein', 34, 'insulin'), ('CHEBI_28384', 'vitamin K', 79, 'Vitamin K'), ('CHEBI_33229', 'vitamin (role)', 100, 'Vitamin'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 108, 'K2has'), ('NCBITaxon_9606', 'Homo sapiens', 150, 'human'), ('UBERON_0004705', 'fenestra', 185, 'hepatoma'), ('CHEBI_86324', 'quinolone antibiotic', 284, 'vitamin K245'), ('GO_0002234', 'detection of endoplasmic reticulum overloading', 316, 'development of hepatocellular carcinoma'), ('UBERON_0012474', 'hepatic cecum', 331, 'hepatocellular'), ('GO_0000724', 'double-strand break repair via homologous recombination', 357, 'HCC'), ('UBERON_0002107', 'liver', 379, 'liver'), ('CHEBI_64387', 'thiosultap(1-)', 404, 'vitamin K2significantly'), ('CHEBI_27325', 'xanthophyll', 626, 'vitamin K2may'), ('PR_000017209', 'utrophin', 626, 'vitamin K2may')]
PMC4684854	12/2015	S61-PMC4684854	['the APPARENT DISPARITY between findings in VARIOUS STUDIES has caused SOME to reflexively CONCLUDE that Vitamin D status in Pregnancy is IRRELEVANT to maternal-fetal outcomes.']	[('ANOMALY_CURIOUS_FINDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('ANOMALY_CURIOUS_FINDING', 13), ('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 90), ('IMPORTANT_CONSIDERATION', 137)]	8	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy')]
PMC4684854	12/2015	S119-PMC4684854	['economic burden of Gestational Vitamin D deficiency\nthe economic IMPACT of Vitamin D deficiency as it RELATES to maternal-fetal health is DIFFICULT to objectively quantify AS INSUFFICIENT evidence has ACCUMULATED THUS FAR on the totality of short- and long-term sequelae of Vitamin D insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 102), ('DIFFICULT_TASK', 138), ('PROBABLE_UNDERSTANDING', 172), ('INCOMPLETE_EVIDENCE', 175), ('PROBLEM_COMPLICATION', 175), ('INCOMPLETE_EVIDENCE', 201), ('INCOMPLETE_EVIDENCE', 213)]	8	[('GO_0007565', 'female pregnancy', 19, 'Gestational'), ('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC4778858	3/2016	S100-PMC4778858	['HOWEVER, CAUTION for too much Vitamin D supplementation SHOULD BE raised AS ONE STUDY DETERMINED higher concentrations of neonatal 25-Ohd are POSSIBLY ASSOCIATED with an elevated risk of becoming overweight in Adult Life [26].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('FUTURE_WORK', 56), ('PROBABLE_UNDERSTANDING', 73), ('INCOMPLETE_EVIDENCE', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 131, '25-OHD'), ('UBERON_0000113', 'post-juvenile adult stage', 210, 'adult life')]
PMC4785305	3/2016	S31-PMC4785305	['in the middle east and north africa region, there are FEW RECENT rcts that attempted to determine the OPTIMAL regimen of Vitamin D replacement in healthy Pregnant women.38–41WITH the exception of soheilykhah et al 40who ASSESSED the EFFECT of Vitamin D supplementation on Insulin resistance, the primary outcomes in THESE studies were MOSTLY maternal and neonatal 25(Oh)D levels (seeonline supplementary appendix1).']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 58), ('IMPORTANT_CONSIDERATION', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 233), ('INCOMPLETE_EVIDENCE', 316), ('PROBABLE_UNDERSTANDING', 335)]	8	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnant'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('PR_000045358', 'insulin family protein', 272, 'insulin'), ('CHEBI_71657', 'versiconol acetate', 364, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 364, '25 ... OH ... D')]
PMC4889866	5/2016	S89-PMC4889866	['TO OUR KNOWLEDGE, THIS is the FIRST cohort STUDY TO simultaneously ASSESS the EFFECT of both maternal and Cord Blood Vitamin D status on tlr-RELATED immune response and various infectious diseases during Infancy.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 67), ('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 141)]	8	[('UBERON_0002240', 'spinal cord', 106, 'cord'), ('UBERON_0000178', 'blood', 111, 'blood'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007631', 'feeding behavior', 204, 'infancy')]
PMC4903143	5/2016	S98-PMC4903143	['in addition, Gestational Vitamin D levels MAY EVEN IMPACT Adult health AS there is EARLY EVIDENCE that Vitamin D sufficiency in Pregnancy MAY have a PROTECTIVE ROLE in the Development Of Adult-onset multiple Sclerosis [33].']	[('INCOMPLETE_EVIDENCE', 42), ('ANOMALY_CURIOUS_FINDING', 46), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 149), ('SUPERFICIAL_RELATIONSHIP', 160)]	8	[('GO_0007565', 'female pregnancy', 13, 'gestational'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0007023', 'adult organism', 58, 'adult'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 128, 'pregnancy'), ('GO_0048513', 'animal organ development', 172, 'development of ... sclerosis'), ('UBERON_0007023', 'adult organism', 187, 'adult')]
PMC4930210	7/2016	S21-PMC4930210	['a RECENT systematic REVIEW of Vitamin D supplementation in Pregnancy CONCLUDED that EVIDENCE is currently INSUFFICIENT TO SUPPORT DEFINITE clinical RECOMMENDATIONS regarding Vitamin D supplementation in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 106), ('PROBLEM_COMPLICATION', 106), ('PROBABLE_UNDERSTANDING', 130), ('FUTURE_WORK', 148)]	8	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnancy')]
PMC4973215	8/2016	S78-PMC4973215	['furthermore, this study was CONDUCTED in hamilton county, ohio, an area with worse Perinatal outcomes THAN national averages, including higher infant mortality, Preterm Birth and low Birth weight rates, as well as CONSIDERABLE racial DISPARITIES in infant mortality and Perinatal outcomes.34all of Cord Blood samples were collected over one winter season, THUS negating seasonal variations in Vitamin D levels that MAY have been SEEN in OTHER STUDIES.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('IMPORTANT_CONSIDERATION', 214), ('IMPORTANT_CONSIDERATION', 234), ('PROBABLE_UNDERSTANDING', 356), ('INCOMPLETE_EVIDENCE', 415), ('INCOMPLETE_EVIDENCE', 429), ('INCOMPLETE_EVIDENCE', 437)]	8	[('GO_0036268', 'swimming', 83, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 83, 'perinatal'), ('GO_0007565', 'female pregnancy', 161, 'preterm birth'), ('GO_0007567', 'parturition', 183, 'birth'), ('GO_0036268', 'swimming', 270, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 270, 'perinatal'), ('UBERON_0002240', 'spinal cord', 298, 'cord'), ('UBERON_0000178', 'blood', 303, 'blood'), ('CHEBI_27300', 'vitamin D', 393, 'vitamin D')]
PMC4992225	8/2016	S281-PMC4992225	['also, SINCE more than 95\xa0% of the mothers had lower than 30\xa0ng/ml Serum 25-Hydroxyvitamin D concentration, it is NOT CLEAR IF the same results WOULD BE OBSERVED in mothers with higher levels of 25-Hydroxyvitamin D. THEREFORE, we SUGGEST FURTHER clinical TRIALS, using 2000\xa0iu Vitamin D on a larger population, mothers with high levels of depression, and high Serum 25-Hydroxyvitamin D concentrations.']	[('PROBLEM_COMPLICATION', 6), ('FULL_UNKNOWN', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('FUTURE_PREDICTION', 143), ('INCOMPLETE_EVIDENCE', 152), ('PROBABLE_UNDERSTANDING', 215), ('INCOMPLETE_EVIDENCE', 229), ('FUTURE_WORK', 237)]	8	[('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 72, '25-hydroxyvitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 194, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('UBERON_0001977', 'blood serum', 359, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 365, '25-hydroxyvitamin D')]
PMC5051327	9/2016	S59-PMC5051327	['this was CONNECTED to the Cyclic Adenosine Monophosphate (Camp) pathway and RELATED to accelerated relaxation.2829this EFFECT was not seen in Vitamin D Receptor knockout Mice, which IMPLIES that the EFFECT is MEDIATED by the Vitamin D receptor which SEEMS IMPORTANT for Cardiac muscle function.2830using a state Cardiac diagram, asphyxia is slowing the Relaxation phase in the fetal Heart.3132pregnancy is a condition with increased Oestrogen levels.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 76), ('SUPERFICIAL_RELATIONSHIP', 119), ('PROBABLE_UNDERSTANDING', 182), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 209), ('ANOMALY_CURIOUS_FINDING', 250), ('IMPORTANT_CONSIDERATION', 256)]	8	[('CHEBI_23447', 'cyclic nucleotide', 26, 'cyclic adenosine monophosphate'), ('CHEBI_17489', "3',5'-cyclic AMP", 58, 'cAMP'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 142, 'vitamin D receptor'), ('NCBITaxon_10088', 'Mus <genus>', 170, 'mice'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0000948', 'heart', 270, 'cardiac'), ('UBERON_0000948', 'heart', 312, 'cardiac'), ('GO_0032809', 'neuronal cell body membrane', 353, 'relaxation'), ('UBERON_0000948', 'heart', 383, 'heart'), ('CHEBI_50114', 'estrogen', 433, 'oestrogen')]
PMC5062906	10/2016	S264-PMC5062906	['THEREFORE, the Vitamin D-dependent parent of origin EFFECTS REPORTED HERE MAY BE INFLUENCED by EITHER epigenetic mechanisms OR Genetic DIFFERENCES in cis or trans .']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 60), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135)]	8	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('SO_0000704', 'gene', 127, 'genetic')]
PMC5405075	4/2017	S44-PMC5405075	['OF NOTE, Food base approaches MAY BE ASSUMED AS a better representative of long-term Vitamin D Intake, which MIGHT INFLUENCE the fetus during all stages of Gestation and EVEN ex utero .']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 45), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 115), ('ANOMALY_CURIOUS_FINDING', 170)]	8	[('CHEBI_33290', 'food', 9, 'food'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007631', 'feeding behavior', 95, 'intake'), ('GO_0007565', 'female pregnancy', 156, 'gestation')]
PMC5405075	4/2017	S45-PMC5405075	['the INCONSISTENT body of EVIDENCE with glimmer of positivity from observational prospective cohorts, the RATHER low toxicity of Vitamin D, which is a relative inexpensive CANDIDATE in the attenuation of the asthma’s EPIDEMIC BURDEN on PUBLIC HEALTH, were clearly INDICATIVE of THE NEED to proceed to clinical trials.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('INCOMPLETE_EVIDENCE', 171), ('IMPORTANT_CONSIDERATION', 216), ('IMPORTANT_CONSIDERATION', 235), ('PROBABLE_UNDERSTANDING', 263), ('INCOMPLETE_EVIDENCE', 277)]	8	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5405075	4/2017	S84-PMC5405075	['THEREFORE, it remains to be answered IF a real cause-effect RELATIONSHIP exists OR Vitamin D exerts a PROTECTIVE ROLE via OTHER UNDERLYING mechanisms of this MULTIFACTORIAL disease, such as Lung function or protection against Viral infections.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('SUPERFICIAL_RELATIONSHIP', 60), ('SUPERFICIAL_RELATIONSHIP', 102), ('SUPERFICIAL_RELATIONSHIP', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 128), ('DIFFICULT_TASK', 158)]	8	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0002048', 'lung', 190, 'lung'), ('NCBITaxon_1', 'root', 226, 'viral')]
PMC5418719	5/2017	S98-PMC5418719	['CONSIDERING the high prevalence of Vitamin D deficiency in Pregnant mothers, sufficient Vitamin D supply in preterm infants COULD BE IMPORTANT to quickly correct the fetal low Plasma levels of Vitamin D. a Vitamin D intake of 800\xa0iu to 1000\xa0iu per day during first Months Of Life is RECOMMENDED BASED ON european GUIDELINES [21].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 133), ('FUTURE_WORK', 283), ('PROBABLE_UNDERSTANDING', 295), ('ANOMALY_CURIOUS_FINDING', 301), ('PROBABLE_UNDERSTANDING', 313)]	8	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 59, 'pregnant'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 176, 'plasma'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('UBERON_0005445', 'segment of pes', 265, 'months of life')]
PMC5426325	4/2017	S20-PMC5426325	['GIVEN that low bone Mineral density (bmd) is PREDICTIVE of increased fracture risk, AS SHOWN in both case–control and prospective studies – THOUGH principally in Adults(13–20)– maternal Vitamin D insufficiency MAY POTENTIALLY also INFLUENCE fracture RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 84), ('ANOMALY_CURIOUS_FINDING', 140), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 231), ('IMPORTANT_CONSIDERATION', 250)]	8	[('CHEBI_46662', 'mineral', 20, 'mineral'), ('UBERON_0007023', 'adult organism', 162, 'adults'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC5426325	4/2017	S119-PMC5426325	['THUS, we CANNOT RULE OUT WHETHER the Birth cohort results REFLECT a TRUE adverse EFFECT of Vitamin D on bone; one PREVIOUS STUDY did indeed report borderline significant inverse ASSOCIATIONS between maternal late Pregnancy 25(Oh)D concentrations and offspring Forearm fractures(12).']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 68), ('SUPERFICIAL_RELATIONSHIP', 81), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 178)]	8	[('GO_0007567', 'parturition', 37, 'birth'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007565', 'female pregnancy', 213, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 223, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 223, '25(OH)D'), ('UBERON_0002386', 'forelimb zeugopod', 260, 'forearm')]
PMC5474873	6/2017	S161-PMC5474873	['we had NO biological DATA on Vitamin D levels, which COULD have established a clear LINK to Vitamin D, ALTHOUGH it is WELL KNOWN that sun exposure is the MOST IMPORTANT DETERMINANT of Vitamin D status (9,13).']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 84), ('ANOMALY_CURIOUS_FINDING', 103), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 154), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 169)]	8	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC5546866	8/2017	S127-PMC5546866	['the published gwas (8,22) DID NOT stratify Individuals by Vitamin D supplement usage, which COULD ACCOUNT FOR differing ASSOCIATIONS before and after supplementation in our cohort, or the differing FINDINGS MIGHT REFLECT the LOWER POWER in our study.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 92), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 120), ('INCOMPLETE_EVIDENCE', 198), ('INCOMPLETE_EVIDENCE', 207), ('SUPERFICIAL_RELATIONSHIP', 213), ('INCOMPLETE_EVIDENCE', 225)]	8	[('NCBITaxon_1', 'root', 43, 'individuals'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5546866	8/2017	S151-PMC5546866	['OUR FINDINGS SUGGEST that analysis of Snps MAY have an IMPORTANT ROLE in identifying high-risk categories of Individuals who are LIKELY to REQUIRE higher doses of Vitamin D to achieve repletion, and STUDIES ARE NEEDED to establish clinical approaches to Vitamin D supplementation that are centered on individual characteristics.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 129), ('IMPORTANT_CONSIDERATION', 139), ('FUTURE_WORK', 199)]	8	[('SO_0000694', 'SNP', 38, 'SNPs'), ('NCBITaxon_1', 'root', 109, 'individuals'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC5638722	8/2017	S101-PMC5638722	['BECAUSE of this, it is NOT SURPRISING that the results of OUR STUDY DID not SHOW Vitamin D level AS an INDEPENDENT risk FACTOR for neonatal sepsis.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 58), ('ANOMALY_CURIOUS_FINDING', 68), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 97), ('SUPERFICIAL_RELATIONSHIP', 103), ('SUPERFICIAL_RELATIONSHIP', 120)]	8	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC5664622	9/2017	S118-PMC5664622	['it SEEMS that the ESTIMATED Vitamin D consumption is a RELIABLE result AS it is CONSISTENT with OTHER REPORTS, which for years have INDICATED a consistently low amount of Vitamin D in the diet of polish Pregnant women (2.6–2.8 µg/day) [13,35].']	[('ANOMALY_CURIOUS_FINDING', 3), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 55), ('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 132)]	8	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnant')]
PMC5838372	3/2018	S78-PMC5838372	['discussion\nvitamin D deficiency LEADS TO IMPORTANT health PROBLEMS, NOT ONLY in mothers BUT ALSO in their infants, BECAUSE the Vitamin D store of the mother is the MAJOR source of Vitamin D for the fetus (9).']	[('PROBABLE_UNDERSTANDING', 32), ('SUPERFICIAL_RELATIONSHIP', 32), ('IMPORTANT_CONSIDERATION', 41), ('IMPORTANT_CONSIDERATION', 58), ('ANOMALY_CURIOUS_FINDING', 68), ('ANOMALY_CURIOUS_FINDING', 88), ('PROBABLE_UNDERSTANDING', 115), ('IMPORTANT_CONSIDERATION', 164)]	8	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 19, 'D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D')]
PMC5941617	5/2018	S119-PMC5941617	['ONLY FEW STUDIES evaluated the EFFICACY and SAFETY of intermittent Vitamin D supplementation during the first year of Life, particularly in cases with low compliance [109–111], THUS AT PRESENT daily supplementation REMAINS PREFERRED.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 44), ('PROBABLE_UNDERSTANDING', 177), ('INCOMPLETE_EVIDENCE', 182), ('INCOMPLETE_EVIDENCE', 215), ('PROBABLE_UNDERSTANDING', 223)]	8	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0000104', 'life cycle', 118, 'life')]
PMC5941617	5/2018	S168-PMC5941617	['intermittent Vitamin D administration MAY BE CONSIDERED in case of reduced compliance with daily supplementation, BUT ACTUAL EVIDENCE IS INSUFFICIENT to RECOMMEND a PREFERRED doses and interval.']	[('INCOMPLETE_EVIDENCE', 38), ('FUTURE_WORK', 45), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('INCOMPLETE_EVIDENCE', 118), ('PROBLEM_COMPLICATION', 137), ('FUTURE_WORK', 153), ('PROBABLE_UNDERSTANDING', 165)]	8	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC5941617	5/2018	S199-PMC5941617	['particularly, Vitamin D status SHOULD BE monitored AT LEAST yearly in subjects that REQUIRE supplementation during the whole year BECAUSE AFFECTED from pathological conditions or receiving Drugs AFFECTING vitamin D Metabolism (table\xa07) (see “Extraskeletal actions of Vitamin D” for specific RECOMMENDATIONS).']	[('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 31), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 84), ('PROBABLE_UNDERSTANDING', 130), ('SUPERFICIAL_RELATIONSHIP', 138), ('SUPERFICIAL_RELATIONSHIP', 195), ('FUTURE_WORK', 291)]	8	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_23888', 'drug', 189, 'drugs'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 213, 'D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 213, 'D metabolism'), ('UBERON_0001431', 'distal carpal bone 2', 242, 'Extraskeletal'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D')]
PMC5952272	5/2018	S146-PMC5952272	['it is IMPORTANT TO MENTION in this context that the PREVALENCE of autism in somali children Born in sweden was FOUND TO BE 3 to 4 times higher than in the non-somali group (0.7% vs 0.19%).39as somalis have high levels of Melanin, during migration to northern latitudes, such as sweden, they would REQUIRE 5 to 10 times more uv-b exposure than light-skinned Individuals OR an ALTERNATIVE Vitamin D source, such as from the diet or supplementation.40moreover, saad et al41reported that 57% Vitamin D deficient and 30% insufficient patients who received Vitamin D3 (300\u2009iu/kg/day not to exceed 5000\u2009iu/day) for 3\u2009months SHOWED significant improved outcomes (80.72 %), which were MAINLY in the sections of the childhood autism rating scale (cars) and aberrant behaviour checklist subscales that measure behaviour, stereotypy, Eye contact, and attention span.']	[('IMPORTANT_CONSIDERATION', 6), ('IMPORTANT_CONSIDERATION', 52), ('ANOMALY_CURIOUS_FINDING', 111), ('FUTURE_WORK', 297), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 369), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 375), ('INCOMPLETE_EVIDENCE', 617), ('PROBABLE_UNDERSTANDING', 676)]	8	[('GO_0007567', 'parturition', 92, 'born'), ('CHEBI_25179', 'melanins', 221, 'melanin'), ('NCBITaxon_1', 'root', 357, 'individuals'), ('CHEBI_27300', 'vitamin D', 387, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 488, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 551, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 551, 'vitamin D3'), ('UBERON_0000970', 'eye', 822, 'eye')]
BMJ_2010_Apr_29_340_c1640	4/2010	S17-BMJ_2010_Apr_29_340_c1640	['this latitudinal gradient SEEMS environmentally RELATED BECAUSE the risk ASSOCIATED with latitude alters if People move after Birth.45a strong environmental CANDIDATE is the level of ambient regional ultraviolet radiation, acting EITHER directly OR through the generation of Vitamin D.6higher exposure to ultraviolet radiation,7higher Vitamin D intake,8and also higher Serum Vitamin D concentrations9seem to be ASSOCIATED with a reduced risk of onset of multiple sclerosis.']	[('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 48), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 73), ('INCOMPLETE_EVIDENCE', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 230), ('SUPERFICIAL_RELATIONSHIP', 411)]	7	[('NCBITaxon_10088', 'Mus <genus>', 108, 'people'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 335, 'vitamin D'), ('UBERON_0001977', 'blood serum', 369, 'serum'), ('CHEBI_27300', 'vitamin D', 375, 'vitamin D')]
BMJ_2010_Apr_29_340_c1640	4/2010	S94-BMJ_2010_Apr_29_340_c1640	['in this setting, there is STRONG a priori EVIDENCE that sun exposure or Vitamin D, or both, is LIKELY to be the central exposure6and LITTLE a priori evidence for any other strong DETERMINANT of multiple sclerosis LIKELY to be LINKED to maternal ambient Ultraviolet radiation exposure during the first Trimester.']	[('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 42), ('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 179), ('PROBABLE_UNDERSTANDING', 213), ('SUPERFICIAL_RELATIONSHIP', 226)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 253, 'ultraviolet'), ('GO_0009294', 'DNA mediated transformation', 301, 'trimester')]
PMC2581757	11/2008	S14-PMC2581757	['in preeclampsia, an inverse CORRELATION between Vitamin E levels and Lipid peroxidation HAS BEEN FOUND [10] SUGGESTING that Vitamin E content in Plasma MAY BE used as a prognostic MARKER of the LIKELY development of Preeclampsia [11].']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 180), ('PROBABLE_UNDERSTANDING', 194)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin E'), ('CHEBI_18059', 'lipid', 69, 'lipid'), ('GO_0006266', 'DNA ligation', 69, 'lipid'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin E'), ('UBERON_0001969', 'blood plasma', 145, 'plasma'), ('GO_0007128', 'meiotic prophase I', 216, 'preeclampsia')]
PMC2581757	11/2008	S16-PMC2581757	['THUS, decreased Plasma levels of Vitamin E COULD BE a CONTRIBUTORY FACTOR of hypertension in preeclampsia, BUT OTHER STUDIES have not demonstrated significant differences in Plasma Vitamin E levels between normal and Preeclamptic women [13].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 117)]	7	[('UBERON_0001969', 'blood plasma', 16, 'plasma'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin E'), ('UBERON_0001969', 'blood plasma', 174, 'plasma'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin E'), ('GO_0007565', 'female pregnancy', 217, 'preeclamptic')]
PMC2581757	11/2008	S198-PMC2581757	['the activities of antioxidant enzymes were also INFLUENCED by the use of Vitamins C and E. the reduction of sod activity during the development of Preeclampsia was controlled as a CONSEQUENCE of Vitamin consumption: the decrease was FOUND TO BE 14% WHEREAS it was 23% in patients who had not used Vitamins C and E. the most prominent EFFECT of the use of these Vitamins was FOUND TO BE ASSOCIATED with the activity of Glutathione reductase.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('PROBABLE_UNDERSTANDING', 180), ('ANOMALY_CURIOUS_FINDING', 233), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('SUPERFICIAL_RELATIONSHIP', 334), ('ANOMALY_CURIOUS_FINDING', 374), ('SUPERFICIAL_RELATIONSHIP', 386)]	7	[('CHEBI_27300', 'vitamin D', 73, 'vitamins C'), ('PR_000004900', 'complement C3', 82, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 88, 'E'), ('GO_0007128', 'meiotic prophase I', 147, 'preeclampsia'), ('CHEBI_33229', 'vitamin (role)', 195, 'vitamin'), ('CHEBI_27300', 'vitamin D', 297, 'vitamins C'), ('PR_000004900', 'complement C3', 306, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 312, 'E'), ('CHEBI_33277', 'gamma-tocotrienol', 361, 'vitamins'), ('CHEBI_16856', 'glutathione', 418, 'glutathione')]
PMC2582131	11/2008	S85-PMC2582131	['the biologically active form of Vitamin D is 1,25-[Oh] D. HOWEVER, 25-[Oh] D is REGARDED AS the BEST INDICATOR of Vitamin D status in the body because it is the substrate for the Renal and Nonrenal Production Of 1,25-[Oh] D and has a longer biological half-life and higher concentrations in circulation than 1,25-[Oh] D. Plasma 25-[Oh] D REFLECTS Vitamin D from both endogenous and exogenous sources.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('PROBABLE_UNDERSTANDING', 80), ('PROBABLE_UNDERSTANDING', 89), ('IMPORTANT_CONSIDERATION', 96), ('SUPERFICIAL_RELATIONSHIP', 101), ('PROBABLE_UNDERSTANDING', 338), ('SUPERFICIAL_RELATIONSHIP', 338)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_34300', '2-naphthoyl-CoA', 47, '25-[OH] D'), ('CHEBI_34300', '2-naphthoyl-CoA', 67, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0006260', 'DNA replication', 179, 'renal ...'), ('UBERON_0002113', 'kidney', 179, 'renal'), ('UBERON_0000970', 'eye', 189, 'nonrenal'), ('GO_0030164', 'protein denaturation', 198, 'production of ... OH] D'), ('CHEBI_84441', '13(S)-HOTrE', 212, '1,25-[OH] D'), ('CHEBI_34300', '2-naphthoyl-CoA', 310, '25-[OH] D'), ('UBERON_0001969', 'blood plasma', 321, 'Plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 328, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D')]
PMC2821652	2/2010	S34-PMC2821652	['WHILE rickets HAS BEEN traditionally THOUGHT TO be the main sequelae of Vitamin D deficiency, numerous OTHER long-latency disease states (such as multiple sclerosis [23–25], rheumatoid arthritis [26–29], type 1 and 2 diabetes [30–34], Cardiovascular disease [35,36], various cancers [37–43], and systemic lupus erythematosus [44], to name BUT a few) as well as acute infections such as Upper Respiratory illnesses [45] and tuberculosis [46,47] are now LINKED with Vitamin D deficiency that are EXPLAINED by alterations in Immune function [47–49].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 339), ('SUPERFICIAL_RELATIONSHIP', 452), ('PROBABLE_UNDERSTANDING', 494)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 235, 'cardiovascular'), ('UBERON_0001154', 'vermiform appendix', 386, 'upper respiratory'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('UBERON_0002405', 'immune system', 522, 'immune')]
PMC2889879	5/2010	S95-PMC2889879	['we DECIDED not to include dietary Vitamin D ESTIMATES in the final multivariate MODELS AS fish is a rich source of Vitamin D and COULD account for SOME of the EFFECT of fish on our outcome.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80), ('PROBABLE_UNDERSTANDING', 87), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 159)]	7	[('CHEBI_28384', 'vitamin K', 34, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC2913107	8/2010	S19-PMC2913107	['IF the Vitamin D THEORY is TRUE, autism SHOULD BE MORE COMMON in richer well-educated mothers, who are more LIKELY THAN other mothers to practice sun avoidance and use sunblock (1,2).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 27), ('FUTURE_PREDICTION', 40), ('PROBABLE_UNDERSTANDING', 50), ('PROBABLE_UNDERSTANDING', 108), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115)]	7	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D')]
PMC2963768	10/2010	S99-PMC2963768	['THEREFORE, these data from rural bangladesh, in combination with EARLIER FINDINGS from infants in urban pakistan, india, and uae, have DEMONSTRATED that the Vitamin D status of young infants in south asia and the middle east MAY BE no better than that of unsupplemented infants at much higher northern latitudes in north america, where GUIDELINES SUPPORT the provision of routine Vitamin D supplementation to all breastfed infants (21,22).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 225), ('PROBABLE_UNDERSTANDING', 336), ('INCOMPLETE_EVIDENCE', 347)]	7	[('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D')]
PMC2996405	11/2010	S163-PMC2996405	['DESPITE the consistence of this RELATIONSHIP, TO OUR KNOWLEDGE studies CONNECTING schizophrenia and Vitamin D at a molecular level are NOT YET AVAILABLE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 71), ('FULL_UNKNOWN', 135), ('FUTURE_WORK', 139)]	7	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3004407	12/2010	S22-PMC3004407	['AS a result of the CONCERN regarding the prevalence of Vitamin D deficiency among Pregnant women receiving care at community health centers, and TO CLARIFY earlier scientific STUDIES which REPORTED that a majority of african-american and hispanic women are Vitamin D deficient [34–40], a cross-sectional study of Pregnant women presenting at a community health center network in south carolina at latitude 32°n was designed and implemented.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 19), ('PROBLEM_COMPLICATION', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 145), ('FUTURE_WORK', 148), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 189)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('GO_0007565', 'female pregnancy', 313, 'pregnant')]
PMC3004407	12/2010	S158-PMC3004407	['studies TO EXAMINE the BENEFIT of higher doses of Vitamin D during Pregnancy SUGGEST that the dose of Vitamin D FOUND in MOST Prenatal Vitamins—400\u2009iu—is INADEQUATE to meet the NEEDS of the Pregnant woman and her growing fetus [11,32,34,39,60–67].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 112), ('PROBABLE_UNDERSTANDING', 121), ('IMPORTANT_CONSIDERATION', 154), ('IMPORTANT_CONSIDERATION', 177)]	7	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 135, 'vitamins'), ('GO_0007565', 'female pregnancy', 190, 'pregnant')]
PMC3032617	5/2010	S8-PMC3032617	['conclusion\nthe results of THIS STUDY SUGGEST including Vitamin C in the GUIDELINES of multivitamin PREVENTION for Pregnant women, ESPECIALLY in developing countries where seasonal availability of fruits and Vegetables COULD result in adverse clinical outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 72), ('PROBABLE_UNDERSTANDING', 72), ('SUPERFICIAL_RELATIONSHIP', 99), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 218)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin C'), ('GO_0007565', 'female pregnancy', 114, 'pregnant'), ('CHEBI_33267', 'elemental nitrogen', 207, 'vegetables')]
PMC3107676	4/2011	S115-PMC3107676	['by the third month of Pregnancy, APPROXIMATELY 80% reported taking Supplements that MOST LIKELY contained Vitamin C.\ncompared with prevalence ESTIMATES in PREVIOUSLY PUBLISHED STUDIES, the PRESENT STUDY has the highest REPORTED prevalence of Nitrosatable Drug use during early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 84), ('PROBABLE_UNDERSTANDING', 89), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 155), ('QUESTION_ANSWERED_BY_THIS_WORK', 189), ('INCOMPLETE_EVIDENCE', 219)]	7	[('GO_0007565', 'female pregnancy', 22, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 67, 'supplements'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin C'), ('CHEBI_75872', '(R)-sarin', 242, 'nitrosatable drug'), ('GO_0007565', 'female pregnancy', 277, 'pregnancy')]
PMC3235789	12/2011	S115-PMC3235789	['THUS, in addition to the myriad OTHER health REASONS for addressing the POOR UNDERLYING Vitamin D and Folate status of us women [48,49], decreasing the susceptibility of women of Reproductive age to bv MAY provide further RATIONALE.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('PROBABLE_UNDERSTANDING', 45), ('IMPORTANT_CONSIDERATION', 72), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 202), ('PROBABLE_UNDERSTANDING', 222)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 102, 'folate'), ('GO_0000003', 'reproduction', 179, 'reproductive')]
PMC3257641	3/2010	S141-PMC3257641	['a TENTATIVE LINK between Vitamin D status and autism HAS BEEN POSTULATED, arising MAINLY from the FINDINGS of population level studies [117,118].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 2), ('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 62), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 98)]	7	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC3271033	1/2012	S146-PMC3271033	['HOWEVER, the FINDINGS in OUR STUDY APPEAR MEANINGFUL in that the provision of Vitamin D at a dose of 400 iu/day LED TO mean values that were above 30 ng/ml REGARDLESS OF starting value or ethnicity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ANOMALY_CURIOUS_FINDING', 35), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 156)]	7	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3277098	12/2011	S50-PMC3277098	['to date, the MAJORITY of research HAS BEEN conducted using cells sourced from peripheral Blood; HOWEVER SOME authors have PROPOSED that Gut-associated lymphoid Tissue MAY be of RELEVANCE, particularly in regard to oral Vitamin D Intake and Food Allergen sensitization [33].']	[('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 122), ('INCOMPLETE_EVIDENCE', 167), ('IMPORTANT_CONSIDERATION', 177)]	7	[('UBERON_0000178', 'blood', 89, 'blood'), ('UBERON_0001555', 'digestive tract', 136, 'gut'), ('UBERON_0000479', 'tissue', 160, 'tissue'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D'), ('GO_0007631', 'feeding behavior', 229, 'intake'), ('CHEBI_33290', 'food', 240, 'food'), ('CHEBI_50904', 'allergen', 245, 'allergen')]
PMC3338544	4/2012	S12-PMC3338544	['moreover, there is now CONVINCING EXPERIMENTAL EVIDENCE BASED ON a MODEL in sprague-dawley Rats that developmental Vitamin D (Dvd) deficiency is ASSOCIATED with a range of schizophrenia-related neurochemical, neuroanatomical, and behavioural phenotypes[4],[5].']	[('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 23), ('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 56), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 145)]	7	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 91, 'rats'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 126, 'DVD')]
PMC3347028	3/2012	S87-PMC3347028	['it IS NOT SURPRISING, then that during Pregnancy pth as a MARKER of Vitamin D status is a LESS RELIABLE PREDICTOR than in nonpregnant Adults [60,61,62].']	[('PROBABLE_UNDERSTANDING', 3), ('PROBABLE_UNDERSTANDING', 6), ('ANOMALY_CURIOUS_FINDING', 10), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 104)]	7	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adults')]
PMC3347028	3/2012	S125-PMC3347028	['YET, it was THOUGHT for the MOST PART that Vitamin D deficiency was RARE and COULD BE avoided through some sunlight exposure and a daily Vitamin D intake of 200 iu (5 μg) [80].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 28), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 77)]	7	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC3348565	4/2012	S110-PMC3348565	['THUS the LACK OF a PROTECTIVE EFFECT of Vitamin D against pneumonia is PROBABLY not due to MISCLASSIFICATION of outcomes or INADEQUATE supplementation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 71), ('PROBLEM_COMPLICATION', 91), ('PROBLEM_COMPLICATION', 124)]	7	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC3356951	4/2012	S3-PMC3356951	['high prevalence of Vitamin D insufficiency is a PARTICULARLY IMPORTANT PUBLIC HEALTH ISSUE BECAUSE hypovitaminosis D is an INDEPENDENT RISK FACTOR for total mortality in the general population.']	[('ANOMALY_CURIOUS_FINDING', 48), ('IMPORTANT_CONSIDERATION', 61), ('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 85), ('PROBABLE_UNDERSTANDING', 91), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 135)]	7	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 115, 'D')]
PMC3356951	4/2012	S88-PMC3356951	['[68] another example of Extrarenal Regulation of 1α-hydroxylase is that the increased Production Of 1,25(Oh)2D by Keratinocytes in wounds[69] THEREFORE provides a good ESTIMATE of Vitamin D status, BUT Regulation of 1α-hydroxylase activity SHOULD also BE CONSIDERED.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 142), ('INCOMPLETE_EVIDENCE', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('FUTURE_WORK', 240), ('ANOMALY_CURIOUS_FINDING', 252), ('FUTURE_WORK', 255)]	7	[('UBERON_0001691', 'external ear', 24, 'extrarenal'), ('GO_0065007', 'biological regulation', 35, 'regulation'), ('GO_0034205', 'amyloid-beta formation', 86, 'production of ... 2D'), ('CHEBI_82784', 'PVP38-Ag NP', 100, '1,25(OH)2D'), ('CL_0000312', 'keratinocyte', 114, 'keratinocytes'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0065007', 'biological regulation', 202, 'regulation')]
PMC3407995	7/2012	S449-PMC3407995	['the authors CONCLUDED that Vitamin D supplementation of 4000 iu/day for Pregnant women is SAFE and MOST EFFECTIVE in achieving sufficiency in all women and their neonates regardless of race, WHEREAS the current ESTIMATED average REQUIREMENT is comparatively ineffective at achieving adequate circulating 25(Oh)D concentrations, especially in african americans [179].']	[('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 90), ('PROBABLE_UNDERSTANDING', 99), ('SUPERFICIAL_RELATIONSHIP', 104), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 191), ('INCOMPLETE_EVIDENCE', 211), ('IMPORTANT_CONSIDERATION', 229)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 304, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 304, '25(OH)D')]
PMC3501517	11/2012	S217-PMC3501517	['THEREFORE, WHILE Vitamin D MAY not play a ROLE in the acute inflammatory Response or resolution of inflammation, it MAY STILL be IMPORTANT in Controlling infections in the Lung.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 116), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 129)]	7	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0060033', 'anatomical structure regression', 73, 'response'), ('GO_0065007', 'biological regulation', 142, 'controlling'), ('UBERON_0002048', 'lung', 172, 'lung')]
PMC3509518	11/2012	S24-PMC3509518	['THEREFORE, the AIM of THIS STUDY was TO PROSPECTIVELY ASSESS the EFFECTS of Maternal intakes of selected Antioxidants (Β-Carotene, Vitamin C, Vitamin E, copper and zinc) in Pregnancy on early infant allergic outcomes, namely eczema, Immunoglobulin e (Ige)-mediated Food allergy, allergic sensitisation and wheeze in a population at high risk of developing allergic disease BASED ON familial ASSOCIATION.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 65), ('SUPERFICIAL_RELATIONSHIP', 373), ('SUPERFICIAL_RELATIONSHIP', 391)]	7	[('GO_0007618', 'mating', 76, 'maternal'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 105, 'antioxidants'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 119, 'β-carotene'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin E'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('GO_0019815', 'B cell receptor complex', 233, 'Immunoglobulin'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 251, 'IgE'), ('CHEBI_33290', 'food', 265, 'food')]
PMC3515553	12/2012	S127-PMC3515553	['discussion\n\nmain findings\nTO THE BEST OF OUR KNOWLEDGE THIS is the FIRST STUDY to EXAMINE the IMPACT of differential concentrations of circulating Vitamin B-12 on offspring iq through the use of records of Maternal Pregnancy Vitamin B-12 intake, as well as Vitamin B-12 RELATED Genetic variants.']	[('PROBABLE_UNDERSTANDING', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('INCOMPLETE_EVIDENCE', 67), ('QUESTION_ANSWERED_BY_THIS_WORK', 73), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 270)]	7	[('CHEBI_27300', 'vitamin D', 147, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 147, 'vitamin B-12'), ('GO_0007618', 'mating', 206, 'maternal'), ('GO_0007565', 'female pregnancy', 215, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 225, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 235, '12'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 257, 'vitamin B-12'), ('SO_0000704', 'gene', 278, 'genetic')]
PMC3616124	4/2013	S139-PMC3616124	['hp phenotype, Prenatal/multivitamin use at randomization, and Plasma Ascorbate\nhp phenotype INFLUENCES Plasma Ascorbate concentration[35], PROVIDING a POTENTIAL mechanism by which hp phenotype MIGHT INFLUENCE treatment response to Vitamin C and E. we EXAMINED the RELATIONSHIP between hp phenotype and Plasma Ascorbate in a pre-planned analysis.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('PROBABLE_UNDERSTANDING', 139), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 199), ('QUESTION_ANSWERED_BY_THIS_WORK', 251), ('SUPERFICIAL_RELATIONSHIP', 264)]	7	[('GO_0007565', 'female pregnancy', 14, 'Prenatal'), ('UBERON_0001969', 'blood plasma', 62, 'Plasma'), ('CHEBI_2874', 'Asimicin', 69, 'Ascorbate'), ('UBERON_0001969', 'blood plasma', 103, 'plasma'), ('CHEBI_22651', 'ascorbate', 110, 'ascorbate'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 245, 'E'), ('UBERON_0001969', 'blood plasma', 302, 'plasma'), ('CHEBI_22651', 'ascorbate', 309, 'ascorbate')]
PMC3641012	4/2013	S20-PMC3641012	['SIMILARLY, the 25(Oh)D THRESHOLD to define Vitamin D sufficiency is DEBATED; the iom set 50\xa0nmol/l as a lower limit of sufficiency [7], YET OTHER expert bodies such as the american academy of pediatrics have SUGGESTED that Pregnant women attain Serum 25(Oh)D >80\xa0nmol/l [14].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 136), ('ANOMALY_CURIOUS_FINDING', 136), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140), ('INCOMPLETE_EVIDENCE', 208)]	7	[('CHEBI_71657', 'versiconol acetate', 15, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnant'), ('UBERON_0001977', 'blood serum', 245, 'serum'), ('CHEBI_71657', 'versiconol acetate', 251, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 251, '25(OH)D')]
PMC3659910	1/2013	S101-PMC3659910	['a NEW STUDY FINDS that women who develop SEVERE Preeclampsia TEND to have lower Blood levels of Vitamin D than healthy Pregnant women raising the POSSIBILITY that the vitamin plays a ROLE in the COMPLICATION.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 12), ('IMPORTANT_CONSIDERATION', 41), ('PROBABLE_UNDERSTANDING', 61), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 183), ('IMPORTANT_CONSIDERATION', 195)]	7	[('GO_0007128', 'meiotic prophase I', 48, 'preeclampsia'), ('UBERON_0000178', 'blood', 80, 'blood'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnant')]
PMC3702245	6/2013	S9-PMC3702245	['SEVERAL REPORTS in the literature HAVE SHOWN that INADEQUATE or lack of sunlight exposure without appropriate corrective Vitamin D intake or supplements accounts FOR the high prevalence of Vitamin D deficiency in women.11–18\nafter synthesis in the skin, Vitamin D attaches to Vitamin D-binding protein and is transported to the Liver, where it undergoes a process of hydroxylation to form 25-Hydroxyvitamin D [25(Oh)D].9the Serum concentration of 25(Oh)D is the MOST reliable MARKER of Vitamin D nutritional status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 162), ('PROBABLE_UNDERSTANDING', 462), ('SUPERFICIAL_RELATIONSHIP', 476)]	7	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 284, 'D'), ('UBERON_0002107', 'liver', 328, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 389, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 410, '25(OH)D'), ('UBERON_0001977', 'blood serum', 424, 'serum'), ('CHEBI_71657', 'versiconol acetate', 447, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 486, 'vitamin D')]
PMC3702245	6/2013	S75-PMC3702245	['because of CONTROVERSY surrounding Vitamin D REQUIREMENTS during Pregnancy, investigators from south carolina performed a comprehensive, large, randomized controlled study of Vitamin D supplementation in Pregnancy to achieve optimal Vitamin D status, DEFINED as a Serum 25(Oh)D concentration ≥80 nmol/l at Delivery.18BASED on the pharmacokinetics of Vitamin d, the authors INVESTIGATED the SAFETY and EFFECTIVENESS of high-dose Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('IMPORTANT_CONSIDERATION', 45), ('PROBABLE_UNDERSTANDING', 251), ('PROBABLE_UNDERSTANDING', 315), ('QUESTION_ANSWERED_BY_THIS_WORK', 373), ('IMPORTANT_CONSIDERATION', 390), ('SUPERFICIAL_RELATIONSHIP', 401)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('UBERON_0001977', 'blood serum', 264, 'serum'), ('CHEBI_71657', 'versiconol acetate', 270, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 270, '25(OH)D'), ('GO_0007567', 'parturition', 306, 'delivery'), ('CHEBI_33229', 'vitamin (role)', 350, 'vitamin'), ('CHEBI_27300', 'vitamin D', 428, 'vitamin D')]
PMC3705320	3/2013	S173-PMC3705320	['(2008) [24], as well the RECENT iom REPORT (2010) [1], have DEMONSTRATED that the ∆[25(Oh)D] per mcg is a curvilinear inverse FUNCTION of Vitamin D Intake at doses <50 mcg/day, but nearly proportional to Intake at >50 mcg/day [24], which MAY EXPLAIN the greater OBSERVED efficiency of the lower dose.']	[('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 126), ('INCOMPLETE_EVIDENCE', 238), ('PROBABLE_UNDERSTANDING', 242), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_71657', 'versiconol acetate', 84, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0007631', 'feeding behavior', 148, 'intake'), ('GO_0007631', 'feeding behavior', 204, 'intake')]
PMC3717170	5/2013	S140-PMC3717170	['THEREFORE, EVIDENCE from intervention studies—which is the most DIRECT EVIDENCE—is CRITICALLY IMPORTANT before one can conclude that Vitamin D has a ROLE in the prevention or treatment of diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 71), ('IMPORTANT_CONSIDERATION', 83), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 149)]	7	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC3728489	7/2013	S317-PMC3728489	['NOTABLY, breastfed infants are at ESPECIALLY high RISK of Vitamin D deficiency DUE TO POOR penetrance of Vitamin D Metabolites in milk (kovacs,2013; thiele et al.,2013).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 34), ('IMPORTANT_CONSIDERATION', 34), ('IMPORTANT_CONSIDERATION', 50), ('PROBABLE_UNDERSTANDING', 79), ('IMPORTANT_CONSIDERATION', 86), ('PROBLEM_COMPLICATION', 86)]	7	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_25212', 'metabolite', 115, 'metabolites')]
PMC3739737	8/2013	S168-PMC3739737	['THUS, we SPECULATE that the epidemiological CLUES LINKING low Vitamin D and adverse Neurocognitive outcomes MAY BE MEDIATED by ‘two hits’ – in other words low vitamin d MAY exacerbate a separate Neurobiological stressor.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 169)]	7	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0050905', 'neuromuscular process', 84, 'neurocognitive'), ('UBERON_0002906', 'anterior occipital sulcus', 195, 'neurobiological')]
PMC3798907	8/2013	S122-PMC3798907	['ALTHOUGH the main FOCUS of our work was the supplementation of cbmc, we included a parallel study of Adult pbmc TO EXAMINE the EFFECT of the same in vitro Vitamin E supplementation on Adult Pbmc IN LIGHT OF the REPORTS of age RELATED differential responsiveness.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 112), ('SUPERFICIAL_RELATIONSHIP', 127), ('PROBABLE_UNDERSTANDING', 195), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 226)]	7	[('UBERON_0007023', 'adult organism', 101, 'adult'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin E'), ('UBERON_0007023', 'adult organism', 184, 'adult'), ('UBERON_2005026', 'primary head sinus', 190, 'PBMC')]
PMC3814422	10/2013	S15-PMC3814422	['HENCE, the value of analysing dietary Vitamin D intake alone AS a means of EFFECTIVELY establishing the INFLUENCE of Vitamin D on outcomes HAS BEEN QUESTIONED as it leads to considerable MISCLASSIFICATION of total exposure.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 61), ('IMPORTANT_CONSIDERATION', 75), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 139), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('PROBLEM_COMPLICATION', 187)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC3814422	10/2013	S63-PMC3814422	['additional analyses\nTO TEST WHETHER ASSOCIATIONS were driven by a threshold effect of greater risk in those whose mothers had insufficient levels of Vitamin D, we EXAMINED ASSOCIATIONS of categories of 25(Oh)D levels (≥ 50 nmol/l; 27.5–49.99 nmol/l and < 27.5 nmol/l) with outcomes, we also repeated analyses using 75 nmol/l as a higher THRESHOLD for sufficiency as recommended in a more RECENT REVIEW23.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('QUESTION_ANSWERED_BY_THIS_WORK', 163), ('SUPERFICIAL_RELATIONSHIP', 172), ('PROBABLE_UNDERSTANDING', 337), ('INCOMPLETE_EVIDENCE', 388)]	7	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 208, 'D')]
PMC3827489	10/2013	S92-PMC3827489	['this FINDING MAY BE EXPLAINED BY PREVIOUS STUDIES SUGGESTING that higher Vitamin D levels or appropriate Vitamin D intake in Pregnant women is ASSOCIATED with increased infant Birth weight66,67).']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('ANOMALY_CURIOUS_FINDING', 17), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 143)]	7	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant'), ('GO_0007567', 'parturition', 176, 'birth')]
PMC3888066	12/2012	S19-PMC3888066	['finally, neonatal levels of 13-Cis Retinoic Acid are proportionately higher than All-Trans Retinoic Acid levels when compared to maternal levels, SUGGESTING that, in newborns, the equilibrium of cis and trans isomers is shifted toward the more Teratogenic 13-cis Isomer.12this is an IMPORTANT FINDING and POINTS to a deficit in studies that DO NOT demonstrate an association between excess Vitamin A and Birth defects, AS most DO NOT measure levels of Retinoic Acid Isomers in the fetus or newborn.']	[('INCOMPLETE_EVIDENCE', 146), ('IMPORTANT_CONSIDERATION', 283), ('INCOMPLETE_EVIDENCE', 293), ('INCOMPLETE_EVIDENCE', 305), ('INCOMPLETE_EVIDENCE', 341), ('PROBABLE_UNDERSTANDING', 419), ('INCOMPLETE_EVIDENCE', 427)]	7	[('CHEBI_61206', '2-hexenoic acid', 28, '13-cis retinoic acid'), ('CHEBI_16553', 'UDP-4-dehydro-6-deoxy-D-glucose', 81, 'all-trans retinoic acid'), ('CHEBI_50905', 'teratogenic agent', 244, 'teratogenic'), ('GO_0031649', 'heat generation', 244, 'teratogenic'), ('SO_0001017', 'silent_mutation', 263, 'isomer'), ('CHEBI_27300', 'vitamin D', 390, 'vitamin A'), ('GO_0007567', 'parturition', 404, 'birth'), ('CHEBI_26536', 'retinoic acid', 452, 'retinoic acid'), ('SO_0001060', 'sequence_variant', 466, 'isomers')]
PMC3888066	12/2012	S45-PMC3888066	['examples of non-fortified Foods that are high in Vitamin A or beta Carotene are listed intable 5.37\n\ncalculation of Vitamin A and beta Carotene intake during Pregnancy\nthe absorption, Metabolism, storage, and Excretion Of Beta Carotene and Retinol in the mother are NOT COMPLETELY UNDERSTOOD; HOWEVER, most investigators agree that consumption of these forms of Vitamin A is RELATED to maternal Serum levels.38–40in ONE STUDY, maternal diet INFLUENCED Cord levels of Beta Carotene, but not Vitamin A.41absorption Of Beta Carotene from raw carrots and a low fat diet is very low compared to carrot juice.42according to current literature, 6 μg of Ingested Beta Carotene convert to 1 Retinol equivalent, or 1 μg Retinol, but ratios have ranged from 3.3:1 to 26:1.43,44\nbased on the discussion above, it MAY BE apparent that Maternal Ingestion of non-Beta Carotene sources of Vitamin A in foods + fortified foods + nutritional supplements would not LIKELY elevate Retinoic Acid levels in the fetus to Teratogenic levels.']	[('INCOMPLETE_EVIDENCE', 266), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 293), ('SUPERFICIAL_RELATIONSHIP', 375), ('INCOMPLETE_EVIDENCE', 416), ('SUPERFICIAL_RELATIONSHIP', 441), ('INCOMPLETE_EVIDENCE', 801), ('PROBABLE_UNDERSTANDING', 946)]	7	[('CHEBI_33290', 'food', 26, 'foods'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('CHEBI_23042', 'carotene', 67, 'carotene'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin A'), ('CHEBI_23042', 'carotene', 135, 'carotene'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('GO_0008152', 'metabolic process', 184, 'metabolism'), ('GO_0007530', 'sex determination', 209, 'excretion of ... carotene'), ('CHEBI_51438', 'D-isoascorbic acid', 222, 'beta carotene'), ('CHEBI_26536', 'retinoic acid', 240, 'retinol'), ('GO_0060033', 'anatomical structure regression', 240, 'retinol'), ('CHEBI_27300', 'vitamin D', 362, 'vitamin A'), ('UBERON_0001977', 'blood serum', 395, 'serum'), ('UBERON_0002240', 'spinal cord', 452, 'cord'), ('CHEBI_51438', 'D-isoascorbic acid', 467, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 490, 'vitamin A'), ('GO_0046311', 'prenylcysteine biosynthetic process', 513, 'of ... carotene'), ('CHEBI_51438', 'D-isoascorbic acid', 516, 'beta carotene'), ('GO_0007631', 'feeding behavior', 646, 'ingested'), ('CHEBI_51438', 'D-isoascorbic acid', 655, 'beta carotene'), ('CHEBI_26536', 'retinoic acid', 682, 'retinol'), ('CHEBI_26536', 'retinoic acid', 710, 'retinol'), ('GO_0007618', 'mating', 822, 'maternal'), ('GO_0007631', 'feeding behavior', 831, 'ingestion'), ('CHEBI_51438', 'D-isoascorbic acid', 848, 'beta carotene'), ('CHEBI_27300', 'vitamin D', 873, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 961, 'retinoic acid'), ('CHEBI_50905', 'teratogenic agent', 998, 'teratogenic'), ('GO_0031649', 'heat generation', 998, 'teratogenic')]
PMC3991049	11/2013	S2-PMC3991049	['the current GUIDELINES for Vitamin D intake during Pregnancy of 200–400 iu has LITTLE scientific SUPPORT and HAS BEEN RECENTLY CHALLENGED.']	[('IMPORTANT_CONSIDERATION', 12), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 118), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	7	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy')]
PMC3991049	11/2013	S71-PMC3991049	['we used a 50,000 iu dose, AS per our PREVIOUS STUDIES, which DEMONSTRATED no toxicity when Vitamin D deficient rheumatology outpatient and health care professional were supplemented this dose.31–32\nthe CONCERN of using higher doses of Vitamin D MIGHT cause hypercalcemia, hypercalciuria, Renal calculi and soft Tissue and vascular calcification toxicity is LIKELY to worsen with Calcium supplementation.']	[('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 202), ('PROBLEM_COMPLICATION', 202), ('INCOMPLETE_EVIDENCE', 245), ('PROBABLE_UNDERSTANDING', 357)]	7	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('UBERON_0002113', 'kidney', 288, 'renal'), ('UBERON_0000479', 'tissue', 311, 'tissue'), ('CHEBI_22313', 'alkaline earth metal atom', 379, 'calcium')]
PMC4045304	2/2014	S191-PMC4045304	['investigators have ADVANCED the HYPOTHESIS that ASSOCIATION between Vitamin D and autism COULD BE EXPLAINED by the RELATIONSHIP between seasonality and low maternal Serum 25-Hydroxyvitamin D concentration (a valid INDICATOR of Vitamin D status) [73].']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 214)]	7	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 171, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC4113768	7/2014	S214-PMC4113768	['we THEREFORE AIMED TO DETERMINE WHETHER seasonal Vitamin D deficiency occurs in two healthy young Adult populations with moderate or dark skin pigmentation in cape town, WHETHER this had an EFFECT on the number and function of Circulating Blood Cells, their ability to Control to hiv-1 infection and WHETHER Vitamin D supplementation modifies the investigated responses.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 190), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 300)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 98, 'adult'), ('CL_0000080', 'circulating cell', 227, 'circulating'), ('CL_0000081', 'blood cell', 239, 'blood cells'), ('UBERON_0000178', 'blood', 239, 'blood'), ('GO_0065007', 'biological regulation', 269, 'control'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D')]
PMC4113768	7/2014	S1393-PMC4113768	['the AIM of THIS STUDY was THEREFORE TO INVESTIGATE the EFFECTS of Vitamin D on the Gene Expression of IMPORTANT enzymes INVOLVED in Brain Steroidogenesis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('SUPERFICIAL_RELATIONSHIP', 55), ('IMPORTANT_CONSIDERATION', 102), ('SUPERFICIAL_RELATIONSHIP', 120)]	7	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0010467', 'gene expression', 83, 'gene expression'), ('SO_0000704', 'gene', 83, 'gene'), ('UBERON_0000955', 'brain', 132, 'brain'), ('GO_0001501', 'skeletal system development', 138, 'steroidogenesis')]
PMC4113768	7/2014	S1828-PMC4113768	['in SOME of the elderly subjects lower Plasma 25(Oh)D levels coexisting with high alkaline phosphatase activity MAY INDICATE developing osteomalacia.taking INTO ACCOUNT lower Plasma 25(Oh)D, 1,25(Oh)D and calcium levels among the MAJORITY of centenarians, the sufficient Vitamin D and calcium supplementation SHOULD be systematically APPLIED also in the oldest old.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 155), ('PROBABLE_UNDERSTANDING', 229), ('FUTURE_WORK', 308), ('SUPERFICIAL_RELATIONSHIP', 333)]	7	[('UBERON_0001969', 'blood plasma', 38, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 45, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 45, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 174, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 181, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 192, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC4113768	7/2014	S2257-PMC4113768	['it is THUS CONCEIVABLE that polymorphisms in the Gene encoding this protein, the Vitamin D Receptor Gene (Vdr), MAY alter both its structure and functions and HENCE, MAY INFLUENCE one’s susceptibility to various debilitating diseases.']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 112), ('PROBABLE_UNDERSTANDING', 159), ('INCOMPLETE_EVIDENCE', 166), ('SUPERFICIAL_RELATIONSHIP', 170)]	7	[('SO_0000704', 'gene', 49, 'gene'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 81, 'vitamin D receptor'), ('SO_0000704', 'gene', 100, 'gene'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 106, 'VDR')]
PMC4113768	7/2014	S2295-PMC4113768	['IT IS CLEAR that general female public FACES an IMMINENT THREAT of Vitamin D deficiency-RELATED diseases UNLESS aggressive public AWARENESS is conducted.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 39), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 57), ('SUPERFICIAL_RELATIONSHIP', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('IMPORTANT_CONSIDERATION', 130)]	7	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4113768	7/2014	S2499-PMC4113768	['female ballet dancers and gymnasts are known to have POOR Vitamin D status POSSIBLY DUE TO heavy indoor training schedules limiting sun exposure, however it is LIKELY that their high levels of physical activity ameliorate the DETRIMENTAL EFFECTS of low Vitamin D and dietary Calcium.']	[('IMPORTANT_CONSIDERATION', 53), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 160), ('IMPORTANT_CONSIDERATION', 226), ('SUPERFICIAL_RELATIONSHIP', 238)]	7	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 275, 'calcium')]
PMC4113768	7/2014	S2593-PMC4113768	['THUS, OUR STUDY AIMED TO ASSESS IF Intake of Foods fortified with Vitamin D during Gestation had an EFFECT on the RISK of t1d later in Life.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('SUPERFICIAL_RELATIONSHIP', 100), ('IMPORTANT_CONSIDERATION', 114)]	7	[('GO_0007631', 'feeding behavior', 35, 'intake'), ('CHEBI_33290', 'food', 45, 'foods'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'gestation'), ('UBERON_0000104', 'life cycle', 135, 'life')]
PMC4256222	12/2014	S106-PMC4256222	['the PRESENT STUDY is TO OUR KNOWLEDGE the FIRST to INVESTIGATE WHETHER maternal Vitamin D status PREDICTS offspring bone fractures.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('EXPLICIT_QUESTION', 63), ('SUPERFICIAL_RELATIONSHIP', 97)]	7	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC4289064	1/2015	S133-PMC4289064	['“other” refers to oils, flavorings, drinks, candy, honey, and other items that do not fit into other Food groups.10.1371/journal.pone.0114805.t001\n\ncaption (table-wrap): table 1\naverage proportion of total Nutrient Intake by percent yield due to pollinators and country for children 1 to 3 years old.% yield due to pollinatorsenergyvitamin acalciumfolateironzinc bangladesh 00.740.380.550.480.620.6850.050.190.080.140.080.07250.080.100.130.170.110.10650.040.090.090.120.070.04950.080.250.160.100.120.12total1.001.001.001.001.001.00 mozambique 00.570.290.540.300.370.4950.140.130.190.290.200.16250.130.020.160.240.250.19650.140.270.080.150.120.13950.020.300.040.020.050.03total1.001.001.001.001.001.00 uganda 00.680.490.530.400.520.5550.140.090.140.300.130.16250.100.090.240.140.210.17650.040.020.010.080.020.05950.040.320.070.080.120.07total1.001.001.001.001.001.00 zambia 00.480.380.410.300.510.5150.170.110.170.350.210.24250.060.020.140.100.080.10650.120.210.130.180.070.03950.070.270.110.050.110.101000.090.000.040.020.030.02total1.001.001.001.001.001.00\nBASED ON these results, we HYPOTHESIZED that pollinators would be most IMPORTANT for nutritional health ASSOCIATED with Vitamin A, BUT less IMPORTANT for nutritional health ASSOCIATED with all other Nutrients.']	[('PROBABLE_UNDERSTANDING', 1058), ('INCOMPLETE_EVIDENCE', 1085), ('IMPORTANT_CONSIDERATION', 1129), ('SUPERFICIAL_RELATIONSHIP', 1162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1189), ('IMPORTANT_CONSIDERATION', 1198), ('SUPERFICIAL_RELATIONSHIP', 1231)]	7	[('CHEBI_33290', 'food', 101, 'food'), ('CHEBI_33284', 'nutrient', 206, 'nutrient'), ('GO_0007631', 'feeding behavior', 215, 'intake'), ('CHEBI_27300', 'vitamin D', 1178, 'vitamin A'), ('CHEBI_33284', 'nutrient', 1257, 'nutrients')]
PMC4329404	10/2014	S185-PMC4329404	['THEREFORE, ALTHOUGH it does not SEEM LIKELY that Vitamin D deficiency per se causes asthma in early Life, it is LIKELY that Vitamin D deficiency CONTRIBUTES to increased disease severity in children with asthma and that supplementation MAY reduce severity.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 11), ('ANOMALY_CURIOUS_FINDING', 32), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 112), ('SUPERFICIAL_RELATIONSHIP', 145), ('INCOMPLETE_EVIDENCE', 236)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4340999	3/2015	S94-PMC4340999	['for latitudes with distinct seasonal changes in availability of uvb, there is a WELL-DOCUMENTED seasonal cycle in Vitamin D status, with a maximum in late summer and a minimum in late winter.32low Vitamin D during Gestation MAY STRONGLY INFLUENCE susceptibility to obesity later in Life.33\nhowever, relatively LITTLE IS KNOWN about the critical period of fetal growth at which low Vitamin D is of particular IMPORTANCE.']	[('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 224), ('PROBABLE_UNDERSTANDING', 228), ('SUPERFICIAL_RELATIONSHIP', 237), ('FULL_UNKNOWN', 310), ('IMPORTANT_CONSIDERATION', 408)]	7	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('GO_0007565', 'female pregnancy', 214, 'gestation'), ('UBERON_0000104', 'life cycle', 282, 'life'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D')]
PMC4380518	9/2014	S68-PMC4380518	['IN LIGHT OF two RECENT meta-analyses/systematic reviews CONCLUDING that low 25(Oh)D levels during Pregnancy are ASSOCIATED with SEVERAL morbidities in Pregnancy15,16, optimizing Vitamin D status during Pregnancy MAY BE IMPORTANT.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 219)]	7	[('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 76, '25 ... OH ... D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy15'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy')]
PMC4448820	5/2015	S185-PMC4448820	['AS a result of increased INTEREST in the activities of Vitamin D beyond the traditional FOCUS on bone/calcium, an IMPORTANT NEW UNDERSTANDING of Vitamin D’s ROLE in Immune function has EMERGED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 88), ('IMPORTANT_CONSIDERATION', 114), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 185)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('UBERON_0002405', 'immune system', 165, 'immune')]
PMC4448820	5/2015	S291-PMC4448820	['ALTHOUGH SOME EFFECTS of Vitamin D are MEDIATED independently of vdr, the large MAJORITY of the activity of Vitamin D CAN be EXPLAINED via binding of the Vitamin D Metabolite [1,25(Oh)2D] to a single, zinc-finger containing, ligand-activated transcription factor, vdr.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 39), ('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 125)]	7	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 164, 'metabolite'), ('CHEBI_17996', 'chloride', 177, ','), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 178, '25(OH)2D')]
PMC4448820	5/2015	S586-PMC4448820	['also, ALTHOUGH it IS CLEAR that inflammation is ASSOCIATED with decreased Serum Retinol and rbp concentrations, the ROLE of Vitamin A supplementation on inflammation and its MARKERS is LESS CLEAR.']	[('ANOMALY_CURIOUS_FINDING', 6), ('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 174), ('FULL_UNKNOWN', 185), ('INCOMPLETE_EVIDENCE', 185)]	7	[('UBERON_0001977', 'blood serum', 74, 'serum'), ('CHEBI_26536', 'retinoic acid', 80, 'retinol'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin A')]
PMC4448820	5/2015	S1518-PMC4448820	['caption (boxed-text): text box 52\u2003\nCURRENTLY available Vitamin D BIOMARKERS/indicators\n\n● 25(Oh)D:\n○ GENERALLY RECOGNIZED AS the best currently available biomarker\n○ reflects Intake\n○ functional relevance not clearly established\n● functional biomarkers:\n○ Parathyroid hormone\n○ calcium absorption\n○ Bone Resorption\n○ bone Mineral density\n\nINFLUENCE of inflammation on Vitamin D assessment.']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 101), ('INCOMPLETE_EVIDENCE', 111), ('PROBABLE_UNDERSTANDING', 111), ('PROBABLE_UNDERSTANDING', 122), ('SUPERFICIAL_RELATIONSHIP', 339)]	7	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 90, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 90, '25(OH ... D'), ('GO_0007631', 'feeding behavior', 175, 'intake'), ('GO_0007567', 'parturition', 182, '○'), ('UBERON_0001132', 'parathyroid gland', 256, 'parathyroid'), ('GO_0008218', 'bioluminescence', 299, 'bone resorption ○'), ('CHEBI_46662', 'mineral', 322, 'mineral'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin D')]
PMC4452099	6/2015	S100-PMC4452099	['all of these FACTORS, which in DIFFERENT ways MAY BE RELATED to either Vitamin D intake and/or t1d risk, can be ASSUMED to be balanced between the Individuals from the various exposure groups, and THEREFORE CONFOUNDING is not to be expected.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 53), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 197), ('PROBLEM_COMPLICATION', 207)]	7	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('NCBITaxon_1', 'root', 147, 'individuals')]
PMC4488777	5/2015	S150-PMC4488777	['this very clever approach gave the authors of these, and of other SIMILAR STUDIES from both europe and the usa, REASONS to state that their data STRONGLY SUGGEST that the EFFECTS of Vitamin D MAY BE MEDIATED through the Endometrium, not the follicle or Oocyte [56,57].']	[('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 112), ('PROBABLE_UNDERSTANDING', 145), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 171), ('INCOMPLETE_EVIDENCE', 192), ('SUPERFICIAL_RELATIONSHIP', 199)]	7	[('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('UBERON_0001852', 'endolymph', 220, 'endometrium'), ('CL_0000023', 'oocyte', 253, 'oocyte')]
PMC4516377	6/2015	S50-PMC4516377	['these mechanisms are not yet FULLY ELUCIDATED; HOWEVER, SOME STUDIES have provided a FEW PLAUSIBLE explanations.24,25one EXPLANATION is that low Calcium intake increases serum Calcitriol levels, which can stimulate the flow of calcium from Adipocytes by Vitamin D Membrane receptors, identified as ASSOCIATED with rapid Membrane response to Steroids.']	[('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 56), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 121), ('SUPERFICIAL_RELATIONSHIP', 298)]	7	[('CHEBI_22313', 'alkaline earth metal atom', 145, 'calcium'), ('CHEBI_17823', 'calcitriol', 176, 'calcitriol'), ('CL_0000136', 'fat cell', 240, 'adipocytes'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0016020', 'membrane', 264, 'membrane'), ('GO_0016020', 'membrane', 320, 'membrane'), ('CHEBI_35341', 'steroid', 341, 'steroids')]
PMC4595656	10/2015	S119-PMC4595656	['FUTURE DIRECTIONS and conclusions\nin LIGHT of the ACCUMULATING Animal and in vitro EVIDENCE to DATE, it is LIKELY that Vitamin D plays a ROLE in hippocampal development in vivo .']	[('FUTURE_WORK', 0), ('PROBABLE_UNDERSTANDING', 37), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 95), ('PROBABLE_UNDERSTANDING', 107), ('SUPERFICIAL_RELATIONSHIP', 137)]	7	[('NCBITaxon_33208', 'Metazoa', 63, 'animal'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC4598849	10/2015	S61-PMC4598849	['THEREFORE, the inverted u shaped RELATIONSHIP in THIS STUDY MAYBE SUGGESTED that Gestational Vitamin D MAY have dual biological EFFECTS on the fetal growth.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 33), ('QUESTION_ANSWERED_BY_THIS_WORK', 49), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 128)]	7	[('GO_0007565', 'female pregnancy', 81, 'gestational'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC4600246	10/2015	S35-PMC4600246	["THUS, the EFFECT of Vitamin K on cac MIGHT be independent of changes in Serum cytokine levels (BUT NOT NECESSARILY RULING out Vitamin K's benefit on the blunting of the EFFECTS of these cytokines)."]	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95), ('INCOMPLETE_EVIDENCE', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('SUPERFICIAL_RELATIONSHIP', 169)]	7	[('CHEBI_27300', 'vitamin D', 20, 'vitamin K'), ('UBERON_0001977', 'blood serum', 72, 'serum'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin K')]
PMC4624803	10/2015	S17-PMC4624803	['EVEN IF it is PROBABLE that the Vitamin D levels of the mother is close to the levels of the foetus, it is of INTEREST to compare these results with a study of Vitamin D levels in the child AS a hypothetical RISK FACTOR for later development of adhd.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 14), ('ANOMALY_CURIOUS_FINDING', 110), ('FUTURE_WORK', 110), ('PROBABLE_UNDERSTANDING', 190), ('SUPERFICIAL_RELATIONSHIP', 208)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC4684854	12/2015	S117-PMC4684854	['finally, Gestational Vitamin D levels MAY IMPACT Adult health AS there is EARLY EVIDENCE that Vitamin D sufficiency in Pregnancy MAY have a PROTECTIVE ROLE in the development of Adult onset multiple sclerosis [94].']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 62), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 151)]	7	[('GO_0007565', 'female pregnancy', 9, 'gestational'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0007023', 'adult organism', 49, 'adult'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('UBERON_0007023', 'adult organism', 178, 'adult')]
PMC4689556	12/2015	S142-PMC4689556	['we FOUND NO CONSISTENT evidence for a treatment effect on overall or disease-specific unscheduled healthcare utilisation in the first three years, ALTHOUGH it should be NOTED that neither of the intervention regimens resulted in adequate Vitamin D levels in mothers or Cord Blood, JUDGED by current international Vitamin D RECOMMENDATIONS [36,37].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('ANOMALY_CURIOUS_FINDING', 147), ('ANOMALY_CURIOUS_FINDING', 169), ('PROBABLE_UNDERSTANDING', 281), ('FUTURE_WORK', 323)]	7	[('CHEBI_27300', 'vitamin D', 238, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 269, 'cord'), ('UBERON_0000178', 'blood', 274, 'blood'), ('CHEBI_27300', 'vitamin D', 313, 'vitamin D')]
PMC4690051	12/2015	S12-PMC4690051	['WHILE THRESHOLDS for Vitamin D sufficiency HAVE BEEN DEBATED RECENTLY [10,11], low circulating levels of 25(Oh)D HAVE BEEN ASSOCIATED with increased mortality in black and white older adults dwelling in north america [12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 123)]	7	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 105, '25(OH)D')]
PMC4719746	1/2016	S38-PMC4719746	['in THIS PAPER, Vitamin D deficiency was DEFINED AS 25(Oh) D <50\xa0nmol/l, and severe Vitamin D deficiency was DEFINED as 25(Oh) D <25\xa0nmol/l, IN ACCORDANCE WITH RELEVANT LITERATURE [20].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('PROBABLE_UNDERSTANDING', 40), ('PROBABLE_UNDERSTANDING', 48), ('PROBABLE_UNDERSTANDING', 108), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 159), ('INCOMPLETE_EVIDENCE', 168)]	7	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 51, '25(OH) D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 121, '(OH) D')]
PMC4764019	1/2016	S45-PMC4764019	['BECAUSE OTHER FACTORS, such as socioeconomic status and ethnic background, COULD EXPLAIN both the low Vitamin D status and the poor performance in school in this group of children, this ASSOCIATION CANNOT BE CONSIDERED causal.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 81), ('SUPERFICIAL_RELATIONSHIP', 186), ('INCOMPLETE_EVIDENCE', 198)]	7	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4764019	1/2016	S49-PMC4764019	['this is BECAUSE, EVEN IF there were no connection between the Vitamin D status and the observed Learning difficulty, the group of Pregnant women to be studied would HAVE TO BE placed and maintained on a Vitamin D status, which is recognized to be INADEQUATE on OTHER grounds (ie, <18 ng/ml) and THEREFORE productive of harmful outcomes.']	[('PROBLEM_COMPLICATION', 8), ('ANOMALY_CURIOUS_FINDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('IMPORTANT_CONSIDERATION', 165), ('IMPORTANT_CONSIDERATION', 247), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 261), ('PROBABLE_UNDERSTANDING', 295)]	7	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007612', 'learning', 96, 'learning'), ('GO_0007565', 'female pregnancy', 130, 'pregnant'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
PMC4770602	1/2016	S58-PMC4770602	['cases included 68 pregnant women who received supplementation contain Vitamin D (600 iu/d) and control group included 70 pregnant women who received supplementation without Vitamin D. differences between both groups were not statistically significant ( p -value = 0.84)\n\ndiscussion\nEVIDENCE TO EVALUATE the effectiveness of Vitamin D in Pregnancy is no enough and much of what we KNOW comes from observational RATHER than experimental design, THEREFORE, AT PRESENT Vitamin D supplementation is NOT routinely offered to all pregnant women.']	[('INCOMPLETE_EVIDENCE', 282), ('QUESTION_ANSWERED_BY_THIS_WORK', 291), ('INCOMPLETE_EVIDENCE', 380), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 410), ('PROBABLE_UNDERSTANDING', 443), ('INCOMPLETE_EVIDENCE', 454), ('ANOMALY_CURIOUS_FINDING', 494)]	7	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 324, 'vitamin D'), ('GO_0007565', 'female pregnancy', 337, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D')]
PMC4800340	5/2016	S23-PMC4800340	['Vitamin D\nthe POSSIBLE ROLE of Vitamin D in Food allergy HAS BEEN HYPOTHESIZED BECAUSE several observational studies REPORTED varying Food allergy incidence ASSOCIATED with geographic or seasonal variation (sun exposure).']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 79), ('INCOMPLETE_EVIDENCE', 117), ('SUPERFICIAL_RELATIONSHIP', 157)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_33290', 'food', 44, 'food'), ('CHEBI_33290', 'food', 134, 'food')]
PMC4848664	4/2016	S131-PMC4848664	['development of the Folic Acid ul was BASED ON EVIDENCE of masking of Vitamin B-12 deficiency anemia, and THUS, CONCERNS about the Folic Acid ul are ONLY applicable to those with a Vitamin B-12 deficiency and not to the general population.']	[('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 105), ('PROBLEM_COMPLICATION', 111), ('INCOMPLETE_EVIDENCE', 148)]	7	[('CHEBI_30751', 'formic acid', 19, 'folic acid'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 69, 'vitamin B-12'), ('CHEBI_30751', 'formic acid', 130, 'folic acid'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 180, 'vitamin B-12')]
PMC4889866	5/2016	S19-PMC4889866	['THUS, DESPITE a WIDE VARIETY of studies that acknowledged the immunomodulatory ROLE of Vitamin D, the results HAVE BEEN CONFLICTING.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('ANOMALY_CURIOUS_FINDING', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120)]	7	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC4889866	5/2016	S91-PMC4889866	['the REASONS for various CONFLICTING results MIGHT be DUE TO DIFFERENCES in the study designs, age of the study population, definition of clinical outcomes, and also DISPARITIES in the assessment of Vitamin D concentration (use of maternal Blood or Cord Blood).']	[('PROBABLE_UNDERSTANDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 44), ('PROBLEM_COMPLICATION', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('IMPORTANT_CONSIDERATION', 165)]	7	[('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0000178', 'blood', 239, 'blood'), ('UBERON_0002240', 'spinal cord', 248, 'cord'), ('UBERON_0000178', 'blood', 253, 'blood')]
PMC4889866	5/2016	S93-PMC4889866	['THUS, when addressing the IMPACT of Prenatal Vitamin D status on various outcomes, it MIGHT be IMPORTANT to CONSIDER that Vitamin D levels in the Pregnant mothers and Cord Blood MIGHT not always correspond uniformly.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 86), ('IMPORTANT_CONSIDERATION', 95), ('FUTURE_WORK', 108), ('IMPORTANT_CONSIDERATION', 108), ('INCOMPLETE_EVIDENCE', 178)]	7	[('GO_0007565', 'female pregnancy', 36, 'prenatal'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnant'), ('UBERON_0002240', 'spinal cord', 167, 'cord'), ('UBERON_0000178', 'blood', 172, 'blood')]
PMC4889866	5/2016	S108-PMC4889866	['SINCE one POTENTIAL source of Il-10 is Treg, it was SPECULATED that higher Vitamin D level would be ASSOCIATED with less Treg Cells to respond to tlr stimulation, THUS resulting in lower Il-10 response as SEEN in OUR STUDY.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 100), ('PROBABLE_UNDERSTANDING', 163), ('INCOMPLETE_EVIDENCE', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 213)]	7	[('PR_000001470', 'interleukin-28B', 30, 'IL-10'), ('CL_0000901', 'Tr1 cell', 39, 'Treg'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CL_0000960', 'T3 B cell', 121, 'Treg cells'), ('PR_000001470', 'interleukin-28B', 187, 'IL-10')]
PMC4930210	7/2016	S164-PMC4930210	['THUS, it APPEARS that ALTHOUGH winter uvr exposure MAY BE insufficient, VARIATIONS in summer sun exposure will alter fall 25(Oh)D concentration and THUS indirectly INFLUENCE winter Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('ANOMALY_CURIOUS_FINDING', 22), ('INCOMPLETE_EVIDENCE', 51), ('DIFFICULT_TASK', 72), ('PROBABLE_UNDERSTANDING', 148), ('SUPERFICIAL_RELATIONSHIP', 164)]	7	[('CHEBI_71657', 'versiconol acetate', 122, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 122, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4944244	7/2016	S10-PMC4944244	['FURTHER STUDIES NEED TO BE conducted among health care workers to determine their level of knowledge RELATED to Vitamin D, AS they are front liner in detecting the hypovitaminosis d.\n\nbackground\nmalaysia is rich with sunshine, a MAJOR source of Vitamin D. HOWEVER, a study by moy [1] among a cohort of malays SHOWED that 67.9\xa0% had insufficient Vitamin D especially in women, with Serum mean concentration of 25(Oh)D of 36.2\u2009±\u200913.4\xa0nmol/l in women and 56.2\u2009±\u200918.9\xa0nmol/l in men.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 16), ('SUPERFICIAL_RELATIONSHIP', 101), ('PROBABLE_UNDERSTANDING', 123), ('IMPORTANT_CONSIDERATION', 229), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 256), ('INCOMPLETE_EVIDENCE', 309)]	7	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0001977', 'blood serum', 381, 'serum'), ('CHEBI_71657', 'versiconol acetate', 409, '25(OH)D')]
PMC4971719	8/2016	S137-PMC4971719	['BECAUSE our study participants were drawn from a parent study looking at Omega-3 Fatty Acids (Dha and Epa) and their RELATIONSHIP to depression, and to adjust for other POTENTIAL CONFOUNDERS, we CONDUCTED a stepwise linear regression to BETTER UNDERSTAND the ASSOCIATION of Vitamin D with the bdi score.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 169), ('PROBLEM_COMPLICATION', 179), ('QUESTION_ANSWERED_BY_THIS_WORK', 195), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 259)]	7	[('CHEBI_75862', 'alpha-D-rhamnofuranose', 73, 'omega-3 fatty acids'), ('CHEBI_17874', 'dihydrozeatin', 94, 'DHA'), ('CHEBI_34733', 'EPN', 102, 'EPA'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC4973215	8/2016	S83-PMC4973215	['obesity is WELL KNOWN to be a RISK FACTOR for Vitamin D deficiency BECAUSE of a Sequestering Of Vitamin D in Adipose Tissue.35maternal obesity during Pregnancy HAS also BEEN ASSOCIATED with lower Vitamin D levels in neonates at Delivery.24,36,37,38our data are CONSISTENT and illustrate the inverse RELATIONSHIP between maternal bmi at Delivery and Vitamin D status after adjusting for confounding variables.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 160), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 261), ('SUPERFICIAL_RELATIONSHIP', 299)]	7	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0051208', 'sequestering of calcium ion', 80, 'sequestering of vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 109, 'adipose tissue'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('GO_0007567', 'parturition', 228, 'delivery'), ('GO_0007567', 'parturition', 336, 'delivery'), ('CHEBI_27300', 'vitamin D', 349, 'vitamin D')]
PMC4990268	8/2016	S315-PMC4990268	['meta-analyses do not SUPPORT this intervention as a Maternal survival strategy[101,108] HOWEVER the most RECENT such analysis NOTED significant heterogeneity in trial outcomes (i2 = 52%, p = 0.04) MOST LIKELY due TO VARIATIONS in underlying population levels of Vitamin A deficiency between studies[101].']	[('INCOMPLETE_EVIDENCE', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('INCOMPLETE_EVIDENCE', 105), ('ANOMALY_CURIOUS_FINDING', 126), ('PROBABLE_UNDERSTANDING', 197), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('DIFFICULT_TASK', 216)]	7	[('GO_0007618', 'mating', 52, 'maternal'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin A')]
PMC4998950	4/2016	S5-PMC4998950	['conclusions\nif REFLECTING ASSOCIATIONS for Prenatal hypovitaminosis, THESE FINDINGS IMPLY Gestational Vitamin D substitution AS a means of asd PREVENTION.']	[('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 84), ('PROBABLE_UNDERSTANDING', 125), ('SUPERFICIAL_RELATIONSHIP', 143)]	7	[('GO_0007565', 'female pregnancy', 43, 'prenatal'), ('GO_0007565', 'female pregnancy', 90, 'gestational'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4998950	4/2016	S44-PMC4998950	['this DISCREPANCY MIGHT be DUE TO a limited range of exposure in children of immigrant mothers, AS the majority of children and Pregnant mothers with migrant background have neonatal/Gestational Vitamin D deficiency, ACCORDING TO RECENT swedish REPORTS.6,11\ncausality cannot be inferred from our study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('INCOMPLETE_EVIDENCE', 17), ('PROBLEM_COMPLICATION', 26), ('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 244)]	7	[('GO_0007565', 'female pregnancy', 127, 'pregnant'), ('GO_0007565', 'female pregnancy', 182, 'gestational'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
PMC5051327	9/2016	S11-PMC5051327	['IF OUR FINDINGS are SUPPORTED by FURTHER STUDIES, PREFERABLY on SEVERE Birth asphyxia, Vitamin D supplementation/sun exposure in Pregnancy MAY lower the risk of subsequent Birth asphyxia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 20), ('FUTURE_WORK', 33), ('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 64), ('INCOMPLETE_EVIDENCE', 139)]	7	[('GO_0007567', 'parturition', 71, 'birth'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007567', 'parturition', 172, 'birth')]
PMC5051327	9/2016	S68-PMC5051327	['in the logistic regression analysis of Vitamin D levels in women who underwent caesarean section due to suspected fetal distress/Birth asphyxia, we DID NOT adjust for maternal bmi SINCE it SEEMS to be INVOLVED in a causal pathway.35HOWEVER, SIMILAR results were FOUND in stratified analysis of lean women (≤25 in bmi).']	[('INCOMPLETE_EVIDENCE', 148), ('PROBABLE_UNDERSTANDING', 180), ('ANOMALY_CURIOUS_FINDING', 189), ('SUPERFICIAL_RELATIONSHIP', 201), ('ANOMALY_CURIOUS_FINDING', 230), ('INCOMPLETE_EVIDENCE', 241), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007567', 'parturition', 129, 'birth')]
PMC5051327	9/2016	S70-PMC5051327	['SINCE PRIOR STUDIES had REPORTED on INCREASED RISK of emergency caesarean Delivery in RELATION to low Vitamin D, we used caesarean Delivery DUE TO suspected fetal distress AS a main outcome and Birth asphyxia as a secondary outcome.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 36), ('SUPERFICIAL_RELATIONSHIP', 86), ('PROBLEM_COMPLICATION', 140), ('PROBABLE_UNDERSTANDING', 172)]	7	[('GO_0007567', 'parturition', 74, 'delivery'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007567', 'parturition', 131, 'delivery'), ('GO_0007567', 'parturition', 194, 'birth')]
PMC5062906	10/2016	S232-PMC5062906	['ONE LIKELY EXPLANATION for the sporadic methylation changes OBSERVED in response to Vitamin D depletion is perturbation of global epigenetic Programming AS an indirect EFFECT of Dysregulation of master epigenetic REGULATORS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 4), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 60), ('PROBABLE_UNDERSTANDING', 153), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 213)]	7	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'programming'), ('GO_0060233', 'oenocyte delamination', 178, 'dysregulation')]
PMC5062906	10/2016	S283-PMC5062906	['these observations SUGGEST that Vitamin D-induced changes in methylation are MOST LIKELY the result of sporadic epimutations due TO global dysregulation of epigenetic maintenance and that disruption of epigenetic Regulatory mechanisms is MOST LIKELY the causal FACTOR.']	[('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 77), ('PROBABLE_UNDERSTANDING', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 129), ('PROBABLE_UNDERSTANDING', 238), ('PROBABLE_UNDERSTANDING', 243), ('SUPERFICIAL_RELATIONSHIP', 261)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 213, 'regulatory')]
PMC5064894	10/2016	S171-PMC5064894	['in secondary analyses, we will consider aggregation of multiple Vitamin D arms (e.g., group d and e), which will have the benefit of increasing the sample size; HOWEVER, for the a priori primary outcome analysis, we have decided to retain the separation of the groups (according to the design of the mdig trial) to LIMIT the POSSIBILITY of increasing a type ii ERROR IF a TRUE effect of the longer duration or higher-dose intervention were diluted by the lack OF effect of the other group(s).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 161), ('INCOMPLETE_EVIDENCE', 315), ('INCOMPLETE_EVIDENCE', 325), ('PROBLEM_COMPLICATION', 361), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 367), ('PROBABLE_UNDERSTANDING', 372), ('ANOMALY_CURIOUS_FINDING', 460)]	7	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC5064894	10/2016	S194-PMC5064894	['IF SHOWN to reduce the RISK of ari in infancy, integration of maternal Prenatal/Postpartum Vitamin D supplementation into Antenatal Care programs in south asia MAY BE a FEASIBLE primary preventive STRATEGY to reduce THE BURDEN of ari-associated morbidity and mortality in young infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 160), ('PROBABLE_UNDERSTANDING', 169), ('FUTURE_WORK', 197), ('IMPORTANT_CONSIDERATION', 216)]	7	[('GO_0007565', 'female pregnancy', 71, 'prenatal'), ('GO_0007565', 'female pregnancy', 80, 'postpartum'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 122, 'antenatal care')]
PMC5129897	10/2016	S6-PMC5129897	['HOWEVER, the EFFECTS on disease incidence, economic BURDEN, and mortality rate would be phased in gradually over several years PRIMARILY because once a chronic disease is established, Vitamin D AFFECTS its progression ONLY modestly.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('IMPORTANT_CONSIDERATION', 52), ('PROBABLE_UNDERSTANDING', 127), ('SUPERFICIAL_RELATIONSHIP', 194), ('ANOMALY_CURIOUS_FINDING', 218), ('INCOMPLETE_EVIDENCE', 218)]	7	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC5129897	10/2016	S70-PMC5129897	['a meta-analysis of Lung cancer incidence versus 25(Oh)D concentration at the time of enrollment FOUND that relative risk decreased from 1.0 at 20\xa0nmol/l to 0.86 at 40\xa0nmol/l and 0.84 at 50\xa0nmol/l, after which the 95% confidence intervals became very large.47most of the 13 studies were prospective studies with long follow-up times, and ONE STUDY involved smokers who had taken large doses of Vitamin A, which MAY have AFFECTED cancer risk since it competes with Vitamin D.50thus, doubling the calculated change in relative risk to 0.72 at 40\xa0nmol/l and 0.68 at 50\xa0nmol/l and higher SEEMS REASONABLE.']	[('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 337), ('INCOMPLETE_EVIDENCE', 410), ('SUPERFICIAL_RELATIONSHIP', 419), ('ANOMALY_CURIOUS_FINDING', 583), ('PROBABLE_UNDERSTANDING', 583), ('PROBABLE_UNDERSTANDING', 589)]	7	[('UBERON_0002048', 'lung', 19, 'lung'), ('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 48, '25(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 54, 'D'), ('CHEBI_27300', 'vitamin D', 393, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 463, 'vitamin D')]
PMC5129897	10/2016	S93-PMC5129897	['a RECENT PAPER by EXPERTS in ms ESTIMATED that Vitamin D supplementation COULD PREVENT 40% of ms cases.63using that value, the total economic BURDEN of ms in canada could eventually be reduced by $1.5\xa0billion.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 18), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 142)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5129897	10/2016	S190-PMC5129897	['one is reduction in Blood pressure through liberating Nitric Oxide from subcutaneous Nitrogen stores.101another is that uv MAY Modulate the Immune Response to psoriasis, asthma, ms, and infection through mechanisms independent of Vitamin D.102uvb exposure APPARENTLY reduces the risk of ms through both Vitamin D–DEPENDENT and –INDEPENDENT mechanisms.103\nthe CONCERNS regarding RISK of skin cancer and melanoma are OFTEN overstated in comparison with the benefits of non burning, moderate uv exposure.']	[('INCOMPLETE_EVIDENCE', 123), ('ANOMALY_CURIOUS_FINDING', 256), ('SUPERFICIAL_RELATIONSHIP', 313), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBLEM_COMPLICATION', 359), ('IMPORTANT_CONSIDERATION', 378), ('PROBABLE_UNDERSTANDING', 415)]	7	[('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_16480', 'nitric oxide', 54, 'nitric oxide'), ('CHEBI_33300', 'pnictogen', 85, 'nitrogen'), ('GO_0065007', 'biological regulation', 127, 'modulate'), ('GO_0006955', 'immune response', 140, 'immune response'), ('UBERON_0002405', 'immune system', 140, 'immune'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]
PMC5155676	12/2016	S108-PMC5155676	['weight gain in Pregnancy REPRESENTS NOT ONLY increased fat mass BUT ALSO Feto-Placental Tissues and hemodilution (16); our data, THEREFORE, SUGGEST that overall volume of dilution, and not just adiposity, MAY BE IMPORTANT for response to Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('ANOMALY_CURIOUS_FINDING', 36), ('ANOMALY_CURIOUS_FINDING', 64), ('PROBABLE_UNDERSTANDING', 129), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 205), ('IMPORTANT_CONSIDERATION', 212)]	7	[('GO_0007565', 'female pregnancy', 15, 'pregnancy'), ('UBERON_0000981', 'femur', 73, 'feto'), ('UBERON_0002483', 'trabecular bone tissue', 78, 'placental tissues'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
PMC5155676	12/2016	S112-PMC5155676	['HOWEVER, it is NOTABLE that there were marked DIFFERENCES in baseline 25(Oh)D concentrations between these investigations, and we OBSERVED that initial 25(Oh)D status was positively ASSOCIATED with both the LIKELIHOOD of achieving Vitamin D replete status and absolute 25(Oh)D status at 34 weeks of Gestation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 182), ('PROBABLE_UNDERSTANDING', 207)]	7	[('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 76, 'D'), ('CHEBI_63056', 'zinc cation', 152, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 269, '25(OH)D'), ('GO_0007565', 'female pregnancy', 299, 'gestation')]
PMC5155676	12/2016	S124-PMC5155676	['AS such, young Pregnant women MIGHT PARTICULARLY REQUIRE ADVICE on the need for, and compliance with, Vitamin D supplementation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('ANOMALY_CURIOUS_FINDING', 36), ('IMPORTANT_CONSIDERATION', 36), ('FUTURE_WORK', 49), ('IMPORTANT_CONSIDERATION', 49), ('FUTURE_WORK', 57)]	7	[('GO_0007565', 'female pregnancy', 15, 'pregnant'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5351212	3/2017	S39-PMC5351212	['(b) GIVEN the anti-inflammatory properties of Vitamin D, the PRESENT STUDY was DESIGNED TO INVESTIGATE WHETHER use of Calcitriol, [1α, 25-Dihydroxy Vitamin D3 (1,25Ohd)], the hormonally active form of Vitamin D, COULD prevent Poly(I:C)-induced behavioral dysfunctions RELEVANT TO asd, including deficits in Social Interaction, stereotyped behavior, innate anxiety, and Emotional Learning.']	[('PROBABLE_UNDERSTANDING', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('INCOMPLETE_EVIDENCE', 212), ('SUPERFICIAL_RELATIONSHIP', 268)]	7	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 118, 'calcitriol'), ('CHEBI_43176', 'hydroxy group', 138, 'dihydroxy'), ('CHEBI_33279', 'vitamin D5', 148, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 148, 'vitamin D3'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 162, '25OHD'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('CHEBI_77358', 'CDP-dipalmitoyl-sn-glycerol', 226, 'poly(I:C'), ('GO_0019417', 'sulfur oxidation', 307, 'social interaction'), ('GO_0050959', 'echolocation', 369, 'emotional learning')]
PMC5351212	3/2017	S304-PMC5351212	['finally, GIVEN that mia and maternal Vitamin D deficiency are both risk-modifying factors for autism and GIVEN that the distinct OVERLAP in behavioral phenotypes produced in the Animal MODELS of these environmental RISK FACTORS, we ADDRESSED the issue of WHETHER mia induces Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 105), ('SUPERFICIAL_RELATIONSHIP', 129), ('INCOMPLETE_EVIDENCE', 185), ('SUPERFICIAL_RELATIONSHIP', 215), ('QUESTION_ANSWERED_BY_THIS_WORK', 232), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255)]	7	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 178, 'animal'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]
PMC5359891	3/2017	S110-PMC5359891	['lactis ncc 2818 (cncm i-3446) also known as bl818control groupfolic Acid400\xa0μgstandard Preconception recommendationiron12\xa0mgiron is routinely prescribed and taken before/during Pregnancy, though WITHOUT CONVINCING EVIDENCE of benefit; low dose included to lessen LIKELIHOOD of additionally receiving a high-dose Iron product, which HAS BEEN LINKED with Glucose Metabolism in Pregnancycalcium150\xa0mga low dose of Calcium is commonly taken before/during Pregnancy; provision of this will lessen the LIKELIHOOD of additional products being takeniodine150\xa0μgstandard Preconception recommendationhttp://www.cdc.gov/Preconception/documents/clinical-content_womensnutritionfactsheet3.pdfβ-Carotene720\xa0μg (15% of Vitamin A REQUIREMENTS, as Retinol equivalents)required in Pregnancy in some jurisdictions\n\noutcome measurements\nthe primary analysis will adjust for site, ethnicity and Preconception glycaemia to account for POTENTIAL imbalance between treatment arms amongst Pregnancies which reach 28\xa0weeks’ Gestation, examining for differences in means between the control and intervention groups for the primary endpoint, specifically the fasting and/or 60-min and/or 2-h Glucose concentrations following a 75-g ogtt at 28\xa0weeks’ Gestation.']	[('INCOMPLETE_EVIDENCE', 195), ('PROBABLE_UNDERSTANDING', 263), ('INCOMPLETE_EVIDENCE', 332), ('SUPERFICIAL_RELATIONSHIP', 341), ('PROBABLE_UNDERSTANDING', 496), ('IMPORTANT_CONSIDERATION', 714), ('INCOMPLETE_EVIDENCE', 913)]	7	[('CHEBI_82451', "3,3'-Dimethoxybenzidine-4,4'-diisocyanate", 68, 'acid400'), ('GO_0007565', 'female pregnancy', 87, 'preconception'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy'), ('CHEBI_24870', 'ion', 312, 'iron'), ('CHEBI_17234', 'glucose', 353, 'glucose'), ('GO_0006006', 'glucose metabolic process', 353, 'glucose metabolism'), ('GO_0051561', 'positive regulation of mitochondrial calcium ion concentration', 375, 'pregnancyCalcium150'), ('CHEBI_22313', 'alkaline earth metal atom', 411, 'calcium'), ('GO_0007565', 'female pregnancy', 451, 'pregnancy'), ('GO_0007565', 'female pregnancy', 562, 'preconception'), ('GO_0007565', 'female pregnancy', 609, 'preconception'), ('CHEBI_52743', 'bromine-79 atom', 681, 'carotene720'), ('CHEBI_27300', 'vitamin D', 704, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 731, 'retinol'), ('GO_0007565', 'female pregnancy', 763, 'pregnancy'), ('GO_0007565', 'female pregnancy', 874, 'preconception'), ('GO_0007565', 'female pregnancy', 964, 'pregnancies'), ('GO_0007565', 'female pregnancy', 998, 'gestation'), ('CHEBI_17234', 'glucose', 1164, 'glucose'), ('GO_0007565', 'female pregnancy', 1222, 'gestation')]
PMC5385921	4/2017	S142-PMC5385921	['it is FEASIBLE that a SAFE, inexpensive and PUBLICALLY acceptable Vitamin D supplementation in AT-RISK groups MAY reduce the PREVALENCE of this RISK FACTOR.']	[('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 22), ('IMPORTANT_CONSIDERATION', 44), ('IMPORTANT_CONSIDERATION', 95), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 125), ('SUPERFICIAL_RELATIONSHIP', 144)]	7	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5405075	4/2017	S13-PMC5405075	['HOWEVER, it REMAINS UNCLEAR WHETHER maternal Vitamin D deficiency MAY CONTRIBUTE to the development of childhood asthma OR it is the consequence of a GENERALLY altered biochemistry.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 150)]	7	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC5405075	4/2017	S38-PMC5405075	['CONSEQUENTLY, longitudinal studies measuring 25(Oh)D levels, a POSSIBLE more objective INDICATOR of Vitamin D status, were DESIGNED TO explore the POSSIBLE IMPACT of Vitamin D on asthma-like symptoms or asthma.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 87), ('QUESTION_ANSWERED_BY_THIS_WORK', 123), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 156)]	7	[('CHEBI_71657', 'versiconol acetate', 45, '25(OH)D'), ('PR_000010220', 'mannose-binding protein C', 47, '('), ('PR_000006444', 'diacylglycerol kinase delta', 51, 'D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
PMC5418719	5/2017	S138-PMC5418719	['CONSIDERING the EFFICACY and SAFETY of Vitamin D supplementation in THIS STUDY, Vitamin D intake of 800\xa0iu per day MAY optimize Vitamin D levels during early hospitalization in vlbw infants.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 68), ('INCOMPLETE_EVIDENCE', 115)]	7	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC5452160	4/2017	S237-PMC5452160	['CONSIDERING the high prevalence of iron, zinc, Vitamin A, b12, and Folate deficiencies, and PREVIOUSLY presented results on Iodine deficiency in this study population [63], INTERVENTIONS to promote the strengthening of anc, and access and adherence to nutrition and health interventions are URGENTLY NEEDED [64,65].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 173), ('IMPORTANT_CONSIDERATION', 291), ('FUTURE_WORK', 300)]	7	[('CHEBI_27300', 'vitamin D', 47, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 67, 'folate'), ('CHEBI_24859', 'iodine atom', 124, 'iodine')]
PMC5474873	6/2017	S40-PMC5474873	['given the LIMITED RESEARCH, the AIM of THIS STUDY is TO INVESTIGATE the ASSOCIATION between Adult Life sun exposure (AS a PROXY for Vitamin D status) and later pes.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 72), ('PROBABLE_UNDERSTANDING', 117), ('SUPERFICIAL_RELATIONSHIP', 122)]	7	[('UBERON_0000113', 'post-juvenile adult stage', 92, 'adult life'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC5474873	6/2017	S165-PMC5474873	['THE CURRENT STUDY was BASED ON multiple exposure factors (several sun exposure VARIABLES) AS PROXIES for Vitamin D level and their RELATIONSHIP with pes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 22), ('SUPERFICIAL_RELATIONSHIP', 22), ('SUPERFICIAL_RELATIONSHIP', 79), ('PROBABLE_UNDERSTANDING', 90), ('SUPERFICIAL_RELATIONSHIP', 93), ('SUPERFICIAL_RELATIONSHIP', 131)]	7	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 113, 'D')]
PMC5513133	7/2017	S0-PMC5513133	['the ROLE of Vitamin D in pre-eclampsia: a systematic review\n\nabstract\n\nbackground\nthe etiology of pre-eclampsia (pe) is not YET FULLY UNDERSTOOD, THOUGH CURRENT LITERATURE INDICATES an upregulation of Inflammatory Mediators produced by the Placenta AS a POTENTIAL causal mechanism.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 146), ('INCOMPLETE_EVIDENCE', 153), ('INCOMPLETE_EVIDENCE', 172), ('PROBABLE_UNDERSTANDING', 249), ('INCOMPLETE_EVIDENCE', 254)]	7	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_64668', 'geranylgeranyl-chlorophyll a', 201, 'inflammatory mediators'), ('UBERON_0001987', 'placenta', 240, 'placenta')]
PMC5537904	7/2017	S150-PMC5537904	['IT IS POSSIBLE that the differential ASSOCIATIONS between 25(Oh)D and Birthweight according to maternal bmi we OBSERVED are DUE TO VARIATIONS in overall energy intake or OTHER nutritional factors that are concomitant with increased Vitamin D intake and THUS increased 25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 111), ('PROBLEM_COMPLICATION', 124), ('DIFFICULT_TASK', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('PROBABLE_UNDERSTANDING', 253)]	7	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH)D'), ('GO_0007596', 'blood coagulation', 70, 'birthweight'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D')]
PMC5539754	8/2017	S105-PMC5539754	['GIVEN that the ASSOCIATION between early Gestation through extended winter and Insulin resistance is INDEPENDENT of Serum 25Ohd <30\xa0nmol/l, our NOVEL FINDINGS IMPLY that seasonal variation in Insulin resistance MAY NOT be fully EXPLAINED by differences in Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 101), ('INCOMPLETE_EVIDENCE', 144), ('PROBABLE_UNDERSTANDING', 159), ('INCOMPLETE_EVIDENCE', 211), ('PROBABLE_UNDERSTANDING', 228)]	7	[('GO_0007565', 'female pregnancy', 41, 'gestation'), ('PR_000045358', 'insulin family protein', 79, 'insulin'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 122, '25OHD'), ('PR_000045358', 'insulin family protein', 192, 'insulin'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
PMC5634602	10/2017	S147-PMC5634602	['IN FACT, SOME authors, including heaney, have ARGUED that a physiological reference for optimal Vitamin D status would be between 100 and 130 nmol/l stating that BASED ON physiological outcomes such as normalization of pth and adequate Vitamin D supply in Breast Milk this level is SAFE for disease prevention without ASSOCIATION of toxicity [56].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 162), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 282), ('SUPERFICIAL_RELATIONSHIP', 318)]	7	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 256, 'breast milk')]
PMC5679631	11/2017	S159-PMC5679631	['TO OUR KNOWLEDGE, THIS is the FIRST report of a large scale observational study INDICATING that Prenatal Vitamin D exposure, AS measured either by maternal use of multivitamin supplements containing Vitamin D, or 25(Oh)D quintiles, INFLUENCES several IMPORTANT bacterial taxa within the infant Gut.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 80), ('PROBABLE_UNDERSTANDING', 125), ('SUPERFICIAL_RELATIONSHIP', 232), ('IMPORTANT_CONSIDERATION', 251)]	7	[('GO_0007565', 'female pregnancy', 96, 'prenatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D'), ('UBERON_0001555', 'digestive tract', 294, 'gut')]
PMC5732505	12/2017	S50-PMC5732505	['suboptimal Vitamin D status was DEFINED AS 25(Oh)D\u2009<\u200980\xa0nmol/l, and optimal Vitamin D status AS 25(Oh)D\u2009≥\u200980\xa0nmol/l, AS HAS BEEN SUGGESTED BASED ON calcium absorption STUDIES [18].']	[('PROBABLE_UNDERSTANDING', 32), ('PROBABLE_UNDERSTANDING', 40), ('PROBABLE_UNDERSTANDING', 93), ('PROBABLE_UNDERSTANDING', 117), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 167)]	7	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 43, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D')]
PMC5784894	1/2018	S20-PMC5784894	['[14]\nconsidered TOGETHER, THESE FINDINGS IMPLY that early Life Vitamin D exposure has EFFECTS that persist into childhood, MAY IMPACT on peak bone mass accrual and INFLUENCE subsequent bone loss, the development of osteoporosis and the risk of Life-limiting fracture.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 26), ('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 127), ('SUPERFICIAL_RELATIONSHIP', 164)]	7	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0000104', 'life cycle', 244, 'life')]
PMC5784894	1/2018	S173-PMC5784894	['we BELIEVE that our data are ROBUST and that our INFERENCES of a reduced EFFECT of loading in offspring of Vitamin D deplete Animals stand BECAUSE the increased compliance of the Bones in the deplete group MEANS that the strain stimulus induced by the load of 10.5n was greater than in the replete group.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 49), ('PROBABLE_UNDERSTANDING', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBABLE_UNDERSTANDING', 139), ('PROBABLE_UNDERSTANDING', 206)]	7	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 125, 'animals'), ('UBERON_0001474', 'bone element', 179, 'bones')]
PMC5941617	5/2018	S109-PMC5941617	['caption (table-wrap): table 5\n\ndietary reference values of Vitamin D in infants, children, and adolescents as PROPOSED by various organizations and societiesorganization/societyyearcountry/countriesdietary reference value for Vitamin D0–12\xa0months, iu/day1–18\xa0years, iu/dayeuropean Food safety authority [26]2016europeai400 (7–11\xa0months)600 (1–17\xa0years)scientific advisory committee on nutrition [25]2016united kingdomsafe intake (<\u20094\xa0years)340–400400rni (4–18\xa0years)nordic nutrition recommendations [16]2012denmark, finland, iceland, norway, sweden, faroe islands, greenland, åland islandsri400400german nutrition society [17]2012germany, austria, switzerlandai400 (infants)800a(children)health council of the netherlands [18]2012the netherlandsai400400italian society of nutrition [89]2012italyai (<\u2009 12\xa0months)400 (6–12\xa0months)600pri (1–18\xa0years)institute of medicine [10]2011north america, canadaai (<\u2009 12\xa0months)400600rda (1–18\xa0years)the Endocrine society [11]2011worldwidedaily requirementb400–1000600–1000\nai adequate intake, the average observed daily level of Intake by a population group of apparently healthy People that is ASSUMED to be adequate\nsafe intake , a level or range of intakes considered to pose no risk of deficiency and below a level where there is a risk of undesirable EFFECTS\nrni reference Nutrient intake, the amount of a Nutrient that is LIKELY to meet the needs of 97.5% of the population\nri recommended intake, the amount of a Nutrient that meets the known REQUIREMENT and maintains good nutritional status among practically all (97–98%) healthy Individuals in a particular Life Stage or gender group\npri population reference intake, the level of Nutrient intake sufficient to satisfy the needs of ALMOST all (97.5%) healthy subjects in one specific population group\nrda recommended dietary allowance, the estimated intake capable of satisfying the needs of 97.5% of the population\naadequate intake with missing Endogenous Synthesis Of Vitamin D\nbrecommended REQUIREMENTS for subjects at risk of Vitamin D deficiency\nin accordance with the european society for paediatric gastroenterology hepatology and nutrition [espghan] [19] and the european academy of pediatrics [30], we endorsed tolerable upper intake levels of Vitamin D proposed by efsa in 2012 (1000\xa0iu/day for infants: 2000\xa0iu/day for children ages 1 to 10\xa0years; 4000\xa0iu/day for children and adolescents ages 11 to 17\xa0years) [90].']	[('INCOMPLETE_EVIDENCE', 110), ('PROBABLE_UNDERSTANDING', 1134), ('SUPERFICIAL_RELATIONSHIP', 1295), ('PROBABLE_UNDERSTANDING', 1367), ('IMPORTANT_CONSIDERATION', 1488), ('ANOMALY_CURIOUS_FINDING', 1729), ('IMPORTANT_CONSIDERATION', 1990)]	7	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 226, 'vitamin D0'), ('PR_000017299', 'VIP peptides', 226, 'vitamin D0'), ('CHEBI_33290', 'food', 281, 'Food'), ('UBERON_0005063', 'left ventricular compact myocardium', 942, 'Endocrine'), ('GO_0007631', 'feeding behavior', 1068, 'intake'), ('NCBITaxon_10088', 'Mus <genus>', 1119, 'people'), ('CHEBI_33284', 'nutrient', 1317, 'Nutrient'), ('CHEBI_33284', 'nutrient', 1350, 'nutrient'), ('CHEBI_33284', 'nutrient', 1458, 'nutrient'), ('NCBITaxon_1', 'root', 1577, 'individuals'), ('UBERON_0000105', 'life cycle stage', 1605, 'life stage'), ('CHEBI_33284', 'nutrient', 1678, 'nutrient'), ('GO_0009790', 'embryo development', 1943, 'endogenous'), ('GO_0030474', 'spindle pole body duplication', 1954, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1967, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 1975, 'D'), ('CHEBI_27300', 'vitamin D', 2027, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2250, 'vitamin D')]
PMC5941617	5/2018	S125-PMC5941617	['regarding the PREFERRED form of Vitamin D for supplementation, the national institute for health and care excellence GUIDELINE RECOMMENDED Vitamin D drops in infants and young children [114], WHILE other international scientific societies DID NOT make any SPECIFIC RECOMMENDATION.']	[('PROBABLE_UNDERSTANDING', 14), ('PROBABLE_UNDERSTANDING', 117), ('FUTURE_WORK', 127), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192), ('INCOMPLETE_EVIDENCE', 239), ('FUTURE_WORK', 256), ('FUTURE_WORK', 265)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC5941617	5/2018	S471-PMC5941617	['strict adherence to gluten free diet itself MAY REPRESENTS a DETERMINANT of Vitamin D status, BECAUSE it HAS BEEN DEMONSTRATED that sweden cd children on gluten free diet had low Vitamin D intake compared with nordic nutrition recommendation and lower Nutrient density of Vitamin D than healthy children [431].']	[('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 61), ('PROBABLE_UNDERSTANDING', 94), ('INCOMPLETE_EVIDENCE', 105), ('INCOMPLETE_EVIDENCE', 114)]	7	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_33284', 'nutrient', 252, 'nutrient'), ('CHEBI_27300', 'vitamin D', 272, 'vitamin D')]
PMC5941617	5/2018	S537-PMC5941617	['AS literature SHOWS CONTRASTING results because of DIFFERENT methods and study designs, MORE STUDIES ARE NEEDED to define the ROLE of Vitamin D in pathogenesis and severity of depression, particularly in the pediatric age.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 51), ('ANOMALY_CURIOUS_FINDING', 88), ('FUTURE_WORK', 93), ('SUPERFICIAL_RELATIONSHIP', 126)]	7	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D')]
PMC5941617	5/2018	S648-PMC5941617	['Vitamin D status SHOULD BE monitored AT LEAST yearly in subjects that REQUIRE supplementation during the whole year BECAUSE AFFECTED from pathological conditions or receiving Drugs AFFECTING Vitamin D Metabolism (table\xa07).']	[('FUTURE_WORK', 17), ('IMPORTANT_CONSIDERATION', 17), ('PROBABLE_UNDERSTANDING', 37), ('IMPORTANT_CONSIDERATION', 70), ('PROBABLE_UNDERSTANDING', 116), ('SUPERFICIAL_RELATIONSHIP', 124), ('SUPERFICIAL_RELATIONSHIP', 181)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_23888', 'drug', 175, 'drugs'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0008152', 'metabolic process', 201, 'metabolism')]
PMC5941617	5/2018	S672-PMC5941617	['we SUGGEST the evaluation of Vitamin D status ONLY in patients affected by tuberculosis or hiv infection, AS they MAY BENEFIT from Vitamin D supplementation, in particular due to concomitant treatments that INFLUENCE Vitamin D Metabolism.']	[('FUTURE_WORK', 3), ('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 114), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 207)]	7	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0008152', 'metabolic process', 227, 'metabolism')]
PMC5956785	5/2018	S62-PMC5956785	['defining Vitamin D status\nvitamin D deficiency is DEFINED AS a Serum 25(Oh)D concentration less than 30\xa0nmol/l, a 25(Oh)D concentration between 30 and 50\xa0nmol/l IS CONSIDERED insufficient, greater than 50\xa0nmol/l IS CONSIDERED sufficient and a 25(Oh)D status greater than 125\xa0nmol/l IS CONSIDERED AT RISK of adverse EFFECTS [19].']	[('PROBABLE_UNDERSTANDING', 50), ('PROBABLE_UNDERSTANDING', 58), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 212), ('INCOMPLETE_EVIDENCE', 282), ('IMPORTANT_CONSIDERATION', 296), ('SUPERFICIAL_RELATIONSHIP', 315)]	7	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 34, 'D'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 114, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 120, 'D'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D')]
PMC6011374	6/2018	S80-PMC6011374	['caption (table-wrap): table 2\n\nadjusted relative risks (arr) of Pregnancy complications from any complication, Preeclampsia (pe), Gestational hypertension (gh), Gestational diabetes mellitus (gdm), spontaneous Preterm Birth (sptb) and small-for-Gestational age (sga) according to Vitamin D status categorised based on standardised quartiles and clinical definitions of Vitamin D statuspregnancy complicationsall womenany complicationpeghgdmsptbsga n (%) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci)standardised quartiles**\u2003low711 (25)328 (46)0.95 (0.85, 1.07)46 (6)1.02 (0.66, 1.57))57 (8)0.97 (0.67, 1.42)28 (4)0.79 (0.47, 1.30)36 (5)0.83 (0.54, 1.29)84 (12)1.02 (0.75, 1.39)\u2003low-moderate755 (27)318 (42)1.00 (0.90, 1.12)42 (6)1.07 (0.69, 1.64)65 (9)1.06 (0.74, 1.52)25 (3)0.67 (0.39, 1.16)33 (4)0.87 (0.56, 1.3572 (10)0.98 (0.73, 1.32)\u2003moderate-high702 (25)309 (44)1.0†37 (5)1.0†50 (7)1.0†28 (4)1.0†39 (6)1.0†81 (12)1.0†\u2003high630 (23)258 (41)0.93 (0.82, 1.06)†35 (6)1.24 (0.78, 1.96)40 (6)0.87 (0.58, 1.30)10 (2) 0.47(0.23, 0.96) 30 (5)0.77 (0.48, 1.25)60 (10)0.80 (0.57, 1.11)Vitamin d status\u2003<25 nmol/l99 (4)51 (52)1.10 (0.89, 1.36)8 (8)1.44 (0.68, 3.03))6 (6)0.70 (0.32, 1.52)5 (5)0.98 (0.38, 2.52)7 (7)1.44 (0.68, 3.04)13 (13)1.15 (0.66, 2.01)\u200325-50 nmol/l673 (24)301 (45)0.93 (0.83, 1.03)45 (7)1.18 (0.80, 1.75)59 (9)0.97 (0.71, 1.34)26 (4)0.89 (0.54, 1.47)29 (4)0.75 (0.48, 1.16)74 (11)0.93 (0.69, 1.24)\u2003>50-75 nmol/l928 (33)428 (46)1.0†48 (5)1.0†80 (9)1.0†35 (4)1.0†52 (6)1.0†107 (12)1.0†\u2003>75 nmol/l1098 (39)435 (40)0.95 (0.86, 1.04)60 (5)1.28 (0.87, 1.87)67 (6)0.82 (0.59, 1.12)†26 (2)0.78 (0.48, 1.28)51 (5)0.86 (0.59, 1.26)104 (9)0.86 (0.67, 1.12)\n*relative risks compared to all women were adjusted for age, maternal body mass index, ethnicity (non caucasian vs. caucasian), smoking status at 15\u2009±\u20091\xa0weeks’ Gestation (no vs. yes), Alcohol consumption at 15\u2009±\u20091\xa0weeks’ (no vs yes), recreational walking (1-3×/week and\u2009≥\u20094×/week vs. never) and recruitment site (auckland vs. adelaide)\n**Serum 25(Oh)D was standardised for month that Serum was sampled based as previously described [34]\n†reference category\n\nSerum 25(Oh)D, Pregnancy outcome and fetal sex\nas THERE IS EVIDENCE to SUGGEST that Vitamin D Metabolism within the Placenta MAY DIFFER with respect to fetal sex [35] THUS, we ASSESSED the EFFECT of “standardised” Vitamin D status on Pregnancy outcome stratified by fetal sex (table\xa03).']	[('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2251), ('INCOMPLETE_EVIDENCE', 2305), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2309), ('PROBABLE_UNDERSTANDING', 2347), ('QUESTION_ANSWERED_BY_THIS_WORK', 2356), ('SUPERFICIAL_RELATIONSHIP', 2369)]	7	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 111, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('GO_0007565', 'female pregnancy', 161, 'gestational'), ('GO_0007565', 'female pregnancy', 210, 'preterm birth'), ('GO_0007565', 'female pregnancy', 245, 'gestational'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 1141, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1882, 'gestation'), ('CHEBI_30879', 'alcohol', 1906, 'alcohol'), ('UBERON_0001977', 'blood serum', 2060, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 2066, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 2066, '25(OH)D'), ('UBERON_0001977', 'blood serum', 2106, 'serum'), ('UBERON_0001977', 'blood serum', 2180, 'Serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 2189, 'OH)D'), ('GO_0007565', 'female pregnancy', 2195, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 2264, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 2264, 'vitamin D metabolism'), ('UBERON_0001987', 'placenta', 2296, 'placenta'), ('CHEBI_27300', 'vitamin D', 2394, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2414, 'pregnancy')]
PMC6043562	7/2018	S161-PMC6043562	['Prenatal exposure INTERACTIONS MAY play an IMPORTANT ROLE, AS EVIDENCED by the POTENTIAL synergy between Vitamin E and Pm2.5.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 43), ('SUPERFICIAL_RELATIONSHIP', 53), ('PROBABLE_UNDERSTANDING', 59), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 79)]	7	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin E'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 119, 'PM2')]
PMC2290997	4/2008	S95-PMC2290997	['in addition, 25(Oh)D levels are inversely ASSOCIATED with the clinical status of ra patients, and greater intake of Vitamin D HAS BEEN LINKED with lower ra RISK, AS REPORTED in january 2004 in arthritis & rheumatism .']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 156), ('PROBABLE_UNDERSTANDING', 162), ('INCOMPLETE_EVIDENCE', 165)]	6	[('CHEBI_71657', 'versiconol acetate', 13, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC2290997	4/2008	S108-PMC2290997	['THESE days, MOST EXPERTS DEFINE Vitamin D deficiency AS a Serum 25(Oh)D level of less than 20 ng/ml.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 12), ('PROBABLE_UNDERSTANDING', 17), ('PROBABLE_UNDERSTANDING', 25), ('PROBABLE_UNDERSTANDING', 25), ('PROBABLE_UNDERSTANDING', 53)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0001977', 'blood serum', 58, 'serum'), ('CHEBI_71657', 'versiconol acetate', 64, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 64, '25 ... OH ... D')]
PMC2290997	4/2008	S115-PMC2290997	['so when you ESTIMATE the number of deaths LIKELY to be attributable to uv light or Vitamin D, it does is not APPEAR TO BE the BEST policy to ADVISE People to simply keep out of the sun just to prevent skin cancer.”\nto maximize protection against cancer, grant RECOMMENDS raising 25(Oh)D levels to between 40 and 60 ng/ml.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 42), ('ANOMALY_CURIOUS_FINDING', 109), ('IMPORTANT_CONSIDERATION', 126), ('FUTURE_WORK', 141), ('FUTURE_WORK', 260)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 148, 'people'), ('CHEBI_71657', 'versiconol acetate', 279, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 279, '25(OH ... D')]
PMC2396486	6/2008	S102-PMC2396486	['Calbindin is strongly induced by Vitamin D[29], and THUS it is FEASIBLE that the reduction in this protein MAY BE a consequence of the Early Life reduction in Vitamin D. the POTENTIAL LINKS between Vitamin D and Neuronal calcium binding proteins HAS BEEN NOTED in a recent review article[30]\ntwo members of the dynamin family (Dynamin 1 and Dynamin 1-Like proteins) were also significantly down-regulated.']	[('PROBABLE_UNDERSTANDING', 52), ('PROBABLE_UNDERSTANDING', 63), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 184), ('ANOMALY_CURIOUS_FINDING', 246)]	6	[('PR_000004967', 'calbindin', 0, 'Calbindin'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001847', 'lobule of pinna', 135, 'early life'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('CL_0000540', 'neuron', 212, 'neuronal'), ('PR_000006501', 'dickkopf-related protein 3', 327, 'dynamin 1'), ('PR_000006609', 'DNA (cytosine-5)-methyltransferase 3-like', 341, 'dynamin 1-like')]
PMC2582131	11/2008	S125-PMC2582131	['intervention studies[14],[40]–[44]assessing the EFFECT of Vitamin D and Calcium supplements on Glucose Metabolism among non-Pregnant Individuals have yielded MIXED results, which is AT LEAST PARTLY DUE TO VARIATIONS in the dose of supplementation and the duration of follow up.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('PROBABLE_UNDERSTANDING', 182), ('INCOMPLETE_EVIDENCE', 191), ('PROBLEM_COMPLICATION', 198), ('DIFFICULT_TASK', 205)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 72, 'calcium'), ('CHEBI_17234', 'glucose', 95, 'glucose'), ('GO_0006006', 'glucose metabolic process', 95, 'glucose metabolism'), ('GO_0007565', 'female pregnancy', 124, 'pregnant'), ('NCBITaxon_1', 'root', 133, 'individuals')]
PMC2779500	11/2009	S46-PMC2779500	['[31] maintain that Prenatal supplementation of Vitamins B, C, and e SHOULD BE continued DUE TO their MANY REPORTED positive EFFECTS on maternal and fetal health.']	[('FUTURE_WORK', 68), ('PROBABLE_UNDERSTANDING', 88), ('PROBLEM_COMPLICATION', 88), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('GO_0007565', 'female pregnancy', 19, 'prenatal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamins B'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 47, 'vitamins B'), ('CHEBI_18245', 'carboxylato group', 59, 'C'), ('PR_000004900', 'complement C3', 59, 'C')]
PMC2798111	12/2010	S99-PMC2798111	['THUS, OUR FINDINGS in THIS STUDY and our earlier studies [4,32] SUPPORT the RECENT aap RECOMMENDATION of starting Vitamin D supplementation in all breastfed infants within the first few days after Delivery [26].']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 76), ('FUTURE_WORK', 87)]	6	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007567', 'parturition', 197, 'delivery')]
PMC2889879	5/2010	S125-PMC2889879	['HOWEVER, NONE of these covariates change the ESTIMATES substantially, and was THEREFORE not included in the final multivariate MODEL\ncsum of Eicosapentaenoic Acid (Epa), Docosahexaenoic Acid (Dha) and Docosapentaenoic Acid\ndadjusted for age, total energy intake and dietary intake of Vitamin B12, Alcohol and dietary intake of fat other than Eicosapentaenoic Acid, Docosahexaenoic Acid and Docosapentaenoic Acid\nesum of Arachidonic And Linoleic Acids\nfadjusted for age, total energy intake and dietary intake of Vitamin B12, Alcohol and dietary intake of other than Omega-6 Fatty Acids\ngsum of Eicosapentaenoic Acid (Epa), Docosahexaenoic Acid (Dha), Docosapentaenoic Acid and Α-Linolenic Acid\nhadjusted for age, total energy intake and dietary Intake of Vitamin B12, Alcohol and dietary intake of other than Omega-3 Fatty Acids\nthe intake of Vitamin D was significantly ASSOCIATED with a decreased relative risk of both the middle and high levels of psychotic-like symptoms (table4).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 78), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 871)]	6	[('CHEBI_36003', 'decenoic acid', 141, 'eicosapentaenoic acid'), ('CHEBI_34733', 'EPN', 164, 'EPA'), ('CHEBI_36003', 'decenoic acid', 170, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 192, 'DHA'), ('CHEBI_61205', 'docosatetraenoic acid', 201, 'docosapentaenoic acid'), ('CHEBI_33279', 'vitamin D5', 284, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 284, 'vitamin B12'), ('CHEBI_30879', 'alcohol', 297, 'alcohol'), ('CHEBI_36003', 'decenoic acid', 342, 'eicosapentaenoic acid'), ('CHEBI_36003', 'decenoic acid', 365, 'docosahexaenoic acid'), ('CHEBI_61205', 'docosatetraenoic acid', 390, 'docosapentaenoic acid'), ('CHEBI_36431', 'angelic acid', 420, 'arachidonic and'), ('CHEBI_25048', 'linolenic acid', 436, 'linoleic acids'), ('CHEBI_33279', 'vitamin D5', 512, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 512, 'vitamin B12'), ('CHEBI_30879', 'alcohol', 525, 'alcohol'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 566, 'omega-6 fatty acids'), ('CHEBI_36003', 'decenoic acid', 594, 'eicosapentaenoic acid'), ('CHEBI_34733', 'EPN', 617, 'EPA'), ('CHEBI_36003', 'decenoic acid', 623, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 645, 'DHA'), ('CHEBI_61205', 'docosatetraenoic acid', 651, 'docosapentaenoic acid'), ('CHEBI_86354', '2-hydroxyacrylic acid', 677, 'α-linolenic acid'), ('GO_0007631', 'feeding behavior', 745, 'intake'), ('CHEBI_33279', 'vitamin D5', 755, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 755, 'vitamin B12'), ('CHEBI_30879', 'alcohol', 768, 'alcohol'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 809, 'omega-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 843, 'vitamin D')]
PMC2913107	8/2010	S10-PMC2913107	['FOR THIS REASON, in 2007, the canadian paediatric society CAUTIONED Pregnant women they MAY REQUIRE NOT 400 iu/day BUT 2000 iu/day, or more, to PREVENT Gestational Vitamin D deficiency (9).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 58), ('INCOMPLETE_EVIDENCE', 88), ('IMPORTANT_CONSIDERATION', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('SUPERFICIAL_RELATIONSHIP', 144)]	6	[('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('GO_0007565', 'female pregnancy', 152, 'gestational'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC2913107	8/2010	S37-PMC2913107	['WHILE the Omega-3 and mercury content of fish is WELL KNOWN, LESS WELL KNOWN is THE FACT THAT fish is one of the few Foods with SIGNIFICANT amounts of Vitamin D, which, as referenced earlier, PROTECTS the Genome from damage by Toxins.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 49), ('INCOMPLETE_EVIDENCE', 61), ('ANOMALY_CURIOUS_FINDING', 80), ('IMPORTANT_CONSIDERATION', 128), ('SUPERFICIAL_RELATIONSHIP', 192)]	6	[('CHEBI_79370', 'ibho#10', 10, 'omega-3'), ('CHEBI_33290', 'food', 117, 'foods'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('SO_0001026', 'genome', 205, 'genome'), ('CHEBI_27026', 'toxin', 227, 'toxins')]
PMC2963768	10/2010	S109-PMC2963768	['THEREFORE, the MAJOR REASON that bangladeshi infants start Life with POOR Vitamin D stores is low maternal Antenatal 25(Oh)D, which HAS BEEN DOCUMENTED in urban and rural bangladeshi women of Reproductive age (27).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 15), ('PROBABLE_UNDERSTANDING', 21), ('IMPORTANT_CONSIDERATION', 69), ('INCOMPLETE_EVIDENCE', 132), ('INCOMPLETE_EVIDENCE', 141)]	6	[('UBERON_0000104', 'life cycle', 59, 'life'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007567', 'parturition', 107, 'antenatal'), ('CHEBI_71657', 'versiconol acetate', 117, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 123, 'D'), ('GO_0000003', 'reproduction', 192, 'reproductive')]
PMC2963768	10/2010	S118-PMC2963768	['THEREFORE, much remains to be learnt about the DETERMINANTS of Vitamin D status throughout infancy and childhood, PARTICULARLY where 25(Oh)D APPEARS DISCREPANT from that which would be expected BASED ON latitude.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 114), ('ANOMALY_CURIOUS_FINDING', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149), ('SUPERFICIAL_RELATIONSHIP', 194)]	6	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D')]
PMC2996405	11/2010	S11-PMC2996405	['in addition we CONFIRM, at a molecular level, the LINK between schizophrenia and Vitamin D. finally, we discuss a MODEL in which schizophrenia is, at LEAST PARTLY, a maladaptive by-product of latitude DEPENDENT adaptive changes in Vitamin D Metabolism.']	[('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 114), ('PROBABLE_UNDERSTANDING', 150), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 201)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 231, 'vitamin D metabolism')]
PMC2996405	11/2010	S250-PMC2996405	['we also FOUND a molecular RELATIONSHIP of schizophrenia with both latitude and Vitamin D. AT LEAST in one case, our results SUGGEST that schizophrenia COULD BE a maladaptive by-product of latitude DEPENDENT adaptive changes in Vitamin D Metabolism.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 26), ('PROBABLE_UNDERSTANDING', 90), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 151), ('SUPERFICIAL_RELATIONSHIP', 197)]	6	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 227, 'vitamin D metabolism')]
PMC3034879	12/2010	S201-PMC3034879	['it SEEMS UNLIKELY, THEREFORE, that IMPROVING Vitamin D intake merely in infancy would revert the CONSEQUENCES of POOR Vitamin D status during the Fetal Period.']	[('ANOMALY_CURIOUS_FINDING', 3), ('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 19), ('FUTURE_WORK', 35), ('PROBLEM_COMPLICATION', 97), ('IMPORTANT_CONSIDERATION', 113)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0002375', 'cricoid cartilage', 146, 'fetal period')]
PMC3075531	7/2010	S46-PMC3075531	['the REASONS WHY Vitamin D deficiency is THOUGHT TO be a RISK FACTOR for ms are as follows: first, ms frequency increases with increasing latitude, which is strongly inversely CORRELATED with duration and intensity of uvb from sunlight and Vitamin D concentrations.2830–35second, prevalence of ms is lower than EXPECTED at high latitudes in populations with high Consumption of Vitamin-D-rich Fatty fish43536.']	[('PROBABLE_UNDERSTANDING', 4), ('EXPLICIT_QUESTION', 12), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 175), ('ANOMALY_CURIOUS_FINDING', 310)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D'), ('GO_0007631', 'feeding behavior', 362, 'consumption'), ('CHEBI_83326', 'tedizolid phosphate', 377, 'vitamin-D'), ('CHEBI_33250', 'atom', 392, 'fatty')]
PMC3257641	3/2010	S56-PMC3257641	['a RECENT meta-analysis of Vitamin D supplementation in RELATION to bone health in Adults, SHOWED that for every 1 iu increase in oral Vitamin D3, the 25(Oh)D level COULD BE expected to increase by 0.016 nmol/l, with a relatively linear RELATIONSHIP AT LEAST up to 2000 iu/day [45].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 236), ('PROBABLE_UNDERSTANDING', 249)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0007023', 'adult organism', 82, 'adults'), ('CHEBI_33279', 'vitamin D5', 134, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 134, 'vitamin D3'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D')]
PMC3257641	3/2010	S63-PMC3257641	['HOWEVER, the ASSOCIATION between Vitamin D deficiency and defective Reproduction MAY BE the result of hypocalcaemia RATHER than a Vitamin D EFFECT per se , AS the infertile female Vdr null Mice developed normal fertility when Fed a Calcium rich diet [48].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('SUPERFICIAL_RELATIONSHIP', 140), ('PROBABLE_UNDERSTANDING', 156)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0000003', 'reproduction', 68, 'reproduction'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 180, 'VDR'), ('NCBITaxon_10088', 'Mus <genus>', 189, 'mice'), ('GO_0007631', 'feeding behavior', 226, 'fed'), ('CHEBI_22313', 'alkaline earth metal atom', 232, 'calcium')]
PMC3257641	3/2010	S161-PMC3257641	['for these studies, observational studies will NEED to include seasonal variation in Vitamin D status, POTENTIALLY CONFOUNDING by other seasonal factors such as infection, and also deseasonalized interpersonal variation in Ingested Vitamin D or uvr-derived Vitamin D. with regard to these deaseasonalized MARKERS of Vitamin D status, it is highly LIKELY that Vitamin d status in Pregnancy will be CORRELATED with Ingested or uvr-derived Vitamin D exposure for mothers preceding Pregnancy and offspring after Pregnancy.']	[('FUTURE_WORK', 46), ('INCOMPLETE_EVIDENCE', 102), ('PROBLEM_COMPLICATION', 114), ('SUPERFICIAL_RELATIONSHIP', 304), ('PROBABLE_UNDERSTANDING', 346), ('SUPERFICIAL_RELATIONSHIP', 396)]	6	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007631', 'feeding behavior', 222, 'ingested'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 315, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 358, 'vitamin'), ('GO_0007565', 'female pregnancy', 378, 'pregnancy'), ('GO_0007631', 'feeding behavior', 412, 'ingested'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('GO_0007565', 'female pregnancy', 477, 'pregnancy'), ('GO_0007565', 'female pregnancy', 507, 'pregnancy')]
PMC3272870	12/2011	S45-PMC3272870	['moreover, the usual RECOMMENDATIONS to avoid sun exposure reduces dermal Synthesis Of Vitamin D3Although Vitamin D is UNDOUBTEDLY IMPORTANT for foetal Bone Development, we KNOW that it plays a much wider ROLE in health and disease prevention.']	[('FUTURE_WORK', 20), ('ANOMALY_CURIOUS_FINDING', 96), ('PROBABLE_UNDERSTANDING', 118), ('IMPORTANT_CONSIDERATION', 130), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 204)]	6	[('GO_0030474', 'spindle pole body duplication', 73, 'synthesis of ... D3Although'), ('CHEBI_83701', '8-PAHSA(1-)', 86, 'vitamin D3Although'), ('PR_000027594', 'histone H3', 86, 'vitamin D3Although'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0048539', 'bone marrow development', 151, 'bone development')]
PMC3296991	2/2012	S100-PMC3296991	['conclusion\nTHIS STUDY PROVIDES EVIDENCE of ASSOCIATIONS between feto-maternal Vitamin D status, cord pth and balp, and neonatal wbbmc, THOUGH neither Cord nor maternal 25(Oh)D were directly CORRELATED with wbbmc.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 22), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 135), ('SUPERFICIAL_RELATIONSHIP', 190)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 150, 'cord'), ('CHEBI_33010', 'chromide(1-)', 170, '(OH)D')]
PMC3347028	3/2012	S158-PMC3347028	['reports of neonatal seizures due to SEVERE hypocalcemia or rickets in utero that is manifested at Birth from SEVERE maternal and THUS fetal Vitamin D deficiency are RARE and do not further our understanding of POTENTIAL epigenetic EFFECTS of Vitamin D [122,123].']	[('IMPORTANT_CONSIDERATION', 36), ('IMPORTANT_CONSIDERATION', 109), ('PROBABLE_UNDERSTANDING', 129), ('INCOMPLETE_EVIDENCE', 165), ('INCOMPLETE_EVIDENCE', 210), ('SUPERFICIAL_RELATIONSHIP', 231)]	6	[('GO_0007567', 'parturition', 98, 'birth'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D')]
PMC3347028	3/2012	S242-PMC3347028	['a RECENT randomized controlled TRIAL with 350 women of diverse racial and ethnic backgrounds SHOWED that 4000 iu Vitamin D/day is MOST EFFECTIVE in improving the Vitamin D status of Pregnant women, attaining circulating levels of at least 40 ng/ml (100 nmol/l) for 25(Oh)D, and was NECESSARY to achieve OPTIMAL 1,25(Oh)2D production.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 130), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 282), ('IMPORTANT_CONSIDERATION', 303)]	6	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 265, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 267, '(OH ... D'), ('CHEBI_37983', 'sulfur-35 atom', 311, '1'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 313, '25(OH)2D')]
PMC3356951	4/2012	S14-PMC3356951	['[1–3] this PANDEMIC of hypovitaminosis d CAN MAINLY be ATTRIBUTED to lifestyle and environmental FACTORS that reduce exposure to sunlight, which is REQUIRED for ultraviolet-b (uvb)-induced Vitamin D Production in the skin.']	[('IMPORTANT_CONSIDERATION', 11), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 45), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 97), ('IMPORTANT_CONSIDERATION', 148)]	6	[('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0006272', 'leading strand elongation', 197, 'D production')]
PMC3356951	4/2012	S104-PMC3356951	['Heart disease\nSEVERAL STUDIES are PROVIDING EVIDENCE that the PROTECTIVE EFFECT of Vitamin D on the Heart COULD BE via the Renin–angiotensin hormone system, through the suppression of inflammation, or directly on the cells of the Heart and Blood-Vessel Walls.']	[('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 34), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 62), ('SUPERFICIAL_RELATIONSHIP', 73), ('INCOMPLETE_EVIDENCE', 106)]	6	[('UBERON_0000948', 'heart', 0, 'Heart'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('UBERON_0000948', 'heart', 100, 'heart'), ('PR_000014368', 'RuvB-like 1', 123, 'renin'), ('UBERON_0000948', 'heart', 230, 'heart'), ('UBERON_0003512', 'lung blood vessel', 240, 'blood-vessel walls')]
PMC3407995	7/2012	S11-PMC3407995	['RECENT RESEARCH HAS SHOWN that maternal dietary deficiencies of Docosahexaenoic Acid (Dha), Vitamin D, Folic Acid and Iodine are ASSOCIATED with a variety of poor foetal and/or infant health outcomes MOSTLY IMPACTING Brain Development and/or function in infancy and OFTEN throughout Life.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 129), ('PROBABLE_UNDERSTANDING', 200), ('SUPERFICIAL_RELATIONSHIP', 207), ('PROBABLE_UNDERSTANDING', 266)]	6	[('CHEBI_36003', 'decenoic acid', 64, 'docosahexaenoic acid'), ('CHEBI_17874', 'dihydrozeatin', 86, 'DHA'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_30751', 'formic acid', 103, 'folic acid'), ('CHEBI_24859', 'iodine atom', 118, 'iodine'), ('GO_0007420', 'brain development', 217, 'brain development'), ('UBERON_0000955', 'brain', 217, 'brain'), ('UBERON_0000104', 'life cycle', 283, 'life')]
PMC3407995	7/2012	S100-PMC3407995	['THEREFORE at its worst, Vitamin D deficiency CAN be Life threatening to the newborn, WHILE lesser deficiency CAN weaken Skull Bones risking Brain injury during Birth and can CONTRIBUTE to a multitude of future health PROBLEMS.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 174), ('IMPORTANT_CONSIDERATION', 217)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0000104', 'life cycle', 52, 'life'), ('UBERON_0003215', 'alveolus', 120, 'skull bones'), ('UBERON_0000955', 'brain', 140, 'brain'), ('GO_0007567', 'parturition', 160, 'birth')]
PMC3427250	8/2012	S117-PMC3427250	['SOME studies SUGGEST that the dietary requirement during Pregnancy and Lactation MAY BE as high as 6000 iu/d[59]and recognize that AT LEAST 1500–2000 iu/d of Vitamin D MAY BE NEEDED in order to maintain a Blood level of 25(Oh)D above 30 ng/ml[24].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 81), ('PROBABLE_UNDERSTANDING', 131), ('INCOMPLETE_EVIDENCE', 168), ('FUTURE_WORK', 175)]	6	[('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('GO_0007595', 'lactation', 71, 'lactation'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0000178', 'blood', 205, 'blood'), ('CHEBI_71657', 'versiconol acetate', 220, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 220, '25(OH)D')]
PMC3427250	8/2012	S130-PMC3427250	['in addition the current Vitamin D content of multivitamins for Pregnancy, 400 iu, do not EVEN comply with the current belgian RECOMMENDATIONS of 800 iu per day, THEREFORE a PRUDENT step SHOULD AT LEAST be to increase the Vitamin D content in multivitamins for Pregnant women to 800 iu.']	[('ANOMALY_CURIOUS_FINDING', 89), ('FUTURE_WORK', 126), ('PROBABLE_UNDERSTANDING', 161), ('FUTURE_WORK', 173), ('FUTURE_WORK', 186), ('PROBABLE_UNDERSTANDING', 193)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('GO_0007565', 'female pregnancy', 260, 'pregnant')]
PMC3476426	8/2012	S96-PMC3476426	['THESE STUDIES COULD classify them as being ‘Vitamin D INADEQUATE’, which LENDS SUPPORT to the HYPOTHESIS that autism is a Vitamin D deficiency disorder [31,32].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('IMPORTANT_CONSIDERATION', 54), ('PROBABLE_UNDERSTANDING', 73), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 94)]	6	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC3515553	12/2012	S156-PMC3515553	['two studies conducted in india, that measured Vitamin B-12 concentration, REPORTED CONTRADICTORY results, POSSIBLY DUE TO DIFFERING levels of Vitamin B-12 deficiency between the populations[6],[8].']	[('INCOMPLETE_EVIDENCE', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('INCOMPLETE_EVIDENCE', 106), ('PROBABLE_UNDERSTANDING', 115), ('PROBLEM_COMPLICATION', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 46, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 142, 'vitamin B-12')]
PMC3616124	4/2013	S173-PMC3616124	['THEREFORE, we EXAMINED the POTENTIAL for hp phenotype to INFLUENCE the effectiveness of Vitamin C and E in preventing Preeclampsia and SERIOUS COMPLICATIONS of pah.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 135), ('IMPORTANT_CONSIDERATION', 143)]	6	[('CHEBI_27300', 'vitamin D', 88, 'vitamin C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 102, 'E'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia')]
PMC3641012	4/2013	S132-PMC3641012	['AS EVIDENCE that this plateau was not an artifact of diminishing supplement adherence over time, a sensitivity analysis in which 25(Oh)D was MODELED as a function of cumulative Vitamin D dose REVEALED the same PATTERN (figure\xa03), and fit the data well (table\xa05).']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 141), ('INCOMPLETE_EVIDENCE', 192), ('SUPERFICIAL_RELATIONSHIP', 210)]	6	[('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC3659910	1/2013	S79-PMC3659910	['[18] this RECOMMENDATION MAY BE CONTROVERSIAL BECAUSE very high doses of Vitamin D HAVE long BEEN BELIEVED to cause Birth defects.']	[('FUTURE_WORK', 10), ('INCOMPLETE_EVIDENCE', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('PROBABLE_UNDERSTANDING', 46), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 98)]	6	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007567', 'parturition', 116, 'birth')]
PMC3659910	1/2013	S133-PMC3659910	['BECAUSE the POOR Vitamin D stores of the mother MAY impair Vitamin D state in the infant, it is IMPORTANT to know WHETHER rickets can be PREVENTED in breast Fed infants by supplementation of the mother.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 96), ('EXPLICIT_QUESTION', 114), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007631', 'feeding behavior', 157, 'fed')]
PMC3659910	1/2013	S155-PMC3659910	['testing and treatment for Vitamin D deficiency\nwomen of Reproductive age are ASSUMED TO BE able to obtain the RECOMMENDED intake for ALMOST ALL Vitamins without the use of supplements, and no national organization RECOMMENDS routine Vitamin D supplementation during Pregnancy unless a woman is at nutritional RISK.']	[('PROBABLE_UNDERSTANDING', 77), ('FUTURE_PREDICTION', 85), ('FUTURE_WORK', 110), ('PROBABLE_UNDERSTANDING', 133), ('FUTURE_WORK', 214), ('IMPORTANT_CONSIDERATION', 309)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0000003', 'reproduction', 56, 'reproductive'), ('CHEBI_33277', 'gamma-tocotrienol', 144, 'vitamins'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('GO_0007565', 'female pregnancy', 266, 'pregnancy')]
PMC3659910	1/2013	S175-PMC3659910	['a RECENT systematic review CONCLUDED that Antenatal Vitamin D supplementation is EFFECTIVE in improving the Vitamin D status of asian and white women, improves growth in the first year of Life in south asian babies and THEREFORE MAY CONTRIBUTE to reducing the incidence of rickets in this latter group, without evidence of harm.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 81), ('PROBABLE_UNDERSTANDING', 219), ('FUTURE_PREDICTION', 229), ('SUPERFICIAL_RELATIONSHIP', 233)]	6	[('GO_0007567', 'parturition', 42, 'antenatal'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('UBERON_0000104', 'life cycle', 188, 'life')]
PMC3668200	5/2013	S41-PMC3668200	['THEREFORE, daily supplementation with 400 iu of Vitamin D during the last Trimester of Pregnancy HAS BEEN practiced, ALBEIT with MINIMAL EFFECT on circulating 25(Oh)D concentrations in the mother and infant at term.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('ANOMALY_CURIOUS_FINDING', 117), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 74, 'trimester'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_30778', 'gallic acid', 159, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 165, 'D')]
PMC3672018	5/2013	S167-PMC3672018	['THUS, AS IT IS CLEAR that Vitamin D status of danes NEEDS to be improved, the danish health authorities currently DEBATE, WHETHER to resume Vitamin D fortification of Food [35].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 6), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('EXPLICIT_QUESTION', 122)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_33290', 'food', 167, 'food')]
PMC3685533	6/2013	S124-PMC3685533	['after Birth ONLY fs newborns unsupplemented SHOWED Vitamin D levels higher than lob and mbb; no differences were found in case of maternal supplementation in Pregnancy, MOST LIKELY DUE TO a specific ROLE of supplementation in neonates.']	[('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 169), ('PROBABLE_UNDERSTANDING', 181), ('PROBLEM_COMPLICATION', 181), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('GO_0007567', 'parturition', 6, 'birth'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy')]
PMC3695234	7/2013	S21-PMC3695234	['THUS, the available data highlights the NEED FOR FURTHER ANALYSIS of the ASSOCIATIONS between Vitamin D and atopic diseases in DIFFERENT populations.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 40), ('INCOMPLETE_EVIDENCE', 40), ('FUTURE_WORK', 49), ('SUPERFICIAL_RELATIONSHIP', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC3695234	7/2013	S54-PMC3695234	['THEREFORE, the RELATIONSHIP between Vitamin D and ad HAS been INVESTIGATED both HERE and in PREVIOUS STUDIES.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('IMPORTANT_CONSIDERATION', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('QUESTION_ANSWERED_BY_THIS_WORK', 80), ('INCOMPLETE_EVIDENCE', 92)]	6	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3695234	7/2013	S74-PMC3695234	['AS OUR STUDY is LIMITED by its retrospective cross-sectional design, we COULD NOT analyze the RELATIONSHIP between sun exposure and Vitamin D concentration.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 16), ('DIFFICULT_TASK', 72), ('ANOMALY_CURIOUS_FINDING', 78), ('SUPERFICIAL_RELATIONSHIP', 94)]	6	[('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC3702245	6/2013	S38-PMC3702245	['the RELATIONSHIP between maternal Vitamin D status and small-for-Gestational age infants was found to be u-shaped in a study from pittsburgh in the us,81BUT this WAS NOT CONFIRMED in the above studies.68,80the REASONS for this DIFFERENCE are UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 162), ('PROBABLE_UNDERSTANDING', 210), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('FULL_UNKNOWN', 242)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational')]
PMC3702245	6/2013	S74-PMC3702245	['in studies of Adults and nonpregnant women, a Vitamin D intake of up to 10,000 iu/day is ASSOCIATED with achievement of a Serum 25(Oh)D concentration ≥80 nmol/l without Vitamin D toxicity.103,104from a review of PREVIOUS STUDIES, an additional daily intake of 100 iu of Vitamin D increases the Serum 25(Oh)D concentration by 1–2 nmol/l.7,105THEREFORE, knowing the population baseline Serum 25(Oh)D concentration, IT IS POSSIBLE to ESTIMATE the Vitamin D intake REQUIRED to replete body stores and achieve an expected target Serum 25(Oh)d concentration.']	[('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 212), ('PROBABLE_UNDERSTANDING', 338), ('INCOMPLETE_EVIDENCE', 413), ('INCOMPLETE_EVIDENCE', 431), ('IMPORTANT_CONSIDERATION', 461)]	6	[('UBERON_0007023', 'adult organism', 14, 'adults'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0001977', 'blood serum', 122, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 131, 'OH)D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('UBERON_0001977', 'blood serum', 294, 'serum'), ('CHEBI_71657', 'versiconol acetate', 300, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 300, '25(OH)D'), ('UBERON_0001977', 'blood serum', 384, 'serum'), ('CHEBI_33010', 'chromide(1-)', 392, '(OH)D'), ('CHEBI_27300', 'vitamin D', 444, 'vitamin D'), ('UBERON_0001977', 'blood serum', 524, 'serum'), ('CHEBI_30778', 'gallic acid', 530, '25(OH)')]
PMC3705146	5/2013	S223-PMC3705146	['ALTHOUGH no Genetic associations between Vitamin-D receptors or enzymes INVOLVED in its formation or degradation HAVE yet BEEN IDENTIFIED for schizophrenia, that outcome does not NECESSARILY mean that Vitamin D is without effect in modifying the phenotypic plasticity that is obviously present in the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 127), ('PROBABLE_UNDERSTANDING', 179)]	6	[('SO_0000704', 'gene', 12, 'genetic'), ('CHEBI_83326', 'tedizolid phosphate', 41, 'vitamin-D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'vitamin-D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC3717170	5/2013	S47-PMC3717170	['moreover, IT IS POSSIBLE that SOME diseases, such as leprosy and hiv infection, MAY BE ASSOCIATED with dysregulation of the core Vitamin D intracrine Immune mechanism, and MAY THEREFORE require higher circulating levels of 25(Oh)D3To reestablish normal Immune Responses.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 172), ('PROBABLE_UNDERSTANDING', 176)]	6	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_0002405', 'immune system', 150, 'immune'), ('CHEBI_63755', 'o-nitrophenyl group', 223, '25(OH)D3to'), ('GO_0006955', 'immune response', 253, 'immune responses'), ('UBERON_0002405', 'immune system', 253, 'immune')]
PMC3717170	5/2013	S134-PMC3717170	['from a biological perspective, the HYPOTHESIS that Vitamin D MAY BE a DETERMINANT of diabetes risk is PLAUSIBLE, AS both impaired Insulin secretion and action HAVE BEEN reported with Vitamin D insufficiency.']	[('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 113), ('INCOMPLETE_EVIDENCE', 159)]	6	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('PR_000045358', 'insulin family protein', 130, 'insulin'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
PMC3773018	4/2013	S105-PMC3773018	['overall, THIS STUDY UNDERSCORES THE NEED to simultaneously CONSIDER both Cord Blood and Postnatal Vitamin D levels, along with Genetic susceptibility, in the development of fs and Food allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 32), ('FUTURE_WORK', 36), ('FUTURE_WORK', 59), ('IMPORTANT_CONSIDERATION', 59)]	6	[('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('GO_0007567', 'parturition', 88, 'postnatal'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('SO_0000704', 'gene', 127, 'genetic'), ('CHEBI_33290', 'food', 180, 'food')]
PMC3798907	8/2013	S65-PMC3798907	['significant p values for differences in responses between paired samples in cultures with or without Vitamin E supplementation are shown on the RELEVANT panels.nutrients-05-03337-t001_table 1\n\ncaption (table-wrap): table 1\n\nsummary table representing the mean responses of cbmc and Peripheral Blood Mononuclear Cell (Pbmc) samples to control stimuli and Allergens, after supplementation with Vitamin E or Vitamin C. the mean change in response is shown for 70 cbmc samples and 18 pbmc samples, after supplementation with Vitamin E, and for 51 cbmc and 18 pbmc samples, after supplementation with Vitamin C. significant p values for differences in responses between paired samples in cultures with or without Vitamin E/Vitamin C supplementation are shown on the RELEVANT panels.Vitamin eprolififn-γil-4il-10Tgf-βvitamin cprolififn-γil-4il-10tgf-β cordcord tg↑ p< 0.05↓ p< 0.05↓↓↑tg↑↑↑ p< 0.05↓↓hdm↓↓↓↓↑hdm↓↑↑↓ p< 0.05↓con a↓↑↓↓↑con a↓ p< 0.05↑↑↓↓ppd↓ p< 0.001↓↑↓↑ppd↓↑ p< 0.05↑ p< 0.05↓ p< 0.05↓klh↓ p< 0.001↓↓↓↑klh↓↑↑ p< 0.05↓↓ adultadult tg↓↑↑↑↑tg↑ p< 0.05↑↑↓↑hdm↓↑↑↑↑ p< 0.05hdm↓↑↑↓↑con a↓↓↑↓↑ p< 0.05con a↑↓ p< 0.05↑↓ p< 0.05↑ppd↑↓↑↓↑ppd↓↑↑↓↑klh↓↓↑↑↑klh↓↑↑ p< 0.05↓↑\noverall, there was a TREND for Antigen or allergen cbmc cultures supplemented with Vitamin E to exhibit decreased secretion of the cytokines Ifn-Γ, il-10 and Il-4 (figure 1andtable 1), ALTHOUGH Production Of Tgf-Β did NOT fit this pattern and was GENERALLY increased.']	[('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 1191), ('ANOMALY_CURIOUS_FINDING', 1355), ('ANOMALY_CURIOUS_FINDING', 1388), ('PROBABLE_UNDERSTANDING', 1417)]	6	[('CHEBI_27300', 'vitamin D', 101, 'vitamin E'), ('CL_0000111', 'peripheral neuron', 282, 'peripheral blood mononuclear cell'), ('UBERON_0012101', 'perinatal stage', 282, 'peripheral blood'), ('GO_0031097', 'medial cortex', 299, 'mononuclear'), ('CL_0002246', 'peripheral blood stem cell', 317, 'PBMC'), ('CHEBI_33663', 'cyclic hydrocarbon', 354, 'allergens'), ('CHEBI_27300', 'vitamin D', 392, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 405, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 521, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 596, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 708, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 718, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 777, 'Vitamin'), ('PR_000000037', 'BMP receptor type-2', 803, '-10TGF'), ('CHEBI_59132', 'antigen', 1201, 'antigen'), ('CHEBI_27300', 'vitamin D', 1253, 'vitamin E'), ('PR_000008920', 'interferon alpha-7', 1311, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 1328, 'IL-4'), ('GO_0036309', 'protein localization to M-band', 1364, 'production of TGF-β'), ('PR_000000046', 'TGF-beta', 1378, 'TGF-β')]
PMC3798907	8/2013	S100-PMC3798907	['discussion\nTHIS STUDY was BASED ON our novel OBSERVATION in a general population study, that low maternal Vitamin E intake during Pregnancy is INDEPENDENTLY ASSOCIATED with increased in vitro Proliferative Responses by cbmc and an increased LIKELIHOOD of asthma in children aged 5 years.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 26), ('ANOMALY_CURIOUS_FINDING', 45), ('SUPERFICIAL_RELATIONSHIP', 143), ('SUPERFICIAL_RELATIONSHIP', 157), ('PROBABLE_UNDERSTANDING', 241)]	6	[('CHEBI_27300', 'vitamin D', 106, 'vitamin E'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('GO_0001780', 'neutrophil homeostasis', 192, 'proliferative responses')]
PMC3798907	8/2013	S108-PMC3798907	['it is LIKELY that the OBSERVED in vivo epidemiological ASSOCIATIONS with Vitamin E intake REFLECT the EFFECTS of overall Nutrient/dietary patterns ASSOCIATED with higher Vitamin E intake.']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 90), ('SUPERFICIAL_RELATIONSHIP', 102), ('SUPERFICIAL_RELATIONSHIP', 147)]	6	[('CHEBI_27300', 'vitamin D', 73, 'vitamin E'), ('CHEBI_33284', 'nutrient', 121, 'nutrient'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin E')]
PMC3798907	8/2013	S114-PMC3798907	['this SEEMS an UNLIKELY EXPLANATION for the DIFFERENTIAL EFFECTS of Vitamin E supplementation on tg and hdm responses SEEN in the current work because, as in our original observational study, cbmc samples were collected throughout the year [12].']	[('ANOMALY_CURIOUS_FINDING', 5), ('PROBABLE_UNDERSTANDING', 14), ('PROBABLE_UNDERSTANDING', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 117)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin E')]
PMC3814422	10/2013	S12-PMC3814422	['HOWEVER, an OPPOSING argument holds that the increasing PREVALENCE of asthma and atopy MAY BE PARTLY a consequence of the fortification of childhood Foods with Vitamin D and HENCE high Vitamin D status in early childhood3–7.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('IMPORTANT_CONSIDERATION', 56), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 94), ('PROBABLE_UNDERSTANDING', 174)]	6	[('CHEBI_33290', 'food', 149, 'foods'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
PMC3820434	12/2012	S379-PMC3820434	['THEREFORE, it was HYPOTHESIZED that a Mixture of dietary products (Resveratrol, green tea extract, Α -Tocopherol, Vitamin C, N-3 ( ω -3) polyunsaturated Fatty Acids, and tomato extract) selected for their EVIDENCE-BASED antioxidant and anti-inflammatory EFFECTS MAY yield more healthy EFFECTS than any single Molecule.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 254), ('INCOMPLETE_EVIDENCE', 262), ('SUPERFICIAL_RELATIONSHIP', 285)]	6	[('CHEBI_60004', 'mixture', 38, 'mixture'), ('CHEBI_27881', 'resveratrol', 67, 'resveratrol'), ('CHEBI_27725', 'butin', 99, 'α -tocopherol'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin C'), ('CHEBI_30256', 'thiocarbonyl group', 125, 'n-3'), ('CHEBI_35366', 'fatty acid', 153, 'fatty acids'), ('CHEBI_36357', 'polyatomic entity', 309, 'molecule')]
PMC3827489	10/2013	S25-PMC3827489	['THUS, given the IMPORTANT ROLE of Vitamin D in childhood health, THIS REVIEW will FOCUS on the IMPACT of Vitamin D on health and disease in childhood and Adolescence.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('SUPERFICIAL_RELATIONSHIP', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('SUPERFICIAL_RELATIONSHIP', 95)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 154, 'adolescence')]
PMC3873449	12/2013	S197-PMC3873449	['this SUGGESTS that education levels are MOST LIKELY to INFLUENCE women’s health awareness RATHER than directly AFFECT Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 40), ('PROBABLE_UNDERSTANDING', 45), ('SUPERFICIAL_RELATIONSHIP', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('SUPERFICIAL_RELATIONSHIP', 111)]	6	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC4034700	5/2014	S6-PMC4034700	['ALTHOUGH clinical trials on the use of antioxidant Vitamins in Pregnancy proved largely UNSUCCESSFUL, the scope for their use STILL exists GIVEN the beneficial cardioprotective EFFECTS of antioxidant-rich mediterranean diet, periconceptual Vitamin use and the synergistic EFFECT of Vitamin C andl-Arginine.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 88), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 177), ('SUPERFICIAL_RELATIONSHIP', 272)]	6	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 240, 'vitamin'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin C'), ('CHEBI_15511', 'trans-feruloyl-CoA', 296, '-arginine')]
PMC4034700	5/2014	S258-PMC4034700	['ALTHOUGH clinical trials on the use of antioxidant Vitamins in Pregnancy proved largely UNSUCCESSFUL, the scope for their use STILL exists GIVEN the beneficial cardioprotective EFFECTS of antioxidant-rich mediterranean diet, periconceptual Vitamin use and the synergistic EFFECT of Vitamin C andl-Arginine.']	[('ANOMALY_CURIOUS_FINDING', 0), ('DIFFICULT_TASK', 88), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 177), ('SUPERFICIAL_RELATIONSHIP', 272)]	6	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('CHEBI_33229', 'vitamin (role)', 240, 'vitamin'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin C'), ('CHEBI_15511', 'trans-feruloyl-CoA', 296, '-arginine')]
PMC4072587	6/2014	S1-PMC4072587	['it has an IMPORTANT ROLE in Bone Homeostasis, Brain Development and Modulation Of the Immune System and YET the IMPACT of Antenatal Vitamin D deficiency on infant outcomes is POORLY UNDERSTOOD.']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 104), ('SUPERFICIAL_RELATIONSHIP', 112), ('FULL_UNKNOWN', 175), ('PROBABLE_UNDERSTANDING', 182)]	6	[('GO_0055064', 'chloride ion homeostasis', 28, 'bone homeostasis'), ('GO_0007420', 'brain development', 46, 'brain development'), ('UBERON_0000955', 'brain', 46, 'brain'), ('GO_0002022', 'detection of dietary excess', 68, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 86, 'immune system'), ('GO_0007567', 'parturition', 122, 'antenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4113768	7/2014	S55-PMC4113768	['conclusions: the PRESENT INVESTIGATION INDICATES that the Vitamin D status MAY function AS an INDEPENDENT positive PREDICTOR of sod, especially in non-obese, non-smoking elderly women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 115)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4113768	7/2014	S377-PMC4113768	['background: INTERACTIONS between dietary Calcium and Vitamin D MAY have IMPLICATIONS for the Regulation of Serum 25-Hydroxy Vitamin D (25(Oh)D) and its Catabolism, and CONSEQUENTLY for the dietary REQUIREMENT for Vitamin D ((iom) institute of medicine.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 63), ('IMPORTANT_CONSIDERATION', 72), ('SUPERFICIAL_RELATIONSHIP', 93), ('PROBABLE_UNDERSTANDING', 168), ('IMPORTANT_CONSIDERATION', 197)]	6	[('CHEBI_22313', 'alkaline earth metal atom', 41, 'calcium'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0065007', 'biological regulation', 93, 'regulation'), ('UBERON_0001977', 'blood serum', 107, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 113, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 135, '25(OH)D'), ('GO_0009056', 'catabolic process', 152, 'catabolism'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC4113768	7/2014	S386-PMC4113768	['THUS, RECENT dietary Vitamin D REQUIREMENT ESTIMATES will cover the Vitamin D NEEDS of EVEN those in the population who do not have adequate Calcium intakes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6), ('IMPORTANT_CONSIDERATION', 31), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 78), ('ANOMALY_CURIOUS_FINDING', 87)]	6	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 141, 'calcium')]
PMC4113768	7/2014	S485-PMC4113768	['in addition, an ASSOCIATION between INADEQUATE Vitamin D levels and impaired Lung function COULD BE EXPLAINED by an INCREASED RISK of Respiratory infections or a negative INFLUENCE on muscle function.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('IMPORTANT_CONSIDERATION', 36), ('INCOMPLETE_EVIDENCE', 91), ('PROBABLE_UNDERSTANDING', 100), ('IMPORTANT_CONSIDERATION', 116), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002048', 'lung', 77, 'lung'), ('UBERON_0001004', 'respiratory system', 134, 'respiratory')]
PMC4113768	7/2014	S808-PMC4113768	['we THEREFORE AIMED TO ESTABLISH WHETHER maternal Vitamin D and Vitamin D-binding protein (dbp) levels MIGHT RELATE to the Expression of amino acid transporters in Human Placenta.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 108)]	6	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0010467', 'gene expression', 122, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 163, 'human'), ('UBERON_0001987', 'placenta', 169, 'placenta')]
PMC4113768	7/2014	S1329-PMC4113768	['it is HYPOTHESISED that transient changes in Serum calcium MAY BE responsible for Remineralisation of marginally under-mineralised bone; and this MIGHT EXPLAIN WHY Vitamin D most benefits those who are AT RISK of deficiency.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 146), ('PROBABLE_UNDERSTANDING', 152), ('EXPLICIT_QUESTION', 160), ('IMPORTANT_CONSIDERATION', 202)]	6	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('GO_0031147', '1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one metabolic process', 82, 'remineralisation'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D')]
PMC4113768	7/2014	S1535-PMC4113768	['IMPORTANTLY, it is SEEMED that low risk carriers with adequate S-25(Oh)D concentrations achieved EVEN higher S-25(Oh)D concentrations with increasing Vitamin D intake WHEREAS high risk carriers did NOT.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 19), ('PROBABLE_UNDERSTANDING', 19), ('ANOMALY_CURIOUS_FINDING', 97), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167), ('ANOMALY_CURIOUS_FINDING', 198)]	6	[('CHEBI_82715', 'PH 797804', 63, 's-25(OH)D'), ('CHEBI_82715', 'PH 797804', 109, 's-25(OH)D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
PMC4113768	7/2014	S1578-PMC4113768	['AS MOST studies examining Vitamin D status and disease progression to date have included Individuals receiving art, the AIMS of THIS STUDY are TO EVALUATE the EFFECT of vitamin d status over time on immunological outcomes, such as cd4+ cell count and cd4+ percentage in hiv-infected Individuals with hiv viraemia.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 120), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('QUESTION_ANSWERED_BY_THIS_WORK', 143), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('NCBITaxon_1', 'root', 283, 'individuals')]
PMC4113768	7/2014	S1979-PMC4113768	['THEREFORE, we SHOULD PAY more ATTENTION to Food as a natural source of Vitamin D.\n\n2.90.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 14), ('IMPORTANT_CONSIDERATION', 14), ('IMPORTANT_CONSIDERATION', 21), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 30)]	6	[('CHEBI_33290', 'food', 43, 'food'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4113768	7/2014	S2043-PMC4113768	['the RECENT iom 2011 report on dietary reference intakes for Calcium and Vitamin D for north america is apt for the irish population by providing the most COMPREHENSIVE EVIDENCE-BASED REPORT on Vitamin D.\nmethods: since 2007, we have conducted studies of Vitamin D status by measuring Serum 25-Hydroxy Vitamin D (25Ohd) in: preterm infants shortly after Birth ( n = 274) and after 15 weeks ( n = 148); paired term infants and mothers at Birth ( n = 39); children and adolescents from age 1 to 18 years ( n = 252); mothers during Pregnancy and infants at Birth divided according to winter Birth ( n = 30) and summer Birth ( n = 30); Pregnant mothers and ethnicity ( n = 116); patients attending an osteoporosis clinic ( n = 100); patients with cystic fibrosis ( n = 114); patients with multiple sclerosis ( n = 331) compared with healthy relatives ( n = 229) during winter months in 3 different regions in ireland; and patients with psoriasis undergoing phototherapy during the winter months ( n = 29) compared with controls ( n = 29).']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 154), ('INCOMPLETE_EVIDENCE', 168), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('INCOMPLETE_EVIDENCE', 183)]	6	[('CHEBI_31341', 'calcium dihydroxide', 60, 'Calcium'), ('CHEBI_28384', 'vitamin K', 72, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 201, 'D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('UBERON_0001977', 'blood serum', 284, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 290, '25-hydroxy vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 312, '25OHD'), ('GO_0007567', 'parturition', 353, 'birth'), ('GO_0007567', 'parturition', 436, 'birth'), ('GO_0007565', 'female pregnancy', 528, 'pregnancy'), ('GO_0007567', 'parturition', 553, 'birth'), ('GO_0007567', 'parturition', 587, 'birth'), ('GO_0007567', 'parturition', 614, 'birth'), ('GO_0007565', 'female pregnancy', 631, 'pregnant')]
PMC4113768	7/2014	S2088-PMC4113768	['the ESTIMATED average Vitamin D REQUIREMENT from all dietary sources is STRONGLY EVIDENCE-BASED and SHOULD represent the target total daily amount for everyone including Supplement users.']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 32), ('PROBABLE_UNDERSTANDING', 72), ('INCOMPLETE_EVIDENCE', 81), ('FUTURE_WORK', 100), ('IMPORTANT_CONSIDERATION', 100)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 170, 'supplement')]
PMC4113768	7/2014	S2663-PMC4113768	['HOWEVER, there is uncertainty as to WHETHER low Vitamin D status is a TRUE cause of these outcomes, OR simply a MARKER of OTHER lifestyle VARIABLES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('PROBABLE_UNDERSTANDING', 70), ('SUPERFICIAL_RELATIONSHIP', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 138)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC4171568	9/2014	S135-PMC4171568	['Vitamin D as a risk factor for the development of schizophrenia\nit HAS BEEN HYPOTHESIZED that low Prenatal Vitamin D is a risk factor for the incidence of Adult-onset schizophrenia AS the lack of this fat-soluble Vitamin and Steroid Hormone MAY DETRIMENTALLY IMPACT on the developing foetal Brain [102].']	[('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 181), ('INCOMPLETE_EVIDENCE', 241), ('IMPORTANT_CONSIDERATION', 245), ('SUPERFICIAL_RELATIONSHIP', 259)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'prenatal'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0007023', 'adult organism', 155, 'adult'), ('CHEBI_33229', 'vitamin (role)', 213, 'vitamin'), ('CHEBI_26764', 'steroid hormone', 225, 'steroid hormone'), ('UBERON_0000955', 'brain', 291, 'brain')]
PMC4251419	12/2014	S7-PMC4251419	['after the UNDISPUTED IMPORTANCE of Vitamin D for bone health, the STRONGEST EVIDENCE is PROBABLY for an increased RISK of Immune disorders in ASSOCIATION with Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 10), ('IMPORTANT_CONSIDERATION', 21), ('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 88), ('IMPORTANT_CONSIDERATION', 114), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4251419	12/2014	S138-PMC4251419	['the LACK OF any PROTECTIVE EFFECT of Vitamin D supplementation in Adulthood MAY BE BECAUSE the processes necessary for disease have already been put in place much earlier in life.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 83), ('PROBLEM_COMPLICATION', 83)]	6	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 66, 'adulthood')]
PMC4303849	1/2015	S0-PMC4303849	['Regulation Of Calcitriol Biosynthesis and activity: focus on Gestational Vitamin D deficiency and adverse Pregnancy outcomes\n\nabstract\nVitamin D has garnered a great deal of ATTENTION in RECENT years DUE TO a GLOBAL prevalence of Vitamin D deficiency ASSOCIATED with an INCREASED RISK of a variety of Human diseases.']	[('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 187), ('PROBABLE_UNDERSTANDING', 200), ('IMPORTANT_CONSIDERATION', 209), ('SUPERFICIAL_RELATIONSHIP', 251), ('IMPORTANT_CONSIDERATION', 270)]	6	[('GO_1900952', 'positive regulation of 18-methylnonadec-1-ene biosynthetic process', 0, 'Regulation of Calcitriol Biosynthesis'), ('CHEBI_17823', 'calcitriol', 14, 'Calcitriol'), ('PR_000004909', 'complement component C8 beta chain', 14, 'Calcitriol'), ('GO_0007565', 'female pregnancy', 61, 'Gestational'), ('CHEBI_28384', 'vitamin K', 73, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 73, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 135, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 135, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 301, 'human')]
PMC4303849	1/2015	S133-PMC4303849	['25Ohd values lesser than 50 nmol/l MAY sustain long-term adverse health consequences and are classified as “deficiency.” the 75 nmol/l cut-off is the point above which there is no upper stimulation of pth [102] and was thereafter designated as “sufficient.” HOWEVER, heaney POINTED out that 25Ohd concentrations < 80 nmol/l are ASSOCIATED with reduced calcium absorption and osteoporosis risk [103]; therefore, values lesser than 75 nmol/l are considered AS “insufficient.” the conversion factor between 25Ohd nmol/l and ng/ml is 2.5 (table 2).nutrients-07-00443-t001_table 1\n\ncaption (table-wrap): table 1\n\ntargets Modulated by Calcitriol in the Human Placenta (+ = stimulation; − = inhibition).targetbiological networkregulationbioeffectcell typereferenceplacental Lactogencell Life and death+growth controltrophoblast[97]Tnf-Αimmune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Il-6Immune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Csf2 (Colony Stimulating Factor 2)immune function−immunosupressiondecidual Cells[89]hctdimmune function+restraining infectiontrophoblast[90]Decidual Cells[89]Cyp24A1Bone and Mineral Metabolism+Calcitriol Catabolismtrophoblast[12]Decidual Cells[104]Cyp27B1Bone and Mineral Metabolism−Calcitriol synthesistrophoblast[12]Il-10 (Interleukin 10)immune function−reducing risk of infectiontrophoblast[105]Kcnh1 (potassium voltage-Gated channel)Cell Life and Death−unknowntrophoblast[106]Calbindin-D 28 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61,62]Calbindin-D 9 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61]hcg (Human Chorionic Gonadotrophin)Cell Life and Death+, −maintenance of Pregnancytrophoblast[96]3β-hsd (3Β-Hydroxysteroid dehydrogenase) *Cell Life and Death+Progesterone Synthesistrophoblast[95]Cyp19 (aromatase) *Cell Life and Death+Estradiol Synthesistrophoblast[95]Prolactincell Life and Death+Establishment Of Pregnancydecidual Cells[107]Vdrbone and Mineral Metabolism+allowing Calcitriol actionstrophoblast[62]Platelet-Activating factor acetylhydrolasecell life and Death−inactivation of Platelet-Activating factordecidual Macrophages[108]Hoxa10 (Homeobox A10)Cell Life and Death+Embryo Implantationdecidual cells[109]Osteopontinbone and Mineral Metabolism+Embryo Implantationdecidual Cells[104]Hbd2Immune function+restraining infectiontrophoblast[93]Hbd3Immune function+restraining infectiontrophoblast[93]\n* only observed at the enzyme activity level.nutrients-07-00443-t002_table 2\n\ncaption (table-wrap): table 2\n\ncut-offs in Vitamin D status according to the Endocrine society [110].Vitamin D status25ohd (nmol/l)25Ohd (ng/ml)severe deficiency<25<10deficiency<50<20insufficiency<75<30sufficiency75–11030–44toxicity>250>100\ntable 2shows the criteria for vd status as PROPOSED by the Endocrine society.']	[('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 258), ('INCOMPLETE_EVIDENCE', 274), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBABLE_UNDERSTANDING', 455), ('INCOMPLETE_EVIDENCE', 2831)]	6	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 0, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 291, '25OHD'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 504, '25OHD'), ('GO_0065007', 'biological regulation', 616, 'modulated'), ('CHEBI_17823', 'calcitriol', 629, 'calcitriol'), ('NCBITaxon_9606', 'Homo sapiens', 647, 'human'), ('UBERON_0001987', 'placenta', 653, 'placenta'), ('CHEBI_35417', 'alpha-amino-acid residue radical', 767, 'lactogenCell'), ('PR_000009797', 'LIM/homeobox protein Lhx9', 767, 'lactogenCell'), ('UBERON_0000104', 'life cycle', 780, 'life'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 824, 'TNF-αImmune'), ('PR_000008988', 'interleukin-1 family member 5', 922, 'IL-6Immune'), ('PR_000005890', 'crooked neck-like protein 1', 1019, 'CSF2'), ('PR_000005528', 'chloride channel protein, skeletal muscle', 1025, 'colony stimulating factor 2'), ('CL_0000573', 'retinal cone cell', 1094, 'cells'), ('CL_0000635', "Deiter's cell", 1159, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1177, 'CYP24A1Bone'), ('CHEBI_46662', 'mineral', 1193, 'mineral'), ('GO_0008152', 'metabolic process', 1201, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1212, 'Calcitriol'), ('GO_0019065', 'receptor-mediated endocytosis of virus by host cell', 1212, 'Calcitriol catabolismTrophoblast'), ('CL_0000635', "Deiter's cell", 1248, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1267, 'CYP27B1Bone'), ('CHEBI_46662', 'mineral', 1283, 'mineral'), ('GO_0008152', 'metabolic process', 1291, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1302, 'Calcitriol'), ('PR_000001470', 'interleukin-28B', 1337, 'IL-10'), ('PR_000001470', 'interleukin-28B', 1344, 'Interleukin 10'), ('PR_000000793', 'voltage-gated potassium channel KCNH4', 1417, 'KCNH1'), ('PR_000004587', 'beta-1,3-galactosyltransferase 6', 1441, '-gated'), ('GO_0008219', 'cell death', 1456, 'Cell life ... death'), ('PR_000004968', 'calretinin', 1499, 'Calbindin-D 28'), ('CHEBI_46662', 'mineral', 1526, 'mineral'), ('GO_0008152', 'metabolic process', 1534, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1545, 'Calcium'), ('PR_000004998', 'calmodulin-regulated spectrin-associated protein 1', 1579, 'Calbindin-D'), ('CHEBI_46662', 'mineral', 1605, 'mineral'), ('GO_0008152', 'metabolic process', 1613, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1624, 'Calcium'), ('NCBITaxon_9606', 'Homo sapiens', 1660, 'human'), ('PR_000005170', 'CD37 molecule', 1666, 'chorionic gonadotrophin'), ('UBERON_0003124', 'chorion', 1666, 'chorionic'), ('GO_0008219', 'cell death', 1690, 'Cell life ... death'), ('GO_0006412', 'translation', 1728, 'pregnancyTrophoblast'), ('CHEBI_36864', '25-hydroxy steroid', 1760, '3β-hydroxysteroid'), ('GO_0008219', 'cell death', 1794, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1799, 'life'), ('CHEBI_17026', 'progesterone', 1814, 'Progesterone'), ('GO_0072598', 'protein localization to chloroplast', 1814, 'Progesterone synthesisTrophoblast'), ('PR_000006100', 'aromatase', 1851, 'CYP19'), ('GO_0008219', 'cell death', 1870, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1875, 'life'), ('CHEBI_4856', 'esmolol', 1890, 'Estradiol'), ('GO_0072596', 'establishment of protein localization to chloroplast', 1890, 'Estradiol synthesisTrophoblast'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 1924, 'ProlactinCell'), ('GO_0006266', 'DNA ligation', 1938, 'life ... death'), ('GO_0006884', 'cell volume homeostasis', 1953, 'Establishment of pregnancyDecidual cells'), ('CL_0000573', 'retinal cone cell', 1988, 'cells'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1998, 'VDRBone'), ('CHEBI_46662', 'mineral', 2010, 'mineral'), ('GO_0008152', 'metabolic process', 2018, 'metabolism'), ('CHEBI_17823', 'calcitriol', 2038, 'calcitriol'), ('CL_0000233', 'platelet', 2071, 'Platelet'), ('GO_0030168', 'platelet activation', 2071, 'Platelet-activating'), ('GO_0007608', 'sensory perception of smell', 2127, '... death'), ('CL_0000233', 'platelet', 2149, 'platelet'), ('GO_0030168', 'platelet activation', 2149, 'platelet-activating'), ('CL_0000235', 'macrophage', 2184, 'macrophages'), ('PR_000008689', 'homeobox protein Hox-A13', 2200, 'HOXA10'), ('PR_000008469', 'holocytochrome c-type synthase', 2208, 'Homeobox A10'), ('GO_0008219', 'cell death', 2221, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 2226, 'life'), ('GO_0007601', 'visual perception', 2241, 'Embryo'), ('UBERON_0000922', 'embryo', 2241, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2248, 'implantationDecidual'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 2279, 'OsteopontinBone'), ('CHEBI_46662', 'mineral', 2299, 'mineral'), ('GO_0008152', 'metabolic process', 2307, 'metabolism'), ('UBERON_0000922', 'embryo', 2318, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2325, 'implantationDecidual'), ('CL_0000573', 'retinal cone cell', 2346, 'cells'), ('PR_000000035', 'BMP receptor type-1A', 2356, 'HBD2Immune'), ('PR_000000035', 'BMP receptor type-1A', 2412, 'HBD3Immune'), ('CHEBI_27300', 'vitamin D', 2590, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 2624, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 2648, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2648, 'Vitamin'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 2678, '25OHD'), ('UBERON_0005063', 'left ventricular compact myocardium', 2847, 'Endocrine')]
PMC4340999	3/2015	S112-PMC4340999	['ALTHOUGH THE CURRENT STUDY is UNABLE TO precisely determine the REASON for mob variation in Adult measures of ll, general adiposity, and central adiposity, the study improves our current understanding of a POTENTIAL ASSOCIATION of Prenatal low exposure to Vitamin D during late second and early third trimesters with short ll and adiposity in later Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('DIFFICULT_TASK', 30), ('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 216)]	6	[('UBERON_0007023', 'adult organism', 92, 'adult'), ('GO_0007565', 'female pregnancy', 231, 'prenatal'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('UBERON_0000104', 'life cycle', 349, 'life')]
PMC4377870	3/2015	S137-PMC4377870	['Vitamin D\nepidemiological studies SHOW PROMISING ASSOCIATIONS between Vitamin D and Lung health; HOWEVER the mechanisms responsible for these EFFECTS are POORLY UNDERSTOOD.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97), ('SUPERFICIAL_RELATIONSHIP', 142), ('FULL_UNKNOWN', 154)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0002048', 'lung', 84, 'lung')]
PMC4377870	3/2015	S153-PMC4377870	['the ROLE for Vitamin D in enhancing Steroid responsiveness SUGGESTED by observational studies [120] is SUPPORTED by mechanistic studies [121], and in concert with the actions of Vitamin D in infection, MAY EXPLAIN the EFFECT of Vitamin D in reducing asthma exacerbations [111].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 202), ('PROBABLE_UNDERSTANDING', 206), ('SUPERFICIAL_RELATIONSHIP', 218)]	6	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_35341', 'steroid', 36, 'steroid'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC4377870	3/2015	S178-PMC4377870	['a SMALL STUDY in sweden FOUND that in older subjects with SEVERE copd, Intakes of Folic Acid and Selenium were below recommended levels, and although intake of calcium was adequate, Serum calcium levels were low, LIKELY RELATED to their Vitamin D status AS Intake was lower than recommended [141].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 58), ('PROBABLE_UNDERSTANDING', 213), ('SUPERFICIAL_RELATIONSHIP', 220), ('PROBABLE_UNDERSTANDING', 254)]	6	[('GO_0007631', 'feeding behavior', 71, 'intakes'), ('CHEBI_30751', 'formic acid', 82, 'folic acid'), ('CHEBI_27568', 'selenium atom', 97, 'selenium'), ('UBERON_0001977', 'blood serum', 182, 'serum'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('GO_0007631', 'feeding behavior', 257, 'intake')]
PMC4396835	1/2015	S0-PMC4396835	['autism spectrum disorder and low Vitamin D at Birth: a sibling control study\n\nabstract\n\nbackground\ninsufficient Vitamin D activity has attracted increasing INTEREST AS a POSSIBLE UNDERLYING RISK factor in disorders of the Central Nervous System, including autism.']	[('IMPORTANT_CONSIDERATION', 156), ('INCOMPLETE_EVIDENCE', 156), ('PROBABLE_UNDERSTANDING', 165), ('INCOMPLETE_EVIDENCE', 170), ('SUPERFICIAL_RELATIONSHIP', 179), ('SUPERFICIAL_RELATIONSHIP', 190)]	6	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 222, 'central nervous system')]
PMC4405493	4/2015	S158-PMC4405493	['although Vitamin D has a biologically POSSIBLE ROLE in all the aforementioned disorders, this WAS NOT DEMONSTRATED in our population AS Vitamin D deficiency did not increase the odds for adverse Pregnancy outcome in OUR STUDY.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 133), ('QUESTION_ANSWERED_BY_THIS_WORK', 216)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy')]
PMC4427001	4/2015	S40-PMC4427001	['THEREFORE, the AIMS of the PRESENT STUDY were (1) TO DETERMINE Midgestational and early Postpartum Vitamin D status by measuring 25(Oh)D Plasma levels in Pregnant women with and without gdm to CONFIRM the hypothetical deficiency in gdm in central european population and (2) to describe the RELATIONSHIP between Midgestational and Postpartum Vitamin D status and parallel changes of parameters characterising Glucose tolerance.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 291)]	6	[('GO_0007507', 'heart development', 63, 'midgestational'), ('GO_0007565', 'female pregnancy', 88, 'postpartum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 132, 'OH ... D'), ('UBERON_0001969', 'blood plasma', 137, 'plasma'), ('GO_0007565', 'female pregnancy', 154, 'pregnant'), ('GO_0007507', 'heart development', 312, 'midgestational'), ('GO_0007565', 'female pregnancy', 331, 'postpartum'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D'), ('CHEBI_17234', 'glucose', 409, 'glucose')]
PMC4427001	4/2015	S109-PMC4427001	['CONTRADICTORY results COULD BE EXPLAINED by seasonal, geographical, or ethnic Vitamin D variation; the paper does NOT UNFORTUNATELY mention in WHAT season women were included in the study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 31), ('ANOMALY_CURIOUS_FINDING', 114), ('IMPORTANT_CONSIDERATION', 118), ('EXPLICIT_QUESTION', 143)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC4427001	4/2015	S118-PMC4427001	['[26] FOUND an inverse ASSOCIATION between second trimester 25(Oh)D levels < 25\u2009nmol/l and 1\u2009hr after load Glucose (50\u2009g) levels; HOWEVER, ONLY 5% of studied women developed gdm and as mentioned above THRESHOLD for Vitamin D deficiency DIFFERED from our study.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('INCOMPLETE_EVIDENCE', 138), ('PROBABLE_UNDERSTANDING', 200), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 235)]	6	[('CHEBI_71657', 'versiconol acetate', 59, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 59, '25(OH ... D'), ('CHEBI_17234', 'glucose', 106, 'glucose'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC4448820	5/2015	S239-PMC4448820	['in vivo data for Vitamin A– and Vitamin D–DEPENDENT induction of Tregs in Humans are EMERGING but are EXTREMELY DIFFICULT to establish methodologically BECAUSE of the LIKELY need to obtain biopsied materials (144–146).']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 102), ('DIFFICULT_TASK', 112), ('PROBLEM_COMPLICATION', 152), ('PROBABLE_UNDERSTANDING', 167)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 65, 'Tregs'), ('NCBITaxon_9606', 'Homo sapiens', 74, 'humans')]
PMC4448820	5/2015	S595-PMC4448820	['for SOME—and on THE BASIS of the clinical trials, PRESUMABLY most—infectious diseases, Vitamin A supplementation MAY BE beneficial; in OTHER situations it MAY be harmful (369,370).']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 50), ('INCOMPLETE_EVIDENCE', 113), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135), ('INCOMPLETE_EVIDENCE', 155)]	6	[('CHEBI_27300', 'vitamin D', 87, 'vitamin A')]
PMC4448820	5/2015	S1473-PMC4448820	['HOWEVER, recent data from a subset of women recruited as part of a national survey in cameroon INDICATE that Human-milk Vitamin A concentrations (casual samples at ≥1 mo Postpartum) were ASSOCIATED with crp, and this ASSOCIATION SEEMED TO BE EXPLAINED by a decrease in Plasma rbp (776).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 187), ('SUPERFICIAL_RELATIONSHIP', 217), ('ANOMALY_CURIOUS_FINDING', 229), ('PROBABLE_UNDERSTANDING', 242)]	6	[('NCBITaxon_9606', 'Homo sapiens', 109, 'human'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('GO_0007565', 'female pregnancy', 170, 'postpartum'), ('UBERON_0001969', 'blood plasma', 269, 'plasma')]
PMC4466139	6/2015	S15-PMC4466139	['moreover, in RECENT YEARS, Vitamin D deficiency HAS BEEN CONSIDERED AS a POSSIBLE cause of several diseases, including Microbial infections, Cardiovascular and allergic diseases, cancers, type 1 diabetes, multiple sclerosis and other Autoimmune diseases [1–10].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 57), ('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 68), ('INCOMPLETE_EVIDENCE', 73)]	6	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 119, 'microbial'), ('UBERON_0004535', 'cardiovascular system', 141, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 234, 'autoimmune')]
PMC4488777	5/2015	S14-PMC4488777	['introduction\nthe ROLE of Vitamin D in fertility treatment has been RECENTLY DESCRIBED in SOME COMPREHENSIVE REPORTS [1,2].']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 76), ('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 94), ('INCOMPLETE_EVIDENCE', 108)]	6	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
PMC4488777	5/2015	S36-PMC4488777	['an OPTIMAL level of Vitamin D concentration in Blood Serum SHOULD range between 50 and 125 nmol/l [10], EVEN THOUGH SOME environmental STUDIES IMPLY that the target level SHOULD BE set much higher—up to 250, or even at 300 nmol/l [11,12].']	[('IMPORTANT_CONSIDERATION', 3), ('IMPORTANT_CONSIDERATION', 59), ('ANOMALY_CURIOUS_FINDING', 104), ('INCOMPLETE_EVIDENCE', 116), ('PROBABLE_UNDERSTANDING', 143), ('IMPORTANT_CONSIDERATION', 171)]	6	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0001977', 'blood serum', 53, 'serum')]
PMC4488777	5/2015	S39-PMC4488777	['the EFFECT of Vitamin D on Ovarian Granulosa Cells RESPONSIBLE for Steroidogenesis, as well as on Immune System Regulation, was ESTABLISHED after FINDING 1-α-hydroxylase and vdr receptors in Deciduae, Placentas, Ovaries, Endometriums and Pituitary Glands, and was CONFIRMED in vitro by DEMONSTRATING active Metabolites of Vitamin D such as 1,25[Oh]2D and 24,25[Oh]2D in mentioned Tissues [14,15,16,17,18].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 146), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CL_0000477', 'ovarian follicle cell', 27, 'ovarian granulosa cells'), ('UBERON_0000992', 'ovary', 27, 'ovarian'), ('GO_0001501', 'skeletal system development', 67, 'steroidogenesis'), ('UBERON_0002405', 'immune system', 98, 'immune system'), ('GO_0065007', 'biological regulation', 112, 'regulation'), ('UBERON_0002450', 'decidua', 191, 'deciduae'), ('UBERON_0001987', 'placenta', 201, 'placentas'), ('UBERON_0000992', 'ovary', 212, 'ovaries'), ('UBERON_0001852', 'endolymph', 221, 'endometriums'), ('UBERON_0000007', 'pituitary gland', 238, 'pituitary glands'), ('CHEBI_25212', 'metabolite', 307, 'metabolites'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 342, '25[OH]2D'), ('CHEBI_82784', 'PVP38-Ag NP', 358, '25[OH]2D'), ('UBERON_0000479', 'tissue', 380, 'tissues')]
PMC4488777	5/2015	S54-PMC4488777	['since our PREVIOUS REVIEW [2], two NEW ORIGINAL papers HAVE BEEN published, EXPLAINING the SIGNIFICANCE of Vitamin D in pcos pathogenesis.']	[('INCOMPLETE_EVIDENCE', 10), ('FULL_UNKNOWN', 35), ('FULL_UNKNOWN', 39), ('INCOMPLETE_EVIDENCE', 55), ('PROBABLE_UNDERSTANDING', 76), ('IMPORTANT_CONSIDERATION', 91)]	6	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC4516377	6/2015	S14-PMC4516377	['GIVEN the above, THIS integrative REVIEW AIMED TO EVALUATE the ASSOCIATION between calcium intake and Serum Vitamin D levels with body fat (bf) accumulation in children.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('SUPERFICIAL_RELATIONSHIP', 63)]	6	[('UBERON_0001977', 'blood serum', 102, 'serum'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4516377	6/2015	S65-PMC4516377	['THUS, the active transport becomes the main mechanism of calcium absorption when its Ingestion is low.34\nit can be OBSERVED that many of the mechanisms that explain adiposity and its ASSOCIATION with the assessed Micronutrients DEMONSTRATE the close ASSOCIATION between Calcium and the Vitamin D present in the Metabolic events of Adipogenesis, and the fact that the presence or absence of one of them CAN bring damage not only to bone, but health as a whole.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 183), ('QUESTION_ANSWERED_BY_THIS_WORK', 228), ('SUPERFICIAL_RELATIONSHIP', 250), ('INCOMPLETE_EVIDENCE', 402)]	6	[('GO_0007631', 'feeding behavior', 85, 'ingestion'), ('CHEBI_33839', 'macromolecule', 213, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 270, 'calcium'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('GO_0008152', 'metabolic process', 311, 'metabolic'), ('GO_0060612', 'adipose tissue development', 331, 'adipogenesis')]
PMC4586450	10/2015	S245-PMC4586450	['these results SUGGEST that within the range of fat intakes normally consumed by united kingdom preschool children, there is no EVIDENCE of an EFFECT on growth or obesity development of increasing the proportion of ei coming from fat in the diet.vitamin a\nthe sources of Vitamin A (Retinol equivalents) in the diet and changes in Intake between age 1.5 years and age 3.5 years were examined longitudinally (n = 755 with Food records at both ages).23the diet was categorized by core and noncore Foods, and THERE was EVIDENCE that the quality of the diet deteriorated with age.23between age 1.5 years and age 3.5 years, the dietary Intake of Vitamin A decreased by 56 µg/day (95% ci, −17 to −95 µg/d; p = 0.005) MAINLY due to decreased Intake of whole milk (390 g/d at age 1.5 y; 261 g/d at age 3.5 y) and increased Intake of energy-dense, Nutrient-poor Foods such as puddings, cakes, biscuits, confectionery, and crisps.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 504), ('INCOMPLETE_EVIDENCE', 514), ('PROBABLE_UNDERSTANDING', 709)]	6	[('CHEBI_27300', 'vitamin D', 270, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 281, 'retinol'), ('GO_0007631', 'feeding behavior', 329, 'intake'), ('CHEBI_33290', 'food', 419, 'food'), ('CHEBI_33290', 'food', 493, 'foods'), ('GO_0007631', 'feeding behavior', 629, 'intake'), ('CHEBI_27300', 'vitamin D', 639, 'vitamin A'), ('GO_0007631', 'feeding behavior', 733, 'intake'), ('GO_0007631', 'feeding behavior', 813, 'intake'), ('CHEBI_33284', 'nutrient', 837, 'nutrient'), ('CHEBI_33290', 'food', 851, 'foods')]
PMC4595656	10/2015	S4-PMC4595656	['HOWEVER, a SMALL NUMBER OF STUDIES, MOSTLY in vitro , POINT to a ROLE for Vitamin D in Differentiation and Development Of Hippocampal Neurons.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 17), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 65)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0030254', 'protein secretion by the type III secretion system', 87, 'differentiation ...'), ('GO_0048513', 'animal organ development', 107, 'development of ... neurons'), ('CL_0002608', 'hippocampal neuron', 122, 'hippocampal neurons')]
PMC4598849	10/2015	S11-PMC4598849	['the LINK between maternal Vitamin D status and fetal growth, AS measured most frequently by infant Birth weight and small for Gestational age (sga), HAS BEEN explored by a NUMBER OF observational STUDIES9101112131415AND randomized supplementation trials1617181920worldwide with MIXED results.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBABLE_UNDERSTANDING', 61), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 196), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 278)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 99, 'birth'), ('GO_0007565', 'female pregnancy', 126, 'gestational')]
PMC4598849	10/2015	S79-PMC4598849	['in CONCLUSION, THIS STUDY PROVIDES the FIRST epidemiological EVIDENCE that there was an inverted u shaped RELATIONSHIP between neonatal Vitamin D status and fetal growth.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 106)]	6	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC4600246	10/2015	S6-PMC4600246	['moreover, a normal carboxylated mgp protein in the Serum MAY NOT NECESSARILY INDICATE a normal Vitamin K status, AS carboxylated mgp in the Serum COULD BE normal, BUT suboptimal in the Arteries (where Vitamin K2Is needed to prevent vascular calcification.)']	[('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 113), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163)]	6	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin K'), ('UBERON_0001977', 'blood serum', 140, 'serum'), ('UBERON_0001637', 'artery', 185, 'arteries'), ('CHEBI_35684', 'antiplatyhelmintic drug', 201, 'vitamin K2is')]
PMC4605923	11/2015	S2-PMC4605923	['Food intake is a WELL-known environmental FACTOR that INFLUENCES Allergy Development and three specific Nutrients-Vitamin D, Omega 3 polyunsaturated Fatty Acids and Folate-have RECENTLY attracted ATTENTION.1\nthe methyl donor Folate is a WELL-KNOWN Nutrient supplement given during early Pregnancy to prevent neutral Tube defects in the developing fetus.']	[('PROBABLE_UNDERSTANDING', 17), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 177), ('INCOMPLETE_EVIDENCE', 196), ('PROBABLE_UNDERSTANDING', 237)]	6	[('CHEBI_33290', 'food', 0, 'Food'), ('GO_0060021', 'roof of mouth development', 65, 'allergy development'), ('CHEBI_33284', 'nutrient', 104, 'nutrients'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_82673', "2-amino-6,7-dimethyl-4-oxo-8-(1'-D-ribityl)-4,8-dihydropteridine", 125, 'omega 3'), ('CHEBI_35366', 'fatty acid', 149, 'fatty acids'), ('CHEBI_30863', '5-azaorotic acid', 165, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 225, 'folate'), ('CHEBI_33284', 'nutrient', 248, 'nutrient'), ('GO_0007565', 'female pregnancy', 287, 'pregnancy'), ('UBERON_0000025', 'tube', 316, 'tube')]
PMC4624803	10/2015	S116-PMC4624803	['AS a CONSEQUENCE of the LIMITED statistical power, we cannot exclude that the MAY BE a small to medium sized ASSOCIATION between Vitamin D levels at Birth and a later diagnosis of adhd.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 5), ('PROBLEM_COMPLICATION', 5), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 109)]	6	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007567', 'parturition', 149, 'birth')]
PMC4627942	10/2015	S221-PMC4627942	["caption (table-wrap): table 5\n\ntackling malnutrition – prevention EFFORTS: findings from indepth studieshdss siteyearauthorsmain findingsbandim hdss, guinea-bissau2004nielsen et al.during civil war, Vitamin A supplementation for children helped reduce mortality.bandim hdss, guinea-bissau2005nielsen et al.during civil war, supplementary Feeding programme helped reduce mortality in children.filabavi hdss, vietnam2009nga et al.fortification with multiple Micronutrients of biscuits provided in schools reduced risk of anaemia and of iron and zinc deficiencies by 40%.nouna hdss, burkina faso2003müller et al.no significant impact of Zinc supplementation for children on height-for-age, weight-for-age, and weight-for-height scores.kintampo hdss, ghana2007newton et al.no positive EFFECT of Vitamin A supplements in combination with vaccines during the first few months of Life.farafenni hdss, gambia2013van der merwe et al.fish oil supplementation had no effect on growth, Intestinal integrity, morbidity, or cognitive development.kilifi hdss, kenya2010akech et al.use of low-dose hypotonic Fluid resuscitation for children who develop shock AS a result of SEVERE malnutrition has poor outcomes in terms of persistent shock, oliguria, and high case fatality.agincourt hdss, south africa2003deen et al.introduction of who guidelines in two hospitals strengthened the management of malnutrition.kintampo hdss, ghana2006tchum et al.vitamin a supplementation increased Liver reserves of mothers during the Postpartum period, with EFFECTS persisting for at least five months.niakhar hdss, senegal2006ly et al.provision of high energy, Nutrient-dense Food supplements to infants aged between four and seven months contributed to decreased Postpartum weight loss in their mothers.west kiang hdss, gambia2011hawkesworth et al.Nutrient supplementation during Pregnancy had little effect on infants’ risk of cardiovascular disease.west kiang hdss, gambia2009hawkesworth et al.protein-energy supplementation of mothers during Pregnancy had no effect on the Blood pressure of their children in adolescence.west kiang hdss, gambia2009prentice et al.Calcium supplementation for Pregnant mothers had no effect on foetal and infant growth.west kiang hdss, gambia2010jarjou et al.women given Calcium Supplements while Pregnant had lower bone Mineral content, bone area and bone Mineral density at the Hip during the 12-month Lactation period than other women.dikgale hdss, south africa2002nthangeni et al.the majority of People with type 2 diabetes had poor Glycaemic Control and were obese or had high blood pressure and were given poor advice by health educators.africa centre hdss, south africa2002o'donnell et al.agencies working to tackle a flood disaster in bangladesh in 1998 achieved MIXED results in terms of meeting international disaster response standards."]	[('FUTURE_WORK', 66), ('SUPERFICIAL_RELATIONSHIP', 781), ('PROBABLE_UNDERSTANDING', 1143), ('IMPORTANT_CONSIDERATION', 1158), ('SUPERFICIAL_RELATIONSHIP', 1527), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2776)]	6	[('CHEBI_27300', 'vitamin D', 199, 'vitamin A'), ('GO_0007631', 'feeding behavior', 338, 'feeding'), ('CHEBI_33839', 'macromolecule', 456, 'micronutrients'), ('CHEBI_33340', 'zinc group element atom', 634, 'zinc'), ('CHEBI_27300', 'vitamin D', 791, 'vitamin A'), ('UBERON_0000104', 'life cycle', 873, 'life'), ('UBERON_0000160', 'intestine', 974, 'intestinal'), ('UBERON_0006314', 'bodily fluid', 1092, 'fluid'), ('UBERON_0002107', 'liver', 1466, 'liver'), ('GO_0007565', 'female pregnancy', 1503, 'postpartum'), ('CHEBI_33284', 'nutrient', 1631, 'nutrient'), ('CHEBI_33290', 'food', 1646, 'food'), ('GO_0007565', 'female pregnancy', 1734, 'postpartum'), ('CHEBI_33284', 'nutrient', 1819, 'Nutrient'), ('GO_0007565', 'female pregnancy', 1851, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2016, 'pregnancy'), ('UBERON_0000178', 'blood', 2047, 'blood'), ('CHEBI_31341', 'calcium dihydroxide', 2137, 'Calcium'), ('GO_0007565', 'female pregnancy', 2165, 'pregnant'), ('CHEBI_22313', 'alkaline earth metal atom', 2276, 'calcium'), ('CHEBI_33341', 'titanium atom', 2284, 'supplements'), ('GO_0007565', 'female pregnancy', 2302, 'pregnant'), ('CHEBI_46662', 'mineral', 2326, 'mineral'), ('CHEBI_46662', 'mineral', 2362, 'mineral'), ('UBERON_0001464', 'hip', 2385, 'hip'), ('GO_0007595', 'lactation', 2409, 'lactation'), ('NCBITaxon_10088', 'Mus <genus>', 2505, 'people'), ('GO_0051162', 'L-arabitol metabolic process', 2542, 'glycaemic control')]
PMC4632418	10/2015	S98-PMC4632418	['SIMILARLY, our meta-analysis of 20 independent observational studies provided STRONG EVIDENCE that Vitamin D deficiency was ASSOCIATED with an INCREASED RISK of Gestational diabetes.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 78), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 124), ('IMPORTANT_CONSIDERATION', 143)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'gestational')]
PMC4676908	12/2015	S111-PMC4676908	['the content of each anc visit is also IMPORTANT, AS SOME anc INTERVENTIONS MAY not be beneficial, such as high does concomitant supplementation with Vitamin C and Vitamin e to PREVENT pre-eclampsia in high-risk women (poston2006).']	[('IMPORTANT_CONSIDERATION', 38), ('PROBABLE_UNDERSTANDING', 49), ('INCOMPLETE_EVIDENCE', 52), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 149, 'vitamin C'), ('CHEBI_33229', 'vitamin (role)', 163, 'vitamin')]
PMC4684854	12/2015	S137-PMC4684854	["as discussed, individual Vitamin D indices CAN be INFLUENCED by various DETERMINANTS DESPITE specific levels of supplementation; it is THUS the author's RECOMMENDATION that a personalized medical approach be taken via individual screening for 25(Oh)D as a routine part of Preconception and Prenatal care."]	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 50), ('SUPERFICIAL_RELATIONSHIP', 72), ('ANOMALY_CURIOUS_FINDING', 85), ('PROBABLE_UNDERSTANDING', 135), ('FUTURE_WORK', 153)]	6	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 243, '25(OH)D'), ('GO_0007565', 'female pregnancy', 272, 'preconception'), ('GO_0007565', 'female pregnancy', 290, 'prenatal')]
PMC4689556	12/2015	S171-PMC4689556	['a further LIMITATION of the study is its SMALL size and wide confidence intervals, SO that a small EFFECT of Prenatal Vitamin D on child healthcare utilization in the first 3 years CANNOT BE confidently EXCLUDED.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 83), ('SUPERFICIAL_RELATIONSHIP', 99), ('DIFFICULT_TASK', 181), ('INCOMPLETE_EVIDENCE', 203)]	6	[('GO_0007565', 'female pregnancy', 109, 'prenatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC4764019	1/2016	S42-PMC4764019	['mcgrath et al also POINT out that Rats reared on Vitamin D–deficient diets produce pups that have morphologically abnormal Brain structures.9–11schizophrenia is USUALLY considered more a functional disorder with morphological alterations THAN a primarily morphologic one, and the Rat data INDICATE that Vitamin D is ESSENTIAL for normal Brain Development and HENCE plausibly for normal Brain function.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('INCOMPLETE_EVIDENCE', 289), ('IMPORTANT_CONSIDERATION', 316), ('PROBABLE_UNDERSTANDING', 359)]	6	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 34, 'rats'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000955', 'brain', 123, 'brain'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 280, 'rat'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('GO_0007420', 'brain development', 337, 'brain development'), ('UBERON_0000955', 'brain', 337, 'brain'), ('UBERON_0000955', 'brain', 386, 'brain')]
PMC4764019	1/2016	S82-PMC4764019	['in closing, it would SEEM IMPORTANT TO EMPHASIZE that the LIKELY Vitamin D status values (and the corresponding daily intakes) ASSOCIATED with protection from the delayed outcomes DISCUSSED HERE are entirely physiological, not Pharmacological (ie, in the range of 40–60 ng/ml).']	[('ANOMALY_CURIOUS_FINDING', 21), ('IMPORTANT_CONSIDERATION', 26), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 180), ('QUESTION_ANSWERED_BY_THIS_WORK', 190)]	6	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_52217', 'pharmaceutical', 227, 'pharmacological')]
PMC4770602	1/2016	S26-PMC4770602	['THUS, THIS STUDY was AIMED TO EXAMINE the IMPACT of Vitamin D supplementation in reduction of RISK of Preeclampsia in nulliparous women in a randomized controlled trial.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 94)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 102, 'preeclampsia')]
PMC4770602	1/2016	S78-PMC4770602	['THEREFORE, ADDITIONAL well-designed, prospective, randomized TRIALS of supplementation with good sample size that control for dietary exposure will BE NECESSARY to determine a POTENTIAL ROLE for Vitamin D in the PREVENTION of Preeclampsia.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 11), ('FUTURE_WORK', 148), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 186), ('SUPERFICIAL_RELATIONSHIP', 212)]	6	[('CHEBI_27300', 'vitamin D', 195, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 226, 'preeclampsia')]
PMC4785305	3/2016	S168-PMC4785305	['furthermore, GIVEN the LACK OF EVIDENCE-BASED guidelines that define the OPTIMAL rda for Vitamin D supplementation during Pregnancy in our population, and the LIMITED NUMBER of randomised clinical trials completed so far in our region, this trial will fill an IMPORTANT KNOWLEDGE GAP.']	[('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 73), ('INCOMPLETE_EVIDENCE', 159), ('IMPORTANT_CONSIDERATION', 260), ('FULL_UNKNOWN', 270)]	6	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy')]
PMC4811107	3/2016	S109-PMC4811107	["NOT ONLY do these studies INDICATE that use of the Prenatal level of 25(Oh)D to represent the child's early Life Vitamin D level is not specific, but also the data SUGGEST that a maternal THRESHOLD exists below which the mother LIMITS her CONTRIBUTION of 25(Oh)D to the fetus."]	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 164), ('PROBABLE_UNDERSTANDING', 188), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 239)]	6	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 75, 'D'), ('UBERON_0000104', 'life cycle', 108, 'life'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 255, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 257, '(OH)D')]
PMC4811441	3/2016	S141-PMC4811441	['THEREFORE, IT IS POSSIBLE that Vitamin D status in early Pregnancy MIGHT not play a MAJOR ROLE in Placental Development, but that an increment during Gestation MAY prevent the Development Of Pe.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 160)]	6	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('GO_0001890', 'placenta development', 98, 'placental development'), ('UBERON_0001987', 'placenta', 98, 'placental'), ('GO_0007565', 'female pregnancy', 150, 'gestation'), ('GO_0042494', 'detection of bacterial lipoprotein', 176, 'development of PE')]
PMC4889866	5/2016	S15-PMC4889866	['GIVEN the IMPORTANT Immune Modulatory ROLE of Vitamin D, the LINK between toll-like receptors- (tlrs-) mediated Innate Immunity and Vitamin D DESERVES in-depth INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 61), ('IMPORTANT_CONSIDERATION', 142), ('FUTURE_WORK', 160)]	6	[('GO_0051452', 'intracellular pH reduction', 20, 'immune modulatory'), ('UBERON_0002405', 'immune system', 20, 'immune'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0045087', 'innate immune response', 112, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC4889866	5/2016	S102-PMC4889866	['the DIFFERENCE between OUR FINDINGS and those of published reports MIGHT BE EXPLAINED by distinctive study design, AS ours assessed cytokine response to tlr ligands under different Vitamin D concentrations, and not cytokine response to direct Vitamin D stimulation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('INCOMPLETE_EVIDENCE', 67), ('ANOMALY_CURIOUS_FINDING', 73), ('PROBABLE_UNDERSTANDING', 76), ('PROBABLE_UNDERSTANDING', 115)]	6	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4897157	5/2016	S15-PMC4897157	['RECENT report REPORTED that fa was MORE COMMON in children Born in boston, during the autumn and winter seasons, SUGGESTING that seasonal fluctuations in sunlight, and perhaps also Vitamin D levels, MAY BE INVOLVED in the pathogenesis of fa7).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 35), ('INCOMPLETE_EVIDENCE', 113), ('INCOMPLETE_EVIDENCE', 199), ('SUPERFICIAL_RELATIONSHIP', 206)]	6	[('GO_0007567', 'parturition', 59, 'born'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC4910255	6/2016	S283-PMC4910255	['the mechanisms of action are LIKELY to be MULTIFACTORIAL and follow-up REPORTS SUGGEST OTHER mechanisms such as the EFFECT of Vitamin A on Regulation of fetal Lung growth, branching and alveolarisation [67,68].']	[('PROBABLE_UNDERSTANDING', 29), ('DIFFICULT_TASK', 42), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('SUPERFICIAL_RELATIONSHIP', 116)]	6	[('CHEBI_27300', 'vitamin D', 126, 'vitamin A'), ('GO_0065007', 'biological regulation', 139, 'regulation'), ('UBERON_0002048', 'lung', 159, 'lung')]
PMC4923982	5/2016	S114-PMC4923982	['IN LIGHT OF this PROPOSED oxidative pathway, we EXAMINED the POSSIBILITY that the antioxidant Vitamin C modified the ASSOCIATION between iron and gdm, but we FOUND that dietary Intake of Vitamin C above the median had no measurable effect on gdm.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 158)]	6	[('CHEBI_27300', 'vitamin D', 94, 'vitamin C'), ('GO_0007631', 'feeding behavior', 177, 'intake'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin C')]
PMC4930210	7/2016	S22-PMC4930210	['THIS REVIEW HIGHLIGHTED the extremely HETEROGENEOUS evidence in regards to definition of Serum Vitamin D concentration THRESHOLD and the LACK OF high-quality interventional studies [10].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 12), ('DIFFICULT_TASK', 38), ('PROBABLE_UNDERSTANDING', 119), ('INCOMPLETE_EVIDENCE', 137), ('ANOMALY_CURIOUS_FINDING', 142)]	6	[('UBERON_0001977', 'blood serum', 89, 'serum'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC4934634	11/2015	S10-PMC4934634	['over the past two decades, it HAS BEEN WELL ACCEPTED that Vitamin D is a pro-hormone, and suboptimal Vitamin D status HAS been increasingly LINKED to a broad range of diseases including, cancer, diabetes, Cardiovascular disease, and Autoimmune disorders.']	[('INCOMPLETE_EVIDENCE', 30), ('FUTURE_WORK', 39), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 44), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 140)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 205, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 233, 'autoimmune')]
PMC4934634	11/2015	S97-PMC4934634	['IN CONTRAST TO iom RECOMMENDATIONS, the endocrine society RECOMMENDS a Vitamin D intake of AT LEAST 600 iu/day, BUT states that 1500–2000 iu/day MAY BE needed for Pregnant or Lactating females to maintain a 25(Oh)D level ≥ 30 ng/ml.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 19), ('FUTURE_WORK', 58), ('PROBABLE_UNDERSTANDING', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 145)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 163, 'pregnant'), ('GO_0007594', 'puparial adhesion', 175, 'lactating'), ('CHEBI_71657', 'versiconol acetate', 207, '25(OH)D')]
PMC4944244	7/2016	S28-PMC4944244	['THEREFORE, it is NECESSARY to determine the PREVALENCE of hypovitaminosis D among Pregnant women and assess its risk FACTORS to overcome the PROBLEMS caused by lack of Vitamin D.\n\nmethods\n\nsubjects and sampling\na cross-sectional study was conducted in petaling district, selangor.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 17), ('IMPORTANT_CONSIDERATION', 44), ('SUPERFICIAL_RELATIONSHIP', 117), ('IMPORTANT_CONSIDERATION', 141), ('PROBLEM_COMPLICATION', 141)]	6	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 74, 'D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4944244	7/2016	S171-PMC4944244	['HOWEVER, this ASSUMPTION would not be EFFECTIVE for countries with less exposure to the sun, where low education was ASSOCIATED with lower Serum 25(Oh)D, PERHAPS AS a result of less dietary intake of Vitamin D and less opportunity for sunbathing leisure and vacation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 154), ('PROBABLE_UNDERSTANDING', 162)]	6	[('UBERON_0001977', 'blood serum', 139, 'serum'), ('CHEBI_71657', 'versiconol acetate', 145, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 145, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
PMC4949006	7/2016	S149-PMC4949006	['THERE ARE NO STUDIES clearly SHOWING DIFFERENCES in maternal outcomes or fetal survival, Birth weight, or Gestational length relative to Vitamin D,118but studies on bone health (and Lung function and asthma at age 6 years119) SUPPORT a level of AT LEAST 50 nmol/l, which implies a need for some supplementation for all Pregnant women.120–123\n\nCalcium\nwomen lose 3% to 5% of their bone mass while Lactating but rapidly regain it within 6 months after weaning.']	[('FULL_UNKNOWN', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 226), ('PROBABLE_UNDERSTANDING', 245)]	6	[('GO_0007567', 'parturition', 89, 'birth'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('UBERON_0002048', 'lung', 182, 'lung'), ('GO_0007565', 'female pregnancy', 319, 'pregnant'), ('CHEBI_31341', 'calcium dihydroxide', 343, 'Calcium'), ('GO_0007594', 'puparial adhesion', 396, 'lactating')]
PMC4973215	8/2016	S92-PMC4973215	['this corresponds to the WELL-KNOWN ASSOCIATION that women with higher bmi TEND to Deliver infants with higher Birth weights.40,41,42\nfurthermore, identification and recognition of women and infants at high risk of Vitamin D deficiency and sga CAN LEAD TO OPPORTUNITIES for risk modification and reduction in adverse outcomes.']	[('PROBABLE_UNDERSTANDING', 24), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 74), ('INCOMPLETE_EVIDENCE', 243), ('PROBABLE_UNDERSTANDING', 247), ('FUTURE_WORK', 255)]	6	[('GO_0007567', 'parturition', 82, 'deliver'), ('GO_0007567', 'parturition', 110, 'birth'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC4976416	7/2016	S23-PMC4976416	['[16]\nheadache is a RECOGNIZED EFFECT of methemoglobinemia, and reduction of previously elevated methemoglobin concentration is PRESUMABLY the mechanism by which Vitamin E improves this symptom, AS improved methemoglobin concentration SEEMS to be the most CONSISTENT laboratory parameter in studies of Vitamin E for protection against dapsone side effects.']	[('PROBABLE_UNDERSTANDING', 19), ('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 127), ('PROBABLE_UNDERSTANDING', 194), ('ANOMALY_CURIOUS_FINDING', 234), ('INCOMPLETE_EVIDENCE', 255)]	6	[('CHEBI_27300', 'vitamin D', 161, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin E')]
PMC4982007	8/2016	S278-PMC4982007	['another LIMITATION was that maternal Vitamin D status was available ONLY during the second trimester; SINCE Vitamin D IS KNOWN to fluctuate with sunlight exposure, the timing of deficiency MAY BE CRUCIAL in determining Cognitive function.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 68), ('PROBABLE_UNDERSTANDING', 102), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 189), ('IMPORTANT_CONSIDERATION', 196)]	6	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0050890', 'cognition', 219, 'cognitive')]
PMC4982007	8/2016	S280-PMC4982007	['THUS, based ON a LIMITED NUMBER OF observational studies evidence LINKING maternal Vitamin D deficiency with reduced offspring Cognitive function is NOT CONCLUSIVE.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0050890', 'cognition', 127, 'cognitive')]
PMC4992225	8/2016	S260-PMC4992225	['it is also POSSIBLE that AS a result of vascular changes in Pregnancy the maternal Cerebral environment is more vulnerable to inflammation PERHAPS, EXPLAINING IN PART the LINK between Vitamin D and depression in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 25), ('INCOMPLETE_EVIDENCE', 139), ('PROBABLE_UNDERSTANDING', 148), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('GO_0007565', 'female pregnancy', 60, 'pregnancy'), ('UBERON_0001893', 'telencephalon', 83, 'cerebral'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 212, 'pregnancy')]
PMC4992225	8/2016	S261-PMC4992225	['IN LIGHT OF the inflammatory nature of depression and the strong ROLE of Vitamin D AS an anti-inflammatory and immunomodulator, inflammation MAY MEDIATE the RELATIONSHIP between vitamin d deficiency and depression during Pregnancy [73,74].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 83), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 145), ('SUPERFICIAL_RELATIONSHIP', 157)]	6	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy')]
PMC4998950	4/2016	S33-PMC4998950	['discussion\nTHIS STUDY is, TO OUR KNOWLEDGE, the FIRST population-based study to ESTIMATE the RELATIONSHIP between maternal Vitamin D deficiency and the RISK of asd in a child.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 93), ('IMPORTANT_CONSIDERATION', 152)]	6	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4998950	4/2016	S46-PMC4998950	['AS Vitamin D deficiency in Pregnancy is both PREVALENT and treatable, FURTHER INVESTIGATION of this ASSOCIATION IS NEEDED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 45), ('FUTURE_WORK', 70), ('FUTURE_WORK', 78), ('SUPERFICIAL_RELATIONSHIP', 100), ('FUTURE_WORK', 112)]	6	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007565', 'female pregnancy', 27, 'pregnancy')]
PMC5014971	8/2016	S35-PMC5014971	['HOWEVER, CONSENSUS on WHAT constitutes adequate Vitamin D status during Pregnancy and the most efficacious means to prevent and treat Vitamin D deficiency/insufficiency in Pregnant women has yet to be reached, leading to DIFFERING assessments of this PUBLIC HEALTH ISSUE [14,19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('EXPLICIT_QUESTION', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('IMPORTANT_CONSIDERATION', 251), ('IMPORTANT_CONSIDERATION', 265)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 172, 'pregnant')]
PMC5014971	8/2016	S94-PMC5014971	['discussion\nthe results of THIS STUDY SUGGEST that practicing obstetrician-gynecologists GENERALLY are SOMEWHAT CONCERNED about the Vitamin D status of their Pregnant patients and consider Vitamin D supplementation during Pregnancy to be SAFE.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 102), ('IMPORTANT_CONSIDERATION', 111), ('IMPORTANT_CONSIDERATION', 237)]	6	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnant'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy')]
PMC5014971	8/2016	S102-PMC5014971	['in SUPPORT of the endocrine society RECOMMENDATIONS, SOME researchers POINT to the LIKELY higher circulating levels of 25-Oh-D in our ancestors that relied PRIMARILY on Photosynthetic Production Of Vitamin D, arguing that our Vitamin D Metabolism is adapted to high endogenous production [17,18].']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 36), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 83), ('PROBABLE_UNDERSTANDING', 156)]	6	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 119, '25-OH-D'), ('GO_0010264', 'myo-inositol hexakisphosphate biosynthetic process', 169, 'photosynthetic'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 184, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0007601', 'visual perception', 226, 'vitamin D'), ('GO_0008152', 'metabolic process', 236, 'metabolism')]
PMC5028238	10/2016	S85-PMC5028238	['this HAS BEEN used TO EXPLAIN WHY northern populations have a higher prevalence of slos.11\ncarriers also are HYPOTHESIZED to have a Reproductive advantage because of the reduced fetal death due to Rachitic Cephalopelvic disproportion.11,35this is again RELATED to increased Vitamin D Production causing improved bone formation.']	[('INCOMPLETE_EVIDENCE', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('PROBABLE_UNDERSTANDING', 22), ('EXPLICIT_QUESTION', 30), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 253)]	6	[('GO_0000003', 'reproduction', 132, 'reproductive'), ('UBERON_0001286', "Bowman's space", 197, 'rachitic cephalopelvic'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 284, 'production')]
PMC5028238	10/2016	S94-PMC5028238	['one POSSIBLE biological EXPLANATION that fits with the literature-derived mechanism (figure 3) is that slos patients spent less time outdoors thereby reducing their Ultraviolet b exposure (another CRITICAL REQUIREMENT for Vitamin D Synthesis).55\n\nGenetic understanding of slos-inducing Dhcr7 mutations: IMPLICATIONS for FUTURE WORK\n\nchanging our understanding of slos genetics using large-scale Genomics studies\nusing exac,24we were able to compare the frequencies of Dhcr7 slos-inducing mutations in the slos population (extracted from the literature) and the assumed-healthy exac population.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 24), ('IMPORTANT_CONSIDERATION', 197), ('IMPORTANT_CONSIDERATION', 206), ('IMPORTANT_CONSIDERATION', 303), ('FUTURE_WORK', 320)]	6	[('CHEBI_75275', 'tetradecyl sulfonic acid', 165, 'ultraviolet'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D'), ('GO_0031151', 'histone methyltransferase activity (H3-K79 specific)', 230, 'D synthesis'), ('SO_0000704', 'gene', 247, 'Genetic'), ('PR_000006474', 'ATP-dependent RNA helicase A', 286, 'DHCR7'), ('SO_0001026', 'genome', 395, 'genomics'), ('PR_000006474', 'ATP-dependent RNA helicase A', 468, 'DHCR7')]
PMC5035678	4/2016	S109-PMC5035678	['discussion\nTO OUR KNOWLEDGE, THIS is the FIRST STUDY TO EVALUATE the EFFECTS of Vitamin D supplementation during Pregnancy on Glucose Metabolism shortly after Delivery.']	[('PROBABLE_UNDERSTANDING', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 69)]	6	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('CHEBI_17234', 'glucose', 126, 'glucose'), ('GO_0006006', 'glucose metabolic process', 126, 'glucose metabolism'), ('GO_0007567', 'parturition', 159, 'delivery')]
PMC5062906	10/2016	S256-PMC5062906	['Genetic INFLUENCES on adiposity MAY also indirectly explain DIFFERENCES in Vitamin D depletion SINCE adiposity HAS BEEN LINKED to Vitamin D levels [55].']	[('SUPERFICIAL_RELATIONSHIP', 8), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 120)]	6	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC5064894	10/2016	S11-PMC5064894	['discussion\nIF SHOWN to reduce the RISK of viral ari in infancy, integration of maternal Prenatal/Postpartum Vitamin D supplementation into Antenatal Care programs in south asia may be a FEASIBLE primary preventive STRATEGY to reduce THE BURDEN of ari-ASSOCIATED morbidity and mortality in young infants.']	[('INCOMPLETE_EVIDENCE', 11), ('IMPORTANT_CONSIDERATION', 34), ('PROBABLE_UNDERSTANDING', 186), ('FUTURE_WORK', 214), ('IMPORTANT_CONSIDERATION', 233), ('SUPERFICIAL_RELATIONSHIP', 251)]	6	[('GO_0007565', 'female pregnancy', 88, 'prenatal'), ('GO_0007565', 'female pregnancy', 97, 'postpartum'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007608', 'sensory perception of smell', 139, 'antenatal care')]
PMC5084734	5/2016	S28-PMC5084734	['gaps in Nutrient intake at this age are GENERALLY greatest for iron and zinc (vitta & dewey2013), BUT OTHER Nutrients MAY BE PROBLEMATIC (such as calcium, Vitamin A and certain b Vitamins) DEPENDING ON the types of foods consumed (dewey2013).']	[('PROBABLE_UNDERSTANDING', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 118), ('PROBLEM_COMPLICATION', 125), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 189)]	6	[('CHEBI_33284', 'nutrient', 8, 'nutrient'), ('CHEBI_33284', 'nutrient', 108, 'nutrients'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin A'), ('CHEBI_33277', 'gamma-tocotrienol', 179, 'vitamins'), ('PR_000027594', 'histone H3', 179, 'vitamins')]
PMC5129897	10/2016	S159-PMC5129897	['the uncertainty in the numbers is ABOUT 50% AS a result of omitting other diseases with LESS EVIDENCE FOR Vitamin D EFFECTS as well as the POSSIBILITY that the ESTIMATES are too high.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 44), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 160)]	6	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC5146866	12/2016	S11-PMC5146866	['background\ncharacterization of the Vitamin D status in the maternal-fetal-neonatal interface is clinically IMPORTANT BECAUSE of the increased rates of detection of Vitamin D insufficiency in Cord Blood (Cb) and the ASSOCIATED RISK for health COMPLICATIONS in infants and children [1,2], including but not limited to rickets [3], infectious and allergic diseases, and type 1 diabetes [4–6].']	[('IMPORTANT_CONSIDERATION', 107), ('PROBABLE_UNDERSTANDING', 117), ('PROBLEM_COMPLICATION', 117), ('SUPERFICIAL_RELATIONSHIP', 215), ('IMPORTANT_CONSIDERATION', 226), ('IMPORTANT_CONSIDERATION', 242)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('UBERON_0009472', 'axilla', 191, 'cord blood'), ('UBERON_2005013', 'concurrent branch afferent branchial artery', 203, 'CB')]
PMC5146866	12/2016	S23-PMC5146866	['DIFFERENCES in the classification [8–10] used to assess the infants’ Vitamin D status and strong DEPENDENCE of their Vitamin D pool on maternal Vitamin D levels [18] MAY BE RESPONSIBLE for the wide VARIABILITY in the REPORTED rates of Vitamin D deficiency/insufficiency in infants at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 97), ('INCOMPLETE_EVIDENCE', 166), ('PROBABLE_UNDERSTANDING', 173), ('DIFFICULT_TASK', 198), ('INCOMPLETE_EVIDENCE', 217)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007567', 'parturition', 284, 'birth')]
PMC5146866	12/2016	S108-PMC5146866	['moreover, DUE TO the high LIKELIHOOD of Vitamin D insufficiency/deficiency at Birth, FURTHER STUDIES MAY be REQUIRED to determine the ROLE of implementing Vitamin D supplementation with respect to the cb Vitamin D status.']	[('PROBLEM_COMPLICATION', 10), ('PROBABLE_UNDERSTANDING', 26), ('FUTURE_WORK', 85), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 108), ('SUPERFICIAL_RELATIONSHIP', 134)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 78, 'birth'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC5155676	12/2016	S17-PMC5155676	['NONETHELESS, the institute of medicine (iom) has SUGGESTED that risk of Vitamin D insufficiency, DEFINED as a 25(Oh)D less than 50 nmol/l, SHOULD BE avoided during Pregnancy (5), and this is SUPPORTED by the RECENT global consensus on the prevention of rickets (6).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 97), ('FUTURE_WORK', 139), ('INCOMPLETE_EVIDENCE', 191), ('INCOMPLETE_EVIDENCE', 208)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('GO_0007565', 'female pregnancy', 164, 'pregnancy')]
PMC5155676	12/2016	S133-PMC5155676	['ALTHOUGH this Genetic information CAN enable a more COMPREHENSIVE understanding of the biochemical response to Vitamin D supplementation, the current inability to undertake genotyping on a widespread population basis means this additional information WOULD NOT ALLOW for alterations to current clinical PRACTICE regarding Vitamin D supplementation in Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 52), ('DIFFICULT_TASK', 251), ('INCOMPLETE_EVIDENCE', 303)]	6	[('SO_0000704', 'gene', 14, 'genetic'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D'), ('GO_0007565', 'female pregnancy', 351, 'pregnancy')]
PMC5223368	12/2016	S144-PMC5223368	['THEREFORE, the positive ASSOCIATION between high temperature at the third Trimester and increased Birth length in THIS STUDY MIGHT be PARTLY EXPLAINED by Vitamin D status of mothers [31].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 114), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 134), ('PROBABLE_UNDERSTANDING', 141)]	6	[('GO_0009294', 'DNA mediated transformation', 74, 'trimester'), ('GO_0007567', 'parturition', 98, 'birth'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC5318550	2/2017	S22-PMC5318550	['owing to its RELATIONSHIP with the duration of the photoperiod, low Vitamin D levels are put forward AS a POTENTIAL mechanism between season of Birth and Neurological outcomes.8\nanother CANDIDATE mechanism for the seasonal PATTERNS in intellectual ability are the educational policies regarding school entry.9age at school entrance and the relative age compared with peers are considered to AFFECT the youngest in class.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBABLE_UNDERSTANDING', 101), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 186), ('SUPERFICIAL_RELATIONSHIP', 223), ('SUPERFICIAL_RELATIONSHIP', 391)]	6	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0007567', 'parturition', 144, 'birth'), ('UBERON_0001016', 'nervous system', 154, 'neurological')]
PMC5340372	3/2017	S93-PMC5340372	['ALTHOUGH a circulating level of 25(Oh)D less than 20 ng/ml is DEFINED AS Vitamin D deficiency [27,28], the mean levels MAY VARY among DIFFERENT populations [29].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 62), ('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 119), ('DIFFICULT_TASK', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134)]	6	[('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 38, 'D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC5340372	3/2017	S117-PMC5340372	['in THIS STUDY, infants with low 25(Oh)D had higher rrs BUT SIMILAR vmaxfrc, which IMPLIES that low Perinatal Vitamin D levels MIGHT be ASSOCIATED with a higher resistance of the Extrathoracic Airway.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ANOMALY_CURIOUS_FINDING', 55), ('SUPERFICIAL_RELATIONSHIP', 59), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135)]	6	[('CHEBI_71657', 'versiconol acetate', 32, '25(OH)D'), ('GO_0036268', 'swimming', 99, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 99, 'perinatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0001601', 'extra-ocular muscle', 178, 'extrathoracic airway')]
PMC5340372	3/2017	S136-PMC5340372	['second, our PREVIOUS report CONCLUDED that relatively low Vitamin D levels were COMMON in the patch population sample of children and young Adults with an inverse CORRELATION between 25(Oh)D level and age being SHOWN HERE [51].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 28), ('PROBABLE_UNDERSTANDING', 80), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 211), ('QUESTION_ANSWERED_BY_THIS_WORK', 217)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0007023', 'adult organism', 140, 'adults'), ('CHEBI_33010', 'chromide(1-)', 185, '(OH)D')]
PMC5372327	3/2017	S39-PMC5372327	['THEREFORE, Vitamin D does NOT ONLY have a ROLE in Modulating Host Defence To Infections, BUT is LIKELY to Control FACTORS in autoimmunity, also in allergic disease.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 42), ('ANOMALY_CURIOUS_FINDING', 89), ('PROBABLE_UNDERSTANDING', 96), ('SUPERFICIAL_RELATIONSHIP', 114)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0065007', 'biological regulation', 50, 'modulating'), ('GO_0030989', 'dynein-driven meiotic oscillatory nuclear movement', 61, 'host defence to infections'), ('GO_0065007', 'biological regulation', 106, 'control')]
PMC5372327	3/2017	S122-PMC5372327	['discussion\nTO THE BEST OF OUR KNOWLEDGE, THIS is the largest and MOST COMPREHENSIVE randomised intervention STUDY TO ASSESS the EFFECTS of Vitamin D supplementation on Skeletal and extra Skeletal outcomes in infants.']	[('PROBABLE_UNDERSTANDING', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('PROBABLE_UNDERSTANDING', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 108), ('QUESTION_ANSWERED_BY_THIS_WORK', 114), ('SUPERFICIAL_RELATIONSHIP', 128)]	6	[('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('UBERON_0004288', 'skeleton', 168, 'skeletal'), ('UBERON_0004288', 'skeleton', 187, 'skeletal')]
PMC5385921	4/2017	S40-PMC5385921	['ALTHOUGH there is SOME DEBATE about the definition of these strata,21there is no DEBATE that children with 25Ohd concentrations of <25 nmol/l have Vitamin D deficiency (AS defined by an increased risk of rickets and increased Parathyroid hormone).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('PROBABLE_UNDERSTANDING', 169)]	6	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 107, '25OHD'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 226, 'parathyroid')]
PMC5385921	4/2017	S121-PMC5385921	['the FINDING from THIS STUDY LENDS weight to the GROWING BODY of epidemiological and Animal MODEL-based research LINKING Gestational Vitamin D deficiency and altered Brain Development.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 112)]	6	[('NCBITaxon_33208', 'Metazoa', 84, 'animal'), ('GO_0007565', 'female pregnancy', 120, 'gestational'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0007420', 'brain development', 165, 'brain development'), ('UBERON_0000955', 'brain', 165, 'brain')]
PMC5405075	4/2017	S2-PMC5405075	['SINCE asthma is presented with high incidence in childhood and neonatal Vitamin D stores DEPEND on maternal Vitamin levels, a POSSIBLE programming EFFECT of maternal Vitamin D status during Gestation was SUGGESTED.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 204)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 108, 'vitamin'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0007565', 'female pregnancy', 190, 'gestation')]
PMC5405075	4/2017	S9-PMC5405075	['SINCE asthma is presented with high incidence in childhood, a POSSIBLE programming EFFECT of maternal Vitamin D status during Gestation HAS BEEN PROPOSED.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 145)]	6	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'gestation')]
PMC5405075	4/2017	S11-PMC5405075	['several OBSERVATIONAL STUDIES explored THIS issue and SUGGESTED a PUTATIVE PROTECTIVE ROLE of Prenatal Vitamin D sufficiency in the development Of Wheezing and Asthma in the offspring [reviewed in ref.']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 66), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 86)]	6	[('GO_0007565', 'female pregnancy', 94, 'prenatal'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0001503', 'ossification', 144, 'of wheezing'), ('GO_0006953', 'acute-phase response', 160, 'asthma')]
PMC5405075	4/2017	S98-PMC5405075	['moreover, any intervention SHOULD BE individualized to initial maternal Vitamin D status and be followed up, SINCE a u -curve ASSOCIATION between Vitamin D circulating levels and IMPACT on allergy and Human health HAS BEEN also PROPOSED (83,84).']	[('FUTURE_WORK', 27), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 126), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 214), ('INCOMPLETE_EVIDENCE', 228)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 201, 'human')]
PMC5418719	5/2017	S101-PMC5418719	['preterm infants with radiologic evidence of rickets or high alkaline phosphatase (>800\xa0iu/l) are GENERALLY given the upper intake total of 800\xa0iu/day of Vitamin D. DESPITE Vitamin D supplementation, it is DIFFICULT to maintain the RECOMMENDED daily Vitamin D intake from dietary in preterm infants, and there are FEW EVIDENCE-based data to support Vitamin D supplementation to meet a desired Serum 25(Oh)D ACCORDING to Vitamin D status at Birth in preterm infants.']	[('PROBABLE_UNDERSTANDING', 97), ('ANOMALY_CURIOUS_FINDING', 164), ('DIFFICULT_TASK', 205), ('FUTURE_WORK', 231), ('INCOMPLETE_EVIDENCE', 313), ('SUPERFICIAL_RELATIONSHIP', 406)]	6	[('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('UBERON_0001977', 'blood serum', 392, 'serum'), ('CHEBI_71657', 'versiconol acetate', 398, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 401, 'OH ... D'), ('CHEBI_27300', 'vitamin D', 419, 'vitamin D'), ('GO_0007567', 'parturition', 439, 'birth')]
PMC5418719	5/2017	S103-PMC5418719	['CONSISTENT with PREVIOUS reports about a dose-response EFFECT of Vitamin D supplementation [2,23], we OBSERVED that early supplementation with 800\xa0iu Vitamin D safely achieved an 88% PROBABILITY of Vitamin D sufficiency at 36 pma in the MAJORITY of infants with Cord-Blood levels of 25(Oh)D\u2009≥\u200910\xa0ng/ml.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 55), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 183), ('PROBABLE_UNDERSTANDING', 237)]	6	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 262, 'cord'), ('UBERON_0000178', 'blood', 267, 'blood'), ('CHEBI_71657', 'versiconol acetate', 283, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 283, '25(OH ... D')]
PMC5418719	5/2017	S105-PMC5418719	['the DIFFERENT response to Vitamin D supplementation COULD BE EXPLAINED by vdr Gene polymorphism INVOLVED in Vitamin D Receptor, which results in Vitamin D deficiency at 36 pma in SOME babies after supplementation [24].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 52), ('ANOMALY_CURIOUS_FINDING', 58), ('PROBABLE_UNDERSTANDING', 61), ('SUPERFICIAL_RELATIONSHIP', 96), ('INCOMPLETE_EVIDENCE', 179)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('SO_0000704', 'gene', 78, 'gene'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 108, 'vitamin D receptor'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5426325	4/2017	S121-PMC5426325	['nonetheless, the decreasing TREND MAY have been AFFECTED by INFLUENCES more powerful than the LIKELY IMPACT of Vitamin D in the modest amounts of 1·25 µg vitamin d/100 g Margarine(31).']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 94), ('SUPERFICIAL_RELATIONSHIP', 101)]	6	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_6784', 'mestranol', 170, 'margarine')]
PMC5426325	4/2017	S122-PMC5426325	['by comparing Individuals from entire adjacent Birth cohorts that were, or were not, exposed to extra Vitamin D from Margarine fortification Prenatally only, but all unexposed thereafter, we ASSUME that all POTENTIAL CONFOUNDERS are equally distributed in both groups, and HENCE that control for CONFOUNDING is not NEEDED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('INCOMPLETE_EVIDENCE', 206), ('PROBLEM_COMPLICATION', 216), ('PROBABLE_UNDERSTANDING', 272), ('PROBLEM_COMPLICATION', 295), ('FUTURE_WORK', 314)]	6	[('NCBITaxon_1', 'root', 13, 'individuals'), ('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_6784', 'mestranol', 116, 'margarine'), ('GO_0019230', 'proprioception', 140, 'prenatally')]
PMC5489519	6/2017	S91-PMC5489519	['THUS, OUR FINDINGS that Vitamin D is ASSOCIATED with altered Trail Expression in Breast Milk MAY BE an IMPORTANT LINK to the mother and infant Immune System.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 93), ('IMPORTANT_CONSIDERATION', 103), ('SUPERFICIAL_RELATIONSHIP', 113)]	6	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 61, 'TRAIL'), ('GO_0010467', 'gene expression', 67, 'expression'), ('UBERON_0001348', 'brown adipose tissue', 81, 'breast milk'), ('UBERON_0002405', 'immune system', 143, 'immune system')]
PMC5489519	6/2017	S115-PMC5489519	['THUS, our results SUGGEST that the Vitamin D modulation of Trail expression in Mammary Epithelial Cells MAY CONTRIBUTE to Trail protein levels in Human Milk, which MAY have IMPLICATIONS for both mother and infant health under Vitamin D deficient and sufficient conditions.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 164), ('IMPORTANT_CONSIDERATION', 173)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 59, 'TRAIL'), ('CL_0002327', 'mammary gland epithelial cell', 79, 'mammary epithelial cells'), ('UBERON_0006954', 'mammary gland myoepithelium', 79, 'mammary epithelial'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 122, 'TRAIL'), ('NCBITaxon_9606', 'Homo sapiens', 146, 'human'), ('UBERON_0001913', 'milk', 152, 'milk'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
PMC5537904	7/2017	S171-PMC5537904	['IT IS POSSIBLE that VARIATIONS in absorption and specific sources of Vitamin D (D2Versus D3) ACCOUNT FOR our differing ESTIMATE, and THUS should be INTERPRETED with caution.']	[('INCOMPLETE_EVIDENCE', 0), ('DIFFICULT_TASK', 20), ('PROBABLE_UNDERSTANDING', 93), ('INCOMPLETE_EVIDENCE', 119), ('PROBABLE_UNDERSTANDING', 133), ('FULL_UNKNOWN', 148)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 80, 'D2versus D3')]
PMC5537904	7/2017	S180-PMC5537904	['we used season of Birth as a crude measurement of sun exposure because we DID NOT have direct measures of uvb-synthesized Vitamin D, and THUS our results for the relative CONTRIBUTION of Oral Intake versus sun exposure SHOULD BE INTERPRETED with CAUTION.']	[('INCOMPLETE_EVIDENCE', 74), ('PROBABLE_UNDERSTANDING', 137), ('SUPERFICIAL_RELATIONSHIP', 171), ('FUTURE_WORK', 219), ('FULL_UNKNOWN', 229), ('INCOMPLETE_EVIDENCE', 246)]	6	[('GO_0007567', 'parturition', 18, 'birth'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('UBERON_0000165', 'mouth', 187, 'oral'), ('GO_0007631', 'feeding behavior', 192, 'intake')]
PMC5546866	8/2017	S27-PMC5546866	['we THEREFORE undertook THIS STUDY TO DETERMINE WHETHER Snps within the Vitamin D Metabolism pathway KNOWN to modify Vitamin D status are also ASSOCIATED with the response to Antenatal Vitamin d supplementation.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('SO_0000694', 'SNP', 55, 'SNPs'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 71, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 174, 'antenatal'), ('CHEBI_33229', 'vitamin (role)', 184, 'vitamin')]
PMC5546866	8/2017	S132-PMC5546866	['we FOUND that the rs10741657 Snp was not associated with baseline 25(Oh)D BUT was ASSOCIATED with the response to Gestational Vitamin D supplementation, THEREFORE SUGGESTING that this Snp ONLY modifies 25(Oh)D status when the substrate is more readily available and that at the baseline measurement, saturation of the enzyme had not been reached.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 82), ('PROBABLE_UNDERSTANDING', 153), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 188)]	6	[('SO_0000694', 'SNP', 29, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 66, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 66, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('SO_0000694', 'SNP', 184, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D')]
PMC5546866	8/2017	S145-PMC5546866	['AS SUCH, CONFIRMATION of THESE FINDINGS in severely Vitamin D–deficient women IS NEEDED AS IT IS POSSIBLE that women with specific genotypes were selectively excluded by this inclusion criterion.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 78), ('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 91)]	6	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC5634437	10/2017	S228-PMC5634437	['THEREFORE, the harmful EFFECTS we OBSERVED for Haloperidol COULD BE due to the elevated 7-Dehydrocholesterol levels and not a reduction in Vitamin D. further mechanism-based STUDIES ARE REQUIRED.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 59), ('FUTURE_WORK', 174), ('FUTURE_WORK', 182)]	6	[('CHEBI_5613', 'haloperidol', 47, 'haloperidol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 88, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC5664622	9/2017	S94-PMC5664622	['REGARDLESS, DESPITE Vitamin/Mineral supplementation in Pregnancy, maternal intake of Vitamin D REMAINS below the RECOMMENDED levels, MOSTLY BECAUSE 75% of the multi-component Supplements for Pregnant women which are available in poland contain small amount of Vitamin D (5–10 µg) [14], as compared to the recommended dose of 37.5–50 µg [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('INCOMPLETE_EVIDENCE', 95), ('FUTURE_WORK', 113), ('PROBABLE_UNDERSTANDING', 133), ('PROBABLE_UNDERSTANDING', 140)]	6	[('CHEBI_33229', 'vitamin (role)', 20, 'vitamin'), ('CHEBI_46662', 'mineral', 28, 'mineral'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 175, 'supplements'), ('GO_0007565', 'female pregnancy', 191, 'pregnant'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D')]
PMC5664622	9/2017	S103-PMC5664622	['in all mother-infant Blood sets, Umbilical Cord Blood Vitamin D concentration was higher by 7.7 ng/ml on average (APPROXIMATELY 40%), as COMPARED TO maternal levels, which is CONSISTENT with MOST studies worldwide, CLAIMING that Cord Blood level was higher than maternal Venous Blood level by 3.9–8.0 ng/ml [7,12,26,32].']	[('INCOMPLETE_EVIDENCE', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 137), ('INCOMPLETE_EVIDENCE', 175), ('PROBABLE_UNDERSTANDING', 191), ('PROBABLE_UNDERSTANDING', 215), ('PROBABLE_UNDERSTANDING', 215)]	6	[('UBERON_0000178', 'blood', 21, 'blood'), ('UBERON_0002331', 'umbilical cord', 33, 'umbilical cord'), ('UBERON_0000178', 'blood', 48, 'blood'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 229, 'cord'), ('UBERON_0000178', 'blood', 234, 'blood'), ('UBERON_0013756', 'venous blood', 271, 'venous blood')]
PMC5706533	11/2017	S159-PMC5706533	['the INTERPRETATION of Micronutrient intervention trials, HOWEVER, is COMPLEX BECAUSE all Individuals have some Vitamin D intake or Endogenous production.35the EFFECT of a given dose depends on the difference between the intervention and control doses (or the difference in mean 25(Oh)D in the intervention versus control group at/near delivery) as well as baseline Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('DIFFICULT_TASK', 69), ('PROBABLE_UNDERSTANDING', 77), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 22, 'micronutrient'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0009790', 'embryo development', 131, 'endogenous'), ('CHEBI_71657', 'versiconol acetate', 278, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 278, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
PMC5758521	1/2018	S128-PMC5758521	['THUS, our OBSERVED negative ASSOCIATIONS of Cord Blood Vitamin E with leptin and adiponectin SUGGEST a POTENTIAL beneficial ROLE of Vitamin E in early Life in preventing the development of childhood obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 124)]	6	[('UBERON_0009472', 'axilla', 44, 'cord blood'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin E'), ('UBERON_0000104', 'life cycle', 151, 'life')]
PMC5758521	1/2018	S155-PMC5758521	['it SHOULD be NOTED that the normal reference values for Vitamins A and E in Cord Blood are NOT AVAILABLE, and our OBSERVED ASSOCIATIONS were MOSTLY moderate.']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 13), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 114), ('SUPERFICIAL_RELATIONSHIP', 123), ('PROBABLE_UNDERSTANDING', 141)]	6	[('CHEBI_27300', 'vitamin D', 56, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 56, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 71, 'E'), ('UBERON_0009472', 'axilla', 76, 'cord blood')]
PMC5812027	2/2018	S73-PMC5812027	['tobacco use and Vitamin D supplement use were also INVESTIGATED as POTENTIAL CONFOUNDERS BUT did not show any confounding effect and were THUS not included in the final MODELS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('INCOMPLETE_EVIDENCE', 67), ('PROBLEM_COMPLICATION', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89), ('PROBABLE_UNDERSTANDING', 138), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169)]	6	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
PMC5941617	5/2018	S3-PMC5941617	['THUS, Vitamin D deficiency MAY AFFECT NOT ONLY Musculoskeletal health BUT ALSO a POTENTIALLY WIDE range of acute and chronic conditions.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 31), ('ANOMALY_CURIOUS_FINDING', 38), ('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93)]	6	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 47, 'musculoskeletal')]
PMC5941617	5/2018	S232-PMC5941617	['the administration of a single large dose of Vitamin D\u2009>\u2009300000\xa0iu is not RECOMMENDED, BECAUSE MAY cause high risk of Vitamin D intoxication with hypercalciuria and hypercalcemia, AS CONFIRMED by RECENT STUDIES [191–195].']	[('FUTURE_WORK', 74), ('PROBLEM_COMPLICATION', 87), ('INCOMPLETE_EVIDENCE', 95), ('PROBABLE_UNDERSTANDING', 180), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 196)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC5941617	5/2018	S394-PMC5941617	['a RECENT large STUDY FOUND NO EVIDENCE that Genetically determined reduction in 25(Oh)D levels conferred an increased risk for ad, SUGGESTING that EFFORTS to increase Vitamin D are UNLIKELY to reduce risks of the atopic disease [349].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 131), ('FUTURE_WORK', 147), ('PROBABLE_UNDERSTANDING', 181)]	6	[('SO_0000704', 'gene', 44, 'genetically'), ('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC5941617	5/2018	S472-PMC5941617	['AS Vitamin D is an IMPORTANT KEY DETERMINANT of bone mass acquisition, SOME authors RECOMMENDED Vitamin D supplementation during winter and spring in all cd children and adolescents to optimize bone recovery [432].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 71), ('FUTURE_WORK', 84)]	6	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC5941617	5/2018	S613-PMC5941617	['MORE STUDIES, particularly rcts, ARE NEEDED to confirm the PROMISING ROLE of Vitamin D in the promotion of the GLOBAL health of children.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('FUTURE_WORK', 33), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 69), ('IMPORTANT_CONSIDERATION', 111)]	6	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC5952272	5/2018	S112-PMC5952272	['while all Nutrients are IMPORTANT for Brain Development, certain Nutrients (eg, protein, Long-Chain polyunsaturated Fatty Acids, iron, copper, zinc, Iodine, Folate, Choline, and Vitamins A, B6, and B12) have particularly large EFFECTS early in Life and exhibit CRITICAL or sensitive periods for Neurodevelopment.8all highly Metabolic, rapidly developing Organs have high iron requirements BECAUSE iron supports fundamental Metabolic Processes.9early-Life id is PARTICULARLY DETRIMENTAL as this is a period of rapid Neurodevelopment.']	[('IMPORTANT_CONSIDERATION', 24), ('SUPERFICIAL_RELATIONSHIP', 227), ('IMPORTANT_CONSIDERATION', 261), ('PROBABLE_UNDERSTANDING', 389), ('ANOMALY_CURIOUS_FINDING', 461), ('IMPORTANT_CONSIDERATION', 474)]	6	[('CHEBI_33284', 'nutrient', 10, 'nutrients'), ('GO_0007420', 'brain development', 38, 'brain development'), ('UBERON_0000955', 'brain', 38, 'brain'), ('CHEBI_33284', 'nutrient', 65, 'nutrients'), ('CHEBI_28911', 'cob(III)alamin', 89, 'long-chain'), ('CHEBI_35366', 'fatty acid', 116, 'fatty acids'), ('CHEBI_24859', 'iodine atom', 149, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 157, 'folate'), ('CHEBI_15354', 'choline', 165, 'choline'), ('CHEBI_27300', 'vitamin D', 178, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 178, 'vitamins A'), ('PR_000004690', 'B-cell lymphoma/leukemia 11A', 190, 'B6'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 198, 'B12'), ('UBERON_0000104', 'life cycle', 244, 'life'), ('GO_0007399', 'nervous system development', 295, 'neurodevelopment'), ('GO_0008152', 'metabolic process', 324, 'metabolic'), ('UBERON_0000062', 'organ', 354, 'organs'), ('GO_0008152', 'metabolic process', 423, 'metabolic processes'), ('UBERON_0000104', 'life cycle', 450, 'life'), ('GO_0007399', 'nervous system development', 515, 'neurodevelopment')]
PMC5956785	5/2018	S207-PMC5956785	['it HAS BEEN THEORIZED that there MAY BE an increased utilization of Vitamin D during active inflammation, POSSIBLY caused by \\the presence of Vitamin D receptor polymorphisms in patients with Autoimmune diseases [6,72].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 106)]	6	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 192, 'autoimmune')]
PMC5956785	5/2018	S250-PMC5956785	['certain vdr Gene polymorphisms MAY BE ASSOCIATED with different biologic response to Vitamin D. the cdx2 polymorphism of the Vdr Gene specifically the gg genotype, HAVE BEEN SUGGESTED to be more represented in patients with jia COMPARED TO healthy controls who more OFTEN have the ga genotype [82].']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228), ('PROBABLE_UNDERSTANDING', 266)]	6	[('SO_0000704', 'gene', 12, 'gene'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 125, 'VDR'), ('SO_0000704', 'gene', 129, 'gene')]
PMC5956785	5/2018	S284-PMC5956785	['being able to SUGGEST specific TARGETS for Vitamin D status AS a POTENTIAL adjunct therapy in the treatment of jia and understanding HOW Genetic variants increase the RISK of disease development will enhance the quality of Life of patients and their families.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 31), ('PROBABLE_UNDERSTANDING', 60), ('INCOMPLETE_EVIDENCE', 65), ('EXPLICIT_QUESTION', 133), ('IMPORTANT_CONSIDERATION', 167)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('SO_0000704', 'gene', 137, 'genetic'), ('UBERON_0000104', 'life cycle', 223, 'life')]
PMC2290997	4/2008	S130-PMC2290997	['“many elderly, ESPECIALLY those living in nursing homes, are Vitamin D deficient, [EVEN] those living in areas CONSIDERED to have adequate sunshine.”\nmany EXPERTS are now RECOMMENDING a middle-ground approach that focuses on modest sun exposures.']	[('IMPORTANT_CONSIDERATION', 15), ('ANOMALY_CURIOUS_FINDING', 83), ('IMPORTANT_CONSIDERATION', 111), ('PROBABLE_UNDERSTANDING', 155), ('FUTURE_WORK', 171)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC2330139	3/2008	S98-PMC2330139	['the FINDINGS that the most commonly used ds by teens were multivitamins (16%) and Vitamin C (6%) IS REASSURING in terms of POTENTIAL health RISKS.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 100), ('INCOMPLETE_EVIDENCE', 123), ('IMPORTANT_CONSIDERATION', 140)]	5	[('CHEBI_27300', 'vitamin D', 82, 'vitamin C')]
PMC2779500	11/2009	S44-PMC2779500	['THESE FINDINGS, among others, UNDOUBTEDLY necessitate CONCERN, and have led authors to QUESTION the benefits of universal Vitamin A supplementation for women in hiv-endemic areas [30,31].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 30), ('IMPORTANT_CONSIDERATION', 54), ('PROBLEM_COMPLICATION', 54), ('EXPLICIT_QUESTION', 87)]	5	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A')]
PMC2798111	12/2010	S16-PMC2798111	["Human Milk's total Vitamin D or its antirachitic activity obtained from mothers receiving 400\u2009iu/day TYPICALLY contains 33–68\u2009iu/l, far below the ESTIMATED daily infant REQUIREMENT of 400\u2009iu/l [3–5], the NECESSARY level for the PREVENTION of rickets [1]."]	[('PROBABLE_UNDERSTANDING', 101), ('INCOMPLETE_EVIDENCE', 146), ('IMPORTANT_CONSIDERATION', 169), ('IMPORTANT_CONSIDERATION', 204), ('SUPERFICIAL_RELATIONSHIP', 228)]	5	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('UBERON_0001913', 'milk', 6, 'milk'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
PMC2798111	12/2010	S97-PMC2798111	['infant Vitamin D levels in exclusively breastfed infants REFLECT maternal Vitamin D status, and GIVEN that the majority of the mothers in this cohort present with circulating 25(Oh)D levels <30\u2009ng/ml, it is NOT SURPRISING that the infants who are almost solely DEPENDENT on the mother for their Vitamin D have corresponding deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('PROBABLE_UNDERSTANDING', 96), ('PROBABLE_UNDERSTANDING', 207), ('ANOMALY_CURIOUS_FINDING', 211), ('SUPERFICIAL_RELATIONSHIP', 261)]	5	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 178, 'OH)D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC2821652	2/2010	S19-PMC2821652	['at the time of Birth, Cord Blood AS a direct reflection of fetal Vitamin D status will contain APPROXIMATELY 50–60% of the maternal circulating levels of 25(Oh)D. this RELATIONSHIP APPEARS TO BE linear EVEN at Pharmacological intakes of Vitamin D [12].']	[('PROBABLE_UNDERSTANDING', 33), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 181), ('ANOMALY_CURIOUS_FINDING', 202)]	5	[('GO_0007567', 'parturition', 15, 'birth'), ('UBERON_0009472', 'axilla', 22, 'cord blood'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 154, '25(OH)D'), ('CHEBI_52217', 'pharmaceutical', 210, 'pharmacological'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
PMC2821652	2/2010	S23-PMC2821652	['THUS, in the Human fetus, Vitamin D Metabolism in all LIKELIHOOD begins with 25(Oh)D. as a result, the nutritional Vitamin D status of the Human fetus/neonate is totally DEPENDENT on the Vitamin D stores of the mother [11]; THUS, IF the mother is hypovitaminotic D, her fetus will experience depleted Vitamin D exposure throughout Gestation [14].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 54), ('SUPERFICIAL_RELATIONSHIP', 170), ('PROBABLE_UNDERSTANDING', 224), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 230)]	5	[('NCBITaxon_9606', 'Homo sapiens', 13, 'human'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 26, 'vitamin D metabolism'), ('CHEBI_71657', 'versiconol acetate', 77, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 139, 'human'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 263, 'D'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('GO_0007565', 'female pregnancy', 331, 'gestation')]
PMC2841444	2/2010	S503-PMC2841444	['DUE TO ethical REASONS RECENT RCTS DID NOT include a placebo group, but compared DIFFERENT treatment modes, using Vitamin K status as the primary outcome.']	[('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 15), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin K')]
PMC2873552	4/2010	S130-PMC2873552	['first, the ASSUMED prime function of pigmentation, one of the MOST CONVINCING AS a recent selection target differentiating ceu and yri populations, is to control Vitamin D synthesis from Ultra Violet exposure [17,29].']	[('PROBABLE_UNDERSTANDING', 11), ('PROBABLE_UNDERSTANDING', 62), ('INCOMPLETE_EVIDENCE', 67), ('PROBABLE_UNDERSTANDING', 67), ('PROBABLE_UNDERSTANDING', 78)]	5	[('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('CHEBI_75275', 'tetradecyl sulfonic acid', 187, 'ultra violet')]
PMC2874518	6/2010	S117-PMC2874518	['a RECENT-meta-analysis of seven studies CONCLUDED that combined Vitamin C and e supplementation had no potential benefit in the improvement of maternal and neonatal outcome and increased the risk of Gestational Hypertension in women at risk of pre-eclampsia.26\nit is WELL ESTABLISHED that there are significant INTERACTIONS between Micronutrients and their Metabolism.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 267), ('PROBABLE_UNDERSTANDING', 267), ('SUPERFICIAL_RELATIONSHIP', 311)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin C'), ('GO_0007549', 'dosage compensation', 199, 'gestational hypertension'), ('CHEBI_33839', 'macromolecule', 332, 'micronutrients'), ('GO_0008152', 'metabolic process', 357, 'metabolism')]
PMC2913107	8/2010	S9-PMC2913107	['UNFORTUNATELY, the tiny 10 μg (400 iu) dose in Prenatal Vitamins is VIRTUALLY IRRELEVANT in PREVENTING the current EPIDEMIC of Gestational Vitamin D deficiency (8).']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 68), ('IMPORTANT_CONSIDERATION', 78), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 115)]	5	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 56, 'vitamins'), ('GO_0007565', 'female pregnancy', 127, 'gestational'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC2913107	8/2010	S41-PMC2913107	['a comment to the authors (20) DETAILED the EVIDENCE that Antiepileptic Drugs are one of the few classes of Drugs that CONSISTENTLY and SIGNIFICANTLY INTERFERE with Vitamin D Metabolism, lowering 25(Oh)D levels.']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 43), ('PROBABLE_UNDERSTANDING', 118), ('IMPORTANT_CONSIDERATION', 135), ('SUPERFICIAL_RELATIONSHIP', 149)]	5	[('CHEBI_35218', 'anthocyanin cation', 57, 'antiepileptic'), ('CHEBI_23888', 'drug', 71, 'drugs'), ('CHEBI_23888', 'drug', 107, 'drugs'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0008152', 'metabolic process', 174, 'metabolism'), ('CHEBI_71657', 'versiconol acetate', 195, '25(OH)D')]
PMC2913107	8/2010	S44-PMC2913107	['OBVIOUSLY, ANOTHER, and more PARSIMONIOUS EXPLANATION, is that Vitamin D is INVOLVED in all three.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 76)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC2963768	10/2010	S107-PMC2963768	['to FURTHER EXPLAIN the APPARENT ‘Vitamin D paradox’ in south asia (3), a range of hypothetical mechanisms CAN BE PROPOSED (table 3).']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 11), ('ANOMALY_CURIOUS_FINDING', 23), ('FUTURE_WORK', 106), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC2963768	10/2010	S108-PMC2963768	['young infants DEPEND ALMOST ENTIRELY on the transplacental transfer of Vitamin D and 25(Oh)D, which EXPLAINS the CONSISTENT ASSOCIATION between maternal and Cord-blood 25(Oh)D (25) and the observation that maternal Antenatal Vitamin D supplementation augments both maternal and Cord-Blood 25(Oh)D (26).']	[('SUPERFICIAL_RELATIONSHIP', 14), ('PROBABLE_UNDERSTANDING', 21), ('PROBABLE_UNDERSTANDING', 100), ('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 157, 'cord'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 168, '25(OH ... D'), ('GO_0007567', 'parturition', 215, 'antenatal'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 278, 'cord'), ('UBERON_0000178', 'blood', 283, 'blood'), ('CHEBI_71657', 'versiconol acetate', 289, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 289, '25 ... OH ... D')]
PMC2996405	11/2010	S167-PMC2996405	['it is THEREFORE POSSIBLE that the same Genes COULD BE Regulated by Vitamin D levels also in Neurons during Brain Development that, in turn, HAVE BEEN ASSOCIATED to schizophrenia [47].']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 150)]	5	[('SO_0000704', 'gene', 39, 'genes'), ('GO_0065007', 'biological regulation', 54, 'regulated'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CL_0000540', 'neuron', 92, 'neurons'), ('GO_0007420', 'brain development', 107, 'brain development'), ('UBERON_0000955', 'brain', 107, 'brain')]
PMC2996405	11/2010	S212-PMC2996405	['as STATED, latitude acts directly OR indirectly, on a WIDE VARIETY of phenomena, THEREFORE it is expected that its EFFECTS are not limited just to Vitamin D and Neural Development.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54), ('PROBABLE_UNDERSTANDING', 81), ('SUPERFICIAL_RELATIONSHIP', 115)]	5	[('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007399', 'nervous system development', 161, 'neural development')]
PMC2996405	11/2010	S213-PMC2996405	['for similar REASONS, we expected that also the LINK between latitude and schizophrenia cannot be completely EXPLAINED by Vitamin D. for example, in the intersection between lrgs and Genes RELATED with schizophrenia (additional file3) there is a Gene INVOLVED in the Circadian Rhythms, timeless .']	[('PROBABLE_UNDERSTANDING', 12), ('SUPERFICIAL_RELATIONSHIP', 47), ('PROBABLE_UNDERSTANDING', 108), ('SUPERFICIAL_RELATIONSHIP', 188), ('SUPERFICIAL_RELATIONSHIP', 250)]	5	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('SO_0000704', 'gene', 182, 'genes'), ('SO_0000704', 'gene', 245, 'gene'), ('GO_0007623', 'circadian rhythm', 266, 'circadian rhythms')]
PMC3004407	12/2010	S143-PMC3004407	['after accounting for the EFFECT of Gestational age through multivariable regression, 25(Oh)D status retained a significant negative ASSOCIATION with pth, CONFIRMING that EVEN during Pregnancy, pth is a PREDICTOR of Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 132), ('PROBABLE_UNDERSTANDING', 154), ('ANOMALY_CURIOUS_FINDING', 170), ('SUPERFICIAL_RELATIONSHIP', 202)]	5	[('GO_0007565', 'female pregnancy', 35, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 87, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D')]
PMC3103150	3/2011	S16-PMC3103150	['this IMPLIES that babies Born to mothers with Vitamin D deficiency are very LIKELY to develop Vitamin D deficiency UNLESS supplemented from outside or adequately exposed to sunlight which is OFTEN NOT PRACTICAL during early Infancy.']	[('PROBABLE_UNDERSTANDING', 5), ('PROBABLE_UNDERSTANDING', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('PROBABLE_UNDERSTANDING', 191), ('DIFFICULT_TASK', 197)]	5	[('GO_0007567', 'parturition', 25, 'born'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0000023', 'wing', 224, 'infancy')]
PMC3257641	3/2010	S5-PMC3257641	['1. review\nthe high PREVALENCE of Vitamin D insufficiency during Pregnancy is increasingly RECOGNIZED, amid GROWING EVIDENCE that the Intrauterine environment CAN have both immediate and long-lasting EFFECTS on health of the offspring.']	[('IMPORTANT_CONSIDERATION', 19), ('PROBABLE_UNDERSTANDING', 90), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 199)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('UBERON_0022293', 'reproductive gland secretion', 133, 'intrauterine')]
PMC3257641	3/2010	S98-PMC3257641	['the media REPORTED on a reduction in both Preterm Birth and small-for-dates babies, with Vitamin D supplementation [41], BUT formal publication of the FINDINGS had not occurred at the time of writing this review, THUS these reports cannot BE formally evaluated.']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('INCOMPLETE_EVIDENCE', 151), ('PROBABLE_UNDERSTANDING', 213), ('ANOMALY_CURIOUS_FINDING', 239)]	5	[('GO_0007565', 'female pregnancy', 42, 'preterm'), ('GO_0007567', 'parturition', 50, 'birth'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC3271033	1/2012	S21-PMC3271033	['furthermore, FEW DATA have EVALUATED hispanic infants who MAY BE at high-risk for low Vitamin D status DUE TO POOR maternal Vitamin D intake [4].']	[('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 58), ('PROBABLE_UNDERSTANDING', 103), ('PROBLEM_COMPLICATION', 110)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC3271033	1/2012	S127-PMC3271033	['regardless, Serum calcium in the Cord Blood and in the first days of Life is LIKELY Controlled by a VARIETY of FACTORS, of which Vitamin D is ONLY one FACTOR.']	[('PROBABLE_UNDERSTANDING', 77), ('DIFFICULT_TASK', 100), ('SUPERFICIAL_RELATIONSHIP', 111), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151)]	5	[('UBERON_0001977', 'blood serum', 12, 'serum'), ('UBERON_0002240', 'spinal cord', 33, 'cord'), ('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0000104', 'life cycle', 69, 'life'), ('GO_0065007', 'biological regulation', 84, 'controlled'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC3271033	1/2012	S131-PMC3271033	['it HAS BEEN SUGGESTED BUT is NOT PROVEN that early Life calcium absorption is PRIMARILY non-Vitamin D DEPENDENT [2].']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('INCOMPLETE_EVIDENCE', 29), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 102)]	5	[('UBERON_0000104', 'life cycle', 51, 'life'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC3271033	1/2012	S132-PMC3271033	['HOWEVER, it is LIKELY that by three months of age, Vitamin D has a KEY ROLE in calcium absorption, especially in Breast-Fed infants with a relatively low Calcium Intake COMPARED TO formula-Fed infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 15), ('IMPORTANT_CONSIDERATION', 67), ('SUPERFICIAL_RELATIONSHIP', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007567', 'parturition', 113, 'breast'), ('UBERON_0000310', 'breast', 113, 'breast'), ('GO_0007631', 'feeding behavior', 120, 'fed'), ('CHEBI_22313', 'alkaline earth metal atom', 154, 'calcium'), ('GO_0007631', 'feeding behavior', 162, 'intake'), ('GO_0007631', 'feeding behavior', 189, 'fed')]
PMC3271033	1/2012	S159-PMC3271033	['OUR FINDINGS SUPPORT current GUIDELINES to begin Vitamin D supplementation of 400 iu/day to all Breast-Fed infants in the first week of Life and to FURTHER ENCOURAGE the provision of adequate Vitamin D to Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 29), ('FUTURE_WORK', 148), ('FUTURE_WORK', 156)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 96, 'breast'), ('UBERON_0000310', 'breast', 96, 'breast'), ('GO_0007631', 'feeding behavior', 103, 'fed'), ('UBERON_0000104', 'life cycle', 136, 'life'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('GO_0007565', 'female pregnancy', 205, 'pregnant')]
PMC3347007	4/2012	S27-PMC3347007	['the danish national Birth cohort (dnbc) offers information on Vitamin D intake in danish Pregnant women as well as information on socio-demographic and lifestyle factors, and is THEREBY an excellent OPPORTUNITY TO investigate POTENTIAL DETERMINANTS of Vitamin D intake.']	[('PROBABLE_UNDERSTANDING', 178), ('FUTURE_WORK', 199), ('QUESTION_ANSWERED_BY_THIS_WORK', 211), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 236)]	5	[('GO_0007567', 'parturition', 20, 'Birth'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnant'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D')]
PMC3347007	4/2012	S137-PMC3347007	['the most common doses of Vitamin D in supplements were 10 µg and 5 µg, INDICATING that the available supplements in denmark all have doses of 5 and 10 µg Vitamin D. low dose supplements make it DIFFICULT for the women to obtain the RECOMMENDED dose of Vitamin D. all Vitamin D supplements aimed at Pregnant women SHOULD THEREFORE contain 10 µg.']	[('INCOMPLETE_EVIDENCE', 71), ('DIFFICULT_TASK', 194), ('FUTURE_WORK', 232), ('FUTURE_WORK', 313), ('PROBABLE_UNDERSTANDING', 320)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('GO_0007565', 'female pregnancy', 298, 'pregnant')]
PMC3347028	3/2012	S126-PMC3347028	['THEREFORE, it came AS quite a SURPRISE when the FIRST REPORT of widespread Vitamin D deficiency in u.s. women of Childbearing age was REPORTED by the center for disease control (cdc) in 2002 [81].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 19), ('ANOMALY_CURIOUS_FINDING', 30), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 134)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 113, 'childbearing')]
PMC3347028	3/2012	S143-PMC3347028	['from the prior sections, IT IS CLEAR that Vitamin D deficiency during Pregnancy is common throughout the world YET WHAT EFFECT does deficiency have on the mother and her developing fetus?']	[('PROBABLE_UNDERSTANDING', 25), ('ANOMALY_CURIOUS_FINDING', 111), ('EXPLICIT_QUESTION', 115), ('SUPERFICIAL_RELATIONSHIP', 120), ('EXPLICIT_QUESTION', 186)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy')]
PMC3355895	1/2011	S171-PMC3355895	['1,25(oh)-Vitamin D HAS BEEN SHOWN to Regulate OTHER Pmca Isoforms (kip and strehler,2004) and is THEREFORE a POTENTIAL CANDIDATE.']	[('INCOMPLETE_EVIDENCE', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 119)]	5	[('CHEBI_37958', 'dye', 0, '1,'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0065007', 'biological regulation', 37, 'regulate'), ('PR_000012924', 'bifunctional polynucleotide phosphatase/kinase', 52, 'PMCA'), ('SO_0001060', 'sequence_variant', 57, 'isoforms')]
PMC3356951	4/2012	S2-PMC3356951	['this PANDEMIC of hypovitaminosis d can MAINLY be ATTRIBUTED to lifestyle (for example, reduced outdoor activities) and environmental (for example, air pollution) FACTORS that reduce exposure to sunlight, which is REQUIRED for ultraviolet-b (uvb)-induced Vitamin D Production in the skin.']	[('IMPORTANT_CONSIDERATION', 5), ('PROBABLE_UNDERSTANDING', 39), ('SUPERFICIAL_RELATIONSHIP', 49), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 213)]	5	[('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 254, 'vitamin D production')]
PMC3356951	4/2012	S19-PMC3356951	['[7] in THIS REVIEW, we will FOCUS on the biology of Vitamin D and summarize the mechanisms that are PRESUMED to underlie the RELATIONSHIP between Vitamin D and its clinical IMPLICATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('PROBABLE_UNDERSTANDING', 100), ('SUPERFICIAL_RELATIONSHIP', 125), ('IMPORTANT_CONSIDERATION', 173)]	5	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC3356951	4/2012	S147-PMC3356951	['caption (table-wrap): table 1\n\nrecommended dietary intakes of Vitamin D for patients AT RISK for Vitamin D deficiency[103]\nescp SUGGESTS that the maintenance tolerable upper limits (ul) of Vitamin D, which is not to BE exceeded without medical supervision, SHOULD BE 1000 iu/d for infants up to 6 months, 1500 iu/d for infants from 6 months to 1 year, AT LEAST 2500 iu/d for children aged 1–3 years, 3000 iu/d for children aged 4–8 years, and 4000 iu/d for everyone over 8 years.']	[('IMPORTANT_CONSIDERATION', 85), ('INCOMPLETE_EVIDENCE', 128), ('ANOMALY_CURIOUS_FINDING', 216), ('FUTURE_WORK', 257), ('PROBABLE_UNDERSTANDING', 352)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]
PMC3407995	7/2012	S85-PMC3407995	['HOWEVER, a recent global review of Vitamin D status HAS SHOWN that its Intake is OFTEN TOO low TO sustain healthy circulating 25(Oh)D in countries without mandatory staple Food fortification and is EVEN too low in countries that do fortify due to low Milk Consumption, vegetarianism, non-supplement use and low fish Intake [46].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 81), ('DIFFICULT_TASK', 87), ('ANOMALY_CURIOUS_FINDING', 198)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007631', 'feeding behavior', 71, 'intake'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 126, '25(OH ... D'), ('CHEBI_33290', 'food', 172, 'food'), ('UBERON_0001913', 'milk', 251, 'milk'), ('GO_0007631', 'feeding behavior', 256, 'consumption'), ('GO_0007631', 'feeding behavior', 316, 'intake')]
PMC3407995	7/2012	S250-PMC3407995	['THEREFORE, results of epidemiological studies provide MOST OF the EVIDENCE SUGGESTING the IMPORTANCE of Vitamin D for foetal/infant Brain health.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 54), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 90)]	5	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0000955', 'brain', 132, 'brain')]
PMC3427192	4/2012	S58-PMC3427192	['THUS, Vitamin D MAY have therapeutic EFFECTIVENESS in Adults with asthma, but MORE STUDIES ARE CLEARLY NEEDED.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37), ('ANOMALY_CURIOUS_FINDING', 78), ('FUTURE_WORK', 83)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0007023', 'adult organism', 54, 'adults')]
PMC3427250	8/2012	S34-PMC3427250	['THEREFORE the AIM of THIS STUDY was to carry out the FIRST national representative random sample survey on Vitamin D status in Pregnant women in a european country and TO ASSESS the determinants of Vitamin D status in the first and third Trimester of Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 168)]	5	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnant'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 238, 'trimester'), ('GO_0007565', 'female pregnancy', 251, 'pregnancy')]
PMC3472720	8/2012	S69-PMC3472720	['it is THEREFORE LIKELY that his/her Immune and Nervous Systems BENEFITED from Vitamin D’s WELL-DESCRIBED anti-inflammatory actions [23].']	[('PROBABLE_UNDERSTANDING', 6), ('PROBABLE_UNDERSTANDING', 16), ('IMPORTANT_CONSIDERATION', 63), ('FUTURE_WORK', 90), ('INCOMPLETE_EVIDENCE', 95)]	5	[('UBERON_0002405', 'immune system', 36, 'immune'), ('UBERON_0001016', 'nervous system', 47, 'nervous systems'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3476426	8/2012	S106-PMC3476426	['THUS, Vitamin D deficiency MAY CONTRIBUTE to higher mutation rates and impaired Repair Of Dna [35] AS a result of increased oxidative stress which was REPORTED in some autistic children [22].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 31), ('PROBABLE_UNDERSTANDING', 99), ('INCOMPLETE_EVIDENCE', 151)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0006281', 'DNA repair', 80, 'repair of DNA')]
PMC3476426	8/2012	S109-PMC3476426	['autism was MORE COMMON among children of the mothers who took Antiepileptic Drugs AS these Drugs are one of the few classes of Drugs that CONSISTENTLY and SIGNIFICANTLY INTERFERE with Vitamin D Metabolism [39].']	[('PROBABLE_UNDERSTANDING', 11), ('PROBABLE_UNDERSTANDING', 82), ('PROBABLE_UNDERSTANDING', 138), ('IMPORTANT_CONSIDERATION', 155), ('SUPERFICIAL_RELATIONSHIP', 169)]	5	[('CHEBI_35218', 'anthocyanin cation', 62, 'antiepileptic'), ('CHEBI_23888', 'drug', 76, 'drugs'), ('CHEBI_23888', 'drug', 91, 'drugs'), ('CHEBI_23888', 'drug', 127, 'drugs'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 184, 'vitamin D metabolism'), ('PR_000006444', 'diacylglycerol kinase delta', 192, 'D')]
PMC3501517	11/2012	S232-PMC3501517	['HOWEVER, the IMPACT of these DIFFERENCES on overall clinical RELEVANCE of Vitamin D deficiency is LIKELY minimal.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 29), ('IMPORTANT_CONSIDERATION', 61), ('PROBABLE_UNDERSTANDING', 98)]	5	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC3515553	12/2012	S141-PMC3515553	['SINCE h. pylori infection MAY cause Malabsorption of Vitamin B-12, non-secretors are HYPOTHESIZED to have better absorption and HENCE higher Plasma concentrations of vitamin B-12 than secretors[33].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 128)]	5	[('GO_0046693', 'sperm storage', 36, 'malabsorption'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 53, 'vitamin B-12'), ('UBERON_0001969', 'blood plasma', 141, 'plasma'), ('PR_000004770', 'Polycomb complex protein BMI-1', 174, 'B-12')]
PMC3515553	12/2012	S170-PMC3515553	['conclusions\nIN SUMMARY, we have FOUND that children Born to mothers with a higher dietary intake of Vitamin B-12 had a slightly higher iq than OTHER children, and that those with mothers carrying PUTATIVE Vitamin B-12-increasing Alleles were more LIKELY to have a higher iq than those Born to mothers without these Alleles.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('PROBABLE_UNDERSTANDING', 196), ('PROBABLE_UNDERSTANDING', 247)]	5	[('GO_0007567', 'parturition', 52, 'born'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 100, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 205, 'vitamin B-12'), ('SO_0001023', 'allele', 229, 'alleles'), ('GO_0007567', 'parturition', 285, 'born'), ('SO_0001023', 'allele', 315, 'alleles')]
PMC3552819	12/2012	S208-PMC3552819	['THEREFORE, upward deflections in the Serum and Urine BIOMARKERS of Calcium Homeostasis signaled a NEED TO BE cautious about the transient EFFECTS of large sudden influxes of Vitamin D, and the risk of dose-dependent toxicity.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('FUTURE_WORK', 98), ('IMPORTANT_CONSIDERATION', 103), ('SUPERFICIAL_RELATIONSHIP', 138)]	5	[('UBERON_0001977', 'blood serum', 37, 'serum'), ('UBERON_0001088', 'urine', 47, 'urine'), ('GO_0055073', 'cadmium ion homeostasis', 67, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC3651971	5/2013	S19-PMC3651971	['this research SUGGESTS that Central Nervous System Development MAY BE PROTECTED in Vitamin A deficiency, POSSIBLY BECAUSE Vitamin A is preferentially allocated to the developing fetus.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 105), ('PROBABLE_UNDERSTANDING', 114)]	5	[('GO_0003204', 'cardiac skeleton development', 28, 'central nervous system development'), ('UBERON_0001017', 'central nervous system', 28, 'central nervous system'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin A')]
PMC3651971	5/2013	S140-PMC3651971	['the HYPOTHESISED EFFECT of Gestational Vitamin A supplementation on Cognition and Motor Development is BASED ON sound THEORY.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 17), ('PROBABLE_UNDERSTANDING', 103), ('SUPERFICIAL_RELATIONSHIP', 103), ('INCOMPLETE_EVIDENCE', 118)]	5	[('GO_0007565', 'female pregnancy', 27, 'gestational'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin A'), ('GO_0050890', 'cognition', 68, 'cognition'), ('GO_0009653', 'anatomical structure morphogenesis', 82, 'motor development')]
PMC3651971	5/2013	S151-PMC3651971	['ANOTHER POSSIBLE EXPLANATION for the LACK OF difference between groups is that unit and mabc are INSUFFICIENTLY PRECISE to pick up on subtle differences in Vitamin A nutriture.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 17), ('INCOMPLETE_EVIDENCE', 37), ('PROBLEM_COMPLICATION', 97)]	5	[('CHEBI_27300', 'vitamin D', 156, 'vitamin A')]
PMC3672018	5/2013	S42-PMC3672018	['furthermore, there are studies SHOWING that low fetal Vitamin D MAY lead to persistent changes in the Immune System, THUS POSSIBLY INFLUENCING the risk of developing Autoimmune diseases such as t1d [14,19,20].']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 64), ('PROBABLE_UNDERSTANDING', 117), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 131)]	5	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0002405', 'immune system', 102, 'immune system'), ('UBERON_0001442', 'skeleton of manus', 166, 'autoimmune')]
PMC3672018	5/2013	S56-PMC3672018	['the Vitamin D fortification of low fat milk was not mandatory and THEREFORE not all low fat Milk distributed in denmark in the time period was fortified with Vitamin D. UNFORTUNATELY, there are no national statistics INDICATING the proportion of Milk Consumed that was fortified with Vitamin D. NEVERTHELESS, the two well-defined time periods of Vitamin D fortification provide a natural framework for comparing the EFFECTS of early exposure to Vitamin D on the Development Of Diseases later in Life amongst exposed and non-exposed adjacent Birth cohorts (figure\xa01).']	[('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 169), ('INCOMPLETE_EVIDENCE', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 295), ('SUPERFICIAL_RELATIONSHIP', 416)]	5	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0001913', 'milk', 92, 'milk'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('UBERON_0001913', 'milk', 246, 'milk'), ('GO_0007631', 'feeding behavior', 251, 'consumed'), ('CHEBI_27300', 'vitamin D', 284, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 346, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 445, 'vitamin D'), ('GO_0009603', 'detection of symbiotic fungus', 462, 'development of diseases'), ('UBERON_0000104', 'life cycle', 495, 'life'), ('GO_0007567', 'parturition', 541, 'birth')]
PMC3672018	5/2013	S162-PMC3672018	['AS diet is USUALLY different between families with higher socioeconomic status and those with lower status [31], maternal socioeconomic status MAY have AFFECTED Margarine/milk Intake and THUS exposure to Vitamin D. information on socioeconomic position, education and ethnicity is available from statistics denmark and can be controlled for.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 152), ('PROBABLE_UNDERSTANDING', 187)]	5	[('CHEBI_6784', 'mestranol', 161, 'margarine'), ('GO_0007631', 'feeding behavior', 176, 'intake'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 212, 'D')]
PMC3679329	6/2013	S8-PMC3679329	['these results SUGGEST that among Pregnant and Lactating women, those who do not use dietary supplements TEND to have a lower intake of healthy Foods, such as beans and vegetables, as well as a lower intake of dietary fiber and Β-Carotene, which are abundant in these Foods, and non-users are more LIKELY than users to have INADEQUATE Intake of micro-Nutrient such as Vitamin C and iron.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 104), ('PROBABLE_UNDERSTANDING', 297), ('IMPORTANT_CONSIDERATION', 323), ('PROBLEM_COMPLICATION', 323)]	5	[('GO_0007565', 'female pregnancy', 33, 'pregnant'), ('GO_0007594', 'puparial adhesion', 46, 'lactating'), ('CHEBI_33290', 'food', 143, 'foods'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 227, 'β-carotene'), ('CHEBI_33290', 'food', 267, 'foods'), ('GO_0007631', 'feeding behavior', 334, 'intake'), ('CHEBI_33284', 'nutrient', 350, 'nutrient'), ('CHEBI_27300', 'vitamin D', 367, 'vitamin C')]
PMC3695234	7/2013	S69-PMC3695234	['ACCORDING TO ANOTHER POINT OF VIEW, strict restriction of the offending Food Allergen provides an ALTERNATIVE EXPLANATION for Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('PROBABLE_UNDERSTANDING', 110)]	5	[('CHEBI_33290', 'food', 72, 'food'), ('CHEBI_50904', 'allergen', 77, 'allergen'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC3695234	7/2013	S75-PMC3695234	['BASED ON the identification of Vitamin D receptors in RELEVANT Immune Cells, it HAS BEEN SUGGESTED that the Vitamin D pathway plays a ROLE in asthma and atopy.19,20using Single Nucleotide Polymorphism selection and genotyping, poon et al.20found six variants that are strongly ASSOCIATED with asthma and four with atopy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 54), ('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 134), ('SUPERFICIAL_RELATIONSHIP', 277)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CL_0000738', 'leukocyte', 63, 'immune cells'), ('UBERON_0002405', 'immune system', 63, 'immune'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('SO_0000694', 'SNP', 170, 'single nucleotide polymorphism')]
PMC3702245	6/2013	S10-PMC3702245	['a second hydroxylation takes place in the Kidney, which converts 25(Oh)D to the most biologically active Metabolite, 1,25-Dihydroxyvitamin D, the major classical physiologic function of which is to increase calcium and Phosphorus absorption from the Gut in order to maintain Calcium Homeostasis and promote mineralization of Osteoid bone.9\nalthough the Renal 1-alpha hydroxylase (Cytochrome P450 [Cyp]27B1) enzyme is a MAJOR DETERMINANT of Synthesis of 1,25-Dihydroxyvitamin D, IT IS KNOWN that Cyp27B1 is Expressed in Nonrenal Tissues to produce 1,25 Dihydroxyvitamin D.6,19in addition, Vitamin D receptors are also Expressed in a variety of Organs, Tissues, and cells (seefigure 1).20the 1,25-Dihydroxyvitamin D locally produced in Extrarenal Tissues, such as immune cells, Pancreatic Beta Cells, the Intestine, Prostate, Breast, and other Organs, Controls multiple Vitamin D-responsive Genes, and THUS plays an important physiologic ROLE in Cardiovascular health,21,22the Adaptive and Innate Immune Responses,23,24insulin secretion,25,26regulation of Cell Proliferation, Differentiation, and Apoptosis, and inhibition of Angiogenesis.27\n\nVitamin D Homeostasis and functions during Pregnancy\nthe classical function of Vitamin D is to maintain calcium Homeostasis.']	[('IMPORTANT_CONSIDERATION', 419), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 478), ('PROBABLE_UNDERSTANDING', 900), ('SUPERFICIAL_RELATIONSHIP', 936)]	5	[('UBERON_0002113', 'kidney', 42, 'kidney'), ('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('CHEBI_39382', 'flufenoxuron', 105, 'metabolite'), ('CHEBI_67472', '15-epi-lupulin B', 117, '1,25-dihydroxyvitamin D'), ('CHEBI_35885', 'secondary phosphine', 219, 'phosphorus'), ('UBERON_0001555', 'digestive tract', 250, 'gut'), ('GO_0055073', 'cadmium ion homeostasis', 275, 'calcium homeostasis'), ('UBERON_0008883', 'osteoid', 325, 'osteoid'), ('UBERON_0002113', 'kidney', 353, 'renal'), ('CHEBI_4056', 'cytochrome', 380, 'cytochrome'), ('PR_000006100', 'aromatase', 380, 'cytochrome P450'), ('PR_000006138', 'cytochrome P450 4F11', 397, 'CYP ... 27B1'), ('GO_0009057', 'macromolecule catabolic process', 440, 'synthesis'), ('CHEBI_67472', '15-epi-lupulin B', 453, '1,25-dihydroxyvitamin D'), ('PR_000006101', 'cytochrome P450 1A1', 495, 'CYP27B1'), ('GO_0010467', 'gene expression', 506, 'expressed'), ('UBERON_0002481', 'bone tissue', 519, 'nonrenal tissues'), ('CHEBI_67469', '15-hydroxyajubractin C', 547, '1,25 dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 588, 'vitamin D'), ('GO_0010467', 'gene expression', 617, 'expressed'), ('UBERON_0000062', 'organ', 643, 'organs'), ('UBERON_0000479', 'tissue', 651, 'tissues'), ('CHEBI_67472', '15-epi-lupulin B', 690, '1,25-dihydroxyvitamin D'), ('UBERON_0005292', 'extraembryonic tissue', 734, 'extrarenal tissues'), ('CL_0000169', 'type B pancreatic cell', 776, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 776, 'pancreatic'), ('UBERON_0000160', 'intestine', 803, 'intestine'), ('UBERON_0002367', 'prostate gland', 814, 'prostate'), ('UBERON_0000310', 'breast', 824, 'breast'), ('UBERON_0000062', 'organ', 842, 'organs'), ('GO_0065007', 'biological regulation', 850, 'controls'), ('CHEBI_27300', 'vitamin D', 868, 'vitamin D'), ('SO_0000704', 'gene', 889, 'genes'), ('UBERON_0004535', 'cardiovascular system', 944, 'cardiovascular'), ('GO_0051886', 'negative regulation of timing of anagen', 975, 'adaptive ...'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 988, 'innate immune responses'), ('UBERON_0002405', 'immune system', 995, 'immune'), ('GO_0030154', 'cell differentiation', 1054, 'cell proliferation ... differentiation'), ('GO_0006915', 'apoptotic process', 1095, 'apoptosis'), ('GO_0001525', 'angiogenesis', 1124, 'angiogenesis'), ('CHEBI_28384', 'vitamin K', 1141, 'Vitamin D'), ('GO_0042592', 'homeostatic process', 1151, 'homeostasis'), ('GO_0007565', 'female pregnancy', 1184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1220, 'vitamin D'), ('GO_0042592', 'homeostatic process', 1253, 'homeostasis')]
PMC3702245	6/2013	S15-PMC3702245	['IN GENERAL, Cord Blood 25(Oh)D concentrations are APPROXIMATELY 60%–89% of the maternal value.11,17,35,41–47THEREFORE, maintaining optimum Vitamin D nutrition during Pregnancy is ESSENTIAL for PREVENTION of hypovitaminosis D in the fetus and Vitamin D deficiency at Birth and in early infancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 50), ('ANOMALY_CURIOUS_FINDING', 106), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('UBERON_0002240', 'spinal cord', 12, 'cord'), ('UBERON_0000178', 'blood', 17, 'blood'), ('CHEBI_71657', 'versiconol acetate', 23, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 23, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 223, 'D'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D'), ('GO_0007567', 'parturition', 266, 'birth')]
PMC3713405	7/2013	S46-PMC3713405	['GIVEN that Vitamin D deficiency is common (1) during winter and spring, (2) at high latitudes (holick et al., 1995), (3) in urban environments (mcgrath et al., 2001) and (4) in dark skinned Individuals (clemens et al., 1982;holick et al., 1995), these ecological data led TO the HYPOTHESIS that low maternal Vitamin D COULD BE a modified risk FACTOR for schizophrenia.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 272), ('INCOMPLETE_EVIDENCE', 279), ('INCOMPLETE_EVIDENCE', 318), ('SUPERFICIAL_RELATIONSHIP', 343)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('NCBITaxon_1', 'root', 190, 'individuals'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D')]
PMC3717170	5/2013	S2-PMC3717170	['HOWEVER, the biological significance of the Expression of the vdr in different Tissues is not FULLY understood, and the ROLE of Vitamin D in Extraskeletal health HAS been a matter of DEBATE.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 94), ('SUPERFICIAL_RELATIONSHIP', 120), ('IMPORTANT_CONSIDERATION', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 183)]	5	[('GO_0010467', 'gene expression', 44, 'expression'), ('UBERON_0000479', 'tissue', 79, 'tissues'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 141, 'extraskeletal')]
PMC3717170	5/2013	S179-PMC3717170	['Vitamin D AFFECTS several pathways RELATED to inflammation and Cell Proliferation, including inhibition of aromatase (conversion from Testosterone to Estrogens), Cox2, prostaglandin receptor, Nf-κb, Hif-1 and Vegf, and stimulation of Igfbp-3 and E-Cadherin.52in addition, poor Vitamin D status is a RISK factor for several Autoimmune diseases, CONFIRMING the ROLE of this Vitamin in Immune function.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 299), ('PROBABLE_UNDERSTANDING', 344), ('SUPERFICIAL_RELATIONSHIP', 359)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0008283', 'cell proliferation', 63, 'cell proliferation'), ('CHEBI_17347', 'testosterone', 134, 'testosterone'), ('CHEBI_50114', 'estrogen', 150, 'estrogens'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 162, 'COX2'), ('GO_0005883', 'neurofilament', 192, 'NF'), ('PR_000008539', 'protein-cysteine N-palmitoyltransferase HHAT-like protein', 199, 'HIF-1'), ('PR_000017279', 'testis-specific basic protein Y 1', 209, 'VEGF'), ('PR_000008940', 'intraflagellar transport protein 88', 234, 'IGFBP-3'), ('PR_000001447', 'cadherin-1', 246, 'E-cadherin'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 323, 'autoimmune'), ('CHEBI_33229', 'vitamin (role)', 372, 'vitamin'), ('UBERON_0002405', 'immune system', 383, 'immune')]
PMC3760821	9/2013	S158-PMC3760821	['the present analysis FURTHER determined that, Cord Blood Vitamin D levels CORRELATED with those of the mother, and were, THUS, PREDOMINANTLY deficient/insufficient and, in women with t1dm, low Vitamin D levels PERSISTED post-Delivery.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 74), ('PROBABLE_UNDERSTANDING', 121), ('PROBABLE_UNDERSTANDING', 127), ('INCOMPLETE_EVIDENCE', 210)]	5	[('UBERON_0002240', 'spinal cord', 46, 'cord'), ('UBERON_0000178', 'blood', 51, 'blood'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007567', 'parturition', 225, 'delivery')]
PMC3760821	9/2013	S163-PMC3760821	['department of health GUIDELINES in the uk CURRENTLY RECOMMEND Pregnant women to supplement with 10 µg/day to protect against Vitamin D deficiency[29], but this is DISPUTED by SOME[30].']	[('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 42), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163), ('INCOMPLETE_EVIDENCE', 175)]	5	[('GO_0007565', 'female pregnancy', 62, 'pregnant'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC3820434	12/2012	S377-PMC3820434	['a POSSIBLE EXPLANATION MAY BE that upon Oral Consumption, circulating and Intracellular levels of Resveratrol in Humans are much lower than that of OTHER IMPORTANT Antioxidants, such as Vitamin C, Uric Acid, Vitamin E, and Glutathione.']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('IMPORTANT_CONSIDERATION', 154)]	5	[('UBERON_0000165', 'mouth', 40, 'oral'), ('GO_0007631', 'feeding behavior', 45, 'consumption'), ('GO_0005622', 'intracellular anatomical structure', 74, 'intracellular'), ('CHEBI_27881', 'resveratrol', 98, 'resveratrol'), ('NCBITaxon_9606', 'Homo sapiens', 113, 'humans'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 164, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin C'), ('CHEBI_27226', 'uric acid', 197, 'uric acid'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin E'), ('CHEBI_16856', 'glutathione', 223, 'glutathione')]
PMC3827489	10/2013	S27-PMC3827489	['diagnostic criteria of Vitamin D insufficiency or deficiency\nNO CONSENSUS on the definition of Vitamin D deficiency exists; HOWEVER, most clinicians and researchers agree on the following stratifications BASED ON the Serum concentration of 25(Oh)D: deficiency, <50.0 nmol/l or <20.0 ng/ml; insufficiency, 50.0-74.9 nmol/l or 20.0-29.9 ng/ml; and sufficiency, ≥75.0 nmol/l or ≥30.0 ng/ml1,6,16,17).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 61), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124), ('INCOMPLETE_EVIDENCE', 204), ('PROBABLE_UNDERSTANDING', 204)]	5	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0001977', 'blood serum', 217, 'serum'), ('CHEBI_71657', 'versiconol acetate', 240, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 240, '25(OH)D')]
PMC3827489	10/2013	S44-PMC3827489	['girls are at particular RISK for low Vitamin D status, which HAS BEEN ASCRIBED to lifestyle factors such as frequent use of sunscreen or coverage of skin by clothing that COULD AFFECT cutaneous Synthesis Of Vitamin D6).']	[('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 61), ('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0034205', 'amyloid-beta formation', 194, 'synthesis of ... D6'), ('CHEBI_33237', 'vitamin D4', 207, 'vitamin D6'), ('PR_000017299', 'VIP peptides', 207, 'vitamin D6')]
PMC3827489	10/2013	S96-PMC3827489	['IN GENERAL, the OBSERVATIONAL EVIDENCE LINKING low maternal Vitamin D status during Pregnancy to an increase in the risk of allergic diseases in the offspring SEEMS more convincing.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 159)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy')]
PMC3829803	11/2013	S208-PMC3829803	['in this context, it is PLAUSIBLE that the modest reduction in the rate of Muv Replication that we OBSERVED with Retinoid ‘treatment’ in vitro COULD translate into clinical BENEFIT during natural disease, AS occurs with Vitamin A treatment in natural Mev infection.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 142), ('IMPORTANT_CONSIDERATION', 172), ('PROBABLE_UNDERSTANDING', 204)]	5	[('NCBITaxon_10088', 'Mus <genus>', 74, 'MuV'), ('PR_000010775', 'PWWP domain-containing DNA repair factor 3A', 74, 'MuV'), ('GO_0006260', 'DNA replication', 78, 'replication'), ('CHEBI_26537', 'retinoid', 112, 'retinoid'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 250, 'MeV')]
PMC3873449	12/2013	S168-PMC3873449	['THEREFORE OTHER EFFECTIVE measures MAY NEED to be taken to improve Vitamin D status in chinese Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 35), ('FUTURE_WORK', 39)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnant')]
PMC3873449	12/2013	S183-PMC3873449	['ANOTHER STUDY SHOWED that Vitamin D supplementation of 4000 iu/day for Pregnant women is MOST EFFECTIVE in achieving sufficiency in all women REGARDLESS OF race [43].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 94), ('INCOMPLETE_EVIDENCE', 142)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 71, 'pregnant')]
PMC3873449	12/2013	S210-PMC3873449	['TO OUR KNOWLEDGE, THIS STUDY is the FIRST to report the INFLUENCE of maternal FACTORS on Vitamin D status in chinese Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 78)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnant')]
PMC3991049	11/2013	S20-PMC3991049	['BECAUSE 25-Hydroxyvitamin D crosses the Placenta,1and Fetal and Cord Blood levels of the new born Vitamin D status CORRELATE with the mother levels of Vitamin D,2,3a higher level of Vitamin D in the fetus MAY raise the concern of POSSIBLE POTENTIAL fetal harm.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 205), ('INCOMPLETE_EVIDENCE', 230), ('INCOMPLETE_EVIDENCE', 239)]	5	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 8, '25-hydroxyvitamin D'), ('UBERON_0001987', 'placenta', 40, 'placenta'), ('UBERON_0000922', 'embryo', 54, 'fetal'), ('UBERON_0002240', 'spinal cord', 64, 'cord'), ('UBERON_0000178', 'blood', 69, 'blood'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC4045304	2/2014	S2-PMC4045304	['several RECENT STUDIES have PUT FORWARD HYPOTHESES to EXPLAIN the mechanism of ASSOCIATION between both Folic Acid and Vitamin D and autism.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 40), ('PROBABLE_UNDERSTANDING', 54), ('SUPERFICIAL_RELATIONSHIP', 79)]	5	[('CHEBI_30751', 'formic acid', 104, 'folic acid'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC4045304	2/2014	S190-PMC4045304	['Vitamin D and autism hypotheses\nseveral HYPOTHESES HAVE BEEN PROPOSED and tested to EXPLAIN the ASSOCIATION between Vitamin D status of mother and/or autistic child.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 40), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 61), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 96)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4045304	2/2014	S193-PMC4045304	['OTHER mechanisms which MAY EXPLAIN the EFFECT of Vitamin D on autism symptoms are that Vitamin D MAY reduce the severity of autism through its anti-inflammatory actions, increasing T-Regulatory Cells, antiautoimmune effects, and upregulating Glutathione, a scavenger of oxidative byproducts [81–84].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 27), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 97)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CL_0000901', 'Tr1 cell', 181, 'T-regulatory cells'), ('GO_0065007', 'biological regulation', 183, 'regulatory'), ('CHEBI_16856', 'glutathione', 242, 'glutathione')]
PMC4045304	2/2014	S266-PMC4045304	['furthermore, OTHER modifiable, nutrition related RISK factors such as Folic Acid, Vitamin D, and maternal Metabolic syndrome MAY ACCOUNT FOR SOME proportion of increase in asd prevalence.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 125), ('PROBABLE_UNDERSTANDING', 129), ('INCOMPLETE_EVIDENCE', 141)]	5	[('CHEBI_30751', 'formic acid', 70, 'folic acid'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0008152', 'metabolic process', 106, 'metabolic')]
PMC4045304	2/2014	S274-PMC4045304	['PLAUSIBLE mechanisms HAVE BEEN put FORWARD to EXPLAIN the palliative ROLE of Vitamin D in children with autism via Dna Repair, anti-inflammatory actions, Autoimmune activities, and increase in Regulatory T Cells or stimulation antioxidant pathways.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 35), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 69)]	5	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0006281', 'DNA repair', 115, 'DNA repair'), ('UBERON_0001442', 'skeleton of manus', 154, 'autoimmune'), ('CL_0000815', 'regulatory T cell', 193, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 193, 'regulatory')]
PMC4113768	7/2014	S161-PMC4113768	['conclusion: THIS research PROVIDES PRELIMINARY EVIDENCE that Vitamin D MIGHT be ASSOCIATED with Sleep quality.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 80)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0030431', 'sleep', 96, 'sleep')]
PMC4113768	7/2014	S286-PMC4113768	['BASED ON the Skeletal and non Skeletal EFFECTS of Vitamin D (vd), it SEEMS REASONABLE to optimize their vd status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 69), ('PROBABLE_UNDERSTANDING', 75)]	5	[('UBERON_0004288', 'skeleton', 13, 'skeletal'), ('UBERON_0004288', 'skeleton', 30, 'skeletal'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC4113768	7/2014	S463-PMC4113768	['populations in developing countries are OFTEN deficient in Vitamin A. u or j shaped curves for benefits of increases in Vitamin D supplementation in are a GROWING CONCERN, as REPORTED in the western world.']	[('PROBABLE_UNDERSTANDING', 40), ('IMPORTANT_CONSIDERATION', 155), ('INCOMPLETE_EVIDENCE', 155), ('IMPORTANT_CONSIDERATION', 163), ('INCOMPLETE_EVIDENCE', 175)]	5	[('CHEBI_27300', 'vitamin D', 59, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4113768	7/2014	S484-PMC4113768	['background: Vitamin D MAY INFLUENCE Tissue Modelling and Repair in the Lungs throughout Life and THUS low levels of Vitamin D MAY have a negative IMPACT on Lung function.']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 26), ('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 146)]	5	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('GO_0048771', 'tissue remodeling', 36, 'tissue modelling'), ('UBERON_0000479', 'tissue', 36, 'tissue'), ('GO_0006281', 'DNA repair', 57, 'repair'), ('UBERON_0002048', 'lung', 71, 'lungs'), ('UBERON_0000104', 'life cycle', 88, 'life'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0002048', 'lung', 156, 'lung')]
PMC4113768	7/2014	S828-PMC4113768	['health professionals SHOULD ensure that women at greatest RISK of Vitamin D deficiency are asked about Vitamin D supplementation; (2) nice public health GUIDELINE 11- all infants and young children aged 6 months to 5 years SHOULD take a daily supplement containing Vitamin D.\nwe surveyed 20 mothers and 15 health professionals on the Postnatal wards.']	[('FUTURE_WORK', 21), ('IMPORTANT_CONSIDERATION', 21), ('IMPORTANT_CONSIDERATION', 58), ('PROBABLE_UNDERSTANDING', 153), ('FUTURE_WORK', 223)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('GO_0007567', 'parturition', 334, 'postnatal')]
PMC4113768	7/2014	S1046-PMC4113768	['THEREFORE, we AIMED TO INVESTIGATE the ASSOCIATION between Serum levels of 25(Oh) Vitamin D and bone turnover MARKERS in a population-based sample of children with Serum calcium levels.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 20), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 110)]	5	[('UBERON_0001977', 'blood serum', 59, 'serum'), ('CHEBI_30778', 'gallic acid', 75, '25(OH)'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001977', 'blood serum', 164, 'serum')]
PMC4113768	7/2014	S1519-PMC4113768	['THUS, Genetic FACTORS MAY help to identify who is MOST AT RISK of developing low Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 55)]	5	[('SO_0000704', 'gene', 6, 'genetic'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4113768	7/2014	S1541-PMC4113768	['OBSERVATIONAL STUDIES SHOW that Vitamin D deficiency MAY increase the LIKELIHOOD of Ebv reactivation, and that there is a weak negative CORRELATION between Vitamin D and anti-Ebna1 titre.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 53), ('PROBABLE_UNDERSTANDING', 70), ('SUPERFICIAL_RELATIONSHIP', 136)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 84, 'EBV'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('PR_000006877', 'Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial', 175, 'EBNA1')]
PMC4113768	7/2014	S1692-PMC4113768	['AS sun is a rich source of Vitamin D so ONCE IT WAS THOUGHT that Vitamin D deficiency is RARE in asia.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 40), ('ANOMALY_CURIOUS_FINDING', 45), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 89)]	5	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4113768	7/2014	S1710-PMC4113768	['we THEREFORE CONDUCTED a study TO DETERMINE the prevalence of Vitamin D deficiency in a cohort of Adults with asthma who were screened for participation in a clinical trial in london, uk, and TO IDENTIFY CORRELATES of poor asthma Control and low Vitamin D status in this population.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 192), ('SUPERFICIAL_RELATIONSHIP', 204)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0007023', 'adult organism', 98, 'adults'), ('GO_0065007', 'biological regulation', 230, 'control'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
PMC4113768	7/2014	S1748-PMC4113768	['MANY STUDIES HAVE SHOWN an inverse ASSOCIATION between 25Ohd levels and a wide range of disorders, THUS Vitamin D supplementation HAS BEEN promoted to support good health.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 99), ('INCOMPLETE_EVIDENCE', 130)]	5	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 55, '25OHD'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4113768	7/2014	S1866-PMC4113768	['; lanham-new, s.\nbackground: maintaining a healthy Vitamin D status is PROBLEMATIC within the uk, largely DUE TO a combination of two FACTORS: required uv exposure for dermal Production Of Vitamin D is limited by seasonality and there are few Vitamin D-rich foods readily available within the diet.']	[('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 71), ('PROBABLE_UNDERSTANDING', 106), ('PROBLEM_COMPLICATION', 106), ('SUPERFICIAL_RELATIONSHIP', 134)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 175, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
PMC4113768	7/2014	S2930-PMC4113768	['conclusions: in CONCLUSION THIS STUDY INDICATES that Vitamin D deficiency promotes the development of dysplasia, increases Proliferation and inflammation, which is LIKELY promote the development of frank squamous Cell carcinoma, WHEREAS sufficiency retards this development.']	[('INCOMPLETE_EVIDENCE', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 38), ('PROBABLE_UNDERSTANDING', 164), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 229)]	5	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0008283', 'cell proliferation', 123, 'proliferation'), ('CL_0000573', 'retinal cone cell', 213, 'cell')]
PMC4155147	4/2007	S79-PMC4155147	['the recommended dosage originally on the package was one tablet “every three hours.” HOWEVER, it was RECENTLY changed to add “up to three times per day as NECESSARY,” BECAUSE the 15,000 units of Vitamin A from three tablets is enough to cause POSSIBLE Liver damage, dizziness, and blurred Vision.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 155), ('PROBABLE_UNDERSTANDING', 167), ('INCOMPLETE_EVIDENCE', 243)]	5	[('CHEBI_27300', 'vitamin D', 195, 'vitamin A'), ('UBERON_0002107', 'liver', 252, 'liver'), ('GO_0007601', 'visual perception', 289, 'vision')]
PMC4188019	1/2010	S80-PMC4188019	['AS this was a pilot STUDY, we ONLY measured 25-Oh Vitamin D. in the FUTURE, we will start including other RELEVANT parameters such as medical history, Serum levels of calcium and Parathyroid hormone.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 30), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 106)]	5	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 44, '25-OH'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0001977', 'blood serum', 151, 'serum'), ('UBERON_0001132', 'parathyroid gland', 179, 'parathyroid')]
PMC4221707	11/2014	S24-PMC4221707	['THUS, the low intake of Folate, Vitamin D, and iron FOUND in swedish women who are of Childbearing age is of SPECIAL CONCERN, as women do not SEEM to improve the quality of their overall diet during Pregnancy [7,15].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 52), ('ANOMALY_CURIOUS_FINDING', 109), ('PROBLEM_COMPLICATION', 117), ('ANOMALY_CURIOUS_FINDING', 142)]	5	[('CHEBI_30863', '5-azaorotic acid', 24, 'folate'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 86, 'childbearing'), ('GO_0007565', 'female pregnancy', 199, 'pregnancy')]
PMC4251419	12/2014	S9-PMC4251419	['clues from epidemiology\nindications that Vitamin D MAY BE ASSOCIATED with disorders of Human Immune function OFTEN originate from OBSERVATIONS of geographic VARIATION in disease occurrence.']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 58), ('PROBABLE_UNDERSTANDING', 109), ('INCOMPLETE_EVIDENCE', 130), ('DIFFICULT_TASK', 157)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 87, 'human'), ('UBERON_0002405', 'immune system', 93, 'immune')]
PMC4251419	12/2014	S23-PMC4251419	['HOWEVER, for AT LEAST some of the Immune-RELATED diseases, it is DIFFICULT to determine WHETHER low sun exposure OR Vitamin D cause, OR are caused by, the disease.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88)]	5	[('UBERON_0002405', 'immune system', 34, 'immune'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4251419	12/2014	S130-PMC4251419	['in addition, with respect to an ability of supplemental Vitamin D to alter the course of Autoimmune diseases, there is DEBATE about the VALIDITY of biochemical OR cellular markers from Blood AS TRULY representative of disease status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('IMPORTANT_CONSIDERATION', 136), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160), ('PROBABLE_UNDERSTANDING', 191), ('PROBABLE_UNDERSTANDING', 194)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 89, 'autoimmune'), ('UBERON_0000178', 'blood', 185, 'blood')]
PMC4258799	11/2014	S307-PMC4258799	['BASED ON their findings, it SEEMS that a combination of Vitamin E and Selenium had a more significant IMPACT on motility compared to morphology.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 102)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin E'), ('CHEBI_27568', 'selenium atom', 70, 'selenium')]
PMC4340999	3/2015	S102-PMC4340999	['ll in the PRESENT STUDY followed an opposite seasonal TREND to that of Adult adiposity measures, for which maternal uvb exposure (and HENCE Vitamin D status) is STILL a reasonable EXPLANATION.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 134), ('IMPORTANT_CONSIDERATION', 161), ('PROBABLE_UNDERSTANDING', 180)]	5	[('UBERON_0007023', 'adult organism', 71, 'adult'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC4377870	3/2015	S103-PMC4377870	['the CONFLICTING results from these supplementation studies are LIKELY to be INFLUENCED by baseline Tissue levels of Vitamin E [72], with Α-Tocopherol supplementation leading to improved Lung function and wheeze in europe, where Γ-Tocopherol levels are low [78,79,80], BUT NOT in the us, where γ-Tocopherol Intake is high due to Soybean oil Consumption [81,82,83].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('PROBABLE_UNDERSTANDING', 63), ('SUPERFICIAL_RELATIONSHIP', 76), ('FULL_UNKNOWN', 268), ('ANOMALY_CURIOUS_FINDING', 272)]	5	[('UBERON_0000479', 'tissue', 99, 'tissue'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin E'), ('CHEBI_27725', 'butin', 137, 'α-tocopherol'), ('UBERON_0002048', 'lung', 186, 'lung'), ('CHEBI_27725', 'butin', 228, 'γ-tocopherol'), ('CHEBI_27013', 'tocopherol', 295, 'tocopherol'), ('GO_0007631', 'feeding behavior', 306, 'intake'), ('CHEBI_36933', 'oxygen-19 atom', 328, 'soybean'), ('GO_0007631', 'feeding behavior', 340, 'consumption')]
PMC4377870	3/2015	S163-PMC4377870	['copd exacerbations are GENERALLY caused by Viral or bacterial Lung infections, and THOUGH Vitamin D has a positive ROLE in reducing infection, there is NO EVIDENCE to support that Vitamin D is ASSOCIATED with ameliorating exacerbations in copd patients [129].']	[('PROBABLE_UNDERSTANDING', 23), ('ANOMALY_CURIOUS_FINDING', 83), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 152), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('NCBITaxon_1', 'root', 43, 'viral'), ('UBERON_0002048', 'lung', 62, 'lung'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D')]
PMC4377879	3/2015	S93-PMC4377879	['observational or experimental data LINKING Water-soluble Vitamins to any risk of maternal mortality are APPARENTLY unavailable [21]; these Vitamins, such as Vitamin C, Thiamin, niacin and riboflavin and others, do HOWEVER APPEAR to decline in Serum or Plasma levels, LIKELY due to extra uptake by the foetus or haemodilution, or in the case of niacin also increased Urinary Excretion [21].']	[('SUPERFICIAL_RELATIONSHIP', 35), ('ANOMALY_CURIOUS_FINDING', 104), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('ANOMALY_CURIOUS_FINDING', 222), ('PROBABLE_UNDERSTANDING', 267)]	5	[('CHEBI_15377', 'water', 43, 'water'), ('CHEBI_33277', 'gamma-tocotrienol', 57, 'vitamins'), ('CHEBI_33277', 'gamma-tocotrienol', 139, 'vitamins'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin C'), ('CHEBI_26948', 'vitamin B1', 168, 'thiamin'), ('UBERON_0001977', 'blood serum', 243, 'serum'), ('UBERON_0001969', 'blood plasma', 252, 'plasma'), ('GO_0046802', 'exit of virus from host cell nucleus by nuclear egress', 366, 'urinary excretion'), ('UBERON_0001088', 'urine', 366, 'urinary')]
PMC4380518	9/2014	S63-PMC4380518	['the OPTIMAL method of Vitamin D measurement REMAINS CONTROVERSIAL, BUT our laboratory uses u.s. national institute of standards and technology level 1 and this method is COMMONLY used clinically and in the literature.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67), ('PROBABLE_UNDERSTANDING', 170)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
PMC4396835	1/2015	S89-PMC4396835	['GIVEN our main HYPOTHESIS of lower Vitamin D status in asd compared to controls, a case COULD BE made for one-tailed tests, HOWEVER, our results are conservatively reported as two-tailed with probabilities <0.05 accepted as significant.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC4396835	1/2015	S128-PMC4396835	['ACCORDINGLY, the swedish somali women and women from the middle east SEEM PARTICULARLY vulnerable to low Vitamin D levels, AFFECTING the Vitamin D status of the offspring, PRESUMABLY due to both dark skin [32] and covered clothing.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 69), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 123), ('PROBABLE_UNDERSTANDING', 172)]	5	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4405493	4/2015	S122-PMC4405493	['recent clinical GUIDELINES SUGGEST that doses of Vitamin D greater than 600 iu/day MAY BE needed to maintain adequate Plasma levels greater than 30 ng/ml (75 nmol/l), BUT the appropriate standard is still DEBATED [19,42–43].']	[('PROBABLE_UNDERSTANDING', 16), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 118, 'plasma')]
PMC4405493	4/2015	S126-PMC4405493	['BECAUSE Vitamin D deficiency is so widespread, determining WHETHER Vitamin D deficiency is ASSOCIATED with adverse Pregnancy outcomes is an area of MAJOR PUBLIC HEALTH CONCERN.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('SUPERFICIAL_RELATIONSHIP', 91), ('IMPORTANT_CONSIDERATION', 148), ('IMPORTANT_CONSIDERATION', 154)]	5	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy')]
PMC4405493	4/2015	S155-PMC4405493	['THUS, in combination with its immunomodulatory and anti-inflammatory properties, Vitamin D MAY play a POTENTIAL ROLE in the PREVENTION of Preterm Birth and small-for-Gestational-age neonates.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 112), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 138, 'preterm birth'), ('GO_0007565', 'female pregnancy', 166, 'gestational')]
PMC4417995	4/2015	S80-PMC4417995	['this would be a CONSEQUENCE of Vitamin D decreased production in covered skin areas, THUS INDICATING a local PROTECTIVE EFFECT of Vitamin D against the development of ad lesions.']	[('PROBABLE_UNDERSTANDING', 16), ('PROBABLE_UNDERSTANDING', 85), ('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 120)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC4417995	4/2015	S110-PMC4417995	['[30] also EVIDENCED that breastfeeding is GENERALLY ASSOCIATED with low Vitamin D intake, AS OPPOSED TO replacement formulas and dairy drinks fortified with Vitamin D, which provide a CONSIDERABLY higher Intake.']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('ANOMALY_CURIOUS_FINDING', 184)]	5	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007631', 'feeding behavior', 204, 'intake')]
PMC4417995	4/2015	S187-PMC4417995	['THEREFORE systematic supplementation of Vitamin D in childhood ad currently cannot be RECOMMENDED EXCEPT for UNCOMMON cases which MAY prove refractory to traditional therapeutic options.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 130)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC4448820	5/2015	S68-PMC4448820	['phase i of the bond program included an evaluation of 6 Nutrients— zinc, iron, Folic Acid, Vitamin B-12, Vitamin A, and Iodine—chosen for their PUBLIC HEALTH IMPORTANCE and BECAUSE they represent the range of ISSUES confronting those who are addressing the ROLE of nutrition in research, clinical care, or program development/evaluation.']	[('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 158), ('PROBABLE_UNDERSTANDING', 173), ('IMPORTANT_CONSIDERATION', 209), ('SUPERFICIAL_RELATIONSHIP', 257)]	5	[('CHEBI_33284', 'nutrient', 56, 'nutrients'), ('CHEBI_30751', 'formic acid', 79, 'folic acid'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 91, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 120, 'iodine')]
PMC4448820	5/2015	S578-PMC4448820	['one POSSIBLE EXPLANATION for the APPARENT lack of benefit of Vitamin A supplementation below 6 mo of age is that infants in SUCH studies are PROTECTED from infection by maternally derived Immune factors (e.g., Serum Igg, factors in Breast Milk) to a greater degree than are older infants.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 13), ('ANOMALY_CURIOUS_FINDING', 33), ('PROBABLE_UNDERSTANDING', 124), ('SUPERFICIAL_RELATIONSHIP', 141)]	5	[('CHEBI_27300', 'vitamin D', 61, 'vitamin A'), ('UBERON_0002405', 'immune system', 188, 'immune'), ('UBERON_0001977', 'blood serum', 210, 'serum'), ('GO_0071735', 'IgG immunoglobulin complex', 216, 'IgG'), ('UBERON_0001348', 'brown adipose tissue', 232, 'breast milk')]
PMC4448820	5/2015	S1516-PMC4448820	['as outlined by wgs 1 and 2, an EXPANDING body of EVIDENCE ATTESTS to the IMPORTANCE of Vitamin D to Immune function and the inflammatory Response, with potential therapeutic applications for acute and chronic infectious and inflammatory diseases (790).']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 58), ('PROBABLE_UNDERSTANDING', 58), ('IMPORTANT_CONSIDERATION', 73)]	5	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('GO_0060033', 'anatomical structure regression', 137, 'response')]
PMC4452099	6/2015	S14-PMC4452099	['there are several REASONS to SUGGEST that Vitamin D supplementation early in Life MAY CONTRIBUTE to PREVENTING t1d.']	[('PROBABLE_UNDERSTANDING', 18), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 100)]	5	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0000104', 'life cycle', 77, 'life')]
PMC4466139	6/2015	S16-PMC4466139	['Vitamin D levels during fetal Life and the Neonatal Period MAY play a ROLE in the development of these conditions through epigenetic changes [11], THEREFORE, Vitamin D status during Pregnancy and in the newborn COULD provide IMPORTANT information.']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 147), ('INCOMPLETE_EVIDENCE', 211), ('IMPORTANT_CONSIDERATION', 225)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 30, 'life'), ('UBERON_0007221', 'neonate stage', 43, 'neonatal period'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy')]
PMC4466139	6/2015	S108-PMC4466139	['Vitamin D deficiency in Pregnancy in spite of taking supplementation MAY BE AS a result of an INSUFFICIENT dose of Vitamin D contained in multivitamins in Prenatal supplements many of which contain only 400 iu or 500 iu, as PREVIOUSLY SHOWN in OTHER studies [33,34].']	[('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 76), ('IMPORTANT_CONSIDERATION', 94), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 244)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 24, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'prenatal')]
PMC4466139	6/2015	S118-PMC4466139	['furthermore, AS maternal Vitamin D deficiency status AFFECTS the newborn, it MAY BE CONSIDERED as a risk FACTOR for other Vitamin D-related disorders in these newborns.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4488777	5/2015	S12-PMC4488777	['Vitamin D is definitely not a trojan horse in Reproductive health, SINCE there were no adverse effects REPORTED for Vitamin D intake of up to 10,000 iu/day, BUT to PROCLAIM it the golden fleece, MORE EVIDENCE IS NEEDED.']	[('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 195)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0000003', 'reproduction', 46, 'reproductive'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC4499946	7/2015	S23-PMC4499946	['Vitamin D status is THEREFORE a logical CANDIDATE AS a modifiable nutritional DETERMINANT of linear growth in communities where stunting is prevalent and Vitamin D status is commonly SUBOPTIMAL.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 40), ('PROBABLE_UNDERSTANDING', 50), ('SUPERFICIAL_RELATIONSHIP', 78), ('IMPORTANT_CONSIDERATION', 183)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC4586450	10/2015	S288-PMC4586450	['it PROVED IMPOSSIBLE to incorporate enough Vitamin D–containing foods to cover the RECOMMENDATIONS, implying that Vitamin D–deficient diets are LIKELY to be the norm.32\nin the mid-2000s, there was a great deal of CONTROVERSY about the nutritional content of school meals.']	[('PROBABLE_UNDERSTANDING', 3), ('DIFFICULT_TASK', 10), ('FUTURE_WORK', 83), ('PROBABLE_UNDERSTANDING', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4595656	10/2015	S8-PMC4595656	['IN LIGHT OF the IMPORTANCE of the hippocampus in ltp and spatial Learning, FURTHER INVESTIGATIONS on the early EFFECTS of Vitamin D deprivation on hippocampal development ARE WARRANTED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('FUTURE_WORK', 75), ('SUPERFICIAL_RELATIONSHIP', 111), ('FUTURE_WORK', 171)]	5	[('GO_0007612', 'learning', 65, 'learning'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC4595656	10/2015	S130-PMC4595656	['low Prenatal Vitamin D HAS BEEN POSTULATED AS an epigenetic risk factor for same (mcgrath,1999), and transient vd IS CONSIDERED a developmental MODEL in schizophrenia research.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 43), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 144)]	5	[('GO_0007565', 'female pregnancy', 4, 'prenatal'), ('CHEBI_27300', 'vitamin D', 13, 'vitamin D')]
PMC4598849	10/2015	S6-PMC4598849	['THIS STUDY PROVIDES the FIRST epidemiological EVIDENCE that there was an inverted u shaped RELATIONSHIP between neonatal Vitamin D status and fetal growth, and the risk of sga reduced at moderate concentration.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4598849	10/2015	S74-PMC4598849	['THUS, FUTURE STUDIES of Vitamin D and growth restriction would BENEFIT from the CONSIDERATION of OTHER Vitamin D family members.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 6), ('IMPORTANT_CONSIDERATION', 63), ('FUTURE_WORK', 80), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4600246	10/2015	S10-PMC4600246	['THUS, UNLESS you are an institutionalised Postmenopausal woman or you have already experienced a fracture, the uspstf does not RECOMMEND Calcium and Vitamin D for preventing a first-time fracture, AS there is a LACK OF EVIDENCE.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('FUTURE_WORK', 127), ('PROBABLE_UNDERSTANDING', 197), ('INCOMPLETE_EVIDENCE', 211)]	5	[('GO_0007595', 'lactation', 42, 'postmenopausal'), ('CHEBI_22313', 'alkaline earth metal atom', 137, 'calcium'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
PMC4684854	12/2015	S84-PMC4684854	['obesity presents a CONFOUNDING INFLUENCE in THIS discussion, however, AS a greater bmi is ASSOCIATED with lower Vitamin D levels as well as greater Insulin resistance and risk for Gestational diabetes.']	[('PROBLEM_COMPLICATION', 19), ('SUPERFICIAL_RELATIONSHIP', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('PROBABLE_UNDERSTANDING', 70), ('SUPERFICIAL_RELATIONSHIP', 90)]	5	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('PR_000045358', 'insulin family protein', 148, 'insulin'), ('GO_0007565', 'female pregnancy', 180, 'gestational')]
PMC4689556	12/2015	S16-PMC4689556	['SEVERAL STUDIES have LINKED low Vitamin D status to a number of resource intensive childhood health PROBLEMS including allergy and infection [2–7], in addition to the WELL-ESTABLISHED EFFECTS on bone Metabolism.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 100), ('PROBABLE_UNDERSTANDING', 167), ('SUPERFICIAL_RELATIONSHIP', 184)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0008152', 'metabolic process', 200, 'metabolism')]
PMC4689556	12/2015	S145-PMC4689556	['our NEW FINDINGS SUGGEST that Prenatal maternal Vitamin D levels MAY BE less IMPORTANT than Postnatal infant Vitamin D levels for determining infant health outcomes, AT LEAST within the insufficient/deficient range.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 65), ('IMPORTANT_CONSIDERATION', 77), ('PROBABLE_UNDERSTANDING', 166)]	5	[('GO_0007565', 'female pregnancy', 30, 'prenatal'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007567', 'parturition', 92, 'postnatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC4690051	12/2015	S74-PMC4690051	['BASED ON supplemental studies of Vitamin D during Pregnancy, a 10 ng/ml increase in 25(Oh)D has resulted in a PROTECTIVE odds ratio for healthy Pregnancy outcomes [37]; THUS, we ASSESSED such EFFECTS on Cognitive and language scaled scores.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 110), ('PROBABLE_UNDERSTANDING', 169), ('QUESTION_ANSWERED_BY_THIS_WORK', 178), ('SUPERFICIAL_RELATIONSHIP', 192)]	5	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 84, '25(OH)D'), ('GO_0007565', 'female pregnancy', 144, 'pregnancy'), ('GO_0050890', 'cognition', 203, 'cognitive')]
PMC4691762	12/2015	S15-PMC4691762	['introduction\nVitamin D is LIKELY to play a ROLE in early infant Immune health, with EMERGING EVIDENCE that early Life Vitamin D deficiency increases the risk of developing childhood diseases such as Food allergy1lower Respiratory infections (lris)2and eczema.3a marked shift to Vitamin D deficiency in early Life in modern populations MAY BE an underlying driver of the REPORTED rise in allergic diseases including Food allergy and eczema.']	[('PROBABLE_UNDERSTANDING', 26), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 335), ('INCOMPLETE_EVIDENCE', 370)]	5	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('UBERON_0002405', 'immune system', 64, 'immune'), ('UBERON_0000104', 'life cycle', 113, 'life'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_33290', 'food', 199, 'food'), ('UBERON_0001004', 'respiratory system', 218, 'respiratory'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D'), ('UBERON_0000104', 'life cycle', 308, 'life'), ('CHEBI_33290', 'food', 415, 'food')]
PMC4764019	1/2016	S12-PMC4764019	['INSTEAD, where i FOCUS HERE is on the nonskeletal CONSEQUENCES both of untreated rickets and of lesser degrees of Vitamin D inadequacy, OFTEN not clinically apparent and occurring at critical periods during maturation, in some instances well before the Life Stages when rickets is typically manifest.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('PROBLEM_COMPLICATION', 50), ('PROBABLE_UNDERSTANDING', 136)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('UBERON_0000104', 'life cycle', 253, 'life stages')]
PMC4764019	1/2016	S67-PMC4764019	['ARE there RECOGNIZED mechanisms whereby Vitamin D status MAY INFLUENCE late-Life outcomes?']	[('EXPLICIT_QUESTION', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('EXPLICIT_QUESTION', 89)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0000104', 'life cycle', 76, 'life')]
PMC4764019	1/2016	S72-PMC4764019	['THAT MEANS that Vitamin D status CAN INFLUENCE not so much the content of our Genetic heritage as WHEN and to WHAT extent it gets Expressed.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 37), ('EXPLICIT_QUESTION', 98), ('EXPLICIT_QUESTION', 110)]	5	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('SO_0000704', 'gene', 78, 'genetic'), ('GO_0010467', 'gene expression', 130, 'expressed')]
PMC4770602	1/2016	S71-PMC4770602	['this result is in SIMILAR with OTHER FINDINGS which REPORTED that Intake of milk, and THEREFORE Vitamin D and Calcium, during Pregnancy is ASSOCIATED with increased infant birth weight.']	[('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 86), ('SUPERFICIAL_RELATIONSHIP', 139)]	5	[('GO_0007631', 'feeding behavior', 66, 'intake'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 110, 'calcium'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy')]
PMC4770602	1/2016	S77-PMC4770602	['THEREFORE, Calcium intake MAY CONFOUND an ASSOCIATION between maternal Vitamin D deficiency and preeclampsia RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 26), ('PROBLEM_COMPLICATION', 30), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 109)]	5	[('CHEBI_22313', 'alkaline earth metal atom', 11, 'calcium'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4778858	3/2016	S129-PMC4778858	['the results are NOT NECESSARILY applicable to the general population AS ONLY white women were studied, and it is WELL ESTABLISHED that Vitamin D levels are lower among People with darker skin Complexions [36,37].']	[('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 69), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 113), ('PROBABLE_UNDERSTANDING', 113)]	5	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 168, 'people'), ('GO_0042600', 'egg chorion', 192, 'complexions')]
PMC4784858	3/2016	S87-PMC4784858	['EVEN IF national GUIDELINES RECOMMEND the use of dietary supplements to meet REQUIREMENTS for some Nutrients (Folate, Vitamin D, iron or Iodine) during Pregnancy, Nutrient intakes from dietary supplements were not included in the pandiet calculation, like in other studies using diet quality indexes for Pregnancy [11–13].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 17), ('FUTURE_WORK', 28), ('IMPORTANT_CONSIDERATION', 77)]	5	[('CHEBI_33284', 'nutrient', 99, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 110, 'folate'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 137, 'iodine'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy'), ('CHEBI_33284', 'nutrient', 163, 'nutrient'), ('GO_0007565', 'female pregnancy', 304, 'pregnancy')]
PMC4811107	3/2016	S99-PMC4811107	['this DIFFERENCE LIKELY LED to the result in which women who were obese before Pregnancy were more LIKELY to have Delivered a child with Vitamin D deficiency COMPARED TO women who had a normal bmi (odds ratio = or = 2.1, 95% confidence interval = ci 1.2, 3.6).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('PROBABLE_UNDERSTANDING', 16), ('SUPERFICIAL_RELATIONSHIP', 23), ('PROBABLE_UNDERSTANDING', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157)]	5	[('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0007567', 'parturition', 113, 'delivered'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC4811441	3/2016	S136-PMC4811441	['also, an increase in 25(Oh)D ≥30 nmol/l was not associated with Pregnancy-induced hypertension.10.1371/journal.pone.0152198.t004\n\ncaption (table-wrap): table 4\nbivariable and multivariable logistic regression analysis of the DETERMINANTS of Pregnancy-induced hypertension.bivariablemultivariableabor95% cipbor95% ciplowerupperlowerupper25(Oh)D t10.0081.0081.0011.0140.0240.0021.0020.9931.0100.709obesity t10.3661.4430.8972.3210.131-0.1690.8440.4641.5380.844nulliparity0.3611.4351.0391.9830.0290.2051.2280.8541.7650.269excessive gwg0.4731.6041.1462.2460.0060.3631.4380.9952.0780.054preexisting medical condition t10.6321.8810.8764.0400.1050.0891.0930.4542.6290.842assisted reproduction0.1821.2000.7881.8280.3950.0841.0880.6561.8030.745tobacco use t1-0.6330.5310.2161.3080.169-0.4470.6400.2621.5630.327height0.0541.0551.0291.083<0.0010.0351.0351.0051.0660.021age ≥40 years t1-0.1410.8680.3732.0240.744-0.1920.8250.3122.1840.699dbp t10.0871.0911.0691.114<0.0010.0881.0921.0671.117<0.001\n25(Oh)d = 25-Hydroxyvitamin D, t1 = first trimester, gwg = Gestational weight gain, dbp = diastolic Blood pressure,\ndichotomous: age ≥40 years, obesity, nulliparity, excessive gwg, preexisting medical condition and assisted reproduction\na.adjusted for multifetal Pregnancy, baseline employment status, Gestational age at t1, month of Conception and northern european country of Birth\n\ndiscussion\nthese results are the primary outcome of the gravid study–TO OUR KNOWLEDGE the FIRST STUDY reporting on the RELATIONSHIP between longitudinal Vitamin D status and its RELATION to pe and Gestational bp trajectory.']	[('SUPERFICIAL_RELATIONSHIP', 225), ('PROBABLE_UNDERSTANDING', 1438), ('INCOMPLETE_EVIDENCE', 1459), ('SUPERFICIAL_RELATIONSHIP', 1488), ('SUPERFICIAL_RELATIONSHIP', 1547)]	5	[('CHEBI_71657', 'versiconol acetate', 21, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 21, '25(OH)D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007565', 'female pregnancy', 241, 'pregnancy'), ('CHEBI_33010', 'chromide(1-)', 338, '(OH)D'), ('CHEBI_63056', 'zinc cation', 984, '25(OH'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 994, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 1043, 'gestational'), ('UBERON_0000178', 'blood', 1084, 'blood'), ('GO_0007565', 'female pregnancy', 1247, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1286, 'gestational'), ('GO_0007620', 'copulation', 1318, 'conception'), ('GO_0007567', 'parturition', 1362, 'birth'), ('CHEBI_27300', 'vitamin D', 1522, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1566, 'gestational')]
PMC4843009	4/2016	S120-PMC4843009	['the present OBSERVATIONS underscore the powerful direct or indirect INFLUENCE of 1,25(Oh)2D3On the Brain, which PRESUMABLY accounts FOR the various Cerebral EFFECTS of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 112), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('SUPERFICIAL_RELATIONSHIP', 157)]	5	[('CHEBI_37958', 'dye', 81, '1,'), ('CHEBI_35448', '1,2-phenylene group', 83, '25(OH)2D3on'), ('UBERON_0000955', 'brain', 99, 'brain'), ('UBERON_0001893', 'telencephalon', 148, 'cerebral'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC4889866	5/2016	S14-PMC4889866	['in addition to allergic diseases, Vitamin D also partakes a POTENTIAL ROLE in Airway inflammation, THUS, STRONGLY LINKED with acute infectious illness such as upper or lower Respiratory Tract infections, sepsis, and hospitalization [7–10].']	[('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 99), ('PROBABLE_UNDERSTANDING', 105), ('SUPERFICIAL_RELATIONSHIP', 114)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 78, 'airway'), ('UBERON_0000065', 'respiratory tract', 174, 'respiratory tract')]
PMC4889866	5/2016	S124-PMC4889866	['THUS, FUTURE STUDIES RELATED to the EFFECT of Prenatal Vitamin D level on neonatal Innate Immunity and subsequent health outcomes will NEED to focus on populations with more Vitamin d sufficient Pregnant mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 6), ('SUPERFICIAL_RELATIONSHIP', 21), ('SUPERFICIAL_RELATIONSHIP', 36), ('FUTURE_WORK', 135)]	5	[('GO_0007565', 'female pregnancy', 46, 'prenatal'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0045087', 'innate immune response', 83, 'innate immunity'), ('CHEBI_33229', 'vitamin (role)', 174, 'vitamin'), ('GO_0007565', 'female pregnancy', 195, 'pregnant')]
PMC4897157	5/2016	S123-PMC4897157	['THEREFORE, we SUGGEST that sun exposure and Vitamin D status during infancy MAY have an IMPACT on the LIKELIHOOD of developing allergic diseases.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 88), ('PROBABLE_UNDERSTANDING', 102)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC4903143	5/2016	S157-PMC4903143	['AS operative Delivery via caesarean Section MAY result in deficiency or disruption of a healthy biome, steps to diminish the need for operative Delivery by addressing POTENTIALLY modifiable DETERMINANTS such as elevated bmi [159] and Vitamin D deficiency [94] in Pregnancy MAY BE in order.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 190), ('INCOMPLETE_EVIDENCE', 273)]	5	[('GO_0007567', 'parturition', 13, 'delivery'), ('GO_0007601', 'visual perception', 36, 'section'), ('GO_0007567', 'parturition', 144, 'delivery'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('GO_0007565', 'female pregnancy', 263, 'pregnancy')]
PMC4930210	7/2016	S126-PMC4930210	['discussion\nTO OUR KNOWLEDGE, THIS is the largest STUDY TO date to SHOW 44% of Pregnant women with a higher socioeconomic status reported Vitamin D intake (diet and supplements) not meeting the dietary reference intakes (dri) recomendations.']	[('PROBABLE_UNDERSTANDING', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('INCOMPLETE_EVIDENCE', 66)]	5	[('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
PMC4934634	11/2015	S164-PMC4934634	['THUS, it is NOT SURPRISING that this study FOUND no effect of the Vitamin D supplementation on incidences of Preterm Birth, Preeclampsia, or small for Gestation age SINCE 23% of participants had persistent Serum 25(Oh)D below 10 ng/ml which IS CONSIDERED Vitamin D deficiency status by both the iom and endocrine society (table 1).']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 43), ('PROBABLE_UNDERSTANDING', 165), ('INCOMPLETE_EVIDENCE', 241)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'preterm birth'), ('GO_0007128', 'meiotic prophase I', 124, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 151, 'gestation'), ('UBERON_0001977', 'blood serum', 206, 'serum'), ('CHEBI_71657', 'versiconol acetate', 212, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 212, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
PMC4934634	11/2015	S265-PMC4934634	['it is not COMPLETELY known HOW large, acute increases in circulating 25(Oh)D levels immediately following supplementation CAN AFFECT a fetus/infant, who are VULNERABLE to Vitamin D toxicity at this time in development.']	[('PROBABLE_UNDERSTANDING', 10), ('EXPLICIT_QUESTION', 27), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 126), ('IMPORTANT_CONSIDERATION', 157)]	5	[('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 69, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC4949006	7/2016	S145-PMC4949006	['HOWEVER, when Vitamin D deficiency is identified during Pregnancy, supplementation with up to 1000 to 2000 iu/d is CONSIDERED SAFE by MOST EXPERTS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 115), ('IMPORTANT_CONSIDERATION', 126), ('PROBABLE_UNDERSTANDING', 134), ('PROBABLE_UNDERSTANDING', 139)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnancy')]
PMC4969253	8/2016	S90-PMC4969253	['circulating levels of Vitamin A (Retinol), Retinyl Esters, or ra do NOT NECESSARILY REFLECT the Retinoid status of target cells, SINCE activation of ra signaling depends on a COMPLEX interplay of the components of this pathway, including the presence of ra-synthesizing enzymes, ra receptors (rar, rxr), co-activators/co-repressors, and ra-Metabolizing enzymes.']	[('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 84), ('PROBABLE_UNDERSTANDING', 129), ('PROBLEM_COMPLICATION', 129), ('DIFFICULT_TASK', 175)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 33, 'retinol'), ('CHEBI_26523', 'reactive oxygen species', 43, 'retinyl esters'), ('CHEBI_26537', 'retinoid', 96, 'retinoid'), ('GO_0008152', 'metabolic process', 340, 'metabolizing')]
PMC4973215	8/2016	S15-PMC4973215	['THUS, the primary PURPOSE of THIS STUDY was to EXAMINE the RELATIONSHIP between race, maternal characteristics, Cord Blood Vitamin D levels and sga status among infants during one winter season in a midwestern us population.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('SUPERFICIAL_RELATIONSHIP', 59)]	5	[('UBERON_0002240', 'spinal cord', 112, 'cord'), ('UBERON_0000178', 'blood', 117, 'blood'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4973215	8/2016	S104-PMC4973215	['we IDENTIFIED additive and modifiable maternal RISK FACTORS that WOULD BENEFIT MOST from risk reduction and targeted Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 47), ('FUTURE_PREDICTION', 65), ('IMPORTANT_CONSIDERATION', 71), ('PROBABLE_UNDERSTANDING', 79)]	5	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC4989298	8/2016	S370-PMC4989298	['published an exhaustive review CONCLUDING that there were NO conclusive DATA identifying a POSSIBLE dose of Vitamin D resulting in PREVENTION of Food allergy [126].']	[('INCOMPLETE_EVIDENCE', 31), ('PROBABLE_UNDERSTANDING', 31), ('FULL_UNKNOWN', 58), ('INCOMPLETE_EVIDENCE', 91), ('SUPERFICIAL_RELATIONSHIP', 131)]	5	[('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_33290', 'food', 145, 'food')]
PMC4997567	8/2016	S94-PMC4997567	['hollis and wagner (2004) [21] NOTICED that ALTHOUGH Breast Milk is adequate for growth and bone mineralization in the first year of Life, it is lacking adequate concentration of Vitamin D. THEREFORE, Vitamin D supplementation MUST BE NECESSARY for Breast-Fed infants.']	[('ANOMALY_CURIOUS_FINDING', 30), ('ANOMALY_CURIOUS_FINDING', 43), ('PROBABLE_UNDERSTANDING', 189), ('IMPORTANT_CONSIDERATION', 226), ('IMPORTANT_CONSIDERATION', 234)]	5	[('UBERON_0000310', 'breast', 52, 'breast'), ('UBERON_0001913', 'milk', 59, 'milk'), ('UBERON_0000104', 'life cycle', 132, 'life'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0000310', 'breast', 248, 'breast'), ('GO_0007631', 'feeding behavior', 255, 'fed')]
PMC4998950	4/2016	S14-PMC4998950	['we considered other parental characteristics described below (also seetable 1) as POTENTIAL CONFOUNDERS or mediators BASED ON their ASSOCIATIONS with asd and Vitamin D deficiency.5,8,9\n\ncaption (table-wrap): table 1\nstudy population characteristics in relation to lifetime maternal history of diagnosed Vitamin D deficiencymaternal history of Vitamin D deficiencycharacteristicnoyes p allindividuals, n (%)509 092 (99.9)547 (0.1)509 639 (100.0)cases of asd with intellectual disability, n (%)2463 (0.5)13 (2.4)<0.00012476 (0.5)cases of asd without intellectual disability, n (%)7396 (1.4)10 (1.8)0.467406 (1.4)male (%)51.352.60.5151.3maternal age, years: mean29.928.5<0.000129.9paternal age, years: mean32.834.0<0.000132.8maternal country of Birth (%)\u2003sweden76.319.2<0.000176.2\u2003europe8.34.60.0028.3\u2003outside europe12.838.9<0.000112.9\u2003sub-saharan africa2.637.3<0.00012.6lowest quintile of disposable family income (%)14.835.6<0.000114.8elementary maternal education (%)15.643.1<0.000115.6elementary paternal education (%)16.832.7<0.000116.8born small for Gestational age (%)2.53.70.092.5premature Birth (<37 weeks, %)5.96.20.075.9maternal history of neuropsychiatric disorder (%)a2.49.3<0.00012.4paternal history of neuropsychiatric disorder (%)a2.02.00.982.0maternal history of affective disorder (%)b15.436.8<0.000115.4paternal history of affective disorder (%)b8.110.80.028.1maternal history of epilepsy (%)1.01.50.251.0paternal history of epilepsy (%)1.00.70.521.0\nparental histories of neuropsychiatric disorder include any in-patient or secondary care out-patient record of diagnosed non-affective psychosis, bipolar disorder, attention-deficit hyperactivity disorder, asd, or intellectual disability.']	[('INCOMPLETE_EVIDENCE', 82), ('PROBLEM_COMPLICATION', 92), ('PROBABLE_UNDERSTANDING', 117), ('SUPERFICIAL_RELATIONSHIP', 117), ('SUPERFICIAL_RELATIONSHIP', 132)]	5	[('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 343, 'vitamin D'), ('GO_0007567', 'parturition', 742, 'birth'), ('GO_0007565', 'female pregnancy', 1053, 'gestational'), ('GO_0007567', 'parturition', 1095, 'birth')]
PMC4998950	4/2016	S37-PMC4998950	['second, maternal Vitamin D status was IDENTIFIED from secondary care records, and THEREFORE under-ascertained and PERHAPS DIFFERENTIALLY so with regard to asd RISK FACTORS.']	[('INCOMPLETE_EVIDENCE', 38), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 159)]	5	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC5014971	8/2016	S26-PMC5014971	['the two groups also RECOMMEND DIFFERENT levels of Vitamin D supplementation, IN LARGE PART DUE TO the DIFFERENT stable levels of circulating 25-Oh-D they are attempting to obtain.']	[('FUTURE_WORK', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 141, '25-OH-D')]
PMC5014971	8/2016	S29-PMC5014971	['OBSERVATIONAL studies have CONSISTENTLY FOUND an ASSOCIATION with low maternal Vitamin D status and INCREASED risk of neonatal infectious disease and later inflammatory and atopic disease in offspring [21].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 27), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 100)]	5	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5014971	8/2016	S33-PMC5014971	['Vitamin D supplementation during Pregnancy is GENERALLY CONSIDERED SAFE, THOUGH rigorous studies on high doses of Vitamin D supplementation are LACKING [25].']	[('PROBABLE_UNDERSTANDING', 46), ('INCOMPLETE_EVIDENCE', 56), ('IMPORTANT_CONSIDERATION', 67), ('ANOMALY_CURIOUS_FINDING', 73), ('INCOMPLETE_EVIDENCE', 144)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC5014971	8/2016	S92-PMC5014971	['these physicians were also more LIKELY to disagree with the following statements: Vitamin D supplementation during Pregnancy is GENERALLY not NECESSARY, they are not CONCERNED about Vitamin D deficiency in their Pregnant patients, Pregnant women taking Prenatal Vitamins are at low RISK for Vitamin D deficiency, and most of my Pregnant patients will get enough vitamin d through sun exposure and diet (table 3).']	[('PROBABLE_UNDERSTANDING', 32), ('PROBABLE_UNDERSTANDING', 128), ('IMPORTANT_CONSIDERATION', 142), ('IMPORTANT_CONSIDERATION', 166), ('IMPORTANT_CONSIDERATION', 282)]	5	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('GO_0007565', 'female pregnancy', 212, 'pregnant'), ('GO_0007565', 'female pregnancy', 231, 'pregnant'), ('GO_0007565', 'female pregnancy', 253, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 262, 'vitamins'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D'), ('GO_0007565', 'female pregnancy', 328, 'pregnant')]
PMC5028238	10/2016	S93-PMC5028238	['however, Vitamin D levels in slos patients are REPORTED to be low.55this COULD BE DUE TO many lifestyle factors that occur when a patient is SERIOUSLY ill with slos.']	[('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 73), ('PROBABLE_UNDERSTANDING', 82), ('PROBLEM_COMPLICATION', 82), ('IMPORTANT_CONSIDERATION', 141)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC5045784	10/2016	S60-PMC5045784	['finally, interventional Animal and Human studies provide STRONG EVIDENCE for a beneficial ROLE of Vitamin D supplementation in Pulmonary outcomes.7,20\nthe ROLE of Vitamin D status in the development of bpd REMAINS incompletely understood.']	[('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 57), ('SUPERFICIAL_RELATIONSHIP', 90), ('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 206)]	5	[('NCBITaxon_33208', 'Metazoa', 24, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 35, 'human'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0002048', 'lung', 127, 'pulmonary'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC5045784	10/2016	S70-PMC5045784	['for example, common Vitamin D-related polymorphisms, in Vitamin D-binding protein or vdr LIKELY alter the bioavailable levels of 25(Oh)D.24A STUDY by koroglu et al.25EXAMINED the ROLE of the vdr variant Fok 1 in bpd risk among 109 preterm neonates but DID NOT FIND a significant change in the odds ratio.']	[('PROBABLE_UNDERSTANDING', 89), ('INCOMPLETE_EVIDENCE', 137), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 252)]	5	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 129, '25(OH ... D'), ('PR_000007593', 'glutamate carboxypeptidase 2', 203, 'Fok 1')]
PMC5084016	10/2016	S135-PMC5084016	['GIVEN the INFLUENCE of sunlight exposure on Vitamin D Metabolism, ATTENTION to ethnic groups with hyper-Pigmented skin or with little exposure to sunlight SHOULD BE paid also during Lactation.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('FUTURE_WORK', 66), ('IMPORTANT_CONSIDERATION', 66), ('FUTURE_WORK', 155)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 44, 'vitamin D metabolism'), ('CHEBI_26130', 'biological pigment', 104, 'pigmented'), ('GO_0007595', 'lactation', 182, 'lactation')]
PMC5084041	10/2016	S14-PMC5084041	['introduction\nduring the past decade, Vitamin D has received INCREASING ATTENTION and has been ASSOCIATED with health BENEFITS in addition to its RECOGNIZED EFFECTS on bone health.']	[('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 94), ('IMPORTANT_CONSIDERATION', 117), ('PROBABLE_UNDERSTANDING', 145), ('SUPERFICIAL_RELATIONSHIP', 156)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5085625	9/2016	S95-PMC5085625	['CONSEQUENTLY, Vitamin D level in early Pregnancy is less LIKELY to play a MAJOR ROLE in Placental Development, and it is later increased in this parameter which may PREVENT the development of pe [13].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 57), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 80), ('SUPERFICIAL_RELATIONSHIP', 165)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('GO_0001890', 'placenta development', 88, 'placental development'), ('UBERON_0001987', 'placenta', 88, 'placental')]
PMC5095257	11/2016	S80-PMC5095257	['one of the POSTULATED mechanisms EXPLAINING a month-of-Birth EFFECT in Autoimmune disease is the ROLE that Vitamin D deficiency MIGHT play in the pathophysiology of such diseases (31).']	[('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 33), ('SUPERFICIAL_RELATIONSHIP', 61), ('SUPERFICIAL_RELATIONSHIP', 97), ('INCOMPLETE_EVIDENCE', 128)]	5	[('GO_0007567', 'parturition', 55, 'birth'), ('UBERON_0001442', 'skeleton of manus', 71, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC5118763	12/2016	S184-PMC5118763	['the presence of OTHER Micronutrients in Mmns such as Vitamins C and a, which CAN improve the absorption of iron (26), MAY EXPLAIN this equivalence DESPITE the lower content of iron in the Mmn.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 122), ('ANOMALY_CURIOUS_FINDING', 147)]	5	[('CHEBI_33839', 'macromolecule', 22, 'micronutrients'), ('UBERON_0002544', 'digit', 40, 'MMNs'), ('CHEBI_27300', 'vitamin D', 53, 'vitamins C'), ('PR_000004900', 'complement C3', 62, 'C'), ('UBERON_0003109', 'parapophysis', 188, 'MMN')]
PMC5129897	10/2016	S86-PMC5129897	['OBSERVATIONAL STUDIES offer GOOD EVIDENCE that Vitamin D AFFECTS RISK of dm.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 28), ('PROBABLE_UNDERSTANDING', 28), ('SUPERFICIAL_RELATIONSHIP', 57), ('IMPORTANT_CONSIDERATION', 65)]	5	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC5129897	10/2016	S178-PMC5129897	['ANOTHER LIMITATION of clinical trials is that they are of short duration—GENERALLY a few months to a few years—YET chronic diseases MAY develop slowly over decades, and the half-life of Vitamin D is about 3\xa0weeks, requiring several months of supplementation to show benefit.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 73), ('ANOMALY_CURIOUS_FINDING', 111), ('INCOMPLETE_EVIDENCE', 132)]	5	[('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
PMC5146866	12/2016	S24-PMC5146866	['DESPITE numerous publications that explored Vitamin D status in cb, FURTHER RESEARCH is REQUIRED to determine the LIKELIHOOD for detection of Vitamin D insufficiency in cb of infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 88), ('PROBABLE_UNDERSTANDING', 114)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
PMC5146866	12/2016	S26-PMC5146866	['TO THE BEST OF OUR KNOWLEDGE, OUR STUDY is the FIRST that in addition to identifying the rate, also ESTIMATES the risk of Vitamin D deficiency/insufficiency in the cb and ASSOCIATED outcome in a diverse population of infants.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 171)]	5	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC5146866	12/2016	S79-PMC5146866	['IMPORTANTLY, the upper limit of Vitamin D that is defined as sufficient [8] COULD BE SUBOPTIMAL BECAUSE Vitamin D levels of <30\xa0ng/ml have been ASSOCIATED with increased secretion of intact Parathyroid hormone and reduced Intestinal calcium absorption in healthy Adults [22,23].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 76), ('IMPORTANT_CONSIDERATION', 85), ('PROBABLE_UNDERSTANDING', 96), ('SUPERFICIAL_RELATIONSHIP', 144)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 190, 'parathyroid'), ('UBERON_0000160', 'intestine', 222, 'intestinal'), ('UBERON_0007023', 'adult organism', 263, 'adults')]
PMC5146866	12/2016	S102-PMC5146866	['HOWEVER, it is UNLIKELY that these limitations will AFFECT the OBSERVED rate of Vitamin D deficiency and insufficiency SEEN at Birth in the studied infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 119)]	5	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007567', 'parturition', 127, 'birth')]
PMC5155676	12/2016	S99-PMC5155676	['THUS, those women who are AT RISK of Vitamin D insufficiency in early Pregnancy, gain greater weight, and Deliver in winter MIGHT NEED supplementation with a higher dose of Cholecalciferol to achieve SIMILAR 25(Oh)D concentrations.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 26), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 130), ('SUPERFICIAL_RELATIONSHIP', 200)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0007567', 'parturition', 106, 'deliver'), ('CHEBI_52550', 'theopalauamide', 173, 'cholecalciferol'), ('CHEBI_71657', 'versiconol acetate', 208, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 214, 'D')]
PMC5155676	12/2016	S103-PMC5155676	['it is WELL RECOGNIZED that Individuals who are overweight or obese are at higher RISK of Vitamin D insufficiency, and this is SIMILARLY OBSERVED in Pregnancy (2,22).']	[('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 11), ('IMPORTANT_CONSIDERATION', 81), ('SUPERFICIAL_RELATIONSHIP', 126), ('INCOMPLETE_EVIDENCE', 136)]	5	[('NCBITaxon_1', 'root', 27, 'individuals'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy')]
PMC5240436	1/2017	S114-PMC5240436	['a PREVIOUS STUDY that provided combined Vitamin A and zinc supplementation to children in ghana LED TO a reduction in the RISK of clinical malaria episodes [46] possibly DUE TO the synergistic EFFECTS of Vitamin A and zinc on Immune function [47].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 96), ('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 170), ('SUPERFICIAL_RELATIONSHIP', 193)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin A'), ('UBERON_0002405', 'immune system', 226, 'immune')]
PMC5340372	3/2017	S99-PMC5340372	['Animal STUDIES have FOUND that Vitamin D deficiency CAN cause deficits in Lung function, which CAN be EXPLAINED by a change in Lung Development [32].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 95), ('PROBABLE_UNDERSTANDING', 102)]	5	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0002048', 'lung', 74, 'lung'), ('GO_0030324', 'lung development', 127, 'lung development'), ('UBERON_0002048', 'lung', 127, 'lung')]
PMC5340372	3/2017	S147-PMC5340372	['ALTHOUGH Cord Vitamin D levels are STRONGLY CORRELATED with maternal Vitamin D levels, the extent of the IMPACT on later Respiratory function is DISTINCTIVE.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 35), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 145)]	5	[('UBERON_0002240', 'spinal cord', 9, 'cord'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0045333', 'cellular respiration', 121, 'respiratory'), ('UBERON_0001004', 'respiratory system', 121, 'respiratory')]
PMC5340372	3/2017	S148-PMC5340372	['we BELIEVE that THIS STUDY PROVIDES a CLEARER UNDERSTANDING of the EFFECT of Perinatal Vitamin D levels on Respiratory function and Respiratory outcome in infancy.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('PROBABLE_UNDERSTANDING', 27), ('PROBABLE_UNDERSTANDING', 38), ('SUPERFICIAL_RELATIONSHIP', 67)]	5	[('GO_0036268', 'swimming', 77, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 77, 'perinatal'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 107, 'respiratory'), ('UBERON_0001004', 'respiratory system', 132, 'respiratory')]
PMC5351212	3/2017	S35-PMC5351212	['THEREFORE, inflammatory factors produced early in Brain Development EITHER directly, by inducing mia, OR indirectly, by the maternal absence of a potent anti-inflammatory factor such as Vitamin D MAY, REPRESENT a CONVERGENT pathway towards developmental Brain abnormalities and psychiatric conditions later in Life.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68), ('INCOMPLETE_EVIDENCE', 196), ('PROBABLE_UNDERSTANDING', 201), ('SUPERFICIAL_RELATIONSHIP', 213)]	5	[('GO_0007420', 'brain development', 50, 'brain development'), ('UBERON_0000955', 'brain', 50, 'brain'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('UBERON_0000955', 'brain', 254, 'brain'), ('UBERON_0000104', 'life cycle', 310, 'life')]
PMC5359891	3/2017	S42-PMC5359891	['meta-analysis of observational studies STRONGLY POINTS to a ROLE for maternal Vitamin D deficiency in gdm [37], and additional Vitamin D in Pregnant women with gdm HAS BEEN SHOWN to have beneficial EFFECTS on glycaemia and total and low-density lipoprotein Cholesterol (ldl)-Cholesterol concentrations [38].']	[('PROBABLE_UNDERSTANDING', 39), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 60), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 198)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 140, 'pregnant'), ('CHEBI_16113', 'cholesterol', 257, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 275, 'cholesterol')]
PMC5385921	4/2017	S56-PMC5385921	['ancestry information and Genetic relatedness derived from observed common Genetic variants\nethnicity is strongly ASSOCIATED with Vitamin D status (darker skinned Individuals are more PRONE to Vitamin D deficiency and insufficiency).19genome-wide genotype data for the children allow us to build models that are BETTER able to account for variation in ethnic background (compared with register-based or self-ascribed ethnicity) and for Genetic relatedness between cohort members that MAY inflate an association statistic when Genes AFFECT the exposure or outcome variable.']	[('SUPERFICIAL_RELATIONSHIP', 113), ('PROBABLE_UNDERSTANDING', 183), ('INCOMPLETE_EVIDENCE', 311), ('INCOMPLETE_EVIDENCE', 483), ('SUPERFICIAL_RELATIONSHIP', 531)]	5	[('SO_0000704', 'gene', 25, 'genetic'), ('SO_0000704', 'gene', 74, 'genetic'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('NCBITaxon_1', 'root', 162, 'individuals'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('SO_0000704', 'gene', 435, 'genetic'), ('SO_0000704', 'gene', 525, 'genes')]
PMC5405075	4/2017	S31-PMC5405075	['the most cited adverse outcome of maternal Vitamin D deficiency is neonatal rickets, WHILE mild hypovitaminosis D COULD BE more pronounced in exclusively Breast-Fed infants, on the BASIS that Breast Milk constitutes a POOR source of Vitamin D compared with formulas (34–36).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('ANOMALY_CURIOUS_FINDING', 85), ('INCOMPLETE_EVIDENCE', 114), ('PROBABLE_UNDERSTANDING', 181), ('IMPORTANT_CONSIDERATION', 218)]	5	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 112, 'D'), ('GO_0007567', 'parturition', 154, 'breast'), ('UBERON_0000310', 'breast', 154, 'breast'), ('GO_0007631', 'feeding behavior', 161, 'fed'), ('UBERON_0001348', 'brown adipose tissue', 192, 'breast milk'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D')]
PMC5405075	4/2017	S32-PMC5405075	['IN THE LIGHT of the POSSIBLE parallel-asthma epidemic, cellular molecular studies along with epidemiological data SUGGEST that Vitamin D deficiency MAY have a programming EFFECT in utero and promote a trajectory to develop asthma in childhood and later in Life (2,37–39).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 171)]	5	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('UBERON_0000104', 'life cycle', 256, 'life')]
PMC5405075	4/2017	S56-PMC5405075	['still, the ASSOCIATION of Vitamin D with asthma, AMBIGUOUSLY emerged from observational studies, COULD NOT be confirmed and established AS a causative FACTOR.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('DIFFICULT_TASK', 97), ('PROBABLE_UNDERSTANDING', 136), ('SUPERFICIAL_RELATIONSHIP', 151)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC5418719	5/2017	S6-PMC5418719	['conclusion\nCONSIDERING the EFFICACY and SAFETY of Vitamin D supplementation in THIS STUDY, Vitamin D intake of 800\xa0iu/day MAY enhance Vitamin D status during early hospitalization in vlbw infants with 25 Ohd concentrations\u2009<\u200910\xa0ng/ml at Birth.']	[('PROBABLE_UNDERSTANDING', 11), ('SUPERFICIAL_RELATIONSHIP', 27), ('IMPORTANT_CONSIDERATION', 40), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('INCOMPLETE_EVIDENCE', 122)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 201, '25 OHD'), ('GO_0007567', 'parturition', 237, 'birth')]
PMC5418719	5/2017	S15-PMC5418719	['CONSIDERING the high incidence of Vitamin D deficiency/insufficiency in preterm infants that miss the late Gestation period, which builds Vitamin D stores from mother to fetus, a Vitamin D supply MIGHT be NECESSARY and URGENT to compensate the sufficient Vitamin D level.']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 196), ('IMPORTANT_CONSIDERATION', 205), ('IMPORTANT_CONSIDERATION', 219)]	5	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'gestation'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
PMC5418719	5/2017	S92-PMC5418719	['WHILE the use of 800\xa0iu/d of Vitamin D achieved Serum 25(Oh)D concentrations to the ADEQUATE range of 30–80\xa0ng/ml without toxicity at 36\xa0weeks pma, this dose MAY STILL be too low to restore Vitamin D stores for the MAJORITY of infants with 25(Oh)D concentrations\u2009<\u200910\xa0ng/ml at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 84), ('INCOMPLETE_EVIDENCE', 158), ('IMPORTANT_CONSIDERATION', 162), ('PROBABLE_UNDERSTANDING', 215)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 240, '25(OH)D'), ('GO_0007567', 'parturition', 277, 'birth')]
PMC5426325	4/2017	S13-PMC5426325	['BASED ON Serum 25-Hydroxy Vitamin D3(25(Oh)D3) measurements, STUDIES HAVE SHOWN a pronounced seasonal variation in Vitamin D status in denmark and other countries with latitudes above 35° north and south(1,2), MOST LIKELY RELATED to insufficient actinic Vitamin D Synthesis during the darker part of the year in such countries.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 210), ('SUPERFICIAL_RELATIONSHIP', 222)]	5	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 15, '25-hydroxy'), ('CHEBI_33279', 'vitamin D5', 26, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 26, 'vitamin D3'), ('CHEBI_62946', 'ammonium sulfate', 37, '25(OH)D3'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 254, 'vitamin D synthesis')]
PMC5513133	7/2017	S52-PMC5513133	['additionally, Vitamin D LIKELY plays a KEY ROLE in the pathology of pre-eclamptic conditions by AFFECTING Blood pressure through Calcium Homeostasis and/or Modulating inflammation and Immunity, which are examined further in THIS review.']	[('PROBABLE_UNDERSTANDING', 24), ('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 96), ('QUESTION_ANSWERED_BY_THIS_WORK', 224)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000178', 'blood', 106, 'blood'), ('GO_0055073', 'cadmium ion homeostasis', 129, 'calcium homeostasis'), ('GO_0065007', 'biological regulation', 156, 'modulating'), ('GO_0007566', 'embryo implantation', 184, 'immunity')]
PMC5513133	7/2017	S71-PMC5513133	['there is currently NOT enough data to strongly SUPPORT the HYPOTHESIS that impaired Angiogenesis EXPLAINS the ASSOCIATION between Vitamin D deficiency and pe [60].']	[('ANOMALY_CURIOUS_FINDING', 19), ('INCOMPLETE_EVIDENCE', 47), ('INCOMPLETE_EVIDENCE', 59), ('PROBABLE_UNDERSTANDING', 97), ('SUPERFICIAL_RELATIONSHIP', 110)]	5	[('GO_0001525', 'angiogenesis', 84, 'angiogenesis'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC5513133	7/2017	S169-PMC5513133	['OF NOTE, Omega-3 Fatty Acids found along with Vitamin D in cod Liver oil are LIKELY to play an INDEPENDENT ROLE in PREVENTING pe [92,93].']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('SUPERFICIAL_RELATIONSHIP', 107), ('SUPERFICIAL_RELATIONSHIP', 115)]	5	[('CHEBI_75862', 'alpha-D-rhamnofuranose', 9, 'omega-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0002107', 'liver', 63, 'liver')]
PMC5524288	7/2017	S126-PMC5524288	['additionally, using Serum 25(Oh)D concentration is a BETTER INDICATOR of Vitamin D status and statistically more powerful than using reported Intake BECAUSE it ACCOUNTS FOR all Vitamin D input sources (sun exposure, Food, and Supplements) and makes provision for inter-Individual VARIABILITY in Vitamin D dose response.']	[('PROBABLE_UNDERSTANDING', 53), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 149), ('INCOMPLETE_EVIDENCE', 160), ('DIFFICULT_TASK', 280)]	5	[('UBERON_0001977', 'blood serum', 20, 'serum'), ('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 28, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 32, 'D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007631', 'feeding behavior', 142, 'intake'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('CHEBI_33290', 'food', 216, 'food'), ('CHEBI_33341', 'titanium atom', 226, 'supplements'), ('NCBITaxon_1', 'root', 269, 'individual'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
PMC5537904	7/2017	S25-PMC5537904	['THUS, the PURPOSE of THIS analysis was TO EXAMINE the ASSOCIATIONS between Prenatal Vitamin D intake, neonatal Vitamin D status, and early Life body composition.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('SUPERFICIAL_RELATIONSHIP', 54)]	5	[('GO_0007565', 'female pregnancy', 75, 'prenatal'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0000104', 'life cycle', 139, 'life')]
PMC5546866	8/2017	S14-PMC5546866	['antenatal Vitamin D supplementation is now RECOMMENDED for all Pregnant women in many national GUIDELINES (1–3) AS SEVERE maternal Vitamin D deficiency CAN result in symptomatic neonatal hypocalcemia (4).']	[('FUTURE_WORK', 43), ('PROBABLE_UNDERSTANDING', 95), ('PROBABLE_UNDERSTANDING', 112), ('IMPORTANT_CONSIDERATION', 115), ('INCOMPLETE_EVIDENCE', 152)]	5	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnant'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC555773	9/2004	S218-PMC555773	['IN GENERAL, it IS REPORTED that patients with UNCONTROLLED ESSENTIAL hypertension have elevated concentrations of Superoxide Anion (o2−⋅), H2O2, Lipid Peroxides, endothelin, and transforming Growth Factor-Beta (Tgf-Beta) with a simultaneous decrease in Endothelial No (eno), sod, Vitamin E, and Long-Chain polyunsaturated Fatty Acids (lcpufas).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 46), ('IMPORTANT_CONSIDERATION', 59)]	5	[('CHEBI_62945', 'thromboxane anion', 114, 'superoxide anion'), ('CHEBI_16240', 'hydrogen peroxide', 139, 'H2O2'), ('CHEBI_48155', 'tetrahydrofurancarboxylic acid', 145, 'lipid peroxides'), ('PR_000008020', 'glucocorticoid-induced transcript 1 protein', 191, 'growth factor-beta'), ('PR_000000046', 'TGF-beta', 211, 'TGF-beta'), ('UBERON_0001986', 'endothelium', 253, 'endothelial'), ('CHEBI_16382', 'iodide', 265, 'NO'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin E'), ('CHEBI_28911', 'cob(III)alamin', 295, 'long-chain'), ('CHEBI_33250', 'atom', 322, 'fatty'), ('CHEBI_37527', 'acid', 328, 'acids')]
PMC5634602	10/2017	S137-PMC5634602	['HOWEVER, given that the MAJORITY of Prenatal Vitamins have 400 iu of Vitamin D and this has not been shown to increase levels in Pregnancy this LIKELY does not have any IMPACT on our DESCRIBED results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 24), ('PROBABLE_UNDERSTANDING', 144), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 183)]	5	[('GO_0007565', 'female pregnancy', 36, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 45, 'vitamins'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC5659607	10/2017	S114-PMC5659607	['these results UNDERLINE that Vitamin D supplementation during Pregnancy MAY BE an IMPORTANT FACTOR in the PREVENTION of childhood asthma.']	[('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 72), ('IMPORTANT_CONSIDERATION', 82), ('SUPERFICIAL_RELATIONSHIP', 92), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy')]
PMC5659607	10/2017	S125-PMC5659607	['finally, vdaart included a large group of african-american women in the trial, who are WELL-KNOWN to have a higher RISK of developing asthma and allergy[25] and had lower Vitamin D levels at randomization COMPARED to the OTHER ethnic groups[12].']	[('FUTURE_WORK', 87), ('PROBABLE_UNDERSTANDING', 92), ('IMPORTANT_CONSIDERATION', 115), ('ANOMALY_CURIOUS_FINDING', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	5	[('CHEBI_27300', 'vitamin D', 171, 'vitamin D')]
PMC5659607	10/2017	S141-PMC5659607	['in addition, AS Human fertility is also INFLUENCED by Vitamin D[29,30], it MAY EVEN be worthwhile to TARGET supplementation before Conception to optimize Implantation of the Fertilized Egg and assure sufficient Vitamin D for Lung and Immune Development from the very beginning of Life.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 40), ('INCOMPLETE_EVIDENCE', 75), ('ANOMALY_CURIOUS_FINDING', 79), ('FUTURE_WORK', 101)]	5	[('NCBITaxon_9606', 'Homo sapiens', 16, 'human'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007620', 'copulation', 131, 'conception'), ('GO_0007566', 'embryo implantation', 154, 'implantation'), ('GO_0009566', 'fertilization', 174, 'fertilized'), ('CL_0000025', 'egg cell', 185, 'egg'), ('UBERON_0007379', 'shelled egg', 185, 'egg'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('GO_0006266', 'DNA ligation', 225, 'lung ...'), ('UBERON_0002048', 'lung', 225, 'lung'), ('GO_0001822', 'kidney development', 234, 'immune development'), ('UBERON_0002405', 'immune system', 234, 'immune'), ('UBERON_0000104', 'life cycle', 280, 'life')]
PMC5659607	10/2017	S154-PMC5659607	['Prenatal care STRATEGIES targeted at raising Vitamin D levels in Pregnant women SHOULD THEREFORE BE CONSIDERED.']	[('FUTURE_WORK', 14), ('FUTURE_WORK', 80), ('PROBABLE_UNDERSTANDING', 87), ('ANOMALY_CURIOUS_FINDING', 97), ('FUTURE_WORK', 100)]	5	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnant')]
PMC5664622	9/2017	S14-PMC5664622	['HOWEVER, OTHER authors CLAIM that maternal concentration that fully normalizes Vitamin D Metabolism and Calcium Homeostasis is AT LEAST 40 ng/ml [10], and still others that >20 ng/ml is NECESSARY to prevent Vitamin D deficiency in the newborn [11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 127), ('IMPORTANT_CONSIDERATION', 186)]	5	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 79, 'vitamin D metabolism'), ('GO_0055073', 'cadmium ion homeostasis', 104, 'calcium homeostasis'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC5679631	11/2017	S116-PMC5679631	['we THEORIZED that Vitamin D COULD IMPACT Intestinal colonization due to its immunomodulatory EFFECTS [17,18]; namely, through its inhibition of Intestinal infections via stimulated Antimicrobial Peptide Production and promotion of anti-Inflammatory Responses by the Immune System.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 3), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 93)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000160', 'intestine', 41, 'intestinal'), ('UBERON_0000160', 'intestine', 144, 'intestinal'), ('CHEBI_65381', 'albizoside C', 181, 'antimicrobial'), ('GO_0001519', 'peptide amidation', 195, 'peptide production'), ('GO_0006888', 'endoplasmic reticulum to Golgi vesicle-mediated transport', 236, 'inflammatory responses'), ('UBERON_0002405', 'immune system', 266, 'immune system')]
PMC5707701	11/2017	S170-PMC5707701	['these inverse CORRELATIONS between SOME of the Carotenoids and current bmi MAY BE due TO the underlying mechanism that an excess of body fat increases the consumption of all antioxidant elements in the diet [63], SO that Lactating women with a higher bmi and more body fat consumed more Vitamins A and E than those with lower bmi, resulting in lower Carotenoids in Human Milk.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 75), ('QUESTION_ANSWERED_BY_THIS_WORK', 86), ('PROBABLE_UNDERSTANDING', 213)]	5	[('CHEBI_50815', 'norgestimate', 47, 'carotenoids'), ('GO_0007594', 'puparial adhesion', 221, 'lactating'), ('CHEBI_27300', 'vitamin D', 287, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 296, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 302, 'E'), ('CHEBI_50815', 'norgestimate', 350, 'carotenoids'), ('NCBITaxon_9606', 'Homo sapiens', 365, 'human'), ('UBERON_0001913', 'milk', 371, 'milk')]
PMC5732505	12/2017	S28-PMC5732505	['case-control STUDIES OFTEN focus on HIGH-RISK groups, for example women who are overweight and sedentary, which are INDEPENDENT RISK FACTORS for Vitamin D deficiency as well (for example [16]).']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 21), ('IMPORTANT_CONSIDERATION', 36), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 128)]	5	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5732505	12/2017	S49-PMC5732505	['we DEFINED Vitamin D deficiency AS 25(Oh)D\u2009<\u200950\xa0nmol/l, and Vitamin D sufficiency AS 25(Oh)D\u2009≥\u200950\xa0nmol/l, SINCE a concentration of ≥50\xa0nmol/l IS CONSIDERED sufficient for bone health [17].']	[('PROBABLE_UNDERSTANDING', 3), ('PROBABLE_UNDERSTANDING', 32), ('PROBABLE_UNDERSTANDING', 82), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 142)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 35, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D')]
PMC5732505	12/2017	S144-PMC5732505	['IN ACCORDANCE with OTHER STUDIES, our results IMPLY that in a Vitamin D sufficient population, the ASSOCIATION between 25(Oh)D and gdm MAY NOT exist [8,21,22].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 99), ('INCOMPLETE_EVIDENCE', 135)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D')]
PMC5784894	1/2018	S21-PMC5784894	['we HYPOTHESISE that Antenatal Vitamin D status MAY BE RESPONSIBLE for altered bone responsiveness to Postnatal mechanical loading, a major anabolic INFLUENCE on bone size, mass and strength, and thus act as a DETERMINANT of later Skeletal ill-health.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 47), ('PROBABLE_UNDERSTANDING', 54), ('SUPERFICIAL_RELATIONSHIP', 148), ('SUPERFICIAL_RELATIONSHIP', 209)]	5	[('GO_0007567', 'parturition', 20, 'antenatal'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 101, 'postnatal'), ('UBERON_0004288', 'skeleton', 230, 'skeletal')]
PMC5812027	2/2018	S118-PMC5812027	['AS the results between change in 25Ohd and neonatal Birth size and Preterm Delivery REMAINED after adjustment for season of Conception, origin and Vitamin D supplementation, Vitamin D status trajectory CAN be SUSPECTED to play a ROLE in healthy Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 202), ('PROBABLE_UNDERSTANDING', 209), ('SUPERFICIAL_RELATIONSHIP', 229)]	5	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 33, '25OHD'), ('GO_0007567', 'parturition', 52, 'birth'), ('GO_0007565', 'female pregnancy', 67, 'preterm'), ('GO_0007567', 'parturition', 75, 'delivery'), ('GO_0007620', 'copulation', 124, 'conception'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy')]
PMC5812027	2/2018	S127-PMC5812027	['this COULD BE INTERPRETED AS SUPPORT of our finding that late RATHER than early Pregnancy Vitamin D status is the stronger PREDICTOR of fetal growth restriction.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('SUPERFICIAL_RELATIONSHIP', 123)]	5	[('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC5812027	2/2018	S143-PMC5812027	['AS most women with high Vitamin D status were Born in sweden and THUS more LIKELY to be familiar with the swedish Health-Care System, IT IS POSSIBLE that they registered earlier for Antenatal Care and were more LIKELY to report Pregnancy Loss.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 65), ('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 134), ('PROBABLE_UNDERSTANDING', 211)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007567', 'parturition', 46, 'born'), ('UBERON_0001008', 'renal system', 114, 'health-care system'), ('GO_0007608', 'sensory perception of smell', 182, 'antenatal care'), ('GO_0006508', 'proteolysis', 228, 'pregnancy loss')]
PMC5838372	3/2018	S20-PMC5838372	['the lack of Vitamin D during Pregnancy is the MOST IMPORTANT RISK FACTOR for infantile rickets and MAY also result in POOR fetal growth and Neonatal Development (8,9,10,11).']	[('PROBABLE_UNDERSTANDING', 46), ('IMPORTANT_CONSIDERATION', 51), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 99), ('IMPORTANT_CONSIDERATION', 118)]	5	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 29, 'pregnancy'), ('GO_0021985', 'neurohypophysis development', 140, 'neonatal development')]
PMC5941617	5/2018	S159-PMC5941617	['1–18\xa0years\nthe promotion of an adequate Vitamin D status is IMPORTANT for older children and adolescents, AS nutritional rickets MAY develop during the entire pediatric age [28] and Vitamin D deficiency MAY negatively AFFECT bone health [25,26].']	[('IMPORTANT_CONSIDERATION', 60), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 218)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
PMC5941617	5/2018	S172-PMC5941617	['CONSIDERING the italian child health care system organization, family pediatricians MAY anamnestically evaluate Vitamin D intake of children and POSSIBLE RISK FACTORS for deficiency during periodic health check-ups [176].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 145), ('SUPERFICIAL_RELATIONSHIP', 154)]	5	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC5941617	5/2018	S226-PMC5941617	['the global CONSENSUS on nutritional rickets RECOMMENDED the administration of 2000\xa0iu/day of Vitamin D in patients aged less than 1\xa0year, 3000–6000\xa0iu/day in patients aged 1 to 12\xa0years and 6000\xa0iu/day in patients older than 12\xa0years for a minimum of 3\xa0months, EVEN IF some children MAY require a longer treatment duration [28].']	[('PROBABLE_UNDERSTANDING', 11), ('FUTURE_WORK', 44), ('ANOMALY_CURIOUS_FINDING', 261), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 266), ('INCOMPLETE_EVIDENCE', 283)]	5	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC5941617	5/2018	S389-PMC5941617	['being Vitamin D INVOLVED in Innate Immunity and in skin barrier integrity, and BECAUSE both FACTORS are dysfunctional in ad, the ASSOCIATION is actively DEBATED.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('PROBABLE_UNDERSTANDING', 79), ('SUPERFICIAL_RELATIONSHIP', 92), ('SUPERFICIAL_RELATIONSHIP', 129), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 153)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0045087', 'innate immune response', 28, 'innate immunity')]
PMC5941617	5/2018	S391-PMC5941617	['HOWEVER, at LEAST two longitudinal STUDIES have CORRELATED the Vitamin D Cord Blood low levels to the development of ad in the offsprings, FINDING that low levels in the Cord Blood significantly increased the risk to develop the disease [347,348].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 139)]	5	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 73, 'cord'), ('UBERON_0000178', 'blood', 78, 'blood'), ('UBERON_0009472', 'axilla', 170, 'cord blood')]
PMC5941617	5/2018	S482-PMC5941617	['a RECENT meta-analysis of 4 rcts and 11 non-rcts, ONLY 1 enrolling children [442], SHOWED that weight loss marginally improved Vitamin D in comparison with weight maintenance under similar Vitamin D intake [443], CONFIRMING that increased adiposity causes SUBOPTIMAL Serum 25(Oh)D concentrations.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 83), ('PROBABLE_UNDERSTANDING', 213), ('IMPORTANT_CONSIDERATION', 256)]	5	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('UBERON_0001977', 'blood serum', 267, 'serum'), ('CHEBI_71657', 'versiconol acetate', 273, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 273, '25(OH ... D')]
PMC5941617	5/2018	S510-PMC5941617	['more RECENTLY, united arab emirates GUIDELINES also RECOMMENDED Vitamin D supplementation in obese children and adolescents (1200–2000\xa0iu/day DEPENDING ON severity of obesity, season and sun exposure) throughout the year IF sufficient Skin Synthesis if Vitamin D is not ensured during winter [27].']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 36), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221)]	5	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0009697', 'salicylic acid biosynthetic process', 235, 'skin synthesis'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D')]
PMC5941617	5/2018	S517-PMC5941617	['AT PRESENT, CONSIDERING that obese italian children have higher prevalence of Vitamin D deficiency and insufficiency then normal weight Individuals, we SUGGEST in obese children and adolescents vitamin D supplementation at higher doses THAN those RECOMMENDED for age (1000–1500\xa0iu/day) from the end of fall to the beginning of spring (november–april) to ensure an adequate Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('FUTURE_WORK', 247)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_1', 'root', 136, 'individuals'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 202, 'D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D')]
PMC5941617	5/2018	S608-PMC5941617	['nutritional rickets cases are STILL REPORTED in italy, THUS adequate national STRATEGIES to prevent Vitamin D deficiency ARE NEEDED.']	[('IMPORTANT_CONSIDERATION', 30), ('INCOMPLETE_EVIDENCE', 36), ('PROBABLE_UNDERSTANDING', 55), ('FUTURE_WORK', 78), ('FUTURE_WORK', 121)]	5	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5941617	5/2018	S715-PMC5941617	['we RECOMMEND against Vitamin D treatment to improve patient’s performance CONSIDERING the LIMITED and CONFLICTING AVAILABLE EVIDENCE.']	[('FUTURE_WORK', 3), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('INCOMPLETE_EVIDENCE', 114)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5956785	5/2018	S21-PMC5956785	['CONSEQUENTLY, low Vitamin D concentrations are ASSOCIATED with an increase in pro-Inflammatory Mediators and more active disease [6,10] CONSISTENT, for example, with the OBSERVATION that low Serum 25(Oh)D is ASSOCIATED with increased disease activity in rheumatoid arthritis [11].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 136), ('ANOMALY_CURIOUS_FINDING', 170), ('SUPERFICIAL_RELATIONSHIP', 208)]	5	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_64664', '(2-nitrophenyl)azo group', 81, '-inflammatory mediators'), ('UBERON_0001977', 'blood serum', 191, 'serum'), ('CHEBI_71657', 'versiconol acetate', 197, '25(OH)D')]
PMC5995352	6/2018	S162-PMC5995352	['AS s-Igf-I, promoting growth by Proliferation of the Growth Plate, is inhibited by active Vitamin D as DEMONSTRATED in Animal and in vitro studies [39–43], we SPECULATE IF higher Vitamin D levels MAY restrict infant linear growth through inhibition of Igf-I, which has higher Serum concentrations in boys than in girls.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 159), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('INCOMPLETE_EVIDENCE', 196)]	5	[('PR_000008919', 'interferon alpha-6', 5, 'IGF-I'), ('GO_0008283', 'cell proliferation', 32, 'proliferation'), ('UBERON_0002516', 'epiphyseal plate', 53, 'growth plate'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 119, 'animal'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('PR_000008919', 'interferon alpha-6', 252, 'IGF-I'), ('UBERON_0001977', 'blood serum', 276, 'serum')]
PMC6011374	6/2018	S119-PMC6011374	['THEREFORE, Vitamin D status MAY BE IMPORTANT in populations where dietary Calcium intake is low which is UNLIKELY in the population of women studied HERE.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 35), ('PROBABLE_UNDERSTANDING', 105), ('QUESTION_ANSWERED_BY_THIS_WORK', 149)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 74, 'calcium')]
PMC2290997	4/2008	S14-PMC2290997	['the BEST-KNOWN benefit of sunlight is its ability to boost the body’s Vitamin D supply; MOST cases of Vitamin D deficiency are DUE TO lack of outdoor sun exposure.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 88), ('PROBLEM_COMPLICATION', 127)]	4	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC2290997	4/2008	S131-PMC2290997	['gilchrest says the american academy of dermatology and MOST dermatologists currently SUGGEST sun protection in combination with Vitamin D supplementation AS a means of minimizing the RISK of both skin cancer and internal cancers.']	[('PROBABLE_UNDERSTANDING', 55), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 154), ('IMPORTANT_CONSIDERATION', 183)]	4	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC2396486	6/2008	S13-PMC2396486	['given that Vitamin D levels in the population fluctuate across the seasons and decrease across higher latitude[4], low Prenatal Vitamin D ‘FITS’ these key environmental features and is THEREFORE a PLAUSIBLE CANDIDATE risk factor for this disease.']	[('SUPERFICIAL_RELATIONSHIP', 139), ('PROBABLE_UNDERSTANDING', 185), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 207)]	4	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'prenatal'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC2582131	11/2008	S88-PMC2582131	['several mechanisms MAY EXPLAIN the OBSERVED ASSOCIATION between Vitamin D deficiency and gdm risk.']	[('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 23), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 44)]	4	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
PMC2646054	3/2009	S185-PMC2646054	['experiments in hypercholesterolemic Rabbits HAVE SHOWN that administration of the antioxidant Vitamin E during Pregnancy resulted in reduced atherosclerotic lesions in the offspring (16,17), INDICATING that maternal oxidative stress LIKELY plays a ROLE in maternal programming for atherosclerosis.']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 191), ('PROBABLE_UNDERSTANDING', 233), ('SUPERFICIAL_RELATIONSHIP', 248)]	4	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 36, 'rabbits'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin E'), ('GO_0007565', 'female pregnancy', 111, 'pregnancy')]
PMC2716336	7/2009	S135-PMC2716336	['HOWEVER, the study population Consumed less Retinol, total Vitamin E and zinc, SOME of which MAY BE EXPLAINED by the lower intake of meat.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 100)]	4	[('GO_0007631', 'feeding behavior', 30, 'consumed'), ('CHEBI_26536', 'retinoic acid', 44, 'retinol'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin E')]
PMC2798111	12/2010	S17-PMC2798111	['THEREFORE, Oral supplementation or sufficient sun exposure is NECESSARY to ensure adequate Vitamin D status for proper calcium absorption and bone mineralization [3–6].RECENT RESEARCH has also LINKED Vitamin D to Innate Immunity [7–9].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 62), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 193)]	4	[('UBERON_0000165', 'mouth', 11, 'oral'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('GO_0045087', 'innate immune response', 213, 'innate immunity')]
PMC2798111	12/2010	S19-PMC2798111	['with THIS KNOWLEDGE, IT IS CLEAR that Vitamin D supplementation of the breastfedinfant is NECESSARY and RECOMMENDED by the american academy of pediatrics and the canadian pediatrics society [5,25].']	[('PROBABLE_UNDERSTANDING', 5), ('PROBABLE_UNDERSTANDING', 21), ('IMPORTANT_CONSIDERATION', 90), ('FUTURE_WORK', 104)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC2889879	5/2010	S36-PMC2889879	['HOWEVER, TO OUR KNOWLEDGE, NO STUDY has investigated the ASSOCIATION between dietary Intake of fish, Omega-3 and Omega-6 Pufa or Vitamin D and the risk of having positive psychotic symptoms in the general Adult population.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('FULL_UNKNOWN', 27), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('GO_0007631', 'feeding behavior', 85, 'intake'), ('CHEBI_79370', 'ibho#10', 101, 'omega-3'), ('CHEBI_82670', 'ELQ-271', 113, 'omega-6 PUFA'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('UBERON_0007023', 'adult organism', 205, 'adult')]
PMC2889879	5/2010	S143-PMC2889879	['THUS, the CORRELATION between Vitamin D intake and Serum levels MAY VARY.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 64), ('DIFFICULT_TASK', 68)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001977', 'blood serum', 51, 'serum')]
PMC2913107	8/2010	S46-PMC2913107	['indeed, without the Genetic TENDENCY for autism, i SUSPECT that SEVERE maternal or early childhood Vitamin D deficiency MAY cause bone abnormalities, as referenced above, with no evidence autism.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 64), ('FUTURE_PREDICTION', 120)]	4	[('SO_0000704', 'gene', 20, 'genetic'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC2963768	10/2010	S0-PMC2963768	['Vitamin D status of infants in northeastern rural bangladesh: preliminary observations and a review of potential determinants\n\nabstract\nVitamin D deficiency is a GLOBAL PUBLIC-HEALTH CONCERN, EVEN in tropical regions where the risk of deficiency was PREVIOUSLY ASSUMED to be low due to cutaneous Vitamin D Synthesis stimulated by exposure to sun.']	[('IMPORTANT_CONSIDERATION', 162), ('ANOMALY_CURIOUS_FINDING', 192), ('INCOMPLETE_EVIDENCE', 250), ('PROBABLE_UNDERSTANDING', 261)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 136, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 296, 'vitamin D synthesis')]
PMC2963768	10/2010	S3-PMC2963768	['THEREFORE, to gain PRELIMINARY INSIGHTS into the Vitamin D status of infants in rural bangladesh, 25(Oh)D was ASSESSED in a group of community-sampled control participants in a pneumonia case-control study in rural sylhet, bangladesh (25°n) during the winter dry season (january-february).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 110)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D')]
PMC2963768	10/2010	S12-PMC2963768	['introduction\nthroughout most of the previous century, Vitamin D deficiency and rickets were predominantly PERCEIVED as PROBLEMS of industrialized countries at northern latitudes, where insufficient exposure to sun and intake of Vitamin D were LINKED to INADEQUATE Intestinal absorption of Calcium and impaired Skeletal mineralization (1).']	[('PROBABLE_UNDERSTANDING', 106), ('IMPORTANT_CONSIDERATION', 119), ('SUPERFICIAL_RELATIONSHIP', 243), ('IMPORTANT_CONSIDERATION', 253)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('UBERON_0000160', 'intestine', 264, 'intestinal'), ('CHEBI_22313', 'alkaline earth metal atom', 289, 'calcium'), ('UBERON_0004288', 'skeleton', 310, 'skeletal')]
PMC2963768	10/2010	S14-PMC2963768	['THUS, Vitamin D deficiency has re-emerged as a GLOBAL PUBLIC-HEALTH CONCERN and is now presumptively LINKED to a range of infectious, inflammatory and neoplastic diseases throughout the Life Course and around the world (1).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('IMPORTANT_CONSIDERATION', 47), ('SUPERFICIAL_RELATIONSHIP', 101)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0001281', 'hepatic sinusoid', 186, 'life course')]
PMC2963768	10/2010	S72-PMC2963768	['in this group, age was the ONLY FACTOR that was significantly ASSOCIATED with Vitamin D deficiency DEFINED by 25(Oh)D <25 nmol/l (table 3).']	[('ANOMALY_CURIOUS_FINDING', 27), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 62), ('PROBABLE_UNDERSTANDING', 99)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 110, '25(OH ... D')]
PMC2963768	10/2010	S154-PMC2963768	['THEREFORE, RECOMMENDATIONS for universal Antenatal and/or infant Vitamin D supplementation in bangladesh BASED ON biochemical data ALONE would be premature.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 105), ('ANOMALY_CURIOUS_FINDING', 131)]	4	[('GO_0007567', 'parturition', 41, 'antenatal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC2996405	11/2010	S156-PMC2996405	['ON THE OTHER HAND, the RELATIONSHIP between Vitamin D and schizophrenia is WELL ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 80)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC3004407	12/2010	S21-PMC3004407	['THEORETICALLY, women at lower latitudes, DESPITE darker pigmentation, SHOULD have less Vitamin D deficiency because of the greater LIKELIHOOD of effective sunlight exposure to induce endogenous Vitamin d synthesis [33].']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 41), ('FUTURE_WORK', 70), ('PROBABLE_UNDERSTANDING', 131)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 194, 'vitamin')]
PMC3004407	12/2010	S24-PMC3004407	["it was HYPOTHESIZED that DESPITE south carolina's lower latitude and abundance of sunlight, given modern-day lifestyles that OFTEN PRECLUDE sunlight exposure, the majority of the women presenting for obstetrical care at this community health center network would have Vitamin D insufficiency and a significant number would have outright Vitamin D deficiency."]	[('INCOMPLETE_EVIDENCE', 7), ('ANOMALY_CURIOUS_FINDING', 25), ('PROBABLE_UNDERSTANDING', 125), ('DIFFICULT_TASK', 131)]	4	[('CHEBI_27300', 'vitamin D', 268, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 337, 'vitamin D')]
PMC3004407	12/2010	S95-PMC3004407	['the odds of Vitamin D deficiency (AS measured by 25(Oh)D concentration) did NOT APPEAR TO change as a function of Gestational age; women in their later stages of Pregnancy had a SIMILAR odds of Vitamin D deficiency and insufficiency for a given race/ethnicity than women who had their 25(Oh)D concentrations measured earlier in Pregnancy ( p = .43).']	[('PROBABLE_UNDERSTANDING', 34), ('ANOMALY_CURIOUS_FINDING', 76), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 178)]	4	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('GO_0007565', 'female pregnancy', 162, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 285, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 291, 'D'), ('GO_0007565', 'female pregnancy', 328, 'pregnancy')]
PMC3004407	12/2010	S150-PMC3004407	['what is MOST CONCERNING is that use of Prenatal Vitamins containing 400\u2009iu/tablet was IRRELEVANT in AFFECTING Vitamin D status: those who took their prescribed Prenatal vitamin containing Vitamin D did not differ from those who did not.']	[('PROBABLE_UNDERSTANDING', 8), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 100)]	4	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 48, 'vitamins'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'prenatal'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D')]
PMC3032617	5/2010	S99-PMC3032617	['in the case of children Born with a body weight lower than 2500g, the significant difference FOUND among groups in favor of the Vitamin C women is INTRIGUING as it CAN be INTERPRETED as more and better energy supply to child during Gestation.']	[('INCOMPLETE_EVIDENCE', 93), ('ANOMALY_CURIOUS_FINDING', 147), ('INCOMPLETE_EVIDENCE', 164), ('PROBABLE_UNDERSTANDING', 171)]	4	[('GO_0007567', 'parturition', 24, 'born'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin C'), ('GO_0007565', 'female pregnancy', 232, 'gestation')]
PMC3032617	5/2010	S108-PMC3032617	['this data SUGGEST AT LEAST two considerations; first of all regular iron, Folic Acid and Vitamin B-Complex PROTECTED women from Blood and energy loss by stimulating Red Blood Cells and THEREFORE Hemoglobin Formation.']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 107), ('PROBABLE_UNDERSTANDING', 185)]	4	[('CHEBI_30751', 'formic acid', 74, 'folic acid'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin B'), ('GO_0032991', 'protein-containing complex', 99, 'complex'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CL_0000232', 'erythrocyte', 165, 'red blood cells'), ('GO_0030154', 'cell differentiation', 165, 'red blood cells'), ('UBERON_0000178', 'blood', 169, 'blood'), ('GO_0042541', 'hemoglobin biosynthetic process', 195, 'hemoglobin formation')]
PMC3032617	5/2010	S112-PMC3032617	['the choice of dosing the Vitamin C supplement 400mg daily matured after reviewing the medical literature were it was HIGHLIGHTED that at doses exceeding 1g daily the PROBABILITY of side-effects such as diarrhea and Renal colic increased greatly [1,3,13,14] on the OTHER side doses up to 500 mg daily are advised by the official statement of the linus pauling’s institute to the general population, this led us to choose this dose as the SAFEST.']	[('INCOMPLETE_EVIDENCE', 117), ('PROBABLE_UNDERSTANDING', 166), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('IMPORTANT_CONSIDERATION', 437)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin C'), ('UBERON_0002113', 'kidney', 215, 'renal')]
PMC3032617	5/2010	S116-PMC3032617	['moreover, the supplementation of a relatively cheap, clinically SAFE and health-bearing integrator as Vitamin C, PROVED to add overall BENEFITS in terms of hospitalization and several other mother-to-child outcomes RELEVANT during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 64), ('PROBABLE_UNDERSTANDING', 113), ('IMPORTANT_CONSIDERATION', 135), ('IMPORTANT_CONSIDERATION', 215)]	4	[('CHEBI_27300', 'vitamin D', 102, 'vitamin C'), ('GO_0007565', 'female pregnancy', 231, 'pregnancy')]
PMC3034879	12/2010	S26-PMC3034879	['PREVIOUSLY the authors of the current study have REPORTED that during the Pregnancy, 69% of the women and 37% of the newborns at Birth were Vitamin D deficient (defined in women AS S-25-Ohd <50\xa0nmol/l [18,19] and in the newborn AS <37.5\xa0nmol/l [20]).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 178), ('PROBABLE_UNDERSTANDING', 228)]	4	[('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007567', 'parturition', 129, 'birth'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_16786', 'vestitone', 181, 'S-'), ('CHEBI_72765', 'verruculogen', 183, '25-OHD'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 183, '25')]
PMC3034879	12/2010	S145-PMC3034879	['we CONSIDER this as a random finding because it is UNLIKELY that higher maternal Vitamin D status would contribute to this and SEVERAL STUDIES have witnessed that Vitamin D deficiency is RELATED to delayed age of walking [24,25].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 187)]	4	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC3034879	12/2010	S180-PMC3034879	['HOWEVER, the number of d3users was very low ( n \u2009=\u200912), which MEANS that FURTHER comparison between DIFFERENT forms of Vitamin D is not justified.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 62), ('FUTURE_WORK', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100)]	4	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC3075531	7/2010	S53-PMC3075531	['THUS, if Vitamin D was PROTECTIVE, these cancers WOULD BE EXPECTED to be RARE among Individuals with ms.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('FUTURE_PREDICTION', 49), ('INCOMPLETE_EVIDENCE', 73)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('NCBITaxon_1', 'root', 84, 'individuals')]
PMC3075531	7/2010	S65-PMC3075531	['furthermore, screening of Serum 25-Hydroxyvitamin D concentrations is LIKELY to identify a large proportion of patients who are Vitamin D deficient or insufficient, and who MIGHT BENEFIT from Vitamin D supplementation for PREVENTION of osteoporosis and other complications, especially multiple sclerosis.']	[('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 173), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 222)]	4	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 32, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
PMC3103150	3/2011	S2-PMC3103150	['THEREFORE, we undertook THIS STUDY TO DETERMINE the prevalence of Vitamin D deficiency and insufficiency [Serum 25 Hydroxyvitamin D (25Ohd) ≤ 15 ng/ml and 15-20 ng/ml, respectively] among healthy term Breastfed 3 month old infants and their mothers, evaluate for clinical and radiological rickets in those infants having 25Ohd < 10 ng/ml, and check for seasonal variation and PREDICTORS of infants’ Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('SUPERFICIAL_RELATIONSHIP', 376)]	4	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 112, '25 hydroxyvitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 133, '25OHD'), ('GO_0007567', 'parturition', 201, 'breastfed'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 321, '25OHD'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D')]
PMC3103150	3/2011	S42-PMC3103150	['the cut-off for elevated pth was taken as 46 pg/ml BASED ON RECENT STUDIES in Vitamin D replete subjects17.']	[('INCOMPLETE_EVIDENCE', 51), ('PROBABLE_UNDERSTANDING', 51), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 60)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3231892	4/2011	S21-PMC3231892	['women of Reproductive age, ESPECIALLY Pregnant women, in developing countries are recognized to be AT RISK of multiple Micronutrient deficiencies, such as Iron, Folic Acid, Iodine, zinc, Vitamins A and d, riboflavin, b6 and b12, with the LIKELIHOOD of adverse EFFECTS on the mother and Pregnancy outcomes [1,6].']	[('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 99), ('PROBABLE_UNDERSTANDING', 238), ('SUPERFICIAL_RELATIONSHIP', 260)]	4	[('GO_0000003', 'reproduction', 9, 'reproductive'), ('GO_0007565', 'female pregnancy', 38, 'pregnant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 119, 'micronutrient'), ('CHEBI_24870', 'ion', 155, 'iron'), ('CHEBI_30751', 'formic acid', 161, 'folic acid'), ('CHEBI_24859', 'iodine atom', 173, 'iodine'), ('CHEBI_27300', 'vitamin D', 187, 'vitamins A'), ('GO_0007565', 'female pregnancy', 286, 'pregnancy')]
PMC3257641	3/2010	S79-PMC3257641	['Human STUDIES ARE NEEDED AS inter-species variation in Vitamin D REQUIREMENTS and Metabolism MAY occur [55].']	[('FUTURE_WORK', 6), ('PROBABLE_UNDERSTANDING', 25), ('IMPORTANT_CONSIDERATION', 65), ('INCOMPLETE_EVIDENCE', 93)]	4	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0008152', 'metabolic process', 82, 'metabolism')]
PMC3271033	1/2012	S137-PMC3271033	['THEREFORE, in considering early Vitamin D supplementation, the QUESTION becomes WHETHER there is physiological BENEFIT to rapid replenishment with Vitamin D (e.g.']	[('PROBABLE_UNDERSTANDING', 0), ('EXPLICIT_QUESTION', 63), ('EXPLICIT_QUESTION', 80), ('IMPORTANT_CONSIDERATION', 111)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D')]
PMC3271033	1/2012	S140-PMC3271033	['HOWEVER, it APPEARS that, AT LEAST in a southern us setting, 400 iu/day is adequate for infants REGARDLESS OF Vitamin D status at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 96)]	4	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007567', 'parturition', 130, 'birth')]
PMC3277098	12/2011	S25-PMC3277098	['WHILE the incidence of rickets has been largely reduced in western countries through the use of dietary supplementation and uv exposure [12], the same societies continue to experience a high prevalence of sub-clinical Vitamin D deficiency or insufficiency [13] that is LIKELY RELATED to indoor lifestyle habits with limited sun exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 269), ('SUPERFICIAL_RELATIONSHIP', 276)]	4	[('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC3277098	12/2011	S29-PMC3277098	['such populations are THEREFORE reliant on dietary or supplemental sources of Vitamin D; a FACTOR that MAY BE playing a ROLE in the current allergy epidemic [16,17].']	[('PROBABLE_UNDERSTANDING', 21), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 119)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC3277098	12/2011	S47-PMC3277098	['this MAY BE one POSSIBLE EXPLANATION for the epidemiological LINKS between both Autoimmune disease and allergy with Vitamin D deficiency [31].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 25), ('SUPERFICIAL_RELATIONSHIP', 61)]	4	[('UBERON_0001442', 'skeleton of manus', 80, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC3277098	12/2011	S205-PMC3277098	['AS this early Life stage is RELEVANT TO programming of future Immune function it is CRUCIAL to understand the EFFECTS of Vitamin D and identify optimal status levels.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('UBERON_0000104', 'life cycle', 14, 'life'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC3347007	4/2012	S10-PMC3347007	['sun exposure MAY also increase the risk of skin cancer and it MAY THEREFORE be problematic to ENCOURAGE sun exposure as the only source of Vitamin D [2].']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 62), ('PROBABLE_UNDERSTANDING', 66), ('FUTURE_WORK', 94)]	4	[('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
PMC3347007	4/2012	S161-PMC3347007	['AS EXPECTED, Pregnancy-planners were more LIKELY to have sufficient total Vitamin D intake, PROBABLY BECAUSE they were more conscious about their Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 42), ('PROBABLE_UNDERSTANDING', 92), ('PROBABLE_UNDERSTANDING', 101)]	4	[('GO_0007565', 'female pregnancy', 13, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy')]
PMC3347028	3/2012	S78-PMC3347028	['these in vitro FINDINGS HELP to EXPLAIN the significant ASSOCIATION between Vitamin D deficiency and Autoimmune diseases, such as systemic lupus erythematosus [25], multiple sclerosis [26,27,28,29,30,31,32,33,34,35], rheumatoid arthritis [31,36,37], diabetes—both types 1 [31,38,39,40,41,42] and 2 [43,44,45], and certain cancers, such as Colon [46,47,48,49], Breast [50,51,52,53,54,55], and Prostate [55,56,57,58,59].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 24), ('PROBABLE_UNDERSTANDING', 32), ('SUPERFICIAL_RELATIONSHIP', 56)]	4	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 101, 'autoimmune'), ('UBERON_0001155', 'colon', 339, 'colon'), ('UBERON_0000310', 'breast', 360, 'breast'), ('UBERON_0002367', 'prostate gland', 392, 'prostate')]
PMC3347028	3/2012	S82-PMC3347028	['in nonpregnant adolescents and Adults, increased pth is ASSOCIATED with lower circulating concentrations of ionized calcium, which is MOST OFTEN PRECIPITATED by Vitamin D deficiency and decreased Intestinal calcium absorption.']	[('SUPERFICIAL_RELATIONSHIP', 56), ('PROBABLE_UNDERSTANDING', 134), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('UBERON_0007023', 'adult organism', 31, 'adults'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('UBERON_0000160', 'intestine', 196, 'intestinal')]
PMC3347028	3/2012	S166-PMC3347028	['GIVES INVALUABLE INSIGHT into Vitamin D status of darker Pigmented Individuals living in a sun-rich environment in eastern africa [141].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 6), ('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 17)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 57, 'pigmented'), ('NCBITaxon_1', 'root', 67, 'individuals')]
PMC3356951	4/2012	S11-PMC3356951	['in THIS REVIEW, we will summarize the mechanisms that are PRESUMED to underlie the RELATIONSHIP between Vitamin D and understand its biology and clinical IMPLICATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 154)]	4	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC3356951	4/2012	S127-PMC3356951	['[94] it is THEORIZED that Vitamin D MAY increase muscle strength, thereby PREVENTING falls.']	[('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 74)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
PMC3376765	6/2012	S144-PMC3376765	['BECAUSE the KEY comparisons we make in our rct are between daily supplements with iron versus iron and zinc or between weekly iron supplements with iron versus iron and zinc, Vitamin B-12 is not a factor in INTERPRETING these DIFFERENCES.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('PROBABLE_UNDERSTANDING', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226)]	4	[('CHEBI_27300', 'vitamin D', 175, 'vitamin B')]
PMC3395583	7/2012	S0-PMC3395583	['month of Birth, Vitamin D and risk of Immune-mediated disease: a case control study\n\nabstract\n\nbackground\na season of Birth EFFECT in Immune-mediated diseases (id) such as multiple sclerosis and type 1 diabetes HAS BEEN CONSISTENTLY REPORTED.']	[('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 211), ('PROBABLE_UNDERSTANDING', 220), ('INCOMPLETE_EVIDENCE', 233)]	4	[('GO_0007567', 'parturition', 9, 'birth'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0002405', 'immune system', 38, 'immune'), ('GO_0007567', 'parturition', 118, 'birth'), ('UBERON_0002405', 'immune system', 134, 'immune')]
PMC3407995	7/2012	S444-PMC3407995	['there HAS BEEN little toxicity REPORTED in Adults taking doses of Vitamin D as high as 10,000 iu/day (250 µg/day) of Vitamin d [176,177,178] ALTHOUGH toxicity becomes GENERALLY present at 20,000 iu/day (500 µg/day).']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 31), ('ANOMALY_CURIOUS_FINDING', 141), ('PROBABLE_UNDERSTANDING', 167)]	4	[('UBERON_0007023', 'adult organism', 43, 'adults'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 117, 'vitamin')]
PMC3470091	9/2012	S12-PMC3470091	['conclusions: the single 300,000 im dose of Vitamin D is REGARDED AS an EFFECTIVE and SAFE to promptly improve Vitamin D status in gdm.']	[('PROBABLE_UNDERSTANDING', 56), ('PROBABLE_UNDERSTANDING', 65), ('SUPERFICIAL_RELATIONSHIP', 71), ('IMPORTANT_CONSIDERATION', 85)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC3470091	9/2012	S15-PMC3470091	['these changes occur ACCORDING TO the needs for the mineralization of the fetus Bones as well as adequate secretion of Vitamin D in mother’s Milk.1\nDUE TO rapid fetal development, PARTICULARLY bone Calcification at the terminal stages of Pregnancy, there is a POSSIBILITY of Vitamin D deficiency to occur in mothers.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('PROBABLE_UNDERSTANDING', 147), ('IMPORTANT_CONSIDERATION', 179), ('INCOMPLETE_EVIDENCE', 259)]	4	[('UBERON_0001474', 'bone element', 79, 'bones'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0001913', 'milk', 140, 'milk'), ('GO_0051301', 'cell division', 197, 'calcification'), ('GO_0007565', 'female pregnancy', 237, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
PMC3476426	8/2012	S50-PMC3476426	['ACCORDING TO current recommendations, Serum 25-Hydroxy Vitamin D levels < 30 and < 10 ng/ml were DEFINED AS Vitamin D insufficiency and Vitamin D deficiency, respectively, WHILE levels > 30 ng/ml were defined as Vitamin D sufficiency [25].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172)]	4	[('UBERON_0001977', 'blood serum', 38, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 44, '25-hydroxy vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC3476426	8/2012	S110-PMC3476426	['UNFORTUNATELY, the tiny 10 μg (400 iu) dose in Prenatal Vitamins is VIRTUALLY IRRELEVANT in PREVENTING Gestational Vitamin D deficiency [40].']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 68), ('IMPORTANT_CONSIDERATION', 78), ('SUPERFICIAL_RELATIONSHIP', 92)]	4	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 56, 'vitamins'), ('GO_0007565', 'female pregnancy', 103, 'gestational'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3476426	8/2012	S115-PMC3476426	['THUS, the results of OUR STUDY DID NOT signify the reduced duration of sun exposure AS a causal factor of 25 Hydroxy Vitamin D deficiency in autistic children.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 31), ('PROBABLE_UNDERSTANDING', 84)]	4	[('CHEBI_45557', 'sec-butyl group', 106, '25 hydroxy'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC3476426	8/2012	S138-PMC3476426	['THUS, Vitamin D deficiency MAY BE a CONTRIBUTING FACTOR to the production of Brain-specific auto-Antibodies AS a result of deficiency of Tregs in some autistic children.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 36), ('PROBABLE_UNDERSTANDING', 108)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('UBERON_0000955', 'brain', 77, 'brain'), ('GO_0042571', 'immunoglobulin complex, circulating', 97, 'antibodies'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 137, 'Tregs')]
PMC3504157	11/2012	S23-PMC3504157	['MANY health providers NOW RECOMMEND nhps including Prenatal Vitamins, iron supplementation, calcium, and Vitamin D for a range of RECOGNIZED indications including deficiency states such as rickets and anemia, as well as illnesses such as multiple sclerosis.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 22), ('FUTURE_WORK', 26), ('PROBABLE_UNDERSTANDING', 130)]	4	[('GO_0007565', 'female pregnancy', 51, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 60, 'vitamins'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC3515553	12/2012	S6-PMC3515553	['the expected EFFECT of maternal Vitamin B-12 on offspring iq, GIVEN the RELATIONSHIPS between Snps and Vitamin B-12, and Snps and iq was consistent with the OBSERVATIONAL result.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBABLE_UNDERSTANDING', 62), ('SUPERFICIAL_RELATIONSHIP', 72), ('INCOMPLETE_EVIDENCE', 157)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 32, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 42, '12'), ('SO_0000694', 'SNP', 94, 'SNPs'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 103, 'vitamin B-12'), ('SO_0000694', 'SNP', 121, 'SNPs')]
PMC3515553	12/2012	S60-PMC3515553	['Haplotypes consisting of both tcn2 Snps were evaluated AS POTENTIAL instrumental variables that MAY EXPLAIN better than genotypes part of the variation in circulating Vitamin B-12.']	[('PROBABLE_UNDERSTANDING', 55), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 96), ('PROBABLE_UNDERSTANDING', 100)]	4	[('SO_0001024', 'haplotype', 0, 'Haplotypes'), ('SO_0000694', 'SNP', 35, 'SNPs'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 167, 'vitamin B-12')]
PMC3515553	12/2012	S75-PMC3515553	['AS offspring genotype MAY INFLUENCE Cognitive ability per se , we adjusted for offspring genotype to estimate the EFFECT of maternal Vitamin B-12 status during Pregnancy on offspring iq.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 114)]	4	[('GO_0050890', 'cognition', 36, 'cognitive'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 133, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 143, '12'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy')]
PMC3515553	12/2012	S119-PMC3515553	['maternal dietary intake of Vitamin B-12 was ASSOCIATED with the MAJORITY (7 out of 11 (64%)) of POTENTIAL CONFOUNDERS and with two of the three Mediators tested (table s7).']	[('SUPERFICIAL_RELATIONSHIP', 44), ('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 96), ('PROBLEM_COMPLICATION', 106)]	4	[('CHEBI_27300', 'vitamin D', 27, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 27, 'vitamin B-12'), ('CHEBI_35222', 'inhibitor', 144, 'mediators')]
PMC3515553	12/2012	S153-PMC3515553	['it HAS been PREVIOUSLY SHOWN that maternal cobalamin status is a strong PREDICTOR of Vitamin B-12 in breastfed infants up to AT LEAST 6 months of age[35].']	[('IMPORTANT_CONSIDERATION', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 72), ('PROBABLE_UNDERSTANDING', 125)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 85, 'vitamin B-12')]
PMC3552819	12/2012	S16-PMC3552819	['the pharmacokinetics of oral Vitamin D3 are CONVENTIONALLY described with respect to its EFFECT on the Serum concentration of the predominant circulating Metabolite, 25-Hydroxyvitamin D ([25(Oh)D]), which is a WELL-ESTABLISHED BIOMARKER of systemic Vitamin D status [9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('SUPERFICIAL_RELATIONSHIP', 89), ('PROBABLE_UNDERSTANDING', 210), ('SUPERFICIAL_RELATIONSHIP', 227)]	4	[('CHEBI_33279', 'vitamin D5', 29, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 29, 'vitamin D3'), ('UBERON_0001977', 'blood serum', 103, 'serum'), ('CHEBI_39382', 'flufenoxuron', 154, 'metabolite'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 166, '25-hydroxyvitamin D'), ('CHEBI_33010', 'chromide(1-)', 190, '(OH)D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
PMC3599191	1/2013	S118-PMC3599191	['EVEN the lack of OTHER micro-Nutrients such as Selenium, Vitamins E, d and c, zinc and Folic Acid is RESPONSIBLE for the onset of disorders AFFECTING the Respiratory System in the offspring [46].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 17), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('CHEBI_33284', 'nutrient', 29, 'nutrients'), ('CHEBI_27568', 'selenium atom', 47, 'selenium'), ('CHEBI_27300', 'vitamin D', 57, 'vitamins E'), ('CHEBI_30751', 'formic acid', 87, 'folic acid'), ('UBERON_0001004', 'respiratory system', 154, 'respiratory system')]
PMC3613945	2/2013	S29-PMC3613945	['Genotype-phenotype ASSOCIATIONS and Vitamin D Metabolism\nmature Serum dbp concentration is a quantitative trait with a significant hereditable component (66%), AS ESTABLISHED by twin studies published AT LEAST a decade ago30,31.']	[('SUPERFICIAL_RELATIONSHIP', 19), ('PROBABLE_UNDERSTANDING', 160), ('INCOMPLETE_EVIDENCE', 163), ('PROBABLE_UNDERSTANDING', 201)]	4	[('SO_0001026', 'genome', 0, 'Genotype'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 36, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 64, 'serum')]
PMC3613945	2/2013	S121-PMC3613945	['AS SUCH, polymorphisms in the dbp Gene MIGHT provide INSIGHT into the ROLE of Vitamin D and diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 70)]	4	[('SO_0000704', 'gene', 34, 'gene'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3613945	2/2013	S320-PMC3613945	['IT IS BECOMING CLEAR that dbp is indeed a multifunctional protein with an IMPORTANT auxiliary ROLE in the RELATIONSHIP between Vitamin D and Innate Immunity.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 74), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 106)]	4	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0045087', 'innate immune response', 141, 'innate immunity')]
PMC3641012	4/2013	S249-PMC3641012	['because of the high dose of Vitamin D not previously studied in Pregnancy, enrolment was LIMITED to healthy women at low risk of Pregnancy complications, and who were most LIKELY to adhere to the protocol; as such, generalizability of the findings MAY BE LIMITED.']	[('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 172), ('INCOMPLETE_EVIDENCE', 248), ('INCOMPLETE_EVIDENCE', 255)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC3659910	1/2013	S13-PMC3659910	['CONCERNS about Vitamin D have RESURFACED in medical and scientific literature OWING TO its multiple EFFECTS on Human health.']	[('IMPORTANT_CONSIDERATION', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 100)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 111, 'human')]
PMC3659910	1/2013	S64-PMC3659910	["although Liver and cod Liver oil contain Vitamin D, they are not recommended in Pregnancy as they also contain too much Vitamin A.\nVitamin D is a unique Nutrient BECAUSE its REQUIREMENT can be met by both endogenous production from sunlight as well as exogenous dietary sources, which COMPLICATES determining the body's daily nutritional REQUIREMENTS."]	[('PROBABLE_UNDERSTANDING', 162), ('IMPORTANT_CONSIDERATION', 174), ('DIFFICULT_TASK', 285), ('IMPORTANT_CONSIDERATION', 338)]	4	[('UBERON_0002107', 'liver', 9, 'liver'), ('UBERON_0002107', 'liver', 23, 'liver'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('CHEBI_28384', 'vitamin K', 131, 'Vitamin D'), ('CHEBI_33284', 'nutrient', 153, 'nutrient')]
PMC3659910	1/2013	S138-PMC3659910	['OTHER SUGGESTS Vitamin D supplementation of 400 iu/day to Breast Fed infants is the MOST secure way of PREVENTING rickets in infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 103)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007567', 'parturition', 58, 'breast fed')]
PMC3659910	1/2013	S158-PMC3659910	['the BASIS for these RECOMMENDATIONS was made BEFORE IT WAS POSSIBLE to measure the circulating concentration of 25-Hydroxyvitamin D [25(Oh) D], the INDICATOR of nutritional Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 4), ('FUTURE_WORK', 20), ('DIFFICULT_TASK', 45), ('SUPERFICIAL_RELATIONSHIP', 148)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 112, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH) D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC3659910	1/2013	S185-PMC3659910	['HOWEVER, getting 25(Oh) D levels consistently above 75 nmol/l (30 ng/ml) MAY REQUIRE AT LEAST 1500-2000 iu/day of Vitamin D. if a mother is Vitamin D deficient, Breast Milk is not a good source of Vitamin D, so infants need to be given Vitamin D supplementation until they are weaned.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 73), ('FUTURE_WORK', 77), ('PROBABLE_UNDERSTANDING', 85)]	4	[('CHEBI_71657', 'versiconol acetate', 17, '25(OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 24, 'D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('UBERON_0000310', 'breast', 161, 'breast'), ('UBERON_0001913', 'milk', 168, 'milk'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
PMC3672018	5/2013	S20-PMC3672018	['low Vitamin D during Gestation and in early Life MAY THEREFORE play an IMPORTANT ROLE for susceptibility to bone fragility, obesity and Autoimmune diseases later in Life [6].']	[('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 53), ('IMPORTANT_CONSIDERATION', 71), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('GO_0007565', 'female pregnancy', 21, 'gestation'), ('UBERON_0000104', 'life cycle', 44, 'life'), ('UBERON_0001442', 'skeleton of manus', 136, 'autoimmune'), ('UBERON_0000104', 'life cycle', 165, 'life')]
PMC3672018	5/2013	S34-PMC3672018	['adverse health EFFECTS of low Vitamin D MAY THEREFORE be MOST evident in Organs or Tissues whose development occurs in these trimesters, e.g.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 40), ('PROBABLE_UNDERSTANDING', 44), ('PROBABLE_UNDERSTANDING', 57)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000062', 'organ', 73, 'organs'), ('UBERON_0000479', 'tissue', 83, 'tissues')]
PMC3672018	5/2013	S37-PMC3672018	['a FEW STUDIES SUGGEST that low fetal Vitamin D MAY reduce bone Mineral content, CONSEQUENTLY leading to fragility fractures [14].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 47), ('PROBABLE_UNDERSTANDING', 80)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_46662', 'mineral', 63, 'mineral')]
PMC3672018	5/2013	S107-PMC3672018	['25(Oh)D3 level from dbs cards\nBECAUSE the 25(Oh)D3 levels in the newborn Blood REFLECTS the Vitamin D status of the newborn as well as the mother at the end of Pregnancy [29], measurement of 25(Oh)D3 levels in dbs will serve as VALIDATION for the EFFECT of fortification for incident cases.']	[('PROBABLE_UNDERSTANDING', 30), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 247)]	4	[('CHEBI_62946', 'ammonium sulfate', 0, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 0, '25(OH)D3'), ('CHEBI_62946', 'ammonium sulfate', 42, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 42, '25(OH)D3'), ('UBERON_0000178', 'blood', 73, 'blood'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy'), ('CHEBI_62946', 'ammonium sulfate', 191, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 191, '25(OH)D3')]
PMC3672018	5/2013	S155-PMC3672018	['neither CONFOUNDING from external or internal factors, nor the LACK OF individual data on Vitamin D intake, is a prerequisite for the study, AS the INFLUENCES of lifestyle differences (e.g.']	[('PROBLEM_COMPLICATION', 8), ('INCOMPLETE_EVIDENCE', 63), ('PROBABLE_UNDERSTANDING', 141), ('SUPERFICIAL_RELATIONSHIP', 148)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC3672018	5/2013	S179-PMC3672018	['results from this study are LIKELY to CONSIDERABLY increase our current understanding of the SIGNIFICANCE of early Vitamin D intake in RELATION to later health.']	[('PROBABLE_UNDERSTANDING', 28), ('ANOMALY_CURIOUS_FINDING', 38), ('IMPORTANT_CONSIDERATION', 93), ('SUPERFICIAL_RELATIONSHIP', 135)]	4	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3679329	6/2013	S79-PMC3679329	['a population based cohort study of Adults in the us DEMONSTRATED that supplement users, COMPARED TO non-users, GENERALLY had higher average Intakes of Foods which are IMPORTANT sources of Vitamin C and Carotenoids (i.e., fruits and certain vegetables) [12].']	[('INCOMPLETE_EVIDENCE', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('PROBABLE_UNDERSTANDING', 111), ('IMPORTANT_CONSIDERATION', 167)]	4	[('UBERON_0007023', 'adult organism', 35, 'adults'), ('GO_0007631', 'feeding behavior', 140, 'intakes'), ('CHEBI_33290', 'food', 151, 'foods'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin C'), ('CHEBI_50815', 'norgestimate', 202, 'carotenoids')]
PMC3685533	6/2013	S15-PMC3685533	['circulating 25Ohd is the MAJOR circulating form of Vitamin D and is CONSIDERED AS the primary INDICATOR of Vitamin D status [1].']	[('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 68), ('PROBABLE_UNDERSTANDING', 79), ('SUPERFICIAL_RELATIONSHIP', 94)]	4	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 12, '25OHD'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC3695234	7/2013	S59-PMC3695234	['BASED ON the RELATIONSHIP between Vitamin D deficiency and ad, trials of Vitamin D supplementation in atopic populations or high-risk groups HAVE BEEN conducted.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 141)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC3695234	7/2013	S78-PMC3695234	['THUS, these data INDICATE the POTENTIAL ROLE of Vitamin D in a select group of ad patients.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 40)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC3702245	6/2013	S3-PMC3702245	['THEREFORE, an overview of the CURRENT understanding of Vitamin D nutrition in Pregnancy and a review of the results of studies to optimize Vitamin D status during Pregnancy and in the offspring is of PUBLIC HEALTH IMPORTANCE and timely.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 200), ('IMPORTANT_CONSIDERATION', 214)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 163, 'pregnancy')]
PMC3702245	6/2013	S20-PMC3702245	['implications of low Vitamin D status during Pregnancy\n\nSkeletal and calcemic COMPLICATIONS\nit is GENERALLY ACCEPTED that maternal Vitamin D deficiency CAN result in osteomalacia.']	[('PROBLEM_COMPLICATION', 77), ('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 151)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('UBERON_0004288', 'skeleton', 55, 'Skeletal'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3702245	6/2013	S91-PMC3702245	['based on this protocol, the authors CONCLUDED that 4000 iu/day of Vitamin D3Supplementation is SAFE and MOST EFFECTIVE in achieving Vitamin D sufficiency in mothers and adequate Vitamin D status in their offspring, irrespective of ethnicity.']	[('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 95), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 109)]	4	[('CHEBI_52915', 'phosphatediyl group', 66, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 66, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC3705146	5/2013	S28-PMC3705146	['EVEN in the far reaches of populations in the arctic circle, the IMPACT of low light on skin type prevalence (karlsson et al.,2000) was not so extreme, MOST LIKELY BECAUSE a diet rich in Vitamin D from seafood helped to mitigate the lack of sun.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 152), ('PROBABLE_UNDERSTANDING', 164)]	4	[('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC3717170	5/2013	S187-PMC3717170	['there is GENERAL CONSENSUS that the earlier RECOMMENDATION of 400 iu of Vitamin D/day was INSUFFICIENT.']	[('PROBABLE_UNDERSTANDING', 9), ('FUTURE_WORK', 44), ('IMPORTANT_CONSIDERATION', 90), ('PROBLEM_COMPLICATION', 90)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC3717170	5/2013	S192-PMC3717170	['this CONCLUSION was based on data from the 2001–2004 nhanes survey57that primarily sampled caucasians, with LIMITED sampling in northern latitudes during the winter, the time and region that People would MOST LIKELY have lower Vitamin D levels.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 108), ('PROBABLE_UNDERSTANDING', 204), ('PROBABLE_UNDERSTANDING', 209)]	4	[('NCBITaxon_10088', 'Mus <genus>', 191, 'people'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC3739737	8/2013	S165-PMC3739737	['this FINDING is IN KEEPING WITH the WELL-KNOWN neuroprotective properties of Vitamin D[3].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 41)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC3760821	9/2013	S43-PMC3760821	['further, it HAS BEEN SUGGESTED that Vitamin D CAN alter Glucose and Insulin Metabolism, and, THEREFORE, IMPACT on energy available to the foetus[11].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 93), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_17234', 'glucose', 56, 'glucose'), ('GO_0007369', 'gastrulation', 56, 'glucose ...'), ('GO_1901142', 'insulin metabolic process', 68, 'insulin metabolism'), ('PR_000045358', 'insulin family protein', 68, 'insulin')]
PMC3773018	4/2013	S69-PMC3773018	['AS SUCH, IT IS POSSIBLE that SOME of the children in this study did not consume 1,000 ml Vitamin D-fortified formula per day, and were not Fed additional Vitamin D supplements to meet the RECOMMENDED intake of 400 iu/day for infants, children, and adolescents (30).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 29), ('FUTURE_WORK', 188)]	4	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007631', 'feeding behavior', 139, 'fed'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
PMC3773018	4/2013	S70-PMC3773018	['another EXPLANATION is that BECAUSE these 460 children were predominantly black (>50%), and they TEND to be more LIKELY to have Vitamin D insufficiency (10).']	[('PROBABLE_UNDERSTANDING', 8), ('PROBABLE_UNDERSTANDING', 28), ('SUPERFICIAL_RELATIONSHIP', 97), ('PROBABLE_UNDERSTANDING', 113)]	4	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC3798907	8/2013	S93-PMC3798907	['it can be seen that the EFFECTS of Vitamin E supplementation on cbmc responses to these Allergens were GENERALLY inhibitory, with the NOTABLE EXCEPTIONS of stronger Proliferation to tg and increased secretion of the Regulatory cytokine Tgf-Β in cultures stimulated with either hdm or tg.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 103), ('ANOMALY_CURIOUS_FINDING', 134), ('ANOMALY_CURIOUS_FINDING', 142)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin E'), ('CHEBI_33663', 'cyclic hydrocarbon', 88, 'allergens'), ('GO_0008283', 'cell proliferation', 165, 'proliferation'), ('GO_0065007', 'biological regulation', 216, 'regulatory'), ('PR_000000046', 'TGF-beta', 236, 'TGF-β')]
PMC3798907	8/2013	S116-PMC3798907	['on the one hand, the POSSIBLE therapeutic use of Vitamin E to help produce a “balanced” Th-Cell profile in early Life is SUPPORTED by the FINDING that supplementation of cbmc with this Nutrient GENERALLY inhibited cytokines characteristic of Th Effector Responses, including both th1 (Ifn-Γ) and th2 (il-4) cytokines.']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 121), ('INCOMPLETE_EVIDENCE', 138), ('PROBABLE_UNDERSTANDING', 194)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin E'), ('CL_0000545', 'T-helper 1 cell', 88, 'Th-cell'), ('UBERON_0000104', 'life cycle', 113, 'life'), ('CHEBI_33284', 'nutrient', 185, 'nutrient'), ('GO_0007596', 'blood coagulation', 242, 'Th ... responses'), ('CHEBI_35224', 'effector', 245, 'effector'), ('PR_000008920', 'interferon alpha-7', 285, 'IFN-γ')]
PMC3798907	8/2013	S145-PMC3798907	['HOWEVER, such a shared property cannot provide an EXPLANATION where Vitamins E and C DIFFER in their EFFECTS on cbmc and pbmc responses.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('SUPERFICIAL_RELATIONSHIP', 101)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamins E'), ('CHEBI_18245', 'carboxylato group', 83, 'C'), ('PR_000004900', 'complement C3', 83, 'C')]
PMC3809191	1/2013	S60-PMC3809191	['first, Serum 25 (Oh) D concentrations determined in late trimester MAY not show the status of maternal Vitamin D during the whole Pregnancy Period and HENCE to IDENTIFY the ASSOCIATION of Gdm Development and Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 67), ('PROBABLE_UNDERSTANDING', 151), ('QUESTION_ANSWERED_BY_THIS_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 173)]	4	[('UBERON_0001977', 'blood serum', 7, 'serum'), ('CHEBI_71657', 'versiconol acetate', 13, '25 (OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 21, 'D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('UBERON_0018298', 'stylocone', 130, 'pregnancy period'), ('GO_0072147', 'glomerular parietal epithelial cell fate commitment', 188, 'GDM development'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D')]
PMC3827489	10/2013	S5-PMC3827489	['it is RECOMMENDED that all infants, children, and adolescents have a minimum daily intake of 400 iu (10 µg) of Vitamin D. SINCE the vitamin d status of the newborn is highly RELATED to maternal Vitamin D levels, optimal Vitamin D levels in the mother during Pregnancy SHOULD BE maintained.']	[('FUTURE_WORK', 6), ('PROBABLE_UNDERSTANDING', 122), ('SUPERFICIAL_RELATIONSHIP', 174), ('FUTURE_WORK', 268)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 258, 'pregnancy')]
PMC3827489	10/2013	S39-PMC3827489	['seasonal variability has an IMPORTANT IMPACT on Vitamin D status24); the Vitamin D levels are lowest in winter, compared with spring, summer, and autumn20)BECAUSE MOST Vitamin D is produced following exposure to sunlight.']	[('IMPORTANT_CONSIDERATION', 28), ('SUPERFICIAL_RELATIONSHIP', 38), ('PROBABLE_UNDERSTANDING', 155), ('PROBABLE_UNDERSTANDING', 163)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC3827489	10/2013	S43-PMC3827489	['THEREFORE, they MAY not have enough exposure to sunlight for optimal cutaneous Production Of Vitamin D.\nA STUDY conducted in the united states SPECULATED that american adolescents tend to consume less dairy products27).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 143)]	4	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 79, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
PMC3827489	10/2013	S47-PMC3827489	['low Vitamin D status in black Individuals MAY BE ATTRIBUTED MAINLY to decreased skin Synthesis Of Vitamin D due to greater skin pigmentation32)OR to the high prevalence of obesity in black populations25,33,34).']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 49), ('PROBABLE_UNDERSTANDING', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143)]	4	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('NCBITaxon_1', 'root', 30, 'individuals'), ('GO_0030474', 'spindle pole body duplication', 85, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC3827489	10/2013	S99-PMC3827489	['in 2011, the u.s. Endocrine task force on Vitamin D REPORTED that 600 iu/day MAY not be sufficient to correct Vitamin D deficiency in Pregnant and Lactating women, and THEREFORE SUGGESTED 1,500-2,000 iu/day for Pregnant and Lactating women with Vitamin D deficiency75).']	[('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 168), ('INCOMPLETE_EVIDENCE', 178)]	4	[('GO_0009790', 'embryo development', 18, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 42, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 134, 'pregnant'), ('GO_0007594', 'puparial adhesion', 147, 'lactating'), ('GO_0007565', 'female pregnancy', 211, 'pregnant'), ('GO_0007594', 'puparial adhesion', 224, 'lactating'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
PMC3873449	12/2013	S23-PMC3873449	['it is SUGGESTED that Vitamin D is LIKELY to have an EFFECT on several offspring outcomes such as a race-DEPENDENT lowering of Birthweight, type i diabetes and early childhood infections.']	[('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 34), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007596', 'blood coagulation', 126, 'birthweight')]
PMC3882256	1/2014	S108-PMC3882256	['there was also no association between cord ferritin and either maternal dietary iron intake or hemoglobin.10.1371/journal.pone.0084684.t005\n\ncaption (table-wrap): table 5\nmultivariable linear regression estimates from stratified analyses for associations between Maternal Iron intake and hemoglobin in Pregnancy with offspring vascular indicators and body mass index with testing for EFFECT modification by maternal Vitamin C intake during Pregnancy and child sex (n\u200a=\u200a2958).offspring pulse wavevelocity (m/s)offspring Flow mediateddilatation (%)offspring systolic bloodpressure (mmhg)offspring diastolic bloodpressure (mmhg)offspring body massindex (kg/m2)b#99% ci®p*b#99% ci®p*b#99% ci®p*b#99% ci®p*b#99% ci®p* Maternal Pregnancy dietary iron intake (continuous) (per 10 mg/d) in participants with Vitamin Cintake >50 mg/day0−0.3, 0.30.50.6−0.2, 1.50.5−0.3−2.4, 1.90.70.8−1.1, 2.70.80−.0.7, 0.60.3in participants with Vitamin Cintake ≤50 mg/day0.2−0.7, 1.1−0.3−2.7, 2.1−1.8−7.3, 3.71.2−4.0, 6.41.2−1.1, 3.5males0.2−0.2, 0.60.40.6−0.4, 1.60.20.4−2.3, 3.10.90.9−1.5, 3.20.70.2−0.7, 1.00.4females0−0.4, 0.40.5−0.7, 1.6−0.9−3.8, 2.00.7−1.9, 3.30.1−0.9, 1.0 maternal Pregnancy Iron supplement use in participants with Vitamin cintake >50 mg/day0−0.1, 0.20.20.30, 0.70.1−0.8−1.7, 0.10.9−0.4−1.2, 0.50.90.1−0.2, 0.30.9in participants with Vitamin Cintake ≤50 mg/day0.2−0.1, 0.5−0.3−1.1, 0.6−0.8−2.7, 1.2−0.1−2.0, 1.80−0.8, 0.8males0.1−0.1, 0.20.80.2−0.2, 0.60.9−0.9−2.1, 0.30.7−0.9−1.9, 0.10.06−0.1−0.4, 0.30.5females0.1−0.1, 0.20.3−0.3, 0.7−0.7−1.9, 0.50.2−0.8, 1.30.1−0.3, 0.5 maternal early Pregnancy anemia (<11 g/dl) males0−0.4, 0.40.90.2−0.9, 1.20.3−1.3−4.1, 1.40.80.3−2.1, 2.60.40.4−0.5, 1.20.2females−0.1−0.5, 0.4−0.5−1.7, 0.7−1.0−4.1, 2.1−0.9−3.7, 1.8−0.2−1.2, 0.8\n#adjusting for potential CONFOUNDING characteristics: maternal age, pre-Pregnancy bmi, smoking in Pregnancy, educational qualification (AS a PROXY for socioeconomic status), parity, and maternal total energy intake in the models with dietary iron intake as exposure).']	[('SUPERFICIAL_RELATIONSHIP', 384), ('PROBLEM_COMPLICATION', 1794), ('PROBABLE_UNDERSTANDING', 1905), ('SUPERFICIAL_RELATIONSHIP', 1910)]	4	[('GO_0007618', 'mating', 263, 'maternal'), ('CHEBI_24870', 'ion', 272, 'iron'), ('GO_0007565', 'female pregnancy', 302, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 416, 'vitamin C'), ('GO_0007565', 'female pregnancy', 440, 'pregnancy'), ('GO_0007601', 'visual perception', 519, 'flow'), ('GO_0007618', 'mating', 713, 'Maternal'), ('GO_0007565', 'female pregnancy', 722, 'pregnancy'), ('CHEBI_64167', 'alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp', 800, 'vitamin Cintake'), ('CHEBI_64167', 'alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp', 920, 'vitamin Cintake'), ('GO_0007565', 'female pregnancy', 1164, 'pregnancy'), ('CHEBI_24870', 'ion', 1174, 'iron'), ('CHEBI_33229', 'vitamin (role)', 1215, 'vitamin'), ('CHEBI_64167', 'alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp', 1334, 'vitamin Cintake'), ('GO_0007565', 'female pregnancy', 1589, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1841, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1867, 'pregnancy')]
PMC3991049	11/2013	S21-PMC3991049	['a high prevalence of Vitamin D insufficiency was FOUND in Pregnant women in different studies with DIFFERENT ethnic and geographical backgrounds.4–8the average Prenatal Vitamins contain 400 iu of Vitamin D, which PARTIALLY EXPLAINS this high prevalence of Vitamin D insufficiency in Pregnant women.']	[('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('INCOMPLETE_EVIDENCE', 213), ('PROBABLE_UNDERSTANDING', 223)]	4	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnant'), ('GO_0007565', 'female pregnancy', 160, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 169, 'vitamins'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('GO_0007565', 'female pregnancy', 283, 'pregnant')]
PMC4045304	2/2014	S192-PMC4045304	['BECAUSE activated Vitamin D (1, 25-Dihydroxy Vitamin D), a Secosteroid, upregulates the Dna Repair Gene, Vitamin deficiency during development MAY inhibit the Repair of de novo dna mutations in fetuses and infants and THUS CONTRIBUTE to risk of autism.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 143), ('PROBABLE_UNDERSTANDING', 218), ('SUPERFICIAL_RELATIONSHIP', 223)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_50341', '1-hydroxyethyl group', 29, '1, 25-dihydroxy'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_35785', 'sphingoid', 59, 'secosteroid'), ('GO_0006281', 'DNA repair', 88, 'DNA repair'), ('SO_0000704', 'gene', 99, 'gene'), ('CHEBI_33229', 'vitamin (role)', 105, 'vitamin'), ('GO_0006281', 'DNA repair', 159, 'repair')]
PMC4113768	7/2014	S136-PMC4113768	['FURTHER ANALYSIS is underway to assess POSSIBLE EXPLANATIONS for these varying RELATIONSHIPS between Vitamin D status and bone geometry by ethnicity and bone site.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 39), ('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 79)]	4	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4113768	7/2014	S149-PMC4113768	['THEREFORE, in THIS STUDY, ASSOCIATIONS between sleep quality and Vitamin D status in uk dwelling south asian (a) and caucasian (c) women were INVESTIGATED.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 142)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4113768	7/2014	S211-PMC4113768	['CONSEQUENTLY, AS uvb penetration Of the Skin is REQUIRED for Vitamin D Production, citizens are AT RISK of Vitamin D deficiency in winter.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 14), ('IMPORTANT_CONSIDERATION', 48), ('IMPORTANT_CONSIDERATION', 96)]	4	[('GO_0001503', 'ossification', 33, 'of ... skin'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 71, 'production'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC4113768	7/2014	S456-PMC4113768	['THEREFORE, the larger mean foetal Lateral Ventricle size SEEN in october–december is LIKELY to RELATE to adverse exposure in june–september, when maternal Vitamin D status is highest.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 85), ('SUPERFICIAL_RELATIONSHIP', 95)]	4	[('UBERON_0002285', 'telencephalic ventricle', 34, 'lateral ventricle'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4113768	7/2014	S668-PMC4113768	['; dyall, l.; kepa, m.\nbackground: POSSIBLE CONSEQUENCES of low Vitamin D status include osteoporosis, falls, Cardiovascular disease, cancer, and diabetes, all of which are LIKELY to be more SERIOUS for men and women of advanced age (>80 years) compared to younger Adults.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBLEM_COMPLICATION', 43), ('PROBABLE_UNDERSTANDING', 172), ('IMPORTANT_CONSIDERATION', 190)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 109, 'cardiovascular'), ('UBERON_0007023', 'adult organism', 264, 'adults')]
PMC4113768	7/2014	S747-PMC4113768	['25(Oh)D assay standardization is, THEREFORE, ESSENTIAL to the development of EVIDENCED-BASED clinical and PUBLIC HEALTH guidelines for Vitamin D.\nmethods: Vitamin D standardization program (vdsp) is an international program designed to promote the standardized laboratory measurement of 25(Oh)D. it was established in 2010 by the us nih office of dietary supplements in collaboration with us national institute of standards and technology (nist), cdc, and ghent university.']	[('PROBABLE_UNDERSTANDING', 34), ('IMPORTANT_CONSIDERATION', 45), ('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 106)]	4	[('CHEBI_71657', 'versiconol acetate', 0, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 6, 'D'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 155, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 287, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 287, '25(OH)D')]
PMC4113768	7/2014	S788-PMC4113768	['the Respiratory Epithelium is VITAL in the Defence Against such Infections, and THUS MAY BE an IMPORTANT FOCUS as to where Vitamin D has its immunomodulatory actions.']	[('IMPORTANT_CONSIDERATION', 30), ('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 85), ('IMPORTANT_CONSIDERATION', 95)]	4	[('UBERON_0004802', 'respiratory tract epithelium', 4, 'respiratory epithelium'), ('GO_0002235', 'detection of unfolded protein', 43, 'defence against'), ('GO_0007567', 'parturition', 64, 'infections'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4113768	7/2014	S1582-PMC4113768	['severe Vitamin D deficiency was DEFINED AS <25 nmol/l, Vitamin D deficiency AS <50 nmol/l and Vitamin D insufficiency AS <75 nmol/l.']	[('PROBABLE_UNDERSTANDING', 32), ('PROBABLE_UNDERSTANDING', 40), ('PROBABLE_UNDERSTANDING', 76), ('PROBABLE_UNDERSTANDING', 118)]	4	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC4113768	7/2014	S1678-PMC4113768	['it HAS BEEN PROVEN in MANY STUDIES that Vitamin D has a strong immunomodulator EFFECT and Vitamin D Receptor (Vdr) increases the Expression of certain anti-Mycobacterial Compound in Macrophages called cathecidilin.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 79)]	4	[('CHEBI_28384', 'vitamin K', 40, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 40, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 90, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 110, 'VDR'), ('GO_0010467', 'gene expression', 129, 'expression'), ('CHEBI_52217', 'pharmaceutical', 156, 'mycobacterial'), ('CHEBI_36357', 'polyatomic entity', 170, 'compound'), ('CL_0000235', 'macrophage', 182, 'macrophages')]
PMC4113768	7/2014	S1693-PMC4113768	['BUT MANY STUDIES in india PROVED Vitamin D deficiency in healthy subjects.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 26), ('PROBABLE_UNDERSTANDING', 26)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4113768	7/2014	S1970-PMC4113768	['SINCE Vitamin D is also obtained from dietary sources and Vitamin D supplements; THIS STUDY INVESTIGATED the INFLUENCE of Food and Vitamin D supplements on the Serum 25-Hydroxy Vitamin D (25(Oh)D) concentration in children in the netherlands between october and april.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 92), ('SUPERFICIAL_RELATIONSHIP', 109)]	4	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_33290', 'food', 122, 'food'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('UBERON_0001977', 'blood serum', 160, 'serum'), ('CHEBI_43176', 'hydroxy group', 169, 'hydroxy'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D')]
PMC4113768	7/2014	S2040-PMC4113768	['one of our early OBSERVATIONS was to note the primacy of Oral Intake over sunlight exposure in both the prevention and correction of hypovitaminosis d. we have DEMONSTRATED immense improvement in Vitamin D status since that time, DUE TO ready availability of low dose Vitamin D supplements and DUE TO the increasing fortification of foodstuffs with Vitamin D, starting with the fortification of milk in the mid-1980s.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 160), ('PROBABLE_UNDERSTANDING', 230), ('PROBABLE_UNDERSTANDING', 294)]	4	[('UBERON_0000165', 'mouth', 57, 'oral'), ('GO_0007631', 'feeding behavior', 62, 'intake'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 349, 'vitamin D')]
PMC4113768	7/2014	S2441-PMC4113768	['healthcare providers SHOULD BE AWARE that Vitamin D deficiency is LIKELY to be currently under-diagnosed in tb patients.']	[('FUTURE_WORK', 21), ('IMPORTANT_CONSIDERATION', 21), ('IMPORTANT_CONSIDERATION', 31), ('PROBABLE_UNDERSTANDING', 66)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC4113768	7/2014	S2448-PMC4113768	['HOWEVER it is BECOMING CLEAR that subgroups of the population are AT RISK of Vitamin D deficiency because of INADEQUATE sunlight exposure.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 14), ('IMPORTANT_CONSIDERATION', 66), ('IMPORTANT_CONSIDERATION', 109)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC4113768	7/2014	S2662-PMC4113768	['there is ACCUMULATING EVIDENCE from meta-analyses of cohort studies that Vitamin D deficiency, AS measured by low Serum levels of 25-Hydroxy Vitamin D (25(Oh)D), PREDICTS INCREASED RISK of all-cause mortality, Cardiovascular disease and hypertension.']	[('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 171)]	4	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0001977', 'blood serum', 114, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 130, '25-hydroxy vitamin D'), ('CHEBI_33010', 'chromide(1-)', 154, '(OH)D'), ('UBERON_0004535', 'cardiovascular system', 210, 'cardiovascular')]
PMC4113768	7/2014	S2673-PMC4113768	['the isolated decrease in systolic bp among the Vitamin D group at 5-months follow-up is MOST LIKELY a chance FINDING, SINCE this small difference was not observed at 18-months.']	[('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 109), ('PROBABLE_UNDERSTANDING', 118), ('PROBLEM_COMPLICATION', 118)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC4113768	7/2014	S3180-PMC4113768	['background: there are FEW STUDIES that look AT Vitamin D status in children living in sunny climates AS it is ASSUMED that they receive adequate Vitamin D from sun exposure.']	[('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 44), ('PROBABLE_UNDERSTANDING', 101), ('PROBABLE_UNDERSTANDING', 110)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC4169453	9/2014	S15-PMC4169453	['Postpartum deterioration of Vitamin D status MIGHT be EXPLAINED, AT LEAST IN PART, by less frequent multivitamin intake during Lactation compared to Pregnancy[5],[6]and decreasing multivitamin Intake in the course of Lactation[2].']	[('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 54), ('PROBABLE_UNDERSTANDING', 65), ('INCOMPLETE_EVIDENCE', 74)]	4	[('GO_0007567', 'parturition', 0, 'Postpartum'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007595', 'lactation', 127, 'lactation'), ('GO_0007565', 'female pregnancy', 149, 'pregnancy'), ('GO_0007631', 'feeding behavior', 193, 'intake'), ('GO_0007595', 'lactation', 217, 'lactation')]
PMC4169453	9/2014	S221-PMC4169453	['keeping IN MIND the diminutive DIFFERENCES in 25(Oh)D levels among the study groups, we ASSUMED that the Vitamin D status in nursing women had no IMPACT on bone mass and body composition.']	[('IMPORTANT_CONSIDERATION', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 146)]	4	[('CHEBI_71657', 'versiconol acetate', 46, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 52, 'D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC4221707	11/2014	S11-PMC4221707	['AS they also had a low intake (below the nordic nutritional recommendations) of Folate, Vitamin D, and Iron from foods, some of these women and their unborn children are POSSIBLY AT RISK for adverse EFFECTS on the Pregnancy and Birth outcome.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 170), ('IMPORTANT_CONSIDERATION', 179), ('SUPERFICIAL_RELATIONSHIP', 199)]	4	[('CHEBI_30863', '5-azaorotic acid', 80, 'folate'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_24870', 'ion', 103, 'iron'), ('GO_0007565', 'female pregnancy', 214, 'pregnancy'), ('GO_0007567', 'parturition', 228, 'birth')]
PMC4221707	11/2014	S178-PMC4221707	['IN GENERAL, this 2009 report FOUND that the intake of Folate and Vitamin D from foods was not sufficient to cover the nutritional demands during Pregnancy, and supplements were USUALLY REQUIRED before and during Pregnancy [37,38].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 177), ('IMPORTANT_CONSIDERATION', 185)]	4	[('CHEBI_30863', '5-azaorotic acid', 54, 'folate'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('GO_0007565', 'female pregnancy', 212, 'pregnancy')]
PMC4231606	10/2013	S16-PMC4231606	['conclusion\nchildren with s-ecc APPEAR to have relatively POOR nutritional health COMPARED TO caries-free controls, and were significantly more LIKELY to have low Vitamin D, calcium, and albumin concentrations and elevated pth levels.']	[('ANOMALY_CURIOUS_FINDING', 31), ('IMPORTANT_CONSIDERATION', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('PROBABLE_UNDERSTANDING', 143)]	4	[('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
PMC4231606	10/2013	S155-PMC4231606	['THIS STUDY SUGGESTS a CLEAR RELATIONSHIP between Vitamin D levels and the caries status of preschool children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 22), ('SUPERFICIAL_RELATIONSHIP', 28)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4251419	12/2014	S12-PMC4251419	['THUS, higher latitude is OFTEN taken AS a PROXY for both lower levels of ultraviolet radiation (uvr) and lower Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 25), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC4256222	12/2014	S120-PMC4256222	['one POTENTIAL EXPLANATION for the null ASSOCIATION between maternal Vitamin D status and offspring bone fractures MAY BE the low prevalence of Vitamin D deficiency in our study population.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 14), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 114)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC4256222	12/2014	S133-PMC4256222	['until 1995, we ONLY have access to diagnoses recorded during hospitalization, which MAY EXPLAIN WHY maternal Vitamin D status in our data is unassociated with offspring bone fractures.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 84), ('PROBABLE_UNDERSTANDING', 88), ('EXPLICIT_QUESTION', 96)]	4	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC4256222	12/2014	S138-PMC4256222	['THUS, we cannot preclude that early Vitamin D supplementation IMPACTED offspring bone fracture RISK in our data and has blurred an ASSOCIATION with maternal Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 131)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
PMC4258799	11/2014	S299-PMC4258799	['in women with unexplained infertility, oral Vitamin E intake improved the Endometrial response, POSSIBLY DUE TO its antioxidant and anticoagulant EFFECTS as well as by Modulating the anti-Estrogenic EFFECT of Clomiphene Citrate.']	[('INCOMPLETE_EVIDENCE', 96), ('PROBABLE_UNDERSTANDING', 105), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 199)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin E'), ('UBERON_0001983', 'crypt of Lieberkuhn', 74, 'endometrial'), ('GO_0065007', 'biological regulation', 168, 'modulating'), ('CHEBI_59715', 'sodium squarate', 188, 'estrogenic'), ('CHEBI_3753', 'clomiphene citrate', 209, 'clomiphene citrate')]
PMC4302429	1/2015	S168-PMC4302429	['the IMPORTANCE of Vitamin D for the resistance to infections HAS long BEEN appreciated but POORLY UNDERSTOOD.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 61), ('FULL_UNKNOWN', 91), ('PROBABLE_UNDERSTANDING', 98)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC4302429	1/2015	S185-PMC4302429	['one REASON for the mild Antimicrobial properties of Vitamin D3 in the present in-vivo MODEL MIGHT be that, UNLIKE the Human Cathelicidin Gene, the Mouse Gene does not contain a Vitamin D response element, and is not induced directly by 1,25(Oh)2D [16].']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107)]	4	[('CHEBI_65381', 'albizoside C', 24, 'antimicrobial'), ('CHEBI_33279', 'vitamin D5', 52, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 52, 'vitamin D3'), ('NCBITaxon_9606', 'Homo sapiens', 118, 'human'), ('PR_000006009', 'alpha-catulin', 124, 'cathelicidin'), ('SO_0000704', 'gene', 137, 'gene'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'mouse'), ('SO_0000704', 'gene', 153, 'gene'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('CHEBI_37958', 'dye', 236, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 238, '25(OH)2D')]
PMC4329404	10/2014	S181-PMC4329404	['a PROMISING ROLE of Vitamin D supplementation in children with asthma is the POTENTIAL of minimizing the development of a very early feature of Airway Remodelling, increased thickness of the reticular basement membrane (41,42), which would incorporate a NOVEL therapeutic target in asthma.']	[('PROBABLE_UNDERSTANDING', 2), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 77), ('FULL_UNKNOWN', 254)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0003313', 'heart rudiment development', 144, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 144, 'airway')]
PMC4377870	3/2015	S142-PMC4377870	['Vitamin D APPEARS to have a PROTECTIVE ROLE against the susceptibility to and severity of these infections [111], AS active Vitamin D (1,25 (Oh)2d) modifies Production Of Antimicrobial Cathelicidins and defensins that kill bacteria and induce wound Repair [112].']	[('ANOMALY_CURIOUS_FINDING', 10), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 39), ('PROBABLE_UNDERSTANDING', 114)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_76285', '(R)-vedaprofen', 136, ',25 (OH'), ('GO_0030154', 'cell differentiation', 157, 'production of ... cathelicidins'), ('CHEBI_65381', 'albizoside C', 171, 'antimicrobial'), ('GO_0006281', 'DNA repair', 249, 'repair')]
PMC4377879	3/2015	S92-PMC4377879	['AS Pregnancy does not require additional Vitamin E and it is common in MOST diets, additional Vitamin E is UNLIKELY to be REQUIRED [21].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 71), ('PROBABLE_UNDERSTANDING', 107), ('IMPORTANT_CONSIDERATION', 122)]	4	[('GO_0007565', 'female pregnancy', 3, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin E')]
PMC4377879	3/2015	S292-PMC4377879	['Micronutrients LIKELY to be IMPORTANT for maternal, infant and child outcomes include iron, Iodine, Folate, Vitamin B12, Vitamin D, Calcium, and Selenium, PROBABLY zinc and MAYBE others, along with appropriate dietary energy intakes.']	[('PROBABLE_UNDERSTANDING', 15), ('IMPORTANT_CONSIDERATION', 28), ('PROBABLE_UNDERSTANDING', 155), ('INCOMPLETE_EVIDENCE', 173)]	4	[('CHEBI_34850', 'milrinone lactate', 0, 'Micronutrients'), ('CHEBI_24859', 'iodine atom', 92, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 100, 'folate'), ('CHEBI_33279', 'vitamin D5', 108, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 132, 'calcium'), ('CHEBI_27568', 'selenium atom', 145, 'selenium')]
PMC4380518	9/2014	S10-PMC4380518	['our HYPOTHESIS was that lack of Prenatal vitamin (pnv) use WOULD BE ASSOCIATED with Vitamin D deficiency (DEFINED as <50 nmol/).']	[('INCOMPLETE_EVIDENCE', 4), ('FUTURE_PREDICTION', 59), ('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 106)]	4	[('GO_0007565', 'female pregnancy', 32, 'prenatal'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC4383575	1/2015	S147-PMC4383575	['several POTENTIAL modifiable FACTORS, such as higher maternal bmi, high dairy product intake, low Intake of healthy Food and fruits rich in Vitamin C, as well AS Delivery by cesarean section and country of Birth, were ASSOCIATED with higher adduct levels.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 29), ('PROBABLE_UNDERSTANDING', 159), ('SUPERFICIAL_RELATIONSHIP', 218)]	4	[('GO_0007631', 'feeding behavior', 98, 'intake'), ('CHEBI_33290', 'food', 116, 'food'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin C'), ('PR_000004900', 'complement C3', 148, 'C'), ('GO_0007567', 'parturition', 162, 'delivery'), ('GO_0007567', 'parturition', 206, 'birth')]
PMC4396835	1/2015	S21-PMC4396835	['later, the negative IMPACT of Prenatal Vitamin D deficiency on Brain Development was POSTULATED by mcgrath [17], MAINLY BASED on epidemiological data.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 113), ('QUESTION_ANSWERED_BY_THIS_WORK', 120)]	4	[('GO_0007565', 'female pregnancy', 30, 'prenatal'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007420', 'brain development', 63, 'brain development'), ('UBERON_0000955', 'brain', 63, 'brain')]
PMC4417995	4/2015	S83-PMC4417995	['this indirectly CHALLENGES the HYPOTHESIS that the increased prevalence of atopic disease CAN be a CONSEQUENCE of Vitamin D insufficiency secondary to reduced solar/uvb exposure.']	[('DIFFICULT_TASK', 16), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 90), ('PROBABLE_UNDERSTANDING', 99)]	4	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4427001	4/2015	S29-PMC4427001	["circulating Plasma concentration of 25(Oh)D IS CONSIDERED the MOST RELIABLE INDICATOR of Individual's Vitamin D status."]	[('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 62), ('IMPORTANT_CONSIDERATION', 67), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('UBERON_0001969', 'blood plasma', 12, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 36, '25(OH)D'), ('NCBITaxon_1', 'root', 89, 'individual'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC4448820	5/2015	S867-PMC4448820	['ANOTHER example is the observation that Vitamin A supplementation, which GENERALLY lowers mortality in children, increased the RISK of Mother-To-Child Hiv Transmission in pregnant and Postpartum hiv-infected women in tanzania (469), ALTHOUGH not in south africa (470) or malawi (471).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 73), ('IMPORTANT_CONSIDERATION', 127), ('ANOMALY_CURIOUS_FINDING', 233)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin A'), ('GO_0007063', 'regulation of sister chromatid cohesion', 135, 'mother-to-child HIV transmission'), ('GO_0007565', 'female pregnancy', 184, 'postpartum')]
PMC4448820	5/2015	S1037-PMC4448820	['● observational studies IDENTIFIED an inverse ASSOCIATION between asthma risk and Vitamin A status, which MAY BE EXPLAINED by reduction in Serum Retinol due to inflammation.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 106), ('PROBABLE_UNDERSTANDING', 113)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin A'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('CHEBI_26536', 'retinoic acid', 145, 'retinol')]
PMC4448820	5/2015	S1453-PMC4448820	['○ BECAUSE it CORRELATES well with Retinol, rbp measurements CAN be used to ESTIMATE Vitamin A status.']	[('PROBABLE_UNDERSTANDING', 2), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 75)]	4	[('CHEBI_26536', 'retinoic acid', 34, 'retinol'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A')]
PMC4452099	6/2015	S77-PMC4452099	['when assessing the benefits of Food fortification, MOSTLY medium SCALE clinical TRIALS are conducted, SO FAR SHOWING that Vitamin D-fortified Foods improve Vitamin D status in Adults [22].']	[('INCOMPLETE_EVIDENCE', 51), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 109)]	4	[('CHEBI_33290', 'food', 31, 'food'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_33290', 'food', 142, 'foods'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('UBERON_0007023', 'adult organism', 176, 'adults')]
PMC4452099	6/2015	S92-PMC4452099	['AS the maternal Vitamin D fortification had EFFECT on babies´ Vitamin D levels via Breast feeding, Vitamin D intake during the first year of Life was LIKELY to HAVE BEEN lower than the maternal Intake.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('PROBABLE_UNDERSTANDING', 150), ('INCOMPLETE_EVIDENCE', 160)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0000310', 'breast', 83, 'breast'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('UBERON_0000104', 'life cycle', 141, 'life'), ('GO_0007631', 'feeding behavior', 194, 'intake')]
PMC4466139	6/2015	S46-PMC4466139	['the analysis was also performed CONSIDERING AS sufficient Vitamin D levels ≥50 nmol/l, AS insufficient levels between 25 nmol/l and 50 nmol/l, and as deficient levels <25 nmol/l, as RECOMMENDED by the institute of medicine [14].']	[('PROBABLE_UNDERSTANDING', 32), ('PROBABLE_UNDERSTANDING', 44), ('PROBABLE_UNDERSTANDING', 87), ('FUTURE_WORK', 182)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC4466139	6/2015	S95-PMC4466139	['AS ALREADY KNOWN, Placental Transfer provides Vitamin D from mother to fetus, especially in the last trimester of Gestation [31] THUS neonatal and maternal 25Ohd levels are closely LINKED.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 129), ('SUPERFICIAL_RELATIONSHIP', 181)]	4	[('UBERON_0001987', 'placenta', 18, 'placental'), ('GO_0006412', 'translation', 28, 'transfer'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'gestation'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 156, '25OHD')]
PMC4488777	5/2015	S189-PMC4488777	['couples with Serum concentration exceeding 50 nmol/l have a higher CHANCE of Conception, but this DOES NOT REGARD all patients, where ESPECIALLY males SHOULD BE supplemented with Vitamin D from the beginning of the therapy.']	[('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 98), ('ANOMALY_CURIOUS_FINDING', 134), ('FUTURE_WORK', 151)]	4	[('UBERON_0001977', 'blood serum', 13, 'serum'), ('GO_0007620', 'copulation', 77, 'conception'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4499946	7/2015	S27-PMC4499946	['because maternal Vitamin D status is the PREDOMINANT DETERMINANT of fetal and neonatal Vitamin D stores [18], Prenatal Vitamin D supplementation represents the OPTIMAL approach to testing the EFFECT of improving maternal-infant Vitamin D status on fetal-infant growth and other health outcomes.']	[('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 160), ('SUPERFICIAL_RELATIONSHIP', 192)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'prenatal'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
PMC4499946	7/2015	S97-PMC4499946	['Pharmacological principles and EMPIRICAL data INDICATE that weekly doses of Vitamin D achieve 25(Oh)D levels SIMILAR TO equivalent daily doses [39]; THUS, the equivalent daily doses in increasing order are 600 iu/day, 2400 iu/day, and 4000 iu/day.']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 109), ('PROBABLE_UNDERSTANDING', 149)]	4	[('CHEBI_52217', 'pharmaceutical', 0, 'Pharmacological'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 94, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 100, 'D')]
PMC4499946	7/2015	S284-PMC4499946	['the only clinical events that will routinely lead to discontinuation of study supplementation are those adverse events that are ascertained to be Supplement-related or the diagnosis of a medical condition that POTENTIALLY or THEORETICALLY increases sensitivity to Vitamin D supplementation following clinical review by the trial steering committee (tsc): confirmed hypercalcemia (see definition above), symptomatic Vitamin D deficiency diagnosed by a study physician or consultant physician (e.g., osteomalacia), fetal or infant death, or onset of a medical condition or initiation of a Medication following enrollment that MAY REASONABLY predispose to Vitamin D sensitivity, altered Vitamin D Metabolism, and/or hypercalcemia (e.g., tuberculosis or therapy for tuberculosis, sarcoidosis, Renal and/or Ureteral stones, Parathyroid disease, Renal or Liver failure, or use of Anticonvulsants).']	[('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 225), ('INCOMPLETE_EVIDENCE', 624), ('PROBABLE_UNDERSTANDING', 628)]	4	[('CHEBI_16158', 'steroid sulfate', 146, 'supplement'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 415, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 423, 'D'), ('CHEBI_60211', 'compound Z', 587, 'medication'), ('CHEBI_27300', 'vitamin D', 653, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 684, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 684, 'vitamin D metabolism'), ('UBERON_0002113', 'kidney', 789, 'renal'), ('UBERON_0000056', 'ureter', 802, 'ureteral'), ('UBERON_0001132', 'parathyroid gland', 819, 'parathyroid'), ('UBERON_0002113', 'kidney', 840, 'renal'), ('UBERON_0002107', 'liver', 849, 'liver'), ('CHEBI_37540', 'arabinarate(2-)', 874, 'anticonvulsants')]
PMC4586450	10/2015	S545-PMC4586450	['it was also EVIDENT that relative intakes of OTHER IMPORTANT Nutrients such as Calcium and Vitamin A declined in the preschool years,23and this was DUE TO the children starting to Consume more energy-dense, Nutrient-poor Foods (table 6).']	[('PROBABLE_UNDERSTANDING', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('IMPORTANT_CONSIDERATION', 51), ('PROBLEM_COMPLICATION', 148)]	4	[('CHEBI_33284', 'nutrient', 61, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 79, 'calcium'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin A'), ('GO_0007631', 'feeding behavior', 180, 'consume'), ('CHEBI_33284', 'nutrient', 207, 'nutrient'), ('CHEBI_33290', 'food', 221, 'foods')]
PMC4595656	10/2015	S19-PMC4595656	['the QUESTION of reduced Vitamin D concentrations on consequent neonatal, infant and child Development in RELATION to the hippocampus is THEREFORE HIGHLY PERTINENT.']	[('EXPLICIT_QUESTION', 4), ('SUPERFICIAL_RELATIONSHIP', 105), ('PROBABLE_UNDERSTANDING', 136), ('IMPORTANT_CONSIDERATION', 146)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0048513', 'animal organ development', 90, '... development')]
PMC4600246	10/2015	S18-PMC4600246	['it HAS BEEN PROPOSED that a substantial amount of APPARENTLY healthy patients are subclinically Vitamin K deficient BASED ON undercarboxylated Osteocalcin and Mgp,25presumably increasing the risk of vascular calcifications, cancer and osteoporosis.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('ANOMALY_CURIOUS_FINDING', 50), ('PROBABLE_UNDERSTANDING', 116)]	4	[('CHEBI_27300', 'vitamin D', 96, 'vitamin K'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 143, 'osteocalcin'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 159, 'MGP')]
PMC4624803	10/2015	S103-PMC4624803	['THIS MEANS THAT our study, like the studies by strøm et al., gale et al., and whitehouse et al [10–12] BUT UNLIKE the RECENTLY published studies in quatar and turkey [5,6], has a prospective design where Vitamin D levels are measured at a time before the child receives a diagnosis.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('INCOMPLETE_EVIDENCE', 118)]	4	[('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
PMC4632418	10/2015	S25-PMC4632418	['THEREFORE, we CONDUCTED THIS meta-analysis to present the EFFECT of maternal Vitamin D level on gdm.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 58)]	4	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC4632418	10/2015	S105-PMC4632418	['our sensitivity analyses SUGGESTED two studies [15,36] conducted in women with Vitamin D sufficiency PROBABLY CONTRIBUTED to the HETEROGENEITY.']	[('INCOMPLETE_EVIDENCE', 25), ('PROBABLE_UNDERSTANDING', 101), ('SUPERFICIAL_RELATIONSHIP', 110), ('DIFFICULT_TASK', 129)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC4645901	8/2014	S52-PMC4645901	['see supplementary file: ds2663.doc - “tables and figures”\n\ndesign\nfollowing discussions with the parents and the clinical team, we RECOGNISED that there was a LACK OF AWARENESS of the IMPORTANCE of Vitamin D for the health and Development Of Babies.']	[('PROBABLE_UNDERSTANDING', 131), ('PROBLEM_COMPLICATION', 159), ('IMPORTANT_CONSIDERATION', 167), ('IMPORTANT_CONSIDERATION', 184)]	4	[('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0048513', 'animal organ development', 227, 'development of babies')]
PMC4645901	8/2014	S83-PMC4645901	['a relatively SMALL data set MEANT it was NOT POSSIBLE to draw convincing CONCLUSIONS between dose of vitamin supplementation during Pregnancy and Vitamin D levels in babies.']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 28), ('DIFFICULT_TASK', 41), ('PROBABLE_UNDERSTANDING', 73)]	4	[('GO_0007565', 'female pregnancy', 132, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC4684854	12/2015	S64-PMC4684854	['many FACTORS MAY AFFECT the resultant status of Vitamin D in the body (AS reflected by measurement of 25(Oh)D levels) after Ingested supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 17), ('PROBABLE_UNDERSTANDING', 71)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 108, 'D'), ('GO_0007631', 'feeding behavior', 124, 'ingested')]
PMC4719746	1/2016	S135-PMC4719746	['at high latitude, seasonal variance is an IMPORTANT EXPLANATORY FACTOR, AS the sun is not capable of producing Vitamin D by skin radiation during winter time [30].']	[('IMPORTANT_CONSIDERATION', 42), ('SUPERFICIAL_RELATIONSHIP', 52), ('SUPERFICIAL_RELATIONSHIP', 64), ('PROBABLE_UNDERSTANDING', 72)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC4729160	1/2016	S19-PMC4729160	['the world health organization (who) DEFINES vitamin a deficiency (vad) AS Tissue concentrations of Vitamin A (Va) low enough to have adverse health consequences, EVEN IF there is no evidence of clinical deficiency [2].']	[('PROBABLE_UNDERSTANDING', 36), ('PROBABLE_UNDERSTANDING', 71), ('ANOMALY_CURIOUS_FINDING', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	4	[('UBERON_0000479', 'tissue', 74, 'tissue'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin A'), ('CHEBI_37958', 'dye', 110, 'VA')]
PMC4729160	1/2016	S108-PMC4729160	['this MAY REFLECT a TRUE reduction in Vitamin A stores with increasing Gestation, as PROPOSED by a large trial of weekly Vitamin A supplementation in bangladesh [24].']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 19), ('INCOMPLETE_EVIDENCE', 84)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin A'), ('GO_0007565', 'female pregnancy', 70, 'gestation'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A')]
PMC4764019	1/2016	S76-PMC4764019	['HENCE, the barker HYPOTHESIS, OR something closely approximating it, is very LIKELY to be operative in the functioning of the Vitamin D economy during Human development.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('PROBABLE_UNDERSTANDING', 77)]	4	[('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 151, 'human')]
PMC4770602	1/2016	S72-PMC4770602	['authors in THIS STUDY SHOWED that the Birth weights of infants Born to women with low milk consumption, observed AS those least LIKELY to consume a daily Vitamin D Intake of 200 iu, was lower compared with those Born to women who did not limit their Consumption of milk.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 113), ('PROBABLE_UNDERSTANDING', 128)]	4	[('GO_0007567', 'parturition', 38, 'birth'), ('GO_0007567', 'parturition', 63, 'born'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007631', 'feeding behavior', 164, 'intake'), ('GO_0007567', 'parturition', 212, 'born'), ('GO_0007631', 'feeding behavior', 250, 'consumption')]
PMC4778858	3/2016	S101-PMC4778858	['the results of THIS STUDY INDICATE that mothers with higher bmi are AT RISK for lower Vitamin D levels, and CONSEQUENTLY, lower Vitamin D levels in their neonates.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 68), ('PROBABLE_UNDERSTANDING', 108)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
PMC4811107	3/2016	S16-PMC4811107	['GIVEN the IMPORTANT ROLE of Vitamin D in health, there has BEEN much discussion about the best ways to prevent and treat Vitamin D deficiency [3,6].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 59)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC4811441	3/2016	S26-PMC4811441	['during the past decade, Vitamin D status has been ATTRIBUTED health BENEFITS beyond its RECOGNIZED EFFECTS on bone health.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 68), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 99)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC4811441	3/2016	S137-PMC4811441	['our results SUGGEST that an increase of AT LEAST 30 nmol/l in 25(Oh)D concentration during Pregnancy is RELATED to lower odds of pe, REGARDLESS OF Vitamin D status in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 40), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 133)]	4	[('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]
PMC4859539	5/2016	S102-PMC4859539	['DIFFERENCES in age, health and initial Vitamin D status between cohorts, as well as study design, MAY EXPLAIN the CONFLICTING data.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 98), ('PROBABLE_UNDERSTANDING', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
PMC4889866	5/2016	S13-PMC4889866	['HENCE, AS a potent Immune modulator, Vitamin D WAS shown to be ASSOCIATED with childhood asthma and allergic diseases [4–6].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 7), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 63)]	4	[('UBERON_0002405', 'immune system', 19, 'immune'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC4889866	5/2016	S106-PMC4889866	['THUS, we SPECULATED that, with increasing Vitamin D level, the ability of tlr to trigger Il-10 Production is diminished when compared to lower concentration, THUS displaying a negative CORRELATION between Vitamin D level and Cytokine Response to Tlr Stimulation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 158), ('SUPERFICIAL_RELATIONSHIP', 185)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0032613', 'interleukin-10 production', 89, 'IL-10 production'), ('PR_000001470', 'interleukin-28B', 89, 'IL-10'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('GO_0008036', 'diuretic hormone receptor activity', 225, 'cytokine response'), ('GO_0031295', 'T cell costimulation', 246, 'TLR stimulation')]
PMC4889866	5/2016	S126-PMC4889866	['THUS, our data could NOT provide detailed mechanism on HOW maternal Vitamin D level AFFECTED neonatal tlr-triggered Il-10 Response.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 21), ('EXPLICIT_QUESTION', 55), ('SUPERFICIAL_RELATIONSHIP', 84)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 116, 'IL-10'), ('GO_1990603', 'dark adaptation', 118, '- ... response')]
PMC4903143	5/2016	S87-PMC4903143	['Vitamin D\nthere is general CONSENSUS in the medical literature that the Vitamin D status of many Individuals and population groups throughout much of the world (as reflected by population measurements of Serum 25(Oh)D levels) is INSUFFICIENT for OPTIMAL health [74].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('PROBABLE_UNDERSTANDING', 27), ('PROBLEM_COMPLICATION', 229), ('IMPORTANT_CONSIDERATION', 246)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_1', 'root', 97, 'individuals'), ('UBERON_0001977', 'blood serum', 204, 'serum'), ('CHEBI_71657', 'versiconol acetate', 210, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 210, '25(OH ... D')]
PMC4930210	7/2016	S14-PMC4930210	['the iom has RECOMMENDED a 25(Oh)D cut point of >50 nmol/l to define Vitamin D sufficiency, AS this level is ASSOCIATED with PREVENTION of the bone manifestations of Vitamin D deficiency (rickets and osteomalacia) for 97.5% of canadians and americans.']	[('FUTURE_WORK', 12), ('PROBABLE_UNDERSTANDING', 91), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 124)]	4	[('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 32, 'D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D')]
PMC4934634	11/2015	S30-PMC4934634	['GIVEN the above it HAS BEEN ARGUED that obese Individuals are a population that is at an INCREASED RISK for Vitamin D deficiency [3,8].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 89)]	4	[('NCBITaxon_1', 'root', 46, 'individuals'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
PMC4934634	11/2015	S131-PMC4934634	['GIVEN the heightened response with co-supplementation, it SUGGESTS that the EFFECTS of Vitamin D on Gestational diabetes MIGHT be enhanced with the use of Calcium.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 121)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'gestational'), ('CHEBI_22313', 'alkaline earth metal atom', 155, 'calcium')]
PMC4934634	11/2015	S177-PMC4934634	['THUS it COULD BE ARGUED that adequate Maternal-fetal transfer of Vitamin D in utero and early Infancy is IMPORTANT for Life-long optimal health.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 105)]	4	[('GO_0007618', 'mating', 38, 'maternal'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('UBERON_0000023', 'wing', 94, 'infancy'), ('UBERON_0000104', 'life cycle', 119, 'life')]
PMC4934634	11/2015	S288-PMC4934634	['also, loss of function mutations in 24-hydroylase was found to be a risk factor for idiopathic infantile hypercalcemia making those infants more susceptible to Vitamin D toxicity EVEN at lower Vitamin D supplementation doses [86], THUS genetics CAN play a ROLE in both Vitamin D deficiency and toxicity.']	[('ANOMALY_CURIOUS_FINDING', 179), ('PROBABLE_UNDERSTANDING', 231), ('INCOMPLETE_EVIDENCE', 245), ('SUPERFICIAL_RELATIONSHIP', 256)]	4	[('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC4969253	8/2016	S84-PMC4969253	['these OBSERVATIONS STRONGLY SUPPORT the IDEA that Prenatal Vitamin A deficiency predisposes to Airway hyperreactivity.']	[('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 19), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 40)]	4	[('GO_0007565', 'female pregnancy', 50, 'prenatal'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin A'), ('UBERON_0001005', 'respiratory airway', 95, 'airway')]
PMC4973215	8/2016	S7-PMC4973215	['conclusion:\nidentification of RISK FACTORS (black race, medicaid status, obesity and lack of Prenatal Vitamin use) CAN LEAD TO OPPORTUNITIES for targeted Prenatal Vitamin supplementation to reduce the risk of neonatal Vitamin D deficiency and sga status.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('FUTURE_WORK', 127)]	4	[('GO_0007565', 'female pregnancy', 93, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 102, 'vitamin'), ('GO_0007565', 'female pregnancy', 154, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 163, 'vitamin'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
PMC4979151	8/2016	S35-PMC4979151	['there is NO standard classification of Vitamin D status based on 25(Oh)D3Concentrations in Cord Blood; THUS, for the PURPOSE of the PRESENT STUDY we stratified the participants into four groups based on Serum 25(Oh)D concentrations as done earlier [20] :(1) ≥76\xa0nmol/l (high); (2) 50–75\xa0nmol/l (moderate); (3) 30–49\xa0nmol/l (low); (4) <30\xa0nmol/l (very low).']	[('FULL_UNKNOWN', 9), ('PROBABLE_UNDERSTANDING', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 132)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_73735', 'gadoterate', 65, '25(OH)D3concentrations'), ('PR_000029608', 'DISP complex protein LRCH3', 65, '25 ... OH ... D3concentrations'), ('UBERON_0002240', 'spinal cord', 91, 'cord'), ('UBERON_0000178', 'blood', 96, 'blood'), ('UBERON_0001977', 'blood serum', 203, 'serum'), ('CHEBI_71657', 'versiconol acetate', 209, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 209, '25(OH)D')]
PMC4990280	8/2016	S159-PMC4990280	['the positive ASSOCIATION between hb and Plasma concentration of ferritin, B12, hepcidin and Vitamin A MAINLY in fe60f group INDICATED a beneficial IMPACT of the higher dose of Antenatal iron on hb concentration in 9 years old children.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBABLE_UNDERSTANDING', 102), ('INCOMPLETE_EVIDENCE', 124), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('UBERON_0001969', 'blood plasma', 40, 'plasma'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 74, 'B12'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin A'), ('GO_0007567', 'parturition', 176, 'antenatal')]
PMC4992225	8/2016	S88-PMC4992225	['we also CONSIDERED Vitamin D INSUFFICIENCY AS a Serum 25-Hydroxyvitamin D of 21–29\xa0ng/ml, and the participants who had Serum 25-Hydroxyvitamin d of\u2009≥\u200930\xa0ng/ml AS sufficient [19,46].']	[('INCOMPLETE_EVIDENCE', 8), ('IMPORTANT_CONSIDERATION', 29), ('PROBABLE_UNDERSTANDING', 43), ('PROBABLE_UNDERSTANDING', 159)]	4	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 54, '25-hydroxyvitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_67376', 'dihydrooroxylin A', 125, '25-hydroxyvitamin')]
PMC4992225	8/2016	S184-PMC4992225	['CONSIDERING the FACTORS AFFECTING Vitamin D Production such as clothing type, skin color and the time of day being exposed to the sun [48–50], these results are JUSTIFIABLE.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 161)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 34, 'vitamin D production')]
PMC4997567	8/2016	S91-PMC4997567	['(2008) [19], and bakeit and megeid (2012) [13], who REVEALED that most of the rickets children were Breast-Fed which may LEAD TO decreased Vitamin D 25-Hydroxy Vitamin D(25-Ohd) intake from OTHER sources and thereby causing rickets.']	[('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 121), ('SUPERFICIAL_RELATIONSHIP', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190)]	4	[('GO_0007567', 'parturition', 100, 'breast'), ('UBERON_0000310', 'breast', 100, 'breast'), ('GO_0007631', 'feeding behavior', 107, 'fed'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_43141', '3-hydroxypropoxy group', 149, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 170, '25-OHD')]
PMC5014971	8/2016	S72-PMC5014971	['physicians that reported having read co 495 were more LIKELY to screen their Pregnant patients (36.9% always or often versus 17.0% that had not read co 495; p< 0.001) AS were physicians that reported that Vitamin D insufficiency was a PROBLEM in their patient population (32.8% always or often versus 9.7%; p = 0.004).']	[('PROBABLE_UNDERSTANDING', 54), ('PROBABLE_UNDERSTANDING', 167), ('IMPORTANT_CONSIDERATION', 235), ('PROBLEM_COMPLICATION', 235)]	4	[('GO_0007565', 'female pregnancy', 77, 'pregnant'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
PMC5014971	8/2016	S87-PMC5014971	['regarding the level of circulating 25-Hydroxyvitamin D below which there is CONCERN for Vitamin D deficiency, respondents were ROUGHLY split between below 20\u2009ng/ml (50\u2009nmol/l) and 32\u2009ng/ml (80\u2009nmol/l) AS the level at which they would RECOMMEND a higher supplementation dose of vitamin d (46.5% versus 40.6%).']	[('IMPORTANT_CONSIDERATION', 76), ('PROBABLE_UNDERSTANDING', 127), ('PROBABLE_UNDERSTANDING', 201), ('FUTURE_WORK', 234)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 35, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5014971	8/2016	S97-PMC5014971	['the responding physicians were GENERALLY not supportive of screening all Pregnant women for Vitamin D status; EVEN among physicians that expressed a CONCERN regarding their patient population, less than half would screen most Pregnant patients.']	[('PROBABLE_UNDERSTANDING', 31), ('ANOMALY_CURIOUS_FINDING', 110), ('IMPORTANT_CONSIDERATION', 149), ('PROBLEM_COMPLICATION', 149)]	4	[('GO_0007565', 'female pregnancy', 73, 'pregnant'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 226, 'pregnant')]
PMC5014971	8/2016	S121-PMC5014971	['the Endocrine society CONSIDERS Pregnant and Lactating women AS HIGH-risk groups for Vitamin D insufficiency and RECOMMENDS universal screening [19].']	[('PROBABLE_UNDERSTANDING', 22), ('PROBABLE_UNDERSTANDING', 61), ('IMPORTANT_CONSIDERATION', 64), ('FUTURE_WORK', 113)]	4	[('UBERON_0005063', 'left ventricular compact myocardium', 4, 'Endocrine'), ('GO_0007565', 'female pregnancy', 32, 'pregnant'), ('GO_0007594', 'puparial adhesion', 45, 'lactating'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC5024513	9/2016	S129-PMC5024513	['in terms of comparison with dietary reference values, combined analysis of the individual study means SHOWED very few statistically significant results, with the EXCEPTION of Vitamin D. one POSSIBLE EXPLANATION for this is that there was a high level of variance between participants in the majority of studies resulting in very wide confidence intervals.']	[('INCOMPLETE_EVIDENCE', 102), ('ANOMALY_CURIOUS_FINDING', 162), ('INCOMPLETE_EVIDENCE', 190), ('PROBABLE_UNDERSTANDING', 199)]	4	[('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
PMC5035678	4/2016	S26-PMC5035678	['objectives\nwe THEREFORE SOUGHT TO EXPLORE the EFFECT of Vitamin D supplementation in women with gdm and hypovitaminosis D, both on post-Partum Glucose levels and Insulin resistance, in a randomized clinical trial.']	[('PROBABLE_UNDERSTANDING', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('SUPERFICIAL_RELATIONSHIP', 46)]	4	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 120, 'D'), ('GO_0007567', 'parturition', 136, 'partum'), ('CHEBI_17234', 'glucose', 143, 'glucose'), ('PR_000045358', 'insulin family protein', 162, 'insulin')]
PMC5039809	10/2016	S110-PMC5039809	['HOWEVER, these STUDIES have TYPICALLY been performed in developing countries with a high prevalence of Vitamin A deficiency, and MANY have used an interventional product containing both Retinol and Β-Carotene (17).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 129)]	4	[('CHEBI_27300', 'vitamin D', 103, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 186, 'retinol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 198, 'β-carotene')]
PMC5045784	10/2016	S58-PMC5045784	["our study is IN AGREEMENT with a study by onwuneme et al.16in which, in a cohort of 94 preterm infants (<32 weeks' Gestation), there was no association with bpd or other morbidities of Prematurity although the authors FOUND an ASSOCIATION between Vitamin D status and acute Respiratory morbidity (AS defined by differences in duration of positive pressure ventilation and highest oxygen concentration required in the delivery room and the odds of requiring assisted ventilation)."]	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 218), ('SUPERFICIAL_RELATIONSHIP', 227), ('PROBABLE_UNDERSTANDING', 297)]	4	[('GO_0007565', 'female pregnancy', 115, 'gestation'), ('GO_0007565', 'female pregnancy', 185, 'prematurity'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 274, 'respiratory')]
PMC5062906	10/2016	S254-PMC5062906	['this is MOST LIKELY the result of Genetic DIFFERENCES in Vitamin D Metabolism and STUDIES are ONGOING to identify and characterize the loci responsible.']	[('PROBABLE_UNDERSTANDING', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 82), ('IMPORTANT_CONSIDERATION', 94)]	4	[('SO_0000704', 'gene', 34, 'genetic'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 57, 'vitamin D metabolism')]
PMC5084016	10/2016	S130-PMC5084016	['low Birth weight, impaired Skeletal Development, and Respiratory infections and allergic diseases in the early years of Life are OFTEN ASSOCIATED with INADEQUATE CONTRIBUTION of Vitamin D from the mother’s diet.']	[('PROBABLE_UNDERSTANDING', 129), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 151), ('SUPERFICIAL_RELATIONSHIP', 162)]	4	[('GO_0007567', 'parturition', 4, 'birth'), ('GO_0001501', 'skeletal system development', 27, 'skeletal development'), ('UBERON_0004288', 'skeleton', 27, 'skeletal'), ('UBERON_0001004', 'respiratory system', 53, 'respiratory'), ('UBERON_0000104', 'life cycle', 120, 'life'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
PMC5084016	10/2016	S213-PMC5084016	['NOTABLY, the values recorded in italy [25,53] DIFFER from those RECOMMENDED by the italian GUIDELINES [7] from 40% (Iodine) to 85% (Vitamin D).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('FUTURE_WORK', 64), ('PROBABLE_UNDERSTANDING', 91)]	4	[('CHEBI_24859', 'iodine atom', 116, 'iodine'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
PMC5085625	9/2016	S84-PMC5085625	['HENCE, we POSTULATE to conduct a well-designed randomized study TO ASSESS the ROLE of Vitamin D in the etiopathogenesis of gh.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 64), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC5085625	9/2016	S90-PMC5085625	['ACCORDING to barebring et al., AT LEAST a 30 nmol/l increase in Serum 25(Oh)D concentration is ASSOCIATED with lower odds of pe, REGARDLESS OF Vitamin D status in early Pregnancy [13].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('PROBABLE_UNDERSTANDING', 31), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 129)]	4	[('UBERON_0001977', 'blood serum', 64, 'serum'), ('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 70, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('GO_0007565', 'female pregnancy', 169, 'pregnancy')]
PMC5085625	9/2016	S125-PMC5085625	['CONSEQUENTLY, these authors RECOMMENDED to conduct a well-designed randomized controlled trial to examine the exact ROLE of Vitamin D supplementation in the PREVENTION of Gdm [49].']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 28), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 157)]	4	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('GO_0070477', 'endospore core', 171, 'GDM')]
PMC5118763	12/2016	S158-PMC5118763	['HOWEVER, there was no dose-response relation between the number of mmn capsules taken and Plasma Vitamin B-12 that COULD EXPLAIN the higher Plasma concentrations of Vitamin B-12 at week 30 in the mmn group.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 121)]	4	[('UBERON_0001969', 'blood plasma', 90, 'plasma'), ('CHEBI_85855', 'diacylglycerol 46:7', 97, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 97, 'vitamin B-12'), ('UBERON_0001969', 'blood plasma', 140, 'plasma'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 165, 'vitamin B-12')]
PMC5118763	12/2016	S162-PMC5118763	['hemodilution and Placental Transport Of Vitamin B-12 To the Fetus (18) MAY BE POSSIBLE EXPLANATIONS for the OBSERVED decrease in Plasma concentrations of Vitamin B-12.']	[('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 78), ('PROBABLE_UNDERSTANDING', 87), ('INCOMPLETE_EVIDENCE', 108)]	4	[('GO_0007565', 'female pregnancy', 17, 'placental'), ('UBERON_0001987', 'placenta', 17, 'placental'), ('GO_0042790', 'nucleolar large rRNA transcription by RNA polymerase I', 27, 'transport of vitamin B-12 to'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 40, 'vitamin B-12'), ('GO_0007631', 'feeding behavior', 60, 'fetus'), ('UBERON_0001969', 'blood plasma', 129, 'plasma'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin B')]
PMC5146866	12/2016	S12-PMC5146866	['assessing Vitamin D status using cb is a CHALLENGE AS the OPTIMAL level of Vitamin D in children is STILL the subject of discussion [7].']	[('DIFFICULT_TASK', 41), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 58), ('IMPORTANT_CONSIDERATION', 100)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5155676	12/2016	S18-PMC5155676	['indeed MANY national GUIDELINES RECOMMEND universal Antenatal Vitamin D supplementation to prevent Vitamin D INSUFFICIENCY (7–9).']	[('INCOMPLETE_EVIDENCE', 7), ('PROBABLE_UNDERSTANDING', 21), ('FUTURE_WORK', 32), ('IMPORTANT_CONSIDERATION', 109)]	4	[('GO_0007567', 'parturition', 52, 'antenatal'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
PMC5155676	12/2016	S24-PMC5155676	['we THEREFORE undertook THIS STUDY TO DETERMINE maternal characteristics ASSOCIATED with achieved 25(Oh)D after Antenatal Vitamin D supplementation in the context of a double-blind, randomized, placebo-controlled trial.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('SUPERFICIAL_RELATIONSHIP', 72)]	4	[('CHEBI_71657', 'versiconol acetate', 97, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 103, 'D'), ('GO_0007567', 'parturition', 111, 'antenatal'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC5223368	12/2016	S135-PMC5223368	['Pregnancy health is STRONGLY ASSOCIATED with Serum 25-Hydroxy Vitamin D [26], and the ROLE of Vitamin D in bone mineralization is WELL KNOWN [26,27].']	[('PROBABLE_UNDERSTANDING', 20), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 130)]	4	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 51, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5223368	12/2016	S138-PMC5223368	['THUS, IF the third trimester is in spring OR in summer, the status of maternal Vitamin D would be better than in OTHER seasons.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC5240436	1/2017	S115-PMC5240436	['CONTRARY to our expectation BASED ON these PREVIOUS STUDIES, sq-Lns and mmn which contained both Vitamin A and zinc were not associated with a lower risk of p. falciparum parasitaemia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 28), ('INCOMPLETE_EVIDENCE', 43)]	4	[('UBERON_0000029', 'lymph node', 64, 'LNS'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A')]
PMC5310660	1/2017	S39-PMC5310660	['this latter plays a significant ROLE, SINCE increased Serum Vitamin D concentration is ASSOCIATED with a decreased risk of multiple sclerosis [10,11], and Vitamin D supplementation during the first year of Life is ASSOCIATED with a significantly decreased risk of type 1 diabetes [12].']	[('SUPERFICIAL_RELATIONSHIP', 32), ('PROBABLE_UNDERSTANDING', 38), ('SUPERFICIAL_RELATIONSHIP', 87), ('SUPERFICIAL_RELATIONSHIP', 214)]	4	[('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('UBERON_0000104', 'life cycle', 206, 'life')]
PMC5318550	2/2017	S136-PMC5318550	['nutrition is regarded as an UNLIKELY driver of seasonal Birth outcomes in developed countries, where Food supply fluctuates little over the year.27likewise, maternal and Cord blood Vitamin D concentrations had ONLY a very modest improvement of the MODEL.']	[('PROBABLE_UNDERSTANDING', 28), ('ANOMALY_CURIOUS_FINDING', 210), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 248)]	4	[('GO_0007567', 'parturition', 56, 'birth'), ('CHEBI_33290', 'food', 101, 'food'), ('UBERON_0002240', 'spinal cord', 170, 'cord'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
PMC5332602	3/2017	S181-PMC5332602	['THUS, UNLIKE in our MODEL of Prenatal Vitamin A deficiency (single-Micronutrient deficiency) (31), protein deficiency AFFECTED the levels or Homeostatic Control of multiple Macro- and Micronutrients, limiting the ability of neonatal Pigs to adapt/maintain Homeostasis through compensatory mechanisms.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 118)]	4	[('GO_0007565', 'female pregnancy', 29, 'prenatal'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 67, 'micronutrient'), ('GO_0042592', 'homeostatic process', 141, 'homeostatic'), ('GO_0065007', 'biological regulation', 153, 'control'), ('CHEBI_34830', 'mefenacet', 173, 'macro'), ('CHEBI_33839', 'macromolecule', 184, 'micronutrients'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'pigs'), ('GO_0042592', 'homeostatic process', 256, 'homeostasis')]
PMC5340372	3/2017	S107-PMC5340372	['THEREFORE, drawing CONCLUSIONS about the EFFECTS of Perinatal and Postnatal Vitamin D status from these results can be DIFFICULT.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 19), ('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 119)]	4	[('GO_0036268', 'swimming', 52, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 52, 'perinatal'), ('GO_0007567', 'parturition', 66, 'postnatal'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC5340372	3/2017	S143-PMC5340372	['last, the sample size was rather SMALL, and the Vitamin D levels of the participants were GENERALLY SUBOPTIMAL in OUR STUDY.']	[('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 90), ('IMPORTANT_CONSIDERATION', 100), ('QUESTION_ANSWERED_BY_THIS_WORK', 114)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5372327	3/2017	S6-PMC5372327	['discussion\nthe study ENABLES evaluation of short and long term EFFECTS of supplemental Vitamin D on growth, Immune functions and Skeletal and developmental parameters in infants, and the EFFECTS of Genetic FACTORS therein.']	[('PROBABLE_UNDERSTANDING', 21), ('SUPERFICIAL_RELATIONSHIP', 63), ('SUPERFICIAL_RELATIONSHIP', 187), ('SUPERFICIAL_RELATIONSHIP', 206)]	4	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0002405', 'immune system', 108, 'immune'), ('UBERON_0004288', 'skeleton', 129, 'skeletal'), ('SO_0000704', 'gene', 198, 'genetic')]
PMC5372327	3/2017	S45-PMC5372327	['identification, treatment, and PREVENTION of Vitamin D deficiency in early childhood MAY THEREFORE have widespread health EFFECTS throughout childhood.']	[('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 85), ('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
PMC5372327	3/2017	S47-PMC5372327	['BASED ON epidemiological studies, low maternal Intake of Vitamin D at Pregnancy and low Cord Blood 25-Ohd concentration HAVE BEEN ASSOCIATED with a higher risk for asthma, allergic rhinitis and atopic eczema in the offspring, as assessed at 5\xa0years of age [35–38].']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 130)]	4	[('GO_0007631', 'feeding behavior', 47, 'intake'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('CHEBI_72765', 'verruculogen', 99, '25-OHD')]
PMC5372327	3/2017	S127-PMC5372327	['results from this study will LIKELY generate NOVEL EVIDENCE-BASED INFORMATION for improving Vitamin D status among the paediatric population worldwide.']	[('PROBABLE_UNDERSTANDING', 29), ('FULL_UNKNOWN', 45), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 66)]	4	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC5405075	4/2017	S33-PMC5405075	['an immunodulatory ROLE of Vitamin D HAS also BEEN DESCRIBED in both Immune System and Lung Cell Maturation, which occurs MAINLY during fetal and early Extrauterine Life (40–42).']	[('SUPERFICIAL_RELATIONSHIP', 18), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 50), ('PROBABLE_UNDERSTANDING', 121)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007566', 'embryo implantation', 68, 'immune system'), ('UBERON_0002405', 'immune system', 68, 'immune system'), ('CL_0000175', 'luteal cell', 86, 'lung cell'), ('GO_0060424', 'lung field specification', 86, 'lung cell maturation'), ('UBERON_0002048', 'lung', 86, 'lung'), ('UBERON_0005928', 'external naris', 151, 'extrauterine life')]
PMC5418719	5/2017	S5-PMC5418719	['Vitamin D intake of 800\xa0iu/day SAFELY achieved an 88% PROBABILITY of Vitamin D sufficiency at 36\xa0weeks Postmenstrual age in vlbw infants with Cord-blood levels of 25(Oh)D\u2009≥\u200910\xa0ng/ml, and 65% PROBABILITY of Vitamin D sufficiency was OBSERVED in infants with 25 Ohd concentrations\u2009<\u200910\xa0ng/ml at Birth.']	[('IMPORTANT_CONSIDERATION', 31), ('PROBABLE_UNDERSTANDING', 54), ('PROBABLE_UNDERSTANDING', 191), ('INCOMPLETE_EVIDENCE', 232)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0008283', 'cell proliferation', 103, 'postmenstrual'), ('UBERON_0002240', 'spinal cord', 142, 'cord'), ('CHEBI_71657', 'versiconol acetate', 163, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 163, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 257, '25 OHD'), ('GO_0007567', 'parturition', 293, 'birth')]
PMC5418719	5/2017	S13-PMC5418719	['the european GUIDELINE on daily Vitamin D supplementation RECOMMEND 800 to 1000\xa0iu/day for preterm infants, WHILE western countries RECOMMEND 400\xa0iu/day [3].']	[('PROBABLE_UNDERSTANDING', 13), ('FUTURE_WORK', 58), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('FUTURE_WORK', 132)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC5474873	6/2017	S32-PMC5474873	['THUS, the ASSOCIATION between Vitamin D, sun exposure, and psychosis REMAINS DEBATED.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC5513133	7/2017	S186-PMC5513133	['SUGGESTED that EARLIER STUDIES have measured total 25(Oh)D AS a Vitamin D/Vitamin D binding protein (vdp) Complex, and not the free vitamin.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('PROBABLE_UNDERSTANDING', 59), ('DIFFICULT_TASK', 106)]	4	[('CHEBI_71657', 'versiconol acetate', 51, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 74, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 74, 'Vitamin D'), ('GO_0032991', 'protein-containing complex', 106, 'complex')]
PMC5513133	7/2017	S204-PMC5513133	['residual CONFOUNDING and differences between groups MAY EXPLAIN the ASSOCIATION between Vitamin D deficiency and pe.']	[('PROBLEM_COMPLICATION', 9), ('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 68)]	4	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5521778	7/2017	S5-PMC5521778	['CONSEQUENTLY, we INVESTIGATED IF gcs counteract Retinoid EFFECTS in Alveolar Epithelial Cells by mechanisms involving Bco1-dependent local Vitamin A Metabolism.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_26537', 'retinoid', 48, 'retinoid'), ('CL_0000322', 'pneumocyte', 68, 'alveolar epithelial cells'), ('UBERON_0004821', 'pulmonary alveolus epithelium', 68, 'alveolar epithelial'), ('PR_000004693', 'Bcl-2-like protein 10', 118, 'BCO1'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin A'), ('GO_0070639', 'vitamin D2 metabolic process', 139, 'vitamin A metabolism')]
PMC5537904	7/2017	S170-PMC5537904	['HOWEVER, this dose also exceeds the united states national academy of sciences Food and nutrition board tolerable upper limit of 4000 iu/day of Vitamin D for pregnant women [63], and THEREFORE cannot be RECOMMENDED based SOLELY on the present results.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 183), ('FUTURE_WORK', 203), ('INCOMPLETE_EVIDENCE', 221)]	4	[('CHEBI_33290', 'food', 79, 'Food'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC5539754	8/2017	S10-PMC5539754	['our NOVEL FINDINGS IMPLY that seasonal variation in Insulin resistance MAY NOT be fully EXPLAINED by differences in Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 19), ('INCOMPLETE_EVIDENCE', 71), ('PROBABLE_UNDERSTANDING', 88)]	4	[('PR_000045358', 'insulin family protein', 52, 'insulin'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC5539754	8/2017	S16-PMC5539754	['the presence of Vitamin D receptors and Expression of 1-α-hydroxylase enzyme in Pancreatic Beta Cells SUGGEST that Vitamin D MAY BE a modulator of Insulin secretion and THUS, INFLUENCE Glucose Homeostasis [6].']	[('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 125), ('PROBABLE_UNDERSTANDING', 169), ('SUPERFICIAL_RELATIONSHIP', 175)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0010467', 'gene expression', 40, 'expression'), ('CL_0000169', 'type B pancreatic cell', 80, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 80, 'pancreatic'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('PR_000045358', 'insulin family protein', 147, 'insulin'), ('CHEBI_17234', 'glucose', 185, 'glucose'), ('GO_0042593', 'glucose homeostasis', 185, 'glucose homeostasis')]
PMC5539754	8/2017	S176-PMC5539754	['WHILE no interaction effect was OBSERVED between season and Vitamin D with regards to Glucose Homeostasis, it is well RECOGNISED that 25Ohd declines in winter, and is a modifiable FACTOR.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 118), ('SUPERFICIAL_RELATIONSHIP', 180)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_17234', 'glucose', 86, 'glucose'), ('GO_0042593', 'glucose homeostasis', 86, 'glucose homeostasis'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 134, '25OHD')]
PMC5546866	8/2017	S26-PMC5546866	['CONSIDERING this and the physiological changes to the Vitamin D pathway in Pregnancy, it is THEREFORE POSSIBLE that the Genetic variants ASSOCIATED with baseline Serum 25(Oh)d status and the response to supplementation also differ between the Pregnant and nonpregnant state.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 92), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 137)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('SO_0000704', 'gene', 120, 'genetic'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_30778', 'gallic acid', 168, '25(OH)'), ('GO_0007565', 'female pregnancy', 243, 'pregnant')]
PMC5638722	8/2017	S1-PMC5638722	['Vitamin D deficiency MAY play a ROLE in the pathogenesis of infections, and low levels of circulating Vitamin D are STRONGLY ASSOCIATED with infectious diseases.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 32), ('PROBABLE_UNDERSTANDING', 116), ('SUPERFICIAL_RELATIONSHIP', 125)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5638722	8/2017	S22-PMC5638722	['moreover, there is a MAJORITY of epidemiological EVIDENCE INDICATING that circulating Vitamin D concentrations from Cord Blood CORRELATE indirectly with increased susceptibility to infection in newborns7).']	[('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 127)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0009472', 'axilla', 116, 'cord blood')]
PMC5638722	8/2017	S131-PMC5638722	['and thirdly, with the consideration AS the POSSIBLE EFFECT of seasonal changes in Vitamin D levels on the results, we ONLY included the babies which are Born during the summer period.']	[('PROBABLE_UNDERSTANDING', 36), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 52), ('INCOMPLETE_EVIDENCE', 118)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007567', 'parturition', 153, 'born')]
PMC5659607	10/2017	S15-PMC5659607	['trial registration\ncopsac2010: clinicaltrials.govnct00856947; vdaart: clinicaltrials.govnct00920621\n\nintroduction\nthere are several REASONS to HYPOTHESIZE that low in utero Vitamin D exposure increases risk of childhood asthma/recurrent wheeze: (1) Genetic studies HAVE SHOWN that polymorphisms in the Vitamin D Receptor are ASSOCIATED with childhood asthma susceptibility[1].']	[('PROBABLE_UNDERSTANDING', 132), ('INCOMPLETE_EVIDENCE', 143), ('INCOMPLETE_EVIDENCE', 265), ('SUPERFICIAL_RELATIONSHIP', 325)]	4	[('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('SO_0000704', 'gene', 249, 'Genetic'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 302, 'vitamin D receptor')]
PMC5659607	10/2017	S22-PMC5659607	['we THEREFORE conducted a combined analysis of the two trials including the primary end-point asthma/recurrent wheeze by age 3 years as well as the secondary end-points specific Ige, total Ige, eczema and Lower Respiratory Tract infections (lrti) and did 25(Oh)D level-based analyses to determine WHETHER nutritional status at entry to the trials INFLUENCED the EFFECT of Vitamin D.\n\nmethods\nvdaart: monitored by nhlbi and copsac: approved by the ethics committee for copenhagen.']	[('PROBABLE_UNDERSTANDING', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 296), ('SUPERFICIAL_RELATIONSHIP', 346), ('SUPERFICIAL_RELATIONSHIP', 361)]	4	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 177, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 188, 'IgE'), ('UBERON_0004905', 'articulation', 204, 'lower respiratory tract'), ('CHEBI_71657', 'versiconol acetate', 254, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 254, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin D')]
PMC5664622	9/2017	S102-PMC5664622	['THUS, it SEEMS IMPOSSIBLE for it to ever become a significant source of Vitamin D, especially in light of exaggerated media REPORTS on chemical Pollutants absorbed by the fish.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 9), ('DIFFICULT_TASK', 15), ('INCOMPLETE_EVIDENCE', 124)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_26199', 'polyprenol', 144, 'pollutants')]
PMC5664622	9/2017	S116-PMC5664622	['the absence of a correlation between Blood Vitamin D levels and its intake from the diet (no supplementation) is MOST PROBABLY a direct result of low Vitamin D Intake (2.1 µg/day), which is CONSISTENT with REPORTS of other authors at a daily Intake of 0.8 µg [12].']	[('PROBABLE_UNDERSTANDING', 113), ('PROBABLE_UNDERSTANDING', 118), ('INCOMPLETE_EVIDENCE', 190), ('INCOMPLETE_EVIDENCE', 206)]	4	[('UBERON_0000178', 'blood', 37, 'blood'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('GO_0007631', 'feeding behavior', 160, 'intake'), ('GO_0007631', 'feeding behavior', 242, 'intake')]
PMC5664622	9/2017	S117-PMC5664622	['IN LIGHT OF the current norms in poland [34], adequate Consumption of Vitamin D from dietary sources was REPORTED by ONLY 6% of the investigated women.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 105), ('ANOMALY_CURIOUS_FINDING', 117), ('INCOMPLETE_EVIDENCE', 117)]	4	[('GO_0007631', 'feeding behavior', 55, 'consumption'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
PMC5679631	11/2017	S122-PMC5679631	['the function of Vitamin D in Regulating Amp Production, THEREFORE, SUGGESTS that Vitamin D status COULD INFLUENCE the composition of the Intestinal microbiota.']	[('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0065007', 'biological regulation', 29, 'regulating'), ('CHEBI_16027', "adenosine 5'-monophosphate", 40, 'AMP'), ('GO_0006754', 'ATP biosynthetic process', 40, 'AMP production'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0000160', 'intestine', 137, 'intestinal')]
PMC5679631	11/2017	S129-PMC5679631	['in SUMMARY, the ROLE of Vitamin D is MOST LIKELY to Regulate the Immune Response to maintain Immune Homeostasis [25] by balancing activation of tolerance and the innate Immune System.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 16), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 42)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0065007', 'biological regulation', 52, 'regulate'), ('GO_0006955', 'immune response', 65, 'immune response'), ('UBERON_0002405', 'immune system', 65, 'immune'), ('GO_0055090', 'acylglycerol homeostasis', 93, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 93, 'immune'), ('GO_0007566', 'embryo implantation', 169, 'immune'), ('UBERON_0002405', 'immune system', 169, 'immune system')]
PMC5679631	11/2017	S142-PMC5679631	['g ., health ISSUES leading to the choice of an alternative lifestyle, COULD BE modifying the EFFECT of Vitamin D on the Intestinal bacteria and, THEREFORE, recruitment group was adjusted for in the multivariable analyses.']	[('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 93), ('PROBABLE_UNDERSTANDING', 145)]	4	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('UBERON_0000160', 'intestine', 120, 'intestinal')]
PMC5706533	11/2017	S145-PMC5706533	['discussion\nthough trials of Prenatal Vitamin D supplementation are being published at an ACCELERATING pace, randomised controlled trials published up to 2017 were GENERALLY SMALL, low quality, and RARELY designed to examine clinical outcomes.']	[('IMPORTANT_CONSIDERATION', 89), ('PROBABLE_UNDERSTANDING', 163), ('INCOMPLETE_EVIDENCE', 173), ('INCOMPLETE_EVIDENCE', 197)]	4	[('GO_0007565', 'female pregnancy', 28, 'prenatal'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5732505	12/2017	S160-PMC5732505	['a POSSIBLE EXPLANATION for this MIGHT be a u-shaped ASSOCIATION between maternal Vitamin D concentration and fetal outcomes in a population with sufficient Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 52)]	4	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC5812027	2/2018	S14-PMC5812027	['THUS, both higher Vitamin D status in late Pregnancy and Gestational Vitamin D status trajectory CAN be SUSPECTED to play a ROLE in healthy Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 124)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('GO_0007565', 'female pregnancy', 57, 'gestational'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 140, 'pregnancy')]
PMC5812027	2/2018	S24-PMC5812027	['THUS, the ASSOCIATION between Vitamin D status and neonatal Birth size is NOT CLEAR and WARRANTS FURTHER INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 88)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 60, 'birth')]
PMC5812027	2/2018	S30-PMC5812027	['THUS, the ASSOCIATION between Vitamin D status and risk of Miscarriage NEEDS FURTHER INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('FUTURE_WORK', 71), ('FUTURE_WORK', 77)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0046660', 'female sex differentiation', 59, 'miscarriage')]
PMC5812027	2/2018	S115-PMC5812027	['THUS, preeclampsia does not SEEM to MEDIATE the ASSOCIATIONS between Vitamin D status trajectory and neonatal Birth size or Preterm Birth.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 48)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007567', 'parturition', 110, 'birth'), ('GO_0007565', 'female pregnancy', 124, 'preterm birth')]
PMC5831579	3/2018	S104-PMC5831579	['fruits and vegetables, foods that require preparation, protein, Carbohydrate, Nutrients related to One-Carbon Metabolism pathway, Dha, Vitamin D, iron, sodium, Calcium and Caffeine were more strongly CORRELATED to the ‘seasoned vegetables and lean meats,’ which was the dietary pattern that COULD CONTRIBUTE MOST to a healthy pre-Pregnancy nutrition [9,17–20], followed by ‘lentils, whole grains and soups’ pattern.']	[('SUPERFICIAL_RELATIONSHIP', 200), ('INCOMPLETE_EVIDENCE', 291), ('SUPERFICIAL_RELATIONSHIP', 297), ('PROBABLE_UNDERSTANDING', 308)]	4	[('CHEBI_16730', 'chloramphenicol 3-acetate', 64, 'carbohydrate'), ('CHEBI_33284', 'nutrient', 78, 'nutrients'), ('GO_0006730', 'one-carbon metabolic process', 99, 'one-carbon metabolism'), ('CHEBI_17874', 'dihydrozeatin', 130, 'DHA'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 160, 'calcium'), ('CHEBI_27732', 'caffeine', 172, 'caffeine'), ('GO_0007565', 'female pregnancy', 330, 'pregnancy')]
PMC5838372	3/2018	S120-PMC5838372	['HOWEVER, mothers’ low Vitamin intake was FOUND AS a RISK FACTOR for the infants’ Vitamin D level.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 47), ('SUPERFICIAL_RELATIONSHIP', 52)]	4	[('CHEBI_33229', 'vitamin (role)', 22, 'vitamin'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC5941617	5/2018	S53-PMC5941617	['the standardization, also RETROSPECTIVELY, SHOULD help to develop FUTURE Vitamin D GUIDELINES [59,60].']	[('INCOMPLETE_EVIDENCE', 26), ('FUTURE_WORK', 43), ('FUTURE_WORK', 66), ('PROBABLE_UNDERSTANDING', 83)]	4	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC5941617	5/2018	S95-PMC5941617	['CONSIDERING Water REQUIREMENTS, formula Fed infants MAY receive 400\xa0iu/day of Vitamin D, which is adequate for the first year of Life [10], only when they come to weigh 5 to 6 kg.']	[('IMPORTANT_CONSIDERATION', 0), ('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 18), ('INCOMPLETE_EVIDENCE', 52)]	4	[('CHEBI_15377', 'water', 12, 'water'), ('GO_0007631', 'feeding behavior', 40, 'fed'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000104', 'life cycle', 129, 'life')]
PMC5941617	5/2018	S105-PMC5941617	['in 2016 also the european Food safety authority (efsa) revised dietary reference values for Vitamin D. CONSIDERING a Serum 25(Oh)D levels of 20\xa0ng/ml AS a SUITABLE target value, under conditions of minimal cutaneous Vitamin D synthesis efsa RECOMMENDED an adequate intake of 400\xa0iu/day for infants aged 7–11\xa0months and of 600\xa0iu/day for children aged 1–17\xa0years [26].']	[('PROBABLE_UNDERSTANDING', 103), ('PROBABLE_UNDERSTANDING', 150), ('IMPORTANT_CONSIDERATION', 155), ('FUTURE_WORK', 241)]	4	[('CHEBI_33290', 'food', 26, 'Food'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 100, 'D'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 123, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC5941617	5/2018	S141-PMC5941617	['in 2013 the aap RECOMMENDED a daily Vitamin D intake of 200–400\xa0iu for vlbw infants, AS their smaller size MAY LEAD TO a lower need for Vitamin D to ensure adequate Serum 25(Oh)D levels.']	[('FUTURE_WORK', 16), ('PROBABLE_UNDERSTANDING', 85), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 111)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_71657', 'versiconol acetate', 171, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 177, 'D')]
PMC5941617	5/2018	S176-PMC5941617	['adolescents are at INCREASED RISK for Vitamin D deficiency [79], THUS the society for adolescent health and medicine RECOMMENDED continuous Vitamin D supplementation (600\xa0iu daily for healthy adolescents, and at LEAST 1000\xa0iu daily for adolescents at risk for Vitamin D deficiency or insufficiency) in addition to Vitamin D received through the diet or via sun exposure [21].']	[('IMPORTANT_CONSIDERATION', 19), ('PROBABLE_UNDERSTANDING', 65), ('FUTURE_WORK', 117), ('PROBABLE_UNDERSTANDING', 212)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 314, 'vitamin D')]
PMC5941617	5/2018	S180-PMC5941617	['regarding italy (latitude 35°29′24″-47°5′31″), an in vitro study SHOWED that no Vitamin D is produced AS a result of sun exposure at the latitude of pisa (43°43’n) from november to february [179], CONFIRMING that sunlight-derived Vitamin D production is ineffective for at least 1\xa0month during the year in countries placed between 23.5° and 66.5° of latitude [180].']	[('INCOMPLETE_EVIDENCE', 65), ('PROBABLE_UNDERSTANDING', 102), ('PROBABLE_UNDERSTANDING', 197), ('PROBABLE_UNDERSTANDING', 197)]	4	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D')]
PMC5941617	5/2018	S190-PMC5941617	['individuals on Anticonvulsants, oral Corticosteroids, Antimicotics and Antiretroviral Drugs SHOULD receive AT LEAST 2–3 times more Vitamin D than the daily REQUIREMENT RECOMMENDED for age, in agreement with the endocrine society [11] and the aap [23].']	[('FUTURE_WORK', 92), ('PROBABLE_UNDERSTANDING', 107), ('IMPORTANT_CONSIDERATION', 156), ('FUTURE_WORK', 168)]	4	[('CHEBI_37540', 'arabinarate(2-)', 15, 'anticonvulsants'), ('CHEBI_50850', 'etabonate ester', 37, 'corticosteroids'), ('CHEBI_33282', 'antibacterial agent', 54, 'antimicotics'), ('CHEBI_33656', 'antiaromatic compound', 71, 'antiretroviral drugs'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5941617	5/2018	S208-PMC5941617	['children of immigrants living in industrialized countries are at INCREASED RISK of rickets BECAUSE they USUALLY present several RISK FACTORS for Vitamin D deficiency such as prolonged breastfeeding without vitamin d supplementation, increased skin pigmentation, reduced sun exposure due to cultural habits (i.e.']	[('IMPORTANT_CONSIDERATION', 65), ('PROBABLE_UNDERSTANDING', 91), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC5941617	5/2018	S269-PMC5941617	['in 2016, sacn and efsa revised dietary reference values for Vitamin D reporting an INCREASED RISK of adverse Musculoskeletal health outcomes at Serum 25(Oh)D levels in the range of deficiency, BUT with DIFFERENT THRESHOLDS (<\u200910\xa0ng/ml and\u2009<\u2009\xa020\xa0ng/ml, respectively) [25,26].']	[('IMPORTANT_CONSIDERATION', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 202), ('PROBABLE_UNDERSTANDING', 212)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 109, 'musculoskeletal'), ('UBERON_0001977', 'blood serum', 144, 'serum'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 150, '25 ... OH ... D')]
PMC5941617	5/2018	S359-PMC5941617	['furthermore, PREVIOUS STUDIES focused on the ASSOCIATION between Serum 25(Oh)D levels and the Expression of Genes INVOLVED in the Proliferation and Cells Differentiation, showing an anti-proliferative activity of Vitamin D with CONSEQUENTLY remodeling inhibition [309–312].']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 228)]	4	[('UBERON_0001977', 'blood serum', 65, 'serum'), ('CHEBI_71657', 'versiconol acetate', 71, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 77, 'D'), ('GO_0010467', 'gene expression', 94, 'expression'), ('SO_0000704', 'gene', 108, 'genes'), ('GO_0007565', 'female pregnancy', 130, 'proliferation ...'), ('GO_0030154', 'cell differentiation', 148, 'cells differentiation'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC5941617	5/2018	S398-PMC5941617	['FOR THESE REASONS AT PRESENT Vitamin D supplementation as adjunctive standard therapy for ad cannot be RECOMMENDED in all the affected children [351].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 18), ('FUTURE_WORK', 103)]	4	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5941617	5/2018	S473-PMC5941617	['nice GUIDELINES ADVICE that People with cd MAY NEED to receive Calcium and Vitamin D supplementation if their dietary intake is insufficient [433].']	[('PROBABLE_UNDERSTANDING', 5), ('FUTURE_WORK', 16), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 47)]	4	[('NCBITaxon_10088', 'Mus <genus>', 28, 'people'), ('CHEBI_22313', 'alkaline earth metal atom', 63, 'calcium'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC5941617	5/2018	S485-PMC5941617	['THUS, several authors have SUGGESTED that Vitamin D deficiency COULD play a ROLE in worsening the comorbidities of pediatric obesity.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5941617	5/2018	S503-PMC5941617	['the Endocrine society [11], united arab emirates GUIDELINES [27] and the society for adolescent health and medicine [21] RECOMMENDED to screen all obese children and adolescents AS they are at INCREASED RISK for Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 49), ('FUTURE_WORK', 121), ('PROBABLE_UNDERSTANDING', 178), ('IMPORTANT_CONSIDERATION', 193)]	4	[('UBERON_0005063', 'left ventricular compact myocardium', 4, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC5941617	5/2018	S560-PMC5941617	['SUGGESTED that a Vitamin D intake of AT LEAST 4000\xa0iu/day SHOULD BE CONSIDERED in all Pregnant women to maintain Serum 25(Oh)D levels ≥40\xa0ng/ml [513,514].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 37), ('FUTURE_WORK', 58), ('FUTURE_WORK', 68)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnant'), ('UBERON_0001977', 'blood serum', 113, 'serum'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 119, '25(OH)D')]
PMC5941617	5/2018	S642-PMC5941617	['individuals on Anticonvulsants, oral Corticosteroids, Antimicotics and Antiretroviral Drugs SHOULD receive AT LEAST 2–3 times more Vitamin D than the daily REQUIREMENT RECOMMENDED for age.']	[('FUTURE_WORK', 92), ('PROBABLE_UNDERSTANDING', 107), ('IMPORTANT_CONSIDERATION', 156), ('FUTURE_WORK', 168)]	4	[('CHEBI_37540', 'arabinarate(2-)', 15, 'anticonvulsants'), ('CHEBI_50850', 'etabonate ester', 37, 'corticosteroids'), ('CHEBI_33282', 'antibacterial agent', 54, 'antimicotics'), ('CHEBI_33656', 'antiaromatic compound', 71, 'antiretroviral drugs'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC5941617	5/2018	S649-PMC5941617	['Skeletal actions of Vitamin D\n\nnutritional rickets\n\nchildren of immigrants living in industrialized countries are at INCREASED RISK of nutritional rickets BECAUSE they USUALLY present several risk FACTORS for vitamin d deficiency such as prolonged breastfeeding without Vitamin D supplementation, increased skin pigmentation, reduced sun exposure due to cultural habits (i.e.']	[('IMPORTANT_CONSIDERATION', 117), ('PROBABLE_UNDERSTANDING', 155), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 197)]	4	[('UBERON_0004288', 'skeleton', 0, 'Skeletal'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D')]
PMC5941617	5/2018	S695-PMC5941617	['we RECOMMEND continuous Vitamin D supplementation at higher doses THAN those RECOMMENDED for age (AT LEAST 1000–1500\xa0iu/day).']	[('FUTURE_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 66), ('FUTURE_WORK', 77), ('PROBABLE_UNDERSTANDING', 98)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5941617	5/2018	S696-PMC5941617	['we RECOMMEND to treat Vitamin D deficiency with daily Vitamin D at higher doses THAN those RECOMMENDED for otherwise healthy pediatric population (AT LEAST 2000–4000\xa0iu/day), for a minimum of 6–8\xa0weeks.']	[('FUTURE_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80), ('FUTURE_WORK', 91), ('PROBABLE_UNDERSTANDING', 147)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
PMC5941617	5/2018	S712-PMC5941617	['in obese subjects with Vitamin D deficiency we RECOMMEND Vitamin D treatment at higher doses THAN those RECOMMENDED for otherwise healthy pediatric population (AT LEAST 2000–4000\xa0iu/day), for a minimum of 6–8\xa0weeks.']	[('FUTURE_WORK', 47), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 93), ('FUTURE_WORK', 104), ('PROBABLE_UNDERSTANDING', 160)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC5941617	5/2018	S728-PMC5941617	['in subjects with asymptomatic Vitamin D deficiency assuming Drugs interfering with Vitamin D Metabolism (Anticonvulsants, oral Corticosteroids, antifungals like Ketoconazole, Anti-retroviral Drugs) we RECOMMEND Vitamin D treatment at higher doses THAN those RECOMMENDED for otherwise healthy pediatric population (AT LEAST 2000–4000\xa0iu/day), for a minimum of 6–8\xa0weeks.']	[('FUTURE_WORK', 201), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('FUTURE_WORK', 258), ('PROBABLE_UNDERSTANDING', 314)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_23888', 'drug', 60, 'drugs'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 83, 'vitamin D metabolism'), ('CHEBI_37540', 'arabinarate(2-)', 105, 'anticonvulsants'), ('CHEBI_50850', 'etabonate ester', 127, 'corticosteroids'), ('CHEBI_47519', 'ketoconazole', 161, 'ketoconazole'), ('CHEBI_59132', 'antigen', 175, 'anti'), ('CHEBI_23888', 'drug', 191, 'drugs'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D')]
PMC5956785	5/2018	S226-PMC5956785	['the authors HYPOTHESIZED that the REASON their patients’ 25(Oh)D concentrations were so high was that their PREVIOUS RESEARCH had FOUND low concentrations of 25(Oh)D and they were encouraging their patients to consume Vitamin D fortified Foods and to spend time in the sun [53].']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 34), ('INCOMPLETE_EVIDENCE', 108), ('INCOMPLETE_EVIDENCE', 130)]	4	[('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 57, '25'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 60, 'OH ... D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 161, 'OH)D'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D'), ('CHEBI_33290', 'food', 238, 'foods')]
PMC1481554	4/2006	S98-PMC1481554	['THUS, with lower Vitamin C content than pregvit®, IT IS POSSIBLE that the systemic absorption of Iron of materna®MAY BE subtherapeutic14.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 50), ('INCOMPLETE_EVIDENCE', 113)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin C'), ('PR_000004900', 'complement C3', 25, 'C'), ('CHEBI_24870', 'ion', 97, 'iron')]
PMC2290997	4/2008	S32-PMC2290997	['in the july 2000 issue of the journal of Human Evolution , california academy of sciences anthropologists nina jablonski and george chaplin wrote that BECAUSE dark skin REQUIRES about five to six times more solar exposure than pale skin for equivalent Vitamin D Photosynthesis, and because the intensity of uvb radiation declines with increasing latitude, one could surmise that skin lightening was an evolutionary adaptation that allowed for optimal survival in low-uvr climes, ASSUMING a traditional diet and outdoor lifestyle.']	[('PROBABLE_UNDERSTANDING', 151), ('IMPORTANT_CONSIDERATION', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 479)]	3	[('NCBITaxon_10088', 'Mus <genus>', 41, 'Human'), ('GO_0006983', 'ER overload response', 47, 'Evolution'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('GO_0006654', 'phosphatidic acid biosynthetic process', 262, 'photosynthesis')]
PMC2290997	4/2008	S84-PMC2290997	['People living at higher latitudes throughout the world are at higher RISK of hypertension, and patients with Cardiovascular disease are OFTEN found to be deficient in Vitamin D, ACCORDING TO research by harvard medical school professor thomas j. wang and colleagues in the 29 january 2008 issue of circulation .']	[('IMPORTANT_CONSIDERATION', 69), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 178)]	3	[('NCBITaxon_10088', 'Mus <genus>', 0, 'People'), ('UBERON_0004535', 'cardiovascular system', 109, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
PMC2685863	5/2009	S12-PMC2685863	['the researchers REASON that a lack of Vitamin D in the Thymus in early Life COULD limit this process, THUS enabling “self-directed” T Cells to survive and trigger an Autoimmune response to the Myelin Sheath on Nerve Fibers—a classic feature of ms.']	[('PROBABLE_UNDERSTANDING', 16), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 102)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0002370', 'thymus', 55, 'thymus'), ('UBERON_0000104', 'life cycle', 71, 'life'), ('CL_0000084', 'T cell', 132, 'T cells'), ('UBERON_0001442', 'skeleton of manus', 166, 'autoimmune'), ('UBERON_0000347', 'entire myelin sheath', 193, 'myelin sheath'), ('UBERON_0006134', 'nerve fiber', 210, 'nerve fibers')]
PMC2821652	2/2010	S75-PMC2821652	['THEREFORE, we were faced with the CHALLENGE of establishing novel criteria for Vitamin D supplement adherence by Serum 25(Oh)D levels; HOW we arrived at this definition is described below.']	[('PROBABLE_UNDERSTANDING', 0), ('DIFFICULT_TASK', 34), ('EXPLICIT_QUESTION', 135)]	3	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0001977', 'blood serum', 113, 'serum'), ('CHEBI_71657', 'versiconol acetate', 119, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 121, '(OH ... D')]
PMC2872349	4/2010	S94-PMC2872349	['in developing populations, OFTEN the Nutrient in short supply is Calcium RATHER than Vitamin D: children of mothers, in a mother-offspring cohort study in pune, india [42], who had a higher frequency of Intake of Calcium-rich Foods during Pregnancy had higher total and Lumbar Spine bmc and areal bmd, INDEPENDENT of parental size and bone composition.']	[('PROBABLE_UNDERSTANDING', 27), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('SUPERFICIAL_RELATIONSHIP', 302)]	3	[('CHEBI_33284', 'nutrient', 37, 'nutrient'), ('CHEBI_22313', 'alkaline earth metal atom', 65, 'calcium'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007631', 'feeding behavior', 203, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 213, 'calcium'), ('CHEBI_33290', 'food', 226, 'foods'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('UBERON_0006074', 'lumbar region of vertebral column', 270, 'lumbar spine')]
PMC2889879	5/2010	S134-PMC2889879	['NO earlier STUDIES that we ARE AWARE OF have evaluated the RELATIONSHIP between Adult Vitamin D levels and psychotic symptoms.']	[('FULL_UNKNOWN', 0), ('PROBABLE_UNDERSTANDING', 27), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('UBERON_0007023', 'adult organism', 80, 'adult'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC2889879	5/2010	S142-PMC2889879	['the absorption of dietary Vitamin D is GENERALLY high at all stages of Life [34], BUT Serum levels also depend on the endogenous Production Of Vitamin D due to sun exposure which is subject to seasonal VARIATIONS.']	[('PROBABLE_UNDERSTANDING', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('DIFFICULT_TASK', 202)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('UBERON_0000104', 'life cycle', 71, 'life'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 129, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
PMC2963768	10/2010	S15-PMC2963768	['low 25(Oh)D is SURPRISINGLY common in south asia, where systemic Vitamin D deficits would be expected to be PREVENTED by cutaneous Vitamin D Synthesis stimulated by exposure to sun at relatively low latitudes (3).']	[('ANOMALY_CURIOUS_FINDING', 15), ('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 108)]	3	[('CHEBI_71657', 'versiconol acetate', 4, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0031151', 'histone methyltransferase activity (H3-K79 specific)', 139, 'D synthesis')]
PMC2963768	10/2010	S85-PMC2963768	['TO OUR KNOWLEDGE, THIS is the FIRST report of Vitamin D status in young infants in bangladesh.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
PMC2963768	10/2010	S103-PMC2963768	['THEREFORE, the representativeness of our data is LIMITED because they REFLECT Vitamin D status during the winter, when ultraviolet radiation exposure is at its nadir, and when cutaneous Vitamin D Synthesis would be expected to be relatively minimal (24).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 186, 'vitamin D synthesis')]
PMC2963768	10/2010	S126-PMC2963768	['the most WIDELY-accepted manifestation of SEVERE Vitamin D deficiency in infancy is rickets, the classical childhood Metabolic bone disease ASSOCIATED with Skeletal hypomineralization and deformities, muscle weakness, and growth impairment (1).']	[('PROBABLE_UNDERSTANDING', 9), ('IMPORTANT_CONSIDERATION', 42), ('SUPERFICIAL_RELATIONSHIP', 140)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0008152', 'metabolic process', 117, 'metabolic'), ('UBERON_0004288', 'skeleton', 156, 'skeletal')]
PMC2963768	10/2010	S146-PMC2963768	['selection of control was necessarily non-random from the perspective of age and gender and, thus, UNFORTUNATELY led to an over-representation of boys; however, there is UNLIKELY to be a gender DIFFERENTIAL in Vitamin D status during early infancy (63).']	[('IMPORTANT_CONSIDERATION', 98), ('PROBABLE_UNDERSTANDING', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193)]	3	[('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
PMC2996405	11/2010	S31-PMC2996405	['the latter is very IMPORTANT SINCE Vitamin D is INVOLVED in many health outcomes (e.g.']	[('IMPORTANT_CONSIDERATION', 19), ('PROBABLE_UNDERSTANDING', 29), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
PMC2996405	11/2010	S50-PMC2996405	['AS most Individuals do not develop cancer until they are past their Reproductive age, from an evolutionary POINT OF VIEW, skin cancer REPRESENTS a less powerful selective force than Vitamin D availability in Serum [21].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('NCBITaxon_1', 'root', 8, 'individuals'), ('GO_0000003', 'reproduction', 68, 'reproductive'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('UBERON_0001977', 'blood serum', 208, 'serum')]
PMC2996405	11/2010	S107-PMC2996405	["also the overlap of 70 Genes between vdr and schizophrenia RELATED Genes was significant (p-value 1.4 × 10-6, fisher's exact test; figure1and additional file3), CONFIRMING the ROLE of Vitamin D in schizophrenia pathogenesis."]	[('SUPERFICIAL_RELATIONSHIP', 59), ('PROBABLE_UNDERSTANDING', 161), ('SUPERFICIAL_RELATIONSHIP', 176)]	3	[('SO_0000704', 'gene', 23, 'genes'), ('SO_0000704', 'gene', 67, 'genes'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
PMC3032617	5/2010	S94-PMC3032617	['AS a CONFIRMATION of this data, EVEN when women in the two groups were stratified for overall number of times hospitalized, the Vitamin C group was shown to achieve significantly better results.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 5), ('ANOMALY_CURIOUS_FINDING', 32)]	3	[('CHEBI_27300', 'vitamin D', 128, 'vitamin C')]
PMC3032617	5/2010	S107-PMC3032617	['considering the IMPORTANCE of systolic Blood pressure during Pregnancy which is a direct reflex of mother’s Blood output and THEREFORE child Nutrient provision, we compared in each group the difference from baseline to end of Pregnancy and a significant average increase was FOUND in both groups from baseline, with a higher increase in the Vitamin C group.']	[('IMPORTANT_CONSIDERATION', 16), ('PROBABLE_UNDERSTANDING', 125), ('INCOMPLETE_EVIDENCE', 275)]	3	[('UBERON_0000178', 'blood', 39, 'blood'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('UBERON_0000178', 'blood', 108, 'blood'), ('CHEBI_33284', 'nutrient', 141, 'nutrient'), ('GO_0007565', 'female pregnancy', 226, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 341, 'vitamin C')]
PMC3169551	9/2011	S134-PMC3169551	['this MAY REFLECT lower coverage with volunteer health workers and lower population densities in africa, where most costing STUDIES of Vitamin A were done.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 9), ('INCOMPLETE_EVIDENCE', 123)]	3	[('CHEBI_27300', 'vitamin D', 134, 'vitamin A')]
PMC3271033	1/2012	S11-PMC3271033	['formula-Fed infants typically consume 300-500 iu/day from their formula and THEREFORE GENERALLY meet the current recommendations without an additional oral supplement of Vitamin D drops ESPECIALLY after the first 6 to 8 weeks of Life.']	[('PROBABLE_UNDERSTANDING', 76), ('PROBABLE_UNDERSTANDING', 86), ('ANOMALY_CURIOUS_FINDING', 186)]	3	[('GO_0007631', 'feeding behavior', 8, 'fed'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('UBERON_0000104', 'life cycle', 229, 'life')]
PMC3271033	1/2012	S113-PMC3271033	['the close RELATIONSHIPS between weight and length and initial bmc IMPLY that calcium transfer across the Placenta is closely RELATED to overall Nutrient transfer and not to Vitamin D status (7).']	[('SUPERFICIAL_RELATIONSHIP', 10), ('PROBABLE_UNDERSTANDING', 66), ('SUPERFICIAL_RELATIONSHIP', 125)]	3	[('UBERON_0001987', 'placenta', 105, 'placenta'), ('CHEBI_33284', 'nutrient', 144, 'nutrient'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC3272870	12/2011	S51-PMC3272870	['Vitamin D is LIKELY SAFE during Pregnancy and Breast feeding when taken by mouth in RECOMMENDED amounts, that is 10 mcg (400 usp units) of Vitamin D daily in normal Pregnancy.']	[('PROBABLE_UNDERSTANDING', 13), ('IMPORTANT_CONSIDERATION', 20), ('FUTURE_WORK', 84)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 32, 'pregnancy'), ('UBERON_0000310', 'breast', 46, 'breast'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy')]
PMC3277098	12/2011	S38-PMC3277098	['Immune Cell Differentiation and Proliferation\nthe ROLE of Vitamin D in Regulation Of the Immune System was FIRST RECOGNIZED through the identification of Vitamin D receptors on Peripheral Blood Mononuclear cells (Lymphocytes) [2].']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 107), ('PROBABLE_UNDERSTANDING', 113)]	3	[('CL_0000902', 'induced T-regulatory cell', 0, 'Immune Cell'), ('GO_0002121', 'inter-male aggressive behavior', 0, 'Immune Cell Differentiation ... Proliferation'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007093', 'mitotic cell cycle checkpoint signaling', 71, 'regulation of ... immune system'), ('UBERON_0002405', 'immune system', 89, 'immune system'), ('CHEBI_28384', 'vitamin K', 154, 'Vitamin D'), ('UBERON_0012101', 'perinatal stage', 177, 'peripheral blood'), ('CL_0000100', 'motor neuron', 194, 'mononuclear'), ('GO_0031097', 'medial cortex', 194, 'mononuclear'), ('CL_0000542', 'lymphocyte', 213, 'lymphocytes')]
PMC3277098	12/2011	S101-PMC3277098	['functional consequences of vdr polymorphisms MAY, THEREFORE, vary with the availability of Vitamin D to Tissues and become apparent, OR exaggerated, in an environment of Vitamin d deficiency, such as observed in the case of several infectious diseases [45,46].']	[('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 50), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('UBERON_0000479', 'tissue', 104, 'tissues'), ('CHEBI_33229', 'vitamin (role)', 170, 'vitamin')]
PMC3347007	4/2012	S11-PMC3347007	['dietary Vitamin D intake is very LIMITED and THEREFORE supplementation is NEEDED to avoid Vitamin D deficiency during sun-deprived periods.']	[('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 45), ('FUTURE_WORK', 74)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
PMC3347007	4/2012	S90-PMC3347007	['intakes below 0.1 µg MIGHT be subject to uncertainty and THEREFORE these were NOT CONSIDERED to be contributing to dietary Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 21), ('PROBABLE_UNDERSTANDING', 57), ('INCOMPLETE_EVIDENCE', 78)]	3	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC3347007	4/2012	S134-PMC3347007	['when the study was conducted there were no formal RECOMMENDATIONS from the danish national board of health on use of Vitamin D supplements during Pregnancy, and both the number of users and the supplement dose MAY THEREFORE be higher today.']	[('FUTURE_WORK', 50), ('INCOMPLETE_EVIDENCE', 210), ('PROBABLE_UNDERSTANDING', 214)]	3	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy')]
PMC3347007	4/2012	S155-PMC3347007	['OTHER STUDIES also FOUND that non-smokers had higher intakes of Vitamin D [19,29] and that non-smokers were more LIKELY to use vitamin D supplements [17,27].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 113)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 135, 'D')]
PMC3347007	4/2012	S156-PMC3347007	['smokers MIGHT be overall less health conscious and THEREFORE not aware of the IMPORTANCE of using Vitamin D supplements in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 78)]	3	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy')]
PMC3347007	4/2012	S157-PMC3347007	['in OTHER studies, overweight women HAVE BEEN FOUND to be less LIKELY to have sufficient Vitamin D intake and to use supplements [17,27,29].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 62)]	3	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC3347007	4/2012	S163-PMC3347007	['we also FOUND civil status to be non-significantly ASSOCIATED with Vitamin D intake, with single women being less LIKELY to have sufficient total Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBABLE_UNDERSTANDING', 114)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
PMC3347028	3/2012	S156-PMC3347028	['BECAUSE Vitamin D status has not been a consistent CONCERN during Pregnancy, long-term DATA are SPARSE.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 87)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy')]
PMC3348565	4/2012	S25-PMC3348565	['THEREFORE, Breastmilk, a normally POOR source of Vitamin D,11becomes EVEN more deficient.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 34), ('ANOMALY_CURIOUS_FINDING', 69)]	3	[('UBERON_0001348', 'brown adipose tissue', 11, 'breastmilk'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC3348565	4/2012	S67-PMC3348565	['given that 73% of children had Vitamin D deficiency in the study region in 2005,12and that the incidence of pneumonia was ten-times higher in vitamin d deficient children than in children without a deficiency in case-control studies1,2we POSTULATED that there WOULD BE AT LEAST a 35% reduction in pneumonia incidence in the Vitamin D compared with the placebo group.']	[('INCOMPLETE_EVIDENCE', 238), ('FUTURE_PREDICTION', 260), ('PROBABLE_UNDERSTANDING', 269)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 324, 'vitamin D')]
PMC3355895	1/2011	S4-PMC3355895	['THUS factors such as maternal lifestyle, diet, body build, physical activity, and Vitamin D status in Pregnancy all APPEAR to INFLUENCE offspring bone Mineral accrual.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 116), ('SUPERFICIAL_RELATIONSHIP', 126)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_46662', 'mineral', 151, 'mineral')]
PMC3355895	1/2011	S91-PMC3355895	['THUS, in populations in nutritional transition, where maternal sunlight exposure is sufficient to maintain adequate Vitamin D status, the availability of calcium becomes a more CRITICAL DETERMINANT of fetal and childhood bone Mineral accrual.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 177), ('SUPERFICIAL_RELATIONSHIP', 186)]	3	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_46662', 'mineral', 226, 'mineral')]
PMC3356951	4/2012	S7-PMC3356951	['AS few Foods contain Vitamin D, guidelines RECOMMENDED supplementation at SUGGESTED daily Intake and tolerable upper limit levels.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 43), ('INCOMPLETE_EVIDENCE', 74)]	3	[('CHEBI_33290', 'food', 7, 'foods'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007631', 'feeding behavior', 90, 'intake')]
PMC3356951	4/2012	S56-PMC3356951	["[52] Vitamin D content of Human Milk is RELATED to the mother's Vitamin D status; THEREFORE mothers who supplement with high doses of Vitamin D MAY have high levels of Vitamin D in their milk."]	[('SUPERFICIAL_RELATIONSHIP', 40), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 144)]	3	[('CHEBI_28384', 'vitamin K', 5, 'Vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 26, 'human'), ('UBERON_0001913', 'milk', 32, 'milk'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
PMC3356951	4/2012	S59-PMC3356951	['their skin cannot synthesize Vitamin D as efficiently, they are LIKELY to spend more time indoors, and they MAY have INADEQUATE intakes of the Vitamin.']	[('PROBABLE_UNDERSTANDING', 64), ('INCOMPLETE_EVIDENCE', 108), ('IMPORTANT_CONSIDERATION', 117)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 143, 'vitamin')]
PMC3356951	4/2012	S92-PMC3356951	['[9] SINCE Vitamin D is fat soluble, orlistat and Cholestyramine CAN reduce its absorption and SHOULD BE taken several hours apart from it.']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 64), ('FUTURE_WORK', 94)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_3647', 'chlorpromazine', 49, 'Cholestyramine')]
PMC3356951	4/2012	S111-PMC3356951	['[85]\n\nobesity\nlow concentrations of circulating Vitamin D are common with obesity and MAY represent a POTENTIAL mechanism EXPLAINING the elevated risk of certain cancers and Cardiovascular outcomes.']	[('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 122)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 174, 'cardiovascular')]
PMC3356951	4/2012	S174-PMC3356951	['very few Foods contain Vitamin D THEREFORE GUIDELINES RECOMMENDED supplementation of Vitamin D at tolerable ul levels.']	[('PROBABLE_UNDERSTANDING', 33), ('PROBABLE_UNDERSTANDING', 43), ('FUTURE_WORK', 54)]	3	[('CHEBI_33290', 'food', 9, 'foods'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC3395583	7/2012	S87-PMC3395583	['NOTABLY, Vitamin D Production is strictly DEPENDENT on uvb radiation and Vitamin D levels THEREFORE follow a seasonal distribution [23].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 90)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 9, 'vitamin D production'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
PMC3407995	7/2012	S82-PMC3407995	['the MAJORITY of circulating Vitamin D, known as Serum 25-Hydroxyvitamin D [25(Oh)D] that is NECESSARY to maintain health and function of the Immune, Reproductive, Muscular, Skeletal and Integumentary System, originates from Vitamin D3 (Cholecalciferol) and REFLECTS endogenous synthesis from exposure to sunlight as well as Intake from the diet [46].']	[('PROBABLE_UNDERSTANDING', 4), ('IMPORTANT_CONSIDERATION', 92), ('SUPERFICIAL_RELATIONSHIP', 257)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001977', 'blood serum', 48, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 54, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 75, '25(OH)D'), ('UBERON_0002405', 'immune system', 141, 'immune ...'), ('GO_0000003', 'reproduction', 149, 'reproductive'), ('UBERON_0022230', 'retrohippocampal region', 149, 'reproductive ...'), ('UBERON_0004469', 'musculature of back', 163, 'muscular ...'), ('UBERON_0004288', 'skeleton', 173, 'skeletal'), ('UBERON_0002416', 'integumental system', 186, 'integumentary system'), ('CHEBI_33279', 'vitamin D5', 224, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 224, 'vitamin D3'), ('CHEBI_52550', 'theopalauamide', 236, 'cholecalciferol'), ('GO_0007631', 'feeding behavior', 324, 'intake')]
PMC3407995	7/2012	S438-PMC3407995	['data from four trials involving 414 women CONSISTENTLY SHOWED that women who received Vitamin D supplements during Pregnancy had higher concentrations of Vitamin D in Serum at term than those women who received no intervention or a placebo; HOWEVER the magnitude of the response was highly heterogenous.']	[('PROBABLE_UNDERSTANDING', 42), ('INCOMPLETE_EVIDENCE', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 241)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0001977', 'blood serum', 167, 'serum')]
PMC3409554	7/2012	S111-PMC3409554	['CONSEQUENTLY, Ferrous Iron supplements SHOULD BE taken between meals, preferably with fruit juice containing Vitamin C [38], which enhances absorption, WHEREAS Milk, coffee, and tea inhibit absorption.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152)]	3	[('CHEBI_5014', 'fenvalerate', 14, 'ferrous iron'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin C'), ('UBERON_0001913', 'milk', 160, 'milk')]
PMC3424155	8/2012	S18-PMC3424155	['moreover, Vitamin D is ASSOCIATED with premature births, obesity and Renal dysfunction in Adulthood, making it more than an ESSENTIAL fat-soluble Vitamin RESPONSIBLE for calcium Metabolism[9],[10].']	[('SUPERFICIAL_RELATIONSHIP', 23), ('IMPORTANT_CONSIDERATION', 124), ('PROBABLE_UNDERSTANDING', 154)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0002113', 'kidney', 69, 'renal'), ('UBERON_0000113', 'post-juvenile adult stage', 90, 'adulthood'), ('CHEBI_33229', 'vitamin (role)', 146, 'vitamin'), ('GO_0008152', 'metabolic process', 178, 'metabolism')]
PMC3424155	8/2012	S189-PMC3424155	['maternal Vitamin D deficiency MAY also have CONTRIBUTED to an increased number of Glomeruli, THUS producing smaller Glomeruli than in Animals Fed sc.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 44), ('PROBABLE_UNDERSTANDING', 93)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('UBERON_0000074', 'renal glomerulus', 82, 'glomeruli'), ('UBERON_0000074', 'renal glomerulus', 116, 'glomeruli'), ('NCBITaxon_33208', 'Metazoa', 134, 'animals'), ('GO_0007631', 'feeding behavior', 142, 'fed')]
PMC3427250	8/2012	S120-PMC3427250	['in the ABSENCE OF survey data from other european countries, we SUSPECT that the prevalence of Vitamin D deficiency in belgium LIKELY reflects the situation in other western european countries.']	[('FULL_UNKNOWN', 7), ('PROBABLE_UNDERSTANDING', 64), ('PROBABLE_UNDERSTANDING', 127)]	3	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC3427250	8/2012	S126-PMC3427250	['THEREFORE, there is an URGENT NEED of randomised controlled trials of Vitamin D supplementation to investigate the maternal and neonatal health benefits of correcting Vitamin D deficiency during Pregnancy[24].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 23), ('FUTURE_WORK', 30)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy')]
PMC3470091	9/2012	S16-PMC3470091	['SINCE, fetus and baby are both DEPENDENT upon mother for Blood and milk respectively, mother’s Vitamin D supplementation is highly VITAL.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('IMPORTANT_CONSIDERATION', 131)]	3	[('UBERON_0000178', 'blood', 57, 'blood'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
PMC3471827	10/2012	S131-PMC3471827	['ALTHOUGH the Α-Tocopherol concentration of the e- Embryos was >50-fold decreased from the control Embryos, they STILL possessed detectable amounts of Vitamin E. this is LIKELY due to the specific allocation of maternal Vitamin E, and its incorporation into the Yolk of the developing Oocyte.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 112), ('PROBABLE_UNDERSTANDING', 169)]	3	[('CHEBI_27725', 'butin', 13, 'α-tocopherol'), ('UBERON_0000922', 'embryo', 50, 'embryos'), ('UBERON_0000922', 'embryo', 98, 'embryos'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin E'), ('UBERON_2000084', 'yolk', 261, 'yolk'), ('CL_0000023', 'oocyte', 284, 'oocyte')]
PMC3471827	10/2012	S135-PMC3471827	['NOTABLY, as morphologic outcomes from each study are ultimately due to Vitamin E deficiency, they LIKELY INVOLVE common mechanisms.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 105)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin E')]
PMC3472720	8/2012	S14-PMC3472720	['BASED ON findings from epidemiology, we predicted that offspring exposed to low Prenatal Vitamin D would be at INCREASED RISK of ms.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('IMPORTANT_CONSIDERATION', 111)]	3	[('GO_0007565', 'female pregnancy', 80, 'prenatal'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC3501517	11/2012	S209-PMC3501517	['one POSSIBLE EXPLANATION for altered Kc/Cxcl1 responsiveness in vdd Mice in the absence of reduced Expression of Cxcr2 MAY BE Vitamin D-dependent post-Translational modifications to Cxcr2.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 119)]	3	[('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 37, 'KC'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 40, 'CXCL1'), ('NCBITaxon_10088', 'Mus <genus>', 68, 'mice'), ('GO_0010467', 'gene expression', 99, 'expression'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 113, 'CXCR2'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0006412', 'translation', 151, 'translational'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 182, 'CXCR2')]
PMC3515553	12/2012	S14-PMC3515553	['BECAUSE of the transfer from mother to offspring of Vitamin B-12 during Pregnancy and Lactation, maternal REQUIREMENTS during these periods are increased and deficiency CAN occur[5].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 106), ('INCOMPLETE_EVIDENCE', 169)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 52, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('GO_0007595', 'lactation', 86, 'lactation')]
PMC3515553	12/2012	S96-PMC3515553	['Maternal rs9606756/rs1801198 Haplotypes carrying at least one PUTATIVE Vitamin B-12 increasing Allele showed higher Cord Blood Vitamin B-12 compared to the Haplotype carrying both Alleles PREVIOUSLY ASSOCIATED with elevated Hcy and lower Vitamin B-12 concentrations (ag, i.e.']	[('PROBABLE_UNDERSTANDING', 62), ('INCOMPLETE_EVIDENCE', 188), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('SO_0001024', 'haplotype', 29, 'haplotypes'), ('CHEBI_85855', 'diacylglycerol 46:7', 71, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 71, 'vitamin B-12'), ('SO_0001023', 'allele', 95, 'allele'), ('UBERON_0009472', 'axilla', 116, 'cord blood'), ('CHEBI_85855', 'diacylglycerol 46:7', 127, 'vitamin B-12'), ('PR_000017269', 'ventral anterior homeobox 2', 127, 'vitamin B-12'), ('SO_0001024', 'haplotype', 156, 'haplotype'), ('SO_0001023', 'allele', 180, 'alleles'), ('CHEBI_37958', 'dye', 224, 'Hcy'), ('PR_000008443', 'huntingtin-associated protein 1', 224, 'Hcy'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 238, 'vitamin B-12')]
PMC3515553	12/2012	S151-PMC3515553	['HOWEVER, the MAJORITY of the children with Cord Blood Vitamin B-12 measures in OUR STUDY were not Vitamin B-12 deficient.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 79)]	3	[('UBERON_0009472', 'axilla', 43, 'cord blood'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 54, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 98, 'vitamin B-12')]
PMC3515553	12/2012	S152-PMC3515553	['it is also LIKELY that we DID NOT have enough statistical power in our analysis to identify an EFFECT of Vitamin B-12 on iq in children.']	[('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 105, 'vitamin B-12')]
PMC3585741	1/2013	S135-PMC3585741	['finally, all the other Nutrients listed (except Vitamin D and zinc) SHOWED an overall nonsignificant TREND for those Consuming below rda levels to be more LIKELY to have epds ≥10 (see table\xa02).']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 101), ('PROBABLE_UNDERSTANDING', 155)]	3	[('CHEBI_33284', 'nutrient', 23, 'nutrients'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007631', 'feeding behavior', 117, 'consuming')]
PMC3586494	2/2013	S120-PMC3586494	['in comparing Vitamin levels in term and preterm infants, term babies had significantly higher levels of Vitamins A, C, and e. the authors concluded that for Vitamins A and E, neonatal levels are DEPENDENT on maternal levels and that preterm babies have fewer Lipid-soluble antioxidant Vitamins in their Serum compared to term infants THUS MAY BE more susceptible to oxidative stress [52].']	[('SUPERFICIAL_RELATIONSHIP', 195), ('PROBABLE_UNDERSTANDING', 334), ('INCOMPLETE_EVIDENCE', 339)]	3	[('CHEBI_33229', 'vitamin (role)', 13, 'vitamin'), ('CHEBI_27300', 'vitamin D', 104, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 104, 'vitamins A'), ('PR_000004900', 'complement C3', 116, 'C'), ('CHEBI_27300', 'vitamin D', 157, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 166, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 172, 'E'), ('CHEBI_18059', 'lipid', 259, 'lipid'), ('CHEBI_33277', 'gamma-tocotrienol', 285, 'vitamins'), ('UBERON_0001977', 'blood serum', 303, 'serum')]
PMC3629265	4/2013	S68-PMC3629265	['it SEEMS UNLIKELY that infants in the first few months of Life would drink 2 l of formula/day, the volume NECESSARY to receive 800 iu/day of Vitamin D. four of our cases presented during the autumn and winter months, the other two infants presented during the early spring.']	[('ANOMALY_CURIOUS_FINDING', 3), ('PROBABLE_UNDERSTANDING', 9), ('IMPORTANT_CONSIDERATION', 106)]	3	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3629265	4/2013	S78-PMC3629265	['these FACTORS CONTRIBUTE to Vitamin D deficiency in the mothers, and THEREFORE, poor Placental transfer to the infant (28).']	[('SUPERFICIAL_RELATIONSHIP', 6), ('SUPERFICIAL_RELATIONSHIP', 14), ('PROBABLE_UNDERSTANDING', 69)]	3	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001987', 'placenta', 85, 'placental')]
PMC3629265	4/2013	S82-PMC3629265	['given the young age of the cases presented (mean age 30 days), maternal Vitamin D deficiency is LIKELY a MAJOR contributing FACTOR in all the cases presented.']	[('PROBABLE_UNDERSTANDING', 96), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 124)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC3651971	5/2013	S100-PMC3651971	['fifty-five per cent of children in both groups were stunted, SUGGESTING comparable levels of chronic undernutrition, ALTHOUGH children Born to mothers in the placebo group had a lower prevalence of anaemia (26% vs 36.6%, p=0.03) and lower exposure to adequately Iodised Salt in their home, BASED ON tested concentrations of ≥30\u2005ppm (78% vs 85.7%, p=0.05), than in the Vitamin A group.']	[('INCOMPLETE_EVIDENCE', 61), ('ANOMALY_CURIOUS_FINDING', 117), ('PROBABLE_UNDERSTANDING', 290)]	3	[('GO_0007567', 'parturition', 135, 'born'), ('CHEBI_24859', 'iodine atom', 262, 'iodised salt'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin A')]
PMC3659910	1/2013	S7-PMC3659910	['THEREFORE, PREVENTION of Vitamin D deficiency among Pregnant women is ESSENTIAL.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 11), ('IMPORTANT_CONSIDERATION', 70)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnant')]
PMC3659910	1/2013	S24-PMC3659910	['modern day cosmetology and our urbanization has eclipsed the sunlight and it is IMPOSSIBLE is to fulfill daily Intake via diet AS a large amount of Vitamin D NEEDS to be Consumed.']	[('DIFFICULT_TASK', 80), ('PROBABLE_UNDERSTANDING', 127), ('IMPORTANT_CONSIDERATION', 158)]	3	[('GO_0007631', 'feeding behavior', 111, 'intake'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('GO_0007631', 'feeding behavior', 170, 'consumed')]
PMC3659910	1/2013	S36-PMC3659910	['BECAUSE of its Steroid structure and function, Vitamin D plays an IMPORTANT ROLE in priming cells for other hormones to do their action.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 66), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('CHEBI_35341', 'steroid', 15, 'steroid'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
PMC3659910	1/2013	S45-PMC3659910	['IT IS CLEAR, HOWEVER, that Vitamin D REQUIREMENTS are increased in mothers during Pregnancy and Lactation.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('IMPORTANT_CONSIDERATION', 37)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0007595', 'lactation', 96, 'lactation')]
PMC3659910	1/2013	S55-PMC3659910	['[12] Vitamin D deficiency CAN result in lower bone Mineral density and an INCREASED RISK of bone loss (osteoporosis) or bone fracture BECAUSE a lack of Vitamin D alters Mineral Metabolism in the body.']	[('INCOMPLETE_EVIDENCE', 26), ('IMPORTANT_CONSIDERATION', 74), ('PROBABLE_UNDERSTANDING', 134)]	3	[('CHEBI_28384', 'vitamin K', 5, 'Vitamin D'), ('CHEBI_46662', 'mineral', 51, 'mineral'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('CHEBI_46662', 'mineral', 169, 'mineral'), ('GO_0008152', 'metabolic process', 177, 'metabolism')]
PMC3659910	1/2013	S89-PMC3659910	['MOST Prenatal Vitamins have around 400 iu of Vitamin D, and MOST health groups RECOMMEND taking no more than 2,000 iu of the Vitamin in supplement form daily.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 60), ('FUTURE_WORK', 79)]	3	[('GO_0007565', 'female pregnancy', 5, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 14, 'vitamins'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 125, 'vitamin')]
PMC3659910	1/2013	S159-PMC3659910	['[4142] endocrine society issues practice guideline on Vitamin D and the GUIDELINE RECOMMEND that clinicians screen for Vitamin D deficiency in People AT RISK for deficiency, including obese Individuals, blacks, Pregnant and Lactating women, and patients with malabsorption syndromes.']	[('PROBABLE_UNDERSTANDING', 72), ('FUTURE_WORK', 82), ('IMPORTANT_CONSIDERATION', 150)]	3	[('CHEBI_28384', 'vitamin K', 54, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 143, 'people'), ('NCBITaxon_1', 'root', 190, 'individuals'), ('GO_0007565', 'female pregnancy', 211, 'pregnant'), ('GO_0007594', 'puparial adhesion', 224, 'lactating')]
PMC3659910	1/2013	S167-PMC3659910	['MOST EXPERTS agree that Serum Vitamin D levels below 50 nmol/l (20 ng/ml) REPRESENT deficiency.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 5), ('PROBABLE_UNDERSTANDING', 74)]	3	[('UBERON_0001977', 'blood serum', 24, 'serum'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC3668200	5/2013	S14-PMC3668200	['at high-latitude areas, conditions of low uv-b radiation EFFECTIVELY facilitate Vitamin D Production in Humans with light skin color, THEREBY PREVENTING Vitamin D deficiency7).']	[('IMPORTANT_CONSIDERATION', 57), ('PROBABLE_UNDERSTANDING', 134), ('SUPERFICIAL_RELATIONSHIP', 142)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 80, 'vitamin D production'), ('NCBITaxon_9606', 'Homo sapiens', 104, 'humans'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC3668200	5/2013	S21-PMC3668200	['although an infant is formula Fed, it cannot be automatically ASSUMED that the infant is adequately supplied with Vitamin D. the daily amount of formula Feeding SHOULD BE taken INTO CONSIDERATION.']	[('PROBABLE_UNDERSTANDING', 62), ('FUTURE_WORK', 161), ('IMPORTANT_CONSIDERATION', 177)]	3	[('GO_0007631', 'feeding behavior', 30, 'fed'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007631', 'feeding behavior', 153, 'feeding')]
PMC3668200	5/2013	S27-PMC3668200	['THEREFORE, IT IS POSSIBLE that EVEN formula-Fed young infants are Vitamin D deficient.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('ANOMALY_CURIOUS_FINDING', 31)]	3	[('GO_0007631', 'feeding behavior', 44, 'fed'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC3668200	5/2013	S42-PMC3668200	['NEVERTHELESS, it is NOTEWORTHY that infants Born to unsupplemented Vitamin D-deficient mothers were LIKELY to have early Vitamin D deficiency compared with those whose mothers were supplemented with Vitamin D during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 20), ('PROBABLE_UNDERSTANDING', 100)]	3	[('GO_0007567', 'parturition', 44, 'born'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy')]
PMC3668200	5/2013	S50-PMC3668200	['with respect to Prenatal supplementation, the GENERALLY prescribed daily intake of 400 iu of Vitamin D is NOT sufficient to achieve the OPTIMAL Vitamin D status in newborns18).']	[('PROBABLE_UNDERSTANDING', 46), ('ANOMALY_CURIOUS_FINDING', 106), ('IMPORTANT_CONSIDERATION', 136)]	3	[('GO_0007565', 'female pregnancy', 16, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC3672018	5/2013	S18-PMC3672018	['CONSEQUENTLY, low Vitamin D INFLUENCES bone health, body growth and composition, and also IMPACTS on immunity [3,4].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 90)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC3672018	5/2013	S31-PMC3672018	['Pregnancy is a time of particular SUSCEPTIBILITY to Vitamin D deficiency, AS both maternal and fetal demands for the Vitamin NEED to be met [11,12].']	[('IMPORTANT_CONSIDERATION', 34), ('PROBABLE_UNDERSTANDING', 74), ('IMPORTANT_CONSIDERATION', 125)]	3	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 117, 'vitamin')]
PMC3672018	5/2013	S178-PMC3672018	['it THUS allows examination of the EFFECTS of low Vitamin D during fetal Life in RELATION to later development of particular diseases.']	[('PROBABLE_UNDERSTANDING', 3), ('SUPERFICIAL_RELATIONSHIP', 34), ('SUPERFICIAL_RELATIONSHIP', 80)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 72, 'life')]
PMC3695234	7/2013	S12-PMC3695234	['THUS, these data SUGGEST a ROLE for Vitamin D in a select group of ad patients.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 27)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC3695234	7/2013	S55-PMC3695234	['there are several biologically PLAUSIBLE EXPLANATIONS for the inverse CORRELATION between Serum Vitamin D and the presence of ad.']	[('INCOMPLETE_EVIDENCE', 31), ('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('UBERON_0001977', 'blood serum', 90, 'serum'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]
PMC3702339	6/2013	S15-PMC3702339	['the world health organization (who) defines Vitamin A deficiency (vad) AS Tissue concentrations of Vitamin A (Va) low enough to have adverse health consequences, EVEN IF there is no evidence of clinical deficiency (3).']	[('PROBABLE_UNDERSTANDING', 71), ('ANOMALY_CURIOUS_FINDING', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('UBERON_0000479', 'tissue', 74, 'tissue'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin A'), ('CHEBI_37958', 'dye', 110, 'VA')]
PMC3713405	7/2013	S95-PMC3713405	['THUS at both the cellular and transcriptional levels, Vitamin D APPEARS fundamentally INVOLVED in the rate of Proliferation and Cell Death in the Brain.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 64), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0008283', 'cell proliferation', 110, 'proliferation'), ('GO_0008219', 'cell death', 128, 'cell death'), ('UBERON_0000955', 'brain', 146, 'brain')]
PMC3717170	5/2013	S146-PMC3717170	['this is a topic of clinical significance BECAUSE myopathy characterized by proximal muscle weakness and atrophy is a common symptom in Vitamin D deficiency states.40the loss of muscular strength and a reduction in muscle mass increases the RISK of falls and LEADS to fractures.']	[('PROBABLE_UNDERSTANDING', 41), ('IMPORTANT_CONSIDERATION', 240), ('SUPERFICIAL_RELATIONSHIP', 258)]	3	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D')]
PMC3717170	5/2013	S175-PMC3717170	['INTERESTINGLY, vdr Expression in Human muscle Tissue decreases with Aging, and Vitamin D level is STRONGLY CORRELATED with muscle quality and lower muscle fat infiltration.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('GO_0010467', 'gene expression', 19, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 33, 'human'), ('UBERON_0000479', 'tissue', 46, 'tissue'), ('GO_0007568', 'aging', 68, 'aging'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC3773018	4/2013	S35-PMC3773018	['we grouped the children according to longitudinal trajectory of 25(Oh)D based on if a child had: 1) low Vitamin D status at Birth (< 11ng/ml) AS SUGGESTED by the institute of medicine (26) or 2) low Postnatal Vitamin D status (< 30ng/ml) ACCORDING TO the Endocrine society clinical practice guidelines on Vitamin D insufficiency (27,28).']	[('PROBABLE_UNDERSTANDING', 142), ('INCOMPLETE_EVIDENCE', 145), ('INCOMPLETE_EVIDENCE', 238)]	3	[('CHEBI_71657', 'versiconol acetate', 64, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 64, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007567', 'parturition', 124, 'birth'), ('GO_0007567', 'parturition', 199, 'postnatal'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 255, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 305, 'Vitamin D')]
PMC3773018	4/2013	S64-PMC3773018	['the MAJORITY of the Vitamin D REQUIREMENT for MOST People in the u.s. is achieved through both sun exposure and fortified Food or Vitamin D nutritional supplements.']	[('PROBABLE_UNDERSTANDING', 4), ('IMPORTANT_CONSIDERATION', 30), ('PROBABLE_UNDERSTANDING', 46)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 51, 'people'), ('CHEBI_33290', 'food', 122, 'food'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
PMC3798907	8/2013	S3-PMC3798907	['IN GENERAL, Vitamin E supplementation was ASSOCIATED with a TREND for reduced proliferative responses after stimulation with Antigens and house dust mite, and with increased Proliferation after stimulation with timothy grass allergen.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 60)]	3	[('CHEBI_27300', 'vitamin D', 12, 'vitamin E'), ('CHEBI_59132', 'antigen', 125, 'antigens'), ('GO_0008283', 'cell proliferation', 174, 'proliferation')]
PMC3798907	8/2013	S14-PMC3798907	['three Birth cohort studies HAVE REPORTED reduced maternal dietary Vitamin E intake during Pregnancy to be ASSOCIATED with an increased LIKELIHOOD of childhood wheezing [9,10] and asthma [11].']	[('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 106), ('PROBABLE_UNDERSTANDING', 135)]	3	[('GO_0007567', 'parturition', 6, 'birth'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin E'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy')]
PMC3798907	8/2013	S70-PMC3798907	['HOWEVER, just as for cbmc, there was a TREND for GENERALLY enhanced secretion of the Regulatory cytokine Tgf-Β when pbmc were supplemented with Vitamin E, and these increases were significant in the cultures responding to con a (13 of 17 cultures exhibiting an increase) or hdm, (13 of 17 cultures exhibiting an increase) (figure 2andtable 1).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('PROBABLE_UNDERSTANDING', 49)]	3	[('GO_0065007', 'biological regulation', 85, 'regulatory'), ('PR_000000046', 'TGF-beta', 105, 'TGF-β'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin E')]
PMC3798907	8/2013	S75-PMC3798907	['the TREND for enhanced Tgf-Β Responses after Vitamin E supplementation was NOT REPLICATED for Vitamin C, which GENERALLY reduced Production Of this Regulatory Cytokine, (figure 3andtable 1).']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 111)]	3	[('GO_0033077', 'T cell differentiation in thymus', 23, 'TGF-β responses'), ('PR_000000046', 'TGF-beta', 23, 'TGF-β'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin C'), ('GO_0008283', 'cell proliferation', 129, 'production of ...'), ('GO_0043654', 'recognition of apoptotic cell', 148, 'regulatory cytokine')]
PMC3809191	1/2013	S17-PMC3809191	['Serum 25 (Oh) D levels ≤20 ng/ml are ACCEPTED AS the cutoff level for Vitamin D deficiency SINCE this level was the highest level to maintain the Serum pth levels below 45 pg/ml.']	[('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 46), ('PROBABLE_UNDERSTANDING', 91)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25 (OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 6, '25 (OH) D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0001977', 'blood serum', 146, 'serum')]
PMC3814422	10/2013	S13-PMC3814422	['studies of maternal dietary Intake have MOSTLY REPORTED inverse RELATIONSHIPS between maternal Vitamin D intake in Pregnancy and early childhood wheeze, asthma, allergic rhinitis and eczema8–10.']	[('INCOMPLETE_EVIDENCE', 40), ('PROBABLE_UNDERSTANDING', 40), ('SUPERFICIAL_RELATIONSHIP', 64)]	3	[('GO_0007631', 'feeding behavior', 28, 'intake'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy')]
PMC3821254	4/2013	S70-PMC3821254	['[12] vitamin p ENHANCES the action of Vitamin C and for this REASON they SHOULD BE taken together.']	[('INCOMPLETE_EVIDENCE', 15), ('PROBABLE_UNDERSTANDING', 61), ('FUTURE_WORK', 73)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin C')]
PMC3827489	10/2013	S20-PMC3827489	['IN LIGHT OF the near universal Expression of the vdr across Tissues, Vitamin D would be expected to play a ROLE in diseases OTHER than those of bone.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 107), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124)]	3	[('GO_0010467', 'gene expression', 31, 'expression'), ('UBERON_0000479', 'tissue', 60, 'tissues'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC3827489	10/2013	S80-PMC3827489	['the inverse ASSOCIATION between higher body fat and low Vitamin D concentrations MAY BE ASCRIBED to Sequestration Of the fat-soluble Vitamin D within Adipose Tissues57).']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 81), ('PROBABLE_UNDERSTANDING', 88)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0051610', 'serotonin uptake', 100, 'sequestration of ... vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('UBERON_0007149', 'inferior thyroid artery', 150, 'adipose tissues57')]
PMC3873449	12/2013	S17-PMC3873449	['adequate 25(Oh)D levels are particularly IMPORTANT for women who Become Pregnant, BECAUSE mothers HAVE to sustain their own Vitamin D stores as well as those of their fetuses [2,3].']	[('IMPORTANT_CONSIDERATION', 41), ('PROBABLE_UNDERSTANDING', 82), ('IMPORTANT_CONSIDERATION', 98)]	3	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('GO_0007567', 'parturition', 65, 'become'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC3873449	12/2013	S92-PMC3873449	['the prevalence of Vitamin D deficiency (25(Oh)D < 50 nmol/l ) was 96.8% and no women had Serum 25(Oh)D concentrations ≥ 75 nmol/l which is CONSIDERED AS an OPTIMAL level.10.1371/journal.pone.0085081.t001\n\ncaption (table-wrap): table 1\nprevalence of Vitamin D deficiency and insufficiency in Pregnant women.25(Oh)D levelsnumber%severe deficiency5644.8(< 25 nmol/l )mild deficiency6552.0(25- < 50 nmol/l)insufficiency43.2(50 - < 75 nmol/l)sufficiency00.0(≥75 nmol/l)total125100.0\n\nmaternal characteristics and Vitamin D status\nmaternal characteristics, stratified by Vitamin D status, are shown intable 2.']	[('IMPORTANT_CONSIDERATION', 139), ('PROBABLE_UNDERSTANDING', 150), ('IMPORTANT_CONSIDERATION', 156)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 40, '25('), ('PR_000006444', 'diacylglycerol kinase delta', 46, 'D'), ('UBERON_0001977', 'blood serum', 89, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 98, 'OH)D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('GO_0007565', 'female pregnancy', 291, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 306, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 508, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 565, 'vitamin D')]
PMC3873449	12/2013	S135-PMC3873449	['THEREFORE it is NECESSARY to educate People about the knowledge of Vitamin D, ESPECIALLY for Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 16), ('IMPORTANT_CONSIDERATION', 78)]	3	[('NCBITaxon_10088', 'Mus <genus>', 37, 'people'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnant')]
PMC3873449	12/2013	S167-PMC3873449	['women in beijing can not produce enough Vitamin D through sunshine exposure in winter DUE TO multiple FACTORS.']	[('PROBABLE_UNDERSTANDING', 86), ('PROBLEM_COMPLICATION', 86), ('SUPERFICIAL_RELATIONSHIP', 102)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
PMC3888066	12/2012	S3-PMC3888066	['THEREFORE, there MAY BE a narrow therapeutic ratio for Vitamin A during Pregnancy that has not PREVIOUSLY been fully appreciated.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin A'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy')]
PMC3888066	12/2012	S41-PMC3888066	['the amount of Vitamin A in the Liver varies between species, but it is not a common Food in a regular diet and is, THEREFORE, UNLIKELY alone to be ASSOCIATED with Teratogenic Retinoic Acid levels.']	[('PROBABLE_UNDERSTANDING', 115), ('PROBABLE_UNDERSTANDING', 126), ('SUPERFICIAL_RELATIONSHIP', 147)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin A'), ('UBERON_0002107', 'liver', 31, 'liver'), ('CHEBI_33290', 'food', 84, 'food'), ('CHEBI_50905', 'teratogenic agent', 163, 'teratogenic'), ('GO_0031649', 'heat generation', 163, 'teratogenic'), ('CHEBI_26536', 'retinoic acid', 175, 'retinoic acid')]
PMC3991049	11/2013	S67-PMC3991049	['the IMPORTANCE of Vitamin D for fetal and infant Skeletal Development HAS LONG BEEN RECOGNIZED.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 74)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0001501', 'skeletal system development', 49, 'skeletal development'), ('UBERON_0004288', 'skeleton', 49, 'skeletal')]
PMC4045304	2/2014	S205-PMC4045304	['heritability of autism MAY BE EXPLAINED by quantitative Genetic variations in SOME facet of Vitamin D Metabolism, such as vdr or in the enzymes that activate Vitamin D [86].']	[('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 30), ('INCOMPLETE_EVIDENCE', 78)]	3	[('SO_0000704', 'gene', 56, 'genetic'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 92, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC4072587	6/2014	S149-PMC4072587	['TO OUR KNOWLEDGE, OUR STUDY is the largest and MOST COMPREHENSIVE study on maternal Vitamin D status to be conducted in vietnam.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('PROBABLE_UNDERSTANDING', 47)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
PMC4113768	7/2014	S101-PMC4113768	['Cyp2R1 and Cyp24A1 are capable of the 25-hydroxylation and 24-Hydroxylation, respectively, of Vitamin D. IT IS REPORTED that different Single Nucleotide Polymorphisms of Cyp2R1 and Cyp24A1 are ASSOCIATED with the 25(Oh)D status (wang, t.j., et al.']	[('PROBABLE_UNDERSTANDING', 105), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 193)]	3	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 0, 'CYP2R1'), ('PR_000006101', 'cytochrome P450 1A1', 11, 'CYP24A1'), ('GO_0006298', 'mismatch repair', 59, '24-hydroxylation'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('SO_0000694', 'SNP', 135, 'single nucleotide polymorphisms'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 170, 'CYP2R1'), ('PR_000006101', 'cytochrome P450 1A1', 181, 'CYP24A1'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D')]
PMC4113768	7/2014	S457-PMC4113768	['our data do not THEREFORE SUPPORT a ROLE for Vitamin D in protection against foetal Lateral Ventriculomegaly.']	[('PROBABLE_UNDERSTANDING', 16), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 36)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001359', 'cerebrospinal fluid', 84, 'lateral ventriculomegaly')]
PMC4113768	7/2014	S462-PMC4113768	['Retinol-x receptors heterodimerize with Retinol-A receptors and the availability of rxr falls in the presence of excessive Vitamin A. westernized populations OFTEN ingest more Vitamin a than is ADVISABLE and up to 30% have circulating concentrations above the recommended maximum level (e.g., in nhanes111).']	[('PROBABLE_UNDERSTANDING', 158), ('FUTURE_WORK', 194), ('IMPORTANT_CONSIDERATION', 194)]	3	[('CHEBI_27810', 'resorcinol', 0, 'Retinol'), ('CHEBI_26536', 'retinoic acid', 40, 'retinol'), ('PR_000004370', 'asialoglycoprotein receptor 2', 48, 'A'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 176, 'vitamin')]
PMC4113768	7/2014	S712-PMC4113768	['subjects in each cohort were classified as having optimal or suboptimal Vitamin D status BASED on a cut-off of 30 ng/ml AS recommended by many EXPERTS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 89), ('PROBABLE_UNDERSTANDING', 120), ('PROBABLE_UNDERSTANDING', 143)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4113768	7/2014	S835-PMC4113768	['only 40% women could give a REASON WHY Vitamin D supplements were IMPORTANT- all of them had taken Supplements.']	[('PROBABLE_UNDERSTANDING', 28), ('EXPLICIT_QUESTION', 35), ('IMPORTANT_CONSIDERATION', 66)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 99, 'supplements')]
PMC4113768	7/2014	S939-PMC4113768	['background: older authors from AT LEAST 1906 onwards were CLEAR that Vitamin D deficiency rickets COULD cause fractures.']	[('PROBABLE_UNDERSTANDING', 31), ('PROBABLE_UNDERSTANDING', 58), ('INCOMPLETE_EVIDENCE', 98)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4113768	7/2014	S963-PMC4113768	['logistic regression was used TO IDENTIFY environmental and Genetic factors independently ASSOCIATED with risk of Vitamin D deficiency DEFINED as Serum 25(Oh)D concentration <50 nmol/l.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('SUPERFICIAL_RELATIONSHIP', 89), ('PROBABLE_UNDERSTANDING', 134)]	3	[('SO_0000704', 'gene', 59, 'genetic'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0001977', 'blood serum', 145, 'serum'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 151, '25(OH ... D')]
PMC4113768	7/2014	S1743-PMC4113768	['in this study, f25ohd and gc-f25ohd, AS ESTIMATES of 25Ohd availability, DID NOT predict Vitamin D usage as assessed by 25ohd3half-life.']	[('PROBABLE_UNDERSTANDING', 37), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 73)]	3	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 53, '25OHD'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4113768	7/2014	S1852-PMC4113768	['moreover, it HAS BEEN RECOGNIZED that Vitamin D has a WIDE RANGE of biological functions, including Cell Differentiation, inhibition of cell growth and Regulation Of Gene Expression.']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54)]	3	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0030154', 'cell differentiation', 100, 'cell differentiation'), ('GO_0010468', 'regulation of gene expression', 152, 'regulation of gene expression'), ('SO_0000704', 'gene', 166, 'gene')]
PMC4113768	7/2014	S1969-PMC4113768	['BECAUSE of the IMPORTANCE of Vitamin D for many functions in the Human body and the limited Vitamin D synthesis in the skin between october and april; it is IMPORTANT to have another source of Vitamin D during these months.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 15), ('IMPORTANT_CONSIDERATION', 157)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 65, 'human'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D')]
PMC4113768	7/2014	S2367-PMC4113768	['increased Vitamin D supplementation is THUS RECOMMENDED to maintain OPTIMAL Serum 25(Oh) Vitamin D levels during the summer season.']	[('PROBABLE_UNDERSTANDING', 39), ('FUTURE_WORK', 44), ('IMPORTANT_CONSIDERATION', 68)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_30778', 'gallic acid', 82, '25(OH)'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4113768	7/2014	S2447-PMC4113768	['; macdonald, h.m.\nbackground: it HAS BEEN ASSUMED that most of the population in the uk obtain sufficient Vitamin D from casual exposure to summer sunlight.']	[('INCOMPLETE_EVIDENCE', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('PROBABLE_UNDERSTANDING', 42)]	3	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4113768	7/2014	S2587-PMC4113768	['in denmark, THEREFORE, national programs for Food fortification with Vitamin D are CONSIDERED.']	[('PROBABLE_UNDERSTANDING', 12), ('FUTURE_WORK', 83), ('IMPORTANT_CONSIDERATION', 83)]	3	[('CHEBI_33290', 'food', 45, 'food'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC4113768	7/2014	S2692-PMC4113768	['there was a RELATIONSHIP between Vitamin D status and ethnicity for Serum and dbs samples ( p< 0.001 and p< 0.001 respectively) with caucasians more LIKELY to have an adequate status and asians more LIKELY to be severely deficient.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('PROBABLE_UNDERSTANDING', 149), ('PROBABLE_UNDERSTANDING', 199)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001977', 'blood serum', 68, 'serum')]
PMC4161853	8/2014	S214-PMC4161853	['HENCE, Vitamin A plays an IMPORTANT ROLE in the Intestinal Immune System as a source of Retinoic Acid (Ra), a Gut-homing factor for Iga Secreting cells in Intestinal Mucosa [117,118].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 36)]	3	[('CHEBI_27300', 'vitamin D', 7, 'vitamin A'), ('UBERON_0000160', 'intestine', 48, 'intestinal'), ('GO_0007566', 'embryo implantation', 59, 'immune'), ('UBERON_0002405', 'immune system', 59, 'immune system'), ('CHEBI_26536', 'retinoic acid', 88, 'retinoic acid'), ('CHEBI_36927', 'carbon-14 atom', 103, 'RA'), ('UBERON_0001555', 'digestive tract', 110, 'gut'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 132, 'IgA'), ('GO_0046903', 'secretion', 136, 'secreting'), ('UBERON_0001242', 'intestinal mucosa', 155, 'intestinal mucosa'), ('CL_0000187', 'muscle cell', 166, 'mucosa')]
PMC4169453	9/2014	S27-PMC4169453	['TO THE BEST OF OUR KNOWLEDGE, bone mass and body composition have NOT BEEN EXAMINED in Lactating women and their offspring BASED ON the level of maternal Vitamin D Intake in randomized control trials.']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 66), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('GO_0007594', 'puparial adhesion', 87, 'lactating'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0007631', 'feeding behavior', 164, 'intake')]
PMC4169453	9/2014	S68-PMC4169453	['Serum 25(Oh)D <20 ng/ml DEFINED the Vitamin D deficiency state, WHEREAS ≥30 ng/ml REFLECTED Vitamin D sufficiency[7].']	[('PROBABLE_UNDERSTANDING', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 64), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 6, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4169453	9/2014	S89-PMC4169453	['it was BASED ON an ASSUMPTION that each 400 iu/d of Vitamin D MAY increase 25(Ohd) level by 2.8–4.8 ng/ml (mean ∼4 ng/ml) and the standard deviation of 25(Oh)D measurements was 8[28],[29].']	[('PROBABLE_UNDERSTANDING', 7), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 62)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_18009', 'NADP(+)', 75, '25(OHD'), ('CHEBI_71657', 'versiconol acetate', 152, '25(OH)D')]
PMC4169453	9/2014	S229-PMC4169453	['Animal data demonstrate that, INSTEAD of Vitamin D, Calcitriol, or the Vitamin D receptor, the increase in Intestinal calcium absorption is LIKELY due to the Pregnancy-RELATED increase in Duodenal Expression of the calcium transporter Gene Trpv6 [53].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 30), ('PROBABLE_UNDERSTANDING', 140), ('SUPERFICIAL_RELATIONSHIP', 168)]	3	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 52, 'calcitriol'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0000160', 'intestine', 107, 'intestinal'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('UBERON_0001245', 'anus', 188, 'duodenal'), ('GO_0010467', 'gene expression', 197, 'expression'), ('SO_0000704', 'gene', 235, 'gene'), ('PR_000016580', 'tropomyosin beta chain', 240, 'Trpv6')]
PMC4169453	9/2014	S230-PMC4169453	['IF the same mechanism exists in Humans, increasing the Vitamin D intake of Lactating women CAN be PRESUMED to have no beneficial effect on bone Mineral content and density.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 91), ('PROBABLE_UNDERSTANDING', 98)]	3	[('NCBITaxon_9606', 'Homo sapiens', 32, 'humans'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 75, 'lactating'), ('CHEBI_46662', 'mineral', 144, 'mineral')]
PMC4188019	1/2010	S78-PMC4188019	['HENCE, their lower Vitamin D levels MIGHT not be only ATTRIBUTABLE to wearing Head/body cover but also to poor dietary Intake.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 36), ('PROBABLE_UNDERSTANDING', 54)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0000033', 'head', 78, 'head'), ('GO_0007631', 'feeding behavior', 119, 'intake')]
PMC4210927	10/2014	S20-PMC4210927	['IN GENERAL, Pregnant women in developed countries are AT RISK of SUBOPTIMAL intakes of Folate, Iron and Vitamin D [20].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 54), ('IMPORTANT_CONSIDERATION', 65)]	3	[('GO_0007565', 'female pregnancy', 12, 'pregnant'), ('CHEBI_30863', '5-azaorotic acid', 87, 'folate'), ('CHEBI_24870', 'ion', 95, 'iron'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC4231606	10/2013	S12-PMC4231606	['children with s-ecc were significantly more LIKELY to have Vitamin D levels below RECOGNIZED THRESHOLDS for optimal and adequate status (i.e.']	[('PROBABLE_UNDERSTANDING', 44), ('PROBABLE_UNDERSTANDING', 82), ('PROBABLE_UNDERSTANDING', 93)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
PMC4231606	10/2013	S30-PMC4231606	['it has a CRITICAL ROLE in Enamel, Dentin, and Oral Bone formation AS Ameloblasts and Odontoblasts are target cells for 1,25-Dihydroxyvitamin D, the active form of Vitamin D [17].']	[('IMPORTANT_CONSIDERATION', 9), ('SUPERFICIAL_RELATIONSHIP', 18), ('PROBABLE_UNDERSTANDING', 66)]	3	[('UBERON_0001752', 'enamel', 26, 'enamel'), ('UBERON_0001751', 'dentine', 34, 'dentin'), ('UBERON_0000165', 'mouth', 46, 'oral'), ('GO_0007567', 'parturition', 51, 'bone'), ('CL_0000059', 'ameloblast', 69, 'ameloblasts'), ('CL_0000060', 'odontoblast', 85, 'odontoblasts'), ('CHEBI_67472', '15-epi-lupulin B', 119, '1,25-dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC4251419	12/2014	S101-PMC4251419	['ALTERNATIVELY, microbiome changes, like those induced following the use of Probiotics, MAY Regulate the responsiveness of Immune Cells to Vitamin D by enhancing the Expression of the Vitamin D receptor (vdr) THUS reducing Tissue inflammation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 87), ('PROBABLE_UNDERSTANDING', 208)]	3	[('CHEBI_26346', 'prostaglandins J', 75, 'probiotics'), ('GO_0065007', 'biological regulation', 91, 'regulate'), ('CL_0000738', 'leukocyte', 122, 'immune cells'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('GO_0007567', 'parturition', 129, 'cells'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0010467', 'gene expression', 165, 'expression'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('UBERON_0000479', 'tissue', 222, 'tissue')]
PMC4251419	12/2014	S158-PMC4251419	['YET Vitamin D supplementation trials are GENERALLY relatively short-term, with supplementation for ONLY 1-2 years.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 99)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
PMC4256222	12/2014	S21-PMC4256222	['TO OUR KNOWLEDGE, NO earlier STUDIES have focused on the INFLUENCE of Vitamin D status during Pregnancy on incident occurrences of offspring bone fractures during childhood.']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 18), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
PMC4329745	10/2014	S29-PMC4329745	['CONSIDERING a Vitamin D deficiency prevalence of 75% ACCORDING TO PREVIOUS STUDIES and a power of 99%, the sample size was calculated as 517 participants\n\n3.1.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 66)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D')]
PMC4340999	3/2015	S101-PMC4340999	['month of Birth and three trimesters in relation to the calendar month of year, season, and the level of uvb radiation\nto OUR KNOWLEDGE, NO PREVIOUS STUDY has examined the RELATIONSHIP between Prenatal Vitamin D status and ll.']	[('PROBABLE_UNDERSTANDING', 121), ('FULL_UNKNOWN', 136), ('SUPERFICIAL_RELATIONSHIP', 171)]	3	[('GO_0007567', 'parturition', 9, 'birth'), ('GO_0007565', 'female pregnancy', 192, 'prenatal'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
PMC4377870	3/2015	S144-PMC4377870	['in vitro studies also SUPPORT the LINK between Vitamin D and Airway Remodelling AS active Vitamin D inhibits Airway Smooth Muscle (Asm) Cell Proliferation [114] and deficiency impairs normal Lung Development [115].']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('PROBABLE_UNDERSTANDING', 80)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0003313', 'heart rudiment development', 61, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 61, 'airway'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CL_0002633', 'respiratory basal cell', 109, 'airway smooth muscle ... cell'), ('UBERON_0001005', 'respiratory airway', 109, 'airway'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 116, 'smooth muscle'), ('UBERON_0001135', 'smooth muscle tissue', 116, 'smooth muscle'), ('UBERON_0001637', 'artery', 131, 'ASM'), ('GO_0008283', 'cell proliferation', 136, 'cell proliferation'), ('GO_0030324', 'lung development', 191, 'lung development'), ('UBERON_0002048', 'lung', 191, 'lung')]
PMC4377888	3/2015	S68-PMC4377888	['the mechanism UNDERLYING this abnormal Kidney phenotype is MOST LIKELY the fact the Vitamin A is a key ligand for the cret receptor, which Controls the earliest processes of Kidney Development (seesection 2for full details).']	[('SUPERFICIAL_RELATIONSHIP', 14), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('UBERON_0002113', 'kidney', 39, 'kidney'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A'), ('GO_0065007', 'biological regulation', 139, 'controls'), ('GO_0001822', 'kidney development', 174, 'kidney development'), ('UBERON_0002113', 'kidney', 174, 'kidney')]
PMC4380518	9/2014	S2-PMC4380518	['we used multivariable logistic regression to ANALYZE ASSOCIATIONS of pnv use and odds of Vitamin D deficiency DEFINED as 25(Oh)D levels < 50 nmol/l.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('SUPERFICIAL_RELATIONSHIP', 53), ('PROBABLE_UNDERSTANDING', 110)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 121, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 121, '25 ... OH ... D')]
PMC4392553	3/2015	S389-PMC4392553	['[27] THUS, disruption of the shikimate pathway CONTRIBUTES to Vitamin K deficiency, which CAN lead to cholestasis.']	[('PROBABLE_UNDERSTANDING', 5), ('SUPERFICIAL_RELATIONSHIP', 47), ('INCOMPLETE_EVIDENCE', 90)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin K')]
PMC4396835	1/2015	S35-PMC4396835	['HOWEVER, TO OUR KNOWLEDGE there HAS BEEN no study analysing Vitamin D levels in samples taken in the Neonatal Period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('INCOMPLETE_EVIDENCE', 32)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0007221', 'neonate stage', 101, 'neonatal period')]
PMC4396835	1/2015	S121-PMC4396835	['the study - TO OUR KNOWLEDGE - is the FIRST in which Vitamin D levels in dried Blood Spots, from the Newborn Period, HAVE BEEN analysed in samples of children with asd and in their non-asd siblings, thereby controlling for shared environmental and Genetic causes for asd.']	[('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 117)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 79, 'blood spots'), ('UBERON_0007221', 'neonate stage', 101, 'newborn period'), ('SO_0000704', 'gene', 248, 'genetic')]
PMC4405493	4/2015	S15-PMC4405493	['the etiology for this increase is LIKELY MULTIFACTORIAL, but due IN PART to low dietary intake of Vitamin D and limited exposure to sunlight.']	[('PROBABLE_UNDERSTANDING', 34), ('DIFFICULT_TASK', 41), ('INCOMPLETE_EVIDENCE', 65)]	3	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4405493	4/2015	S18-PMC4405493	['during Pregnancy, severe maternal Vitamin D deficiency, AS defined as Serum 25-Hydroxyvitamin D (25-Oh Vitamin D) concentrations less than 5 ng/ml, HAS BEEN ASSOCIATED with disordered Skeletal Homeostasis, congenital rickets, and fractures of the newborn [4].']	[('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 157)]	3	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 76, '25-hydroxyvitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 97, '25-OH'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0043276', 'anoikis', 184, 'skeletal homeostasis'), ('UBERON_0004288', 'skeleton', 184, 'skeletal')]
PMC4405493	4/2015	S120-PMC4405493	['the etiology of the decline of Vitamin D status in women is LIKELY MULTIFACTORIAL, but is due IN PART to increasing bmi and increased sun protection, coupled with decreased dietary intake of Vitamin D, such as milk and other dairy products.']	[('PROBABLE_UNDERSTANDING', 60), ('DIFFICULT_TASK', 67), ('INCOMPLETE_EVIDENCE', 94)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
PMC4417995	4/2015	S38-PMC4417995	['THESE STUDIES SUGGEST that deficiencies in Vitamin D levels and/or signaling would favor a PREDOMINANT th2 response and that the presence of Vitamin D, while suppressing th1 effects, also promotes th2 Responses.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 91)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0060033', 'anatomical structure regression', 201, 'responses')]
PMC4417995	4/2015	S45-PMC4417995	['GIVEN the above, Vitamin D deficiency MIGHT PREDISPOSE patients with ad to skin superinfection by staphylococcus aureus or its superantigens [24].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 44)]	3	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC4417995	4/2015	S118-PMC4417995	['THEREFORE, the increased prevalence of ad in children with a higher dietary intake of Vitamin D COULD result from such early alimentary exposure to this Antigen, RATHER than being a direct consequence of Vitamin D Serum levels.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 96), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_59132', 'antigen', 153, 'antigen'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('UBERON_0001977', 'blood serum', 214, 'serum')]
PMC4417995	4/2015	S153-PMC4417995	['the above data MAY EXPLAIN WHY skin infections occur more frequently in winter, when Keratinocytes are less stimulated by Vitamin D to produce Antimicrobial peptides.']	[('INCOMPLETE_EVIDENCE', 15), ('PROBABLE_UNDERSTANDING', 19), ('EXPLICIT_QUESTION', 27)]	3	[('CL_0000312', 'keratinocyte', 85, 'keratinocytes'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_65381', 'albizoside C', 143, 'antimicrobial')]
PMC4427001	4/2015	S33-PMC4427001	['a NUMBER OF STUDIES focused on PUTATIVE ROLE of Vitamin D deficiency in various Pregnancy pathologies including gdm [21–23].']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 31), ('SUPERFICIAL_RELATIONSHIP', 40)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy')]
PMC4448820	5/2015	S281-PMC4448820	['most of the EFFECTS of Vitamin A on Immune or inflammatory Responses CAN be EXPLAINED via binding of the Vitamin A Metabolite, Atra, to 1 of 3 zinc-finger proteins containing members of the Nuclear receptor superfamily, Rar-Α, Rar-Β, and Rar-Γ (185).']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 76)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('GO_0006955', 'immune response', 36, 'immune ... responses'), ('UBERON_0002405', 'immune system', 36, 'immune'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('CHEBI_39382', 'flufenoxuron', 115, 'metabolite'), ('CHEBI_17033', 'biliverdin', 127, 'ATRA'), ('GO_0005634', 'nucleus', 190, 'nuclear'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 220, 'RAR-α'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 227, 'RAR-β'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 238, 'RAR-γ')]
PMC4448820	5/2015	S473-PMC4448820	['caption (boxed-text): text box 17\u2003\nPOSSIBLE mechanisms to EXPLAIN Vitamin A’s ROLE in Immune Response\n\n● vitamin A, via conversion to atra, can inhibit Nf-Κb Activation (118).']	[('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin A'), ('GO_0006955', 'immune response', 86, 'immune response'), ('UBERON_0002405', 'immune system', 86, 'immune'), ('PR_000004370', 'asialoglycoprotein receptor 2', 113, 'A'), ('GO_0051092', 'positive regulation of NF-kappaB transcription factor activity', 152, 'NF-κB activation'), ('GO_0071159', 'NF-kappaB complex', 152, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 152, 'NF-κB')]
PMC4452099	6/2015	S23-PMC4452099	['a RECENT danish fortification trial has PROVED that the Intake of fortified Food PREVENTED Vitamin D deficiency during winter [19].']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 40), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('GO_0007631', 'feeding behavior', 56, 'intake'), ('CHEBI_33290', 'food', 76, 'food'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
PMC4452099	6/2015	S29-PMC4452099	['we HYPOTHESISED that t1d risk will be lower among Individuals Born in denmark during the period of obligatory Margarine fortification—and THEREFORE exposed to Vitamin D fortified Food during Gestation or Infancy—compared to Individuals Born in years when Margarine was not fortified—and CONSEQUENTLY unexposed to extra Vitamin D coming from fortified Margarine at any period of early Life.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 138), ('PROBABLE_UNDERSTANDING', 287)]	3	[('NCBITaxon_1', 'root', 50, 'individuals'), ('GO_0007567', 'parturition', 62, 'born'), ('CHEBI_6784', 'mestranol', 110, 'margarine'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_33290', 'food', 179, 'food'), ('GO_0007565', 'female pregnancy', 191, 'gestation'), ('UBERON_0000023', 'wing', 204, 'infancy'), ('NCBITaxon_1', 'root', 224, 'individuals'), ('GO_0007567', 'parturition', 236, 'born'), ('CHEBI_6784', 'mestranol', 255, 'margarine'), ('CHEBI_27300', 'vitamin D', 319, 'vitamin D'), ('CHEBI_6784', 'mestranol', 351, 'margarine'), ('UBERON_0000104', 'life cycle', 384, 'life')]
PMC4452099	6/2015	S84-PMC4452099	['one REASON for the absence of a detectable RELATIONSHIP between td risk and Early Life exposure to fortified Margarine COULD BE the actual dose of Vitamin D added to Margarine, and therefore the dose which Individuals were exposed to during Gestation and/or during the first year of Life.']	[('PROBABLE_UNDERSTANDING', 4), ('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 119)]	3	[('UBERON_0001847', 'lobule of pinna', 76, 'early life'), ('CHEBI_6784', 'mestranol', 109, 'margarine'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_6784', 'mestranol', 166, 'margarine'), ('NCBITaxon_1', 'root', 206, 'individuals'), ('GO_0007565', 'female pregnancy', 241, 'gestation'), ('UBERON_0000104', 'life cycle', 283, 'life')]
PMC4476607	1/2015	S166-PMC4476607	['BASED ON their dietary habits, many children with fasd are not Consuming adequate or daily-RECOMMENDED amounts of Omega-3 Fatty Acids, Vitamin D, and Choline (figure 5a) (fuglestad et al 2013;werts et al.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('FUTURE_WORK', 91)]	3	[('GO_0007631', 'feeding behavior', 63, 'consuming'), ('CHEBI_75862', 'alpha-D-rhamnofuranose', 114, 'omega-3 fatty acids'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('CHEBI_15354', 'choline', 150, 'choline')]
PMC4488777	5/2015	S21-PMC4488777	['LIKEWISE, in patients with Vitamin D deficiency, a higher occurrence of Uterine myomas is OBSERVED—another established REASON for infertility.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 90), ('PROBABLE_UNDERSTANDING', 119)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0000995', 'uterus', 72, 'uterine')]
PMC4488777	5/2015	S24-PMC4488777	['THEREFORE, a clinician MUST BE careful when prescribing Vitamin D preparations, ESPECIALLY in male patients.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 23), ('ANOMALY_CURIOUS_FINDING', 80)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
PMC4488777	5/2015	S104-PMC4488777	['the authors of the study SUGGEST a direct EFFECT of Vitamin D on Amh production, and THUS longer maintenance of Ovarian reserve in the patients with its higher concentration [46].']	[('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 85)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_16027', "adenosine 5'-monophosphate", 65, 'AMH'), ('UBERON_0000992', 'ovary', 112, 'ovarian')]
PMC4499946	7/2015	S26-PMC4499946	['THEREFORE, in bangladesh, we have OBSERVED that the period of greatest vulnerability with respect to Perinatal Vitamin D deficiency OVERLAPS with a critical period of fetal and early infant growth.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 132)]	3	[('GO_0036268', 'swimming', 101, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 101, 'perinatal'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
PMC4499946	7/2015	S295-PMC4499946	['the mdig trial will THEREFORE offer unique INSIGHTS into the EFFECT of improving maternal-infant Vitamin D status in a low-income setting where Vitamin D insufficiency is common and there is a high prevalence of infant linear growth faltering.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
PMC4516377	6/2015	S37-PMC4516377	['CONSIDERING the studies that assessed the ASSOCIATION between Vitamin D and obesity in children, two were cross-sectional18,20and one longitudinal21(table 1).']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4595656	10/2015	S40-PMC4595656	['its overall CONTRIBUTION to healthy Brain Development renders also LIKELY a ROLE for Vitamin D in the developing hippocampus.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('PROBABLE_UNDERSTANDING', 67), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('GO_0007420', 'brain development', 36, 'brain development'), ('UBERON_0000955', 'brain', 36, 'brain'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
PMC4595656	10/2015	S141-PMC4595656	['this would shed the MOST valuable light POSSIBLE on the ROLE of Vitamin D in early Hippocampal Development.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 56)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0003163', 'sinoatrial node development', 83, 'hippocampal development')]
PMC4600246	10/2015	S17-PMC4600246	['the Menaquinone form of Vitamin K (ie, Vitamin K2) HAS BEEN PRESUMED to be more effective than Vitamin K1At preventing and reversing Arterial calcifications.']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 60), ('PROBABLE_UNDERSTANDING', 60)]	3	[('CHEBI_18154', 'polysaccharide', 4, 'menaquinone'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin K'), ('CHEBI_28934', 'vitamin D2', 39, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 39, 'vitamin K2'), ('CHEBI_83630', 'essential oil', 95, 'vitamin K1at'), ('PR_000009486', 'keratin, type II cytoskeletal 71', 103, 'K1at'), ('UBERON_0001637', 'artery', 133, 'arterial')]
PMC4624803	10/2015	S18-PMC4624803	['the levels of Vitamin D at Birth SHOULD BE a good ESTIMATE of the child’s Vitamin D levels, AT LEAST in the later part of the Gestation.']	[('FUTURE_WORK', 33), ('INCOMPLETE_EVIDENCE', 50), ('PROBABLE_UNDERSTANDING', 92)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007567', 'parturition', 27, 'birth'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'gestation')]
PMC4645901	8/2014	S73-PMC4645901	['this MAY BE due to the increased AWARENESS of Vitamin D deficiency by the general public, and THEREFORE an increased uptake of Vitamin supplements during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 33), ('PROBABLE_UNDERSTANDING', 94)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 127, 'vitamin'), ('GO_0007565', 'female pregnancy', 154, 'pregnancy')]
PMC4670104	12/2015	S19-PMC4670104	['also, apps are OFTEN RECOMMENDED for use in population studies as correction factors for assessing status with respect to Micronutrients, whose indicator concentrations MAY decrease (e.g., Serum Retinol for Vitamin A) or rise (e.g, Serum ferritin for iron) with inflammation [13–15].']	[('PROBABLE_UNDERSTANDING', 15), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 169)]	3	[('CHEBI_33839', 'macromolecule', 122, 'micronutrients'), ('UBERON_0001977', 'blood serum', 189, 'serum'), ('CHEBI_26536', 'retinoic acid', 195, 'retinol'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A'), ('UBERON_0001977', 'blood serum', 232, 'serum')]
PMC4670104	12/2015	S177-PMC4670104	['Rbp4, ttr, Ahsg, and Apoa1/2 are WELL-KNOWN negative Acute Phase proteins [10] that are CONSISTENT with KNOWN redistributions of Vitamin A, Calcium, Phosphate and Lipids during inflammation [57–60].']	[('PROBABLE_UNDERSTANDING', 33), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 104)]	3	[('PR_000013819', 'retinol-binding protein 2', 0, 'RBP4'), ('PR_000003880', 'GTP:AMP phosphotransferase, mitochondrial', 11, 'AHSG'), ('PR_000004100', 'AP-2 complex subunit alpha-2', 21, 'APOA1'), ('GO_0006953', 'acute-phase response', 53, 'acute phase'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin A'), ('CHEBI_22313', 'alkaline earth metal atom', 140, 'calcium'), ('CHEBI_18367', 'phosphate(3-)', 149, 'phosphate'), ('CHEBI_18059', 'lipid', 163, 'lipids')]
PMC4673623	11/2015	S8-PMC4673623	['elevations in circulating maternal Folate were evident in the hf-hed group INDICATING impaired Folate Metabolism (methyl-trap) AS a CONSEQUENCE of maternal Vitamin B-12 depletion.']	[('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 127), ('PROBABLE_UNDERSTANDING', 132)]	3	[('CHEBI_30863', '5-azaorotic acid', 35, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 95, 'folate'), ('GO_0046655', 'folic acid metabolic process', 95, 'folate metabolism'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin B')]
PMC4684854	12/2015	S49-PMC4684854	['the medical literature has achieved GENERAL CONSENSUS that Vitamin D levels throughout much of the globe, as reflected by population measurements of 25(Oh)D3Levels, are generally INADEQUATE [38].']	[('PROBABLE_UNDERSTANDING', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('PROBLEM_COMPLICATION', 179)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_51924', 'ethyl 2-cyanoacetoacetate', 149, '25(OH)D3levels'), ('PR_000006775', 'cytoplasmic dynein 2 heavy chain 1', 155, 'D3levels')]
PMC4684854	12/2015	S90-PMC4684854	['ANOTHER STUDY FOUND that infants Born before 32 weeks of Gestation were 2.4 times more LIKELY to have Vitamin D levels below 50\u2009nmol/l when compared with those Born after 32 weeks of Gestation [61].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('PROBABLE_UNDERSTANDING', 87)]	3	[('GO_0007567', 'parturition', 33, 'born'), ('GO_0007565', 'female pregnancy', 57, 'gestation'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007567', 'parturition', 160, 'born'), ('GO_0007565', 'female pregnancy', 183, 'gestation')]
PMC4684854	12/2015	S98-PMC4684854	['in ONE STUDY, women with Vitamin D levels below 37.5\u2009nmol/l were almost four times as LIKELY to REQUIRE a primary Cesarean Delivery as women with higher levels [67].']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 86), ('IMPORTANT_CONSIDERATION', 96)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0044808', 'oncostatin M production', 114, 'cesarean'), ('GO_0007567', 'parturition', 123, 'delivery')]
PMC4689556	12/2015	S129-PMC4689556	['there was WEAK EVIDENCE that offspring of mothers who received bolus Vitamin D were more LIKELY to have been prescribed a wheezing medication (p = 0.05), and that offspring of mothers who received daily Vitamin D were more LIKELY to have been prescribed an eczema medication (p = 0.04) (table 8).']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 89), ('PROBABLE_UNDERSTANDING', 223)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
PMC4689556	12/2015	S173-PMC4689556	['overall the data SUGGEST that a clinically meaningful RELATIONSHIP between this regime of Vitamin D supplementation in Pregnancy in a deficient population, or these levels of Vitamin D in Cord-Blood or at three years of age, and healthcare utilization is UNLIKELY.']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 54), ('PROBABLE_UNDERSTANDING', 255)]	3	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 188, 'cord'), ('UBERON_0000178', 'blood', 193, 'blood')]
PMC4690051	12/2015	S116-PMC4690051	['the presence of 1α-hydroxylase activity within numerous Brain Regions SUGGESTS that Brain Tissue can locally produce Metabolically active Vitamin D, further IMPLICATING a ROLE for Vitamin D in Brain Development.']	[('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 157), ('SUPERFICIAL_RELATIONSHIP', 171)]	3	[('UBERON_0002616', 'regional part of brain', 56, 'brain regions'), ('UBERON_0000955', 'brain', 84, 'brain'), ('UBERON_0000479', 'tissue', 90, 'tissue'), ('GO_0008152', 'metabolic process', 117, 'metabolically'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0007420', 'brain development', 193, 'brain development'), ('UBERON_0000955', 'brain', 193, 'brain')]
PMC4691762	12/2015	S69-PMC4691762	["participant's Vitamin D status will be defined by their Blood 25Ohd3 level, AS: severely deficient <12.5\u2005nmol/l; moderately deficient 12.5–25\u2005nmol/l; mild deficiency 26–49\u2005nmol/l; sufficient ≥50\u2005nmol/l; and elevated >220\u2005nmol/l.23\nparent baseline questionnaire : to check that potential environmental and OTHER CONFOUNDING factors are balanced between the two randomisation groups, baseline parent questionnaires will collect data on: parental smoking, medication use, parental ancestry, ethnicity, education, employment, occupation, family history of allergy, use of supplements including Vitamin A, d and cod Liver oil, number of siblings; and pet ownership."]	[('PROBABLE_UNDERSTANDING', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 305), ('PROBLEM_COMPLICATION', 311)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000178', 'blood', 56, 'blood'), ('CHEBI_63058', '(2R,3S)-EHNA', 62, '25OHD3'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 62, '25OHD3'), ('CHEBI_27300', 'vitamin D', 590, 'vitamin A'), ('UBERON_0002107', 'liver', 611, 'liver')]
PMC4691762	12/2015	S107-PMC4691762	['furthermore FINDINGS will provide EVIDENCE to inform GUIDELINES for Vitamin D supplementation of infants.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('PROBABLE_UNDERSTANDING', 53)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC4719746	1/2016	S161-PMC4719746	['this cost-effective, and easy-to-administer RECOMMENDATION LIKELY CONTRIBUTED the most to the improved Vitamin D status later in Pregnancy for these women.']	[('FUTURE_WORK', 44), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC4729160	1/2016	S22-PMC4729160	['the MAJORITY of studies focus on vad of Pregnant women, it FOUND Vitamin A deficiency was strongly ASSOCIATED with Pregnancy and Birth outcomes.']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('GO_0007565', 'female pregnancy', 40, 'pregnant'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin A'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('GO_0007567', 'parturition', 129, 'birth')]
PMC4764019	1/2016	S41-PMC4764019	['HENCE, it is LIKELY that the malnutrition of the famine would have included Vitamin D deficiency as well as OTHER inadequacies.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC4764019	1/2016	S55-PMC4764019	['THUS, the EFFECTS of Vitamin D inadequacy are as far-RANGING as the Tissues concerned, all of which require Vitamin D to gain access to information stored in their Genes.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0000479', 'tissue', 68, 'tissues'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('SO_0000704', 'gene', 164, 'genes')]
PMC4770602	1/2016	S22-PMC4770602	['[14151617] lack of adequate sunlight exposure NEEDED to synthesize Vitamin D3 in the skin, and Oral intakes that are TOO low TO meet the increased demands of Pregnancy are REASONS of epidemic deficiency of Vitamin D during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 46), ('DIFFICULT_TASK', 117), ('PROBABLE_UNDERSTANDING', 172)]	3	[('CHEBI_33279', 'vitamin D5', 67, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 67, 'vitamin D3'), ('UBERON_0000165', 'mouth', 95, 'oral'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
PMC4778858	3/2016	S106-PMC4778858	['THUS, well-designed, interventional studies, with both neonatal and longitudinal follow up outcomes, are NECESSARY in order to provide improved RECOMMENDATIONS for Vitamin D supplementation in Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 105), ('FUTURE_WORK', 144)]	3	[('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy')]
PMC4785305	3/2016	S26-PMC4785305	['indeed, the who Pregnancy guidelines clearly STATED that “Vitamin D supplementation will PROBABLY have the most BENEFIT in populations of poor countries, those with darker skin colour and in populations with a high prevalence of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 89), ('IMPORTANT_CONSIDERATION', 112)]	3	[('GO_0007565', 'female pregnancy', 16, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 58, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 229, 'vitamin D')]
PMC4811441	3/2016	S12-PMC4811441	['in conclusion, an increase in 25(Oh)D concentration during Pregnancy of at LEAST 30 nmol/l, REGARDLESS OF Vitamin D status in t1, was ASSOCIATED with a lower odds ratio for Preeclampsia.']	[('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_71657', 'versiconol acetate', 30, '25(OH)D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 173, 'preeclampsia')]
PMC4811441	3/2016	S171-PMC4811441	['in conclusion, an increase in 25(Oh)D concentration during Pregnancy of at LEAST 30 nmol/l, REGARDLESS OF Vitamin D status at t1, was ASSOCIATED with a lower odds ratio for pe.']	[('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_71657', 'versiconol acetate', 30, '25(OH)D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC4843009	4/2016	S130-PMC4843009	['in wild type Animals, dietary Vitamin D does not necessarily INFLUENCE 1,25(Oh)2D3Concentration, AS 1Α-25-Hydroxyvitamin D hydroxylase and THUS 1,25(Oh)2D3Formation is under tight Regulation by Fgf23 and Klotho1.']	[('SUPERFICIAL_RELATIONSHIP', 61), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 139)]	3	[('NCBITaxon_33208', 'Metazoa', 13, 'animals'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_52815', 'cresyl violet', 71, '1,25(OH)2D3concentration'), ('CHEBI_67449', 'ananolignan L', 100, '1α-25-hydroxyvitamin D'), ('CHEBI_77734', 'dexverapamil', 146, '25(OH)2D3formation'), ('GO_0065007', 'biological regulation', 180, 'regulation'), ('PR_000007483', 'fibroblast growth factor 13', 194, 'FGF23'), ('PR_000009207', 'lysine-specific demethylase 5D', 204, 'klotho1')]
PMC4889866	5/2016	S103-PMC4889866	['BECAUSE direct Vitamin D supplementation DEEMED to increase Il-10 Production, our result SUGGESTED a reduced Il-10 response to Tlr Stimulation with higher Vitamin D concentration.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 89)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0032613', 'interleukin-10 production', 60, 'IL-10 production'), ('PR_000001470', 'interleukin-28B', 60, 'IL-10'), ('PR_000001470', 'interleukin-28B', 109, 'IL-10'), ('GO_0031295', 'T cell costimulation', 127, 'TLR stimulation'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC4889866	5/2016	S105-PMC4889866	['AS a potent Anti-inflammatory Immune Modulator, STUDIES HAVE SHOWN Vitamin D to downregulate tlr Expression in Monocytes resulting in reduced downstream Cytokine Production [11,13].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 56)]	3	[('CHEBI_67437', 'Euparin', 12, 'anti-'), ('UBERON_0002405', 'immune system', 30, 'immune'), ('CHEBI_33220', '3-monobromobisphenol A', 37, 'modulator'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0010467', 'gene expression', 97, 'expression'), ('CL_0000576', 'monocyte', 111, 'monocytes'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 153, 'cytokine production')]
PMC4897157	5/2016	S19-PMC4897157	['THEREFORE, it MAY BE HYPOTHESIZED that the level of sun exposure determines the level of Vitamin D in the Human body.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 21)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 106, 'human')]
PMC4897157	5/2016	S112-PMC4897157	['in ANOTHER STUDY, autumn Birth was ASSOCIATED with an increased risk of fa; this risk was greatest among those most LIKELY to experience seasonal variations in Vitamin D during infancy (caucasians) and in those at risk of skin barrier dysfunction (i.e., subjects with a history of eczema)18).']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 116)]	3	[('GO_0007567', 'parturition', 25, 'birth'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D')]
PMC4910734	6/2015	S243-PMC4910734	['additionally, Sulfur-containing antioxidants, such as Taurine and Nac, are superior to Vitamin C and form the ESSENTIAL core of any supplementation plan to counteract Aldehyde toxicity or oxidative stress.L-Carnitine, BUT NOT Acetyl-Carnitine, is LIKELY beneficial for many and can be included.']	[('IMPORTANT_CONSIDERATION', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 218), ('PROBABLE_UNDERSTANDING', 247)]	3	[('CHEBI_36933', 'oxygen-19 atom', 14, 'sulfur'), ('CHEBI_15891', 'taurine', 54, 'taurine'), ('CHEBI_7421', 'NAC', 66, 'NAC'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin C'), ('CHEBI_17478', 'aldehyde', 167, 'aldehyde'), ('CHEBI_86085', '(Z)-p-coumaroylagmatine', 205, 'l-carnitine'), ('CHEBI_17387', 'O-acylcarnitine', 226, 'acetyl-carnitine')]
PMC4934634	11/2015	S32-PMC4934634	['BASED ON lower circulating 25(Oh)D concentrations at a given Vitamin D supplement level in obese and overweight subjects compared to normal weight subjects, ekwaru and coworkers RECENTLY RECOMMENDED that “Vitamin D supplementation be 2–3 times higher for obese subjects and 1.5 times higher for overweight subjects relative to normal weight subjects” [10].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 178), ('FUTURE_WORK', 187)]	3	[('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 27, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
PMC4934634	11/2015	S296-PMC4934634	['additional fortification or supplementation STRATEGIES WOULD BE NEEDED to reach rda levels of Vitamin D intake CONSISTENTLY, especially in Individuals with low intakes of fish/seafood or fortified dairy foods, other fortified foods (e.g., breakfast cereals) and beverages”.']	[('FUTURE_WORK', 44), ('FUTURE_WORK', 55), ('PROBABLE_UNDERSTANDING', 111)]	3	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('NCBITaxon_1', 'root', 139, 'individuals')]
PMC4944244	7/2016	S40-PMC4944244	['these criteria were EXCLUDED AS it would INFLUENCE the Vitamin D level.']	[('INCOMPLETE_EVIDENCE', 20), ('PROBABLE_UNDERSTANDING', 29), ('SUPERFICIAL_RELATIONSHIP', 41)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC4944244	7/2016	S91-PMC4944244	['hypovitaminosis D is expected to be high AS PREVIOUS STUDIES RELATED to Vitamin D conducted in malaysia among children and malay women were also high.']	[('PROBABLE_UNDERSTANDING', 41), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 16, 'D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC4944244	7/2016	S96-PMC4944244	['the Serum Vitamin D level was low PROBABLY BECAUSE our respondents were first Trimester Pregnant women who MAY have morning sickness and limited outdoor physical activity.']	[('PROBABLE_UNDERSTANDING', 34), ('PROBABLE_UNDERSTANDING', 43), ('INCOMPLETE_EVIDENCE', 107)]	3	[('UBERON_0001977', 'blood serum', 4, 'serum'), ('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 78, 'trimester'), ('GO_0007565', 'female pregnancy', 88, 'pregnant')]
PMC4949006	7/2016	S4-PMC4949006	['Folic Acid SHOULD BE supplemented prior to Conception and continued through AT LEAST the first 28 days of fetal Life to prevent Neural Tube defects, and Vitamin C SHOULD be given to women who smoke to lower the incidence of asthma and wheezing in the children.']	[('FUTURE_WORK', 11), ('PROBABLE_UNDERSTANDING', 76), ('FUTURE_WORK', 163)]	3	[('CHEBI_30751', 'formic acid', 0, 'Folic acid'), ('GO_0007620', 'copulation', 43, 'conception'), ('UBERON_0000104', 'life cycle', 112, 'life'), ('UBERON_0001049', 'neural tube', 128, 'neural tube'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin C')]
PMC4969253	8/2016	S24-PMC4969253	['this mechanism LIKELY represents the molecular basis of the Lung agenesis classically DESCRIBED in the MODELS of Vitamin A deficiency.']	[('PROBABLE_UNDERSTANDING', 15), ('INCOMPLETE_EVIDENCE', 86), ('INCOMPLETE_EVIDENCE', 103)]	3	[('UBERON_0002048', 'lung', 60, 'lung'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin A')]
PMC4973215	8/2016	S48-PMC4973215	['for instance, at a mean maternal bmi of 32.3\u2009kg\u2009m−2, an infant who is black, on medicaid and no Prenatal vitamin use has an 86% (95% ci: 82, 97) PROBABILITY of Vitamin D deficiency, WHEREAS a black infant who is not on medicaid and with Prenatal vitamin use has a 66% (95% ci: 44, 67) PROBABILITY of Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('PROBABLE_UNDERSTANDING', 285)]	3	[('GO_0007565', 'female pregnancy', 96, 'prenatal'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 237, 'prenatal'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin D')]
PMC4973215	8/2016	S50-PMC4973215	['AS Vitamin D levels also DIFFERED by race, we stratified the models predicting sga by race and EXAMINED Vitamin D deficiency, smoking, pre-eclampsia, maternal age, medicaid status and bmi at Delivery as covariates (table 3).']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('QUESTION_ANSWERED_BY_THIS_WORK', 95)]	3	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007567', 'parturition', 191, 'delivery')]
PMC4979151	8/2016	S155-PMC4979151	['stimulation of cbmc with B Cell stimulant or tlr ligands such as Lps MIGHT have yielded a more COMPREHENSIVE picture of Vitamin D RELATED cytokine functions.']	[('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 130)]	3	[('CL_0000236', 'B cell', 25, 'B cell'), ('CHEBI_16412', 'lipopolysaccharide', 65, 'LPS'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4990268	8/2016	S294-PMC4990268	['Pregnant women who are Vitamin A deficient and their infants CAN suffer SIGNIFICANT adverse consequences AS a result of this deficiency.']	[('INCOMPLETE_EVIDENCE', 61), ('IMPORTANT_CONSIDERATION', 72), ('PROBABLE_UNDERSTANDING', 105)]	3	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin A')]
PMC4990268	8/2016	S298-PMC4990268	['one additional ISSUE for Vitamin A supplementation in Pregnancy is that high doses of Retinol are a WELL-KNOWN Teratogen IF provided early in Gestation[102].']	[('PROBLEM_COMPLICATION', 15), ('PROBABLE_UNDERSTANDING', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('CHEBI_26536', 'retinoic acid', 86, 'retinol'), ('CHEBI_50117', 'phenylglyoxylyl-CoA', 111, 'teratogen'), ('GO_0007565', 'female pregnancy', 142, 'gestation')]
PMC4990268	8/2016	S337-PMC4990268	['DESPITE this benefit, it was ASSUMED for many years that children younger than 6 months and breastfeeding either exclusively or for the majority of their intake were protected by the Vitamin A in Breastmilk.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 29)]	3	[('CHEBI_27300', 'vitamin D', 183, 'vitamin A'), ('UBERON_0001348', 'brown adipose tissue', 196, 'breastmilk')]
PMC4990268	8/2016	S362-PMC4990268	['HOWEVER, there is significant heterogeneity in results with benefit EVIDENT in settings with significant maternal Vitamin A deficiency but no benefit when maternal Vitamin A deficiency is LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 68), ('FULL_UNKNOWN', 188)]	3	[('CHEBI_27300', 'vitamin D', 114, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin A')]
PMC4992225	8/2016	S37-PMC4992225	['Serum levels of 25-Hydroxyvitamin D REFLECTS the body’s Vitamin D reserves and this is a WELL-KNOWN INDICATOR for examining Vitamin D status [15].']	[('SUPERFICIAL_RELATIONSHIP', 36), ('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 100)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 16, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC4992225	8/2016	S39-PMC4992225	['IN ACCORDANCE to a GUIDELINE by holick et al., 6–8 weeks Consumption of a high dose Vitamin D supplement are ESSENTIAL to obtain an adequate Blood reserves of Vitamin D [19].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 19), ('IMPORTANT_CONSIDERATION', 109)]	3	[('GO_0007631', 'feeding behavior', 57, 'consumption'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0000178', 'blood', 141, 'blood'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
PMC4992225	8/2016	S42-PMC4992225	['THEREFORE, the Brain can regionally activate Vitamin D, which IMPLICATES Vitamin D’s ROLE in Brain function more prominent [22–25].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 62), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('UBERON_0000955', 'brain', 15, 'brain'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0000955', 'brain', 93, 'brain')]
PMC4992225	8/2016	S63-PMC4992225	['ACCORDING TO OUR KNOWLEDGE, THERE WAS NO clinical trial that has evaluated the effectiveness of Vitamin D on Perinatal depression.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 10), ('FULL_UNKNOWN', 28)]	3	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0036268', 'swimming', 109, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 109, 'perinatal')]
PMC4992225	8/2016	S87-PMC4992225	['ACCORDING TO the institute of medicine (iom), we CONSIDERED Vitamin D deficiency AS a Serum 25-Hydroxyvitamin D of less than 20\xa0ng/ml.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 49), ('PROBABLE_UNDERSTANDING', 81)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0001977', 'blood serum', 86, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 92, '25-hydroxyvitamin D')]
PMC4992225	8/2016	S180-PMC4992225	['ACCORDING TO OUR KNOWLEDGE, this study was the FIRST trial held on Vitamin D and Perinatal depression.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 47)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0036268', 'swimming', 81, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 81, 'perinatal')]
PMC4992225	8/2016	S207-PMC4992225	['THEREFORE, it is JUSTIFIABLE that in OUR STUDY, Vitamin D group had lower 25-Hydroxyvitamin D concentration compared to those were in the study by taheri et al.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 37)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 74, '25-hydroxyvitamin D')]
PMC4997421	8/2016	S91-PMC4997421	['BECAUSE maternal Tissues are progressively depleted of Vitamin A to supply fetal demands [14], women who initially possess marginal or EVEN adequate Vitamin A stores at the beginning of Pregnancy are at an INCREASED RISK of Vitamin A inadequacy as Pregnancy progresses.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 135), ('IMPORTANT_CONSIDERATION', 206)]	3	[('UBERON_0000479', 'tissue', 17, 'tissues'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin A'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin A'), ('GO_0007565', 'female pregnancy', 248, 'pregnancy')]
PMC4997421	8/2016	S95-PMC4997421	['THEREFORE, it is IMPERATIVE that women be Vitamin A sufficient prior to Becoming Pregnant in order to avoid depletion of Vitamin A stores DUE TO fetal and Lactation demands and subsequent ramifications to the mother or developing infant.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 17), ('PROBLEM_COMPLICATION', 138)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin A'), ('GO_0007567', 'parturition', 72, 'becoming'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin A'), ('GO_0007595', 'lactation', 155, 'lactation')]
PMC4998950	4/2016	S42-PMC4998950	['HOWEVER, given that Vitamin D deficiency among Pregnant women in sweden is detected ONLY when outright screened for,12many cases of deficiency are LIKELY to manifest well before any official diagnosis is recorded.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 84), ('PROBABLE_UNDERSTANDING', 147)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnant')]
PMC5014971	8/2016	S7-PMC5014971	['physicians who indicated that Vitamin D status was a PROBLEM in their patient population were more LIKELY to screen routinely (32.8% versus 9.7%, p = 0.002) and believe their patients would BENEFIT from supplementation (91.2% versus 16.1%, p = 0.001).']	[('IMPORTANT_CONSIDERATION', 53), ('PROBABLE_UNDERSTANDING', 99), ('IMPORTANT_CONSIDERATION', 190)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC5014971	8/2016	S83-PMC5014971	['physicians who considered Vitamin D insufficiency a PROBLEM among their patients were more LIKELY to think that most of their Pregnant patients would BENEFIT from taking Vitamin D supplements (91.2% versus 16.1%; p< 0.001).']	[('IMPORTANT_CONSIDERATION', 52), ('PROBABLE_UNDERSTANDING', 91), ('IMPORTANT_CONSIDERATION', 150)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'pregnant'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC5014971	8/2016	S90-PMC5014971	['physicians who indicated that Vitamin D insufficiency is a PROBLEM in their patient population were more LIKELY to agree or strongly agree that Vitamin D supplementation during Pregnancy is safe and that all Pregnant women SHOULD BE screened.']	[('IMPORTANT_CONSIDERATION', 59), ('PROBABLE_UNDERSTANDING', 105), ('FUTURE_WORK', 223)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy'), ('GO_0007565', 'female pregnancy', 208, 'pregnant')]
PMC5014971	8/2016	S95-PMC5014971	["the greater the CONCERN is over their patients' Vitamin D status, the more LIKELY the physician is to RECOMMEND supplementation."]	[('PROBLEM_COMPLICATION', 16), ('PROBABLE_UNDERSTANDING', 75), ('FUTURE_WORK', 102)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC5014971	8/2016	S116-PMC5014971	['finally, the fact that Vitamin D levels in our ancient ancestors LIKELY exceeded the iom recommendations does NOT PROVE that those higher levels are conducive to better health and wellbeing in the modern environment.']	[('PROBABLE_UNDERSTANDING', 65), ('ANOMALY_CURIOUS_FINDING', 110), ('PROBABLE_UNDERSTANDING', 114)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
PMC5024431	9/2016	S105-PMC5024431	['Eating Out less/Eat at home morei want to only dine out for 1 meal a weekeat more at home\u2003evening/night time Eating (e.g., healthier and/or restricting)no Eating after 8:00pmlimit snacks at night\u2003follow\xa0canada’s Food guidefollow canada’s Food guide\u2003follow \ufeffvegetarian/vegan dietseat mostly vegan\u2003follow\xa0fad diets (not gluten free)more alkaline and less Acidic Foods\u2003gluten free (includes wheat free)follow celiac diet\u2003follow\xa0other plans (includes fodmap guidelines, Heart healthy, diabetes, optifast®, weight watchers®, dash, dietitian meal plans, weight lifting, Pregnancy diet, unspecified diet plans)following the dietitian’s plan, eat only my shakes this week, follow diet, follow diabetes diet\u2003glycemic indexkeep a low glycemic index diet\u2003clean Eating (includes unprocessed, whole, fresh, raw, natural foods)Eating cleaner, eat as much raw as possible, to eat fresh Food\u2003supplementstake 600-800 iu Vitamin D daily\u2003planning and preparing Food†cook dinner from scratch a minimum of 3 times per week, plan 4–5 smaller meals per daybetter Planning and Preparing Of Food, plan healthy meals, plan meals\u2003goals describing when Food is Eaten or not Eaten/Eating patternseat breakfast, Lunch, dinner & snack every day, not to eat in between mealseat more regularly, try not to snack so much throughout the day\u2003breakfasteating healthy breakfastincorporate cereal or smoothies more often for breakfast\u2003psychological aspects of Eatingdon’t binge, drink Water or 0 cal drink when hungry, stop emotional eatingto Control Food Intake, respect Food AS a means of nutrition and to satisfy hunger\u2003general Eating improvementseat healthy meals and snacks, eat the RECOMMENDED dv of Minerals and Vitamins, eat a variety of foodseat healthy, eat a balanced diet, eat right to avoid ibs symptoms\noverall, there were n\u2009= \u20091,986, n\u2009= \u2009614, n\u2009= \u2009233, and n\u2009= \u20091,134 daily, weekly, monthly, and one-time write your own goal statements, respectively (excluding irrelevant to health/Nonsense goals); these goals were RARELY tracked.']	[('PROBABLE_UNDERSTANDING', 1538), ('FUTURE_WORK', 1649), ('INCOMPLETE_EVIDENCE', 1993)]	3	[('GO_0006897', 'endocytosis', 0, 'Eating out'), ('GO_0018888', '3-chloroacrylic acid metabolic process', 16, 'Eat'), ('GO_0051318', 'G1 phase', 109, 'eating'), ('GO_0051318', 'G1 phase', 155, 'eating'), ('CHEBI_33290', 'food', 212, 'Food'), ('CHEBI_33290', 'food', 238, 'food'), ('CHEBI_37527', 'acid', 353, 'acidic'), ('CHEBI_33290', 'food', 360, 'foods'), ('UBERON_0000948', 'heart', 466, 'heart'), ('GO_0007565', 'female pregnancy', 564, 'pregnancy'), ('GO_0051318', 'G1 phase', 750, 'eating'), ('GO_0007568', 'aging', 813, 'Eating'), ('CHEBI_33290', 'food', 871, 'food'), ('CHEBI_27300', 'vitamin D', 903, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 911, 'D'), ('CHEBI_33290', 'food', 942, 'food'), ('GO_0006260', 'DNA replication', 1040, 'planning'), ('GO_0007565', 'female pregnancy', 1053, 'preparing of food'), ('CHEBI_33290', 'food', 1066, 'food'), ('CHEBI_33290', 'food', 1125, 'food'), ('GO_0036268', 'swimming', 1133, 'eaten'), ('GO_0036268', 'swimming', 1146, 'eaten'), ('GO_0051318', 'G1 phase', 1152, 'eating'), ('UBERON_0010164', 'collection of hairs', 1182, 'Lunch'), ('GO_0050957', 'equilibrioception', 1421, 'eatingDon'), ('CHEBI_15377', 'water', 1446, 'water'), ('GO_0065007', 'biological regulation', 1504, 'control'), ('CHEBI_33290', 'food', 1512, 'food'), ('GO_0007631', 'feeding behavior', 1512, 'food intake'), ('CHEBI_33290', 'food', 1533, 'food'), ('GO_0051318', 'G1 phase', 1592, 'eating'), ('CHEBI_46751', 'quinolizidine', 1667, 'minerals'), ('CHEBI_33277', 'gamma-tocotrienol', 1680, 'vitamins'), ('GO_0001967', 'suckling behavior', 1959, 'nonsense')]
PMC5035678	4/2016	S112-PMC5035678	['fifty eight percent of group c remained Vitamin D deficient, which INDICATES that the usual multivitamin that is prescribed for a majority of Pregnant women (containing 400 iu Vitamin D3) is not adequate to correct hypovitaminosis D. THEREFORE, Pregnant women NEED a higher dose of Vitamin D than that typically consumed.']	[('INCOMPLETE_EVIDENCE', 67), ('PROBABLE_UNDERSTANDING', 234), ('IMPORTANT_CONSIDERATION', 260)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 142, 'pregnant'), ('CHEBI_33279', 'vitamin D5', 176, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 176, 'vitamin D3'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 231, 'D'), ('GO_0007565', 'female pregnancy', 245, 'pregnant'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D')]
PMC5035678	4/2016	S134-PMC5035678	['this negative result was LIKELY caused by inadequate doses of Vitamin D3, time limitations, or the LACK OF a causal RELATION between Vitamin D and type 2 diabetes.']	[('PROBABLE_UNDERSTANDING', 25), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 116)]	3	[('CHEBI_33279', 'vitamin D5', 62, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 62, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
PMC5039809	10/2016	S1-PMC5039809	['TO OUR KNOWLEDGE, the ASSOCIATIONS between maternal Vitamin A status and offspring Bone Development have NOT previously BEEN ELUCIDATED.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 22), ('FULL_UNKNOWN', 105)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin A'), ('GO_0048539', 'bone marrow development', 83, 'bone development')]
PMC5039809	10/2016	S21-PMC5039809	['FEW STUDIES to OUR KNOWLEDGE have RELATED maternal Vitamin A nutrition during Pregnancy to Offspring Bone Development.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 15), ('SUPERFICIAL_RELATIONSHIP', 34)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin A'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0007608', 'sensory perception of smell', 91, 'offspring'), ('GO_0048539', 'bone marrow development', 101, 'bone development')]
PMC5039809	10/2016	S112-PMC5039809	['there are FEW STUDIES to OUR KNOWLEDGE that have RELATED maternal Vitamin A status to offspring Bone Development.']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 25), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin A'), ('GO_0048539', 'bone marrow development', 96, 'bone development')]
PMC5045784	10/2016	S80-PMC5045784	['current american academy of pediatrics GUIDELINES34RECOMMEND Vitamin D intake of 400\u2009iu per day for all children but there are NO specific GUIDELINES for preterm infants.']	[('PROBABLE_UNDERSTANDING', 39), ('PROBABLE_UNDERSTANDING', 39), ('FULL_UNKNOWN', 127)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC5051327	9/2016	S18-PMC5051327	['THEREFORE, cardiotocography (ctg) is the main instrument of fetal Surveillance.13it is PLAUSIBLE that Vitamin D deficiency COULD make the fetal Heart more vulnerable to fetal distress/Birth asphyxia.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 123)]	3	[('GO_0065007', 'biological regulation', 66, 'surveillance'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0000948', 'heart', 144, 'heart'), ('GO_0007567', 'parturition', 184, 'birth')]
PMC5051327	9/2016	S30-PMC5051327	['Vitamin D deficiency was DEFINED AS 25-Oh Vitamin D <50\u2005nmol/l and non-deficiency AS ≥50\u2005nmol/l according to iom.17all Serum samples were analysed at the karolinska university laboratory, with a direct competitive chemiluminescence immunoassay for 25-Oh Vitamin D from diasorin on a liason instrument (diasorin , stillwater, minnesota, usa).']	[('PROBABLE_UNDERSTANDING', 25), ('PROBABLE_UNDERSTANDING', 33), ('PROBABLE_UNDERSTANDING', 82)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 36, '25-OH'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 248, '25-OH'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D')]
PMC5051327	9/2016	S80-PMC5051327	['we SPECULATE that our finding of shorter maternal height among Vitamin D deficient women MIGHT be DUE TO an increased prevalence of Vitamin D deficiency during childhood and Adolescence.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 98)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 174, 'adolescence')]
PMC5062906	10/2016	S70-PMC5062906	['THUS, maternal Vitamin D depletion MOST LIKELY causes heritable disruption of global epigenetic programming in the offspring.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 35), ('PROBABLE_UNDERSTANDING', 40)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
PMC5084041	10/2016	S123-PMC5084041	['this MAY PARTLY be EXPLAINED by less Vitamin D supplement use in late Pregnancy than in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 19)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
PMC5085625	9/2016	S75-PMC5085625	['moreover, the authors searched for a POTENTIAL mechanism EXPLAINING the ASSOCIATION between Vitamin D status and Pregnancy-related hypertensive disorders.']	[('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 57), ('SUPERFICIAL_RELATIONSHIP', 72)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
PMC5129897	10/2016	S192-PMC5129897	['one was a meta-analysis of observational studies.104the OTHER was a study of cancer incidence by occupation in nordic countries.49\n\nconclusions\nmany People living in canada do not have OPTIMAL 25(Oh)D concentrations AS a result of limited solar uvb exposure and/or not obtaining enough Vitamin D from Food or supplements.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 56), ('IMPORTANT_CONSIDERATION', 185), ('PROBABLE_UNDERSTANDING', 216)]	3	[('NCBITaxon_10088', 'Mus <genus>', 149, 'people'), ('CHEBI_71657', 'versiconol acetate', 193, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 193, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 286, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 294, 'D'), ('CHEBI_33290', 'food', 301, 'food')]
PMC5146866	12/2016	S9-PMC5146866	['conclusions\nthe LIKELIHOOD for an infant to be Born with Vitamin D deficiency/insufficiency is relatively high and is RELATED MAINLY to younger maternal age, gravidity, and non-white race/ethnicity.']	[('PROBABLE_UNDERSTANDING', 16), ('SUPERFICIAL_RELATIONSHIP', 118), ('PROBABLE_UNDERSTANDING', 126)]	3	[('GO_0007567', 'parturition', 47, 'born'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D')]
PMC5146866	12/2016	S99-PMC5146866	['TO THE BEST OF OUR KNOWLEDGE, NO PRIOR STUDY has investigated the clinical status of neonates in ASSOCIATION with cb Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 30), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
PMC5155676	12/2016	S127-PMC5155676	['as baseline 25(Oh)D was ASSOCIATED with the LIKELIHOOD of achieving Vitamin D replete status, it is LIKELY that women with very low levels of 25(Oh)D at baseline will require a higher supplementation dose to achieve Vitamin D repletion.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 44), ('PROBABLE_UNDERSTANDING', 100)]	3	[('CHEBI_71657', 'versiconol acetate', 12, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 144, '(OH)D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
PMC5155676	12/2016	S137-PMC5155676	['AS SUCH, personalized Vitamin D supplementation ADVICE MIGHT become part of future Antenatal care.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 48), ('INCOMPLETE_EVIDENCE', 55)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007567', 'parturition', 83, 'antenatal')]
PMC5264377	7/2016	S100-PMC5264377	['ANOTHER PLAUSIBLE EXPLANATION is the molecular abduction of Vitamin D by Adipose Tissue discussed above.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 18)]	3	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 73, 'adipose tissue')]
PMC5310660	1/2017	S38-PMC5310660	['several seasonal factors acting during Pregnancy and the Perinatal Period HAVE BEEN PROPOSED to EXPLAIN these data, including infections, dietary factors (e.g., low intake of antioxidants in winter), and Vitamin D deficiency through lack of sun exposure during Pregnancy.[8].']	[('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 84), ('PROBABLE_UNDERSTANDING', 96)]	3	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('GO_0036268', 'swimming', 57, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 57, 'perinatal period'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('GO_0007565', 'female pregnancy', 261, 'pregnancy')]
PMC5340372	3/2017	S13-PMC5340372	['since the discovery that MOST Tissues and cells have Vitamin D receptors, there has been great INTEREST in its ROLE in the development of many diseases, such as cancer [1], Cardiovascular diseases [2], infectious diseases [3], and Autoimmune disease [4].']	[('PROBABLE_UNDERSTANDING', 25), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('UBERON_0000479', 'tissue', 30, 'tissues'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 173, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 231, 'autoimmune')]
PMC5340372	3/2017	S137-PMC5340372	['the MAJORITY of the participants lived in keelung, a rainy city whose inhabitants have a higher RISK of Vitamin D deficiency than elsewhere DUE TO lack of sun exposure [52].']	[('PROBABLE_UNDERSTANDING', 4), ('IMPORTANT_CONSIDERATION', 96), ('PROBABLE_UNDERSTANDING', 140)]	3	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC5405075	4/2017	S28-PMC5405075	['AS a result, Vitamin D deficiency during Pregnancy exerts SIGNIFICANT IMPACT on Vitamin D status of newborns and subsequently on early Childhood (9,28).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0013628', 'pollical pad', 135, 'childhood')]
PMC5405075	4/2017	S34-PMC5405075	['maternal Vitamin D status and ASSOCIATIONS with asthma in early Life\nthe PUTATIVE EFFECT of Prenatal exposure to Vitamin D on asthmatic phenotypes in early Life has been initially investigated via observational studies based on either maternal dietary Intake of Vitamin D or 25(Oh)D levels in Venous maternal and/or Cord Blood [reviewed in ref.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 73), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 64, 'Life'), ('GO_0007565', 'female pregnancy', 92, 'prenatal'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0000104', 'life cycle', 156, 'life'), ('GO_0007631', 'feeding behavior', 252, 'intake'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 275, '25(OH)D'), ('UBERON_0001638', 'vein', 293, 'venous'), ('UBERON_0002240', 'spinal cord', 316, 'cord'), ('UBERON_0000178', 'blood', 321, 'blood')]
PMC5418719	5/2017	S130-PMC5418719	['preterm infants with these diseases MAY more LIKELY to have low Vitamin D levels INVOLVED in impaired Vitamin D absorption or Metabolism during hospitalization.']	[('INCOMPLETE_EVIDENCE', 36), ('PROBABLE_UNDERSTANDING', 45), ('SUPERFICIAL_RELATIONSHIP', 81)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0008152', 'metabolic process', 126, 'metabolism')]
PMC5426325	4/2017	S146-PMC5426325	['from systematic review and meta-analysis of randomised controlled trials, THERE IS EVIDENCE that Vitamin D-fortified Foods GENERALLY improve Vitamin D status among both children and Adults in a dose-DEPENDENT manner(57–59).']	[('INCOMPLETE_EVIDENCE', 74), ('PROBABLE_UNDERSTANDING', 123), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_33290', 'food', 117, 'foods'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('UBERON_0007023', 'adult organism', 182, 'adults')]
PMC5489519	6/2017	S18-PMC5489519	['THEREFORE, Vitamin D deficient mothers are more LIKELY to have infants with Vitamin D deficiency which AFFECTS Immune and bone health16.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('UBERON_0002405', 'immune system', 111, 'immune')]
PMC5489519	6/2017	S19-PMC5489519	['it HAS BEEN REPORTED that infants of Vitamin D deficient mothers are PRONE to develop rickets17.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 69)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5489519	6/2017	S87-PMC5489519	['THEREFORE, our results INDICATE that Trail\xa0is Expressed in Breast Milk as a FUNCTION of Vitamin D status in mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 37, 'TRAIL'), ('GO_0010467', 'gene expression', 46, 'expressed'), ('UBERON_0001348', 'brown adipose tissue', 59, 'breast milk'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
PMC5489519	6/2017	S99-PMC5489519	['THEREFORE, elevated levels of Trail Expression due to Vitamin D deficiency MAY have a significant IMPACT on both mother and infant bone Growth/Development.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 98)]	3	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 30, 'TRAIL'), ('GO_0010467', 'gene expression', 36, 'expression'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0040007', 'growth', 136, 'growth'), ('GO_0008289', 'lipid binding', 143, 'development')]
PMC5489519	6/2017	S112-PMC5489519	['THEREFORE, IT IS POSSIBLE that elevated levels of Trail INFLUENCE Vitamin D Metabolism in Mammary Epithelial Cells45.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 56)]	3	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 50, 'TRAIL'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 66, 'vitamin D metabolism'), ('CL_0002327', 'mammary gland epithelial cell', 90, 'mammary epithelial cells45'), ('UBERON_0006954', 'mammary gland myoepithelium', 90, 'mammary epithelial')]
PMC5513133	7/2017	S32-PMC5513133	['caption (table-wrap): table 1\n\nsummary of effects of increased Vitamin D on the pathogenesis of pre-eclampsia (pe)stage of pecharacteristic of pe↑ Vitamin dstage 1inflammation-linked abnormal Placental Implantation↓ predisposition to pro-inflammatory response [20]↑ Regulation of Genes associated with Placental invasion and normal Implantation [20]stage 2vascular Endothelial dysfunction↑ Vascular structure, elasticity and Intima-Media thickness↓ Blood pressure (Regulation of Renin-angiotension system) [63]↓oxidative stress [24]proteinuria mediated by Renal Vascular Endothelial Growth Factor (Vegf)↑ Vascular Smooth Muscle Cell Proliferation by increasing vegf Gene transcription [19]\n\nbiological PLAUSIBILITY of the ROLE of Vitamin D in pe\nVitamin D3, or Cholecalciferol, is formed endogenously when 7-Dehydrocholesterol in Keratinocytes is converted to a seco-Steroid pro-hormone upon irradiation by uv-b light.']	[('INCOMPLETE_EVIDENCE', 702), ('PROBABLE_UNDERSTANDING', 702), ('SUPERFICIAL_RELATIONSHIP', 722)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 147, 'Vitamin'), ('UBERON_0001987', 'placenta', 192, 'placental'), ('GO_0007566', 'embryo implantation', 202, 'implantation'), ('GO_0007567', 'parturition', 214, '↓'), ('GO_0065007', 'biological regulation', 266, 'Regulation'), ('SO_0000704', 'gene', 280, 'genes'), ('UBERON_0001987', 'placenta', 302, 'placental'), ('GO_0007566', 'embryo implantation', 332, 'implantation'), ('UBERON_0001986', 'endothelium', 365, 'Endothelial'), ('GO_0031674', 'I band', 390, 'Vascular'), ('GO_0005622', 'intracellular anatomical structure', 425, 'intima'), ('UBERON_0009472', 'axilla', 425, 'intima'), ('UBERON_0000951', 'rotator muscle of the vertebral column', 432, 'media'), ('UBERON_0000178', 'blood', 449, 'Blood'), ('GO_0065007', 'biological regulation', 465, 'regulation'), ('PR_000014368', 'RuvB-like 1', 479, 'renin'), ('UBERON_0002113', 'kidney', 556, 'renal'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 562, 'vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 571, 'endothelial'), ('PR_000017279', 'testis-specific basic protein Y 1', 598, 'VEGF'), ('CL_0000359', 'vascular associated smooth muscle cell', 605, 'Vascular smooth muscle cell'), ('UBERON_0006849', 'scapula', 605, 'Vascular'), ('UBERON_0001135', 'smooth muscle tissue', 614, 'smooth muscle'), ('GO_0007601', 'visual perception', 621, 'muscle'), ('GO_0008283', 'cell proliferation', 628, 'cell proliferation'), ('SO_0000704', 'gene', 666, 'gene'), ('CHEBI_27300', 'vitamin D', 730, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 746, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 746, 'Vitamin D3'), ('CHEBI_52550', 'theopalauamide', 761, 'cholecalciferol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 806, '7-dehydrocholesterol'), ('CL_0000312', 'keratinocyte', 830, 'keratinocytes'), ('CHEBI_35341', 'steroid', 867, 'steroid')]
PMC5521778	7/2017	S47-PMC5521778	['THIS STUDY PROVIDES the FIRST EVIDENCE that Gcs antagonize Vitamin A Signaling through suppression of Bco1 Expression and defines a Pparα-dependent transcriptional mechanism.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 24)]	3	[('CL_0000740', 'retinal ganglion cell', 44, 'GCs'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin A'), ('GO_0038092', 'nodal signaling pathway', 59, 'vitamin A signaling'), ('PR_000004693', 'Bcl-2-like protein 10', 102, 'BCO1'), ('GO_0010467', 'gene expression', 107, 'expression'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 132, 'PPARα')]
PMC5539754	8/2017	S18-PMC5539754	['HOWEVER, the MAJORITY of Vitamin D supplementation intervention trials in Pregnancy have not had a SIGNIFICANT IMPACT on maternal and offspring health [10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('IMPORTANT_CONSIDERATION', 99)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy')]
PMC5539754	8/2017	S160-PMC5539754	['thus, RECOMMENDATIONS for Vitamin D supplementation to improve Glucose Homeostasis in Pregnancy CANNOT BE made BASED ON our results.']	[('FUTURE_WORK', 6), ('INCOMPLETE_EVIDENCE', 96), ('PROBABLE_UNDERSTANDING', 111)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_17234', 'glucose', 63, 'glucose'), ('GO_0042593', 'glucose homeostasis', 63, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy')]
PMC5634602	10/2017	S38-PMC5634602	['preterm infants have a smaller size, leading to decreased volume Intake, and OFTEN have a compromised nutritional status during the initial hospitalization and are EVEN less LIKELY to get adequate Vitamin D intake from diet [15].']	[('PROBABLE_UNDERSTANDING', 77), ('ANOMALY_CURIOUS_FINDING', 164), ('PROBABLE_UNDERSTANDING', 174)]	3	[('GO_0007631', 'feeding behavior', 65, 'intake'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
PMC5634602	10/2017	S40-PMC5634602	['additionally, we will EVALUATE response to supplementation in the subset of infants weighing <1200 grams AS there is MINIMAL information available regarding response to Vitamin D supplementation in this specific high-risk group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('PROBABLE_UNDERSTANDING', 105), ('INCOMPLETE_EVIDENCE', 117)]	3	[('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC5634602	10/2017	S89-PMC5634602	['a notable DIFFERENCE between THIS STUDY and ours is that in natarajan’s intervention the dose of Vitamin D supplementation was reduced to ACCOUNT FOR dietary intake of vitamin D and the total intake of Vitamin D was 400 iu or 800 iu.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('PROBABLE_UNDERSTANDING', 138)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 176, 'D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC5634602	10/2017	S136-PMC5634602	['we were unable to adequately assess maternal Vitamin D intake during Pregnancy in the cohort studied, AS maternal records OFTEN DID NOT report the amount of Vitamin D in the prescribed Prenatal vitamin.']	[('PROBABLE_UNDERSTANDING', 102), ('PROBABLE_UNDERSTANDING', 122), ('INCOMPLETE_EVIDENCE', 128)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0007565', 'female pregnancy', 185, 'prenatal')]
PMC5638722	8/2017	S4-PMC5638722	['in the PRESENT STUDY, severe Vitamin D deficiency (group 1) was DEFINED AS a 25-Hydroxyvitamin D (25(Oh)D) concentration <5 ng/ml; Vitamin D insufficiency (group 2), 25(Oh)D concentration ≥5 ng/ml and <15 ng/ml; and Vitamin D sufficiency (group 3), 25(Oh)D concentration ≥15 ng/ml.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('PROBABLE_UNDERSTANDING', 64), ('PROBABLE_UNDERSTANDING', 72)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 77, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 166, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 172, 'D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 249, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 255, 'D')]
PMC5638722	8/2017	S127-PMC5638722	['in THE literature, Cord-Blood Vitamin D levels are REPORTED to be MAINLY 20% lower than the maternal Blood levels25).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 51), ('PROBABLE_UNDERSTANDING', 66)]	3	[('UBERON_0002240', 'spinal cord', 19, 'cord'), ('UBERON_0000178', 'blood', 24, 'blood'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000178', 'blood', 101, 'blood')]
PMC5659607	10/2017	S118-PMC5659607	['this resulted in more power to detect TRUE EFFECTS of the Vitamin D supplementation than the individual intent-to-treat analyses, illustrated by a similar overall effect estimate in the analyses, which now reached statistical SIGNIFICANCE.']	[('PROBABLE_UNDERSTANDING', 38), ('SUPERFICIAL_RELATIONSHIP', 43), ('IMPORTANT_CONSIDERATION', 226)]	3	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5659607	10/2017	S140-PMC5659607	['THEREFORE, initiating the supplementation at 10–18 weeks’ Gestation in vdaart and in particular at 22–26 weeks’ Gestation in copsac2010was PRESUMABLY too late to achieve a maximal EFFECT of Vitamin D on fetal Lung Development.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 139), ('SUPERFICIAL_RELATIONSHIP', 180)]	3	[('GO_0007565', 'female pregnancy', 58, 'gestation'), ('GO_0007565', 'female pregnancy', 112, 'gestation'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('GO_0030324', 'lung development', 209, 'lung development'), ('UBERON_0002048', 'lung', 209, 'lung')]
PMC5664622	9/2017	S6-PMC5664622	['THEREFORE, summer improves the levels of Vitamin D in the body but does not guarantee the RECOMMENDED concentration and supplementation throughout the whole year is ESSENTIAL.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 90), ('IMPORTANT_CONSIDERATION', 165)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5664622	9/2017	S15-PMC5664622	['AS dietary sources of Vitamin D have FAILED to meet the RECOMMENDED levels for years [12,13], Vitamin D concentration is in fact enhanced by supplementation and exposure to sunlight [2,5].']	[('PROBABLE_UNDERSTANDING', 0), ('DIFFICULT_TASK', 37), ('FUTURE_WORK', 56)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
PMC5664622	9/2017	S16-PMC5664622	['in CONSEQUENCE, season of the year, geographic location and lifestyle have become the KEY FACTORS as far as sources of Vitamin D are concerned.']	[('PROBABLE_UNDERSTANDING', 3), ('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 90)]	3	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC5664622	9/2017	S75-PMC5664622	['the summer group had higher values, which MOST PROBABLY had its source in more sun exposure, AS there were no differences in Vitamin D intake between both groups.']	[('PROBABLE_UNDERSTANDING', 42), ('PROBABLE_UNDERSTANDING', 47), ('PROBABLE_UNDERSTANDING', 93)]	3	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC5664622	9/2017	S113-PMC5664622	['it is MOST PROBABLY the result of the fact that gdm women in this sample more OFTEN used single-component Vitamin D preparations, or even several supplements at once, as compared to healthy women (35.8% vs. 11.5%, respectively).']	[('PROBABLE_UNDERSTANDING', 6), ('PROBABLE_UNDERSTANDING', 11), ('PROBABLE_UNDERSTANDING', 78)]	3	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
PMC5679631	11/2017	S128-PMC5679631	['a state of Vitamin D deficiency resulting in a pro-inflammatory state and INCREASED susceptibility to Intestinal infections, THEREFORE, MAY lead to altered microbial colonization known as Dysbiosis or disturbance of the balance between beneficial commensal and pathogenic species [24].']	[('IMPORTANT_CONSIDERATION', 74), ('PROBABLE_UNDERSTANDING', 125), ('INCOMPLETE_EVIDENCE', 136)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000160', 'intestine', 102, 'intestinal'), ('GO_0046067', 'dGDP catabolic process', 188, 'dysbiosis')]
PMC5679631	11/2017	S146-PMC5679631	['in a FUTURE STUDY, it would be PREFERABLE to investigate the IMPACT of Postnatal Vitamin D supplementation in older infants whose 25(Oh)D concentrations have reached a steady state.']	[('FUTURE_WORK', 5), ('PROBABLE_UNDERSTANDING', 31), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('GO_0007567', 'parturition', 71, 'postnatal'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 130, '25(OH)D')]
PMC5685050	10/2014	S43-PMC5685050	['thai women are at risk for Vitamin D insufficiency LIKELY DUE TO sunscreen usage and sun avoidant behavior DUE TO the desire to maintain a fair complexion.']	[('PROBABLE_UNDERSTANDING', 51), ('PROBLEM_COMPLICATION', 58), ('PROBLEM_COMPLICATION', 107)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC5716389	9/2017	S10-PMC5716389	['maternal nutritional status, and exposure during fetal Life to an inadequately nurturing environment, COULD THUS IMPACT fetal Immune Development [3,4], in particular, Micronutrients including zinc, iron, Vitamin A and protein energy malnutrition (pem).']	[('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 108), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('UBERON_0000104', 'life cycle', 55, 'life'), ('GO_0001822', 'kidney development', 126, 'immune development'), ('UBERON_0002405', 'immune system', 126, 'immune'), ('CHEBI_33839', 'macromolecule', 167, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin A')]
PMC5732505	12/2017	S15-PMC5732505	['a sufficient maternal Vitamin D status, specified AS 25(Oh)D above 50\xa0nmol/l, MAY BE a threshold above which the physiological REQUIREMENTS of Pregnancy are achieved.']	[('PROBABLE_UNDERSTANDING', 50), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 127)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 53, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 59, 'D'), ('GO_0007565', 'female pregnancy', 143, 'pregnancy')]
PMC5732505	12/2017	S19-PMC5732505	['HOWEVER, DUE TO recent changes in national health policies, intake of Vitamin D has increased RESULTING IN decreasing rates of Vitamin D deficiency [2–5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('SUPERFICIAL_RELATIONSHIP', 94)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
PMC5732505	12/2017	S176-PMC5732505	['sufficient maternal Vitamin D status, specified AS 25(Oh)D above 50\xa0nmol/l, SEEMS a threshold value, above which the physiological REQUIREMENTS of Pregnancy are achieved.']	[('PROBABLE_UNDERSTANDING', 48), ('PROBABLE_UNDERSTANDING', 76), ('IMPORTANT_CONSIDERATION', 131)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 51, '25(OH)D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy')]
PMC5784894	1/2018	S18-PMC5784894	['[12] previous epidemiological work SUGGESTS a RELATIONSHIP between season of Birth, and HENCE maternal sunlight exposure and cutaneous Vitamin D Synthesis, and hip fracture risk in older people[13].']	[('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 46), ('PROBABLE_UNDERSTANDING', 88)]	3	[('GO_0007567', 'parturition', 77, 'birth'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 135, 'vitamin D synthesis')]
PMC5812027	2/2018	S137-PMC5812027	['TO OUR KNOWLEDGE, ours is one of the FIRST studies to find ASSOCIATIONS between Vitamin D status and Pregnancy loss.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
PMC5812027	2/2018	S164-PMC5812027	['both higher late Pregnancy Vitamin D status and Gestational Vitamin D status trajectory CAN be SUSPECTED to play a ROLE in healthy Pregnancy.']	[('INCOMPLETE_EVIDENCE', 88), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 115)]	3	[('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'gestational'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy')]
PMC5941617	5/2018	S98-PMC5941617	['THUS, dietary sources of Vitamin D SHOULD NOT BE considered significant for Humans except SOME populations living at higher latitudes where fish, fish oil and fish eggs are frequently Consumed [88].']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 35), ('INCOMPLETE_EVIDENCE', 90)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 76, 'humans'), ('GO_0007631', 'feeding behavior', 184, 'consumed')]
PMC5941617	5/2018	S113-PMC5941617	['moreover, newborns from deficient mothers are at INCREASED RISK for Vitamin D deficiency AS Cord Blood and neonatal 25(Oh)D levels highly CORRELATE with maternal Vitamin d status during Gestation [92,93].']	[('IMPORTANT_CONSIDERATION', 49), ('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 92, 'cord'), ('UBERON_0000178', 'blood', 97, 'blood'), ('CHEBI_71657', 'versiconol acetate', 116, '25(OH)D'), ('CHEBI_33229', 'vitamin (role)', 162, 'vitamin'), ('GO_0007565', 'female pregnancy', 186, 'gestation')]
PMC5941617	5/2018	S143-PMC5941617	['DIFFERENTLY, CONSIDERING the high prevalence of Vitamin D deficiency during Pregnancy, the espghan RECOMMENDED for preterm infants a Vitamin D intake of 800–1000\xa0iu/day during the first months of Life to rapidly correct fetal low Serum 25(Oh)D levels [125].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('FUTURE_WORK', 99)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('UBERON_0000104', 'life cycle', 196, 'life'), ('UBERON_0001977', 'blood serum', 230, 'serum'), ('CHEBI_71657', 'versiconol acetate', 236, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 236, '25(OH ... D')]
PMC5941617	5/2018	S179-PMC5941617	['for example, arab emirates GUIDELINES RECOMMENDED Vitamin D supplementation between may and october BECAUSE arabian People avoid sun exposure during summer due to excessive heat [27].']	[('PROBABLE_UNDERSTANDING', 27), ('FUTURE_WORK', 38), ('PROBABLE_UNDERSTANDING', 100)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 116, 'people')]
PMC5941617	5/2018	S255-PMC5941617	['THUS, Vitamin D supplementation during infancy is IMPORTANT to optimize bone mass acquisition and body composition, but high doses are not RECOMMENDED.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 50), ('FUTURE_WORK', 139)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC5941617	5/2018	S312-PMC5941617	['THUS, the results of this study do not SUPPORT the routine use of high-dose Vitamin D supplementation in children for the PREVENTION of Viral Upper Respiratory Tract infections [271].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 122)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('NCBITaxon_1', 'root', 136, 'viral'), ('UBERON_0001557', 'upper respiratory tract', 142, 'upper respiratory tract')]
PMC5941617	5/2018	S358-PMC5941617	['CONSEQUENTLY, SEVERAL STUDIES in vivo and in vitro SHOWED that Vitamin D supplementation inhibits the th2 Expression contrasting allergic diseases [309–314].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 51)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0010467', 'gene expression', 106, 'expression')]
PMC5941617	5/2018	S451-PMC5941617	['clinical GUIDELINE for Skeletal health of children and adolescents with ibd RECOMMEND to treat Vitamin D deficiency and insufficiency administering a cumulative dose of AT LEAST 400000\xa0iu, and 250000\xa0iu of Vitamin D, respectively.']	[('PROBABLE_UNDERSTANDING', 9), ('FUTURE_WORK', 76), ('PROBABLE_UNDERSTANDING', 169)]	3	[('UBERON_0004288', 'skeleton', 23, 'skeletal'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D')]
PMC5941617	5/2018	S474-PMC5941617	['other authors REINFORCE that Vitamin D supplementation SHOULD BE offered to cd patients AT LEAST during the first years of gluten free diet [423].']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 55), ('PROBABLE_UNDERSTANDING', 88)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC5941617	5/2018	S483-PMC5941617	['ON THE CONTRARY, two meta-analyses enrolling MAINLY Adults SHOWED that Vitamin D supplementation did not decrease adiposity [444,445].']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 45), ('INCOMPLETE_EVIDENCE', 59)]	3	[('UBERON_0007023', 'adult organism', 52, 'adults'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC5941617	5/2018	S526-PMC5941617	['THEREFORE, FURTHER rcts ARE NEEDED before RECOMMENDING routine Vitamin D supplementation in children with autism.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 11), ('FUTURE_WORK', 42)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC5941617	5/2018	S582-PMC5941617	['a RECENT 1-year-RCT compared three different regimens for asymptomatic children and adolescents with Vitamin D deficiency and insufficiency (400\xa0iu/day, 45000\xa0iu weekly for 2\xa0months then 400\xa0iu daily, 2000\xa0iu/day for 3\xa0months then 1000\xa0iu/day), SUGGESTING that low loading dose with high maintenance dose is PREFERRED to achieve steady increase in Serum 25(Oh)D levels avoiding hypercalcemic side effects [521].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 245), ('PROBABLE_UNDERSTANDING', 308)]	3	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0001977', 'blood serum', 348, 'serum'), ('CHEBI_71657', 'versiconol acetate', 354, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 354, '25(OH)D')]
PMC5941617	5/2018	S698-PMC5941617	['after achieving Vitamin D sufficiency, we RECOMMEND to continue with Vitamin D supplementation at higher doses than those RECOMMENDED for age (AT LEAST 1000–1500\xa0iu/day).']	[('FUTURE_WORK', 42), ('FUTURE_WORK', 122), ('PROBABLE_UNDERSTANDING', 143)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
PMC5941617	5/2018	S701-PMC5941617	['RECOMMENDATIONS for treatment of Vitamin D deficiency in patients with newly diagnosed cd are equivalent to those for ibds patients, AS both these conditions are ASSOCIATED with Intestinal malabsorption.']	[('FUTURE_WORK', 0), ('PROBABLE_UNDERSTANDING', 133), ('SUPERFICIAL_RELATIONSHIP', 162)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0000160', 'intestine', 178, 'intestinal')]
PMC5941617	5/2018	S702-PMC5941617	['AS gluten-free diet restores normal Intestinal absorption, after treatment of deficiency we RECOMMEND Vitamin D supplementation according to the modalities and REQUIREMENTS for otherwise healthy children and adolescents.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 92), ('IMPORTANT_CONSIDERATION', 160)]	3	[('UBERON_0000160', 'intestine', 36, 'intestinal'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
PMC5952272	5/2018	S82-PMC5952272	['THUS, Vitamin E status CAN be considered AS quite satisfactory.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 41)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin E')]
PMC5956785	5/2018	S229-PMC5956785	['they FOUND that the MAJORITY of pediatric rheumatologists are RECOMMENDING Vitamin D for patients who were on long-term Corticosteroids [76].']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 20), ('FUTURE_WORK', 62)]	3	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_50850', 'etabonate ester', 120, 'corticosteroids')]
PMC5995352	6/2018	S28-PMC5995352	['this leaves the infant more SUSCEPTIBLE to developing Vitamin D deficiency rickets if not receiving adequate Vitamin D supplementation, AS the lower inborn Vitamin D stores will decrease to severely insufficient levels sooner IN ACCORDANCE WITH the half-life of 25Ohd.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 226)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 262, '25OHD')]
PMC5995352	6/2018	S31-PMC5995352	['low foetal Vitamin D stores MAY THEREFORE further decrease to CRITICAL levels soon after Birth, in the absence of infant Vitamin D supplementation.']	[('INCOMPLETE_EVIDENCE', 28), ('PROBABLE_UNDERSTANDING', 32), ('IMPORTANT_CONSIDERATION', 62)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007567', 'parturition', 89, 'birth'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC6011374	6/2018	S64-PMC6011374	['caption (table-wrap): table 1\n\nparticipant characteristics and comparison of characteristics between women recruited at the adelaide and auckland scope centresall women (n = 2800)adelaide (n = 1156)auckland (n = 1644) p value*age yrs , mean (sd)28 (6)23.73 (5.11)30.44 (4.82)<0.0001bmi kg/m2, mean (sd)25.8 (5.44)27.04 (6.56)24.88 (4.26)<0.0001ethnicity<0.0001\u2003caucasian2449 (87)1060 (92)1389 (84)\u2003non caucasian351 (13)96 (8)255 (16)smoking status, n (%)<0.0001\u2003no2152 (77)704 (61)1448 (88)\u2003quit during Pregnancy306 (11)175 (15)131 (8)\u2003smoking342 (12)277 (24)65 (4)Alcohol consumption, n (%)<0.0001\u2003no1480 (53)708 (61)772 (47)\u2003stopped during pregnancy1185 (42)397 (34)788 (48)\u2003consuming Alcohol135 (5)51 (4)84 (5)fruit intake, n (%)<0.0001\u2003≥1x per day2032 (73)586 (51)1446 (88)\u20033-6x per week405 (14)272 (24)133 (8)\u20031-2x per week223 (8)181 (16)42 (3)\u20031-3x per month or less140 (5)117 (10)23 (1)recreational walking<0.0001\u2003never428 (15)265 (23)163 (10)\u20031-3 times/week1773 (63)668 (58)1105 (68)\u2003≥4 times/week590 (22)221 (19)369 (23)time watching tv<0.0001\u2003<5 hours per day2404 (86)901 (78)1503 (92)\u2003≥5 hours per day387 (14)253 (22)134 (8)season Serum was sampled0.3213\u2003summer636 (23)278 (24)358 (22)\u2003autumn705 (25)273 (24)432 (26)\u2003winter727 (26)300 (26)427 (26)\u2003spring732 (26)305 (26)427 (26)Serum 25(Oh)D nmol/l , mean (sd)68.09 (27.14)60.06 (23.68)73.74 (27.99)<0.0001vitamin D status<0.0001\u2003<25 nmol/l99 (4)48 (4)51 (3)\u200325-50 nmol/l673 (24)375 (32)298 (18)\u200350-75 nmol/l928 (33)422 (37)506 (31)\u2003>75 nmol/l1098 (39)311 (27)787 (48)\n* p values for continuous variables were determined using a welch’s t-test and categorical variables a fisher’s exact test comparing adelaide and auckland women\n\nstandardising Serum 25(Oh)D based on seasonal variation\nAS EXPECTED, there was a seasonal INFLUENCE on Serum 25(Oh)D and THUS, “standardised” Vitamin D concentrations were calculated to account for the month of Serum collection.']	[('INCOMPLETE_EVIDENCE', 1748), ('SUPERFICIAL_RELATIONSHIP', 1782), ('PROBABLE_UNDERSTANDING', 1813)]	3	[('GO_0007602', 'phototransduction', 503, 'pregnancy306'), ('CHEBI_30879', 'alcohol', 565, 'Alcohol'), ('CHEBI_78635', 'fatty alcohol 16:1', 687, 'alcohol135'), ('UBERON_0001977', 'blood serum', 1142, 'serum'), ('UBERON_0001977', 'blood serum', 1289, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 1295, '25(OH)D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1375, 'D'), ('UBERON_0001977', 'blood serum', 1706, 'serum'), ('CHEBI_71657', 'versiconol acetate', 1712, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1712, '25(OH)D'), ('UBERON_0001977', 'blood serum', 1795, 'serum'), ('CHEBI_71657', 'versiconol acetate', 1801, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1801, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1834, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1903, 'serum')]
PMC6011374	6/2018	S101-PMC6011374	['THEREFORE, the protective ROLE of high 25(Oh)D 15\u2009±\u20091\xa0weeks’ Gestation against gdm, as seen with a decreased risk of gdm in women within the ‘high’ quartile of standardised Vitamin D compared to moderate-high, is CONSISTENT with knowledge about Vitamin D and diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 213)]	3	[('CHEBI_71657', 'versiconol acetate', 39, '25(OH)D'), ('GO_0007565', 'female pregnancy', 61, 'gestation'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D')]
PMC6011374	6/2018	S111-PMC6011374	['lack of statistically significant associations with other Pregnancy complications MAY reflect the fact that this was a largely Vitamin D-replete population (>\u200972% with Serum 25(Oh)D\u2009>\u200950\xa0nmol/l) LIKELY DUE TO their residence latitude as low Serum 25(Oh)D was found in the scope ireland cohort [52].']	[('INCOMPLETE_EVIDENCE', 82), ('PROBABLE_UNDERSTANDING', 195), ('PROBLEM_COMPLICATION', 202)]	3	[('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('UBERON_0001977', 'blood serum', 168, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 177, 'OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 180, 'D'), ('UBERON_0001977', 'blood serum', 241, 'serum'), ('CHEBI_71657', 'versiconol acetate', 247, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 247, '25(OH)D')]
PMC2290997	4/2008	S29-PMC2290997	['evolution of the great solar debate\nin the 2002 book bone loss and osteoporosis in past populations: an anthropological perspective , reinhold vieth, a nutrition professor at the university of toronto, writes that early Primates PROBABLY acquired their relatively high Vitamin D REQUIREMENTS from frequent Grooming and Ingestion of oils rich in Vitamin D precursors that were Secreted by their skin onto their fur.']	[('PROBABLE_UNDERSTANDING', 229), ('IMPORTANT_CONSIDERATION', 279)]	2	[('NCBITaxon_33208', 'Metazoa', 220, 'primates'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('GO_0040007', 'growth', 306, 'grooming'), ('GO_0007631', 'feeding behavior', 319, 'ingestion'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('GO_0046903', 'secretion', 376, 'secreted')]
PMC2581757	11/2008	S188-PMC2581757	['they INFERRED a CORRELATION between the Pai-1/Pai-2 (Plasminogen Activator Inhibitor) ratio with Vitamins C and e levels.']	[('PROBABLE_UNDERSTANDING', 5), ('SUPERFICIAL_RELATIONSHIP', 16)]	2	[('PR_000014702', 'plasminogen activator inhibitor 1', 40, 'PAI-1'), ('PR_000014700', 'serpin B9', 46, 'PAI-2'), ('PR_000014700', 'serpin B9', 53, 'plasminogen activator inhibitor'), ('CHEBI_35222', 'inhibitor', 75, 'inhibitor'), ('CHEBI_27300', 'vitamin D', 97, 'vitamins C')]
PMC2582131	11/2008	S79-PMC2582131	['the risk for gdm was highest for overweight women who were classified as being deficient for Vitamin D (25-[Oh] D<20 ng/ml in Pregnancy); they experienced an APPROXIMATELY 5-fold increased risk as compared with lean women of higher Plasma 25-[Oh] D levels (adjusted or\u200a=\u200a4.93, 95% ci 1.63–14.9) ( table 3 ).10.1371/journal.pone.0003753.t003\n\ncaption (table-wrap): table 3\nodds ratios (or) and 95% confidence intervals (ci) for Gestational diabetes (gdm) according to both maternal Plasma 25-Hydroxyvitamin D deficient status and pre-Pregnancy overweight status.Vitamin D deficiency*overweight**gdm casescontrolsunadjusted or (95% ci)adjusted1or (95% ci)(n\u200a=\u200a57)(n\u200a=\u200a114)nono22751.00 (referent)1.00 (referent)yesno792.65 (0.89–7.93)2.36 (0.75–7.43)noyes16232.37 (1.07–5.25)2.24 (0.99–5.08)yesyes1275.84 (2.05–16.6)4.93 (1.63–14.9) p value for interaction term0.930.93\nVitamin D deficiency is DEFINED as maternal Plasma 25-Hydroxyvitamin D concentrations <20 ng/ml (holick mf,[reference 1]).']	[('INCOMPLETE_EVIDENCE', 158), ('PROBABLE_UNDERSTANDING', 891)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_34300', '2-naphthoyl-CoA', 104, '25-[OH] D'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('UBERON_0001969', 'blood plasma', 232, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 239, '25-[OH] D'), ('GO_0007565', 'female pregnancy', 427, 'gestational'), ('UBERON_0001969', 'blood plasma', 481, 'plasma'), ('CHEBI_27844', "2',3'-cyclic AMP", 488, '25-Hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 533, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 561, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 867, 'Vitamin D'), ('UBERON_0001969', 'blood plasma', 911, 'plasma'), ('CHEBI_27844', "2',3'-cyclic AMP", 918, '25-Hydroxyvitamin D')]
PMC2582131	11/2008	S86-PMC2582131	['it has become increasingly CLEAR that Vitamin D has physiological functions beyond bone health[6]; Vitamin D receptors were Expressed in a large number of other Tissues including those INVOLVED in the Regulation Of Glucose Metabolism, such as Muscle and Pancreatic Β Cells[1].']	[('PROBABLE_UNDERSTANDING', 27), ('SUPERFICIAL_RELATIONSHIP', 185)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0010467', 'gene expression', 124, 'expressed'), ('UBERON_0000479', 'tissue', 161, 'tissues'), ('GO_0010906', 'regulation of glucose metabolic process', 201, 'regulation of glucose metabolism'), ('CHEBI_17234', 'glucose', 215, 'glucose'), ('CL_0000187', 'muscle cell', 243, 'muscle ...'), ('CL_0000173', 'pancreatic D cell', 254, 'pancreatic β cells'), ('UBERON_0001264', 'pancreas', 254, 'pancreatic')]
PMC2582131	11/2008	S110-PMC2582131	['first, determination of 25-[Oh] D concentrations using Plasma collected in early Pregnancy served to define the temporal RELATIONSHIP between maternal Vitamin D deficiency and subsequent risk of gdm BECAUSE, in general, Pregnant women develop Gestational diabetes during the late 2ndor 3rdtrimester.']	[('SUPERFICIAL_RELATIONSHIP', 121), ('PROBABLE_UNDERSTANDING', 199)]	2	[('CHEBI_34300', '2-naphthoyl-CoA', 24, '25-[OH] D'), ('UBERON_0001969', 'blood plasma', 55, 'plasma'), ('GO_0007565', 'female pregnancy', 81, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 220, 'pregnant'), ('GO_0007565', 'female pregnancy', 243, 'gestational')]
PMC2685863	5/2009	S18-PMC2685863	['“in fact that amount is not EVEN close.” CONSIDERING that the body makes up to 20,000 iu of Vitamin D when exposed to sunlight for 30 minutes on a summer day, ebers says 2,000 iu/day “is not a dangerous amount.”\n\npubmed central:']	[('ANOMALY_CURIOUS_FINDING', 28), ('PROBABLE_UNDERSTANDING', 41)]	2	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC2821652	2/2010	S16-PMC2821652	['due TO the limited dietary sources of Vitamin D, Serum Vitamin D levels are PRIMARILY determined by sunlight exposure.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('PROBABLE_UNDERSTANDING', 76)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0001977', 'blood serum', 49, 'serum'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC2821652	2/2010	S57-PMC2821652	['at each study visit, AS a MARKER of Vitamin D status, circulating levels of 25(Oh)D and Vitamin D3Were measured in patient Serum.']	[('PROBABLE_UNDERSTANDING', 21), ('SUPERFICIAL_RELATIONSHIP', 26)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('CHEBI_73706', 'bromosuccinate', 88, 'vitamin D3were'), ('UBERON_0001977', 'blood serum', 123, 'serum')]
PMC2963768	10/2010	S148-PMC2963768	['aside from these caveats, the community-based sampling was LIKELY random with respect to most DETERMINANTS of Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 94)]	2	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC3034879	12/2010	S166-PMC3034879	['the greater increase in bmc in low d group is LIKELY to be due to increased calcium accrual, AS reverted Vitamin D status enhances calcium absorption.']	[('PROBABLE_UNDERSTANDING', 46), ('PROBABLE_UNDERSTANDING', 93)]	2	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
PMC3103150	3/2011	S40-PMC3103150	['definitions:\nVitamin D deficiency was defined as 25ohd < 15 ng/ml, severe Vitamin D deficiency AS 25ohd <5 ng/ml and insufficiency AS 25ohd 15-20 ng/ml.']	[('PROBABLE_UNDERSTANDING', 95), ('PROBABLE_UNDERSTANDING', 131)]	2	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC3103150	3/2011	S115-PMC3103150	['ALTERNATIVE EXPLANATION can be that these infants accrued lower stores of Vitamin D in utero as the latter half of Pregnancy was in winter season.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 12)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy')]
PMC3257641	3/2010	S85-PMC3257641	['Immunomodulation\nearly Life Immunomodulation is LIKELY to also be AFFECTED by Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 66)]	2	[('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 0, 'Immunomodulation'), ('UBERON_0000104', 'life cycle', 23, 'life'), ('GO_0050900', 'leukocyte migration', 28, 'immunomodulation'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC3271033	1/2012	S156-PMC3271033	['THUS, IT IS CLEAR that a southern us location is not protective against seasonal deficiency of Vitamin D or low Cord 25(Oh)D levels.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 6)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 112, 'cord'), ('CHEBI_71657', 'versiconol acetate', 117, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 123, 'D')]
PMC3277098	12/2011	S2-PMC3277098	['it has since been RECOGNIZED that the active form of Vitamin D, 1α,25(Oh)2D3, has direct AFFECTS on Naïve and Activated Helper T cells, Regulatory T Cells, Activated B Cells and Dendritic Cells.']	[('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 89)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_73394', 'Ala-Ser', 67, '25(OH)2D3'), ('CL_0000540', 'neuron', 100, 'naïve ...'), ('CL_0002627', 'mature astrocyte', 110, 'activated'), ('CL_0000545', 'T-helper 1 cell', 120, 'helper T'), ('CL_0000815', 'regulatory T cell', 136, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 136, 'regulatory'), ('CL_0002063', 'type II pneumocyte', 156, 'activated B cells'), ('CL_0000451', 'dendritic cell', 178, 'dendritic cells')]
PMC3296991	2/2012	S95-PMC3296991	['it is LIKELY that the elevation in balp OBSERVED in Vitamin D deficiency is due to increased release from Osteoblasts accumulated in unmineralized bone Matrix.']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 40)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CL_0000062', 'osteoblast', 106, 'osteoblasts'), ('GO_0031012', 'extracellular matrix', 152, 'matrix')]
PMC3347007	4/2012	S79-PMC3347007	['67.6% of participants reported use of Vitamin D supplements in any dose (table 1) and 36.9% reported use of Vitamin D supplements of AT LEAST 10 µg, which is the dose now RECOMMENDED during Pregnancy by the danish national board of health .']	[('PROBABLE_UNDERSTANDING', 133), ('FUTURE_WORK', 171)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0007565', 'female pregnancy', 190, 'pregnancy')]
PMC3347007	4/2012	S147-PMC3347007	['we FOUND a lower LIKELIHOOD of sufficient total Vitamin D intake among young, smoking, multiparous women.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 17)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
PMC3347007	4/2012	S149-PMC3347007	['multiparous women were found to be less LIKELY to have sufficient total Vitamin D intakes COMPARED TO nulliparous women.']	[('PROBABLE_UNDERSTANDING', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90)]	2	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC3347028	3/2012	S83-PMC3347028	['THUS, pth levels are RELATED to Vitamin D status as well: pth upregulates 1-α-hydroxylase, the enzyme responsible for 1-α-hydroxylation of 25(Oh)D, converting 25(Oh)D to 1,25(Oh)2D.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 21)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 139, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 159, '25(OH)D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 172, '25(OH)2D')]
PMC3347028	3/2012	S153-PMC3347028	['FOUND significantly wider posterior Fontanelle diameter in neonates of mothers with Vitamin D deficiency (AS defined by a 25(Oh)D level <34.9 nmol/l or ~14 ng/ml) compared to neonates whose mothers were not deficient [102].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 106)]	2	[('UBERON_0002221', 'fontanelle', 36, 'fontanelle'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 122, '25(OH)D')]
PMC3347028	3/2012	S184-PMC3347028	['AS PREDICTED by Vitamin D pharmacokinetics, supplements of 1000 iu/day of Vitamin D to Pregnant women result in a 12.5 to 15.0 nmol/l increase in circulating 25(Oh)D concentrations in both maternal and Cord Serum compared with nonsupplemented controls [75,76,77].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 3)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 87, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 158, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 158, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 202, 'cord'), ('UBERON_0001977', 'blood serum', 207, 'serum')]
PMC3348565	4/2012	S26-PMC3348565	['furthermore, the common practice of swaddling infants MIGHT reduce exposure to sunlight.2THUS young children are at a high risk of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 89)]	2	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
PMC3348565	4/2012	S47-PMC3348565	['procedures\nwe chose a quarterly supplementation regimen because in routine programme conditions a quarterly regimen is LIKELY to have better adherence than a daily regimen,13,14and HAS BEEN shown to be effective at maintaining the Serum Vitamin D concentration within normal ranges for 2–3 months in a french high-risk infant population.16the syringes containing Vitamin D or placebo were stored in conditions recommended by the manufacturer—a dry cool environment—between 2 and 24 weeks before administration.']	[('PROBABLE_UNDERSTANDING', 119), ('INCOMPLETE_EVIDENCE', 181)]	2	[('UBERON_0001977', 'blood serum', 231, 'serum'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D')]
PMC3348565	4/2012	S119-PMC3348565	['our sample testing SUGGEST that the Vitamin D group maintained above mean adequate Vitamin D concetrations verses CONSISTENTLY low concentrations in the placebo group.']	[('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 114)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC3348565	4/2012	S128-PMC3348565	['the optimum concentrations of Vitamin D for Adults and children6are BASED ON non-immunological and, MOSTLY, bone outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 100)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0007023', 'adult organism', 44, 'adults')]
PMC3355895	1/2011	S88-PMC3355895	['in developing southern hemisphere populations where sunshine is in abundance, OFTEN calcium nutrition is a greater ISSUE than that of 25(oh)-Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 78), ('IMPORTANT_CONSIDERATION', 115)]	2	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
PMC3356951	4/2012	S17-PMC3356951	['many health care providers have increased their RECOMMENDATIONS for Vitamin D supplementation to AT LEAST 1000 iu.']	[('FUTURE_WORK', 48), ('PROBABLE_UNDERSTANDING', 97)]	2	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
PMC3356951	4/2012	S41-PMC3356951	['[36] People with a naturally dark skin tone have natural sun protection and REQUIRE AT LEAST three to five times longer exposure to make the same amount of Vitamin D as a Person with a white skin tone.']	[('IMPORTANT_CONSIDERATION', 76), ('PROBABLE_UNDERSTANDING', 84)]	2	[('NCBITaxon_10088', 'Mus <genus>', 5, 'People'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 171, 'person')]
PMC3356951	4/2012	S43-PMC3356951	['[39]\npatients with one of the fat malabsorption syndromes and bariatric patients are OFTEN UNABLE TO absorb the fat-soluble Vitamin D, and patients with nephritic syndrome lose 25(Oh)D bound to the Vitamin D-binding protein in the Urine.']	[('PROBABLE_UNDERSTANDING', 85), ('DIFFICULT_TASK', 91)]	2	[('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 177, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('UBERON_0001088', 'urine', 231, 'urine')]
PMC3356951	4/2012	S73-PMC3356951	['[5859]\n\nsources of Vitamin D\na MAJOR source of Vitamin D for MOST Humans is synthesized from the exposure of the skin to sunlight typically between 1000 h and 1500 h in the spring, summer, and fall.']	[('IMPORTANT_CONSIDERATION', 31), ('PROBABLE_UNDERSTANDING', 61)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 66, 'humans')]
PMC3356951	4/2012	S74-PMC3356951	['[1293360] Vitamin D produced in the skin MAY last AT LEAST twice as long in the Blood compared with Ingested Vitamin D.[61] when an Adult wearing a bathing suit is exposed to one minimal erythemal dose of uv radiation (a slight pinkness to the skin 24 h after exposure), the amount of vitamin d produced is equivalent to Ingesting between 10,000 and 25,000 iu.']	[('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 50)]	2	[('CHEBI_28384', 'vitamin K', 10, 'Vitamin D'), ('UBERON_0000178', 'blood', 80, 'blood'), ('GO_0007631', 'feeding behavior', 100, 'ingested'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('UBERON_0007023', 'adult organism', 132, 'adult'), ('GO_0007567', 'parturition', 321, 'ingesting')]
PMC3356951	4/2012	S106-PMC3356951	['[17] in ANOTHER STUDY, which followed men and women for 4 years, patients with low Vitamin D concentrations (<15 ng/ml) were three times more LIKELY to be diagnosed with hypertension than those with high concentrations (>30 ng/ml).']	[('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 142)]	2	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
PMC3366289	7/2011	S122-PMC3366289	['Ascorbic Acid and Vitamin A in the flour MIGHT have been RESPONSIBLE for effective iron absorption [24,25].']	[('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 57)]	2	[('CHEBI_2874', 'Asimicin', 0, 'Ascorbic acid'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin A')]
PMC3424155	8/2012	S164-PMC3424155	['discussion\nmicronutrient deficiency during development, such as maternal Vitamin D deficiency, is a subject of increasing IMPORTANCE BECAUSE of the nutritional deficiencies caused by excessive consumption of junk Food during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 122), ('PROBABLE_UNDERSTANDING', 133)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_33290', 'food', 213, 'food'), ('GO_0007565', 'female pregnancy', 225, 'pregnancy')]
PMC3424155	8/2012	S170-PMC3424155	['Vitamin D is NORMALLY stored in the Liver and Adipose Tissue, and after six weeks on a restricted diet, the Vitamin D levels were EXTREMELY reduced without alteration of calcium or Phosphate levels in the rodents[21].']	[('PROBABLE_UNDERSTANDING', 13), ('IMPORTANT_CONSIDERATION', 130)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0002107', 'liver', 36, 'liver'), ('UBERON_0001013', 'adipose tissue', 46, 'adipose tissue'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('CHEBI_18367', 'phosphate(3-)', 181, 'phosphate')]
PMC3427192	4/2012	S26-PMC3427192	['similarly, in a finnish Birth cohort, infants supplemented with Vitamin D during the first year of Life were not more LIKELY to have asthma in early Adulthood.67rather, in that STUDY67AND another,68the prevalence of allergic sensitization was greater at age 6 and age 31 y in those subjects who received regular Vitamin D supplementation during infancy.']	[('PROBABLE_UNDERSTANDING', 118), ('INCOMPLETE_EVIDENCE', 177)]	2	[('GO_0007567', 'parturition', 24, 'birth'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0000104', 'life cycle', 99, 'life'), ('UBERON_0000113', 'post-juvenile adult stage', 149, 'adulthood'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D')]
PMC3427192	4/2012	S69-PMC3427192	['these studies also DIFFER significantly in terms of the populations studied, the timing of the Vitamin D intake assessments and the 25(Oh)D sampling, the 25(Oh)D THRESHOLDS used for determining insufficiency, and the Respiratory outcomes of interest.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('PROBABLE_UNDERSTANDING', 162)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 154, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 154, '25'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 157, 'OH ... D'), ('UBERON_0001004', 'respiratory system', 217, 'respiratory')]
PMC3427250	8/2012	S111-PMC3427250	['sunscreen Lotions prevent uv radiation from reaching the skin and MIGHT THEREFORE reduce the skin’s Vitamin D production[56].']	[('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 72)]	2	[('CHEBI_75702', 'dU5', 10, 'lotions'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC3427250	8/2012	S127-PMC3427250	['given the high prevalence of Vitamin D deficiency in Pregnant women in belgium and PROBABLY in many european countries, a Vitamin D nutrition policy IS NEEDED at the country and european level.']	[('PROBABLE_UNDERSTANDING', 83), ('FUTURE_WORK', 149)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007565', 'female pregnancy', 53, 'pregnant'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
PMC3470091	9/2012	S17-PMC3470091	['studies have INDICATED that during Pregnancy Vitamin D deficiency varies from 18% to 84%, which varies with the region under the study and type of clothing.2,3vitamin d deficiency among Breast-Fed children in the regions with heavy sunshine such as the middle east is high.3-5this hypovitaminosis which is DUE TO limited exposure to sun of mothers’ and their babies as well as low Vitamin D intake by mothers.']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 306)]	2	[('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007567', 'parturition', 186, 'breast'), ('UBERON_0000310', 'breast', 186, 'breast'), ('GO_0007631', 'feeding behavior', 193, 'fed'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D')]
PMC3470091	9/2012	S67-PMC3470091	['caption (table-wrap): table 3:\n\nthe number and (percentage) frequency distribution of Vitamin D status in the intervention group (ig) and control group (cg) before and after interventiongroupsvitamin D status (nmol/l)igcgbeforeafterbeforeaftersevere deficient (<12.5)0000moderate deficient (12.5-24.9)15(62.5%)09(42.9%)10(47.6%)mild deficient (25-34.9)4(16.7%)1(4.2%)7(33.3%)3(14.3%)optimal (>35)5(20.8%)23(95.8%)4(19%)6(28.6%)\n\ndiscussion\nif Vitamin D deficiency is DEFINED as Serum concentration of 25(Oh) Vitamin D3 lower than 35 nmol/l,12ABOUT 80% of the mothers with gdm in the present study were suffering to some degrees from Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 467), ('INCOMPLETE_EVIDENCE', 542)]	2	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 200, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 200, 'D'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D'), ('UBERON_0001977', 'blood serum', 478, 'serum'), ('CHEBI_30778', 'gallic acid', 501, '25(OH)'), ('CHEBI_33279', 'vitamin D5', 508, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 508, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 633, 'vitamin D')]
PMC3470091	9/2012	S75-PMC3470091	['the mechanism of pth reduction is that an increased Serum Vitamin D LEADS to a decrease in pth Gene Translation, and THUS pth secretion.']	[('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 117)]	2	[('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('SO_0000704', 'gene', 95, 'gene'), ('GO_0006412', 'translation', 100, 'translation')]
PMC3470091	9/2012	S88-PMC3470091	['THEREFORE, a single dose of 300,000 iu dose employed in this study is of higher EFFECTIVENESS compared with an Oral dose, especially in People suffering from Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('UBERON_0000165', 'mouth', 111, 'oral'), ('NCBITaxon_10088', 'Mus <genus>', 136, 'people'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
PMC3476426	8/2012	S20-PMC3476426	['it has since been RECOGNIZED that the active form of Vitamin D has direct AFFECTS on Naïve and Activated Helper T Cells, Regulatory T Cells, Activated B Cells, and Dendritic Cells.']	[('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CL_0000540', 'neuron', 85, 'naïve ...'), ('CL_0002131', 'regular ventricular cardiac myocyte', 95, 'activated helper T cells'), ('CL_0000815', 'regulatory T cell', 121, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 121, 'regulatory'), ('CL_0002063', 'type II pneumocyte', 141, 'activated B cells'), ('CL_0000451', 'dendritic cell', 164, 'dendritic cells')]
PMC3476426	8/2012	S111-PMC3476426	['FOR THIS REASON, in 2007, the canadian paediatric society RECOMMENDED 2000 iu/day, or more, to prevent Gestational Vitamin D deficiency [25].']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 58)]	2	[('GO_0007565', 'female pregnancy', 103, 'gestational'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
PMC3501517	11/2012	S95-PMC3501517	['alkaline phosphatase was significantly higher in the vdd group as compared with the vds group, LIKELY REFLECTING increased Bone Resorption as a response to secondary hyperparathyroidism, resulting from Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 95), ('PROBABLE_UNDERSTANDING', 102)]	2	[('GO_0045453', 'bone resorption', 123, 'bone resorption'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
PMC3501517	11/2012	S233-PMC3501517	['the data SUGGEST that Vitamin D supplementation is UNLIKELY to be an effective therapy for acute Lung injury.']	[('INCOMPLETE_EVIDENCE', 9), ('PROBABLE_UNDERSTANDING', 51)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002048', 'lung', 97, 'lung')]
PMC3509518	11/2012	S122-PMC3509518	['in the PRESENT STUDY, the MAJORITY of mothers reported dietary Vitamin C intakes above the rdi of 60 mg Vitamin C daily, thereby well meeting the expected needs [18].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('PROBABLE_UNDERSTANDING', 26)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin C')]
PMC3515553	12/2012	S69-PMC3515553	['in these analyses, we log transformed Vitamin B-12 to base 2 so that results are INTERPRETED as a mean difference in iq per doubling of Vitamin B-12 intake or status.10.1371/journal.pone.0051084.t002\n\ncaption (table-wrap): table 2\nASSOCIATION of maternal dietary vitamin b-12 Intake during Pregnancy with offspring iq at age 8.']	[('PROBABLE_UNDERSTANDING', 81), ('SUPERFICIAL_RELATIONSHIP', 231)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 38, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin B'), ('GO_0007631', 'feeding behavior', 276, 'intake'), ('GO_0007565', 'female pregnancy', 290, 'pregnancy')]
PMC3521768	12/2012	S57-PMC3521768	['HENCE the AVAILABLE sample size consisting of 228 Vitamin A deficient and 347 non-deficient and 316 zinc deficient and 259 non-deficient subjects was judged to be adequate.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 10)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin A')]
PMC3552819	12/2012	S64-PMC3552819	['the reference range for albumin-adjusted Serum calcium was set at 2.10 – 2.60 mmol/l, the upper limit of which was a CONSERVATIVE THRESHOLD relative to those used by: the local laboratory in dhaka (2.62 mmol/l), the us institute of medicine (iom) 1997 dietary reference intakes (dris) for Vitamin D (2.75 mmol/l) [15], and the iom revised 2011 Vitamin D dris (2.63 mmol/l) [1].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('PROBABLE_UNDERSTANDING', 130)]	2	[('UBERON_0001977', 'blood serum', 41, 'serum'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D')]
PMC3552819	12/2012	S66-PMC3552819	['confirmed hypercalcemia was A priori defined as albumin-adjusted Serum calcium concentration > 2.60 mmol/l on both specimens, SINCE hypercalcemia caused by Vitamin D intoxication would not be expected to resolve within a few days without intervention.']	[('FUTURE_WORK', 28), ('PROBABLE_UNDERSTANDING', 126)]	2	[('UBERON_0001977', 'blood serum', 65, 'serum'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
PMC3616124	4/2013	S192-PMC3616124	['THEREFORE, we cannot determine WHETHER Vitamin E OR C alone would have been efficacious.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin E'), ('CHEBI_18245', 'carboxylato group', 52, 'C')]
PMC3629265	4/2013	S49-PMC3629265	['in the 2 youngest infants in our series, it is LIKELY that profound maternal Vitamin D deficiency was the most significant FACTOR leading to the early presentation of these infants.']	[('PROBABLE_UNDERSTANDING', 47), ('SUPERFICIAL_RELATIONSHIP', 123)]	2	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC3629265	4/2013	S62-PMC3629265	['these infants were PRESUMED to be Vitamin D deficient though Vitamin D levels were NOT CONSISTENTLY available.']	[('PROBABLE_UNDERSTANDING', 19), ('INCOMPLETE_EVIDENCE', 83)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC3629265	4/2013	S88-PMC3629265	['it is LIKELY that other asymptomatic infants with Vitamin D deficiency remain undiagnosed from this high-RISK population.']	[('PROBABLE_UNDERSTANDING', 6), ('IMPORTANT_CONSIDERATION', 104)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
PMC3641012	4/2013	S55-PMC3641012	['Serum aliquots were frozen at −20°c and shipped at ambient temperature from bangladesh to toronto for measurement of Serum 25(Oh)D concentration, a WELL-ESTABLISHED BIOMARKER of systemic Vitamin D status [17].']	[('PROBABLE_UNDERSTANDING', 148), ('SUPERFICIAL_RELATIONSHIP', 165)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 123, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
PMC3641012	4/2013	S94-PMC3641012	['this approach enabled the estimation of the average difference in 25(Oh)D between the two groups at a PRESUMED ‘steady-state’ (i.e., where group-averaged 25(Oh)D did not continue to appreciably rise DESPITE ongoing Vitamin D supplementation).']	[('PROBABLE_UNDERSTANDING', 102), ('ANOMALY_CURIOUS_FINDING', 199)]	2	[('CHEBI_71657', 'versiconol acetate', 66, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 154, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D')]
PMC3651971	5/2013	S37-PMC3651971	['beyond 6\u2005months of age, the national, semiannual Vitamin A supplementation programme, implemented from 1995 onwards, offered children in the sarlahi district Supplements containing 100\u2005000\u2005iu up to 11\u2005months, and 200\u2005000\u2005iu from 12 to ∼60\u2005months of age, with coverage routinely reaching ≥80%.30the study children were THEREFORE LIKELY to have started receiving Vitamin A periodically through the national programme from age 6\u2005months onwards, but there are no individual records of their programme participation.']	[('PROBABLE_UNDERSTANDING', 318), ('PROBABLE_UNDERSTANDING', 328)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('CHEBI_33341', 'titanium atom', 158, 'supplements'), ('CHEBI_27300', 'vitamin D', 361, 'vitamin A')]
PMC3659910	1/2013	S21-PMC3659910	['[34] it is now RECOGNIZED that everyone is AT RISK for Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 15), ('IMPORTANT_CONSIDERATION', 43)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC3659910	1/2013	S38-PMC3659910	['[8] the active form of Vitamin D (1,25-Dihydroxyvitamin D3, 1,25[Oh] 2D3) has WELL-ESTABLISHED EFFECTS on bone Metabolism and Mineral Homeostasis.']	[('PROBABLE_UNDERSTANDING', 78), ('SUPERFICIAL_RELATIONSHIP', 95)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_63912', '19-hydroxyprostaglandin H2', 34, '1,25-dihydroxyvitamin D3'), ('CHEBI_64115', '(1S,2R)-5-methoxy-1-methyl-2-(propylamino)tetralin hydrochloride', 62, '25[OH] 2D3'), ('GO_0008152', 'metabolic process', 111, 'metabolism'), ('CHEBI_46662', 'mineral', 126, 'mineral'), ('GO_0055085', 'transmembrane transport', 126, 'mineral homeostasis')]
PMC3659910	1/2013	S66-PMC3659910	["THUS, increasing Vitamin D intake from Vitamin D fortified foods, and Vitamin D supplements, in combination with SENSIBLE sun exposure, maximize a Person's vitamin d status to promote good health."]	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 113)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'person')]
PMC3659910	1/2013	S88-PMC3659910	['REPORTED that as hypoparathyroid patients have completed many Pregnancies while receiving Ergocalciferol,[21] it is UNLIKELY that material Vitamin D, 25(Oh) D, or 24,25(Oh) 2D per se are Teratogens.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 116)]	2	[('GO_0007565', 'female pregnancy', 62, 'pregnancies'), ('CHEBI_4910', 'etomidate', 90, 'ergocalciferol'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 150, '25(OH) D'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 166, '25(OH) 2D'), ('CHEBI_50114', 'estrogen', 187, 'teratogens')]
PMC3659910	1/2013	S93-PMC3659910	['HOWEVER, hypervitaminosis D has NEVER OCCURRED when physiologic amounts of Vitamin D are Ingested.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 32)]	2	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 26, 'D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007631', 'feeding behavior', 89, 'ingested')]
PMC3668200	5/2013	S9-PMC3668200	['MOST physicians consider 1,25-Oh2-D as a KEY substance to the assessment of Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 41)]	2	[('CHEBI_82627', '15(R)-HPETE', 25, '1,25-OH2-D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
PMC3672018	5/2013	S15-PMC3672018	['widely distributed in body Tissues, a vdr, once bound to a Vitamin D ligand, travels to the Nucleus where it binds to sites within the Human Genome and CONSEQUENTLY INFLUENCES the activity, or Expression, of individual Genes.']	[('PROBABLE_UNDERSTANDING', 152), ('SUPERFICIAL_RELATIONSHIP', 165)]	2	[('UBERON_0000479', 'tissue', 27, 'tissues'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0005634', 'nucleus', 92, 'nucleus'), ('NCBITaxon_9606', 'Homo sapiens', 135, 'human'), ('SO_0001026', 'genome', 141, 'genome'), ('GO_0010467', 'gene expression', 193, 'expression'), ('SO_0000704', 'gene', 219, 'genes')]
PMC3702245	6/2013	S79-PMC3702245	['Vitamin D status was monitored in the mother during Pregnancy and in Cord Blood AS a SURROGATE marker of infant Vitamin D status at Birth.']	[('PROBABLE_UNDERSTANDING', 80), ('SUPERFICIAL_RELATIONSHIP', 85)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 69, 'cord'), ('UBERON_0000178', 'blood', 74, 'blood'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007567', 'parturition', 132, 'birth')]
PMC3705320	3/2013	S18-PMC3705320	['THEREFORE, to guide the design of clinical trials of Antenatal Vitamin D supplementation in bangladesh, we CONDUCTED a randomized open-label pilot trial of two Antenatal Vitamin d3 supplementation doses that were several fold higher than those in typical Prenatal supplements.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 107)]	2	[('GO_0007567', 'parturition', 53, 'antenatal'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007567', 'parturition', 160, 'antenatal'), ('CHEBI_33229', 'vitamin (role)', 170, 'vitamin'), ('GO_0007565', 'female pregnancy', 255, 'prenatal')]
PMC3713405	7/2013	S58-PMC3713405	['in this MODEL the exposure to Vitamin D3Depletion is only transient AS all dams are returned to a normal Vitamin D containing diet Ate Birth.']	[('INCOMPLETE_EVIDENCE', 8), ('PROBABLE_UNDERSTANDING', 68)]	2	[('CHEBI_61669', '2-methylbutanenitrile', 30, 'vitamin D3depletion'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 30, 'vitamin D3depletion'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0009636', 'response to toxic substance', 131, 'ate'), ('GO_0007567', 'parturition', 135, 'birth')]
PMC3717170	5/2013	S91-PMC3717170	['targeting Ca2+Signaling and the Vitamin D/Ca2+–dependent calpains and caspases in Adipocytes with Vitamin D supplementation MAY THEREFORE be an effective and affordable approach for chemoprevention and treatment of obesity.']	[('INCOMPLETE_EVIDENCE', 124), ('PROBABLE_UNDERSTANDING', 128)]	2	[('CHEBI_29108', 'calcium(2+)', 10, 'Ca2+'), ('GO_0016215', 'acyl-CoA desaturase activity', 10, 'Ca2'), ('GO_0023051', 'regulation of signaling', 14, 'signaling'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_51231', 'DAPI', 42, 'Ca2+–'), ('CL_0000136', 'fat cell', 82, 'adipocytes'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC3739737	8/2013	S172-PMC3739737	['the results STRONGLY SUGGEST that low Vitamin D status exacerbates disease progression[41].']	[('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 21)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
PMC3760821	9/2013	S108-PMC3760821	['the results in this table have not been analysed with respect to season and observed differences in t1dm and control women are, THEREFORE, DUE TO differences in season of sampling.10.1371/journal.pone.0074068.t002\n\ncaption (table-wrap): table 2\nVitamin D deficiency and insufficiency of Pregnant women and neonates, split by maternal diabetes, using various cut-off levels.Pregnant womengestation and level of Vitamin D deficiencycontrol groupt1dm groupn%n%≤14 weeks<12.5 nmol/l14.511.8<25 nmol/l1045.5916.4<50 nmol/l1672.74174.5<75 nmol/l2090.95090.9<100 nmol/l22100.05498.2>14<28 weeks<12.5 nmol/l25.011.5<25 nmol/l2152.51929.2<50 nmol/l3485.04670.8<75 nmol/l3997.56193.8<100 nmol/l40100.065100.0≥28 weeks<12.5 nmol/l611.534.8<25 nmol/l2650.02845.2<50 nmol/l4586.55182.3<75 nmol/l5198.162100.0<100 nmol/l52100.062100.0 Pregnant womenneonatal level of Vitamin D deficiencycontrol groupt1dm groupn%n% Cord Blood<12.5 nmol/l832.01628.6<25 nmol/l2392.04478.6<50 nmol/l25100.056100.0\ndata are cumulative n and cumulative %.']	[('PROBABLE_UNDERSTANDING', 128), ('PROBLEM_COMPLICATION', 139)]	2	[('CHEBI_28384', 'vitamin K', 245, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 245, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 287, 'pregnant'), ('GO_0007565', 'female pregnancy', 373, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 410, 'vitamin D'), ('GO_0007565', 'female pregnancy', 821, 'Pregnant'), ('CHEBI_27300', 'vitamin D', 853, 'vitamin D'), ('UBERON_0000948', 'heart', 901, 'Cord'), ('UBERON_0000178', 'blood', 906, 'blood')]
PMC3773018	4/2013	S53-PMC3773018	['HOWEVER, children with persistently low Vitamin D status had the highest risk of fs (or= 2.04, 95%ci: 1.02–4.04), AS compared to those with sufficient Vitamin D status at Birth and follow-up.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 114)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007567', 'parturition', 171, 'birth')]
PMC3773018	4/2013	S68-PMC3773018	['given that fewer than 10% of our subjects were exclusively Breastfed (table 1), these infants and toddlers SHOULD have had the highest intake of Vitamin D via fortified formulas, which, in the u.s., all contain AT LEAST 400 iu/l of Vitamin D (29).']	[('FUTURE_WORK', 107), ('PROBABLE_UNDERSTANDING', 211)]	2	[('GO_0007567', 'parturition', 59, 'breastfed'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]
PMC3798907	8/2013	S103-PMC3798907	['vitamin c was included as a control comparator GIVEN the absence of epidemiological evidence of an ASSOCIATION between Maternal Vitamin C intake during Pregnancy and cbmc responses and childhood asthma [9,10,11].']	[('PROBABLE_UNDERSTANDING', 47), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('GO_0007618', 'mating', 119, 'maternal'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin C'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy')]
PMC3798907	8/2013	S105-PMC3798907	['this EXPLANATION PREDICTS that that Vitamin E supplementation of cbmc cultures would reduce proliferative responses.']	[('PROBABLE_UNDERSTANDING', 5), ('INCOMPLETE_EVIDENCE', 17)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin E')]
PMC3814422	10/2013	S142-PMC3814422	['reassuringly, our data also SUGGEST that higher maternal Vitamin D status in Pregnancy is UNLIKELY to increase the risk of atopy in the offspring.']	[('INCOMPLETE_EVIDENCE', 28), ('PROBABLE_UNDERSTANDING', 90)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy')]
PMC3827489	10/2013	S61-PMC3827489	['THUS, it is IMPORTANT to maintain sufficient Serum Vitamin D levels in order to enhance normal Calcification of the Growth Plate and bone mineralization.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 12)]	2	[('UBERON_0001977', 'blood serum', 45, 'serum'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0051301', 'cell division', 95, 'calcification'), ('UBERON_0002516', 'epiphyseal plate', 116, 'growth plate')]
PMC3827489	10/2013	S90-PMC3827489	['THEREFORE, adequate Vitamin D levels in the mother during Pregnancy promote BETTER bone health in the offspring65).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 76)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy')]
PMC3873449	12/2013	S41-PMC3873449	['maternal pre-Pregnant weight and pre-Pregnant body mass index (bmi) are also included SINCE Adipose Tissue HAS BEEN SHOWN to Sequester Vitamin D [14].']	[('PROBABLE_UNDERSTANDING', 86), ('INCOMPLETE_EVIDENCE', 107)]	2	[('GO_0007565', 'female pregnancy', 13, 'pregnant'), ('GO_0007565', 'female pregnancy', 37, 'pregnant'), ('UBERON_0001013', 'adipose tissue', 92, 'adipose tissue'), ('GO_0051235', 'maintenance of location', 125, 'sequester'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D')]
PMC3873449	12/2013	S127-PMC3873449	['THUS, keeping enough sunlight exposure is IMPORTANT to prevent Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 42)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
PMC3873449	12/2013	S203-PMC3873449	['THEREFORE, there were no enough subjects who were over weight or obese for analysis of the IMPACT of this factor on Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 91)]	2	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
PMC3882256	1/2014	S86-PMC3882256	['women with dietary iron intake equal to or more than the uk reference Nutrient intake for iron were more LIKELY to be older, vegetarian, with higher educational qualification, report higher total energy and Vitamin C intake, have lower pre-Pregnancy body mass index, and were less LIKELY to smoke during Pregnancy.10.1371/journal.pone.0084684.t001\n\ncaption (table-wrap): table 1\nstudy sample characteristics (complete cases for exposures, outcomes, confounders and Mediators n\u200a=\u200a2958) and alspac sample characteristics (with dietary iron intake data n\u200a=\u200a12116).complete case samplealspac sample (with dietary data) dietary iron Intake # (mg/day) (m, sd * ) 10.7 (3.2)10.4 (3.4) dietary iron intake <uk rni ## (%, 95% ci ** ) 89.2 (88.0, 90.3)90.3 (89.7, 90.8) dietary iron intake <uk lrni ### (%, 95% ci) 18.0 (16.7, 19.5)25.0 (24.2, 25.8) dietary Vitamin C intake ## (mg/day) (m, sd) 85.9 (34.5)80.1 (35.3) age of mother (yrs) (m, sd) 29.5 (4.2)28.5 (4.8) pre-Pregnancy bmi (kg/m2) (m, sd) 22.8 (3.5)22.9 (3.6) total energy Intake (kj) (m, sd) 7,483 (1,908)7,415 (2,081) smoking in Pregnancy (%, 95% ci ** ) 15.4 (14.1, 16.7)25.2 (24.4, 26.0) caucasian (%, 95% ci) 98.8 (98.4, 99.2)97.5 (97.2, 97.8) university degree (%, 95% ci) 18.6 (17.2, 20.0)13.8 (13.1, 14.4) vegetarian (%, 95% ci) 6.1 (5.3, 7.0)5.2 (4.8, 5.6) primigravida (%, 95% ci) 48.8 (47.0, 50.6)44.8 (43.9, 45.7) early Pregnancy maternal anemia (<11 g/dl) (%, 95% ci) 4.4 (3.7, 5.1)5.1 (4.6, 5.5) report taking Iron supplements before 32 wks Gestation (%, 95% ci) 44.9 (43.1, 46.7)47.5 (46.6, 48.4) child gender (male) (%, 95% ci) 50.8 (49.0, 52.6)51.5 (50.6, 52.4) Birthweight (g) (m, sd) 3,448 (499)3,411 (544) Gestational age (wks) (m, sd) 39.6 (1.6)39.5 (1.8)\n#Food frequency questionnaire at 32 weeks Gestation.']	[('PROBABLE_UNDERSTANDING', 105), ('PROBABLE_UNDERSTANDING', 281)]	2	[('CHEBI_33284', 'nutrient', 70, 'Nutrient'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin C'), ('GO_0007565', 'female pregnancy', 240, 'pregnancy'), ('GO_0007565', 'female pregnancy', 304, 'pregnancy'), ('CHEBI_35222', 'inhibitor', 465, 'mediators'), ('GO_0007631', 'feeding behavior', 628, 'intake'), ('CHEBI_27300', 'vitamin D', 848, 'vitamin C'), ('GO_0007565', 'female pregnancy', 961, 'pregnancy'), ('GO_0007631', 'feeding behavior', 1025, 'intake'), ('GO_0007565', 'female pregnancy', 1083, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1384, 'pregnancy'), ('CHEBI_24870', 'ion', 1476, 'iron'), ('GO_0007565', 'female pregnancy', 1507, 'gestation'), ('GO_0007608', 'sensory perception of smell', 1631, 'Birthweight'), ('GO_0007565', 'female pregnancy', 1678, 'Gestational'), ('CHEBI_33290', 'food', 1730, 'Food'), ('GO_0007565', 'female pregnancy', 1771, 'gestation')]
PMC4045304	2/2014	S208-PMC4045304	['these OBSERVATIONS IMPLY that Vitamin D levels in autistic children are highly heritable [87].']	[('INCOMPLETE_EVIDENCE', 6), ('PROBABLE_UNDERSTANDING', 19)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC4051754	6/2014	S44-PMC4051754	['the numerical difference between the two groups in Prepartum concentrations of Vitamin A, and partly, Vitamin E, are LIKELY RELATED with the dry matter intake which was higher in of vs. re Prepartum (see[10]for Feed Intake).']	[('PROBABLE_UNDERSTANDING', 117), ('SUPERFICIAL_RELATIONSHIP', 124)]	2	[('GO_0007565', 'female pregnancy', 51, 'prepartum'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin E'), ('GO_0007565', 'female pregnancy', 189, 'prepartum'), ('GO_0007631', 'feeding behavior', 211, 'feed intake')]
PMC4072587	6/2014	S18-PMC4072587	['[12]categorised Vitamin D insufficiency for Pregnancy outcomes AS Serum 25-Ohd concentration less than 75 nmol/l, and for Vitamin D insufficiency for Birth outcomes, AS Serum 25-Ohd concentration less than 37.5 nmol/l[12].']	[('PROBABLE_UNDERSTANDING', 63), ('PROBABLE_UNDERSTANDING', 166)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_72765', 'verruculogen', 72, '25-OHD'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0007567', 'parturition', 150, 'birth'), ('UBERON_0001977', 'blood serum', 169, 'serum'), ('CHEBI_72765', 'verruculogen', 175, '25-OHD')]
PMC4099383	7/2014	S61-PMC4099383	['the PROTECTIVE elements within these diets are LIKELY to include selenium, zinc, Folate, Vitamin E, and other antioxidants.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBABLE_UNDERSTANDING', 47)]	2	[('CHEBI_30863', '5-azaorotic acid', 81, 'folate'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin E')]
PMC4113768	7/2014	S287-PMC4113768	['circulating vd is predominantly bound to Vitamin D Binding Protein (Vdbp) and Albumin (alb) and HENCE assessment of vd status during acute phase of critical illness MAY BE hazardous.']	[('PROBABLE_UNDERSTANDING', 96), ('INCOMPLETE_EVIDENCE', 165)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'vitamin D binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 68, 'VDBP'), ('PR_000005908', 'alpha-crystallin B chain', 78, 'albumin')]
PMC4113768	7/2014	S851-PMC4113768	['clinical and laboratory evidence SUGGEST that muscle is a target Tissue for Vitamin D, with myopathy a RECOGNISED feature of d deficient Individuals and receptors present in Skeletal muscle.']	[('INCOMPLETE_EVIDENCE', 33), ('PROBABLE_UNDERSTANDING', 103)]	2	[('UBERON_0000479', 'tissue', 65, 'tissue'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('NCBITaxon_1', 'root', 137, 'individuals'), ('UBERON_0004288', 'skeleton', 174, 'skeletal')]
PMC4113768	7/2014	S941-PMC4113768	['radiology 2012, 262 , 234-241) the CONCLUSION was that fractures in early childhood were UNLIKELY to be caused by Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 89)]	2	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
PMC4113768	7/2014	S1077-PMC4113768	['higher Serum 25(Oh) Vitamin D levels were CONSISTENTLY FOUND among subjects with no prevalent Cardiovascular risk factors ( p> 0.05) except for those subjects with serum crp level ≥3 mg/l, tc/Hdl-C ratio ≥5, and those with 4 or more Pregnancies.']	[('PROBABLE_UNDERSTANDING', 42), ('INCOMPLETE_EVIDENCE', 55)]	2	[('UBERON_0001977', 'blood serum', 7, 'serum'), ('CHEBI_30778', 'gallic acid', 13, '25(OH)'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 94, 'cardiovascular'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 192, 'HDL-C'), ('GO_0007565', 'female pregnancy', 233, 'pregnancies')]
PMC4113768	7/2014	S1200-PMC4113768	['the percentage of patients with 25Ohd < 50 nmol/l fell (from 70% in 2007 to 58% in 2010), PERHAPS AS a result of including those who had started Vitamin D replacement.']	[('INCOMPLETE_EVIDENCE', 90), ('PROBABLE_UNDERSTANDING', 98)]	2	[('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 32, '25OHD'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC4113768	7/2014	S1331-PMC4113768	["Vitamin D supplementation in an edinburgh general practice population and ANECDOTAL evidence\n\nrhein, h.m.; johnson, g.\nbackground: after we became aware of the widespread Vitamin D deficiency in our scottish general practice population in edinburgh at a latitude of 56', our patients have received for the past few years the offer of prescriptions for Vitamin D supplements: 20,000 iu weekly for MOST Adults, 2000 iu daily for Pregnant women, 1000 iu daily for children aged 5–12, 400 iu daily for babies and children aged 0–5."]	[('INCOMPLETE_EVIDENCE', 74), ('PROBABLE_UNDERSTANDING', 396)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 352, 'vitamin D'), ('UBERON_0007023', 'adult organism', 401, 'adults'), ('GO_0007565', 'female pregnancy', 427, 'pregnant')]
PMC4113768	7/2014	S1345-PMC4113768	['it is our IMPRESSION that quality of Life in MOST cancer patients was good after Vitamin D supplementation, and in those who died this was right up until their final stage.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('PROBABLE_UNDERSTANDING', 45)]	2	[('UBERON_0000104', 'life cycle', 37, 'life'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
PMC4113768	7/2014	S1533-PMC4113768	['carriers of a high grs of Cyp2R1 (rs10741657 and rs10766197) and gc (rs4588 and rs842999) were more PRONE to be Vitamin D insufficient COMPARED TO carriers of low grs.']	[('PROBABLE_UNDERSTANDING', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 135)]	2	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 26, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
PMC4113768	7/2014	S1613-PMC4113768	['conclusions: tdf has the PREDOMINANT EFFECT on bmd irrespective of Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 25), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC4113768	7/2014	S1881-PMC4113768	['by proving the effectiveness of Food fortification in this manner, the OPPORTUNITY now exists to increase the diversity and range of Foods available to the population that could provide adequate Vitamin D. population groups TYPICALLY resistant to traditional methods of supplementation ( i.e.']	[('FUTURE_WORK', 71), ('PROBABLE_UNDERSTANDING', 224)]	2	[('CHEBI_33290', 'food', 32, 'food'), ('CHEBI_33290', 'food', 133, 'foods'), ('CHEBI_27300', 'vitamin D', 195, 'vitamin D')]
PMC4113768	7/2014	S2087-PMC4113768	['higher doses of Vitamin D AS a means to prevent or correct privational Vitamin D deficiency or to attain supraphysiological levels SHOULD BE avoided.']	[('PROBABLE_UNDERSTANDING', 26), ('FUTURE_WORK', 131)]	2	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
PMC4113768	7/2014	S2110-PMC4113768	['a main REASON is the INADEQUATE uvb radiation during fall and winter in northern latitudes, which limits the endogenous Vitamin D production.']	[('PROBABLE_UNDERSTANDING', 7), ('IMPORTANT_CONSIDERATION', 21)]	2	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4113768	7/2014	S2256-PMC4113768	['background: the latter part of the twentieth century has witnessed the identification of Nuclear Vitamin D receptors in almost every cell of the Human body, thereby EXPLAINING both Skeletal and PROPOSED Extra-Skeletal activities.']	[('PROBABLE_UNDERSTANDING', 165), ('INCOMPLETE_EVIDENCE', 194)]	2	[('GO_0005634', 'nucleus', 89, 'nuclear'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 105, 'D'), ('NCBITaxon_9606', 'Homo sapiens', 145, 'human'), ('UBERON_0004288', 'skeleton', 181, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 203, 'extra-skeletal')]
PMC4113768	7/2014	S2365-PMC4113768	['in both groups, hdl-C levels improved significantly AS 25(Oh) Vitamin D levels increased with subsequent follow-ups, EVEN after adjusting for age, gender and bmi ( p< 0.001).']	[('PROBABLE_UNDERSTANDING', 52), ('ANOMALY_CURIOUS_FINDING', 117)]	2	[('PR_000000037', 'BMP receptor type-2', 19, '-C'), ('CHEBI_30778', 'gallic acid', 55, '25(OH)'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4113768	7/2014	S2646-PMC4113768	['median maternal 25(Oh)D was 61 nmol/l (iqr 43–88 nmol/l), and ONLY 9.2% of mothers were using Vitamin D supplementation (at LEAST 400 iu/day) in late Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 62), ('PROBABLE_UNDERSTANDING', 124)]	2	[('CHEBI_71657', 'versiconol acetate', 16, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 16, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy')]
PMC4113768	7/2014	S2665-PMC4113768	['PREVIOUS rcts MAINLY have given Vitamin D for short periods (<6 months) or at too low doses.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 14)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D')]
PMC4113768	7/2014	S2782-PMC4113768	['we THEREFORE INVESTIGATED the Expression of components of Vitamin D (Vitamin D Receptor [Vdr], 25-Hydroxy Vitamin D3-1α-hydroxylase [Cyp27B1; 1α-ohase], 24-hydroxylase [Cyp24A1; 24-Ohase], rxr) and tlr (Tlr 1,2,4, Myd88 and cd14) signalling in Human Urinary Bladder Epithelial Cells.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13)]	2	[('GO_0010467', 'gene expression', 30, 'expression'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('PR_000001683', 'vasopressin V2 receptor', 69, 'vitamin D receptor'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 89, 'VDR'), ('CHEBI_43141', '3-hydroxypropoxy group', 95, '25-hydroxy'), ('CHEBI_33279', 'vitamin D5', 106, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 106, 'vitamin D3'), ('PR_000006101', 'cytochrome P450 1A1', 133, 'CYP27B1'), ('PR_000006101', 'cytochrome P450 1A1', 169, 'CYP24A1'), ('CHEBI_50024', 'o-aminophenylarsonous acid', 178, '24-OHase'), ('PR_000001155', 'Toll-like receptor 4', 203, 'TLR 1'), ('PR_000010222', 'muscleblind-like protein 2', 209, '2'), ('PR_000017527', 'YEATS domain-containing protein 4', 211, '4'), ('PR_000010883', 'myozenin-2', 214, 'MyD88'), ('NCBITaxon_9606', 'Homo sapiens', 244, 'human'), ('CL_0002535', 'epithelial cell of cervix', 250, 'urinary bladder epithelial cells'), ('UBERON_0001255', 'urinary bladder', 250, 'urinary bladder'), ('UBERON_0000483', 'epithelium', 266, 'epithelial')]
PMC4169453	9/2014	S205-PMC4169453	['THEREFORE, breastfeeding infants NEED additional Vitamin D supplementation when maternal intake is 1200 iu/d.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 33)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4221707	11/2014	S7-PMC4221707	['intake of Folate and Vitamin D supplements was GENERALLY high in the Pregnant group and LED TO significantly higher total estimated Intake of Vitamin D and Folate in the pregnant group.']	[('PROBABLE_UNDERSTANDING', 47), ('SUPERFICIAL_RELATIONSHIP', 88)]	2	[('CHEBI_30863', '5-azaorotic acid', 10, 'folate'), ('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('GO_0007631', 'feeding behavior', 132, 'intake'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 156, 'folate')]
PMC4251419	12/2014	S156-PMC4251419	['it is LIKELY that there is a loss of study power and a risk of harm IF participants in Vitamin D supplementation trials already have adequate 25(Oh)d levels at baseline [91].']	[('PROBABLE_UNDERSTANDING', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 68)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 142, '25(OH)')]
PMC4256222	12/2014	S16-PMC4256222	['CONSEQUENTLY, offspring of mothers with low status of Vitamin D MAY BE in a deficient state already from the first days of Life.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 64)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0000104', 'life cycle', 123, 'life')]
PMC4256222	12/2014	S76-PMC4256222	['total Vitamin D status was significantly ASSOCIATED with parity (p\u200a=\u200a0.004), with parous women being more LIKELY to be in deficient or insufficient state.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('PROBABLE_UNDERSTANDING', 106)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
PMC4303849	1/2015	S2-PMC4303849	['THEREFORE, factors that Regulate Vitamin D Metabolism are of main IMPORTANCE, especially during Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 66)]	2	[('GO_0065007', 'biological regulation', 24, 'regulate'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 33, 'vitamin D metabolism'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy')]
PMC4340999	3/2015	S106-PMC4340999	['lucas et al FOUND that seasonal variation in Vitamin D status in australian Adults (living in an area spanning 27°–43° south) had greater amplitude compared to australian Adults living in a different region, and Vitamin D deficiency increased with increasing latitude, REFLECTING stronger seasonal variation in ambient uvb and less skin exposure due to colder temperatures.38hunan, being another site presenting seasonal variation in ll, has lower latitude than seven other study sites but the greatest yearly sunshine variation of all the study sites (seeetable 1).']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 269)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0007023', 'adult organism', 76, 'adults'), ('UBERON_0007023', 'adult organism', 171, 'adults'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
PMC4377870	3/2015	S119-PMC4377870	['in copd there is currently NOT ENOUGH EVIDENCE to make CONCLUSIONS about Vitamin E supplementation.']	[('INCOMPLETE_EVIDENCE', 27), ('PROBABLE_UNDERSTANDING', 55)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin E')]
PMC4380518	9/2014	S23-PMC4380518	['we DEFINED Vitamin D deficiency as <50 nmol/l, a COMMON cut-point in the literature.5,22,23\n\nstatistical analyses\nfirst, we analyzed bivariate associations between 25(Oh)D category and pnv use as well as covariates including maternal age, race/ethnicity, smoking, education and bmi.']	[('PROBABLE_UNDERSTANDING', 3), ('PROBABLE_UNDERSTANDING', 49)]	2	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 164, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 164, '25(OH)D')]
PMC4380518	9/2014	S48-PMC4380518	['both overweight/obesity as well as darker skin pigmentation are both WELL-ESTABLISHED RISK FACTORS for Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 69), ('SUPERFICIAL_RELATIONSHIP', 86)]	2	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
PMC4383226	2/2015	S25-PMC4383226	['FOUND that children who received Vitamin A supplements were less LIKELY to become infected with malaria.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 65)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin A')]
PMC4392553	3/2015	S438-PMC4392553	['[36]\nosteoarthritis is another pathology LIKELY RELATED to Mn deficiency, impaired Chondroitin Sulfate Synthesis and impaired Vitamin D activation.']	[('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('PR_000010460', 'carbohydrate-responsive element-binding protein', 59, 'Mn'), ('CHEBI_37397', 'chondroitin sulfate', 83, 'chondroitin sulfate'), ('GO_0030206', 'chondroitin sulfate biosynthetic process', 83, 'chondroitin sulfate synthesis'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC4396835	1/2015	S26-PMC4396835	['this is RELEVANT SINCE the Synthesis Of Vitamin D In Skin is impaired by Melanin [32].']	[('IMPORTANT_CONSIDERATION', 8), ('PROBABLE_UNDERSTANDING', 17)]	2	[('GO_0019915', 'lipid storage', 27, 'synthesis of vitamin D in skin'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_25179', 'melanins', 73, 'melanin')]
PMC4396835	1/2015	S71-PMC4396835	['DUE TO the WELL-KNOWN ethnic disparity of Vitamin D status, we chose to categorise the participants into three ethnic origin groups: swedish, miscellaneous (non-scandinavian europe, south america and east asia) and african/middle east.']	[('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 11)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC4396888	3/2015	S105-PMC4396888	['the MAJORITY of pw and rdw had an INADEQUATE Nutrient adequacy ratio nar (<0.66) with respect to protein, and Micronutrients like iron, calcium, Vitamin A, Vitamin C, Thiamine, riboflavin, niacin, zinc and Vitamin B12.']	[('PROBABLE_UNDERSTANDING', 4), ('IMPORTANT_CONSIDERATION', 34)]	2	[('CHEBI_33284', 'nutrient', 45, 'nutrient'), ('CHEBI_33839', 'macromolecule', 110, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin C'), ('CHEBI_26948', 'vitamin B1', 167, 'thiamine'), ('CHEBI_33279', 'vitamin D5', 206, 'vitamin B12')]
PMC4405493	4/2015	S124-PMC4405493	['other RISK FACTORS for Vitamin D deficiency include ethnicity, AS darker skinned Individuals have decreased Vitamin D3 Synthesis in response to ultraviolet light.']	[('SUPERFICIAL_RELATIONSHIP', 6), ('PROBABLE_UNDERSTANDING', 63)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('NCBITaxon_1', 'root', 81, 'individuals'), ('CHEBI_33279', 'vitamin D5', 108, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 108, 'vitamin D3'), ('GO_0009057', 'macromolecule catabolic process', 119, 'synthesis')]
PMC4438628	5/2015	S190-PMC4438628	['psychological stress\nprocessed and ultra-processed Foods\nFood Additives\nAdvanced Glycation End Products (Ages)\nabsence of Phytochemicals\ninadequate essential Fats\ninadequate Vitamin D\ninadequate magnesium\nAntibiotic administration\npotentially pathogenic Oral bacteria\nlack of physical activity/excess indoor screen time\ntobacco use\nAlcohol use\nsleep problems/Circadian disruptions\ncrowding\nclimatic stress\nenvironmental Toxins\n\nsummary and future directions\nDESPITE its obvious ripple into so many aspects of societal health, the ‘no health without mental health’ dictum is OFTEN afforded only lip service by funding bodies [309].']	[('ANOMALY_CURIOUS_FINDING', 458), ('PROBABLE_UNDERSTANDING', 574)]	2	[('CHEBI_33290', 'food', 51, 'foods'), ('CHEBI_78601', '11,21-dioxoprogesterone', 57, 'Food additives'), ('GO_0006116', 'NADH oxidation', 72, 'Advanced glycation'), ('CHEBI_46678', 'amosite asbestos', 81, 'glycation end products'), ('CHEBI_74913', 'AOPE', 105, 'AGEs'), ('CHEBI_26254', 'prenylnaphthoquinone', 122, 'phytochemicals'), ('CHEBI_33250', 'atom', 158, 'fats'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_33282', 'antibacterial agent', 205, 'Antibiotic'), ('UBERON_0000165', 'mouth', 254, 'oral'), ('CHEBI_30879', 'alcohol', 332, 'Alcohol'), ('GO_0051216', 'cartilage development', 359, 'circadian'), ('CHEBI_27026', 'toxin', 420, 'toxins')]
PMC4448820	5/2015	S297-PMC4448820	['because Vitamins A and D share a Nuclear receptor (rxr), compete for coactivators and corepressors, and reciprocally Regulate the Expression of their receptors, a wide variety of combined EFFECTS on Gene Regulation LIKELY occurs (190–192).']	[('SUPERFICIAL_RELATIONSHIP', 188), ('PROBABLE_UNDERSTANDING', 215)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 23, 'D'), ('GO_0005634', 'nucleus', 33, 'nuclear'), ('GO_0065007', 'biological regulation', 117, 'regulate'), ('GO_0010467', 'gene expression', 130, 'expression'), ('SO_0000704', 'gene', 199, 'gene'), ('GO_0065007', 'biological regulation', 204, 'regulation')]
PMC4448820	5/2015	S560-PMC4448820	['the challenge of obtaining Vitamin A, a fat-soluble Vitamin, is great in many settings BECAUSE preformed Vitamin A is found PRIMARILY in Animal-source foods including Liver, eggs, and whole Milk.']	[('PROBABLE_UNDERSTANDING', 87), ('PROBABLE_UNDERSTANDING', 124)]	2	[('CHEBI_27300', 'vitamin D', 27, 'vitamin A'), ('CHEBI_33229', 'vitamin (role)', 52, 'vitamin'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 137, 'animal'), ('UBERON_0002107', 'liver', 167, 'liver'), ('UBERON_0001913', 'milk', 190, 'milk')]
PMC4448820	5/2015	S594-PMC4448820	['FOR THIS REASON, Vitamin A supplementation MAY BE a double-edged sword.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 43)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin A')]
PMC4488777	5/2015	S8-PMC4488777	['MOST experts agree that Vitamin D supplementation is a necessity, PARTICULARLY in women suffering from obesity, Insulin resistance or small Ovarian reserve, as well as in men with oligo- and asthenozoospermia if Serum concentration should fall below 50 nmol/l (normal range up to 125 nmol/l).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 66)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('PR_000045358', 'insulin family protein', 112, 'insulin'), ('UBERON_0000992', 'ovary', 140, 'ovarian'), ('UBERON_0001977', 'blood serum', 212, 'serum')]
PMC4488777	5/2015	S32-PMC4488777	['for THE TIME BEING, we KNOW that Vitamin D exists in two forms: Vitamin D2(Ergocalciferol) and D3(Cholecalciferol).']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 23)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_28934', 'vitamin D2', 64, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 64, 'vitamin D2'), ('CHEBI_4910', 'etomidate', 75, 'ergocalciferol'), ('PR_000001177', 'D(2) dopamine receptor', 95, 'D3'), ('CHEBI_52550', 'theopalauamide', 98, 'cholecalciferol')]
PMC4488777	5/2015	S161-PMC4488777	['as STATED by the authors, the results of their study PROVE an increased Production Of active form Of Vitamin D in the first trimester Decidua, which Modulates reactions in a Paracrine manner between the mother’s and the Embryo’s Immune System during the Implantation.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 53)]	2	[('GO_0040007', 'growth', 72, 'production of ... of vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0002450', 'decidua', 134, 'decidua'), ('GO_0065007', 'biological regulation', 149, 'modulates'), ('GO_0038001', 'paracrine signaling', 174, 'paracrine'), ('UBERON_0000922', 'embryo', 220, 'embryo'), ('UBERON_0002405', 'immune system', 229, 'immune system'), ('GO_0007566', 'embryo implantation', 254, 'implantation')]
PMC4499946	7/2015	S257-PMC4499946	['Serum Calcium is the best available BIOMARKER of Vitamin D toxicity [57,58]; THEREFORE, hypercalcemia is the primary biochemical safety outcome.']	[('SUPERFICIAL_RELATIONSHIP', 36), ('PROBABLE_UNDERSTANDING', 77)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_22313', 'alkaline earth metal atom', 6, 'calcium'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
PMC4516377	6/2015	S68-PMC4516377	['suggested mechanisms to EXPLAIN the cyclical ASSOCIATION between Vitamin D deficiency and increased body fat deposition.']	[('PROBABLE_UNDERSTANDING', 24), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
PMC4595656	10/2015	S47-PMC4595656	['THEREFORE they are germane to an overall understanding of the ROLE of Vitamin D in Hippocampal Development.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 62)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0003163', 'sinoatrial node development', 83, 'hippocampal development')]
PMC4600246	10/2015	S42-PMC4600246	['Vitamin K and warfarin\nsince warfarin directly leads to the inhibition of Vitamin K, it would be PRESUMED that there COULD BE increased Arterial calcifications in patients given warfarin.']	[('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 117)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin K'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin K'), ('UBERON_0001637', 'artery', 136, 'arterial')]
PMC4632423	10/2015	S107-PMC4632423	['likewise concentrations of Anti-Oxidant Micronutrient Vitamins A, E and Selenium are often lower in smokers [30], PERHAPS BECAUSE of increased utilisation, and more of the obese women in our study were current smokers.']	[('INCOMPLETE_EVIDENCE', 114), ('PROBABLE_UNDERSTANDING', 122)]	2	[('CHEBI_74351', 'aclacinomycin T', 27, 'anti-oxidant'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 40, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 54, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 63, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 66, 'E'), ('CHEBI_27568', 'selenium atom', 72, 'selenium')]
PMC4673623	11/2015	S113-PMC4673623	['a POSSIBLE EXPLANATION for the rise in Folate is impaired Vitamin B-12 dependent methionine synthase activity, with subsequent cellular accumulation of 5-Methyl-Thf (i.e., Metabolic trapping of Folate; methyl trap) (caudill et\xa0al.2012).']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 11)]	2	[('CHEBI_30863', '5-azaorotic acid', 39, 'folate'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 58, 'vitamin B-12'), ('CHEBI_44700', 'L-ornithyl group', 152, '5-methyl'), ('CHEBI_17038', 'fecosterol', 161, 'THF'), ('GO_0008152', 'metabolic process', 172, 'metabolic'), ('CHEBI_30863', '5-azaorotic acid', 194, 'folate')]
PMC4719746	1/2016	S16-PMC4719746	['also studies of multiethnic populations in australia have uncovered maternal country of Birth in asia and africa AS RISK FACTOR of Vitamin D deficiency in Pregnancy [11].']	[('PROBABLE_UNDERSTANDING', 113), ('SUPERFICIAL_RELATIONSHIP', 116)]	2	[('GO_0007567', 'parturition', 88, 'birth'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'pregnancy')]
PMC4719746	1/2016	S142-PMC4719746	['GUIDELINES from scandinavia and uk RECOMMEND all Pregnant women supplement intake with 10\xa0μg (400\xa0iu) Vitamin D daily to prevent Vitamin D deficiency [21,34,35].']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 35)]	2	[('GO_0007565', 'female pregnancy', 49, 'pregnant'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC4729160	1/2016	S117-PMC4729160	['the REASON MAYBE that population was easily to access to Foods rich in preformed Vitamin A.']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 11)]	2	[('CHEBI_33290', 'food', 57, 'foods'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 89, 'A')]
PMC4764019	1/2016	S31-PMC4764019	['once again, may Births would have followed a winter-long, Vitamin D–deprived Pregnancy, WHEREAS november Births would have followed a summer-long pregnancy with PRESUMABLY higher Vitamin D status values.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('PROBABLE_UNDERSTANDING', 161)]	2	[('GO_0007567', 'parturition', 16, 'births'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0007567', 'parturition', 105, 'births'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
PMC4764019	1/2016	S71-PMC4764019	['the enzymes responsible for doing this are themselves encoded in the Genome,14and AT LEAST SOME have Vitamin D response elements of their own.']	[('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 91)]	2	[('SO_0001026', 'genome', 69, 'genome'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC4765528	12/2015	S108-PMC4765528	['the programming effect of an adverse in-utero environment and the role of epigenetics\nIT IS CLEAR that there is a strong Genetic predisposition to osteoporosis and although the Genes that Regulate bone mass have not been COMPLETELY established, responsible Gene variants include Vitamin D receptor polymorphisms [47], Collagen-1 Receptor [48] and Oestrogen receptor variants [49].']	[('PROBABLE_UNDERSTANDING', 86), ('PROBABLE_UNDERSTANDING', 221)]	2	[('SO_0000704', 'gene', 121, 'genetic'), ('SO_0000704', 'gene', 177, 'genes'), ('GO_0065007', 'biological regulation', 188, 'regulate'), ('SO_0000704', 'gene', 257, 'gene'), ('CHEBI_27300', 'vitamin D', 279, 'vitamin D'), ('PR_000003266', 'collagen type II alpha chain', 318, 'collagen-1 receptor'), ('CHEBI_50114', 'estrogen', 347, 'oestrogen')]
PMC4770602	1/2016	S24-PMC4770602	['furthermore, because Vitamin D supplementation is simple and cost-effective with a low LIKELIHOOD of toxicity, increased supplementation in Pregnant women is RECOMMEND previously.']	[('PROBABLE_UNDERSTANDING', 87), ('FUTURE_WORK', 158)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 140, 'pregnant')]
PMC4785305	3/2016	S86-PMC4785305	['Vitamin D supplementation ≤200\u2005iu daily.ii\nexclusion criteria:\n25(Oh)D level <25\u2005nmol/l, AS it would be UNETHICAL to randomise Pregnant women to the low dose of Vitamin D, and 25(Oh)D level >75\u2005nmol/l (30\u2005ng/ml), as Vitamin D supplementation with routine Prenatal multivitamins would be sufficient.']	[('PROBABLE_UNDERSTANDING', 89), ('DIFFICULT_TASK', 104)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 63, '25(OH)D'), ('GO_0007565', 'female pregnancy', 127, 'pregnant'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 176, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 182, 'D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0007565', 'female pregnancy', 255, 'prenatal')]
PMC4785305	3/2016	S120-PMC4785305	['CONSIDERING that each 100\u2005iu Vitamin D supplementation increases the level by 1.7\u2005nmol/l,49the EXPECTED levels reached in the low-dose and high-dose arms would be 67\u2005nmol/l and 106\u2005nmol/l, respectively.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 95)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
PMC4908484	6/2016	S9-PMC4908484	['the Production Of Vitamin D by these Tissues/Organs is low compared to the amount produced by Kidneys, and this Vitamin D is PROBABLY not released back into the Blood BUT acts within the Tissue where it is made (garcion et\xa0al.2002; tetich et\xa0al.2004; cranney et\xa0al.2007).']	[('PROBABLE_UNDERSTANDING', 125), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 167)]	2	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 4, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0000479', 'tissue', 37, 'tissues'), ('UBERON_0000062', 'organ', 45, 'organs'), ('UBERON_0002113', 'kidney', 94, 'kidneys'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0000178', 'blood', 161, 'blood'), ('UBERON_0000479', 'tissue', 187, 'tissue')]
PMC4908484	6/2016	S169-PMC4908484	['THUS, THERE IS EVIDENCE that the neuroprotective action of Vitamin D involves Neuronal calcium Regulation, Antioxidative pathway, Immunomodulation, and Detoxification.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CL_0000540', 'neuron', 78, 'neuronal'), ('GO_0065007', 'biological regulation', 95, 'regulation'), ('GO_0019286', 'glycine betaine biosynthetic process from glycine', 107, 'antioxidative'), ('GO_0050900', 'leukocyte migration', 130, 'immunomodulation'), ('GO_0098754', 'detoxification', 152, 'detoxification')]
PMC4930210	7/2016	S68-PMC4930210	['Plasma concentrations of 25(Oh)D at <25 nmol/l [3,4], <50 nmol/l [3,4], and <75 nmol/l [5,6] were used to REFLECT several laboratory definitions of Vitamin D status CURRENTLY used.']	[('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 165)]	2	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 31, 'D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4934634	11/2015	S4-PMC4934634	['Vitamin D is found naturally in only a few foods THUS supplementation CAN provide an accessible and effective way to raise Vitamin D status when dietary intakes and sunlight exposure are low.']	[('PROBABLE_UNDERSTANDING', 49), ('INCOMPLETE_EVIDENCE', 70)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
PMC4934634	11/2015	S12-PMC4934634	['currently, it is RECOGNIZED that Vitamin D deficiency CAN be demonstrated in numerous ethnic populations and locations around the world.']	[('PROBABLE_UNDERSTANDING', 17), ('INCOMPLETE_EVIDENCE', 54)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D')]
PMC4934634	11/2015	S93-PMC4934634	['evaluation of nhanes data from 2001 to 2006 using iom GUIDELINES REPORTS that 7% of Pregnant women are Vitamin D deficient (< 12 ng/ml) and 21% are Vitamin D insufficient (12–20 ng/ml) [35].']	[('PROBABLE_UNDERSTANDING', 54), ('INCOMPLETE_EVIDENCE', 65)]	2	[('GO_0007565', 'female pregnancy', 84, 'pregnant'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
PMC4934634	11/2015	S168-PMC4934634	['infants of mothers receiving Vitamin D supplementation were more LIKELY to reach Vitamin D sufficiency at Birth compare to infants of non-supplemented mothers (46.2% vs. 14%, respectively), HOWEVER, over half of the infants in the Supplement group still had suboptimal Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 65), ('ANOMALY_CURIOUS_FINDING', 190)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 106, 'birth'), ('CHEBI_16158', 'steroid sulfate', 231, 'supplement'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC4934634	11/2015	S178-PMC4934634	['Breast Milk is low in Vitamin D concentration and is the primary source of Vitamin D in breastfed infants [36] AS it is RECOMMENDED that infants younger than 6 months be kept out of direct sunlight and the exposure to sun be minimized with the use of protective clothing, hats and sunscreen [66].']	[('PROBABLE_UNDERSTANDING', 111), ('FUTURE_WORK', 120)]	2	[('UBERON_0013538', 'Brodmann (1909) area 7', 0, 'Breast milk'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
PMC4934634	11/2015	S262-PMC4934634	['a one-time, Oral bolus of Vitamin D is an EFFECTIVE way to treat Vitamin D deficiency AS 25(Oh)D levels quickly rise following supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 86)]	2	[('UBERON_0000165', 'mouth', 12, 'oral'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D')]
PMC4934634	11/2015	S302-PMC4934634	['among the changes, is the REQUIREMENT that manufacturers declare the amount of Vitamin D on the label, AS it is one of the new “Nutrients of public health significance” based on nhanes dietary intake data [106].']	[('IMPORTANT_CONSIDERATION', 26), ('PROBABLE_UNDERSTANDING', 103)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('CHEBI_33284', 'nutrient', 128, 'nutrients')]
PMC4944244	7/2016	S94-PMC4944244	['this high prevalence of hypovitaminosis D was DUE TO age, Abdominal obesity and Metabolic syndrome AFFECTING Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 40, 'D'), ('UBERON_0000916', 'abdomen', 58, 'abdominal'), ('GO_0008152', 'metabolic process', 80, 'metabolic'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
PMC4944244	7/2016	S107-PMC4944244	['the low Vitamin D status in tehran was PROBABLY DUE TO wearing of full dress and veil among all women, regardless of race and religion.']	[('PROBABLE_UNDERSTANDING', 39), ('PROBLEM_COMPLICATION', 48)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D')]
PMC4969253	8/2016	S43-PMC4969253	['the decreasing ra reporter signals in proximal Airways where sm is already formed and the aberrant sm phenotype of Vitamin A-ra deficiency STRONGLY SUGGEST that endogenous ra represses Sm differentiation.']	[('PROBABLE_UNDERSTANDING', 139), ('INCOMPLETE_EVIDENCE', 148)]	2	[('UBERON_0001005', 'respiratory airway', 47, 'airways'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin A'), ('PR_000000035', 'BMP receptor type-1A', 185, 'SM')]
PMC4969253	8/2016	S63-PMC4969253	['the MAJORITY of these STUDIES used an intramuscular regimen of a “standard” dose vs a higher dose of Vitamin A.']	[('PROBABLE_UNDERSTANDING', 4), ('INCOMPLETE_EVIDENCE', 22)]	2	[('CHEBI_27300', 'vitamin D', 101, 'vitamin A')]
PMC4971719	8/2016	S82-PMC4971719	['THUS, MOST of the current literature uses 25-Oh-D as the assessment of overall Vitamin D status [28,42,43].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 6)]	2	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 42, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC4971719	8/2016	S118-PMC4971719	['Vitamin D levels at 12–20 weeks were STRONGLY CORRELATED with Vitamin D levels at 34–36 weeks (pearson’s ρ \u2009=\u20090.60, p \u2009<\u2009.0001).']	[('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 46)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC4976416	7/2016	S61-PMC4976416	['[42] antioxidants such as Vitamin E MIGHT, THEREFORE, be beneficial.']	[('INCOMPLETE_EVIDENCE', 36), ('PROBABLE_UNDERSTANDING', 43)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin E')]
PMC4976416	7/2016	S70-PMC4976416	['[51] in a healthy Adult who had been on a normal diet it would take an ESTIMATED 4 years to fully deplete body stores of Vitamin E.[52]\n\ntopical vitamin E in dermatology\ntopical Vitamin E has emerged as a popular treatment for a number of skin disorders OWING TO its antioxidant properties.']	[('INCOMPLETE_EVIDENCE', 71), ('PROBABLE_UNDERSTANDING', 254)]	2	[('UBERON_0007023', 'adult organism', 18, 'adult'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin E'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 153, 'E'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin E')]
PMC4976416	7/2016	S82-PMC4976416	['Vitamin E being a fat-soluble Vitamin, administration of a dose higher than daily REQUIREMENT results in accumulation inside the body, resulting in hypervitaminosis e. healthy Adults taking Vitamin E daily at a dose of 100 mg for more than 1 year are LIKELY to get hypervitaminosis E, manifesting as reduced Platelet Aggregation and interference with Vitamin K Metabolism resulting in bleeding tendencies.']	[('IMPORTANT_CONSIDERATION', 82), ('PROBABLE_UNDERSTANDING', 251)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('PR_000017279', 'testis-specific basic protein Y 1', 0, 'Vitamin E'), ('CHEBI_33229', 'vitamin (role)', 30, 'vitamin'), ('UBERON_0007023', 'adult organism', 176, 'adults'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin E'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 282, 'E'), ('CL_0000233', 'platelet', 308, 'platelet'), ('GO_0070527', 'platelet aggregation', 308, 'platelet aggregation'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin K'), ('GO_0007601', 'visual perception', 351, 'vitamin K'), ('GO_0008152', 'metabolic process', 361, 'metabolism')]
PMC4988030	8/2016	S93-PMC4988030	['these Nutrients (total and saturated fat, Cholesterol, sodium, calcium, fiber, Folate, iron, Vitamins C and d, and Choline) were chosen BASED ON their importance to an overall healthy diet and increased Nutrient needs during Pregnancy [33–37].']	[('PROBABLE_UNDERSTANDING', 136), ('SUPERFICIAL_RELATIONSHIP', 136)]	2	[('CHEBI_33284', 'nutrient', 6, 'nutrients'), ('CHEBI_16113', 'cholesterol', 42, 'cholesterol'), ('CHEBI_30863', '5-azaorotic acid', 79, 'folate'), ('CHEBI_27300', 'vitamin D', 93, 'vitamins C'), ('CHEBI_15354', 'choline', 115, 'choline'), ('CHEBI_33284', 'nutrient', 203, 'nutrient'), ('GO_0007565', 'female pregnancy', 225, 'pregnancy')]
PMC4990268	8/2016	S334-PMC4990268	['women who are Vitamin A deficient have lower levels in Breastmilk THUS limiting the intake during this CRUCIAL age[115].']	[('PROBABLE_UNDERSTANDING', 66), ('IMPORTANT_CONSIDERATION', 103)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin A'), ('UBERON_0001348', 'brown adipose tissue', 55, 'breastmilk')]
PMC4990268	8/2016	S363-PMC4990268	['prepositioning a single capsule of Vitamin A (50,000 iu) at the location of Delivery in those settings where BENEFIT can be expected (primarily poorer, south asian populations) is FEASIBLE.']	[('IMPORTANT_CONSIDERATION', 109), ('PROBABLE_UNDERSTANDING', 180)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin A'), ('GO_0007567', 'parturition', 76, 'delivery')]
PMC4992225	8/2016	S194-PMC4992225	['in the PRESENT STUDY, the mean Vitamin D concentrations in Vitamin D group were significantly higher after taking 2000\xa0iu of Vitamin D supplementation per day for AT LEAST 8 weeks.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('PROBABLE_UNDERSTANDING', 163)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4992225	8/2016	S223-PMC4992225	['there was an inverse RELATIONSHIP between the Vitamin D logarithm and depression scores, AS by adding one unit to the Vitamin D concentration logarithm, equal to 2.72\xa0ng/ml, a 46\xa0% reduction in the depression scores occurred [63].']	[('SUPERFICIAL_RELATIONSHIP', 21), ('PROBABLE_UNDERSTANDING', 89)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC4997421	8/2016	S1-PMC4997421	['BECAUSE maternal Tissue is progressively depleted of Vitamin A to supply fetal demands, women who become Pregnant while possessing marginal Vitamin A reserves are at INCREASED RISK of vitamin a inadequacy as Pregnancy progresses.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 166)]	2	[('UBERON_0000479', 'tissue', 17, 'tissue'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin A'), ('GO_0007565', 'female pregnancy', 105, 'pregnant'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin A'), ('GO_0007565', 'female pregnancy', 208, 'pregnancy')]
PMC4997421	8/2016	S19-PMC4997421	['SINCE there is no de novo fetal Synthesis Of Vitamin A, the fetus relies completely on circulating maternal Vitamin A.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0)]	2	[('GO_0006557', 'S-adenosylmethioninamine biosynthetic process', 32, 'synthesis of vitamin A'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 53, 'A'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 116, 'A')]
PMC4997421	8/2016	S112-PMC4997421	['individuals in the lowest income households are the least LIKELY to consume vegetables and fruits [25,35,36], which are the primary sources of pro-Vitamin A Compounds, and are more LIKELY to consume Foods high in fat and Sugar and low in fiber [37,38].']	[('PROBABLE_UNDERSTANDING', 58), ('PROBABLE_UNDERSTANDING', 181)]	2	[('CHEBI_27300', 'vitamin D', 147, 'vitamin A'), ('CHEBI_36357', 'polyatomic entity', 157, 'compounds'), ('CHEBI_33290', 'food', 199, 'foods'), ('CHEBI_24870', 'ion', 221, 'sugar')]
PMC5014971	8/2016	S12-PMC5014971	['our species evolved under circumstances of extensive sun exposure, so in the evolutionary sense Vitamin D was not a TRUE Vitamin but RATHER an endogenously Photosynthetically produced precursor to the active Steroid hormone (1,25-Dihydroxyvitamin D).']	[('PROBABLE_UNDERSTANDING', 116), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133)]	2	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 121, 'vitamin'), ('GO_0007602', 'phototransduction', 156, 'photosynthetically'), ('CHEBI_35341', 'steroid', 208, 'steroid'), ('CHEBI_67472', '15-epi-lupulin B', 225, '1,25-dihydroxyvitamin D')]
PMC5014971	8/2016	S13-PMC5014971	['the geographic expansion of humanity, the modern environment, and medical CONCERNS over the sequela of extensive sun exposure (e.g., melanoma) have created conditions where for much of modern humanity Endogenous Vitamin D Production is LIKELY far below that of our ancestors.']	[('IMPORTANT_CONSIDERATION', 74), ('PROBABLE_UNDERSTANDING', 236)]	2	[('GO_0009790', 'embryo development', 201, 'endogenous'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 212, 'vitamin D production')]
PMC5014971	8/2016	S96-PMC5014971	['the respondents SEEMED GENERALLY knowledgeable regarding conditions that increase the risk of Vitamin D insufficiency, such as malabsorption syndrome, Gastric bypass surgery, alcohol abuse, african american race, and obesity.']	[('ANOMALY_CURIOUS_FINDING', 16), ('PROBABLE_UNDERSTANDING', 23)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001844', 'cochlea', 151, 'gastric')]
PMC5024513	9/2016	S104-PMC5024513	['caption (table-wrap): table 5\n\nintake of Micronutrients in individual studies compared to uk and us dietary reference values - mineralscomparison to uk dietary reference valuecomparison to us dietary reference valuenutrientstudysecond trimesterthird trimestermean over Pregnancysecond trimesterthird trimestermean over Pregnancy n =meanconfidence interval n =meanconfidence interval n =meanconfidence interval n =meanconfidence interval n =meanconfidence interval n =meanconfidence intervalcalcium mg/dayabaker (2009)290↔840800, 880290↓840800, 880chan (2006)23↔835711, 95923↔862714, 101023↓835711, 95924↓862714, 1010derbyshire (2009)20↑1007867, 114720↓1007867, 1147giddens (2000)59↑989904, 107459↓989904, 1074gutierrez (1999)46↑15611334, 178946↑16551424, 188646↑15611334, 178946↑16551424, 1886job (1995)70↔923756, 109070↓923756, 1090lee (2013)133↑916838, 995156↑886824, 948133↓916838, 995156↓886824, 948pobocik (2003)434↓743689, 797434↓743689, 797phosphorous mg/daybchan (2006)23↑934811, 105723↑961812, 111023↓934811, 105724↓961812, 1110giddens (2000)59↑13401248, 143259↔13401248, 1432lee (2013)133↑12641182, 1347156↑11961131, 1261133↔12641182, 1347156↔11961131, 1261pobocik (2003)434↑13381279, 1397434↑13381279, 1397iron mg/daycbaker (2009)290↑1715, 19290↓1715, 19castillo-duran (2001) a249↑15.515, 16249↑16.816, 17249↓15.515, 16249↓16.816, 17castillo-duran (2001) b258↑16.616, 17258↑16.816, 17258↓16.616, 17258↓16.816, 17chan (2006)23↑2218, 2623↑2520, 3023↓2218, 2623↔2520, 30derbyshire (2009)20↓12.611, 1420↔12.611, 14giddens (2000)59↔1615, 1759↓1615, 17gutierrez (1999)46↑17.715, 2046↑22.717, 2846↓17.715, 2046↔22.717, 28job (1995)70↓11.210, 1270↓11.210, 12lee (2013)133↑18.817, 20156↑18.617, 20133↓18.817, 20156↓18.617, 20pobocik (2003)434↑2019, 21434↓2019, 21magnesium mg/daydbaker (2009)290↓236227, 245↓236227, 245chan (2006)23↓263230, 29623↓264231, 297↓263230, 296↓264231, 297derbyshire (2009)20↓244218, 270↓244218, 270giddens (2000)59↓252234, 270↓252234, 270lee (2013)133↓237222, 253156↓231218, 244↓237222, 253↓231218, 244pobocik (2003)434↓270258, 282↓270258, 282potassium mg/dayechan (2006)23↓28022512, 309223↓29542635, 327323↓28022512, 309223↓29542635, 3273derbyshire (2009)20↓29482659, 323720↓29482659, 3237zinc mg/dayfbaker (2009)290↑8.17.8, 8.4290↓8.17.8, 8.4castillo-duran (2001) a249↑7.47.1, 7.7249↑7.77.4, 8249↓7.47.1, 7.7249↓7.77.4, 8castillo-duran (2001) b258↑7.47.1, 7.7258↑7.47.2, 7.6258↓7.47.1, 7.7258↓7.47.2, 7.6chan (2006)23↑1611.9, 20.123↑1813.5, 22.523↔1611.9, 20.123↑1813.5, 22.5derbyshire (2009)20↑8.17.4, 8.9207.4, 8.9giddens (2000)59↑11.610.5, 12.759↑11.610.5, 12.7gutierrez (1999)46↑14.512.6, 16.446↑15.313.4, 17.246↑14.512.6, 16.446↑15.313.4, 17.2job (1995)70↑9.58.5, 10.570↑9.58.5, 10.5lee (2013)133↑12.8156↑12.611.4, 13.8133↑12.8156↑12.611.4, 13.8pobocik (2003)434↑1312.2, 13.8434↑1312.2, 13.8sodium mg/daygchan (2006)23↑33162809, 382323↑33232812, 3834↑33162809, 3823↑33232812, 3834derbyshire (2009)20↑30892722, 3456↑30892722, 3456copper μg/dayhgiddens (2000)59↑12001098, 130259↑12001098, 1302lee (2013)133↑11001015, 1185156↑10851021, 1151133↑11001015, 1185156↑10851021, 1151selenium μg/dayigiddens (2000)59↑116109, 12359↑116109, 123\nacomparison to uk Rni 800\xa0mg/day and us rda 1300\xa0mg/day,bcomparison to uk Rni 625\xa0mg/day and us rda 1250\xa0mg/day,ccomparison to uk rni 14.8\xa0mg/day and us rda 27\xa0mg/day,dcomparison to uk rni 300\xa0mg/day and us rda 400\xa0mg/day,ecomparison to uk rni 3500\xa0mg/day and us rda 4700\xa0mg/day,fcomparison to uk rni 7\xa0mg/day and us rda 12\xa0mg/day,gcomparison to uk Rni 1500\xa0mg/day and us rda 1600\xa0mg/day,hcomparison to uk Rni 1000\xa0μg/day and us Rda 1000\xa0μg/day,icomparison to uk rni 60\xa0μg/day and us rda 60\xa0μg/day, ↑ study mean higher than reference value ( p \u2009<\u20090.05), ↔ study mean not different to reference value ( p \u2009<\u20090.05), ↓ study mean lower than reference value ( p \u2009<\u20090.05)\n\ncaption (table-wrap): table 6\n\nintake of Micronutrients in individual studies compared to uk and us dietary reference values - Vitaminscomparison to uk dietary reference valuecomparison to us dietary reference valuenutrientstudysecond trimesterthird trimestermean over Pregnancysecond trimesterthird trimestermean over Pregnancy n =meanconfidence interval n =meanconfidence interval n =meanconfidence interval n =meanconfidence interval n =meanconfidence interval n =meanconfidence intervalvitamin d μg/dayabaker (2009)290↓2.12, 2.3290↓2.12, 2.3chan (2006)23↓2.81.9, 3.723↓3.12.2, 423↓2.81.9, 3.723↓3.12.2, 4derbyshire (2009)20↓2.01.5, 2.620↓2.01.5, 2.6giddens (2000)59↓6.45.7, 7.159↓6.45.7, 7.1lee (2013)133↓5.44.7, 6.1156↓5.14.6, 5.6133↓5.44.7, 6.1156↓5.14.6, 5.6vitamin ebbaker (2009)290↓8.98.3, 9.5derbyshire (2009)20↓7.76.5, 8.9gutierrez (1999)46↓10.710.746↓11.28.2, 14.1lee (2013)133↓6.96.2, 7.6156↓6.96.4, 7.4pobocik (2003)434↓87.2, 8.8vitamin ccbaker (2009)290↑160146, 174290↑160146, 174derbyshire (2009)20↑138111, 16520↑138111, 165giddens (2000)59↑128112, 14459↑128112, 144gutierrez (1999)46↑252208, 29646↑231190, 27146↑252208, 29646↑231190, 271job (1995)70↑13592, 17870↑13592, 178lee (2013)133↑9781, 113156↑10694, 118133↑9781, 113156↑10694, 118pobocik (2003)434↑167150, 184434↑167150, 184folatedbaker (2009)290↔285269, 301290↓285269, 301derbyshire (2009)20↓227205, 24920↓227205, 249giddens (2000)59↔312277, 34759↓312277, 347gutierrez (1999)46↑447355, 54046↑393340, 44546↓447355, 54046↓393340, 445lee (2013)133↑829723, 935156↑849645, 1053133↑829723, 935156↑849645, 1053pobocik (2003)434↔292269, 315434↓292269, 315riboflavinechan (2006)23↑2.31.8, 2.823↑2.42, 2.823↑2.31.8, 2.823↑2.42, 2.8giddens (2000)59↑2.359↑2.32.1, 2.5lee (2013)133↑2.52.3, 2.7156↑2.4133↑2.52.3, 2.7156↑2.42.2, 2.6pobocik (2003)434↑2.1434↑2.12, 2.2b12fbaker (2009)290↑5.34.7, 5.9290↑5.34.7, 5.9chan (2006)23↑53.8, 6.223↑5.23.7, 6.723↑53.8, 6.223↑5.23.7, 6.7giddens (2000)59↑5.34.6, 659↑5.34.6, 6lee (2013)133↑5.65, 6.2156↑5.55, 6133↑5.65, 6.2156↑5.55, 6pobocik (2003)434↑5.54.8, 6.2434↑5.54.8, 6.2thiamingbaker (2009)290↑1.61.5, 1.7290↑1.61.5, 1.7giddens (2000)59↑2.11.9, 2.359↑2.11.9, 2.3lee (2013)133↑2.11.9, 2.3156↑2.11.9, 2.3133↑2.11.9, 2.3156↑2.11.9, 2.3pobocik (2003)4342.42.3, 2.54342.42.3, 2.5niacinhbaker (2009)290↑3332, 35290↑3432, 35giddens (2000)59↑2422, 2659↑2422, 26lee (2013)133↑2826, 30156↑2624, 27133↑2826, 30156↑2624, 27pobocik (2003)434↑3029, 31434↑3029, 31b6ibaker (2009)290↑2.32.1, 2.4290↑2.32.1, 2.4giddens (2000)59↑1.91.7, 2.159↑1.91.7, 2.1lee (2013)133↑2.22, 2.4156↑2.11.9, 2.3133↑2.22, 2.4156↑2.11.9, 2.3pobocik (2003)434↑21.9, 2.1434↑21.9, 2.1vitamin ajbaker (2009)290↑759651, 867290↑759651, 867derbyshire (2009)20↑555439, 67120↓555439, 671giddens (2000)↑10559↑1053907, 1199↑105359↑1053907, 1199gutierrez (1999)46↑24921466, 351846↑1971432, 252346↑24921466, 351846↑19781432, 2523job (1995)70↑973802, 114470↑973802, 1144lee (2013)133↑698614, 783156↑666615, 717133↑698614, 783156↓666615, 717pobocik (2003)434↑109944, 1242434↑1093944, 1242vitamin kklee (2013)133↔7057, 83156↔7059, 81\nacomparison to uk Rni 10\xa0μg/day and us rda 15\xa0μg/day,bcomparison to us rda 15\xa0mg/day,ccomparison to uk Rni 40\xa0mg/day and us rda 80\xa0mg/day,dcomparison to uk rni 200\xa0μg/day and us rda 600\xa0μg/day,ecomparison to uk rni 1.1\xa0mg/day and us rda 1.4\xa0mg/day,fcomparison to uk rni 1.5\xa0μg/day and us rda 2.6\xa0μg/day,gcomparison to uk rni 0.8\xa0mg/day and us rda 1.4\xa0mg/day,hcomparison to uk rni 14\xa0mg/day and us rda 18\xa0mg/day,icomparison to uk rni 1.2\xa0mg/day and us rda 1.9\xa0mg/day,jcomparison to uk rni 600\xa0μg/day and us rda 750\xa0μg/day,kcomparison to us ai 75\xa0μg/day, ↑ study mean higher than reference value ( p \u2009<\u20090.05), ↔ study mean not different to reference value ( p \u2009<\u20090.05), ↓ study mean lower than reference value ( p \u2009<\u20090.05)\nthe individual study results SHOW that the MAJORITY of reported Nutrient Intakes were significantly below both the uk rni and us rda for Vitamin D, potassium and magnesium and below the us rda for Calcium, Vitamin E, Folate, Phosphorous and iron.']	[('INCOMPLETE_EVIDENCE', 7670), ('PROBABLE_UNDERSTANDING', 7684)]	2	[('CHEBI_33839', 'macromolecule', 41, 'micronutrients'), ('GO_0007605', 'sensory perception of sound', 269, 'pregnancySecond'), ('GO_0007565', 'female pregnancy', 319, 'pregnancy'), ('CHEBI_52240', 'p-quaterphenyl', 3186, 'RNI'), ('CHEBI_52240', 'p-quaterphenyl', 3242, 'RNI'), ('CHEBI_52240', 'p-quaterphenyl', 3517, 'RNI'), ('CHEBI_52240', 'p-quaterphenyl', 3574, 'RNI'), ('CHEBI_34944', 'RU 5135', 3597, 'RDA'), ('CHEBI_33839', 'macromolecule', 3877, 'micronutrients'), ('CHEBI_60409', 'Ins-1-P-Cer(d18:0/2-OH-26:0)', 3963, 'vitaminsComparison'), ('GO_0007605', 'sensory perception of sound', 4105, 'pregnancySecond'), ('GO_0007565', 'female pregnancy', 4155, 'pregnancy'), ('CHEBI_52240', 'p-quaterphenyl', 6938, 'RNI'), ('CHEBI_52240', 'p-quaterphenyl', 7023, 'RNI'), ('CHEBI_33284', 'nutrient', 7705, 'nutrient'), ('GO_0007631', 'feeding behavior', 7714, 'intakes'), ('CHEBI_27300', 'vitamin D', 7778, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 7838, 'calcium'), ('CHEBI_27300', 'vitamin D', 7847, 'vitamin E'), ('CHEBI_30863', '5-azaorotic acid', 7858, 'folate'), ('CHEBI_30207', 'phosphorus(.)', 7866, 'phosphorous')]
PMC5035678	4/2016	S142-PMC5035678	['THUS, the effectiveness of longer periods of supplementation with Vitamin D is DOUBTFUL.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 79)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D')]
PMC5051327	9/2016	S37-PMC5051327	['the mean 25-Oh Vitamin D level was expected to be 50±27.5\u2005nmol/l, BASED ON a scandinavian study.8\n\nresults\nthe background characteristics were not different between cases and controls other than an expected increased PROBABILITY of being Nulliparous and having a Preterm Delivery among women undergoing caesarean Delivery due to suspected fetal distress (table 1).']	[('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 217)]	2	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 9, '25-OH'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0046662', 'regulation of oviposition', 238, 'nulliparous'), ('GO_0007565', 'female pregnancy', 263, 'preterm'), ('GO_0007567', 'parturition', 271, 'delivery'), ('GO_0007567', 'parturition', 313, 'delivery')]
PMC5051327	9/2016	S61-PMC5051327	['these mechanisms are POSSIBLE EXPLANATIONS of our finding that the rate of Birth asphyxia was more than doubled in women with Vitamin D deficiency compared to non-deficient women.']	[('INCOMPLETE_EVIDENCE', 21), ('PROBABLE_UNDERSTANDING', 30)]	2	[('GO_0007567', 'parturition', 75, 'birth'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
PMC5051327	9/2016	S82-PMC5051327	['we FOUND that women Delivered by emergency caesarean section due to suspected fetal distress had lower Vitamin D levels in early Pregnancy and Birth asphyxia was MORE COMMON in Vitamin D deficient women as compared to non-deficient women.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 162)]	2	[('GO_0007567', 'parturition', 20, 'delivered'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy'), ('GO_0007567', 'parturition', 143, 'birth'), ('CHEBI_33229', 'vitamin (role)', 177, 'vitamin'), ('PR_000006444', 'diacylglycerol kinase delta', 185, 'D')]
PMC5084016	10/2016	S119-PMC5084016	['the hydroxylation into 1,25-Hydroxy-Vitamin D in the Proximal Renal Tubules is closely Regulated by feedback mechanisms and PRIMARILY DEPENDS on the requirement for calcium and Phosphorus [57].']	[('PROBABLE_UNDERSTANDING', 124), ('SUPERFICIAL_RELATIONSHIP', 134)]	2	[('CHEBI_67771', 'Xestoproxamine C, (rel)-', 23, '1,25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0001092', 'vertebral bone 1', 53, 'proximal'), ('UBERON_0009773', 'renal tubule', 62, 'renal tubules'), ('GO_0065007', 'biological regulation', 87, 'regulated'), ('CHEBI_35885', 'secondary phosphine', 177, 'phosphorus')]
PMC5085625	9/2016	S22-PMC5085625	['according TO the Endocrine society, insufficiency and deficiency of Vitamin D are DEFINED as concentrations of 25(Oh)D equal to 20–30 ng/ml and <20 ng/ml, respectively.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('PROBABLE_UNDERSTANDING', 82)]	2	[('UBERON_0005063', 'left ventricular compact myocardium', 17, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 111, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 117, 'D')]
PMC5085625	9/2016	S44-PMC5085625	['HOWEVER, deficiency of Vitamin D (concentration 25(Oh)D <20 ng/ml) was RECOGNIZED in as many as 45.6% patients participating in the study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 71)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 51, 'OH ... D')]
PMC5085625	9/2016	S64-PMC5085625	['one POTENTIAL EXPLANATION for such a high prevalence of Vitamin D insufficiency/deficiency among Pregnant polish women is a relatively low number of sunny days in our country.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 14)]	2	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 97, 'pregnant')]
PMC5129285	11/2016	S276-PMC5129285	['other dysbiotic INFLUENCES which are MORE COMMON along ses disadvantaged lines include sedentary behavior, Circadian disruptions, Sleep problems with functional constipation, and low levels of Vitamin D [249].']	[('SUPERFICIAL_RELATIONSHIP', 16), ('PROBABLE_UNDERSTANDING', 37)]	2	[('GO_0051216', 'cartilage development', 107, 'circadian'), ('GO_0030431', 'sleep', 130, 'sleep'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D')]
PMC5129897	10/2016	S184-PMC5129897	['supplements are RECOMMENDED BECAUSE getting Vitamin D from foods alone is hard.']	[('FUTURE_WORK', 16), ('PROBABLE_UNDERSTANDING', 28)]	2	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
PMC5133057	10/2016	S19-PMC5133057	['furthermore, TO OUR KNOWLEDGE, no research concomitantly evaluated the ASSOCIATION of diet, C-Reactive Protein levels, and social, nutritional, and Gestational variables with the Vitamin A status of this population.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('CHEBI_59147', '3-[(4-methoxyphenylsulfonyloxy)methyl]-5,5-dimethylbutyrolactone', 92, 'C-reactive protein'), ('PR_000005890', 'crooked neck-like protein 1', 92, 'C-reactive protein'), ('GO_0007565', 'female pregnancy', 148, 'gestational'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin A')]
PMC5146866	12/2016	S13-PMC5146866	['for the child population, t he american academy of pediatrics (aap) DEFINES a Vitamin D level of 20\xa0ng/ml AS sufficient [8].']	[('PROBABLE_UNDERSTANDING', 68), ('PROBABLE_UNDERSTANDING', 106)]	2	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
PMC5146866	12/2016	S41-PMC5146866	['THEREFORE, the total level of cb Vitamin D measured in THIS STUDY is equal to [25(Oh)D3] levels, which is the main contributor to the [25(Oh)D] pool.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 55)]	2	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_62946', 'ammonium sulfate', 79, '25(OH)D3'), ('CHEBI_71657', 'versiconol acetate', 135, '25(OH)D')]
PMC5264377	7/2016	S14-PMC5264377	['Humans obtain their daily levels of Vitamin D MAINLY by Endogenous Biosynthesis induced by exposure to ultraviolet b (uvb) radiation, in concert with a small CONTRIBUTION from the Intake of different Food sources.']	[('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 158)]	2	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Humans'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0009790', 'embryo development', 56, 'endogenous'), ('GO_0009057', 'macromolecule catabolic process', 67, 'biosynthesis'), ('GO_0007631', 'feeding behavior', 180, 'intake'), ('CHEBI_33290', 'food', 200, 'food')]
PMC5322422	2/2017	S10-PMC5322422	['THEREFORE, infants who accumulate inactive Vitamin K-dependent Coagulation factors have an increased bleeding TENDENCY [2].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 110)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin K'), ('GO_0050817', 'coagulation', 63, 'coagulation')]
PMC5322422	2/2017	S51-PMC5322422	['IN LIGHT OF these pathologic findings as well as the medical history and clinical response to Vitamin K and ffp, the final diagnosis for this patient was Thymic hemorrhage secondary to Vitamin K deficiency, with POSSIBLE component of Thymic hyperplasia.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 212)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin K'), ('UBERON_0002370', 'thymus', 154, 'thymic'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin K'), ('UBERON_0002370', 'thymus', 234, 'thymic')]
PMC5322422	2/2017	S63-PMC5322422	['this form nearly always occurs in exclusively Breast-Fed infants and is OFTEN ASSOCIATED with undiagnosed Hepatobiliary dysfunction impairing absorption of Vitamin K [1].']	[('PROBABLE_UNDERSTANDING', 72), ('SUPERFICIAL_RELATIONSHIP', 78)]	2	[('GO_0007567', 'parturition', 46, 'breast'), ('UBERON_0000310', 'breast', 46, 'breast'), ('GO_0007631', 'feeding behavior', 53, 'fed'), ('UBERON_0002423', 'hepatobiliary system', 106, 'hepatobiliary'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin K')]
PMC5381088	4/2017	S82-PMC5381088	['THUS, an increase in Intake of various Nutrients, including protein, Folate, calcium, Vitamin C and Vitamin D, is RECOMMENDED [47].']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 114)]	2	[('GO_0007631', 'feeding behavior', 21, 'intake'), ('CHEBI_33284', 'nutrient', 39, 'nutrients'), ('CHEBI_30863', '5-azaorotic acid', 69, 'folate'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC5418719	5/2017	S9-PMC5418719	['furthermore, very low Birth weight (vlbw) infants OFTEN have less time to store Vitamin D from mother due to a decreased trans-Placental transfer and may also have an increased Vitamin D REQUIREMENT.']	[('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 187)]	2	[('GO_0007567', 'parturition', 22, 'birth'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0001987', 'placenta', 127, 'placental'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
PMC5489519	6/2017	S7-PMC5489519	['CONSISTENTLY, Vitamin D Regulated Trail mrna Expression in hme-1 cells.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 24)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0065007', 'biological regulation', 24, 'regulated'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 34, 'TRAIL'), ('GO_0010467', 'gene expression', 45, 'expression')]
PMC5489519	6/2017	S28-PMC5489519	['THEREFORE, we HYPOTHESIZE that Vitamin D deficiency in mothers alters Trail Expression in Breast Milk.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 70, 'TRAIL'), ('GO_0010467', 'gene expression', 76, 'expression'), ('UBERON_0001348', 'brown adipose tissue', 90, 'breast milk')]
PMC5489519	6/2017	S37-PMC5489519	['measurement of total circulating 25(Oh)D concentrations IDENTIFIED seven samples with normal range (>30\u2009ng/ml) and THEREFORE considered Vitamin D-sufficient group.']	[('INCOMPLETE_EVIDENCE', 56), ('PROBABLE_UNDERSTANDING', 115)]	2	[('CHEBI_71657', 'versiconol acetate', 33, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 33, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
PMC5489519	6/2017	S89-PMC5489519	['Vitamin D supplementation of mothers results in Vitamin D sufficiency in Breast-Fed infants13, THUS POTENTIALLY Modulating the Immune signature of maternal Breast Milk to her recipient infant.']	[('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 100)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0000310', 'breast', 73, 'breast'), ('GO_0007631', 'feeding behavior', 80, 'fed'), ('GO_0065007', 'biological regulation', 112, 'modulating'), ('UBERON_0002405', 'immune system', 127, 'immune'), ('UBERON_0001348', 'brown adipose tissue', 156, 'breast milk')]
PMC5489519	6/2017	S107-PMC5489519	['THEREFORE, specific modulators of the Trail Signaling axis and Vitamin D analogs MAY lead to the development of randomized clinical trials to rescue from the consequences of Vitamin D deficiency in both mother and infant.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 81)]	2	[('GO_0038008', 'TRAF-mediated signal transduction', 38, 'TRAIL signaling'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 38, 'TRAIL'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
PMC5489519	6/2017	S114-PMC5489519	['it is LIKELY that the down-regulation of the Trail-Α and β in response to high doses (>20\u2009nm) of Vitamin D COULD BE a compensatory mechanism to protect the Mammary Cells.']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 107)]	2	[('PR_000001719', 'transient receptor potential cation channel TRPM8', 45, 'TRAIL-α'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CL_0002325', 'mammary alveolar cell', 156, 'mammary cells'), ('UBERON_0002391', 'lymph', 156, 'mammary')]
PMC5513133	7/2017	S213-PMC5513133	['individuals receive the MAJORITY of their Vitamin D from sunlight, LINKING seasonality to the development of pe.']	[('PROBABLE_UNDERSTANDING', 24), ('SUPERFICIAL_RELATIONSHIP', 67)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
PMC5537904	7/2017	S68-PMC5537904	['we ESTIMATED weeks of daily Vitamin D supplement use for offspring by summing the weeks of daily Vitamin D use (when reported by the mother as an “other” Supplement) and weeks of daily multivitamin use, AS infant multivitamin supplements typically contain Vitamin D [42].']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 203)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 154, 'supplement'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
PMC5539754	8/2017	S104-PMC5539754	['additionally, those at risk of Vitamin D deficiency in early Pregnancy are more LIKELY to have increased fasting Glucose in late Pregnancy, INDEPENDENT of season.']	[('PROBABLE_UNDERSTANDING', 80), ('SUPERFICIAL_RELATIONSHIP', 140)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('CHEBI_17234', 'glucose', 113, 'glucose'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
PMC5539754	8/2017	S175-PMC5539754	['participants at risk of Vitamin D deficiency at their first Antenatal visit were LIKELY to have increased fasting Glucose at 28\xa0weeks’ Gestation, REGARDLESS OF season.']	[('PROBABLE_UNDERSTANDING', 81), ('INCOMPLETE_EVIDENCE', 146)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007567', 'parturition', 60, 'antenatal'), ('CHEBI_17234', 'glucose', 114, 'glucose'), ('GO_0007565', 'female pregnancy', 135, 'gestation')]
PMC5546866	8/2017	S16-PMC5546866	['RISK FACTORS for Vitamin D deficiency, in addition to geographic and seasonal variation, are WELL ESTABLISHED.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('PROBABLE_UNDERSTANDING', 93)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
PMC5634437	10/2017	S226-PMC5634437	['THEREFORE, Drugs increasing Dhcr7 Expression COULD inadvertently lower maternal Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 45)]	2	[('CHEBI_23888', 'drug', 11, 'drugs'), ('PR_000006474', 'ATP-dependent RNA helicase A', 28, 'DHCR7'), ('GO_0010467', 'gene expression', 34, 'expression'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC5634602	10/2017	S34-PMC5634602	['the Fetus relies solely on maternal stores for Vitamin D in utero, and TYPICALLY has Cord Blood levels APPROXIMATELY 50–75% of the maternal value [6,27,28].']	[('PROBABLE_UNDERSTANDING', 71), ('INCOMPLETE_EVIDENCE', 103)]	2	[('UBERON_0000312', 'inner cambium layer of periosteum', 4, 'fetus'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 85, 'cord'), ('UBERON_0000178', 'blood', 90, 'blood')]
PMC5638722	8/2017	S27-PMC5638722	['TO THE BEST OF OUR KNOWLEDGE, no study evaluated the ASSOCIATION between neonatal sepsis and Cord Blood Vitamin D levels in preterm infants910).']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('UBERON_0002240', 'spinal cord', 93, 'cord'), ('UBERON_0000178', 'blood', 98, 'blood'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
PMC5659607	10/2017	S19-PMC5659607	['THEREFORE, we RECENTLY conducted two independent randomized controlled trials (rcts) of increased Vitamin D supplementation during Pregnancy to prevent childhood asthma/recurrent wheeze in the offspring by age 3 years: the Vitamin D antenatal asthma reduction trial (vdaart[7]) and the copenhagen prospective studies on asthma in childhood 2010 (copsac2010[8]).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14)]	2	[('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 223, 'Vitamin D')]
PMC5664622	9/2017	S74-PMC5664622	['discussion\nIN LIGHT OF current RECOMMENDATIONS, mean maternal Vitamin D concentration in our study population was deficient.']	[('PROBABLE_UNDERSTANDING', 11), ('FUTURE_WORK', 31)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC5664622	9/2017	S114-PMC5664622	['AS Vitamin D concentration was measured immediately before the Delivery, we LACK DATA on pre-Pregnancy, as well as the first Trimester of Pregnancy, values.']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 76)]	2	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007567', 'parturition', 63, 'delivery'), ('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 125, 'trimester'), ('GO_0007565', 'female pregnancy', 138, 'pregnancy')]
PMC5664622	9/2017	S115-PMC5664622	['THUS, we were unable to evaluate the RELATIONSHIP between Vitamin D levels and the development Of Gdm.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0044477', 'envenomation resulting in negative regulation of platelet aggregation in other organism', 95, 'of GDM')]
PMC5679631	11/2017	S12-PMC5679631	['difficile were ASSOCIATED with Vitamin D supplementation of Breast Fed infants whose mothers were more LIKELY to adhere to an alternative lifestyle in terms of, e .']	[('SUPERFICIAL_RELATIONSHIP', 15), ('PROBABLE_UNDERSTANDING', 103)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('UBERON_0000310', 'breast', 60, 'breast'), ('GO_0007631', 'feeding behavior', 67, 'fed')]
PMC5679631	11/2017	S42-PMC5679631	['diet and sunlight exposure were NOT CONSIDERED AS 25(Oh)D concentrations were measured in mothers providing an estimation of exposure based on all sources and only “yellow fat spreads” were fortified with Vitamin D in the netherlands at the time of the study.']	[('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 47)]	2	[('CHEBI_71657', 'versiconol acetate', 50, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
PMC5679631	11/2017	S84-PMC5679631	['the characteristics of the Breast Fed children were fairly SIMILAR between the children receiving Vitamin D supplementation and those who did not, except that mothers who were recruited in the conventional recruitment group were more LIKELY to give their child Vitamin D supplementation than those in the alternative recruitment group.']	[('SUPERFICIAL_RELATIONSHIP', 59), ('PROBABLE_UNDERSTANDING', 234)]	2	[('GO_0007567', 'parturition', 27, 'breast fed'), ('UBERON_0000310', 'breast', 27, 'breast'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D')]
PMC5706533	11/2017	S77-PMC5706533	['among regular dose trials, effective doses were no higher in populations with lower baseline Vitamin D status, and placebo controlled trials DID NOT consistently use higher effective doses nor were they more LIKELY to be conducted in populations deficient in Vitamin D compared with active control trials (fig 3).']	[('INCOMPLETE_EVIDENCE', 141), ('PROBABLE_UNDERSTANDING', 208)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
PMC5707701	11/2017	S163-PMC5707701	['the intake of 4 mg/day of Vitamin E (Α-Tocopherol) for infants aged less than six months is RECOMMENDED BASED ON a value of adequate intake (ai) in the dietary reference intakes (dris) [61].']	[('FUTURE_WORK', 92), ('PROBABLE_UNDERSTANDING', 104)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin E'), ('CHEBI_27725', 'butin', 37, 'α-tocopherol')]
PMC5732505	12/2017	S1-PMC5732505	['in finland, maternal Vitamin D status has improved CONSIDERABLY DUE TO national health policies.']	[('ANOMALY_CURIOUS_FINDING', 51), ('PROBABLE_UNDERSTANDING', 64)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
PMC5732505	12/2017	S13-PMC5732505	['conclusions\nmaternal Vitamin D concentration was SIMILAR in mothers with and without gdm in a MOSTLY Vitamin D sufficient population.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('PROBABLE_UNDERSTANDING', 94)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
PMC5732505	12/2017	S99-PMC5732505	['MAJORITY (95%) of the mothers took Vitamin D supplements during Pregnancy, MOST of them were highly educated (75% had at least a bachelor level education), and 73% had normal weight before Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 75)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy')]
PMC5732505	12/2017	S134-PMC5732505	['ALMOST ALL mother-child pairs (97%) were Vitamin D sufficient [25(Oh)D\u2009≥\u200950\xa0nmol/l], and ABOUT half of the mother-child pairs had optimal Vitamin D status [25(Oh)D\u2009≥\u200980\xa0nmol/l].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 89)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 156, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 162, 'D')]
PMC5812027	2/2018	S62-PMC5812027	['season was coded as a binary variable, since this EXPLAINED 30% of Vitamin D status in a PREVIOUS STUDY in Pregnant women at the same latitude [16].']	[('PROBABLE_UNDERSTANDING', 50), ('INCOMPLETE_EVIDENCE', 89)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'pregnant')]
PMC5941617	5/2018	S90-PMC5941617	['children REQUIRE less sunlight exposure than Adults to produce sufficient quantities of Vitamin D, both BECAUSE of their higher body surface-area-to-volume ratio and of their increased capacity to produce Vitamin D [85].']	[('IMPORTANT_CONSIDERATION', 9), ('PROBABLE_UNDERSTANDING', 104)]	2	[('UBERON_0007023', 'adult organism', 45, 'adults'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
PMC5941617	5/2018	S188-PMC5941617	['CONSIDERING the results of italian studies, we SUGGEST Vitamin D supplementation from the end of fall to the beginning of spring (november–april) in children and adolescents with reduced sun exposure during summer.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 47)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
PMC5941617	5/2018	S217-PMC5941617	['particularly, adolescents MAY develop non-specific symptoms, such as Lower Limb pain or difficulties in climbing stairs, BECAUSE of proximal myopathy secondary to Vitamin D deficiency [189].']	[('INCOMPLETE_EVIDENCE', 26), ('PROBABLE_UNDERSTANDING', 121)]	2	[('UBERON_0002103', 'hindlimb', 69, 'lower limb'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
PMC5941617	5/2018	S233-PMC5941617	['after rickets healing, Vitamin D supplementation SHOULD continue according to age (AT LEAST 400\xa0iu/day in the first year of Life and 600\xa0iu/day from 1 to 18\xa0years) [11,23,28,183,188].']	[('FUTURE_WORK', 49), ('PROBABLE_UNDERSTANDING', 83)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('UBERON_0000104', 'life cycle', 124, 'life')]
PMC5941617	5/2018	S440-PMC5941617	['clinical GUIDELINE for Skeletal health of children and adolescents with ibd in 2011 RECOMMENDED monitoring Vitamin D levels at least yearly, at the end of winter/beginning of spring, especially in dark skinned subjects.']	[('PROBABLE_UNDERSTANDING', 9), ('FUTURE_WORK', 84)]	2	[('UBERON_0004288', 'skeleton', 23, 'skeletal'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
PMC5941617	5/2018	S572-PMC5941617	['after completion of treatment, Serum 25(Oh)D concentrations SHOULD BE revaluated, AS it is not unusual for a second course of treatment to be necessary to achieve adequate Vitamin D status [23].']	[('FUTURE_WORK', 60), ('PROBABLE_UNDERSTANDING', 82)]	2	[('UBERON_0001977', 'blood serum', 31, 'serum'), ('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 37, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
PMC5941617	5/2018	S616-PMC5941617	['evaluation of Vitamin D status\n\nthe isotope dilution- lc-ms/ms is CONSIDERED the PREFERRED method for measuring Serum 25(Oh)D levels, especially in the Neonatal Period.']	[('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 81)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0001977', 'blood serum', 112, 'serum'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 118, '25(OH ... D'), ('UBERON_0007221', 'neonate stage', 152, 'neonatal period')]
PMC5941617	5/2018	S697-PMC5941617	['intermittent bolus doses of Vitamin D for a cumulative dose of AT LEAST 400000\xa0iu SHOULD BE reserved for ibds patients with Vitamin D deficiency and poor compliance with daily treatment.']	[('PROBABLE_UNDERSTANDING', 63), ('FUTURE_WORK', 82)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
PMC5952272	5/2018	S99-PMC5952272	['children aged 6 to 59 months\nas a result of the low quality of Food the mothers of the same household were taking, there was an accumulating deficiency of Vitamin E. it is more LIKELY that children of vitamin-deficient women due to nutritional reasons are also well deficient in the same Vitamins, ALTHOUGH the severity is higher.']	[('PROBABLE_UNDERSTANDING', 177), ('ANOMALY_CURIOUS_FINDING', 298)]	2	[('CHEBI_33290', 'food', 63, 'food'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin E'), ('CHEBI_33277', 'gamma-tocotrienol', 288, 'vitamins')]
PMC5956785	5/2018	S15-PMC5956785	['AS an Immune and inflammatory Mediator, Vitamin D is IMPLICATED in the pathogenesis of Autoimmune diseases including, as examples, multiple sclerosis, type 1 diabetes, rheumatoid arthritis, crohn’s disease, and chronic childhood arthritis [4–6].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 53)]	2	[('UBERON_0002405', 'immune system', 6, 'immune'), ('CHEBI_35222', 'inhibitor', 30, 'mediator'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 87, 'autoimmune')]
PMC5956785	5/2018	S66-PMC5956785	['the endocrine society has published clinical practice GUIDELINES for patients AT RISK of Vitamin D deficiency [20].']	[('PROBABLE_UNDERSTANDING', 54), ('IMPORTANT_CONSIDERATION', 78)]	2	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC6011374	6/2018	S115-PMC6011374	['furthermore, multivitamin supplements available during the study period contained very little (maximum 50\xa0iu), if any, Vitamin D and THUS are\xa0an UNLIKELY source of variation within the population.']	[('PROBABLE_UNDERSTANDING', 133), ('PROBABLE_UNDERSTANDING', 145)]	2	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
PMC6039335	7/2018	S287-PMC6039335	['THUS, the dietary Vitamin C requirement for beef cattle is NOT SPECIFIED in the nrc [146].']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 59)]	2	[('CHEBI_27300', 'vitamin D', 18, 'vitamin C')]
PMC6039335	7/2018	S291-PMC6039335	['a Rumen-protected form of Vitamin C is PREFERRED as a dietary supplement because Vitamin C is MOST LIKELY degraded in the Rumen [146].']	[('PROBABLE_UNDERSTANDING', 39), ('PROBABLE_UNDERSTANDING', 94)]	2	[('UBERON_0007365', 'rumen', 2, 'rumen'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin C'), ('UBERON_0007365', 'rumen', 122, 'rumen')]
PMC2582131	11/2008	S114-PMC2582131	['first, a single measurement of Plasma 25-[Oh] D concentrations is not LIKELY to provide a time-integrated measure of maternal Vitamin D status during the entire study Pregnancy.']	[('PROBABLE_UNDERSTANDING', 70)]	1	[('UBERON_0001969', 'blood plasma', 31, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 38, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy')]
PMC2606998	6/2007	S74-PMC2606998	['when recalculating for the ASSUMED 20% underreporting during Pregnancy, mean intakes of Folate, Vitamin\u2009D, Selenium, Vitamin\u2009E and iron were still below ri.']	[('PROBABLE_UNDERSTANDING', 27)]	1	[('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('CHEBI_30863', '5-azaorotic acid', 88, 'folate'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27568', 'selenium atom', 107, 'selenium'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin E')]
PMC2606998	6/2007	S98-PMC2606998	['ALMOST ALL Milk with up to 1.5% fat content is fortified with Vitamin\u2009D in sweden15, and included in the intake data.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('UBERON_0001913', 'milk', 11, 'milk'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC2798111	12/2010	S45-PMC2798111	['THEREFORE, the dietary source of Vitamin D in these infants came from the Vitamin D supplement provided.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
PMC2821652	2/2010	S78-PMC2821652	["THEREFORE, the average of each subject's steady-state 25(Oh)D levels (i.e., levels obtained at least 2 months after initiation of Vitamin D therapy) was calculated, and the subject's baseline 25(Oh)D level was subtracted from that value to obtain a value for the change in 25(Oh)D level during the study (change 25Ohd)."]	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_71657', 'versiconol acetate', 54, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 54, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 192, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 192, '25(OH ... D'), ('CHEBI_71657', 'versiconol acetate', 273, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 279, 'D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 312, '25OHD')]
PMC2874518	6/2010	S110-PMC2874518	['one of the brands had the additional components of b-Carotene, Vitamin K, Selenium and Iodine as well as higher doses of Vitamins E, B1, b6 and b12 and zinc (AT LEAST double) compared with the other main brand.']	[('PROBABLE_UNDERSTANDING', 158)]	1	[('CHEBI_23042', 'carotene', 53, 'carotene'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin K'), ('CHEBI_27568', 'selenium atom', 74, 'selenium'), ('CHEBI_24859', 'iodine atom', 87, 'iodine'), ('CHEBI_27300', 'vitamin D', 121, 'vitamins E'), ('PR_000004693', 'Bcl-2-like protein 10', 133, 'B1')]
PMC2913107	8/2010	S39-PMC2913107	['similar to rickets, city life affords less Vitamin D, BECAUSE of tall buildings, indoor occupations and increased urban air pollution, all of which block ultraviolet b light from penetrating the atmosphere.']	[('PROBABLE_UNDERSTANDING', 54)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
PMC3004407	12/2010	S87-PMC3004407	['the mean Vitamin D status of the cohort, AS measured by total circulating 25(Oh)D, was 21.7 ± 9.7\u2009ng/ml (range 3.8 to 73.8; unavailable for 7 participants).']	[('PROBABLE_UNDERSTANDING', 41)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 74, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 74, '25(OH)D')]
PMC3034879	12/2010	S168-PMC3034879	['initially, 70% of the mothers were Vitamin D deficient during the Pregnancy AS their mean Serum 25-Ohd for first trimester and 2\xa0days Postpartum was less than 50\xa0nmol/l.']	[('PROBABLE_UNDERSTANDING', 76)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('UBERON_0001977', 'blood serum', 90, 'serum'), ('CHEBI_72765', 'verruculogen', 96, '25-OHD'), ('GO_0007565', 'female pregnancy', 134, 'postpartum')]
PMC3034879	12/2010	S181-PMC3034879	['BECAUSE of Vitamin D supplementation, S-25-Ohd concentration increased during the follow-up.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_86929', 'S b G-5,5-G b S A CH2', 38, 'S-25-OHD')]
PMC3103150	3/2011	S107-PMC3103150	['the intake of Vitamin D is inadequate AS Food items (except infant formula) are not fortified and there is no policy of routine Vitamin D supplementation in pregnant/Lactating women and infants.']	[('PROBABLE_UNDERSTANDING', 38)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_33290', 'food', 41, 'food'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 166, 'lactating')]
PMC3107676	4/2011	S114-PMC3107676	['during the first and second months of Pregnancy, a sizable proportion of women who took Nitrosatable Drugs denied taking vitamin supplements with Vitamin C (41.6% and 19.3%, respectively), a WELL-DOCUMENTED Inhibitor Of Nitrosation.']	[('PROBABLE_UNDERSTANDING', 191)]	1	[('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('CHEBI_7496', 'nelfinavir', 88, 'nitrosatable drugs'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin C'), ('CHEBI_50854', 'hydrocortamate hydrochloride', 207, 'inhibitor of'), ('CHEBI_52846', 'cycloalkane ring', 220, 'nitrosation')]
PMC3257641	3/2010	S90-PMC3257641	['in a cross sectional study, caesarean section was almost four-times MORE COMMON in women with Vitamin D insufficiency (Serum 25(Oh)D < 37.5 nmol/l) compared to Vitamin D-sufficient women (Serum 25(Oh)D ≥ 37.5 nmol/l), after adjustment for race, age, education level, insurance status, and Alcohol use (adjusted or 3.84; 95% ci 1.71–8.62) [59].']	[('PROBABLE_UNDERSTANDING', 68)]	1	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_71657', 'versiconol acetate', 125, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 125, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('UBERON_0001977', 'blood serum', 188, 'serum'), ('CHEBI_71657', 'versiconol acetate', 194, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 194, '25(OH)D'), ('CHEBI_30879', 'alcohol', 289, 'alcohol')]
PMC3347007	4/2012	S87-PMC3347007	['caption (fig): figure 2\n\nproportion of women (%) reporting intake of Vitamin D supplements ≥10 µg per day per Gestational week in Gestational week 1 to 39 BASED ON information from dnbc interviews 2 and 3 ( n = 68,447).nutrients-04-00259-t002_table 2\n\ncaption (table-wrap): table 2\n\nmean intake of Vitamin D from diet, supplements and total intake, along with ranking of sources according to quartiles of total Vitamin D intake ( n = 68,447) *.quartiles of total Vitamin D intake (µg/day)1234mean Vitamin D intakeµg/day (%)orderµg/day (%)orderµg/day (%)orderµg/day (%)ordertotal2.62 (100)6.82 (100)11.20 (100)16.29 (100)supplements0.03 (1.15)23.31 (48.53)27.88 (70.36)111.46 (70.35)1diet2.59 (98.85)13.51 (51.47)13.33 (29.73)24.83 (29.65)2\n* based on information from the Food frequency questionnaire covering Intake in Gestational weeks 21–25.nutrients-04-00259-t003_table 3\n\ncaption (table-wrap): table 3\n\nmean intake of Vitamin D from Food groups according to quartiles of dietary Vitamin D intake in Gestational weeks 21–25 ( n = 68,447) *.quartiles of dietary Vitamin D intake (µg/day)1234mean Vitamin D intakeµg/day (%)orderµg/day (%)orderµg/day (%)orderµg/day (%)orderall Food groups1.7 (100)2.6 (100)3.7 (100)6.3 (100)Pork0.2 (11.8)30.2 (7.7)40.2 (5.4)40.2 (3.2)3beef/veal0.2 (11.8)30.2 (7.7)40.2 (5.4)40.2 (3.2)3processed meat0.1 (5.9)40.1 (3.8)50.1 (2.7)50.1 (1.6)4fish and seafood0.4 (23.5)10.9 (34.6)11.8 (48.6)14.3 (68.3)1egg0.2 (11.8)30.4 (15.4)30.4 (10.8)30.5 (7.9)2low fat dairy0.3 (17.6)20.5 (19.2)20.5 (13.5)20.5 (7.9)2\n* based on information from the Food frequency questionnaire.']	[('PROBABLE_UNDERSTANDING', 155)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'gestational'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('CHEBI_27300', 'vitamin D', 298, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 463, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 497, 'vitamin D'), ('CHEBI_33290', 'food', 772, 'food'), ('GO_0007631', 'feeding behavior', 810, 'intake'), ('GO_0007565', 'female pregnancy', 820, 'gestational'), ('CHEBI_27300', 'vitamin D', 923, 'vitamin D'), ('CHEBI_33290', 'food', 938, 'food'), ('CHEBI_27300', 'vitamin D', 984, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1004, 'gestational'), ('CHEBI_27300', 'vitamin D', 1065, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1099, 'vitamin D'), ('CHEBI_33290', 'food', 1179, 'food'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 1226, 'Pork0'), ('CHEBI_33290', 'food', 1570, 'food')]
PMC3347007	4/2012	S93-PMC3347007	['the same was TRUE for low fat dairy products and eggs; however, the increase in Vitamin D was very small.']	[('PROBABLE_UNDERSTANDING', 13)]	1	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
PMC3347028	3/2012	S21-PMC3347028	['in the TRUE sense of the word, Vitamin D is not a “Vitamin” because the main source of Vitamin D is that which we synthesize ourselves—in our skin—with less than 10% coming from dietary sources.']	[('PROBABLE_UNDERSTANDING', 7)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 51, 'vitamin'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC3347028	3/2012	S41-PMC3347028	['THUS, those with impaired Liver function will have diminished conversion of Vitamin D to 25(Oh)D. following its synthesis, 25(Oh) then enters the circulation where it is tightly bound to Vdbp.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('UBERON_0002107', 'liver', 26, 'liver'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 123, '25(OH)'), ('PR_000017279', 'testis-specific basic protein Y 1', 187, 'VDBP')]
PMC3347028	3/2012	S53-PMC3347028	['during Pregnancy, the Placenta is PROBABLY the most prominent site for Extra-Renal activation of Vitamin D [13].']	[('PROBABLE_UNDERSTANDING', 34)]	1	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('UBERON_0001987', 'placenta', 22, 'placenta'), ('UBERON_0000478', 'extraembryonic structure', 71, 'extra-renal'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
PMC3347028	3/2012	S62-PMC3347028	['NOT SURPRISINGLY, the Vitamin D receptor element (vdre) is contained in the Promoter Region Of the Gene for Ll-37.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('SO_0000096', 'proplastid_gene', 76, 'promoter region of ... gene'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 108, 'LL-37')]
PMC3348565	4/2012	S103-PMC3348565	["the mean Serum Calcifediol concentration was CONSISTENTLY and significantly higher in the Vitamin D group than in the placebo group at 1 week, 4 weeks, and 3 months after administration of the first dose of Vitamin D during the winter and at 2 weeks' post administration of dose 3 (spring;figure 3)."]	[('PROBABLE_UNDERSTANDING', 45)]	1	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_22975', 'cadinane sesquiterpenoid', 15, 'calcifediol'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
PMC3356951	4/2012	S60-PMC3356951	['[23]\n\nPeople with limited sun exposure\nhomebound Individuals, women who wear long Robes and Head coverings for religious reasons, and People with occupations that limit sun exposure are UNLIKELY to obtain adequate Vitamin D from sunlight.']	[('PROBABLE_UNDERSTANDING', 186)]	1	[('NCBITaxon_10088', 'Mus <genus>', 6, 'People'), ('NCBITaxon_1', 'root', 49, 'individuals'), ('UBERON_0002211', 'nerve root', 82, 'robes'), ('UBERON_0000033', 'head', 92, 'head'), ('NCBITaxon_10088', 'Mus <genus>', 134, 'people'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
PMC3356951	4/2012	S100-PMC3356951	['in the health professionals follow-up study (hpfs), subjects with high Vitamin D concentrations were half as LIKELY to be diagnosed with Colon cancer as those with low concentrations.']	[('PROBABLE_UNDERSTANDING', 109)]	1	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0001155', 'colon', 137, 'colon')]
PMC3366289	7/2011	S76-PMC3366289	['Serum Retinol <1.05\xa0μmol/l and Breast Milk Retinol ≤1.05\xa0μmol/l or ≤28\xa0μmol/kg Milk fat (≤8\xa0μg/g milk fat) were considered INDICATIVE of low Vitamin A status and low Breast Milk Vitamin A content [18].']	[('PROBABLE_UNDERSTANDING', 123)]	1	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_26536', 'retinoic acid', 6, 'retinol'), ('UBERON_0000310', 'breast', 31, 'breast'), ('UBERON_0001913', 'milk', 38, 'milk'), ('CHEBI_26536', 'retinoic acid', 43, 'retinol'), ('UBERON_0001913', 'milk', 79, 'milk'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin A'), ('UBERON_0000310', 'breast', 166, 'breast'), ('UBERON_0001913', 'milk', 173, 'milk'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A')]
PMC3407995	7/2012	S440-PMC3407995	['women with pre-eclampsia who received 1200 iu Vitamin D along with 375 mg of elemental Calcium per day were as LIKELY to develop pre-eclampsia as women who received no supplementation.']	[('PROBABLE_UNDERSTANDING', 111)]	1	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 87, 'calcium')]
PMC3471827	10/2012	S106-PMC3471827	['the dramatic phenotype observed in Zebrafish Embryos, has not been noted in Vitamin E deficient Rats LIKELY because their Embryos are resorbed prior to Neurogenesis or Eye Formation[1].']	[('PROBABLE_UNDERSTANDING', 101)]	1	[('NCBITaxon_7955', 'Danio rerio', 35, 'zebrafish'), ('UBERON_0000922', 'embryo', 45, 'embryos'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin E'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 96, 'rats'), ('UBERON_0000922', 'embryo', 122, 'embryos'), ('GO_0022008', 'neurogenesis', 152, 'neurogenesis'), ('GO_0001654', 'eye development', 168, 'eye formation'), ('UBERON_0000970', 'eye', 168, 'eye')]
PMC3476426	8/2012	S5-PMC3476426	['Serum 25-Hydroxy Vitamin D levels 10–30 ng/ml and < 10 ng/ml were DEFINED as Vitamin D insufficiency and deficiency, respectively.']	[('PROBABLE_UNDERSTANDING', 66)]	1	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 6, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC3476426	8/2012	S49-PMC3476426	['assay of Serum 25-Hydroxy Vitamin D\nthis assay employs by enzyme-linked immunosorbent assay using a competitive protein binding assay kit for the measurement of 25-Hydroxy Vitamin D, which is BASED ON the competition of 25-Hydroxy Vitamin D present in the sample with 25-Hydroxy Vitamin D Tracer, for the binding pocket of Vitamin D protein (vdbp, Gc-Globulin).']	[('PROBABLE_UNDERSTANDING', 192)]	1	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 15, '25-hydroxy vitamin D'), ('CHEBI_67825', '17beta,21beta-epoxyhopan-3-one', 164, 'hydroxy vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 220, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 239, 'D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 268, '25-hydroxy vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 287, 'D'), ('CHEBI_35204', 'tracer', 289, 'tracer'), ('CHEBI_27300', 'vitamin D', 323, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 331, 'D'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 348, 'Gc-globulin')]
PMC3515553	12/2012	S73-PMC3515553	['Genetic analysis\nmaternal and offspring genotypes were coded 0, 1, 2, based on the number of PUTATIVE Vitamin B-12 increasing Alleles, and were checked for deviation from hardy-weinberg equilibrium using the genhw function implemented in the program stata 11.0 (stata corporation, college station, texas).']	[('PROBABLE_UNDERSTANDING', 93)]	1	[('SO_0000704', 'gene', 0, 'Genetic'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 102, 'vitamin B-12'), ('SO_0001023', 'allele', 126, 'alleles')]
PMC3534321	12/2012	S122-PMC3534321	['in the MAJORITY of trials, the antioxidant regimen assessed was a combination of Vitamins C and e therapies.']	[('PROBABLE_UNDERSTANDING', 7)]	1	[('CHEBI_27300', 'vitamin D', 81, 'vitamins C')]
PMC3641012	4/2013	S126-PMC3641012	['most participants in both groups were Vitamin D insufficient by the iom THRESHOLD (25(Oh)D\u2009<50\xa0nmol/l) at baseline (table\xa02).']	[('PROBABLE_UNDERSTANDING', 72)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 83, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 89, 'D')]
PMC3659910	1/2013	S71-PMC3659910	['[16] this deficiency is BECAUSE body fat stores much of the Vitamin D made in the skin, making it less available to the body.']	[('PROBABLE_UNDERSTANDING', 24)]	1	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
PMC3672018	5/2013	S33-PMC3672018	['for instance, mothers with babies Born between february and april will have had low sun-related uvb exposure, and HENCE, lower Vitamin D exposure for their offspring during the third trimester, while babies Born between may and july will have had low exposure in their second trimester and those Born between august and october will have had low exposure during the first Trimester.']	[('PROBABLE_UNDERSTANDING', 114)]	1	[('GO_0007567', 'parturition', 34, 'born'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007567', 'parturition', 207, 'born'), ('GO_0007567', 'parturition', 296, 'born'), ('GO_0009294', 'DNA mediated transformation', 372, 'trimester')]
PMC3672018	5/2013	S125-PMC3672018	['case–control analyses are ENVISAGED for a comparison of Blood spot Vitamin D levels between subjects with a disease outcome and subjects who have not developed this outcome.']	[('PROBABLE_UNDERSTANDING', 26)]	1	[('UBERON_0000178', 'blood', 56, 'blood'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
PMC3705320	3/2013	S69-PMC3705320	['confirmed hypercalcemia was a priori defined as albumin-adjusted Serum calcium concentration >2.60 mmol/l on both specimens (SINCE hypercalcemia caused by Vitamin D intoxication would not be expected to resolve within a few days without intervention).']	[('PROBABLE_UNDERSTANDING', 125)]	1	[('UBERON_0001977', 'blood serum', 65, 'serum'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
PMC3713405	7/2013	S53-PMC3713405	['Rats are maintained on this diet for 6 weeks, after which and prior to Mating, Serum Vitamin D3Depletion is confirmed by measuring the stable Vitamin D Metabolite 25 Hydroxy-Vitamin D (25(Oh)D3) AS <0.34 ng/ml (eyles et al., 2009).']	[('PROBABLE_UNDERSTANDING', 195)]	1	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rats'), ('GO_0007618', 'mating', 71, 'mating'), ('UBERON_0001977', 'blood serum', 79, 'serum'), ('CHEBI_61669', '2-methylbutanenitrile', 85, 'vitamin D3depletion'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 85, 'vitamin D3depletion'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 152, 'metabolite'), ('CHEBI_67724', 'Tetrahydrofurospongin-2', 166, 'hydroxy-'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 182, 'D'), ('CHEBI_62946', 'ammonium sulfate', 185, '25(OH)D3'), ('PR_000001177', 'D(2) dopamine receptor', 191, 'D3')]
PMC3717170	5/2013	S203-PMC3717170	['in practical terms, young, healthy, light-skinned Individuals with good diets that include dairy products and who have adequate exposure to sunlight are not LIKELY to be Vitamin D deficient or need to be tested.']	[('PROBABLE_UNDERSTANDING', 157)]	1	[('NCBITaxon_1', 'root', 50, 'individuals'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
PMC3728489	7/2013	S318-PMC3728489	['the average level of Vitamin D in Breast Milk is TYPICALLY 25 iu per liter or less.']	[('PROBABLE_UNDERSTANDING', 49)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0000310', 'breast', 34, 'breast'), ('UBERON_0001913', 'milk', 41, 'milk')]
PMC3814422	10/2013	S132-PMC3814422	['the MAJORITY of positive findings come from studies of maternal dietary intake of Vitamin D in Pregnancy8–10,28.']	[('PROBABLE_UNDERSTANDING', 4)]	1	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy8')]
PMC3827489	10/2013	S10-PMC3827489	['sun exposure is the main source of Vitamin D in Humans, AS only a small amount is obtained from the diet1).']	[('PROBABLE_UNDERSTANDING', 56)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 48, 'humans')]
PMC3873449	12/2013	S94-PMC3873449	['better educated women were less COMMON in the severe Vitamin D deficient group than that in women with 25(Oh)D ≥ 25 nmol/l.']	[('PROBABLE_UNDERSTANDING', 32)]	1	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 103, '25(OH)D'), ('PR_000010220', 'mannose-binding protein C', 105, '('), ('PR_000006444', 'diacylglycerol kinase delta', 109, 'D')]
PMC3873449	12/2013	S158-PMC3873449	['THEREFORE, People living in high latitudes would not achieve sufficient Vitamin D from sunlight exposure in winter.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('NCBITaxon_10088', 'Mus <genus>', 11, 'people'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
PMC3873449	12/2013	S161-PMC3873449	['it is NOT SURPRISING that there is a high prevalence of Vitamin D deficiency in Pregnant women residing in beijing in winter.']	[('PROBABLE_UNDERSTANDING', 6)]	1	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnant')]
PMC3873449	12/2013	S184-PMC3873449	['in 2011, the us endocrine society endorsed the need for at LEAST 600 iu(15 ug)/ day of Vitamin D supplementation for women during Pregnancy and up to 1500–2000 iu/day to maintain 25(Oh)D Blood levels above 30 ng/ml [16].']	[('PROBABLE_UNDERSTANDING', 59)]	1	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 179, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 179, '25(OH)D'), ('UBERON_0000178', 'blood', 187, 'blood')]
PMC3991049	11/2013	S60-PMC3991049	['we observed no toxic levels of Vitamin D during the study and non reached levels above (>80\xa0ng/ml) during Pregnancy AS the highest Vitamin D level was 70\xa0ng/ml in Pregnant mothers, and no toxic level reached in their new Born with a highest level of 59\xa0ng/dl.']	[('PROBABLE_UNDERSTANDING', 116)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0007565', 'female pregnancy', 163, 'pregnant'), ('GO_0007567', 'parturition', 221, 'born')]
PMC4113768	7/2014	S223-PMC4113768	['conclusions: the MAJORITY of healthy young Adults with moderate or dark skin pigmentation in cape town become Vitamin D deficient in winter.']	[('PROBABLE_UNDERSTANDING', 17)]	1	[('UBERON_0007023', 'adult organism', 43, 'adults'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
PMC4113768	7/2014	S700-PMC4113768	['conclusions: a finger-prick dried Blood spot method is FEASIBLE and acceptable way of assessing the Vitamin D status of primary schoolchildren.']	[('PROBABLE_UNDERSTANDING', 55)]	1	[('UBERON_0000178', 'blood', 34, 'blood'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
PMC4113768	7/2014	S1069-PMC4113768	['in saudi arabia this is due to a combination of PUTATIVE factors including: urbanization, demographic shifts, sedentary lifestyle, nutritional deficits, avoidance of sunlight because of the extreme heat, and decreases in the cutaneous Production Of Vitamin D within an Aging population.']	[('PROBABLE_UNDERSTANDING', 48)]	1	[('GO_0018240', 'protein S-linked glycosylation via cysteine', 235, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('GO_0007568', 'aging', 269, 'aging')]
PMC4113768	7/2014	S1673-PMC4113768	['differences in mean Serum 25(Oh)D concentration between the two time points were not EXPLAINED by differences in use of Vitamin D supplements, self-reported sun exposure or season of sampling at follow-up vs. baseline.']	[('PROBABLE_UNDERSTANDING', 85)]	1	[('UBERON_0001977', 'blood serum', 20, 'serum'), ('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 26, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
PMC4113768	7/2014	S2214-PMC4113768	['doctor-diagnosed Food allergy was significantly MORE COMMON up to age 2 years in Vitamin D group (10/39: 25.7%) than in Placebo group (3/40: 7.5%; rr = 3.42, 95% ci = 1.02 to 11.77, p = 0.030).']	[('PROBABLE_UNDERSTANDING', 48)]	1	[('CHEBI_33290', 'food', 17, 'food'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 120, 'placebo')]
PMC4113768	7/2014	S2215-PMC4113768	['moreover, at least one secondary outcome was also significantly MORE COMMON in Vitamin D group (17/39: 43.6%) than in placebo group (7/40: 17.5%; rr = 2.49, 95% ci = 1.16 to 5.34, p = 0.012).']	[('PROBABLE_UNDERSTANDING', 64)]	1	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
PMC4113768	7/2014	S2540-PMC4113768	['intakes of up to 20,000 iu per day are UNLIKELY to result in Vitamin D toxicity.']	[('PROBABLE_UNDERSTANDING', 39)]	1	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC4113768	7/2014	S2549-PMC4113768	['the risk for hypercalcemia in this sample of healthy volunteers was low and did not increase AS a result of higher levels of Vitamin D supplementation.']	[('PROBABLE_UNDERSTANDING', 93)]	1	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
PMC4113768	7/2014	S3353-PMC4113768	['in addition, CONSENSUS has not been reached with regard to the concentration of 25(Oh)D to define Vitamin D deficiency for infants and children.']	[('PROBABLE_UNDERSTANDING', 13)]	1	[('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
PMC4251419	12/2014	S10-PMC4251419	['in many regions of the world, Vitamin D is PRIMARILY synthesised in the skin following sun exposure (specifically uv-b irradiation).']	[('PROBABLE_UNDERSTANDING', 43)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
PMC4256222	12/2014	S42-PMC4256222	['we DEFINED the total maternal Vitamin D status as the sum of measured 25(Oh)D2 and 25(Oh)D3 concentrations.']	[('PROBABLE_UNDERSTANDING', 3)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_77765', '2,4,6-trihydroxybenzophenone(1-)', 70, '25(OH)D2'), ('CHEBI_62946', 'ammonium sulfate', 83, '25(OH)D3')]
PMC4256222	12/2014	S74-PMC4256222	['women without a measured Vitamin D status were more OFTEN in the 30thweek of Gestation during the winter months (dec/jan/feb).']	[('PROBABLE_UNDERSTANDING', 52)]	1	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'gestation')]
PMC4258799	11/2014	S308-PMC4258799	['besides Selenium, Vitamin E is OFTEN administered in combination with Vitamin C, another Chain Breaking antioxidant.']	[('PROBABLE_UNDERSTANDING', 31)]	1	[('CHEBI_27568', 'selenium atom', 8, 'selenium'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin C'), ('CHEBI_52841', 'benzoxazolium ion', 89, 'chain breaking')]
PMC4277121	12/2015	S257-PMC4277121	['for two Drugs, Fluoxetine and sag 1.1, treatment solely in the early Postnatal time periods resulted in successful l/m at young Adult ages of 6 weeks and 16 weeks, respectively.53,77indeed, for rescue on the mwm (but not on the spontaneous alternation y-maze), sag 1.1 treatment involved only a single p0 injection.77three Drugs were tested by the treatment of only Pregnant dams: Fluoxetine and Nap/sal were injected during Gestation;59,98and Choline was provided in Food to dams during Gestation and through weaning.105in another treatment, Vitamin E was provided in Food both to dams during Gestation and to the offspring through to the age of l/m testing.94in each case, the Prenatal Drug exposure resulted in AT LEAST the partial rescue of l/m in Adult offspring.']	[('PROBABLE_UNDERSTANDING', 714)]	1	[('CHEBI_23888', 'drug', 8, 'drugs'), ('CHEBI_5131', 'flurochloridone', 15, 'fluoxetine'), ('GO_0007567', 'parturition', 69, 'postnatal'), ('UBERON_0007023', 'adult organism', 128, 'adult'), ('CHEBI_23888', 'drug', 323, 'drugs'), ('GO_0007565', 'female pregnancy', 366, 'pregnant'), ('CHEBI_5131', 'flurochloridone', 381, 'fluoxetine'), ('CHEBI_13389', 'NAD', 396, 'NAP'), ('GO_0007565', 'female pregnancy', 425, 'gestation'), ('CHEBI_15354', 'choline', 444, 'choline'), ('CHEBI_33290', 'food', 468, 'food'), ('GO_0007565', 'female pregnancy', 488, 'gestation'), ('CHEBI_27300', 'vitamin D', 543, 'vitamin E'), ('CHEBI_33290', 'food', 569, 'food'), ('GO_0007565', 'female pregnancy', 594, 'gestation'), ('GO_0007565', 'female pregnancy', 679, 'prenatal'), ('CHEBI_23888', 'drug', 688, 'drug'), ('UBERON_0007023', 'adult organism', 752, 'adult')]
PMC4329404	10/2014	S104-PMC4329404	['a significant reduction in total Ige was EVIDENT if Vitamin D was introduced into the diet at weaning.']	[('PROBABLE_UNDERSTANDING', 41)]	1	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 33, 'IgE'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D')]
PMC4329404	10/2014	S164-PMC4329404	['a Vitamin D-sufficient positive control group is THEREFORE not reported.']	[('PROBABLE_UNDERSTANDING', 49)]	1	[('CHEBI_27300', 'vitamin D', 2, 'vitamin D')]
PMC4340999	3/2015	S96-PMC4340999	['mothers with babies Born in spring and early summer had low sun-related uvb exposure in winter, and HENCE, lower Vitamin D exposure for their offspring during the late second and early third trimesters (figure4).']	[('PROBABLE_UNDERSTANDING', 100)]	1	[('GO_0007567', 'parturition', 20, 'born'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D')]
PMC4377870	3/2015	S97-PMC4377870	['Vitamin E works synergistically with Vitamin C, AS following neutralisation of Ros, oxidised Vitamin E Isoforms can be processed back into their reduced form by Vitamin C [71].']	[('PROBABLE_UNDERSTANDING', 48)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('PR_000017279', 'testis-specific basic protein Y 1', 0, 'Vitamin E'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin C'), ('CHEBI_8756', 'RNA (poly(A))', 79, 'ROS'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin E'), ('SO_0001060', 'sequence_variant', 103, 'isoforms'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin C'), ('PR_000004900', 'complement C3', 169, 'C')]
PMC4383226	2/2015	S6-PMC4383226	['children receiving Vitamin A were less LIKELY to present with parasitemia (rr=0.46, 95% ci=0.39–0.54) and antigenemia (rr=0.23, 95% ci=0.17–0.29).']	[('PROBABLE_UNDERSTANDING', 39)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin A')]
PMC4396835	1/2015	S122-PMC4396835	['the participants were recruited from two distinct cohorts of swedish Born children with asd; one drawn from a representative group of children with asd, living in gothenburg, the other consisting of children with asd and with somali background, living in stockholm and REPRESENTING high risk for Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 269)]	1	[('GO_0007567', 'parturition', 69, 'born'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D')]
PMC4405493	4/2015	S23-PMC4405493	['the MAJORITY of randomized control trials and observational studies measure Vitamin D late in the Pregnancy, when Prenatal Vitamins containing 400 iu of Vitamin D have been prescribed [13].']	[('PROBABLE_UNDERSTANDING', 4)]	1	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('GO_0007565', 'female pregnancy', 114, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 123, 'vitamins'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
PMC4427001	4/2015	S23-PMC4427001	['IN GENERAL, Vitamin D decreases Cell Proliferation and stimulates Cell Maturation and Apoptosis.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0008283', 'cell proliferation', 32, 'cell proliferation'), ('GO_0048469', 'cell maturation', 66, 'cell maturation'), ('GO_0006915', 'apoptotic process', 86, 'apoptosis')]
PMC4448820	5/2015	S575-PMC4448820	['large randomized trials led to meta-analyses CONCLUDING that prophylactic Vitamin A supplementation of children between 6 mo and 5 y of age reduces overall mortality by 23–30% (290, 327–328) ( table 7 ).']	[('PROBABLE_UNDERSTANDING', 45)]	1	[('CHEBI_27300', 'vitamin D', 74, 'vitamin A')]
PMC4452099	6/2015	S90-PMC4452099	['BECAUSE Vitamin D travels freely through the Placenta, the doses of foetal Vitamin D will be similar with the doses that the Pregnant women were getting [29].']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0001987', 'placenta', 45, 'placenta'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant')]
PMC4466139	6/2015	S35-PMC4466139	['we considered, and analyzed AS adequately supplemented all mothers with an intake of 400 iu Vitamin D per day as recommended by the institute of medicine [14].']	[('PROBABLE_UNDERSTANDING', 28)]	1	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
PMC4466139	6/2015	S105-PMC4466139	['all mothers supplemented with Vitamin D had higher values of 25Ohd and the same was TRUE for their babies.']	[('PROBABLE_UNDERSTANDING', 84)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 61, '25OHD')]
PMC4586450	10/2015	S249-PMC4586450	['children in the lowest quartile for Vitamin D intake at 1.5 years were twice as LIKELY to remain in that quartile at 3.5 years (odds ratio [or], 2.35; 95% ci, 1.56–3.55).']	[('PROBABLE_UNDERSTANDING', 80)]	1	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
PMC4592566	10/2015	S47-PMC4592566	['the topic guide contained a list of LIKELY pre-Pregnancy actions which interviewers could use as a prompt if needed (the list included: supplements – Folic Acid, multivitamins for Pregnancy, ordinary multivitamins, Vitamin D, iron, omega 3, Vitamin C, zinc; lifestyle actions – Eating a healthy diet, weight, Caffeine, Alcohol, smoking, Drugs, including street Drugs, prescription Drugs, over-the-counter Drugs; and health care advice – seeing a health professional for advice about getting Pregnant, immunizations, Dental checks, Sexually Transmitted infections, and stopping contraception).']	[('PROBABLE_UNDERSTANDING', 36)]	1	[('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('CHEBI_30751', 'formic acid', 150, 'folic acid'), ('GO_0007565', 'female pregnancy', 180, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin C'), ('GO_0051318', 'G1 phase', 278, 'eating'), ('CHEBI_27732', 'caffeine', 309, 'caffeine'), ('CHEBI_30879', 'alcohol', 319, 'alcohol'), ('CHEBI_23888', 'drug', 337, 'drugs'), ('CHEBI_23888', 'drug', 361, 'drugs'), ('CHEBI_23888', 'drug', 381, 'drugs'), ('CHEBI_23888', 'drug', 405, 'drugs'), ('GO_0007565', 'female pregnancy', 491, 'pregnant'), ('UBERON_0001091', 'calcareous tooth', 516, 'dental'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 531, 'sexually transmitted')]
PMC4645901	8/2014	S25-PMC4645901	['our REASON for testing Vitamin D was borne out of raised alkaline phosphatase levels on a significant number of babies who ended up being either Vitamin D insufficent or deficient.']	[('PROBABLE_UNDERSTANDING', 4)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
PMC4645901	8/2014	S26-PMC4645901	['deficiency was DEFINED as <25 nmol/l while insufficiency was <50 nmol/l on Serum 25 (Oh) Vitamin D assays.']	[('PROBABLE_UNDERSTANDING', 15)]	1	[('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_30778', 'gallic acid', 81, '25 (OH)'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
PMC4645901	8/2014	S82-PMC4645901	['this would have undoubtedly helped to raise the Vitamin D levels of mothers and THUS availability in the Breast Milk.']	[('PROBABLE_UNDERSTANDING', 80)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 105, 'breast milk')]
PMC4673623	11/2015	S115-PMC4673623	['CONSEQUENTLY, in Vitamin B-12 deficiency, cellular and circulating levels of Homocysteine and 5-Methyl-Thf will rise.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin B'), ('PR_000004770', 'Polycomb complex protein BMI-1', 25, 'B-12'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 77, 'homocysteine'), ('CHEBI_44700', 'L-ornithyl group', 94, '5-methyl'), ('CHEBI_17038', 'fecosterol', 103, 'THF')]
PMC4719746	1/2016	S47-PMC4719746	['all participants were asked about their Intake of Vitamin D supplements including Prenatal Vitamins during the past two weeks at both visits, and self-reported intake was categorized AS “ Vitamin D ≥10\xa0μg/day” and “no or Vitamin D <10\xa0μg/day”.']	[('PROBABLE_UNDERSTANDING', 183)]	1	[('GO_0007631', 'feeding behavior', 40, 'intake'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 91, 'vitamins'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
PMC4719746	1/2016	S157-PMC4719746	['supplementation with a higher dose of Vitamin D than 20\xa0μg or 30\xa0μg would LIKELY be sufficient to achieve acceptable 25(Oh)D concentration in Pregnancy.']	[('PROBABLE_UNDERSTANDING', 74)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 117, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 117, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy')]
PMC4764019	1/2016	S54-PMC4764019	['these Genes cover a broad range of functions ranging from cell-to-Cell adhesion, to Macrophage Production of defensins in response to mycobacterial infection, to Intestinal calcium absorption, and many others.13in ESSENTIALLY all such actions, Vitamin D, in its active form as 1,25(Oh)2D3, functions as a part of the molecular apparatus opening the Genome, permitting Expression of the Genes concerned.']	[('PROBABLE_UNDERSTANDING', 214)]	1	[('SO_0000704', 'gene', 6, 'genes'), ('GO_1901646', 'negative regulation of synoviocyte proliferation', 62, '- ...'), ('GO_0007049', 'cell cycle', 66, 'cell'), ('CL_0000235', 'macrophage', 84, 'macrophage'), ('GO_0007128', 'meiotic prophase I', 95, 'production'), ('UBERON_0000160', 'intestine', 162, 'intestinal'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('CHEBI_37958', 'dye', 277, '1,'), ('CHEBI_73394', 'Ala-Ser', 279, '25(OH)2D3'), ('SO_0001026', 'genome', 349, 'genome'), ('GO_0010467', 'gene expression', 368, 'expression'), ('SO_0000704', 'gene', 386, 'genes')]
PMC4772030	1/2016	S55-PMC4772030	['Retinol <1.05 µmol/l was considered INDICATIVE of low Vitamin A and tdp <65 nmol/l of deficient Thiamine status [21,22].']	[('PROBABLE_UNDERSTANDING', 36)]	1	[('CHEBI_27810', 'resorcinol', 0, 'Retinol'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin A'), ('CHEBI_26948', 'vitamin B1', 96, 'thiamine')]
PMC4784858	3/2016	S132-PMC4784858	['such was the case for 8 out of 34 Nutrients (Thiamin, riboflavin, niacin, Vitamin B6, Folate, Vitamin D, Iodine and zinc) for the french sample and 12 out of 30 (la, ala, Vitamin A, Thiamin, riboflavin, niacin, Vitamin B6, Folate, Vitamin B12, Vitamin C, magnesium and zinc) for the us sample (s4 table).fig 2presents the five Vitamins and Minerals for which the probability of adequacy was lowered the most in the french sample (Thiamin, niacin, Vitamin B6, Folate and Iodine) and in the us sample (Thiamin, Vitamin B6, folate, magnesium and zinc).10.1371/journal.pone.0149858.g002\n\ncaption (fig): fig 2\nprobabilities of adequacy composing pandiet scores for the five Vitamins and Minerals for which the PROBABILITY of adequacy was lowered the most when simulating the changes in the nutritional requirements in the First Trimester of Pregnancy in the french sample (left panel) and in the us sample (right panel).']	[('PROBABLE_UNDERSTANDING', 705)]	1	[('CHEBI_33284', 'nutrient', 34, 'nutrients'), ('CHEBI_26948', 'vitamin B1', 45, 'thiamin'), ('CHEBI_33237', 'vitamin D4', 74, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 86, 'folate'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 105, 'iodine'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin A'), ('CHEBI_26948', 'vitamin B1', 182, 'thiamin'), ('CHEBI_33237', 'vitamin D4', 211, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 223, 'folate'), ('CHEBI_33279', 'vitamin D5', 231, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin C'), ('CHEBI_33277', 'gamma-tocotrienol', 327, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 340, 'minerals'), ('CHEBI_26948', 'vitamin B1', 430, 'thiamin'), ('CHEBI_33237', 'vitamin D4', 447, 'vitamin B6'), ('CHEBI_30863', '5-azaorotic acid', 459, 'folate'), ('CHEBI_24859', 'iodine atom', 470, 'iodine'), ('CHEBI_26948', 'vitamin B1', 500, 'thiamin'), ('CHEBI_33237', 'vitamin D4', 509, 'vitamin B6'), ('CHEBI_33277', 'gamma-tocotrienol', 669, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 682, 'minerals'), ('GO_0007631', 'feeding behavior', 817, 'first'), ('GO_0009294', 'DNA mediated transformation', 823, 'trimester'), ('GO_0007565', 'female pregnancy', 836, 'pregnancy')]
PMC4785305	3/2016	S88-PMC4785305	['current Medications LIKELY to interfere with Vitamin D Metabolism (enzyme inducing Anticonvulsants, antituberculosis).']	[('PROBABLE_UNDERSTANDING', 20)]	1	[('CHEBI_25441', 'mycothiols', 8, 'medications'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007601', 'visual perception', 45, 'vitamin D'), ('GO_0008152', 'metabolic process', 55, 'metabolism'), ('CHEBI_37540', 'arabinarate(2-)', 83, 'anticonvulsants')]
PMC4889866	5/2016	S76-PMC4889866	['association of maternal and Cord Vitamin D level with Tlr-Stimulated cytokine Response\nBECAUSE the distribution of most cytokine levels and Vitamin D concentrations was highly skewed (data not shown), we used natural log-transformed 25(Oh)D and cytokine levels for correlation analysis.']	[('PROBABLE_UNDERSTANDING', 87)]	1	[('UBERON_0000948', 'heart', 28, 'Cord'), ('CHEBI_28384', 'vitamin K', 33, 'Vitamin D'), ('GO_0036462', 'TRAIL-activated apoptotic signaling pathway', 54, 'TLR-Stimulated'), ('GO_0060033', 'anatomical structure regression', 78, 'Response'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 233, '25(OH ... D')]
PMC4896250	4/2016	S3558-PMC4896250	['using 30ng/ml as the “PRESUMED normal” cut-off for this population, the prevalence of Vitamin D deficiency doubled to 55%.']	[('PROBABLE_UNDERSTANDING', 22)]	1	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
PMC4896250	4/2016	S6641-PMC4896250	['Acitretin is a WELL-KNOWN second generation Vitamin A derivative, widely used in palmoplantar psoriasis with less cost.']	[('PROBABLE_UNDERSTANDING', 15)]	1	[('CHEBI_2372', 'acalyphin', 0, 'Acitretin'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin A')]
PMC4910734	6/2015	S227-PMC4910734	['nonsulfur-containing Antioxidants, such as Vitamin C and Vitamin E, are not LIKELY to be as effective in neutralizing Aldehyde toxicity and would require much higher doses.']	[('PROBABLE_UNDERSTANDING', 76)]	1	[('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 21, 'antioxidants'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin E'), ('CHEBI_17478', 'aldehyde', 118, 'aldehyde')]
PMC4934634	11/2015	S29-PMC4934634	['high levels of body fat can Sequester Vitamin D into Adipose Cells THUS reducing its bioavailability to other Tissues.']	[('PROBABLE_UNDERSTANDING', 67)]	1	[('GO_0051235', 'maintenance of location', 28, 'sequester'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CL_0000136', 'fat cell', 53, 'adipose cells'), ('UBERON_2000251', 'adipose fin', 53, 'adipose'), ('UBERON_0000479', 'tissue', 110, 'tissues')]
PMC4934634	11/2015	S54-PMC4934634	['male Rats Fed a Vitamin D deficient diet prior to Mating were 17% less LIKELY to Inseminate females than Vitamin D replete Rats [20].']	[('PROBABLE_UNDERSTANDING', 71)]	1	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 5, 'rats'), ('GO_0007631', 'feeding behavior', 10, 'fed'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007618', 'mating', 50, 'mating'), ('GO_0007631', 'feeding behavior', 81, 'inseminate'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 123, 'rats')]
PMC4934634	11/2015	S106-PMC4934634	['cathelicidins, Antimicrobial peptides that can defend against pathogens, are up regulated by Vitamin D. vdr can bind to response elements Of the Human Cathelicidin peptide Gene (Cathelicidin Antimicrobial peptide; camp) increasing the Killing ability of Innate Immune Cells, Macrophages, THUS strengthening the innate Immune System’s response [41].']	[('PROBABLE_UNDERSTANDING', 288)]	1	[('CHEBI_65381', 'albizoside C', 15, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('SO_0001467', 'RST', 138, 'of'), ('NCBITaxon_9606', 'Homo sapiens', 145, 'human'), ('PR_000006009', 'alpha-catulin', 151, 'cathelicidin'), ('SO_0000704', 'gene', 172, 'gene'), ('CHEBI_3364', 'Canthiumine', 178, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 178, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 191, 'antimicrobial'), ('GO_0007601', 'visual perception', 235, 'killing'), ('CL_0002088', 'interstitial cell of Cajal', 254, 'innate immune cells'), ('GO_0044409', 'entry into host', 254, 'innate immune cells'), ('UBERON_0002405', 'immune system', 261, 'immune'), ('CL_0000235', 'macrophage', 275, 'macrophages'), ('UBERON_0002405', 'immune system', 318, 'immune system')]
PMC4934634	11/2015	S255-PMC4934634	['the women in both groups had mean baseline levels considered Vitamin D deficient THUS supplementing higher amounts than 1200 iu/day would be needed to achieve sufficiency for this population.']	[('PROBABLE_UNDERSTANDING', 81)]	1	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
PMC4944244	7/2016	S49-PMC4944244	['they also underwent skin color measurement using the fitzpatrick skin type chart measurement (fstcm) and mexameter (mx) 18; weight and height measurements and Blood test for Vitamin D. hypovitaminosis D was DEFINED as Serum 25(Oh)D\u2009<\u200950\xa0nmol/l.']	[('PROBABLE_UNDERSTANDING', 207)]	1	[('UBERON_0000178', 'blood', 159, 'blood'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 201, 'D'), ('UBERON_0001977', 'blood serum', 218, 'serum'), ('CHEBI_71657', 'versiconol acetate', 224, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 224, '25(OH)D')]
PMC4949006	7/2016	S194-PMC4949006	['there is GOOD EVIDENCE for supplementation with Vitamin C in Pregnant women who smoke.']	[('PROBABLE_UNDERSTANDING', 9)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin C'), ('GO_0007565', 'female pregnancy', 61, 'pregnant')]
PMC4971719	8/2016	S92-PMC4971719	['we defined these two groups based upon assessment from the institute of medicine that MOST Individuals are assured good bone health with levels that are 20\xa0ng/ml or higher, as well as the Endocrine society’s clinical practice guideline definition of Vitamin D deficiency of 25 Oh Vitamin D levels <20 [43,45].']	[('PROBABLE_UNDERSTANDING', 86)]	1	[('NCBITaxon_1', 'root', 91, 'individuals'), ('UBERON_0005063', 'left ventricular compact myocardium', 188, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('CHEBI_63058', '(2R,3S)-EHNA', 274, '25 OH'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D')]
PMC4971719	8/2016	S97-PMC4971719	['in this model, low Vitamin D and other variables were considered categorically (Dha <2.0 as % of total Fatty Acids, epa <0.1 AS % of total Fatty Acids, age >35, positive tobacco use, bmi >30, and positive initiation of Anti-Depressant Medications).']	[('PROBABLE_UNDERSTANDING', 125)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_17874', 'dihydrozeatin', 80, 'DHA'), ('CHEBI_35366', 'fatty acid', 103, 'fatty acids'), ('CHEBI_35366', 'fatty acid', 139, 'fatty acids'), ('CHEBI_35474', 'anxiolytic drug', 219, 'anti-depressant'), ('CHEBI_25441', 'mycothiols', 235, 'medications')]
PMC4971719	8/2016	S122-PMC4971719	['the “low Vitamin D” group was younger (mean age 27.8\xa0years versus 30.8\xa0years, p 0.03) and more LIKELY to report tobacco use (32\xa0% versus 6\xa0%, p 0.004).']	[('PROBABLE_UNDERSTANDING', 95)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
PMC4973215	8/2016	S88-PMC4973215	['black mothers on medicaid who were obese and did not take Prenatal Vitamins had the highest PROBABILITY of having an infant with Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 92)]	1	[('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 67, 'vitamins'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
PMC4973215	8/2016	S90-PMC4973215	['pre-eclampsia, coupled with black race and Vitamin D deficiency, resulted in significant increases in the predicted PROBABILITY of Delivering an sga infant.']	[('PROBABLE_UNDERSTANDING', 116)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0006900', 'vesicle budding from membrane', 131, 'delivering')]
PMC4976416	7/2016	S50-PMC4976416	['Pycnogenol is a standardized extract of the bark of the french maritime pine ( pinus pinaster ), a WELL-KNOWN, potent antioxidant, several times more powerful than Vitamin E and in addition, regenerates Vitamin E and increases the endogenous antioxidant enzyme system.']	[('PROBABLE_UNDERSTANDING', 99)]	1	[('CHEBI_26375', 'pterins', 0, 'Pycnogenol'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin E')]
PMC4997421	8/2016	S76-PMC4997421	['the overall prevalence of Vitamin A deficiency in our cohort, AS defined by Serum Retinol concentrations of ˂0.70 µmol/l, was very low at less than 1%.']	[('PROBABLE_UNDERSTANDING', 62)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin A'), ('UBERON_0001977', 'blood serum', 76, 'serum'), ('CHEBI_26536', 'retinoic acid', 82, 'retinol')]
PMC4997421	8/2016	S78-PMC4997421	['the MAJORITY of the population (96.1%) was Vitamin A sufficient with Serum Retinol concentrations >1.05 µmol/l.']	[('PROBABLE_UNDERSTANDING', 4)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin A'), ('UBERON_0001977', 'blood serum', 69, 'serum'), ('CHEBI_26536', 'retinoic acid', 75, 'retinol')]
PMC4998950	4/2016	S39-PMC4998950	['lastly, we used Vitamin D deficiency recorded at any time as the exposure – and not timed to Pregnancy, AS no cases diagnosed before the Birth of a child were identified.']	[('PROBABLE_UNDERSTANDING', 104)]	1	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('GO_0007567', 'parturition', 137, 'birth')]
PMC5014971	8/2016	S77-PMC5014971	['patient factors that would increase the LIKELIHOOD that a physician would screen for Vitamin D status included evidence of malabsorption syndrome (82.2%), Gastric bypass surgery (79.2%), family history of osteoporosis (75.8%), and evidence of Alcohol abuse (56.4%).']	[('PROBABLE_UNDERSTANDING', 40)]	1	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0001844', 'cochlea', 155, 'gastric'), ('CHEBI_30879', 'alcohol', 243, 'alcohol')]
PMC5028238	10/2016	S84-PMC5028238	["a heterozygote advantage for Individuals with one dhcr7 mutation would THEREFORE exist to allow most of the body's 7-Dehydrocholesterol to be converted into Vitamin D (and not Cholesterol)."]	[('PROBABLE_UNDERSTANDING', 71)]	1	[('NCBITaxon_1', 'root', 29, 'individuals'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 115, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_16113', 'cholesterol', 176, 'cholesterol')]
PMC5028238	10/2016	S92-PMC5028238	['THEREFORE, fromfigure 3and the literature, we would expect them to have high Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D')]
PMC5051327	9/2016	S9-PMC5051327	['Birth asphyxia was MORE COMMON in women with Vitamin D deficiency (n=95) in early Pregnancy (or 2.4, 95% ci 1.1 to 5.7).']	[('PROBABLE_UNDERSTANDING', 19)]	1	[('GO_0007567', 'parturition', 0, 'Birth'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy')]
PMC5051327	9/2016	S53-PMC5051327	['in addition, Birth asphyxia was MORE COMMON in women with Vitamin D deficiency than in non-deficient women.']	[('PROBABLE_UNDERSTANDING', 32)]	1	[('GO_0007567', 'parturition', 13, 'birth'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
PMC5084016	10/2016	S138-PMC5084016	['an intake of 15 µg/day (600 iu/day), e.g., in women of Childbearing age, is THEREFORE needed to meet the requirement for Vitamin D during breastfeeding, as highlighted in the aforementioned consensus document.']	[('PROBABLE_UNDERSTANDING', 76)]	1	[('GO_0007129', 'homologous chromosome pairing at meiosis', 55, 'childbearing'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
PMC5146866	12/2016	S7-PMC5146866	['the LIKELIHOOD for infants to be Born with an insufficient Vitamin D level increases with younger maternal age and the number of Pregnancies as well as asian ethnicity.']	[('PROBABLE_UNDERSTANDING', 4)]	1	[('GO_0007567', 'parturition', 33, 'born'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancies')]
PMC5146866	12/2016	S42-PMC5146866	['data presentation and statistical analyses\nthe results of [25(Oh) D] were analyzed as a continuous variable and were also stratified with respect to the aap’s definition of Vitamin D status [8,9] AS severe (<5\xa0ng/ml) or mild/moderate deficient (5–15\xa0ng/ml), insufficient (16–20\xa0ng/ml), and sufficient (21–100\xa0ng/ml).']	[('PROBABLE_UNDERSTANDING', 196)]	1	[('CHEBI_71657', 'versiconol acetate', 59, '25(OH) D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
PMC5146866	12/2016	S84-PMC5146866	['TO THE BEST OF OUR KNOWLEDGE, no us study has compared the cb Vitamin D levels of infants with respect to the maternal race/ethnicity.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
PMC5155676	12/2016	S101-PMC5155676	['TO OUR KNOWLEDGE, the factors which determine the response to Vitamin D supplementation in Pregnancy have not previously been assessed.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy')]
PMC5372327	3/2017	S58-PMC5372327	['Genetic Regulation Of Mineral Homeostasis\nS-25-Ohd concentration has high heritability (28–80%), which EXPLAINS differences in responses to Vitamin D supplementation [53].']	[('PROBABLE_UNDERSTANDING', 103)]	1	[('SO_0000704', 'gene', 0, 'Genetic'), ('GO_1900046', 'regulation of hemostasis', 8, 'regulation of ... homeostasis'), ('CHEBI_46662', 'mineral', 22, 'mineral'), ('CHEBI_86929', 'S b G-5,5-G b S A CH2', 42, 'S-25-OHD'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
PMC5384134	4/2017	S177-PMC5384134	['Vitamin A and zinc supplementation) are OFTEN prioritised over behaviour-change and health promotion-based approaches (e.g.']	[('PROBABLE_UNDERSTANDING', 40)]	1	[('CHEBI_27300', 'vitamin D', 0, 'vitamin A')]
PMC5426325	4/2017	S14-PMC5426325	['CONSEQUENTLY, the Vitamin D status will then depend more on diet, supplementation and/or fortification alone.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
PMC5426325	4/2017	S29-PMC5426325	['HENCE, Prenatal exposure to extra Vitamin D from fortification is assumed to be the only parameter that separates the Individuals in the two exposure groups.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('GO_0007565', 'female pregnancy', 7, 'prenatal'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('NCBITaxon_1', 'root', 118, 'individuals')]
PMC5426325	4/2017	S153-PMC5426325	['for replication, the finish Vitamin D fortification programme (initiated in 2003) may be an option BECAUSE finland, like denmark, has access to nationwide Individual registration of fractures(64).']	[('PROBABLE_UNDERSTANDING', 99)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('NCBITaxon_1', 'root', 155, 'individual')]
PMC5452160	4/2017	S148-PMC5452160	['3.4 predictors of multiple Micronutrient deficiencies\nwhen exploring predictors of mmn deficiencies (≥3 of the following: iron, zinc, Vitamin A, vitamin B12And/or Folate), women in the second Trimester of Pregnancy were less LIKELY to have mmn deficiencies (or: 0.31, 95% ci: 0.21, 0.45) than women in the third trimester.']	[('PROBABLE_UNDERSTANDING', 225)]	1	[('CHEBI_6956', 'Mitragynine', 27, 'Micronutrient'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin A'), ('CHEBI_82295', 'Bitumens', 153, 'B12and'), ('CHEBI_30863', '5-azaorotic acid', 163, 'folate'), ('GO_0009294', 'DNA mediated transformation', 192, 'trimester'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy')]
PMC5489519	6/2017	S36-PMC5489519	['Serum 25(Oh)D levels were measured to evaluate the active form of Vitamin D [1,25(Oh)2D] status in maternal blood as classified by the Endocrine society clinical practice GUIDELINE25.']	[('PROBABLE_UNDERSTANDING', 171)]	1	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_37958', 'dye', 77, '1,'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 79, '25(OH)2D'), ('UBERON_0005063', 'left ventricular compact myocardium', 135, 'Endocrine')]
PMC5513133	7/2017	S123-PMC5513133	['strengths of this study were that Vitamin D was measured in both high and low risk women, REPRESENTING a realistic clinical scenario.']	[('PROBABLE_UNDERSTANDING', 90)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
PMC5521778	7/2017	S21-PMC5521778	['in Humans, fetal Lung Vitamin A stores increase during the third Intrauterine trimester, then level off towards term, and decrease, PRESUMABLY by Retinoid mobilization, in early Postnatal Life [13].']	[('PROBABLE_UNDERSTANDING', 132)]	1	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('UBERON_0002048', 'lung', 17, 'lung'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('UBERON_0022293', 'reproductive gland secretion', 65, 'intrauterine'), ('CHEBI_26537', 'retinoid', 146, 'retinoid'), ('GO_0007567', 'parturition', 178, 'postnatal'), ('UBERON_0000104', 'life cycle', 188, 'life')]
PMC5539754	8/2017	S157-PMC5539754	['winter-time supplementation of 1000\xa0iu/day Vitamin D is an EFFECTIVE STRATEGY to improve 25Ohd in Pregnancy [45].']	[('PROBABLE_UNDERSTANDING', 59)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 89, '25OHD'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy')]
PMC5579643	8/2017	S2-PMC5579643	['essential Fatty Acids, zinc and Vitamin D are LIKELY to enhance the anti-inflammatory and antioxidative barrier and promote Immunologic tolerance.']	[('PROBABLE_UNDERSTANDING', 46)]	1	[('CHEBI_35366', 'fatty acid', 10, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0000913', 'interstitial fluid', 124, 'immunologic')]
PMC5579643	8/2017	S62-PMC5579643	['ALMOST ALL cells Of the Adaptive Immune System Express the Vitamin D receptor, making them also capable of being Vitamin responsive.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CL_1001434', 'olfactory bulb interneuron', 17, 'of ... adaptive immune system'), ('GO_0019825', 'oxygen binding', 24, 'adaptive immune'), ('UBERON_0002405', 'immune system', 33, 'immune system'), ('GO_0010467', 'gene expression', 47, 'express'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 113, 'vitamin')]
PMC5623264	9/2017	S78-PMC5623264	['Vitamin E\ntwenty-one rcts and quasi-rcts randomising 22\u2009129 Pregnant women living in areas with inadequate Vitamin E intake or areas with PRESUMED adequate intake were included in this review.46any Vitamin E supplementation did not reduce ptb, sga or iugr.']	[('PROBABLE_UNDERSTANDING', 138)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin E'), ('PR_000017279', 'testis-specific basic protein Y 1', 0, 'Vitamin E'), ('GO_0007565', 'female pregnancy', 60, 'pregnant'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin E')]
PMC5634602	10/2017	S32-PMC5634602	['it is LIKELY that preterm infants will have a compromised Vitamin D status at Birth.']	[('PROBABLE_UNDERSTANDING', 6)]	1	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007567', 'parturition', 78, 'birth')]
PMC5638722	8/2017	S45-PMC5638722	['according to this categorization; severe Vitamin D deficiency (group 1) was DEFINED as 25-Hydroxyvitamin D (25-Ohd) concentration <5 ng/ml; Vitamin D insufficiency (group 2), 5 ng/ml <25-Ohd concentration <15 ng/ml; and Vitamin D sufficiency (group 3), 25-Ohd concentration ≥15 ng/ml12).']	[('PROBABLE_UNDERSTANDING', 76)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 87, '25-hydroxyvitamin D'), ('CHEBI_72765', 'verruculogen', 108, '25-OHD'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 184, '25-OHD'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 253, '25-OHD')]
PMC5685050	10/2014	S47-PMC5685050	['THUS, dietary intake of Vitamin D in thai People is generally low.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 42, 'people')]
PMC5697969	12/2017	S145-PMC5697969	['the PROBABILITY of an adequate Intake (above the ear) increased more in the nutrition-focused mnch group than in the standard mnch group at endline, except for intakes of niacin, Vitamin C, and Vitamin B-6.']	[('PROBABLE_UNDERSTANDING', 4)]	1	[('GO_0007631', 'feeding behavior', 31, 'intake'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin C'), ('PR_000004900', 'complement C3', 187, 'C'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin B'), ('PR_000017255', 'Vang-like protein 1', 194, 'vitamin B-6')]
PMC5732505	12/2017	S48-PMC5732505	['we employed ucb 25(Oh)D to REFLECT both the maternal Vitamin D status at the end of Pregnancy and the newborn’s Vitamin D status at Birth [1].']	[('PROBABLE_UNDERSTANDING', 27)]	1	[('CHEBI_71657', 'versiconol acetate', 16, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007567', 'parturition', 132, 'birth')]
PMC5784894	1/2018	S125-PMC5784894	['THUS Bones of offspring of Vitamin D deplete dams are less stiff than those of replete dams.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('UBERON_0001474', 'bone element', 5, 'bones'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
PMC5784894	1/2018	S149-PMC5784894	['they also IMPLY that later correction of Vitamin D deficiency does not restore bone’s responsiveness to mechanical stimulation.']	[('PROBABLE_UNDERSTANDING', 10)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D')]
PMC5838372	3/2018	S83-PMC5838372	['the international association of endocrinology DEFINED a Vitamin D level of 21-29 ng /ml as insufficiency and <20 ng/ml as deficiency in Adults (21).']	[('PROBABLE_UNDERSTANDING', 47)]	1	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0007023', 'adult organism', 137, 'adults')]
PMC5941617	5/2018	S24-PMC5941617	['further literature search was performed focusing available international GUIDELINES on Vitamin D supplementation in children.']	[('PROBABLE_UNDERSTANDING', 73)]	1	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
PMC5941617	5/2018	S45-PMC5941617	['caption (table-wrap): table 3\n\ncut-off points for the definition of Vitamin D status based on circulating levels of 25(Oh)Dsevere deficiencydeficiencyinsufficiencysufficiency25(Oh)D< 10\xa0ng/ml (< 25\xa0nmol/l)< 20\xa0ng/ml (< 50\xa0nmol/l)20–29\xa0ng/ml (50–74\xa0nmol/l)≥ 30\xa0ng/ml (≥ 75\xa0nmol/l)\nconversion factor: ng/ml\u2009=\u2009nmol/l*0.401; nmol/l\u2009=\u2009ng/ml*2.496\nVitamin D status is DEFINED by the measurement of 25(Oh)D concentrations.']	[('PROBABLE_UNDERSTANDING', 362)]	1	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_77894', 'aci-nitroethane', 116, '25(OH)DSevere'), ('CHEBI_33010', 'chromide(1-)', 176, '(OH)D'), ('CHEBI_28384', 'vitamin K', 342, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 392, '25(OH)D')]
PMC5941617	5/2018	S92-PMC5941617	['THUS, during this period an adequate Vitamin D status can be maintained only from endogenous stores accumulated during previous summer or by exogenous supplementation.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
PMC5941617	5/2018	S654-PMC5941617	['daily administration of Vitamin D is PREFERRED in infants.']	[('PROBABLE_UNDERSTANDING', 37)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
PMC5956785	5/2018	S167-PMC5956785	['at latitudes 42° and 53onorth, between october to april, uvb radiation is not intense enough to elicit endogenous Vitamin D Synthesis [65] THUS potentiating the risk of Vitamin D deficiency, [63].']	[('PROBABLE_UNDERSTANDING', 139)]	1	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 114, 'vitamin D synthesis'), ('PR_000006444', 'diacylglycerol kinase delta', 122, 'D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
PMC5995352	6/2018	S32-PMC5995352	['Skeletal manifestations of Vitamin D deficiency rickets rarely becomes apparent after weeks, more OFTEN after months from Birth [10].']	[('PROBABLE_UNDERSTANDING', 98)]	1	[('UBERON_0004288', 'skeleton', 0, 'Skeletal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007567', 'parturition', 122, 'birth')]
PMC5995352	6/2018	S92-PMC5995352	['compared to children in the highest Cord 25Ohd quartile, children in the lowest quartile were more often Born during winter and spring and more LIKELY had mothers of non-western ethnicity, mothers with pre-Gestational bmi above 25 kg/m2, mothers with parity above three children, mothers who took less than the recommended Vitamin D supplement of 10 μg/day, or mothers who Smoked during Pregnancy,table 1.10.1371/journal.pone.0198724.t001\n\ncaption (table-wrap): table 1\nbasic characteristics of the 2010 participants.nquartiles of Cord 25Ohd, nmol/lp-value*< 30.730.8–45.145.2–60.6> 60.7 maternal characteristics maternal height, cm2010168.3 ± 6.51168.0 ± 6.6168.2 ± 6.1168.5 ± 6.10.7maternal pre-Gestational weight, kg201069 [60–80]266 [60–74]66 [59–75]65 [59–73]<0.001 Pregestational bmi, kg/m2201024.3 [21.8–28.1]23.3 [21.4–26.0]23.5 [21.1–26.2]22.8 [21.0–25.6]<0.001 Gestational weight gain, kg87315.1 ± 6.315.0 ± 5.615.5 ± 5.614.5 ± 5.20.4maternal age, y201029.8 ± 4.630.4 ± 4.330.3 ± 4.330.0 ± 4.60.1smoking in Pregnancy, n (%) <0.001 \u2003smoker9843 (8.6)18 (3.6)19 (3.8)18 (3.6)\u2003non-smoker1912460 (91.4)484 (96.4)484 (96.2)484 (96.4)maternal educational level, n (%)0.2\u2003lower25274 (19.5)64 (16.3)54 (13.7)60 (17.7)\u2003intermediate908218 (57.5)230 (58.7)245 (62.2)215 (63.2)\u2003higher34587 (23.0)98 (25.0)95 (24.1)65 (19.1)ethnicity, n (%) <0.001 \u2003western1918459 (93.2)482 (95.8)486 (98.6)491 (97.1)\u2003non-western9244 (6.8)20 (4.2)17 (1.4)11 (2.9)skin-type**, n (%)0.2\u2003i/ii white29986 (22.6)84 (21.3)66 (16.7)63 (18.4)\u2003iii darker white889207 (54.3)239 (60.5)249 (62.8)194 (56.7)\u2003iv brown30982 (21.5)67 (16.9)78 (19.7)82 (23.9)\u2003v/vi dark brown176 (1.6)5 (1.3)3 (0.6)3 (1.0)parity, n (%) <0.001 \u2003first child1109230 (45.7)282 (56.2)295 (58.7)302 (60.2)\u2003second child679204 (40.6)164 (32.7)156 (31.0)155 (30.9)\u2003third child or more22269 (13.7)56 (11.1)52 (10.3)45 (8.9)time spent outdoors, mother, n (%) 0.002 \u2003never/rarely3111 (2.9)7 (1.8)7 (1.8)6 (1.8)\u2003sometimes29595 (24.9)84 (21.2)62 (15.7)54 (15.8)\u2003often920204 (54.4)252 (63.6)256 (64.7)208 (60.8)\u2003most of the time27072 (18.8)53 (13.4)71 (17.8)74 (21.6)Vitamin D supplementation in Pregnancy, mother, n (%) <0.001 \u2003≤10 μg/day15764 (23.4)33 (10.7)36 (11.4)24 (8.5)\u2003>10 μg/day1023210 (76.6)275 (89.3)281 (88.6)257 (91.5) paternal characteristics paternal height, cm1223182.6 ± 6.7182.5 ± 7.0183.2± 6.6182.3± 6.70.3 child characteristics Gestational age (ga) at Birth, w201040 [39–41]40 [39–41]40 [39–41]40 [39–41]0.6season of Birth n (%) <0.001 \u2003winter (dec-feb)489190 (37.7)143 (28.5)107 (21.3)49 (9.8)\u2003spring (mar-may)496158 (31.4)144 (28.7)106 (21.1)88 (17.5)\u2003summer (jun-aug)47729 (5.8)78 (15.5)135 (26.8)235 (46.8)\u2003autumn (sep-nov)548126 (25.1)137 (27.3)155 (30.8)130 (25.9)child sex, n (%)0.6\u2003girls948241 (47.9)228 (45.4)247 (49.1)232 (46.2)\u2003boys1062262 (52.1)274 (54.6)256 (50.9)270 (53.8)child age at 18 months examination, m135018.7 [18.3–19.4]18.8 [18.2–19.4]18.0 [18.4–19.6]19.0 [18.4–19.5]0.03 duration of exclusive breastfeeding, w123018 [6–34]19 [11–24]20 [10–24]20 [12–24]0.06intake of infant formula after 8 weeks of age0.06\u2003yes9219 (6.5)21 (6.2)34 (10.3)18 (5.2)\u2003no1219275 (93.5)319 (93.8)297 (89.7)328 (94.8)dietary intake of Calcium, mg/day1243489 [213–756]495 [230–751]495 [224–757]489 [211–747]0.06dietary intake of Vitamin D, μg/day11851.14 ± 1.011.18 ± 1.661.04 ± 0.900.98 ± 1.00.2vitamin D supplementation, μg/day9433.47 ± 2.213.98 ± 1.363.88 ± 1.454.03 ± 1.59 0.002\nanova was used for comparing means of numerical, normally distributed variables.']	[('PROBABLE_UNDERSTANDING', 144)]	1	[('UBERON_0002240', 'spinal cord', 36, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 41, '25OHD'), ('GO_0007567', 'parturition', 105, 'born'), ('GO_0007565', 'female pregnancy', 206, 'gestational'), ('CHEBI_27300', 'vitamin D', 323, 'vitamin D'), ('GO_0007601', 'visual perception', 373, 'smoked'), ('GO_0007565', 'female pregnancy', 387, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 531, 'cord'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 536, '25OHD'), ('GO_0007565', 'female pregnancy', 697, 'gestational'), ('GO_0007565', 'female pregnancy', 771, 'Pregestational'), ('GO_0007565', 'female pregnancy', 871, 'Gestational'), ('GO_0007565', 'female pregnancy', 1017, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 2097, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 2126, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2379, 'Gestational'), ('GO_0007567', 'parturition', 2403, 'birth'), ('GO_0007567', 'parturition', 2468, 'birth'), ('CHEBI_22313', 'alkaline earth metal atom', 3186, 'calcium'), ('CHEBI_27300', 'vitamin D', 3279, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 3354, 'D')]
PMC6039335	7/2018	S333-PMC6039335	['in addition, japanese farmers GENERALLY restrict Vitamin A levels in the diet during the mid-fattening stage to produce highly marbled japanese black cattle beef.']	[('PROBABLE_UNDERSTANDING', 30)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin A')]
